data_2krj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2krj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.782 0.325 . . . . 2.6600000000000001 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -127.7 164.02 23.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 8.1099999999999994 110.913 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.9 117.77 2.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 5.2000000000000002 110.889 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 10.2 pt -108.71 148.51 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 3.9900000000000002 111.169 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -168.99 60.5 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 3.8599999999999999 110.853 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.64 135.65 25.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 6.5700000000000003 110.888 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -147.8 107.07 3.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 6.7599999999999998 110.939 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.1 p -94.24 158.59 35.64 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.63 0.729 . . . . 4.7599999999999998 111.081 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -178.53 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.713 2.275 . . . . 2.8300000000000001 112.342 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 56.1 24.01 7.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.445 . . . . 3.8900000000000001 110.834 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.2 mmm -165.28 131.29 2.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 4.5899999999999999 110.844 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -66.14 142.01 57.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 2.8500000000000001 110.896 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -61.38 -18.12 57.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 8.6899999999999995 110.848 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.39 -34.78 65.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 3.1099999999999999 110.848 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.5 -45.55 68.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 2.54 110.847 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.59 -39.08 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 1.79 111.142 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -55.99 -53.67 54.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 2.27 110.827 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -74.72 -32.63 62.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 4.4100000000000001 110.933 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.17 -57.93 7.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 1.72 111.049 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.2 mp -75.93 -41.15 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 3.2000000000000002 111.111 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -38.08 52.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 5.7000000000000002 110.882 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.45 -26.59 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 3.9100000000000001 110.866 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.61 63.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 1.6899999999999999 111.072 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -74.4 -30.42 61.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 6.5099999999999998 110.913 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -77.06 -55.11 5.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 3.2400000000000002 110.866 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.6 p -52.9 -27.42 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 2.9399999999999999 111.129 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -89.5 -53.76 4.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 4.75 110.925 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -58.98 -19.49 43.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 2.2799999999999998 110.89 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -50.93 -30.09 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 3.04 110.911 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.94 61.49 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 2.9100000000000001 111.074 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.27 140.55 11.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.598 0.713 . . . . 2.5699999999999998 111.123 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -12.54 33.11 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.641 2.227 . . . . 2.1600000000000001 112.391 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.3 mp -54.63 175.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 3.5800000000000001 110.917 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -118.23 -169.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 6.0899999999999999 110.888 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -130.69 134.39 46.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 8.6500000000000004 110.907 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -156.86 89.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 2.4700000000000002 110.868 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 97.95 7.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 5.3099999999999996 110.892 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.3 tt -83.49 130.59 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 5.3499999999999996 111.106 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -78.43 -28.48 46.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 4.5300000000000002 110.9 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.1 m -149.59 120.87 7.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 4.6100000000000003 111.144 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.87 85.34 0.99 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 2.9500000000000002 112.501 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.77 167.28 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.776 0.322 . . . . 10.970000000000001 110.901 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.57 -161.99 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 4.3200000000000003 111.11 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -50.77 -25.22 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 2.8199999999999998 110.852 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.1 mm -102.5 114.43 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 4.04 111.124 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.24 158.03 25.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 4.2800000000000002 110.918 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 41.7 t -148.03 111.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 2.5800000000000001 111.175 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.9 t -148.51 144.82 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 2.3900000000000001 111.099 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -104.71 136.68 43.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 4.46 110.921 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.41 168.38 19.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 2.2400000000000002 111.134 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.2 111.8 22.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 7.6200000000000001 110.903 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.39 -128.58 27.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 1.5 112.476 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.51 110.92 6.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.331 . . . . 2.6000000000000001 111.158 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -92.49 41.95 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 5.0300000000000002 110.879 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.9 -53.87 4.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 2.71 112.461 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -145.11 28.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 5.2000000000000002 110.871 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -107.08 -169.55 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 6.1699999999999999 110.864 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -104.83 90.3 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 5.9299999999999997 110.828 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.6 149.53 8.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 2.5899999999999999 111.09 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -120.8 -82.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 7.1799999999999997 110.91 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.97 -170.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 4.1699999999999999 110.856 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -97.59 -160.72 31.09 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.709 -0.758 . . . . 2.7999999999999998 112.508 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -52.97 118.6 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 6.9100000000000001 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 123.61 -54.38 0.72 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.743 -0.741 . . . . 2.4500000000000002 112.484 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.76 -137.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.738 -0.744 . . . . 1.99 112.473 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.3 mt -78.03 90.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.897 0.38 . . . . 4.0300000000000002 111.137 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.04 -33.49 52.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 5.5999999999999996 110.92 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.09 123.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 2.7000000000000002 111.091 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -138.56 113.8 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 4.6900000000000004 110.864 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -99.27 125.01 44.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 1.7 111.099 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -63.61 164.16 10.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 3.52 110.867 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.61 169.94 0.25 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.706 -0.759 . . . . 1.0800000000000001 112.527 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -169.37 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.753 2.302 . . . . 1.1100000000000001 112.332 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.7 -152.02 19.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 1.22 112.506 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m -91.88 148.55 22.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 3.0499999999999998 110.83 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.83 -102.47 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.732 . . . . 1.3799999999999999 112.467 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 72.9 mt -56.11 -35.43 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 2.8900000000000001 111.143 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -52.73 100.46 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 2.3100000000000001 112.456 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 104.33 21.65 9.22 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.759 -0.734 . . . . 2.1600000000000001 112.484 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -95.08 139.4 31.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 2.2799999999999998 110.872 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.67 140.4 34.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 1.7 111.052 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -128.65 110.52 12.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 6.4100000000000001 110.847 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -113.7 120.16 39.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 4.1699999999999999 110.9 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -58.99 123.99 18.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 6.7300000000000004 110.874 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -74.74 -48.83 23.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 7.7300000000000004 110.926 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.4 -16.66 56.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 3.8500000000000001 110.867 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 4.3799999999999999 110.896 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.85 95.93 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 5.6299999999999999 110.878 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -79.73 148.57 31.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 8.4700000000000006 110.933 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -148.47 174.31 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 2.6899999999999999 111.13 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.62 -171.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 2.54 111.13 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -63.93 -21.52 66.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 5.2400000000000002 110.876 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.3 m -90.61 -49.2 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 2.8300000000000001 110.848 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -52.09 172.37 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 2.96 112.516 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -51.73 -88.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 2.0 112.509 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 m -60.19 99.55 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.78 0.324 . . . . 2.6600000000000001 111.145 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.476 ' ND2' ' H ' ' A' ' 243' ' ' VAL . 1.9 m-20 -76.46 107.9 9.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 3.0800000000000001 110.891 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.38 -36.91 71.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 2.8199999999999998 110.905 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -71.13 -64.35 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 6.2800000000000002 110.827 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.3 tp -51.67 -49.51 62.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 3.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 96.4 m -55.32 -48.79 73.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 1.8700000000000001 111.143 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.82 -31.88 63.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 1.73 111.125 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.7 -31.87 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 1.75 111.16 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -75.12 -41.75 57.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 3.3500000000000001 110.868 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -71.0 -43.44 67.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 4.6500000000000004 110.876 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 9.9 tt -64.72 -29.88 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 3.54 111.153 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -68.7 -42.63 79.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 0.93999999999999995 112.48 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -65.19 -23.7 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.339 . . . . 3.27 110.904 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.79 30.38 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 2.0499999999999998 110.83 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -61.65 0.68 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 3.6800000000000002 110.951 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 179.7 32.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 2.1299999999999999 112.475 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.15 149.46 27.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.814 0.34 . . . . 3.21 110.919 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -78.16 -98.7 0.21 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.748 . . . . 3.3799999999999999 112.528 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -178.76 40.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.846 0.355 . . . . 2.9500000000000002 110.822 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.53 -71.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 4.5599999999999996 110.893 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 47.6 t 65.56 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 6.1600000000000001 110.864 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.22 156.84 75.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.588 0.708 . . . . 2.9300000000000002 110.889 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -49.12 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.679 2.252 . . . . 2.27 112.378 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -34.31 73.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 110.894 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.6 153.32 2.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 2.9100000000000001 111.104 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.9 t -87.51 7.7 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 4.9800000000000004 111.151 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -17.36 35.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 5.6299999999999999 110.892 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.94 143.31 15.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.635 0.731 . . . . 5.6600000000000001 110.915 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 76.57 1.14 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.628 2.219 . . . . 2.7799999999999998 112.33 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.6 t -157.05 168.8 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 3.5499999999999998 111.142 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -110.43 112.62 24.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 4.3600000000000003 110.924 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -140.69 147.46 39.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 4.2699999999999996 110.851 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -106.84 125.82 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 4.3399999999999999 110.905 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.476 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 7.1 p -121.26 154.72 25.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 3.4700000000000002 111.168 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.07 125.91 25.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 2.8300000000000001 110.897 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.63 -24.49 34.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 3.5899999999999999 111.106 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -60.29 -39.66 87.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 3.75 110.896 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 51.9 p -105.43 1.89 28.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 3.1699999999999999 111.187 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.02 111.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 4.8399999999999999 110.854 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -174.52 157.37 2.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 3.79 110.892 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.84 150.6 23.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 3.1099999999999999 110.893 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.5 t -154.58 -172.6 4.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 4.25 110.854 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 65.13 176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 3.9300000000000002 111.134 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.96 -22.08 66.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 3.71 110.888 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -50.77 -29.57 11.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 3.3900000000000001 110.91 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 1.1 tt -52.74 -29.56 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 3.1099999999999999 111.105 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -21.03 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 6.0999999999999996 110.905 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.97 -6.04 81.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 2.02 112.492 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.7 tp -106.98 -34.99 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 2.02 111.144 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -78.59 -37.38 42.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 4.1200000000000001 110.891 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 4.0700000000000003 110.829 -179.802 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.774 0.321 . . . . 3.0899999999999999 111.159 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -128.67 159.53 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 5.4800000000000004 110.872 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -161.65 153.92 19.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 5.5 110.883 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 26.1 mt -107.79 148.91 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 2.6699999999999999 111.121 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -115.76 -75.02 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 3.8300000000000001 110.928 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 120' ' ' ASN . 1.5 m-80 -98.98 175.9 5.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 6.5899999999999999 110.906 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -144.04 163.32 33.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 7.3899999999999997 110.864 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p -76.88 113.77 33.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.59 0.709 . . . . 3.71 111.139 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.71 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.255 . . . . 2.8399999999999999 112.358 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -57.63 -28.46 63.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 3.4399999999999999 110.874 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -101.29 152.77 20.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 3.8500000000000001 110.869 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -60.95 143.52 54.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 3.3300000000000001 110.886 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.0 ptt-85 -56.83 -24.3 50.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 7.9199999999999999 110.867 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.76 -44.91 19.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 3.9399999999999999 110.924 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.12 -51.32 68.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 2.3599999999999999 110.884 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.6 -38.18 78.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 1.8799999999999999 111.171 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.81 -54.45 44.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 3.9700000000000002 110.879 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -73.55 -32.34 64.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 3.8100000000000001 110.911 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.94 -57.56 8.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 1.9099999999999999 111.091 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -76.76 -40.11 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 3.21 111.161 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -54.5 -30.77 54.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 4.8899999999999997 110.885 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -78.45 -25.21 45.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 4.7000000000000002 110.925 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.91 -34.19 65.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 1.97 111.118 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.82 -30.52 61.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 5.1500000000000004 110.904 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -55.72 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 4.6900000000000004 110.873 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.1 p -49.35 -34.01 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 3.1600000000000001 111.184 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -80.28 -54.44 5.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 7.96 110.932 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.8 t -55.22 -26.63 40.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 2.98 110.841 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -53.25 -39.38 63.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 3.6400000000000001 110.91 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 m -123.31 18.09 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 3.3100000000000001 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.4 p -144.83 152.93 53.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.708 . . . . 4.21 111.158 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -87.84 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.672 2.248 . . . . 3.5 112.313 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 53.18 -175.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 4.2199999999999998 110.911 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -142.35 138.14 31.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 4.6699999999999999 110.85 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -112.48 128.18 56.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 8.0099999999999998 110.898 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.6 t -156.77 89.62 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 2.29 110.868 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 131.84 39.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 3.3199999999999998 110.899 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.5 pt -148.88 124.78 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 3.4100000000000001 111.16 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -60.67 -23.67 65.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 5.3899999999999997 110.896 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.3 m -133.9 112.03 10.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 3.3399999999999999 111.163 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 170.62 -179.05 42.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.789 -0.72 . . . . 2.0899999999999999 112.514 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.6 mtm -110.67 127.54 55.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.32 . . . . 5.6500000000000004 110.888 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -122.95 130.06 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 1.97 111.097 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -19.66 64.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 3.1800000000000002 110.874 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 mm -103.5 84.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 4.0300000000000002 111.106 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -87.96 115.94 25.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 2.3799999999999999 110.919 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 94.7 t -100.71 110.27 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 2.3599999999999999 111.131 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 50.2 t -137.53 143.09 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 2.27 111.15 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -81.0 115.5 20.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 7.0499999999999998 110.868 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.08 154.83 18.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 3.0699999999999998 111.064 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.49 118.68 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 5.9800000000000004 110.885 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.88 -128.15 32.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 1.3500000000000001 112.505 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.65 119.05 23.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 2.9300000000000002 111.11 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -95.1 41.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 7.4000000000000004 110.87 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.93 -43.5 2.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 3.1000000000000001 112.462 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.23 61.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 5.6699999999999999 110.884 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.82 -168.42 2.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 4.0700000000000003 110.892 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -76.59 95.96 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 6.3600000000000003 110.892 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.93 138.1 58.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 2.4500000000000002 111.123 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -136.67 106.85 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 7.7199999999999998 110.925 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.67 168.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 4.21 110.834 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.96 -133.59 2.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 3.1200000000000001 112.467 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -51.45 119.04 3.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.759 0.314 . . . . 5.3300000000000001 110.901 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 114.06 28.65 3.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 4.79 112.492 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.17 -137.17 3.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 2.4399999999999999 112.488 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.0 mm -76.88 123.38 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.346 . . . . 2.7999999999999998 111.107 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.43 -12.06 26.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.469 . . . . 5.5899999999999999 110.932 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.77 132.57 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 2.8100000000000001 111.091 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.09 110.18 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 3.7200000000000002 110.905 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.87 112.02 14.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 1.79 111.113 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.9 170.12 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 3.7000000000000002 110.899 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.46 169.41 0.27 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.82999999999999996 112.476 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -171.18 0.44 Allowed 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.736 2.291 . . . . 0.92000000000000004 112.317 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.33 -145.71 16.56 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 1.1299999999999999 112.477 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.8 m -92.17 153.52 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 2.46 110.908 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.51 -107.32 0.41 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 1.46 112.497 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.18 -24.77 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 2.8500000000000001 111.111 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.09 96.95 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.736 -0.745 . . . . 2.4500000000000002 112.51 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 117.8 -16.55 12.26 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.772 -0.728 . . . . 2.04 112.475 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -50.43 145.04 6.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.821 0.343 . . . . 2.2799999999999998 110.882 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.57 133.45 42.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 1.8 111.101 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -121.77 109.96 15.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 3.3700000000000001 110.853 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -90.24 111.8 23.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 3.9700000000000002 110.888 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.51 99.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 5.96 110.829 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -75.56 69.93 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 9.5600000000000005 110.836 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 43.6 t0 64.67 20.4 12.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 3.8399999999999999 110.884 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.4 18.37 19.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 4.4000000000000004 110.862 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.09 153.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 7.1500000000000004 110.867 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -105.74 173.7 6.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 8.1300000000000008 110.899 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.13 172.86 17.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 2.75 111.092 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.74 -170.55 2.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 2.6299999999999999 111.113 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -61.66 -20.72 63.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 5.0899999999999999 110.872 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.42 -36.41 9.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 2.6800000000000002 110.883 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.94 -179.68 0.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.789 -0.72 . . . . 3.23 112.477 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -54.08 -91.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 2.3700000000000001 112.492 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 92.0 m -70.5 98.84 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.352 . . . . 2.8300000000000001 111.139 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.06 111.07 1.78 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 3.29 110.891 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.66 -34.21 67.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 3.0499999999999998 110.938 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -71.85 -64.86 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 6.79 110.882 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.7 -46.45 70.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 4.1399999999999997 110.906 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 77.3 m -54.91 -40.12 69.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 2.1299999999999999 111.145 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.85 -32.27 63.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 2.0499999999999998 111.081 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.53 -34.49 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 1.97 111.101 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -71.41 -38.85 71.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 3.27 110.872 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.44 -52.89 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 3.8999999999999999 110.859 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 9.9 tt -51.93 -32.53 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.484 . . . . 3.52 111.096 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.26 -34.14 46.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.752 . . . . 1.03 112.455 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -25.61 67.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.798 0.332 . . . . 3.8799999999999999 110.842 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.47 24.9 4.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 2.4199999999999999 110.842 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.43 -64.75 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 4.1900000000000004 110.916 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 170.87 48.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.726 . . . . 1.9399999999999999 112.496 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 56.4 mt -145.23 -74.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.389 . . . . 4.4400000000000004 110.886 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 57.1 -102.51 0.21 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 4.5999999999999996 112.495 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -119.32 119.27 33.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 2.7599999999999998 110.857 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 11.0 t -99.14 -80.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 4.5 110.874 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.19 -38.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 4.5499999999999998 110.872 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.41 107.41 0.72 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.61 0.719 . . . . 2.3900000000000001 110.828 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -44.42 2.11 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.647 2.231 . . . . 1.97 112.341 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -32.02 70.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 5.5599999999999996 110.881 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -71.63 170.65 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 2.9700000000000002 111.1 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.5 m -95.96 8.15 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 6.2400000000000002 111.092 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -89.18 3.14 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 4.3499999999999996 110.892 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 160.09 0.52 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.667 0.746 . . . . 10.65 110.849 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -30.33 22.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.66 2.24 . . . . 3.7400000000000002 112.353 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.8 p -84.84 169.33 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 3.8999999999999999 111.162 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -119.6 114.73 22.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 11.390000000000001 110.901 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.28 133.18 51.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 4.04 110.888 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -61.6 125.63 24.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 4.4100000000000001 110.929 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.06 155.27 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 3.2599999999999998 111.144 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.15 112.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 2.7400000000000002 110.928 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.2 pt -76.58 -13.89 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 4.3300000000000001 111.099 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.56 -26.85 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 4.4199999999999999 110.863 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 46.0 p -120.99 20.6 11.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 3.8100000000000001 111.096 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.66 148.5 40.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 5.0999999999999996 110.893 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 179.98 147.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 3.8999999999999999 110.919 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.0 tt -74.89 144.27 43.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 3.2999999999999998 110.905 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.9 m -154.6 -172.03 4.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 4.25 110.861 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 67.11 -171.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 3.7799999999999998 111.076 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.73 -23.59 30.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 3.54 110.861 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.87 -29.75 29.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 3.2999999999999998 110.875 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 17.8 tt -68.55 -31.25 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 2.8700000000000001 111.144 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -32.71 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 6.1299999999999999 110.861 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.61 -17.13 47.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 1.5600000000000001 112.477 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.0 tp -110.9 -35.81 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 2.3100000000000001 111.186 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -73.53 -24.75 60.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 3.1400000000000001 110.877 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 3.0699999999999998 110.868 -179.779 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.4 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.81 0.338 . . . . 3.0699999999999998 111.146 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -152.05 141.42 21.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 5.0899999999999999 110.898 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.13 150.24 29.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 5.5300000000000002 110.871 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.7 mt -108.01 148.88 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 2.9199999999999999 111.151 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -102.68 -71.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 4.0599999999999996 110.868 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.27 172.48 7.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 6.8099999999999996 110.905 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -127.45 164.34 22.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 5.7199999999999998 110.949 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.41 129.21 42.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.566 0.698 . . . . 3.3300000000000001 111.127 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 133.55 25.83 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.678 2.252 . . . . 2.5899999999999999 112.346 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 t70 67.74 11.5 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 6.1299999999999999 110.864 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.5 tpt -106.09 152.54 23.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 4.0800000000000001 110.869 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -58.7 115.73 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 3.73 110.892 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -59.71 -20.18 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 6.04 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -80.15 -39.43 29.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.204 -0.453 . . . . 3.8700000000000001 110.9 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.51 -46.25 60.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 3.3100000000000001 110.897 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.98 -35.28 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.95 111.086 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.61 -54.61 37.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 3.0299999999999998 110.879 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -71.36 -32.38 68.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 3.8700000000000001 110.905 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.29 -51.96 49.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 1.6899999999999999 111.163 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.7 mp -82.73 -46.01 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 3.21 111.13 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -50.44 -45.49 55.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 7.3200000000000003 110.86 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -20.4 51.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 3.9500000000000002 110.883 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.6 -35.43 65.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 1.8100000000000001 111.093 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -72.42 -24.83 61.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 6.4900000000000002 110.894 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -31.5 60.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 4.5099999999999998 110.936 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.49 -30.93 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 3.29 111.108 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -94.57 -32.72 13.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 4.9699999999999998 110.92 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -63.68 -15.74 59.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 2.6000000000000001 110.857 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -83.0 -12.79 56.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 2.8300000000000001 110.946 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.6 p -118.84 -28.46 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 4.3899999999999997 111.136 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.0 t -107.22 141.65 23.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.581 0.705 . . . . 3.8500000000000001 111.19 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -6.07 17.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.656 2.238 . . . . 2.4100000000000001 112.347 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.2 tp -49.86 161.01 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 3.5299999999999998 110.915 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.28 138.06 54.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 6.25 110.915 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -114.38 128.65 56.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 10.58 110.896 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.27 99.86 4.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 2.6299999999999999 110.853 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 103.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 3.2000000000000002 110.877 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 tt -97.28 135.28 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 4.7800000000000002 111.115 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -102.52 41.71 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 3.9500000000000002 110.891 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.98 169.77 7.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 4.6299999999999999 111.119 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.08 -169.76 0.54 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 2.4300000000000002 112.486 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.3 mtm -108.48 148.19 30.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 7.9100000000000001 110.87 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.2 159.91 16.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 2.1600000000000001 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.87 -44.72 67.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 2.4300000000000002 110.906 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.1 pp -104.02 140.78 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 4.6100000000000003 111.114 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.2 115.27 17.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 2.3399999999999999 110.934 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.81 119.38 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 2.4900000000000002 111.133 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.7 t -138.47 140.91 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 2.1499999999999999 111.176 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.62 102.97 14.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 6.1600000000000001 110.854 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.67 177.35 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 2.23 111.108 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -135.64 111.74 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 4.7699999999999996 110.825 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 72.82 -135.78 22.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.737 . . . . 1.8799999999999999 112.497 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.16 110.96 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.334 . . . . 2.3399999999999999 111.081 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -70.61 -15.64 62.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 4.0499999999999998 110.871 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.04 -25.09 14.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 2.75 112.487 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -80.27 -74.81 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.351 . . . . 6.0300000000000002 110.872 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -178.68 33.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 7.0300000000000002 110.859 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -129.18 64.93 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 5.6600000000000001 110.825 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.26 145.43 30.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 2.5299999999999998 111.101 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -54.93 174.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 11.960000000000001 110.907 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -137.99 9.95 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 5.3700000000000001 110.881 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.91 139.81 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.708 -0.758 . . . . 2.9300000000000002 112.489 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 119.23 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.366 . . . . 4.0499999999999998 110.873 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 124.09 -18.48 7.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.718 -0.753 . . . . 2.8599999999999999 112.495 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -117.65 -125.96 3.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 2.1699999999999999 112.498 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.7 mp -79.23 93.27 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 2.8199999999999998 111.125 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.9 pp -50.43 -26.43 5.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 4.3799999999999999 110.906 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 179.45 168.9 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 2.8399999999999999 111.101 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.87 130.8 53.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 3.9199999999999999 110.867 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -142.1 103.71 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 1.73 111.072 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.28 165.53 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 3.9199999999999999 110.885 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -56.51 -176.74 0.31 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 0.97999999999999998 112.477 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.703 2.269 . . . . 0.87 112.313 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.13 -149.46 17.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 1.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.7 p -91.73 151.73 20.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 3.1299999999999999 110.823 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 50.35 -103.98 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 1.45 112.478 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 30.7 mm -57.02 -25.98 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.371 . . . . 3.5 111.142 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.33 100.1 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 2.5299999999999998 112.536 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.44 18.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.739 -0.743 . . . . 1.8700000000000001 112.469 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.22 145.17 8.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.778 0.323 . . . . 2.1200000000000001 110.844 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -136.95 128.69 28.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 1.8300000000000001 111.1 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.09 123.59 50.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 3.7200000000000002 110.85 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.52 143.83 41.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 5.5599999999999996 110.913 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.67 -77.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 5.79 110.879 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 66.94 41.22 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 7.5199999999999996 110.914 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.9 t0 66.18 47.5 1.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 3.3199999999999998 110.836 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.78 -77.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 4.5899999999999999 110.834 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.83 138.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 5.0499999999999998 110.873 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -106.28 138.95 41.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 10.93 110.92 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.45 165.68 35.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 2.2000000000000002 111.173 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -170.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 2.5699999999999998 111.162 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -57.24 -46.6 82.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 5.0499999999999998 110.888 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.54 -34.84 40.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 2.7200000000000002 110.901 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -50.87 170.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 3.1699999999999999 112.539 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -45.13 -83.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 2.2799999999999998 112.527 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.13 97.56 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 3.54 111.134 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -61.49 113.14 2.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 3.5299999999999998 110.897 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.57 -35.91 70.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 3.2999999999999998 110.975 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -71.34 -35.94 71.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 5.6799999999999997 110.867 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.78 -48.55 11.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 3.46 110.914 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 53.3 m -55.25 -28.83 55.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 2.0800000000000001 111.148 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.38 -46.06 67.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 1.6899999999999999 111.072 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.86 -42.71 93.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 1.9299999999999999 111.124 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -54.1 -34.66 60.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 3.3999999999999999 110.855 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -29.6 61.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 4.2999999999999998 110.894 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.3 mm -56.24 -59.87 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 2.6800000000000002 111.127 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.65 -31.75 79.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 1.05 112.487 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -44.49 86.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 3.75 110.895 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.75 24.95 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 2.27 110.879 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 mp -127.97 -38.5 1.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 3.3599999999999999 110.924 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 161.73 -54.74 0.31 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 2.1800000000000002 112.475 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.6 mt -73.2 -178.57 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 3.8999999999999999 110.913 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 156.31 -94.93 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 4.46 112.499 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -96.12 98.3 10.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.768 0.318 . . . . 2.0699999999999998 110.879 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.8 m -101.35 -75.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 5.1399999999999997 110.845 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.65 -33.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 4.8799999999999999 110.893 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -47.91 107.57 0.76 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.581 0.705 . . . . 3.1000000000000001 110.875 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -41.83 3.95 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 2.9399999999999999 112.376 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.42 46.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 5.6900000000000004 110.904 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -136.58 174.45 10.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 2.0099999999999998 111.119 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.46 7.6 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 4.0300000000000002 111.129 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -87.32 -48.47 7.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 6.0 110.877 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.8 139.86 21.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.741 . . . . 6.2999999999999998 110.882 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 79.1 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.713 2.275 . . . . 3.0600000000000001 112.311 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.5 t -157.02 118.61 3.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 3.79 111.144 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -70.22 131.05 43.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 4.2400000000000002 110.896 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -162.85 93.23 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 4.6200000000000001 110.923 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -50.87 119.64 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.448 . . . . 4.8499999999999996 110.929 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.1 t -114.82 152.09 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 3.5600000000000001 111.12 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.79 113.25 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 2.7599999999999998 110.893 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -57.42 -37.98 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 3.46 111.188 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.68 -28.41 68.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 4.0899999999999999 110.877 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 30.0 p -115.65 17.94 16.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 3.9100000000000001 111.15 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -82.53 121.69 27.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 6.4900000000000002 110.889 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -164.65 151.81 11.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 4.7000000000000002 110.835 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.07 139.1 42.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 3.75 110.871 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.35 -171.09 3.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 3.8999999999999999 110.829 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 70.7 165.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 4.5300000000000002 111.099 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -59.31 -20.46 54.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 2.6400000000000001 110.868 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -50.06 -29.4 8.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 3.6800000000000002 110.89 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 7.4 tt -51.98 -29.04 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 2.7599999999999998 111.11 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -83.4 -31.16 26.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 5.4100000000000001 110.866 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.74 -24.64 69.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 1.97 112.491 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 4.1 tp -102.88 -30.98 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 1.8899999999999999 111.144 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -61.67 -36.55 81.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 3.4199999999999999 110.907 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 3.3399999999999999 110.863 -179.801 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.834 0.349 . . . . 3.1000000000000001 111.178 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.84 162.62 39.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 5.1900000000000004 110.93 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -161.94 138.09 7.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 5.3499999999999996 110.86 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.0 pt -107.75 136.06 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 3.48 111.143 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -151.59 43.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 4.2800000000000002 110.948 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.76 151.41 51.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 6.4400000000000004 110.85 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -144.06 129.92 19.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 5.7800000000000002 110.94 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.58 159.5 58.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.616 0.722 . . . . 3.0600000000000001 111.144 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -86.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.68 2.253 . . . . 2.7999999999999998 112.338 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.92 75.58 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 4.2400000000000002 110.892 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.4 tpt -165.16 138.36 4.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 3.7599999999999998 110.863 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.27 120.01 8.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 4.1900000000000004 110.892 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -60.96 -19.37 60.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 6.0800000000000001 110.863 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -78.86 -29.24 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 3.1099999999999999 110.902 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.3 -44.82 24.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 2.8300000000000001 110.9 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.8 p -58.93 -43.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 2.3900000000000001 111.113 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.48 -45.7 76.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 3.1299999999999999 110.917 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -74.65 -32.49 62.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 3.2400000000000002 110.878 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.83 -44.58 63.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 2.0600000000000001 111.087 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.8 mm -83.06 -48.83 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.414 . . . . 3.23 111.136 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -50.62 -44.99 57.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 4.2199999999999998 110.889 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -78.22 -20.52 51.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 3.8500000000000001 110.931 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.34 -40.88 71.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 2.4900000000000002 111.126 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -48.24 34.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 5.1600000000000001 110.874 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -52.39 -28.65 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 4.5800000000000001 110.926 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.7 t -55.79 -56.43 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 3.1200000000000001 111.143 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -82.15 -40.72 21.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 5.1299999999999999 110.886 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.79 -24.45 35.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 2.25 110.867 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -75.28 -27.39 59.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 2.71 110.851 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.05 41.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 3.46 111.112 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 36.3 m -150.94 132.37 7.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.689 . . . . 2.6499999999999999 111.189 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 70.09 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.669 2.246 . . . . 2.9700000000000002 112.325 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 tp -138.29 -171.88 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 3.8500000000000001 110.863 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -128.23 142.34 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 5.9199999999999999 110.876 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.85 122.52 20.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 8.1199999999999992 110.844 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 t -156.82 112.21 2.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 3.0499999999999998 110.877 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.55 107.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 3.6200000000000001 110.949 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.6 mt -91.57 144.41 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 4.5999999999999996 111.142 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -94.7 22.86 5.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 5.1299999999999999 110.906 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.17 167.77 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 6.6900000000000004 111.129 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -79.37 -0.09 82.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 3.79 112.487 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 10.7 mtt -83.15 100.34 10.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.726 0.298 . . . . 7.71 110.859 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -148.36 129.83 14.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 2.6299999999999999 111.1 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.49 -26.53 41.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 2.77 110.847 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.4 pt -123.98 142.5 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.205 -0.452 . . . . 3.7799999999999998 111.154 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.461 ' C ' ' CD2' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -133.17 164.13 27.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 3.1400000000000001 110.894 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.6 t -121.93 115.64 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 2.4500000000000002 111.096 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.4 t -145.18 142.08 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 2.5 111.135 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -105.39 133.97 49.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 4.71 110.926 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.28 142.18 6.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 2.8700000000000001 111.076 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -107.25 167.21 10.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 5.8799999999999999 110.888 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.94 -141.08 25.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 1.8100000000000001 112.451 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.13 148.68 48.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 3.2599999999999998 111.072 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -115.68 22.25 13.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 4.4900000000000002 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.45 14.53 62.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.669 -0.777 . . . . 3.4100000000000001 112.49 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.56 -75.95 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.778 0.323 . . . . 6.3899999999999997 110.807 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.34 62.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 4.6699999999999999 110.872 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -137.7 42.57 2.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 7.6299999999999999 110.841 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 118.86 22.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.1699999999999999 111.095 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -179.07 98.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 9.4700000000000006 110.926 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.88 -175.77 4.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 5.75 110.855 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.42 106.97 2.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 3.0600000000000001 112.502 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -50.31 119.39 3.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.337 . . . . 5.54 110.896 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.76 -27.76 19.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.752 -0.737 . . . . 2.6800000000000002 112.505 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -81.48 -140.0 2.9 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 1.52 112.453 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.9 mm -80.63 92.46 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.36 . . . . 3.02 111.122 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 pp -44.81 -33.77 2.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 4.1200000000000001 110.918 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 179.96 179.79 0.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 2.7000000000000002 111.122 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.87 128.5 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 7.0499999999999998 110.891 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.08 123.65 38.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 1.8999999999999999 111.097 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.5 169.96 4.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 3.5600000000000001 110.839 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.34 177.16 0.32 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 0.97999999999999998 112.501 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 160.1 50.97 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.91000000000000003 112.314 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 152.49 -146.41 14.97 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 1.29 112.471 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 99.0 p -107.46 124.45 49.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.91 0.386 . . . . 2.5299999999999998 110.857 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.93 -57.65 3.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.699 -0.762 . . . . 1.78 112.506 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.6 22.08 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 3.0899999999999999 111.125 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.78 -114.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 3.1800000000000002 112.479 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -94.29 42.76 2.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 2.0699999999999998 112.499 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.35 127.14 30.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 1.98 110.868 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.72 131.77 34.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 2.46 111.145 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -125.45 137.73 53.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 3.9199999999999999 110.866 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -139.97 102.75 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 3.7999999999999998 110.884 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -52.39 120.98 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 6.7000000000000002 110.914 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -67.78 -29.19 68.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 8.1899999999999995 110.893 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -78.29 -19.36 53.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 4.7400000000000002 110.867 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -177.48 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 3.8599999999999999 110.907 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -118.35 109.51 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 5.8799999999999999 110.925 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -101.93 122.21 43.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 7.7800000000000002 110.943 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 p -135.64 174.41 10.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 2.3700000000000001 111.131 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -175.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 2.3100000000000001 111.157 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -51.75 -35.21 42.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 5.6200000000000001 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -60.37 2.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 2.1699999999999999 110.867 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.51 171.52 0.28 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 2.9500000000000002 112.508 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -52.28 -89.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 2.1899999999999999 112.466 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.12 108.81 2.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 2.3500000000000001 111.1 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.67 114.82 23.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 3.79 110.889 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.79 -35.87 45.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 2.9500000000000002 110.938 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -71.36 -60.76 2.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 6.6500000000000004 110.867 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.5 tp -52.11 -55.31 21.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.193 -0.458 . . . . 3.6800000000000002 110.882 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.1 m -54.88 -45.83 74.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 1.8 111.144 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.49 -32.07 62.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 1.8100000000000001 111.114 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.0 t -76.35 -30.07 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 2.27 111.148 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -65.47 -36.68 84.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 3.3599999999999999 110.826 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -66.88 -20.95 66.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 6.04 110.89 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.96 -42.87 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 2.5299999999999998 111.132 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.98 -38.13 36.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.725 -0.75 . . . . 0.95999999999999996 112.469 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -23.63 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 3.8300000000000001 110.842 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.4 p -109.97 17.78 20.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 4.0199999999999996 110.895 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.43 94.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 3.5699999999999998 110.906 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 58.73 -178.72 1.61 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 3.0899999999999999 112.477 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 71.04 -68.84 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 4.2599999999999998 110.888 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 98.63 -66.92 0.69 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.728 . . . . 3.2799999999999998 112.487 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -173.52 133.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 2.6000000000000001 110.871 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.0 m 63.21 163.32 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 6.3899999999999997 110.859 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 25.2 t -178.86 -64.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 7.1299999999999999 110.885 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.92 156.79 51.4 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 2.8100000000000001 110.862 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 165.66 30.22 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.686 2.258 . . . . 2.7000000000000002 112.349 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.68 28.4 4.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 6.1100000000000003 110.879 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -122.7 -169.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 2.7000000000000002 111.107 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.8 m -95.58 -29.29 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 4.1500000000000004 111.158 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.1 tpt -58.2 -23.66 56.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 5.0 110.828 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.18 150.71 29.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.683 0.754 . . . . 5.1299999999999999 110.859 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -48.69 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.657 2.238 . . . . 3.3199999999999998 112.342 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -85.61 138.83 31.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 4.4400000000000004 111.19 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.13 135.98 52.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 5.2300000000000004 110.924 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 102.89 8.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 5.5 110.877 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -51.65 131.34 29.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 4.5 110.905 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.78 132.8 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 3.48 111.17 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.99 132.61 23.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 2.9399999999999999 110.858 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -14.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 4.3300000000000001 111.178 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -71.26 -29.12 64.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 4.7000000000000002 110.863 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.92 -6.06 10.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 3.3199999999999998 111.142 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -51.94 127.36 20.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 6.8300000000000001 110.877 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -173.1 142.06 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 5.9100000000000001 110.823 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.53 170.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 3.9900000000000002 110.934 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.98 160.95 16.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 4.2599999999999998 110.843 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -61.83 -55.56 28.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 5.3499999999999996 111.1 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.49 -29.38 50.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 2.4100000000000001 110.898 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.08 -30.43 67.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 3.3500000000000001 110.896 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 60.6 mt -62.31 -30.8 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 3.8199999999999998 111.161 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -75.84 -28.17 58.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 4.9299999999999997 110.882 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.69 -3.41 88.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 1.4199999999999999 112.487 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 10.4 tp -120.93 -31.53 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.777 0.322 . . . . 1.79 111.115 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -78.67 -44.52 23.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 3.4100000000000001 110.96 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 2.6200000000000001 110.867 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.806 0.336 . . . . 2.96 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -145.23 166.34 25.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 5.0599999999999996 110.977 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -161.8 138.21 8.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 4.8899999999999997 110.924 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.3 mt -108.07 148.42 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 3.2200000000000002 111.112 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -162.25 56.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 4.75 110.886 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 135.14 10.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 6.2300000000000004 110.936 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -147.7 106.51 3.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 7.5599999999999996 110.972 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.8 153.65 45.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.573 0.701 . . . . 4.8899999999999997 111.123 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -15.01 36.9 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 2.7799999999999998 112.327 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -51.45 -69.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 5.7400000000000002 110.905 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 34.7 mmt -107.79 160.35 15.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 4.3600000000000003 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.03 166.84 2.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 3.3100000000000001 110.893 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.51 -19.46 60.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 7.04 110.891 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.5 -38.67 33.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 3.1000000000000001 110.895 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -71.24 -41.15 70.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 2.5099999999999998 110.877 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.8 p -74.09 -27.88 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 1.8100000000000001 111.115 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -71.23 -53.87 12.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 2.6099999999999999 110.871 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -69.75 -32.45 70.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 3.6099999999999999 110.933 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.92 -58.2 6.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.512 . . . . 1.72 111.081 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mm -69.19 -45.47 79.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 3.48 111.126 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -34.54 31.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 5.75 110.84 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -78.71 -31.79 46.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 3.6299999999999999 110.914 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.48 65.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 2.2400000000000002 111.104 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -74.1 -27.87 61.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 6.9500000000000002 110.867 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -79.33 -50.9 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 3.1899999999999999 110.905 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.5 p -51.23 -41.96 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 3.21 111.086 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -49.63 17.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 4.7000000000000002 110.9 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.6 p -58.91 -19.9 46.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 2.4700000000000002 110.867 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -72.12 -17.11 62.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 3.1000000000000001 110.872 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.2 m -139.59 29.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 2.8700000000000001 111.147 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.3 p -148.48 152.26 38.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.57 0.7 . . . . 3.5800000000000001 111.173 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -14.98 36.98 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.668 2.245 . . . . 2.1099999999999999 112.379 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.02 163.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 4.1200000000000001 110.95 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -118.34 -172.39 2.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 6.25 110.926 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -135.64 119.99 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 7.96 110.867 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.4 t -140.7 89.95 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 3.0600000000000001 110.848 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 116.56 22.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 2.8300000000000001 110.92 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.79 116.82 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 3.5899999999999999 111.139 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -53.73 -27.76 30.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 4.4900000000000002 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.0 m -160.3 133.79 6.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 4.8200000000000003 111.155 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.94 -134.39 5.22 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 2.1200000000000001 112.526 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.8 138.22 31.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 10.93 110.828 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.31 130.06 16.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 2.4399999999999999 111.08 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.53 -28.35 37.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 2.8500000000000001 110.893 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.57 140.87 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 5.0999999999999996 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -120.18 114.01 21.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 2.4100000000000001 110.903 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.8 t -92.67 110.97 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 2.1499999999999999 111.104 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.2 t -143.22 139.98 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 2.0699999999999998 111.172 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -84.28 131.43 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 4.6699999999999999 110.936 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.41 176.64 5.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 2.7999999999999998 111.101 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.96 111.64 5.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 6.04 110.866 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.93 -127.02 27.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.766 -0.73 . . . . 1.4199999999999999 112.481 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.06 110.81 20.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 2.4199999999999999 111.105 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -90.52 66.54 6.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 3.9700000000000002 110.866 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.94 -91.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 3.1600000000000001 112.475 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.8 75.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 5.3499999999999996 110.863 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -157.36 -169.69 2.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 5.5099999999999998 110.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -78.53 95.57 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 4.7599999999999998 110.867 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.55 136.36 38.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 2.1099999999999999 111.109 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -112.78 -169.61 1.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 6.9699999999999998 110.862 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -141.79 164.6 29.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 4.0099999999999998 110.857 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.21 -156.08 17.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 2.6200000000000001 112.504 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.52 119.16 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 4.4500000000000002 110.927 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 133.71 -82.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.77 -0.728 . . . . 2.4300000000000002 112.496 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.33 -133.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 2.3900000000000001 112.493 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.1 mm -75.1 142.11 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 2.6499999999999999 111.107 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.5 -11.3 14.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 3.75 110.913 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.19 144.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 2.1600000000000001 111.089 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -143.64 117.09 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 3.6499999999999999 110.882 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.99 130.1 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 1.46 111.069 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.23 166.01 21.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 3.25 110.91 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.62 172.83 0.35 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.777 -0.725 . . . . 0.81999999999999995 112.478 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 172.08 13.3 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 0.81000000000000005 112.297 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 145.2 -154.97 26.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 1.02 112.47 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.4 p -88.78 135.44 33.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.936 0.398 . . . . 2.5800000000000001 110.844 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.72 -81.94 0.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 1.1399999999999999 112.496 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.71 50.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 3.5 111.157 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.1 -110.95 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 2.6400000000000001 112.462 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -90.78 41.45 2.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 2.4199999999999999 112.497 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.43 143.58 8.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 2.2999999999999998 110.873 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -121.52 130.98 53.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 1.72 111.124 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -122.03 126.67 49.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 3.79 110.876 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -139.45 150.35 45.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 4.3399999999999999 110.882 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 69.13 45.68 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 6.4800000000000004 110.867 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.29 58.99 1.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 8.1500000000000004 110.875 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.46 16.62 8.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 4.2699999999999996 110.84 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.57 -1.09 14.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 4.3099999999999996 110.942 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.75 150.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 7.3700000000000001 110.852 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -105.4 176.93 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 9.0600000000000005 110.904 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.26 172.89 17.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 2.5299999999999998 111.148 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.76 -173.39 2.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 2.0699999999999998 111.131 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -65.69 -20.33 66.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 5.3099999999999996 110.862 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -70.18 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 2.4300000000000002 110.856 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.66 -169.61 11.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 3.4100000000000001 112.457 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 49.29 -166.29 0.3 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 2.4500000000000002 112.483 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.87 99.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 2.46 111.144 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 214' ' ' LEU . 32.1 t30 -61.71 120.71 11.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 4.2000000000000002 110.849 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.88 -37.85 66.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 3.1299999999999999 110.842 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -71.58 -67.32 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 6.0 110.886 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.401 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 3.9 tp -48.31 -53.67 16.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 3.5800000000000001 110.931 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 37.5 m -55.21 -41.58 72.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 1.8100000000000001 111.113 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.54 -44.99 95.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 1.8700000000000001 111.12 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.77 -23.14 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 1.8700000000000001 111.14 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -72.65 -62.27 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 3.4700000000000002 110.857 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -55.37 26.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 4.6399999999999997 110.893 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.1 tt -51.55 -29.95 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 3.6099999999999999 111.143 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.98 -52.48 49.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 1.1000000000000001 112.479 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -72.12 -23.12 61.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 3.8199999999999998 110.83 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.12 -9.76 58.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 2.5699999999999998 110.847 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.13 -19.08 14.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 3.2000000000000002 110.903 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 145.23 -31.5 1.7 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 2.7400000000000002 112.477 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.9 179.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.343 . . . . 3.5699999999999998 110.958 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 173.79 66.89 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.68 -0.771 . . . . 2.7200000000000002 112.42 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 11.0 m80 63.47 106.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.349 . . . . 2.6499999999999999 110.872 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.2 t -80.91 -79.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 5.8899999999999997 110.855 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 175.93 -54.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 4.2199999999999998 110.848 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.95 126.63 34.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 2.7400000000000002 110.88 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -177.73 1.99 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.692 2.261 . . . . 2.3399999999999999 112.327 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.6 28.09 4.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 4.5199999999999996 110.9 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -115.36 178.71 4.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 2.2599999999999998 111.134 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 18.0 t -95.55 -9.44 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 4.1600000000000001 111.174 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 28.9 mmt -86.53 -38.48 17.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 5.8499999999999996 110.889 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.34 137.47 68.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.731 . . . . 5.3399999999999999 110.867 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 73.62 1.31 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.692 2.261 . . . . 2.6800000000000002 112.341 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.71 148.6 21.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 2.9700000000000002 111.158 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -113.32 112.76 24.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 3.8799999999999999 110.899 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 35.7 tttt -135.97 119.81 17.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 5.5599999999999996 110.918 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -51.71 132.0 30.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 4.0800000000000001 110.937 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 56.7 t -136.38 121.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 3.2200000000000002 111.12 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.02 130.96 26.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 4.0700000000000003 110.928 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 23.9 pt -56.67 -24.16 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 3.9500000000000002 111.151 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.5 -37.64 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 3.1200000000000001 110.872 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.4 m -104.02 27.98 7.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 3.7400000000000002 111.087 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -103.01 130.84 50.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 6.8899999999999997 110.844 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -163.88 139.73 6.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 5.8200000000000003 110.835 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.2 pp -52.4 170.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 4.3200000000000003 110.927 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.0 t -89.85 147.57 23.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 4.8600000000000003 110.893 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.51 -60.98 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 5.2699999999999996 111.095 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.48 -26.3 30.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 3.5 110.869 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.55 -34.74 74.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 3.4500000000000002 110.849 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.3 mt -55.17 -41.59 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 3.9399999999999999 111.132 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -14.3 61.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 5.3200000000000003 110.847 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -93.4 -14.48 53.57 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 1.6499999999999999 112.485 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 10.7 tp -110.32 -29.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 2.0800000000000001 111.089 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -67.83 -32.06 72.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 4.1799999999999997 110.915 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 3.3100000000000001 110.843 -179.779 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.815 0.34 . . . . 2.9300000000000002 111.153 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -127.63 152.76 47.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 7.8899999999999997 110.883 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -160.24 123.32 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 8.2899999999999991 110.829 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.5 mt -108.16 131.94 57.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 2.8599999999999999 111.137 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -131.38 49.76 2.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 4.5999999999999996 110.86 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -179.87 126.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 6.0999999999999996 110.905 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -118.7 163.07 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 6.8200000000000003 110.922 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.3 m -86.63 131.57 45.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.63 0.728 . . . . 4.1600000000000001 111.074 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -48.91 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.697 2.264 . . . . 3.0499999999999998 112.393 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.36 54.57 2.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 4.3899999999999997 110.836 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -165.44 141.94 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 3.3900000000000001 110.918 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.29 135.54 57.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 4.5300000000000002 110.911 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -54.26 -25.59 24.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 7.04 110.878 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -78.27 -37.87 44.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 4.7199999999999998 110.887 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.51 -45.55 90.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 3.2000000000000002 110.84 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.4 p -74.32 -32.62 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 2.25 111.112 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.23 -54.35 11.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 3.6899999999999999 110.89 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -65.21 -32.17 73.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 4.5800000000000001 110.934 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.51 -57.75 8.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 1.8999999999999999 111.114 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.5 mm -70.16 -49.12 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 3.29 111.13 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -49.76 -46.06 50.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 5.1100000000000003 110.862 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -20.41 49.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 4.0 110.849 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.04 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 2.3100000000000001 111.089 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.23 -26.79 67.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 6.1600000000000001 110.883 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -28.92 66.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 4.1399999999999997 110.913 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.96 -56.03 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 2.9300000000000002 111.113 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -43.54 65.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 4.7999999999999998 110.942 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.6 t -56.01 -32.39 63.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 2.4199999999999999 110.887 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -51.59 -32.23 27.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 2.8399999999999999 110.913 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.2 m -138.93 36.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 3.1000000000000001 111.098 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.4 m -155.38 131.6 5.76 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.573 0.701 . . . . 2.71 111.12 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 72.13 1.47 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.675 2.25 . . . . 2.1600000000000001 112.323 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.04 130.32 23.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 3.6899999999999999 110.884 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.42 133.29 56.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 5.9900000000000002 110.886 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -99.53 131.25 45.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 8.6799999999999997 110.902 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.6 m -113.41 90.15 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 2.5299999999999998 110.832 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 122.21 19.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 3.6000000000000001 110.883 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 pp -144.63 161.49 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 3.7999999999999998 111.157 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.44 34.22 3.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 5.2199999999999998 110.9 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 t -161.66 142.98 11.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 4.5499999999999998 111.139 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 85.78 176.4 50.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.73 . . . . 1.96 112.502 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.98 164.06 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 6.46 110.845 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.71 144.51 47.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 2.1000000000000001 111.134 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.4 -26.81 32.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 2.4399999999999999 110.884 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.9 mm -104.1 135.35 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 3.5 111.139 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -133.17 118.26 18.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 2.2000000000000002 110.929 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 89.5 t -105.65 110.54 31.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 2.7000000000000002 111.131 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.96 145.43 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 2.2000000000000002 111.106 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -107.25 109.03 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 6.4500000000000002 110.879 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.67 178.76 4.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 2.1499999999999999 111.082 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.08 111.63 17.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 5.71 110.887 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.37 -123.75 16.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.717 -0.754 . . . . 1.6699999999999999 112.494 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.22 110.41 20.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 2.8999999999999999 111.122 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -79.39 58.76 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 3.9199999999999999 110.885 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.8 -63.69 2.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.702 -0.761 . . . . 4.2999999999999998 112.507 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -179.5 42.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.77 0.319 . . . . 7.6500000000000004 110.867 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -111.23 -78.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 4.9900000000000002 110.829 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -138.16 98.12 3.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 5.2699999999999996 110.837 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.85 113.61 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 2.5099999999999998 111.128 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -111.12 131.58 54.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 7.0599999999999996 110.904 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.82 171.06 13.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 4.3799999999999999 110.887 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.06 -162.18 27.95 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 2.8599999999999999 112.475 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -50.3 119.17 3.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 4.5899999999999999 110.887 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 128.06 -15.85 6.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 2.48 112.497 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -127.21 -133.75 3.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.71 -0.757 . . . . 1.6299999999999999 112.496 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.85 90.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 3.6600000000000001 111.138 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.8 pp -48.31 -31.71 6.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 3.8700000000000001 110.886 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 176.87 153.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 2.0800000000000001 111.124 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -142.92 106.27 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 4.6299999999999999 110.896 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -96.22 108.41 20.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 2.0499999999999998 111.085 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.43 168.81 5.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 3.8700000000000001 110.86 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.49 171.49 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.747 . . . . 0.88 112.526 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -170.62 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 0.84999999999999998 112.336 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 126.42 -152.01 18.2 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 1.1699999999999999 112.486 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.16 152.81 20.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 2.4100000000000001 110.835 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 50.83 -104.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 1.51 112.497 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 34.0 mm -54.8 -26.56 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 3.3399999999999999 111.124 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.85 108.03 1.69 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.659 -0.781 . . . . 2.4700000000000002 112.491 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 108.17 -24.33 23.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.792 -0.718 . . . . 1.8600000000000001 112.502 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -49.8 147.27 3.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 2.2000000000000002 110.887 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.85 145.79 30.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 2.1400000000000001 111.112 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -121.78 152.95 38.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 3.52 110.841 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -133.53 103.19 5.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 4.0700000000000003 110.861 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 47.39 70.62 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 5.7599999999999998 110.889 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.59 -48.82 63.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 7.3899999999999997 110.872 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -127.93 0.47 5.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 4.4299999999999997 110.862 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.72 -168.73 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 3.7799999999999998 110.915 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -114.96 160.07 19.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 7.2800000000000002 110.918 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -106.15 152.52 23.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 7.2800000000000002 110.892 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.09 174.03 16.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 2.4199999999999999 111.133 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.74 -172.28 3.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 2.7799999999999998 111.182 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -55.92 -32.85 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 6.6299999999999999 110.842 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -56.45 5.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 3.2400000000000002 110.814 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -49.3 155.28 1.97 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 2.8500000000000001 112.488 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.48 -58.75 7.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 2.3399999999999999 112.5 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.19 102.91 15.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 3.0699999999999998 111.167 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.14 121.66 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 3.8900000000000001 110.859 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -35.28 64.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 3.1299999999999999 110.901 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -71.96 -67.82 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 6.2800000000000002 110.87 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.9 tp -49.6 -47.34 49.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 3.2200000000000002 110.866 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 99.4 m -55.31 -44.2 75.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 2.1899999999999999 111.107 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.52 69.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 1.9099999999999999 111.071 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.3 t -72.82 -29.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 1.78 111.127 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -71.89 -39.39 69.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 2.98 110.826 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -74.31 -51.62 14.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 4.3399999999999999 110.932 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.0 tt -54.94 -27.32 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 3.4500000000000002 111.135 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.81 -27.41 62.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.776 -0.726 . . . . 0.90000000000000002 112.502 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -81.76 -43.88 17.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.757 0.313 . . . . 3.6400000000000001 110.837 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.5 p -86.53 52.26 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 1.9399999999999999 110.848 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 mt -159.12 -46.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 2.8599999999999999 110.887 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -172.51 -61.88 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 2.0800000000000001 112.496 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.6 mp -60.89 171.71 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 3.8500000000000001 110.926 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 177.46 65.08 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 2.7799999999999998 112.487 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.1 m170 64.22 157.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.32 . . . . 2.3799999999999999 110.853 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.6 t -163.86 -70.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 4.9299999999999997 110.863 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.7 -32.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 4.8499999999999996 110.871 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -45.2 105.81 0.49 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.677 0.751 . . . . 2.2400000000000002 110.834 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 233' ' ' LYS . 54.0 Cg_endo -69.69 175.67 7.73 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.722 2.281 . . . . 2.02 112.349 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.25 42.66 0.31 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 4.8300000000000001 110.869 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -135.18 151.06 50.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 2.2000000000000002 111.093 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.84 -14.59 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 3.6299999999999999 111.159 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -81.96 -39.66 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 6.3600000000000003 110.847 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -50.99 134.52 29.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.662 0.744 . . . . 5.0800000000000001 110.902 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 76.45 1.15 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.722 2.282 . . . . 3.0800000000000001 112.323 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.5 m -157.3 152.66 26.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 3.5699999999999998 111.137 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -111.72 112.32 23.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 6.4400000000000004 110.89 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.48 -169.15 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 5.2999999999999998 110.913 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -121.48 107.86 12.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 4.8300000000000001 110.901 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.93 154.58 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 4.2800000000000002 111.135 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -74.22 124.99 27.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 3.23 110.86 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 11.8 tt -76.47 -35.48 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 4.1699999999999999 111.113 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -53.48 -31.9 47.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 3.52 110.881 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.9 t -113.68 30.07 7.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 3.8199999999999998 111.109 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -52.05 134.47 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 7.0499999999999998 110.873 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -179.9 142.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 4.4800000000000004 110.926 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.21 147.8 47.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 3.48 110.866 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.1 -172.02 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 3.79 110.872 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 66.4 163.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 4.4900000000000002 111.118 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -57.67 -25.11 59.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 2.6800000000000002 110.815 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -51.62 -29.83 19.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 3.04 110.853 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 12.7 tt -50.88 -29.59 7.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 3.23 111.153 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -92.07 -40.15 11.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 6.9299999999999997 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.97 -20.51 41.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 1.95 112.462 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 8.2 tp -91.41 -32.83 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 2.23 111.128 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.19 -44.4 38.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 3.9399999999999999 110.957 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 2.9399999999999999 110.883 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.2 p . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.853 0.358 . . . . 2.5800000000000001 111.109 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -150.26 151.32 32.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 5.0199999999999996 110.938 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.83 161.63 29.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 6.25 110.92 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.4 mt -108.09 148.93 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 2.8100000000000001 111.082 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.15 -69.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 3.2200000000000002 110.901 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -98.59 176.89 5.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 6.4800000000000004 110.895 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -146.39 155.01 42.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 7.5 110.904 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.53 134.9 53.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.601 0.715 . . . . 3.1299999999999999 111.11 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 135.25 29.87 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.689 2.259 . . . . 2.6699999999999999 112.354 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.45 11.39 8.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 5.9000000000000004 110.865 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.48 147.32 29.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 3.9900000000000002 110.839 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -58.63 115.34 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 4.29 110.893 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -21.94 61.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 6.6900000000000004 110.862 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -80.55 -40.01 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 3.27 110.831 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.72 -47.87 61.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 2.8100000000000001 110.87 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.97 -40.8 90.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 1.8300000000000001 111.142 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.83 -54.07 33.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 3.1299999999999999 110.912 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -68.17 -32.28 72.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 3.8399999999999999 110.936 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.64 -41.07 54.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 1.9399999999999999 111.151 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.8 mm -83.62 -49.4 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 3.21 111.129 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -59.66 4.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 6.7300000000000004 110.841 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -29.86 61.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 6.0499999999999998 110.915 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.14 -33.37 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 1.8999999999999999 111.112 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.36 -24.66 60.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 4.7599999999999998 110.896 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.22 -54.02 6.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 3.3500000000000001 110.884 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.6 p -52.08 -28.81 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 3.2400000000000002 111.12 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -89.11 -55.44 3.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 5.0199999999999996 110.897 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 81.6 p -55.26 -22.56 18.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 2.5099999999999998 110.855 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.83 -29.78 12.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 3.0600000000000001 110.905 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -128.3 46.36 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 2.7200000000000002 111.137 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.46 142.35 13.52 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.619 0.723 . . . . 2.4700000000000002 111.113 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -11.91 31.79 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.702 2.268 . . . . 1.8400000000000001 112.345 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.2 167.2 4.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 4.0899999999999999 110.914 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.76 -172.95 2.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 7.1399999999999997 110.887 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -131.84 127.58 36.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 7.6200000000000001 110.9 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.97 89.92 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 3.0499999999999998 110.885 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 95.18 7.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 3.3500000000000001 110.918 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.81 133.19 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 4.04 111.13 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.1 -28.96 67.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 4.8399999999999999 110.916 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.62 174.32 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 3.9900000000000002 111.175 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.94 134.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.719 . . . . 2.27 112.487 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.1 mtm -68.99 160.33 31.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 7.6299999999999999 110.866 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.68 144.63 37.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 2.04 111.124 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.48 -33.54 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 2.3799999999999999 110.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.3 mm -103.99 94.47 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 4.0199999999999996 111.124 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -105.13 117.46 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 2.8500000000000001 110.86 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.2 t -102.25 109.24 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 2.7599999999999998 111.076 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.7 t -138.88 141.11 37.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 2.7400000000000002 111.187 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.91 152.76 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 4.4500000000000002 110.89 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.41 173.33 10.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 2.0099999999999998 111.112 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.67 120.0 13.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 6.0700000000000003 110.819 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 53.62 -134.77 42.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 1.9399999999999999 112.488 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.91 110.48 20.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 2.1200000000000001 111.061 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.23 56.38 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 3.9399999999999999 110.859 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.34 -58.94 3.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 2.6800000000000002 112.493 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -162.3 33.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 5.4699999999999998 110.847 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -110.74 -168.88 1.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 5.1399999999999997 110.878 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.75 114.89 16.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 7.7300000000000004 110.876 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.05 147.83 40.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 2.77 111.11 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -59.86 -170.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 11.31 110.875 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -137.92 165.39 26.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 5.25 110.87 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -50.82 133.35 31.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 3.8799999999999999 112.504 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 129.89 27.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 5.4900000000000002 110.934 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.87 -13.39 29.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 3.8399999999999999 112.459 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -108.58 -136.95 7.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 3.2799999999999998 112.514 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.7 mt -71.47 110.88 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 4.4699999999999998 111.174 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -42.55 55.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 4.7400000000000002 110.931 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.84 -179.74 0.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 3.1099999999999999 111.078 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -142.15 129.58 21.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 4.8300000000000001 110.843 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -115.76 121.63 43.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 1.78 111.059 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.28 165.8 8.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 3.8799999999999999 110.859 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.37 170.2 0.34 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.90000000000000002 112.478 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -170.3 0.38 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.738 2.292 . . . . 1.0 112.364 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.14 -149.14 18.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 1.23 112.497 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 99.3 p -92.24 155.56 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 2.3199999999999998 110.899 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.42 -104.4 0.15 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 1.3700000000000001 112.485 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 38.0 mt -61.31 -26.52 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 2.8399999999999999 111.121 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.15 99.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 2.6899999999999999 112.515 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 116.73 -18.9 12.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 1.76 112.456 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -49.83 137.57 16.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.826 0.345 . . . . 2.0099999999999998 110.883 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -131.39 149.93 52.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 2.0899999999999999 111.099 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.58 109.89 7.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 3.7799999999999998 110.83 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -107.84 125.81 51.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 7.1299999999999999 110.889 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 49.67 78.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 6.6299999999999999 110.871 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -76.61 60.79 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 8.5 110.901 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.6 26.6 16.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 5.3399999999999999 110.856 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -97.42 -42.54 7.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 3.7999999999999998 110.848 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 178.68 119.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 5.3700000000000001 110.871 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -106.76 124.71 50.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 10.51 110.923 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.1 159.92 38.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 2.1899999999999999 111.141 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.3 177.84 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 2.0800000000000001 111.146 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -55.39 -24.97 32.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 5.5800000000000001 110.865 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.98 -42.0 10.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 3.3399999999999999 110.861 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -57.21 -175.93 0.36 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 3.2400000000000002 112.503 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.4 -87.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.737 . . . . 2.4900000000000002 112.461 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 60.1 m -73.89 98.74 3.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.827 0.346 . . . . 2.7599999999999998 111.126 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -61.62 110.77 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 4.9100000000000001 110.846 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.33 -44.41 71.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.13 -0.487 . . . . 3.1499999999999999 110.907 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.96 -40.31 96.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 6.7999999999999998 110.896 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.44 -47.06 28.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 3.8199999999999998 110.904 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 24.0 m -55.54 -49.6 72.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 2.3399999999999999 111.141 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.84 -32.09 63.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 1.8799999999999999 111.076 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 62.9 t -80.77 -29.82 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 2.1699999999999999 111.066 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -73.56 -48.73 30.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 2.9700000000000002 110.871 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -63.59 -49.21 74.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 4.8399999999999999 110.884 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.6 tt -57.82 -25.41 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 3.71 111.162 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 -27.52 70.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 1.46 112.481 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -74.97 -28.67 60.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 4.9800000000000004 110.877 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.88 40.93 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 2.2000000000000002 110.859 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.72 -40.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 2.6400000000000001 110.922 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 147.85 122.32 1.29 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 2.54 112.46 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.6 tp -179.19 -63.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 4.9199999999999999 110.912 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 62.74 15.33 54.27 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 3.5299999999999998 112.475 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 17.5 m80 51.98 67.15 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 2.7999999999999998 110.833 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 65.1 m -51.89 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 5.6600000000000001 110.866 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 177.2 101.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 4.7400000000000002 110.888 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.65 85.17 7.29 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 3.6600000000000001 110.887 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -29.78 23.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 2.7799999999999998 112.325 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 8.38 43.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 6.6799999999999997 110.952 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -124.74 -177.49 3.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 2.6400000000000001 111.129 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 16.7 m -95.83 -7.6 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 5.5999999999999996 111.115 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.9 ttp -54.15 -27.22 32.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 6.1299999999999999 110.892 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.25 157.58 1.15 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.633 0.73 . . . . 5.1600000000000001 110.871 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.34 28.3 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.67 2.246 . . . . 2.6400000000000001 112.297 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.2 m -99.42 137.4 37.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 3.8799999999999999 111.185 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -63.14 142.07 58.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 4.9800000000000004 110.945 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 96.62 4.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 4.1299999999999999 110.919 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -61.59 125.84 25.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 4.7199999999999998 110.899 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.92 177.19 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 3.6299999999999999 111.136 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.1 128.45 34.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 2.79 110.878 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.0 tp -55.83 -25.29 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 4.3700000000000001 111.13 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -65.36 -39.4 92.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 3.6299999999999999 110.894 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 65.2 p -99.6 2.72 44.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 3.4199999999999999 111.154 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -51.91 108.32 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 5.4100000000000001 110.877 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -174.45 139.24 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 4.3700000000000001 110.832 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.59 151.75 4.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 3.52 110.917 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.1 -179.0 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 4.7400000000000002 110.848 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 64.55 -178.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 4.0499999999999998 111.119 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -23.23 51.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 2.7200000000000002 110.831 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -53.19 -30.12 35.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 3.0499999999999998 110.863 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.2 tt -65.1 -29.99 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 3.6299999999999999 111.11 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -99.04 -1.71 39.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 7.8499999999999996 110.885 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -90.17 17.85 51.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.693 -0.765 . . . . 1.8 112.532 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.87 -40.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 2.1000000000000001 111.1 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -24.77 56.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 3.5099999999999998 110.867 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 2.3700000000000001 110.833 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.766 0.317 . . . . 3.46 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.47 136.7 52.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 8.2300000000000004 110.911 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -141.14 143.33 34.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 5.1500000000000004 110.864 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.5 mt -108.01 148.36 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 3.4700000000000002 111.162 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -111.9 -69.46 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 4.0300000000000002 110.914 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -107.36 -169.84 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 5.6699999999999999 110.877 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -146.62 140.73 26.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 7.0700000000000003 110.946 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 72.3 p -53.08 109.71 1.61 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.552 0.692 . . . . 3.5699999999999998 111.129 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 122' ' ' THR . 53.7 Cg_endo -69.8 -48.74 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.647 2.231 . . . . 3.0099999999999998 112.307 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.21 -33.55 75.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 4.6500000000000004 110.858 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.2 tpt -101.34 178.88 4.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 3.96 110.853 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -78.92 128.83 33.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 4.25 110.849 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -52.96 -28.12 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 6.8700000000000001 110.908 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.77 -32.49 40.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 3.2999999999999998 110.899 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -65.6 -43.05 90.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 2.7200000000000002 110.881 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.2 p -74.09 -35.54 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 2.0099999999999998 111.143 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.0 -44.4 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 2.48 110.846 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -71.76 -39.63 69.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 4.7300000000000004 110.932 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.16 -59.24 5.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 1.9199999999999999 111.168 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 pt -56.43 -29.4 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 3.9900000000000002 111.139 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.08 -57.64 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 5.0999999999999996 110.827 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.19 -25.64 42.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 3.9100000000000001 110.869 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.59 -43.75 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 2.2599999999999998 111.091 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -73.68 -23.93 59.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 4.8700000000000001 110.84 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -78.13 -31.41 49.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 3.5800000000000001 110.912 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.7 t -51.09 -56.2 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 3.1200000000000001 111.089 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -42.13 61.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 5.2300000000000004 110.917 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.67 -22.38 13.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 2.2400000000000002 110.841 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -57.62 -21.84 41.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 3.3599999999999999 110.909 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.51 62.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 3.2000000000000002 111.173 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.02 147.53 16.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.632 0.73 . . . . 2.6800000000000002 111.114 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -8.53 23.85 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.688 2.259 . . . . 2.8700000000000001 112.362 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 pp -66.22 -172.28 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 5.1699999999999999 110.923 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.77 -174.89 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 7.0700000000000003 110.899 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -132.32 122.34 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 7.9800000000000004 110.891 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.4 t -144.93 89.94 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 2.25 110.869 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -82.31 117.1 22.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 4.8499999999999996 110.894 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.2 159.84 42.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 3.7599999999999998 111.11 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -99.88 -27.96 13.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 3.8999999999999999 110.876 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.4 m -113.73 116.73 29.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 3.6299999999999999 111.088 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.33 147.35 6.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 2.0600000000000001 112.484 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.2 164.67 26.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.766 0.317 . . . . 6.8200000000000003 110.891 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.0 142.9 27.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 2.21 111.106 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -51.93 53.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 2.2400000000000002 110.859 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.9 pt -104.63 139.85 24.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 3.6499999999999999 111.141 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -135.44 162.94 31.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 3.1299999999999999 110.941 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.21 121.74 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 3.0600000000000001 111.095 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.5 p -139.43 163.31 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 3.7000000000000002 111.144 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -121.02 133.13 55.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 5.1299999999999999 110.892 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.86 167.73 20.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 1.9099999999999999 111.112 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.68 146.59 32.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 6.3499999999999996 110.878 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.37 -151.48 3.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 2.46 112.502 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.79 125.35 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 3.0299999999999998 111.088 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -112.39 43.54 1.6 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 4.1900000000000004 110.847 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.14 76.59 0.26 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 3.21 112.462 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.2 t70 63.86 47.71 3.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.736 0.303 . . . . 5.9400000000000004 110.825 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.2 -169.02 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 4.6500000000000004 110.851 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -76.83 124.08 27.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 6.7400000000000002 110.851 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.29 144.96 31.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 2.6400000000000001 111.131 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -130.32 -169.66 2.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 7.4500000000000002 110.887 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -151.28 -170.53 3.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 5.04 110.86 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -115.92 -153.13 10.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.758 . . . . 3.2200000000000002 112.445 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.71 133.61 25.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 3.9399999999999999 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 111.96 -18.97 23.6 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 2.4300000000000002 112.496 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -143.98 -129.09 2.21 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.747 -0.739 . . . . 1.5900000000000001 112.49 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.5 mm -77.2 125.45 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.89 0.376 . . . . 3.3700000000000001 111.144 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.89 -5.91 40.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 5.2800000000000002 110.911 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.6 123.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 2.8399999999999999 111.114 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 114.23 18.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 4.7800000000000002 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.64 117.5 24.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 1.52 111.075 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -64.41 170.79 3.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 4.2800000000000002 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.05 172.08 0.17 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.751 -0.737 . . . . 0.94999999999999996 112.489 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 172.23 13.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 0.87 112.333 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 159.35 -133.6 3.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 1.3899999999999999 112.507 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 34.5 t -134.09 128.42 34.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.367 . . . . 3.73 110.88 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 85.52 -70.36 3.08 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.741 -0.742 . . . . 2.04 112.486 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.7 -27.04 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.358 . . . . 4.1299999999999999 111.119 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.11 129.14 29.0 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 2.2999999999999998 112.525 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.69 -9.57 67.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 2.0800000000000001 112.511 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -51.19 157.61 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.8200000000000001 110.874 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.97 121.28 32.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 1.97 111.08 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -111.05 115.52 29.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 4.2300000000000004 110.838 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -143.94 150.23 38.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 4.2300000000000004 110.875 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.406 ' N ' ' HE1' ' A' ' 203' ' ' TRP . 0.9 OUTLIER 75.16 -168.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 7.1500000000000004 110.855 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.87 96.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 6.9100000000000001 110.923 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.2 t70 55.95 68.97 0.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 4.0800000000000001 110.888 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -174.75 -41.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 4.2699999999999996 110.879 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 11.7 t80 67.24 131.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 6.5599999999999996 110.885 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.406 ' HE1' ' N ' ' A' ' 198' ' ' ASP . 21.3 m95 -105.72 -174.91 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 8.2699999999999996 110.877 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 168.27 27.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 2.52 111.184 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -175.1 3.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 2.4399999999999999 111.143 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -52.76 -47.95 67.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 5.1799999999999997 110.909 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.4 p -78.39 -31.94 48.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 3.21 110.879 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -50.38 167.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 3.0299999999999998 112.483 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.83 -72.71 0.44 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 2.0600000000000001 112.502 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.3 98.64 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.796 0.332 . . . . 2.8500000000000001 111.133 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -69.57 132.39 46.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 5.7300000000000004 110.87 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -57.99 -41.3 82.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 4.46 110.908 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -70.74 -60.72 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 6.8300000000000001 110.899 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.43 -34.89 26.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 3.8100000000000001 110.898 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 82.5 m -79.91 -41.6 25.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 2.21 111.148 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.89 98.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 1.8899999999999999 111.102 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 53.5 t -51.27 -40.74 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 1.96 111.156 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -64.74 -36.41 84.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 3.3599999999999999 110.85 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -74.64 -45.75 42.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 4.4699999999999998 110.883 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.09 -37.04 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 3.3900000000000001 111.187 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.07 -37.78 36.94 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.686 -0.769 . . . . 0.72999999999999998 112.467 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -54.86 -40.64 69.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 3.3500000000000001 110.879 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.6 8.75 26.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 2.6000000000000001 110.879 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.33 88.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 3.4700000000000002 110.944 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 71.12 179.32 29.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.738 -0.744 . . . . 2.7999999999999998 112.51 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 54.3 -175.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 3.8300000000000001 110.896 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.8 -115.68 0.96 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 2.5800000000000001 112.464 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.44 142.82 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 2.25 110.881 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.83 -78.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 7.5999999999999996 110.845 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.51 -78.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 5.4400000000000004 110.882 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 153.21 48.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.599 0.714 . . . . 3.8900000000000001 110.858 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 233' ' ' LYS . 54.0 Cg_endo -69.73 -177.12 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.677 2.252 . . . . 2.8300000000000001 112.358 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.47 43.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 5.25 110.887 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -135.54 163.5 29.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 2.3999999999999999 111.101 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.16 7.4 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 4.0999999999999996 111.14 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -98.43 -26.08 14.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 4.7300000000000004 110.906 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.68 141.59 55.6 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.632 0.73 . . . . 5.1600000000000001 110.888 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 64.97 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.683 2.256 . . . . 2.6000000000000001 112.349 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.1 t -158.03 134.2 9.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 3.4500000000000002 111.169 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -76.3 127.49 32.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 5.6600000000000001 110.951 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -140.58 92.74 2.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 4.8799999999999999 110.915 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -62.41 125.61 24.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 4.5999999999999996 110.912 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.49 177.32 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.494 . . . . 3.5600000000000001 111.153 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -62.09 114.28 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 3.9100000000000001 110.845 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 18.4 tt -76.36 -32.75 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 4.04 111.172 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.43 -30.79 65.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 3.3900000000000001 110.866 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.56 28.05 9.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 4.6100000000000003 111.11 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -51.76 149.86 4.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 6.6799999999999997 110.913 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -179.71 156.2 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 5.1299999999999999 110.885 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.83 157.49 19.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 3.2799999999999998 110.955 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.65 -171.64 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 3.8399999999999999 110.904 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 68.72 160.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 4.3499999999999996 111.109 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.84 -21.48 56.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 3.2799999999999998 110.886 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.84 -29.74 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 4.04 110.886 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 1.2 tt -51.14 -29.53 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 2.5899999999999999 111.143 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -90.59 -34.07 15.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 5.8399999999999999 110.842 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.55 -17.07 47.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 1.6499999999999999 112.507 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 4.0 tp -99.95 -31.61 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 1.8600000000000001 111.179 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.78 -43.39 25.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 4.7000000000000002 110.899 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 2.3199999999999998 110.841 -179.791 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.818 0.342 . . . . 2.96 111.136 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -131.95 145.83 51.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 4.7599999999999998 110.942 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -142.29 160.51 40.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 5.5800000000000001 110.9 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.3 mt -106.59 148.92 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 3.3799999999999999 111.172 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -106.77 -69.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 5.1100000000000003 110.86 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -118.37 174.88 5.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 6.6799999999999997 110.881 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -134.45 163.27 30.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 6.8399999999999999 110.918 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.51 131.86 40.75 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.546 0.688 . . . . 3.4399999999999999 111.114 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -19.43 36.14 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.702 2.268 . . . . 2.1499999999999999 112.334 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.64 -69.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 4.4800000000000004 110.874 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 38.0 mmm -101.19 168.12 9.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 4.4800000000000004 110.87 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -59.39 158.23 9.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 3.0800000000000001 110.892 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -70.78 -11.26 60.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 7.6399999999999997 110.888 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -79.73 -36.69 37.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 3.0899999999999999 110.886 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.07 -40.77 71.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 2.6800000000000002 110.866 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.3 -36.2 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 1.8999999999999999 111.107 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -66.34 -43.97 84.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 3.7799999999999998 110.855 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -48.98 23.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 4.1200000000000001 110.937 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.78 -26.88 66.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 2.4500000000000002 111.094 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mm -70.85 -50.93 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 3.4399999999999999 111.15 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -75.2 -22.7 57.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 4.8700000000000001 110.879 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -77.62 -29.92 52.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 3.8500000000000001 110.934 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.5 -52.08 62.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 1.96 111.039 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.09 -28.38 52.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 5.6299999999999999 110.887 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -70.49 -27.95 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 3.1400000000000001 110.898 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.4 t -51.08 -56.1 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 2.71 111.16 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -77.44 -29.06 52.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 5.1100000000000003 110.921 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 p -55.19 -41.61 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 2.6699999999999999 110.807 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.69 -16.19 62.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 3.29 110.9 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.79 39.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 2.9900000000000002 111.139 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 91.9 m -155.63 133.65 6.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.583 0.706 . . . . 2.7999999999999998 111.17 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 74.56 1.28 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.738 2.292 . . . . 2.3599999999999999 112.341 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tp -163.13 -169.65 2.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 4.3700000000000001 110.941 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -148.25 176.27 10.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 5.5999999999999996 110.875 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -135.81 120.03 17.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 8.3900000000000006 110.87 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 t -110.44 89.99 3.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 2.5699999999999998 110.843 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.16 93.4 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 3.3399999999999999 110.882 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.57 163.96 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 4.7199999999999998 111.155 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -103.01 -5.78 23.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 3.6200000000000001 110.891 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.57 175.73 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 5.0800000000000001 111.184 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.48 -165.55 1.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 3.0299999999999998 112.476 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.4 mtm -110.77 151.92 27.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 5.5800000000000001 110.867 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.35 130.14 55.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 2.1299999999999999 111.087 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.41 -20.82 62.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 2.54 110.883 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.0 mm -103.47 84.58 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 3.3900000000000001 111.144 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.72 117.72 24.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 2.5099999999999998 110.945 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 99.4 t -105.3 110.77 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 2.3399999999999999 111.085 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.6 t -127.07 143.2 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 2.25 111.15 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -97.77 100.21 11.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 9.4000000000000004 110.903 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.26 144.03 50.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 2.21 111.1 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.74 164.1 14.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 8.1400000000000006 110.849 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.52 -138.03 29.36 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.768 -0.729 . . . . 1.4399999999999999 112.502 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.23 128.24 33.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 2.2599999999999998 111.137 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -95.67 24.87 4.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 4.5099999999999998 110.887 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.8 -28.17 10.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.761 -0.733 . . . . 2.3199999999999998 112.481 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.46 34.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.817 0.341 . . . . 5.25 110.874 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.56 -173.84 2.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 110.903 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.61 118.83 26.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 7.2400000000000002 110.864 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.41 139.9 35.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 2.1800000000000002 111.086 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -154.02 88.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 8.4499999999999993 110.87 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -128.49 -168.42 1.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 5.5300000000000002 110.859 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.62 106.1 0.91 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.748 -0.739 . . . . 3.2799999999999998 112.477 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.94 119.11 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 6.1100000000000003 110.891 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.61 -24.52 21.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 2.29 112.494 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -82.88 -140.72 3.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.675 -0.774 . . . . 1.6699999999999999 112.51 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.62 110.53 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 2.9300000000000002 111.105 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -57.38 8.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.478 . . . . 4.9900000000000002 110.915 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.01 123.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 2.1200000000000001 111.093 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -95.3 153.58 17.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 4.3399999999999999 110.831 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -152.46 113.04 4.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 1.8700000000000001 111.06 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.67 157.4 24.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 3.8900000000000001 110.885 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.94 -171.0 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 1.29 112.497 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -169.86 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.731 2.287 . . . . 1.1599999999999999 112.338 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 125.37 -156.34 19.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 1.2 112.512 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.8 p -88.92 145.58 25.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 3.25 110.861 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.08 -102.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 1.45 112.43 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 82.0 mt -52.57 -27.73 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 2.7599999999999998 111.153 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.59 111.56 2.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 2.6600000000000001 112.474 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.43 -16.14 56.89 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 1.8100000000000001 112.507 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -49.94 138.41 15.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 2.2599999999999998 110.905 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -129.96 141.17 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 2.0299999999999998 111.097 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.77 144.57 46.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 3.8300000000000001 110.871 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -144.45 148.5 34.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 3.9100000000000001 110.903 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.5 t70 70.48 -75.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 5.8600000000000003 110.882 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 46.85 41.33 10.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 8.8300000000000001 110.919 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.5 t0 62.98 41.1 8.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 3.54 110.888 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -118.45 1.87 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 4.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.12 115.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 5.9100000000000001 110.899 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.11 170.19 8.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 8.0800000000000001 110.946 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.81 172.92 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 2.77 111.161 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.35 -170.15 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 2.21 111.161 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -76.77 -21.39 55.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 5.6799999999999997 110.853 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.9 t -61.08 -68.9 0.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 3.1600000000000001 110.843 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -132.9 -166.69 11.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.716 -0.754 . . . . 3.2799999999999998 112.481 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 50.07 -168.06 0.31 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.697 -0.763 . . . . 2.27 112.497 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -56.46 99.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 2.3900000000000001 111.114 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.0 103.76 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 3.3599999999999999 110.846 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.6 tt -57.51 -38.27 74.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 3.1600000000000001 110.901 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -71.47 -64.26 0.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 6.2800000000000002 110.837 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.7 tp -50.8 -53.68 29.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 3.1299999999999999 110.915 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 85.5 m -55.37 -44.24 75.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 1.9199999999999999 111.167 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.68 -43.91 76.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 1.8100000000000001 111.098 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.6 t -55.09 -41.87 61.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 1.75 111.14 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -60.23 -31.33 70.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 3.3599999999999999 110.857 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -74.62 -40.35 61.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 3.6600000000000001 110.884 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.4 mm -54.64 -43.35 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 2.4900000000000002 111.101 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.87 -50.47 7.83 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.733 -0.746 . . . . 0.95999999999999996 112.528 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.81 -31.69 62.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 3.25 110.865 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.9 p -95.24 22.11 7.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 2.3999999999999999 110.846 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 17.2 mt -142.31 18.03 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 3.5099999999999998 110.888 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.26 70.08 1.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 2.1400000000000001 112.499 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -130.28 169.47 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 4.7400000000000002 110.928 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -82.29 -120.89 0.62 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 3.5 112.45 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.87 33.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.331 . . . . 3.3900000000000001 110.819 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.0 m -153.09 -75.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 6.1399999999999997 110.832 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.0 t 57.7 -169.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 6.6799999999999997 110.888 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.06 160.29 0.87 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.632 0.729 . . . . 2.9199999999999999 110.851 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -14.84 36.46 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.639 2.226 . . . . 2.5099999999999998 112.346 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.74 -19.7 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 4.4900000000000002 110.889 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.57 170.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 2.3300000000000001 111.067 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.9 t -88.17 -1.37 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 3.9500000000000002 111.156 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -30.2 20.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 4.7999999999999998 110.897 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.53 137.69 31.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.638 0.732 . . . . 5.1299999999999999 110.877 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 77.97 1.02 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 3.04 112.375 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.1 p -156.41 168.03 28.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 3.3599999999999999 111.136 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -125.37 112.53 16.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 5.0300000000000002 110.922 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.01 153.02 48.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 3.29 110.888 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -111.13 102.47 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 4.4500000000000002 110.94 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.5 t -107.57 157.21 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 3.1800000000000002 111.146 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.92 135.32 40.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 3.6200000000000001 110.855 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 19.6 pt -58.17 -22.61 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 3.98 111.116 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -21.41 24.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 3.6299999999999999 110.903 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.9 m -100.73 -6.11 25.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 3.8399999999999999 111.116 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.06 158.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 6.8799999999999999 110.848 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -178.22 149.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 4.8700000000000001 110.879 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -83.87 150.82 25.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 3.8900000000000001 110.888 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.67 123.61 32.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 3.6699999999999999 110.894 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -44.73 -54.79 5.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 5.1399999999999997 111.067 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.08 -39.63 63.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 3.5899999999999999 110.895 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -71.68 -34.53 69.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 2.7599999999999998 110.905 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -30.84 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 2.8599999999999999 111.111 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -79.39 -35.38 40.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 6.9400000000000004 110.88 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -61.17 -16.72 49.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 1.73 112.479 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 7.5 tp -114.45 -36.27 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 1.95 111.172 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? -67.37 -50.71 58.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 4.75 110.881 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 2.8100000000000001 110.852 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.775 0.322 . . . . 2.8300000000000001 111.132 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -144.58 136.78 26.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 4.9900000000000002 110.908 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.27 133.63 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 5.1299999999999999 110.878 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 26.5 mt -108.05 141.61 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 3.7599999999999998 111.16 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -157.44 47.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 5.0099999999999998 110.83 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -147.23 143.72 28.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 6.7400000000000002 110.914 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -148.29 162.47 39.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 7.1900000000000004 110.934 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 123' ' ' PRO . 1.0 OUTLIER -87.8 156.73 52.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.562 0.696 . . . . 3.9500000000000002 111.164 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 122' ' ' THR . 53.7 Cg_endo -69.71 -52.18 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.664 2.243 . . . . 3.02 112.352 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -66.94 -46.0 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 5.4299999999999997 110.932 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 10.7 mmt -98.26 122.88 41.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 4.4400000000000004 110.888 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -56.2 171.78 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 4.4800000000000004 110.879 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -67.2 -10.56 51.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 7.0300000000000002 110.853 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -34.17 71.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 5.1799999999999997 110.902 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.31 -41.23 41.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 3.8100000000000001 110.875 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.17 -33.99 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 2.3199999999999998 111.113 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -49.92 -53.02 28.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 2.6499999999999999 110.847 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -76.16 -33.1 59.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 4.5599999999999996 110.924 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.38 -58.65 7.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 2.04 111.098 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.3 mm -67.78 -45.48 84.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 3.5099999999999998 111.093 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -50.3 -48.99 54.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 4.5700000000000003 110.854 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -76.83 -20.37 56.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 6.3399999999999999 110.885 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.01 -37.96 69.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 2.0899999999999999 111.141 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.31 -25.17 60.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 4.9400000000000004 110.901 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -73.63 -27.79 61.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 3.6899999999999999 110.932 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.94 -55.94 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 3.0 111.151 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -44.21 61.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 5.25 110.945 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.3 m -54.87 -24.87 25.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 3.46 110.855 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -58.08 -22.62 51.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 2.5299999999999998 110.899 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.5 m -140.3 37.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 2.8799999999999999 111.14 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.8 m -142.88 131.52 11.53 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.62 0.724 . . . . 2.4100000000000001 111.149 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 66.75 1.77 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 2.3199999999999998 112.305 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tp -140.62 166.25 25.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 3.4300000000000002 110.906 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -118.38 162.29 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 5.1699999999999999 110.905 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -135.8 119.84 17.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 8.0199999999999996 110.881 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 98.4 p -127.35 90.01 3.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 2.8300000000000001 110.894 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 120.13 12.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 3.1099999999999999 110.882 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.5 pt -148.03 156.93 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 4.0300000000000002 111.161 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -96.52 -24.33 16.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 3.9500000000000002 110.874 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.71 175.51 6.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 3.9700000000000002 111.148 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.46 -171.95 42.88 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.712 -0.756 . . . . 2.52 112.507 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mtt -110.65 157.09 20.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.794 0.33 . . . . 5.7699999999999996 110.846 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -137.08 146.57 45.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.96 111.094 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.75 -17.79 32.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 2.77 110.901 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.3 mm -104.31 84.47 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 3.5499999999999998 111.164 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.78 117.15 29.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 2.3300000000000001 110.902 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.71 110.75 30.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 2.4500000000000002 111.097 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.2 t -133.97 141.94 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 2.2799999999999998 111.158 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -80.81 145.7 31.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 4.6299999999999999 110.857 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.27 156.0 16.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 2.5099999999999998 111.094 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.62 140.1 31.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 6.2999999999999998 110.829 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.43 -136.4 35.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 1.8300000000000001 112.468 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.29 127.71 33.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 1.95 111.061 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -101.22 25.31 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 7.3799999999999999 110.865 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.19 92.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.807 -0.711 . . . . 2.7799999999999998 112.505 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.9 t0 63.71 59.03 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.341 . . . . 5.5 110.848 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -158.03 -170.5 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 4.1600000000000001 110.868 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -96.07 106.25 18.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 6.3399999999999999 110.866 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.03 159.17 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 2.1299999999999999 111.063 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.09 -74.06 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 7.2300000000000004 110.866 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -179.28 -74.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 4.2699999999999996 110.894 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.08 -155.06 24.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 3.0 112.501 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -59.43 123.06 15.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.844 0.354 . . . . 6.3600000000000003 110.864 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.38 90.6 0.64 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 3.2999999999999998 112.459 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.25 -140.59 11.02 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.794 -0.717 . . . . 2.3500000000000001 112.507 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.0 mt -72.06 92.24 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.893 0.378 . . . . 3.1000000000000001 111.187 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.8 pp -48.51 -28.96 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 4.2000000000000002 110.921 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 179.14 178.3 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 2.73 111.065 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -151.64 125.49 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 4.1299999999999999 110.885 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.93 104.9 8.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 1.46 111.13 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.09 165.81 8.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 4.4900000000000002 110.921 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.4 171.12 0.28 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.784 -0.722 . . . . 1.24 112.521 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -170.04 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.691 2.261 . . . . 1.3999999999999999 112.317 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.12 -112.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 1.46 112.459 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.87 135.24 43.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 2.8100000000000001 110.875 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.61 -86.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 1.1100000000000001 112.467 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 90.8 mt -71.76 -23.45 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 2.7999999999999998 111.097 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -58.46 117.3 10.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.749 . . . . 2.46 112.474 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.71 -14.6 64.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.723 -0.751 . . . . 1.78 112.494 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -51.63 128.64 23.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.812 0.339 . . . . 2.0299999999999998 110.862 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -117.27 148.76 41.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 1.6799999999999999 111.098 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -137.08 124.78 22.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 3.7400000000000002 110.835 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.35 143.41 35.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 5.4900000000000002 110.853 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -77.93 58.08 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 6.1500000000000004 110.899 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -73.18 -13.51 61.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 9.5999999999999996 110.882 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -127.5 7.11 6.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 6.2199999999999998 110.91 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -121.74 -34.98 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 6.0199999999999996 110.862 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.52 91.69 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 9.0199999999999996 110.898 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -104.51 122.53 45.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 10.48 110.938 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.11 162.53 38.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 2.5800000000000001 111.168 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.52 -170.21 1.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 2.71 111.136 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -47.17 -46.95 24.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 7.5800000000000001 110.849 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -59.22 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 2.9399999999999999 110.847 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.26 171.2 0.25 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.738 . . . . 3.29 112.448 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.99 -90.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.744 . . . . 2.0499999999999998 112.514 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.02 97.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.321 . . . . 2.1400000000000001 111.169 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -68.34 117.82 10.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 3.5600000000000001 110.873 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.35 -40.26 58.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 3.2200000000000002 110.914 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -71.45 -56.22 6.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 6.0199999999999996 110.909 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.34 -54.74 27.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 3.77 110.892 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 92.3 m -55.52 -38.42 69.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 1.9299999999999999 111.164 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.61 -50.66 69.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.99 111.071 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.01 -36.15 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 1.8999999999999999 111.129 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -59.73 -41.89 91.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 3.1299999999999999 110.873 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -66.71 -36.87 83.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 4.21 110.864 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.8 mm -57.85 -57.89 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 2.6000000000000001 111.171 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.34 -41.61 99.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 1.05 112.471 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -46.33 65.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 4.71 110.863 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.25 23.44 5.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 2.8199999999999998 110.807 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.96 87.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.185 -0.462 . . . . 3.8100000000000001 110.883 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 131.47 -81.87 0.32 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 3.8100000000000001 112.454 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.45 179.26 3.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 4.4699999999999998 110.953 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.44 120.22 1.32 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.732 -0.747 . . . . 3.3199999999999998 112.444 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.9 m80 63.34 91.35 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.815 0.341 . . . . 2.9199999999999999 110.886 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.9 t -98.12 -75.49 0.55 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.166 -0.47 . . . . 4.8399999999999999 110.918 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.0 t -178.99 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.508 . . . . 5.0 110.861 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.1 116.86 7.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.638 0.732 . . . . 2.6600000000000001 110.909 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -8.73 24.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.726 2.284 . . . . 2.54 112.319 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 -24.21 13.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 6.1600000000000001 110.882 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.9 169.08 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.5499999999999998 111.105 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.6 7.35 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 4.0199999999999996 111.142 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -89.26 -34.13 16.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 5.3700000000000001 110.884 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.94 138.34 95.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.677 0.751 . . . . 5.0599999999999996 110.815 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 87.4 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.655 2.237 . . . . 2.8199999999999998 112.35 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.08 139.49 14.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 3.1000000000000001 111.179 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.74 112.28 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 4.0999999999999996 110.916 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -129.26 -169.18 2.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 6.6399999999999997 110.881 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -114.53 79.57 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 4.3200000000000003 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.8 t -107.33 159.95 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 3.8100000000000001 111.119 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.84 112.88 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 5.4800000000000004 110.829 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.5 pp -76.69 -33.11 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 4.4800000000000004 111.124 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -72.26 -39.2 68.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 4.4699999999999998 110.88 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.13 17.97 13.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 3.7200000000000002 111.194 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -70.62 138.23 50.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 8.3800000000000008 110.853 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -154.38 134.18 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 4.7000000000000002 110.887 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.24 171.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 3.9399999999999999 110.94 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 97.7 p -89.58 -172.8 3.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 5.5700000000000003 110.842 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -85.76 -59.88 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 4.9100000000000001 111.157 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -37.2 62.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 3.8199999999999998 110.846 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -70.49 -29.77 66.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 3.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.82 -28.39 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 2.7599999999999998 111.124 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -87.73 -36.49 17.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 5.4000000000000004 110.908 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.82 -17.48 50.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.708 -0.758 . . . . 1.74 112.512 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.3 tp -109.59 -30.37 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 2.1899999999999999 111.141 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -77.65 -40.07 43.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 3.6800000000000002 110.901 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 3.3799999999999999 110.862 -179.794 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.78 0.324 . . . . 3.8900000000000001 111.152 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -139.67 136.57 34.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 5.7300000000000004 110.913 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.03 107.09 15.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 4.9199999999999999 110.823 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.1 mt -75.23 138.76 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 3.4700000000000002 111.142 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -98.3 -74.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 5.2800000000000002 110.863 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.35 145.47 47.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 6.9400000000000004 110.873 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -85.69 163.25 18.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 7.2999999999999998 110.911 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.7 p -100.87 137.94 19.91 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.557 0.694 . . . . 4.3300000000000001 111.163 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -171.49 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.684 2.256 . . . . 2.71 112.335 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 56.64 22.97 7.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 4.0599999999999996 110.887 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -165.28 142.82 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 5.4000000000000004 110.895 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.45 142.52 58.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 2.7000000000000002 110.885 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -56.03 -25.2 43.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 5.8399999999999999 110.855 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -75.69 -38.83 58.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 3.1200000000000001 110.943 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.26 -51.12 67.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 2.4700000000000002 110.903 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.1 -39.6 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 2.0899999999999999 111.164 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -68.12 -54.6 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 2.9500000000000002 110.882 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -62.16 -33.29 74.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 3.7999999999999998 110.93 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.21 -57.98 8.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 1.8799999999999999 111.098 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.6 mt -67.51 -49.27 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 3.3700000000000001 111.111 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -49.58 -46.82 49.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 4.8300000000000001 110.915 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -78.63 -29.02 45.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 4.0199999999999996 110.849 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.03 -54.14 48.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 2.5800000000000001 111.069 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -61.2 -40.63 94.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 5.5999999999999996 110.882 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -55.22 -28.07 50.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 2.8500000000000001 110.891 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.3 t -60.98 -49.48 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 2.8199999999999998 111.137 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -70.61 -48.46 55.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 5.04 110.959 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.05 -20.39 38.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 3.9300000000000002 110.87 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.11 -31.88 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 3.8100000000000001 110.894 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.59 51.19 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 2.9199999999999999 111.139 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.73 140.57 13.68 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.559 0.695 . . . . 2.79 111.123 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -38.17 8.17 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.654 2.236 . . . . 1.96 112.323 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.53 104.34 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 3.8900000000000001 110.899 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.22 129.47 49.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 5.8799999999999999 110.889 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -138.34 153.54 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 12.83 110.886 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.6 t -104.29 132.28 50.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 3.54 110.809 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.34 147.3 31.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 4.3899999999999997 110.962 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 58.1 mt -135.68 119.07 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 3.8700000000000001 111.153 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.13 -39.91 57.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 3.3399999999999999 110.924 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 95.7 m -137.27 109.42 7.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 3.5 111.131 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 173.05 -153.99 19.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 2.1499999999999999 112.494 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.98 135.61 51.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 6.3700000000000001 110.86 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.89 -175.15 2.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 2.0 111.041 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.33 -26.36 6.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 3.1099999999999999 110.902 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.4 pp -135.58 141.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 4.5199999999999996 111.166 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.39 165.47 24.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.455 . . . . 3.79 110.936 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.21 110.96 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 3.96 111.146 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.0 t -126.86 154.52 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 2.3199999999999998 111.158 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -123.05 137.73 54.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 4.5999999999999996 110.858 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.95 174.56 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 3.4700000000000002 111.102 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -125.71 169.4 12.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 5.46 110.852 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.43 -138.39 28.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 2.4399999999999999 112.518 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.07 129.96 35.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 3.0600000000000001 111.109 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -89.75 11.01 21.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 5.1500000000000004 110.899 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 58.85 18.4 39.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 4.0700000000000003 112.48 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -148.19 29.08 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.749 0.309 . . . . 7.1200000000000001 110.856 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.3 t70 64.37 47.41 3.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 6.7199999999999998 110.873 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -137.45 70.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 5.96 110.871 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.59 159.83 23.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 2.3900000000000001 111.077 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -98.07 -169.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 11.26 110.9 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -143.67 -39.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 4.8600000000000003 110.858 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.43 166.58 21.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.721 -0.752 . . . . 2.5499999999999998 112.524 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -50.12 118.74 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 4.5099999999999998 110.899 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.65 -55.12 0.75 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 2.8500000000000001 112.472 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.53 -118.78 4.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 1.9299999999999999 112.502 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.1 mm -74.1 140.19 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 2.7200000000000002 111.12 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -124.34 -5.12 7.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 4.0499999999999998 110.901 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 179.82 131.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 2.1499999999999999 111.109 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -113.58 143.08 45.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 5.0 110.819 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -154.14 129.97 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 1.5600000000000001 111.163 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.88 170.73 10.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 4.7599999999999998 110.858 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.99 171.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 1.03 112.481 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 160.51 49.45 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.692 2.261 . . . . 0.85999999999999999 112.374 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 157.05 -142.44 8.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.727 . . . . 1.1599999999999999 112.548 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 88.5 p -106.53 117.21 33.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 2.5699999999999998 110.838 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.14 -58.59 3.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 1.79 112.465 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 10.6 mt -93.37 21.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 3.7000000000000002 111.155 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.79 -115.79 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 3.0 112.51 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -88.43 44.95 3.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 2.1800000000000002 112.496 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.98 130.65 44.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 2.2200000000000002 110.813 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -107.49 109.63 21.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 2.1200000000000001 111.104 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -113.81 110.62 20.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 6.2400000000000002 110.816 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -103.26 118.92 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 3.8700000000000001 110.888 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -50.77 145.63 6.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 7.0199999999999996 110.883 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.22 -21.66 23.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 8.1999999999999993 110.862 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -94.69 -6.39 43.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 4.5 110.83 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -73.48 -25.25 60.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 4.0899999999999999 110.852 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 18.3 t80 67.59 128.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 6.3899999999999997 110.861 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -105.57 172.19 6.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 7.5800000000000001 110.963 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.17 173.29 17.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 2.0 111.127 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -170.74 0.36 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 2.7599999999999998 111.156 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -67.13 -21.1 65.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 5.4699999999999998 110.866 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.26 -33.5 9.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 2.54 110.878 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -54.19 177.17 0.3 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 3.4399999999999999 112.494 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.73 -88.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.733 -0.746 . . . . 2.54 112.473 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.9 m -76.33 98.54 4.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 2.5600000000000001 111.146 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.89 123.02 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 4.0999999999999996 110.838 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.4 tt -72.38 -35.85 68.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 3.3599999999999999 110.929 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -71.86 -34.79 69.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 6.9800000000000004 110.859 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -52.97 6.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 3.8300000000000001 110.922 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 94.4 m -55.07 -37.77 67.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 1.99 111.175 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.26 85.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.7 111.105 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.1 t -64.35 -39.94 87.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 2.0299999999999998 111.145 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -69.32 -43.17 74.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 3.7599999999999998 110.824 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -70.32 -56.37 6.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 3.8500000000000001 110.9 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 76.5 mt -50.48 -33.82 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 3.7599999999999998 111.119 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.8 -43.01 99.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 1.22 112.455 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -75.37 -29.14 59.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.836 0.35 . . . . 4.0199999999999996 110.906 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.49 -16.97 64.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 3.2000000000000002 110.83 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.98 -23.03 16.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 3.3999999999999999 110.935 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 136.37 69.18 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 2.23 112.468 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.0 mt -160.44 134.62 7.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 3.96 110.89 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -131.68 51.26 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 3.4900000000000002 112.5 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.8 m80 66.19 144.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 2.1899999999999999 110.878 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.5 t -122.09 -79.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 5.1900000000000004 110.861 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 175.15 -32.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 4.9299999999999997 110.906 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 86.1 m-20 -45.66 105.84 0.5 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.543 0.687 . . . . 3.29 110.907 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.4 Cg_endo -69.82 172.56 12.48 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.633 2.222 . . . . 2.8300000000000001 112.342 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.8 30.56 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 4.2400000000000002 110.947 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -126.73 172.21 10.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 2.1699999999999999 111.111 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 9.5 p -89.66 7.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 4.0800000000000001 111.155 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.9 mmm -88.02 -39.15 14.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 4.7800000000000002 110.837 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.52 143.29 20.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.661 0.743 . . . . 5.4299999999999997 110.886 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 70.41 1.6 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.704 2.269 . . . . 2.7999999999999998 112.336 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.06 165.99 33.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 3.3900000000000001 111.085 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -131.49 113.13 13.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 4.4000000000000004 110.9 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -132.01 139.57 48.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 3.6000000000000001 110.907 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -69.7 127.87 34.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 4.71 110.879 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.55 177.19 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 3.2999999999999998 111.131 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.55 125.34 27.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 3.1099999999999999 110.89 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 24.0 pt -57.09 -24.65 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 4.3799999999999999 111.115 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -77.81 -39.59 43.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 3.6699999999999999 110.888 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.81 34.12 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 4.8799999999999999 111.158 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.96 19.34 4.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 4.9199999999999999 110.878 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -84.28 149.82 25.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 4.5300000000000002 110.87 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.13 158.18 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 3.52 110.935 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.69 -172.71 4.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 4.2000000000000002 110.865 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 64.63 -177.16 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 3.7200000000000002 111.089 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -67.75 -22.05 65.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 3.5899999999999999 110.874 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -51.36 -30.01 17.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 3.4399999999999999 110.823 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -51.27 -29.96 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 2.4300000000000002 111.117 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -88.98 -31.42 18.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 7.2699999999999996 110.867 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.06 -18.27 40.45 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 1.78 112.482 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -101.4 -29.57 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 2.96 111.133 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -79.78 -32.64 40.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 3.8199999999999998 110.919 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 3.4399999999999999 110.857 -179.832 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.842 0.353 . . . . 3.3700000000000001 111.09 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.0 151.46 31.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 4.7000000000000002 110.953 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -137.99 127.95 25.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 5.7000000000000002 110.901 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 82.9 mt -108.2 143.96 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 3.0699999999999998 111.135 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -145.26 35.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 4.2000000000000002 110.856 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -133.23 152.56 51.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 5.9199999999999999 110.908 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -146.49 117.9 7.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 7.5700000000000003 110.949 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.5 t -82.17 114.22 49.42 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.63 0.729 . . . . 3.8799999999999999 111.13 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -44.03 2.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.698 2.265 . . . . 2.5099999999999998 112.315 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.6 -40.29 59.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 3.8900000000000001 110.841 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -101.38 159.68 15.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 4.0700000000000003 110.892 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.23 129.65 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.433 . . . . 3.9500000000000002 110.848 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -57.84 -22.68 49.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 7.5800000000000001 110.847 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.56 -32.09 47.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 3.3999999999999999 110.911 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.29 -43.85 48.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 2.9100000000000001 110.844 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.03 -36.42 77.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 1.97 111.12 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.62 -54.65 36.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 3.2599999999999998 110.854 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -69.45 -36.8 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 6.0899999999999999 110.892 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.17 -57.75 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 2.0 111.154 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 12.8 mt -68.4 -49.21 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 3.6000000000000001 111.166 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -51.95 -40.47 60.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 5.0099999999999998 110.867 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -78.2 -21.76 49.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 4.54 110.886 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.86 -53.11 60.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 1.8799999999999999 111.052 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -57.12 -23.97 50.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 7.0099999999999998 110.851 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -39.57 51.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 3.29 110.904 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.7 t -57.37 -44.69 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 3.1299999999999999 111.094 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -67.26 -59.34 3.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 11.539999999999999 110.92 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -56.23 -23.87 38.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 2.96 110.871 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -67.99 -12.39 60.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 3.73 110.848 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.84 30.39 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 3.5699999999999998 111.136 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.49 157.88 31.73 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.59 0.71 . . . . 3.6499999999999999 111.081 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -25.14 29.07 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.689 2.259 . . . . 2.6299999999999999 112.357 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.49 175.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 4.8499999999999996 110.91 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.32 -178.07 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 5.4900000000000002 110.926 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -135.63 151.75 50.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 8.2899999999999991 110.911 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.5 t -156.37 89.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 2.3599999999999999 110.825 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.43 137.52 54.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 2.9700000000000002 110.897 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.57 165.93 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 4.5700000000000003 111.139 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.07 -29.99 5.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 4.6900000000000004 110.887 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 91.7 m -117.78 110.3 17.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 3.5800000000000001 111.177 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 142.54 -171.31 24.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 2.0 112.489 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -110.47 157.81 19.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 5.75 110.864 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -146.99 141.89 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 2.3199999999999998 111.091 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.89 -15.67 62.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.428 . . . . 2.3700000000000001 110.892 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.6 mm -104.03 141.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 3.6600000000000001 111.111 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 tt -130.78 134.43 46.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 3.5299999999999998 110.94 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -124.86 110.76 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 2.3799999999999999 111.13 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.25 141.21 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 2.2599999999999998 111.152 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -81.19 152.72 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 4.9100000000000001 110.865 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -161.58 167.23 25.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 2.2799999999999998 111.06 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -139.54 117.74 11.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 6.4900000000000002 110.851 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.06 -137.85 17.2 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.738 . . . . 2.2000000000000002 112.503 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -80.55 110.34 15.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 2.73 111.139 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.08 56.9 3.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 4.5 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 52.0 27.23 21.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.73 . . . . 2.9500000000000002 112.465 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -163.08 -167.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.797 0.332 . . . . 6.0999999999999996 110.862 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -80.55 55.95 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 6.8200000000000003 110.894 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -137.93 34.67 2.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 8.1500000000000004 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.8 127.81 34.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 2.3100000000000001 111.149 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.81 -82.16 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 7.3600000000000003 110.861 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.78 -77.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 5.0199999999999996 110.853 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 126.36 -161.1 20.76 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.747 -0.74 . . . . 3.1499999999999999 112.469 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -53.32 119.3 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 4.4299999999999997 110.9 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.46 -14.03 62.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 2.5 112.465 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.87 -150.56 7.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 1.8799999999999999 112.497 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.3 mt -71.29 96.66 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 3.2400000000000002 111.146 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.4 pp -48.18 -29.65 3.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 4.1500000000000004 110.907 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 178.62 176.0 0.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 2.6699999999999999 111.09 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.35 120.77 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 3.9500000000000002 110.88 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -109.75 117.55 34.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 1.53 111.111 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -63.79 166.14 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 5.2199999999999998 110.876 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.92 172.61 0.27 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.729 -0.748 . . . . 0.93999999999999995 112.481 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -179.2 2.77 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.682 2.255 . . . . 0.98999999999999999 112.339 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.39 -136.88 8.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 1.28 112.5 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.2 p -108.72 130.97 55.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.924 0.392 . . . . 3.1499999999999999 110.872 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.36 -85.39 0.18 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.761 -0.733 . . . . 1.3899999999999999 112.451 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.09 -7.95 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 3.6099999999999999 111.137 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.97 -84.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 2.77 112.504 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -76.18 -2.35 72.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 2.48 112.504 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -49.03 114.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 2.2599999999999998 110.866 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -122.2 154.14 37.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 2.4900000000000002 111.106 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -133.14 149.52 52.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 3.6800000000000002 110.864 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -130.0 143.87 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 4.1399999999999997 110.847 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.88 -73.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 5.6299999999999999 110.884 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 63.8 -80.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 8.6300000000000008 110.909 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -14.04 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 6.2699999999999996 110.916 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -91.46 15.76 11.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 6.8200000000000003 110.917 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 67.23 122.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 7.6500000000000004 110.918 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.43 -170.64 1.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 8.5399999999999991 110.934 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.01 172.76 18.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 3.3500000000000001 111.181 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.78 -170.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 2.3100000000000001 111.163 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -57.17 -20.9 29.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 5.0899999999999999 110.851 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.32 -69.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 2.6099999999999999 110.838 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.51 -160.43 10.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.731 . . . . 4.2699999999999996 112.511 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 50.94 -161.85 1.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 3.3900000000000001 112.498 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 97.4 m -64.95 104.75 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 2.7599999999999998 111.177 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.89 141.76 58.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 3.6800000000000002 110.885 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.53 -54.21 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 3.4199999999999999 110.904 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -51.97 18.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 6.8300000000000001 110.936 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 12.3 tp -49.31 -38.45 27.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 3.0699999999999998 110.967 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 60.2 m -79.75 -42.66 24.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 1.77 111.127 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.65 -36.84 77.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 2.0600000000000001 111.138 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.01 -43.84 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 2.3599999999999999 111.145 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -54.2 -31.64 53.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 3.3300000000000001 110.888 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -33.11 64.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 3.8399999999999999 110.867 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 40.9 mm -55.32 -50.38 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 2.5499999999999998 111.129 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.95 -28.58 60.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 1.1100000000000001 112.453 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -47.52 75.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.33 . . . . 3.5499999999999998 110.832 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.98 29.23 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 2.0600000000000001 110.864 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.0 mt -132.24 -39.96 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 2.9199999999999999 110.933 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.61 -30.86 0.2 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 1.74 112.482 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.3 mp -90.75 90.51 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 3.98 110.936 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.1 -89.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.712 -0.756 . . . . 3.5 112.504 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -118.71 89.84 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 2.8799999999999999 110.887 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.46 172.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 5.9900000000000002 110.853 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 8.2 t -112.92 -27.33 8.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 4.21 110.879 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -51.77 112.49 3.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.724 . . . . 3.2799999999999998 110.84 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.8 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 2.1299999999999999 112.318 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -27.31 69.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 4.71 110.923 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -72.13 167.68 19.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 2.5699999999999998 111.092 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.0 m -95.49 -15.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 5.8499999999999996 111.165 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 9.0 tpt -58.22 -21.9 49.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 5.6100000000000003 110.876 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -52.22 137.38 38.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.652 0.739 . . . . 5.0099999999999998 110.858 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 76.52 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.693 2.262 . . . . 2.8599999999999999 112.35 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.8 t -157.32 167.67 29.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 4.0 111.193 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -115.14 112.22 22.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.263 -0.426 . . . . 5.1699999999999999 110.943 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -136.22 -169.6 2.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 3.4199999999999999 110.896 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -107.24 142.57 36.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 6.1900000000000004 110.917 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.7 t -149.47 143.05 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 3.1400000000000001 111.182 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.87 126.06 26.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 2.75 110.832 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.8 tt -58.09 -22.83 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 4.0 111.132 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.25 -31.28 12.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 3.6400000000000001 110.916 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.93 33.53 2.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 2.8500000000000001 111.137 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -104.21 129.08 52.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 6.04 110.916 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -176.55 129.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 4.0199999999999996 110.898 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.8 mt -58.44 114.65 2.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 5.1299999999999999 110.9 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.02 108.2 9.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 5.25 110.895 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 174.18 172.59 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 4.3499999999999996 111.1 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -18.64 49.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 3.23 110.915 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -52.4 -30.44 29.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 3.5899999999999999 110.868 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 68.6 mt -51.36 -29.0 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 4.0599999999999996 111.116 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -87.55 -33.13 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 5.8099999999999996 110.85 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.58 -14.66 77.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 2.0800000000000001 112.47 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 7.2 tp -92.29 -34.36 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.784 0.326 . . . . 2.23 111.137 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -79.31 -40.84 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 4.4199999999999999 110.941 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 3.27 110.867 -179.799 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.2 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.841 0.353 . . . . 3.25 111.119 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -152.41 136.6 16.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 6.3300000000000001 110.941 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -161.45 145.77 13.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 5.7699999999999996 110.868 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.7 mt -108.07 148.81 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 2.5699999999999998 111.144 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -156.45 38.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 3.4700000000000002 110.907 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -135.39 148.81 49.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 6.5199999999999996 110.92 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -147.86 122.51 9.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 6.4400000000000004 110.891 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.56 147.38 41.89 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.55 0.69 . . . . 3.9199999999999999 111.118 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -168.02 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.652 2.235 . . . . 2.8300000000000001 112.339 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 73.82 -62.29 0.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 3.8999999999999999 110.84 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 36.2 mmt -100.92 137.26 39.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 4.4199999999999999 110.874 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.31 158.15 9.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 3.3300000000000001 110.896 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -52.57 -30.96 33.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 10.289999999999999 110.889 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.49 -45.38 72.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 2.8799999999999999 110.908 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.71 -44.72 93.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 2.3599999999999999 110.893 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.49 -37.02 49.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 2.0800000000000001 111.108 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -63.75 -54.5 34.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 2.7400000000000002 110.872 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -59.31 -33.47 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 3.79 110.927 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.15 71.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 1.9099999999999999 111.119 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.3 mm -83.13 -44.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 3.5800000000000001 111.17 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.69 -45.23 58.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 4.8600000000000003 110.923 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -78.09 -20.48 52.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 3.9100000000000001 110.907 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.03 -53.69 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 1.6000000000000001 111.099 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -36.11 75.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 4.7999999999999998 110.885 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -28.1 69.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 3.4700000000000002 110.893 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.28 -56.19 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 2.98 111.124 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -73.26 -34.41 65.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 4.9699999999999998 110.884 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.8 t -56.25 -23.49 36.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 2.48 110.874 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.28 -16.6 63.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 2.6000000000000001 110.885 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.2 t -114.41 -33.46 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 4.5999999999999996 111.121 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 t -107.19 146.0 32.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.614 0.721 . . . . 4.0 111.146 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -7.61 21.51 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 2.9100000000000001 112.313 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.23 150.34 3.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 3.54 110.965 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.59 -173.15 2.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 8.1099999999999994 110.923 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -135.56 119.83 17.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 8.1600000000000001 110.92 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -111.16 89.95 3.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 3.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.9 110.57 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 3.1899999999999999 110.878 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.33 162.84 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 4.0499999999999998 111.151 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -113.12 51.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 5.1600000000000001 110.851 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.7 t -175.63 160.17 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 4.9400000000000004 111.147 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.47 139.81 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 2.6800000000000002 112.491 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.82 164.3 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.357 . . . . 7.1200000000000001 110.86 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.02 136.77 23.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 2.2999999999999998 111.081 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.92 -45.48 64.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 2.54 110.867 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.7 pt -108.79 135.53 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 4.0599999999999996 111.079 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.19 125.46 29.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 3.9500000000000002 110.922 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 t -94.52 112.57 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 2.2200000000000002 111.117 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.1 t -145.03 144.42 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 2.2799999999999998 111.108 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -108.06 137.89 45.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 4.54 110.896 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.56 164.01 31.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 2.5899999999999999 111.105 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.32 126.42 52.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 6.25 110.85 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.72 -142.46 20.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.738 . . . . 1.3500000000000001 112.516 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.02 124.42 24.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 2.0899999999999999 111.134 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -89.62 76.64 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 3.8199999999999998 110.833 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.27 45.72 64.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 2.4199999999999999 112.499 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.78 88.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 6.6399999999999997 110.843 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -166.35 -74.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 4.3300000000000001 110.865 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -137.36 93.74 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 4.96 110.829 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.24 128.86 34.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 2.0299999999999998 111.116 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.66 -37.23 1.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 7.9000000000000004 110.918 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.13 168.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 6.1299999999999999 110.86 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.85 -148.49 7.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 3.8300000000000001 112.473 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.27 135.09 27.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 5.8600000000000003 110.838 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.98 -19.12 6.14 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.738 . . . . 5.0999999999999996 112.497 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.16 -107.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 3.02 112.535 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.4 mm -71.4 149.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.898 0.38 . . . . 3.8599999999999999 111.095 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.49 -18.66 10.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 5.46 110.884 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 175.64 124.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 2.7000000000000002 111.098 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -104.09 164.07 11.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 6.3799999999999999 110.818 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -179.68 109.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 1.7 111.098 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -71.11 150.8 45.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 5.3799999999999999 110.935 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.6 -167.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 1.1499999999999999 112.474 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 160.76 48.53 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.658 2.238 . . . . 1.6100000000000001 112.355 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 147.1 -163.45 28.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.742 . . . . 1.1299999999999999 112.49 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.08 140.67 29.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.895 0.378 . . . . 2.6499999999999999 110.841 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.25 -64.96 2.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.681 -0.771 . . . . 1.54 112.513 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.74 61.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.36 . . . . 4.0899999999999999 111.131 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -88.62 46.33 3.32 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 3.48 112.444 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.38 31.82 0.88 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 2.02 112.472 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -64.51 139.29 58.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.771 0.32 . . . . 2.9100000000000001 110.929 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.5 119.8 35.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 2.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -115.18 109.88 18.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 4.5700000000000003 110.859 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -113.0 101.66 9.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 3.6099999999999999 110.882 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.41 117.18 2.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 6.4000000000000004 110.857 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -64.22 -48.61 75.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 7.8200000000000003 110.942 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -50.16 -30.45 11.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 3.7999999999999998 110.895 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -169.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 3.7200000000000002 110.882 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -125.31 116.73 22.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 5.6500000000000004 110.869 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -105.06 97.41 7.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 8.3200000000000003 110.957 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.85 172.95 6.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 2.1200000000000001 111.11 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.42 173.57 6.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 2.1099999999999999 111.121 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -21.4 59.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.437 . . . . 10.42 110.891 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.05 -64.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 2.23 110.833 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.08 -177.14 14.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.772 -0.727 . . . . 3.4399999999999999 112.478 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 51.47 -170.88 0.31 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 2.4700000000000002 112.519 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -56.7 99.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 2.2799999999999998 111.134 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.11 111.66 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 3.9700000000000002 110.867 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.8 -35.65 71.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 3.2200000000000002 110.925 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -71.37 -62.43 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 6.0700000000000003 110.859 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.3 tp -51.34 -53.51 35.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 3.2599999999999998 110.917 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 23.3 m -55.58 -49.4 72.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 1.8799999999999999 111.142 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.63 -44.2 76.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 1.8500000000000001 111.075 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 23.7 t -66.4 -46.57 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 2.1200000000000001 111.104 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -54.02 -29.46 43.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 3.5699999999999998 110.856 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.59 -42.1 59.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 3.3599999999999999 110.879 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.5 mm -51.21 -32.95 13.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 2.6200000000000001 111.095 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.65 -55.36 8.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 1.1599999999999999 112.522 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -37.49 77.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 3.8700000000000001 110.811 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.0 p -65.23 -34.58 78.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 3.7400000000000002 110.878 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.1 mp -95.31 23.47 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 2.8399999999999999 110.902 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.44 98.89 0.27 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 1.95 112.513 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 18.7 tp -149.76 156.6 42.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.793 0.33 . . . . 4.4699999999999998 110.956 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.93 -109.16 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 3.77 112.497 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.3 147.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 2.79 110.875 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.27 -77.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 7.1399999999999997 110.894 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t 62.89 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 5.8799999999999999 110.886 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.0 159.49 68.47 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.635 0.731 . . . . 2.79 110.808 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -24.98 29.12 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 2.23 112.361 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.6 -31.11 12.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 4.8099999999999996 110.941 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -52.46 172.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 2.8399999999999999 111.093 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.38 7.48 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 3.4199999999999999 111.121 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -27.5 36.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 5.1600000000000001 110.875 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.447 ' O ' ' CG ' ' A' ' 237' ' ' PHE . 3.0 p90 -47.61 114.59 3.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.681 0.753 . . . . 10.52 110.888 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 61.68 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.669 2.246 . . . . 2.52 112.334 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.93 169.18 21.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 3.1899999999999999 111.113 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -109.13 113.01 25.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 4.4199999999999999 110.962 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -135.29 123.57 23.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 4.5499999999999998 110.902 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -66.58 141.37 57.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 4.4699999999999998 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 97.8 t -150.39 144.36 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 3.2200000000000002 111.103 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.56 126.93 21.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 3.1200000000000001 110.872 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.27 -25.38 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 4.7199999999999998 111.107 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.05 -39.5 23.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 3.8100000000000001 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.1 p -93.13 10.01 33.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 3.46 111.13 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -79.42 122.84 26.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 6.2300000000000004 110.864 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -163.81 148.02 10.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 4.0999999999999996 110.883 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.12 151.97 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 3.3199999999999998 110.929 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 6.3 t -89.2 -171.47 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 3.9100000000000001 110.9 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -84.06 -56.34 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 5.1799999999999997 111.12 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.71 -38.27 60.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 3.29 110.846 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.53 -29.05 65.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 3.02 110.858 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -27.56 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 2.6200000000000001 111.147 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.0 mtp85 -87.79 -23.43 24.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 5.5599999999999996 110.87 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.45 -22.96 64.17 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.718 -0.753 . . . . 2.4500000000000002 112.504 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.5 tp -92.87 -31.05 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.329 . . . . 2.2200000000000002 111.155 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -78.9 -42.55 26.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 4.0700000000000003 110.911 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 4.6799999999999997 110.821 -179.789 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.743 0.306 . . . . 4.1699999999999999 111.112 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -142.08 136.53 30.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 5.8499999999999996 110.935 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -107.93 103.28 12.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 7.7000000000000002 110.917 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.7 mm -70.73 148.44 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 4.0 111.145 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -109.29 -75.09 0.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 5.1600000000000001 110.877 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -140.07 146.13 38.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 6.6699999999999999 110.883 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -92.5 163.26 13.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.207 -0.451 . . . . 7.5499999999999998 110.913 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.32 159.32 29.65 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.564 0.697 . . . . 4.7400000000000002 111.156 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.8 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.671 2.248 . . . . 2.8100000000000001 112.345 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 73.84 -63.39 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 4.4500000000000002 110.819 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.81 144.62 29.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 7.6799999999999997 110.881 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.09 161.82 15.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 4.0599999999999996 110.901 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -21.92 48.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 7.8099999999999996 110.859 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -79.78 -36.67 36.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 4.9900000000000002 110.895 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.0 -44.02 93.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 2.4399999999999999 110.887 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 p -74.58 -34.59 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 2.0299999999999998 111.077 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.66 -54.61 11.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 2.5800000000000001 110.852 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -62.82 -33.33 75.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 4.04 110.928 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.92 -58.73 6.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 1.5700000000000001 111.125 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 9.5 pt -65.69 -28.31 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 4.1699999999999999 111.119 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -48.25 -56.12 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 5.3499999999999996 110.851 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -26.17 44.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 3.7200000000000002 110.871 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.59 -33.97 64.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 1.9399999999999999 111.114 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -73.69 -30.75 63.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 7.2199999999999998 110.842 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -78.99 -29.12 43.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 4.6900000000000004 110.935 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -50.73 -42.52 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 2.9500000000000002 111.136 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -96.18 -44.88 7.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 4.8300000000000001 110.941 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.0 m -54.99 -24.99 26.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 4.3300000000000001 110.89 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -61.36 -21.39 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 2.6899999999999999 110.88 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.1 41.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 2.79 111.121 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.62 128.6 4.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.595 0.712 . . . . 2.8599999999999999 111.183 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 78.15 1.0 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.707 2.271 . . . . 2.7200000000000002 112.383 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.64 102.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 4.79 110.908 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.93 128.7 47.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 6.5300000000000002 110.882 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -138.81 152.41 47.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 12.33 110.895 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.01 152.23 23.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 4.7400000000000002 110.804 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -58.5 151.34 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 4.2400000000000002 110.863 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.0 mp -137.75 130.33 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 4.1699999999999999 111.161 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.15 -13.1 61.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 4.0700000000000003 110.901 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.0 -178.57 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 5.8600000000000003 111.122 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.18 48.22 2.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 3.8300000000000001 112.466 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.15 99.6 7.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.34 . . . . 8.0199999999999996 110.858 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.43 129.78 13.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.426 . . . . 2.2799999999999998 111.098 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -19.1 57.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 4.9500000000000002 110.844 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.2 pt -138.21 141.74 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 4.6200000000000001 111.126 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -114.21 118.65 34.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 2.2599999999999998 110.93 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 89.0 t -92.39 125.46 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 2.52 111.143 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.22 164.59 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 4.0499999999999998 111.123 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -137.52 101.09 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 9.2799999999999994 110.86 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -125.72 155.46 40.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 2.3999999999999999 111.107 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.93 127.4 53.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 6.1600000000000001 110.848 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.19 -144.51 13.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.691 -0.766 . . . . 1.46 112.505 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.7 123.04 18.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 2.23 111.088 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -95.15 25.4 4.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 4.0099999999999998 110.878 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.89 -23.03 30.86 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.694 -0.765 . . . . 2.4300000000000002 112.448 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -179.31 35.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 5.1900000000000004 110.886 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.98 -169.46 2.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 5.2999999999999998 110.886 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -77.05 114.55 15.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 4.9100000000000001 110.819 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.4 128.8 34.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 2.0800000000000001 111.101 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -131.21 170.66 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 7.1699999999999999 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -122.87 165.04 17.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 4.54 110.865 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.22 -142.09 1.49 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.725 -0.75 . . . . 3.3300000000000001 112.434 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -50.51 119.14 3.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 4.0899999999999999 110.926 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.11 -73.94 0.44 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.754 -0.736 . . . . 2.5899999999999999 112.47 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -89.67 -143.26 9.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.751 . . . . 1.8799999999999999 112.513 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.5 mm -71.29 133.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.889 0.376 . . . . 3.1499999999999999 111.113 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.47 -14.12 17.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 3.6899999999999999 110.946 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.88 125.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 2.6600000000000001 111.075 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -143.67 106.93 4.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 4.2699999999999996 110.915 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -100.34 142.31 32.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 1.4399999999999999 111.148 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.39 170.03 16.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 3.6499999999999999 110.915 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -53.96 176.67 0.3 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.687 -0.768 . . . . 0.93000000000000005 112.49 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -169.92 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.677 2.252 . . . . 1.28 112.367 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.54 -141.94 13.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 1.5700000000000001 112.51 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.1 m -127.03 146.26 50.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.928 0.394 . . . . 4.2000000000000002 110.873 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.22 -58.96 3.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.76 -0.733 . . . . 1.5 112.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.1 mm -106.12 -23.22 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.378 . . . . 3.4500000000000002 111.169 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.06 128.5 39.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 2.4900000000000002 112.509 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 89.8 -15.44 59.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 2.02 112.513 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -51.77 147.46 6.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 2.4300000000000002 110.871 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -121.34 109.39 14.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 1.99 111.093 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -96.99 110.46 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 5.0300000000000002 110.864 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -115.64 104.95 12.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 3.7200000000000002 110.886 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -51.7 113.45 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 7.2400000000000002 110.819 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.93 -41.18 77.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 7.2599999999999998 110.906 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.76 -51.06 59.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 4.4500000000000002 110.881 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -54.4 148.29 12.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 4.3399999999999999 110.862 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -89.27 121.44 31.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 8.0099999999999998 110.865 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -107.4 99.29 8.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 8.0600000000000005 110.912 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.2 t -157.1 134.14 10.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 5.3499999999999996 111.154 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.3 t -106.88 72.41 0.89 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 4.4199999999999999 111.135 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -82.66 -67.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 9.3100000000000005 110.86 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.5 m -114.23 -71.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 3.6299999999999999 110.843 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.41 4.75 1.32 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 5.4100000000000001 112.456 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.14 -161.43 0.97 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 3.1600000000000001 112.467 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.9 m -59.2 96.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 2.4300000000000002 111.14 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.38 127.41 35.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 2.9300000000000002 110.88 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -37.98 66.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 4.54 110.971 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -72.29 -32.49 66.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 6.4699999999999998 110.903 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.82 -60.04 2.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 3.7799999999999998 110.963 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -38.27 68.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 2.2799999999999998 111.166 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.96 74.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 1.97 111.087 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 58.7 t -49.18 -43.07 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 2.0099999999999998 111.109 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -36.66 71.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 4.1900000000000004 110.86 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.51 -42.83 58.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 3.9100000000000001 110.858 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 45.2 mm -50.06 -39.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 2.4700000000000002 111.111 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.11 -51.98 6.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.78 -0.724 . . . . 0.83999999999999997 112.499 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -55.49 -26.86 44.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 3.3199999999999998 110.867 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.27 24.73 4.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 2.25 110.905 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 mp -148.92 17.96 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 2.48 110.94 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 88.33 77.21 1.29 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.749 . . . . 1.8300000000000001 112.499 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -130.27 179.56 5.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.358 . . . . 4.1200000000000001 110.942 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.61 -123.73 3.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.805 -0.712 . . . . 3.4399999999999999 112.507 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.61 150.56 12.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 2.8199999999999998 110.815 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.3 m 61.0 -92.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 7.54 110.843 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 32.3 m 59.6 -86.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.499 . . . . 4.9699999999999998 110.847 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.5 155.96 75.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.611 0.719 . . . . 2.52 110.864 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 233' ' ' LYS . 53.6 Cg_endo -69.76 168.79 20.55 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.717 2.278 . . . . 2.7999999999999998 112.335 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.7 41.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 5.8600000000000003 110.868 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -130.85 153.79 48.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 2.2400000000000002 111.082 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 99.7 t -56.05 -25.74 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 5.2999999999999998 111.097 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.5 tpp -66.4 -18.2 65.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 5.8399999999999999 110.85 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -109.72 82.22 2.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.657 0.742 . . . . 5.4299999999999997 110.861 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 104.93 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.651 2.234 . . . . 4.9500000000000002 112.345 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.8 t -157.29 127.77 6.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 3.5099999999999998 111.136 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -61.82 120.92 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 4.79 110.938 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -162.61 140.9 8.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 4.21 110.892 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -58.59 125.24 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 5.8499999999999996 110.929 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.4 t -150.49 143.66 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 3.7000000000000002 111.117 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.51 122.02 8.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 4.0 110.902 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 22.3 pt -74.74 -23.9 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 4.9000000000000004 111.092 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -87.22 -23.71 24.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 5.5800000000000001 110.919 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.2 m -100.95 6.54 43.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 3.5600000000000001 111.176 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -50.24 132.8 24.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 5.4199999999999999 110.849 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -179.56 148.05 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 5.4900000000000002 110.87 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.32 171.07 11.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 3.6099999999999999 110.928 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.8 p -89.94 170.37 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 5.3799999999999999 110.895 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.84 -53.75 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 5.1699999999999999 111.099 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -18.84 51.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 3.0299999999999998 110.923 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.43 -36.34 73.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 2.7200000000000002 110.847 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.96 -32.17 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 4.0099999999999998 111.154 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -59.03 -26.11 64.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 11.31 110.863 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -98.97 45.17 1.61 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 2.2599999999999998 112.467 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 7.5 tp -176.69 -36.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.761 0.315 . . . . 2.2400000000000002 111.105 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.21 -44.27 26.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 4.3200000000000003 110.905 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 3.0600000000000001 110.89 -179.817 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.829 0.347 . . . . 3.6299999999999999 111.129 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -152.57 136.62 16.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 5.5599999999999996 110.941 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 45.4 ptt85 -123.1 127.55 48.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 6.9699999999999998 110.896 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.9 pt -107.59 148.53 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 3.77 111.141 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -149.02 -41.07 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 4.1699999999999999 110.882 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -96.2 150.38 20.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 6.5199999999999996 110.919 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -147.7 134.28 19.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 7.0800000000000001 110.902 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.04 146.85 18.29 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.613 0.72 . . . . 3.46 111.166 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 163.51 38.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 2.8500000000000001 112.327 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.54 16.13 9.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 3.8399999999999999 110.86 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.5 tpt -145.36 131.36 19.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 4.3700000000000001 110.867 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.34 135.22 57.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 3.6200000000000001 110.878 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -59.07 -20.16 50.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 6.7800000000000002 110.861 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -74.09 -30.5 62.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 3.8500000000000001 110.875 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.98 -44.94 75.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 3.4500000000000002 110.874 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.41 -28.33 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 2.2400000000000002 111.092 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -71.88 -47.97 49.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 3.23 110.841 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.57 -39.1 58.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 4.4800000000000004 110.9 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.73 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 2.1400000000000001 111.093 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.15 -28.55 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 5.2800000000000002 111.084 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -56.1 -41.23 74.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 4.1500000000000004 110.824 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.1 -19.65 46.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 3.8900000000000001 110.895 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.42 -38.54 34.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 2.3199999999999998 111.064 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.28 -25.71 58.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 7.3899999999999997 110.878 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -80.69 -51.15 9.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 3.0099999999999998 110.888 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.7 p -49.21 -42.28 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 3.4100000000000001 111.102 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -75.84 -50.8 14.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 4.8899999999999997 110.882 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 76.7 p -55.15 -24.96 29.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 2.25 110.859 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.99 -31.61 30.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 4.1900000000000004 110.854 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -119.24 45.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 3.0 111.167 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.46 135.44 8.3 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.565 0.698 . . . . 3.1699999999999999 111.124 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -23.74 30.31 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.697 2.265 . . . . 2.1400000000000001 112.346 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.71 113.4 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 4.4800000000000004 110.935 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.32 129.12 39.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 6.1600000000000001 110.918 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -137.52 154.48 49.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.441 . . . . 13.58 110.886 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.9 t -101.86 122.8 44.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 3.9500000000000002 110.845 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.25 142.27 43.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 3.6000000000000001 110.891 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 71.6 mt -113.24 117.6 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 3.8500000000000001 111.146 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.7 -39.84 59.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 5.4000000000000004 110.858 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 97.2 m -139.14 112.31 8.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 4.3700000000000001 111.14 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.25 -163.59 31.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.783 -0.722 . . . . 3.0299999999999998 112.481 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.73 143.85 38.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 5.79 110.91 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -113.12 160.44 18.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 2.48 111.088 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.45 -34.31 61.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 3.48 110.897 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 66.3 mt -104.7 141.04 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 3.6600000000000001 111.129 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -121.64 117.31 26.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 2.6800000000000002 110.93 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.0 t -95.45 110.99 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 2.9399999999999999 111.096 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.8 t -149.7 142.21 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 2.3500000000000001 111.123 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -80.4 152.8 28.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 5.2599999999999998 110.907 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.3 176.17 8.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 2.5 111.076 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -144.85 111.97 5.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 6.04 110.893 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.12 -125.3 27.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 1.3700000000000001 112.502 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.68 114.86 23.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.333 . . . . 3.0899999999999999 111.12 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -89.16 48.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 4.2400000000000002 110.923 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.85 45.81 5.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.731 . . . . 3.48 112.526 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.74 96.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.337 . . . . 8.3699999999999992 110.869 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.4 -74.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 4.6600000000000001 110.846 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -128.06 80.73 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 5.29 110.868 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.22 113.26 19.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 2.5499999999999998 111.084 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 141.31 43.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 6.9699999999999998 110.888 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 p30 178.69 -174.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 4.9900000000000002 110.86 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.65 106.04 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 3.5299999999999998 112.521 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.26 118.96 2.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 6.7800000000000002 110.919 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 121.16 -41.44 1.9 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.748 . . . . 3.0899999999999999 112.533 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -75.91 -114.03 0.12 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 1.8200000000000001 112.516 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.8 mm -92.44 135.18 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 3.21 111.102 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.94 -20.84 13.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 4.3200000000000003 110.892 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.62 124.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 2.2200000000000002 111.128 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -109.46 146.74 34.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 4.5300000000000002 110.842 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -155.76 122.34 5.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 1.54 111.119 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.67 169.45 18.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 3.5699999999999998 110.897 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.16 177.55 0.27 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.711 -0.757 . . . . 1.1499999999999999 112.485 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 153.12 69.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.73 2.287 . . . . 1.3400000000000001 112.331 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.79 175.2 27.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.746 -0.74 . . . . 1.6499999999999999 112.513 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 88.9 p -58.72 158.89 7.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 2.54 110.891 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.85 -102.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 1.49 112.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.64 -73.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 3.48 111.11 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 50.54 -132.63 30.76 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 2.7999999999999998 112.51 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -88.66 47.1 3.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 2.21 112.486 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.92 154.97 37.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 2.46 110.883 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.95 109.52 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 2.2200000000000002 111.02 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -111.44 109.89 20.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 4.5199999999999996 110.812 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -106.33 103.2 12.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 3.8599999999999999 110.871 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.66 101.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 7.5300000000000002 110.87 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.9 -29.15 26.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 7.1900000000000004 110.886 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -32.81 70.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 3.8500000000000001 110.838 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.84 -174.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 3.5 110.939 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -114.17 76.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 5.5700000000000003 110.844 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -73.6 147.52 43.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 8.1500000000000004 110.938 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.66 173.09 17.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 3.0499999999999998 111.143 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -173.86 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 2.71 111.117 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -55.64 -48.97 74.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 5.4900000000000002 110.84 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -81.92 -25.09 35.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 3.4199999999999999 110.835 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.8 -172.13 0.39 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 4.0499999999999998 112.474 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.47 -86.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 3.4500000000000002 112.511 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -93.63 109.51 21.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 2.8500000000000001 111.127 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -49.92 114.31 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 4.2000000000000002 110.911 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.54 -35.77 78.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 4.3600000000000003 110.934 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.9 -57.93 3.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 6.7300000000000004 110.928 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 14.8 tp -47.9 -45.41 30.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 2.98 110.889 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 24.8 m -59.37 -44.8 92.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 1.72 111.102 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.28 80.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 1.77 111.122 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.4 t -49.21 -50.47 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 2.1600000000000001 111.159 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -54.08 -33.63 58.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 3.3700000000000001 110.882 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.73 -41.57 59.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 3.98 110.855 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 39.1 mm -53.37 -37.93 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 2.6400000000000001 111.105 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.99 -53.56 5.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 0.92000000000000004 112.493 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -57.15 -24.92 57.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 3.4300000000000002 110.872 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.3 m -87.25 -17.58 32.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 2.1699999999999999 110.864 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.2 mp -120.82 24.83 10.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 2.7400000000000002 110.95 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.87 106.52 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 1.98 112.466 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.12 -67.01 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 5.1900000000000004 110.905 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 67.13 121.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 3.48 112.486 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -51.71 152.68 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 2.4199999999999999 110.866 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 73.7 m -134.05 -77.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 4.6100000000000003 110.856 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 8.2 t 178.09 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 6.2699999999999996 110.895 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -48.4 108.01 0.85 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.612 0.72 . . . . 2.8199999999999998 110.883 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 157.02 61.85 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.717 2.278 . . . . 2.04 112.314 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.14 17.9 8.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 7.04 110.927 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.46 175.45 5.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 2.4100000000000001 111.099 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 49.7 t -71.46 -18.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 6.1100000000000003 111.139 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -74.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 7.5599999999999996 110.823 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -128.36 65.14 69.89 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.658 0.742 . . . . 7.7400000000000002 110.903 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -169.88 0.36 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.669 2.246 . . . . 7.5199999999999996 112.367 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.49 155.37 40.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 3.3100000000000001 111.137 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -62.09 118.7 7.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 4.6699999999999999 110.912 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.64 -168.94 1.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 4.1799999999999997 110.922 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -132.75 102.55 5.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 4.8700000000000001 110.942 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.69 157.08 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 3.3999999999999999 111.108 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -58.63 114.64 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 2.6600000000000001 110.864 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -69.2 -25.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 4.71 111.118 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -28.6 32.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 4.46 110.895 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.29 13.27 32.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 3.25 111.153 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -51.28 164.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 6.4299999999999997 110.877 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -179.44 146.97 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 3.9100000000000001 110.863 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 40.7 tp -66.98 162.48 21.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 3.5600000000000001 110.91 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.77 145.22 25.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 5.5800000000000001 110.846 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.22 -71.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 4.25 111.115 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.09 -35.06 59.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 3.7000000000000002 110.841 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -70.82 -29.99 66.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 2.8799999999999999 110.85 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -51.58 -28.51 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 2.8700000000000001 111.106 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.8 mtp85 -79.88 -37.77 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 6.8499999999999996 110.824 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.36 58.88 3.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.741 -0.742 . . . . 2.4100000000000001 112.505 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 5.2 tp -177.89 -39.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.321 . . . . 2.5299999999999998 111.151 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -73.55 -30.89 63.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 4.8799999999999999 110.901 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 4.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.782 0.325 . . . . 2.6699999999999999 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -146.96 136.67 23.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 4.8700000000000001 110.875 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -135.21 126.23 27.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 4.8799999999999999 110.859 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.1 pt -104.82 133.96 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 4.0 111.103 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -135.55 29.37 3.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 3.7000000000000002 110.904 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -112.86 151.33 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 6.46 110.926 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -147.69 145.23 28.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 7.0899999999999999 110.943 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.67 133.14 23.83 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.601 0.715 . . . . 4.3799999999999999 111.121 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -49.56 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.69 2.26 . . . . 3.02 112.329 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -30.99 15.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 4.3899999999999997 110.876 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 24.7 mtp -108.01 164.57 12.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 6.3300000000000001 110.906 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -86.55 161.53 18.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 3.8399999999999999 110.873 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -25.49 36.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 8.4800000000000004 110.909 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -80.07 -41.17 26.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 5.1699999999999999 110.883 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -55.66 -53.03 61.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 2.25 110.873 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.1 -37.57 79.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 2.54 111.161 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -61.44 -54.25 45.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 2.5499999999999998 110.845 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -70.37 -32.54 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 3.9900000000000002 110.955 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.24 -57.45 8.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 1.8600000000000001 111.079 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -76.06 -45.67 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 3.0800000000000001 111.129 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.61 -37.35 39.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 5.4299999999999997 110.856 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -78.53 -30.68 47.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 4.71 110.883 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.73 -35.96 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 1.73 111.073 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -74.51 -28.15 60.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 4.8200000000000003 110.878 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.34 -50.42 10.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 3.5699999999999998 110.932 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -50.09 -30.99 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 3.04 111.143 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -88.76 -43.48 11.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 5.0199999999999996 110.926 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 70.7 p -54.75 -24.79 23.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.6400000000000001 110.871 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.31 -24.43 43.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 3.1699999999999999 110.864 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -140.94 46.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 3.0 111.103 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 m -155.76 132.06 5.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 2.5099999999999998 111.142 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -8.36 23.4 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.712 2.275 . . . . 1.8 112.364 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.65 147.01 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 3.7200000000000002 110.891 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 137.24 53.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 6.0 110.894 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -99.35 134.48 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 7.7000000000000002 110.923 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.4 t -123.87 89.91 3.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 2.2799999999999998 110.836 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.88 119.92 19.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 3.29 110.863 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.14 149.29 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 3.7599999999999998 111.086 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.43 -24.53 34.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 4.2699999999999996 110.893 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.2 m -139.77 132.16 28.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 4.2000000000000002 111.142 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.19 162.8 11.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.802 -0.713 . . . . 2.52 112.516 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 42.0 mtt -95.02 166.39 11.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 7.9800000000000004 110.902 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -142.86 163.49 32.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 2.23 111.093 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -25.53 65.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.7200000000000002 110.897 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.9 mm -104.02 84.54 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 4.1200000000000001 111.094 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -81.06 115.78 20.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 2.4100000000000001 110.945 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.84 107.98 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 3.3700000000000001 111.154 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.4 t -138.27 145.08 29.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 2.3100000000000001 111.066 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -93.11 129.48 39.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 4.9000000000000004 110.866 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -111.09 178.39 4.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 2.0699999999999998 111.117 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -144.02 112.24 6.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 5.29 110.866 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 58.66 -131.15 51.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 1.48 112.521 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.95 110.55 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 2.1400000000000001 111.096 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -85.36 53.64 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 4.2400000000000002 110.882 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 78.62 -57.74 4.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.733 -0.746 . . . . 3.0899999999999999 112.499 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -162.7 46.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 5.5599999999999996 110.882 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.31 -169.13 1.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 4.5999999999999996 110.869 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -76.75 96.4 4.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 4.6100000000000003 110.911 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.39 143.64 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 2.8199999999999998 111.11 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -155.75 139.18 15.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 8.0800000000000001 110.906 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.17 -175.47 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 4.7800000000000002 110.841 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.74 99.32 1.09 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 3.9199999999999999 112.464 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.04 118.95 2.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 4.2000000000000002 110.865 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.16 -34.74 5.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 3.7000000000000002 112.479 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.79 -147.63 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 2.0099999999999998 112.494 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.6 mm -71.62 89.47 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 3.6299999999999999 111.104 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.6 pp -45.2 -32.89 2.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 4.3399999999999999 110.919 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 178.61 167.91 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 2.54 111.12 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -146.52 106.3 3.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 3.8900000000000001 110.858 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -90.63 121.3 32.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 1.6799999999999999 111.106 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.94 151.68 42.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 3.9900000000000002 110.873 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.68 167.33 0.47 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 1.1799999999999999 112.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 154.37 67.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 1.0900000000000001 112.327 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 167.56 -110.03 0.37 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 1.78 112.48 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 93.3 p -131.28 142.25 50.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.401 . . . . 3.7200000000000002 110.806 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.08 -87.43 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 1.55 112.484 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 10.4 tt -91.94 14.93 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 4.29 111.124 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -55.71 -68.47 1.67 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.783 -0.723 . . . . 2.71 112.492 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -85.62 2.85 87.81 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 2.6499999999999999 112.453 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.14 139.4 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.812 0.339 . . . . 2.6200000000000001 110.849 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -134.31 154.68 51.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 1.9399999999999999 111.09 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -135.21 129.9 34.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 3.4399999999999999 110.833 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -108.8 106.18 16.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 4.3300000000000001 110.888 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.45 82.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 5.7599999999999998 110.845 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -51.33 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 8.2599999999999998 110.843 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.92 28.83 5.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 4.6399999999999997 110.853 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -95.04 -80.97 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 4.5599999999999996 110.895 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 174.27 134.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 5.5899999999999999 110.867 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 95.27 5.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 7.9199999999999999 110.917 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 2.6 m -157.04 120.32 4.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 3.9199999999999999 111.117 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.5 t -111.5 65.38 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 4.6699999999999999 111.169 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -88.47 -68.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 10.800000000000001 110.866 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.81 -43.32 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 4.0599999999999996 110.909 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -155.59 -112.76 0.42 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.751 . . . . 4.7999999999999998 112.469 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 40.63 -133.99 2.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 3.6099999999999999 112.475 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.49 97.05 9.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 2.9500000000000002 111.16 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.8 111.44 23.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 4.3899999999999997 110.899 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 13.2 tp -51.45 -31.44 23.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 5.7199999999999998 110.918 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.96 -68.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 5.0700000000000003 110.871 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.6 mp -76.89 -36.83 56.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 4.9400000000000004 110.876 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 70.2 m -54.56 -45.8 73.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 1.8799999999999999 111.173 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.5 -44.65 76.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 2.1499999999999999 111.101 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 29.4 t -51.35 -49.88 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 1.72 111.171 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -55.29 -33.77 63.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 3.25 110.832 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.52 -40.71 61.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 110.885 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 42.9 mm -50.78 -47.48 28.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 2.4300000000000002 111.116 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.98 -23.99 70.44 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 1.1599999999999999 112.495 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -49.44 70.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 3.8900000000000001 110.869 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 43.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 2.27 110.828 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.3 mt -144.33 -42.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 3.54 110.923 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 168.71 -38.0 0.21 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.787 -0.72 . . . . 2.3300000000000001 112.529 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.19 177.91 7.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 4.1200000000000001 110.922 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.42 -77.62 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.729 . . . . 3.48 112.477 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -143.11 113.98 7.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.865 0.364 . . . . 1.8300000000000001 110.866 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.1 t -92.35 -78.16 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 5.2400000000000002 110.902 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.4 t 176.85 -33.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 5.0999999999999996 110.853 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -49.55 108.13 0.92 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 2.4199999999999999 110.85 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.9 Cg_endo -69.79 167.78 23.48 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.688 2.259 . . . . 1.75 112.329 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.65 29.82 6.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 5.1699999999999999 110.931 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.73 -174.61 2.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 2.3300000000000001 111.101 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.56 -4.1 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 3.6899999999999999 111.112 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.6 tpt -83.25 -41.66 18.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 4.6100000000000003 110.849 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.32 149.83 6.91 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.659 0.742 . . . . 4.8399999999999999 110.893 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -7.23 20.5 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.685 2.256 . . . . 2.7200000000000002 112.351 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.7 t -84.86 138.01 32.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 3.6299999999999999 111.139 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -66.25 145.44 55.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 5.25 110.892 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.88 102.39 15.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 5.6299999999999999 110.888 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -91.8 44.37 1.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 7.1600000000000001 110.941 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.18 177.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 4.5700000000000003 111.141 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.79 126.26 26.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 3.1400000000000001 110.836 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 25.0 pt -76.42 -30.28 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 4.2699999999999996 111.106 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -65.86 -39.57 90.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 5.8899999999999997 110.853 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.6 t -94.71 -4.77 46.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 4.4199999999999999 111.116 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -51.84 144.18 11.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 6.3799999999999999 110.887 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -175.05 151.45 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 4.0700000000000003 110.857 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.45 145.3 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 3.1000000000000001 110.932 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.42 -172.24 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 4.1799999999999997 110.849 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 65.56 161.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 4.4800000000000004 111.118 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -22.89 51.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 3.2000000000000002 110.903 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -51.32 -29.75 16.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 3.6400000000000001 110.888 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 8.2 tt -50.74 -29.65 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 3.2400000000000002 111.164 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -92.34 -31.16 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 7.8499999999999996 110.827 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.06 -16.86 60.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.778 -0.725 . . . . 1.8500000000000001 112.494 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 8.4 tp -93.33 -31.47 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.776 0.322 . . . . 1.99 111.121 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -78.43 -48.2 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 5.4000000000000004 110.912 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 2.79 110.876 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.815 0.34 . . . . 2.9900000000000002 111.153 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -127.56 152.43 47.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 7.0 110.889 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -161.88 133.79 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 5.4100000000000001 110.904 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 86.8 mt -108.12 144.06 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 3.7200000000000002 111.122 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -108.96 -76.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 4.7599999999999998 110.881 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.81 -178.28 4.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 6.5599999999999996 110.9 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -140.85 163.23 33.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 6.1799999999999997 110.916 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.0 m -73.73 131.34 82.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.528 0.68 . . . . 3.9100000000000001 111.142 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -34.87 13.73 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.702 2.268 . . . . 2.6299999999999999 112.366 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -50.49 -53.73 27.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 4.9699999999999998 110.848 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 19.6 mmt -101.33 154.6 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 4.4900000000000002 110.888 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -59.1 149.09 28.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 3.6099999999999999 110.899 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -58.5 -20.87 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 5.4299999999999997 110.888 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.24 -37.28 61.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 3.7999999999999998 110.909 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -61.62 -52.2 65.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 3.0499999999999998 110.886 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.43 -30.0 43.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 1.8799999999999999 111.149 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.42 -48.73 47.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 3.3900000000000001 110.871 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -75.36 -33.56 61.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.461 . . . . 4.1299999999999999 110.925 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.45 -58.8 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 1.96 111.103 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 pp -68.34 -28.01 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 5.1500000000000004 111.107 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.61 -51.0 52.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 5.46 110.908 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -78.63 -32.07 47.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 3.9300000000000002 110.936 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.85 65.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 2.1699999999999999 111.111 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -73.96 -28.38 61.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 6.0 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.07 -51.34 9.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 4.29 110.913 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.9 p -51.15 -29.84 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 3.3599999999999999 111.141 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -85.91 -51.38 6.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 4.6600000000000001 110.918 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.6 p -60.98 -17.23 50.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 2.3300000000000001 110.894 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -50.4 -30.69 12.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 4.0300000000000002 110.936 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.6 m -133.39 36.42 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 2.9300000000000002 111.069 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.08 132.96 9.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.566 0.698 . . . . 2.5699999999999998 111.148 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 64.9 1.79 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.712 2.274 . . . . 2.1200000000000001 112.316 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mp -121.1 150.05 41.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 4.1399999999999997 110.899 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.0 174.34 6.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 5.4299999999999997 110.893 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -112.57 126.09 54.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 10.06 110.903 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.5 t -133.38 89.99 2.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 2.9199999999999999 110.869 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -81.75 121.94 27.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 3.3799999999999999 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.0 mt -137.48 113.21 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 4.2699999999999996 111.127 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.07 -28.92 27.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 4.0800000000000001 110.844 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 94.9 m -160.73 110.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 4.7999999999999998 111.13 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -173.32 -134.15 1.78 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.758 . . . . 2.3500000000000001 112.466 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 120.51 42.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.321 . . . . 6.29 110.89 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.94 129.41 43.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 2.6600000000000001 111.084 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.06 -18.73 28.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 2.4100000000000001 110.866 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.82 127.04 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 4.25 111.133 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.24 166.38 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 3.8999999999999999 110.938 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.24 110.09 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 4.2199999999999998 111.074 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.66 174.71 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 3.0600000000000001 111.123 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -106.78 125.06 50.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 6.29 110.904 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -125.71 148.34 49.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 2.48 111.12 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.63 111.57 13.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 5.4699999999999998 110.853 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.61 -139.56 16.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 1.6399999999999999 112.457 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.06 111.09 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 2.96 111.135 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -92.29 43.69 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 3.7999999999999998 110.823 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.83 95.53 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.721 -0.752 . . . . 3.0099999999999998 112.487 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.4 41.79 7.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.819 0.342 . . . . 6.3399999999999999 110.87 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.12 -168.81 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 4.4199999999999999 110.919 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -76.9 102.95 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 5.4000000000000004 110.853 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.73 112.3 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 2.0699999999999998 111.093 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -70.01 -168.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 7.29 110.868 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -131.95 -41.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 4.6900000000000004 110.915 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 123.22 -172.42 16.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 2.7000000000000002 112.504 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.06 118.8 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.331 . . . . 5.8700000000000001 110.883 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.62 -47.34 1.05 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 2.54 112.485 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -88.86 -121.01 1.83 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.717 -0.754 . . . . 1.53 112.477 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.32 148.51 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 4.5 111.152 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -29.55 7.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 4.6399999999999997 110.935 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.69 123.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 2.5 111.096 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -94.97 162.94 13.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 3.9700000000000002 110.891 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -173.23 105.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 1.8799999999999999 111.048 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.88 170.19 4.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 3.8399999999999999 110.867 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.09 165.87 1.13 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 1.45 112.458 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 165.24 31.71 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 1.03 112.367 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.04 -136.44 5.03 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 1.3799999999999999 112.47 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.89 121.26 44.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 4.29 110.832 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.21 -62.93 2.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.756 . . . . 1.98 112.505 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.7 mt -93.95 21.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 3.1800000000000002 111.138 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.7 -106.99 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 2.7200000000000002 112.483 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -92.07 37.66 3.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 2.3399999999999999 112.493 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -50.77 126.06 14.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.794 0.33 . . . . 2.1000000000000001 110.89 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.86 145.97 28.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 2.5299999999999998 111.098 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -139.79 107.69 5.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 4.0499999999999998 110.829 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -143.82 108.52 4.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 4.2800000000000002 110.883 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 t70 179.38 -82.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 8.2200000000000006 110.832 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.41 153.57 28.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 7.7300000000000004 110.913 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 64.69 125.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 6.4699999999999998 110.905 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 63.57 70.45 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 4.5700000000000003 110.909 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -45.78 157.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 6.3099999999999996 110.87 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -105.35 175.05 5.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 8.3699999999999992 110.905 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.28 173.44 16.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 2.0600000000000001 111.144 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -171.51 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 2.73 111.142 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -67.01 -21.76 65.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 6.1200000000000001 110.876 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.6 m -103.62 -24.71 13.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 2.9199999999999999 110.812 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -62.48 -160.43 0.18 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 3.02 112.503 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -60.6 -101.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 2.25 112.492 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.4 t -80.42 103.57 10.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 4.5300000000000002 111.105 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.512 ' ND2' ' H ' ' A' ' 243' ' ' VAL . 9.8 m-20 -50.38 116.37 1.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 3.71 110.929 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 11.5 tp -60.76 -39.29 88.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 4.0700000000000003 110.954 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -34.7 68.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 6.7699999999999996 110.881 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -55.07 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 3.98 110.944 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 98.4 m -54.97 -38.47 67.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 2.23 111.151 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.14 -32.25 61.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 2.04 111.086 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.0 t -70.64 -25.53 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 2.04 111.135 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -69.57 -61.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 3.1200000000000001 110.868 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.99 -50.02 75.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 4.7199999999999998 110.869 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 72.1 mt -51.42 -29.52 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 2.98 111.161 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.56 -44.36 16.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 0.80000000000000004 112.492 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.59 -34.33 76.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 3.6299999999999999 110.83 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -28.91 18.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 3.2000000000000002 110.903 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.3 mp -93.73 -24.64 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 2.6200000000000001 110.923 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 126.38 105.49 1.43 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 2.3599999999999999 112.489 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.37 -68.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 3.6499999999999999 110.866 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 73.31 31.59 61.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 3.4199999999999999 112.468 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 21.6 m80 64.47 155.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 2.2200000000000002 110.877 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 59.4 m -124.84 -78.14 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 4.8099999999999996 110.86 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.16 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 5.2699999999999996 110.884 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -47.44 106.64 0.62 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.577 0.703 . . . . 3.2999999999999998 110.865 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.3 21.94 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 2.1299999999999999 112.359 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.0 mptt 50.65 29.96 4.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 6.3499999999999996 110.934 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -130.59 -168.88 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 2.5800000000000001 111.101 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.3 t -50.42 -57.26 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 5.3499999999999996 111.13 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 9.8 mmt -59.41 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 4.0800000000000001 110.875 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.72 99.62 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.651 0.739 . . . . 5.7599999999999998 110.915 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 77.95 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.693 2.262 . . . . 4.0 112.283 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.4 p -145.46 125.53 13.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 3.7200000000000002 111.116 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -62.77 126.39 27.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 5.4400000000000004 110.875 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -150.69 92.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 5.0700000000000003 110.89 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -58.68 127.29 31.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 4.6200000000000001 110.91 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.512 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 7.6 p -135.97 154.32 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 3.5699999999999998 111.167 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.19 113.15 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 2.8199999999999998 110.835 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.0 tt -74.28 -34.5 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 3.3900000000000001 111.163 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -24.02 67.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 3.1099999999999999 110.914 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 14.6 19.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 3.5 111.168 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -51.36 156.97 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 6.4000000000000004 110.879 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -178.67 148.15 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 4.2800000000000002 110.88 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.14 161.11 2.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 3.7999999999999998 110.893 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.93 150.76 22.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 5.2400000000000002 110.874 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.96 -68.34 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 4.4299999999999997 111.106 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -53.31 -36.91 61.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 3.6000000000000001 110.853 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -70.96 -29.23 65.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 3.27 110.838 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -51.09 -28.6 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 2.6000000000000001 111.111 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -77.78 -37.19 49.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 6.2400000000000002 110.853 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -78.63 57.11 4.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 2.6600000000000001 112.488 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 4.9 tp -179.16 -40.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 2.1200000000000001 111.17 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -75.03 -45.07 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 3.5600000000000001 110.908 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 3.0899999999999999 110.827 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.822 0.344 . . . . 2.9700000000000002 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -145.57 173.28 12.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 4.4500000000000002 110.962 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -160.5 125.89 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 8.7100000000000009 110.838 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.6 pt -108.17 121.63 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 4.0700000000000003 111.138 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -136.11 47.92 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 4.1600000000000001 110.88 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -137.5 153.23 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 6.6500000000000004 110.867 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -147.4 163.15 37.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 8.6600000000000001 110.883 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 p -125.37 151.72 70.3 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.712 . . . . 3.1899999999999999 111.155 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 169.08 19.75 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.713 2.276 . . . . 3.1800000000000002 112.337 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.1 t70 75.65 -52.06 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 6.0300000000000002 110.824 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -97.66 132.91 42.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 4.5899999999999999 110.895 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.99 155.75 10.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 4.0800000000000001 110.879 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.06 -23.12 12.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 5.9699999999999998 110.851 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -41.01 84.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 3.8999999999999999 110.91 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.36 -54.67 44.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 2.6000000000000001 110.874 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.21 -40.66 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 1.8300000000000001 111.111 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.13 -40.83 61.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 3.2999999999999998 110.875 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -74.61 -31.08 61.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 4.0700000000000003 110.932 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.24 -52.46 35.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 2.3199999999999998 111.096 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.02 -28.52 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 3.3300000000000001 111.152 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -50.98 -55.08 19.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 7.6799999999999997 110.869 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -78.25 -25.94 47.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 4.6600000000000001 110.874 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.82 -37.26 68.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 1.9399999999999999 111.1 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -27.03 61.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 4.6900000000000004 110.852 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.97 -48.81 13.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 3.9300000000000002 110.886 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.6 p -55.8 -27.07 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 3.0899999999999999 111.115 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -91.1 -54.37 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 11.48 110.933 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.5 p -59.22 -18.4 36.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 2.1600000000000001 110.841 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.2 -26.66 61.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 3.2000000000000002 110.921 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.85 -23.87 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 4.6799999999999997 111.114 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.57 145.26 30.67 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.56 0.695 . . . . 2.5699999999999998 111.15 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.58 23.97 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.676 2.251 . . . . 1.9099999999999999 112.308 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -51.6 158.2 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 3.8900000000000001 110.881 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.23 138.71 52.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 6.9199999999999999 110.918 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -101.54 139.25 37.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 7.6699999999999999 110.871 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.0 90.04 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 2.1600000000000001 110.849 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -77.81 122.77 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 4.8300000000000001 110.889 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 15.7 pt -140.18 163.79 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 3.5 111.14 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -109.59 28.9 8.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 3.7599999999999998 110.888 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.6 t -157.65 174.05 15.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 4.2000000000000002 111.145 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.62 -173.62 12.15 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.74 . . . . 2.0800000000000001 112.507 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.46 166.34 10.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 6.3300000000000001 110.873 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -144.62 146.94 32.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 2.1600000000000001 111.113 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -26.65 68.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 2.4399999999999999 110.879 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.8 mm -104.04 109.9 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 3.6800000000000002 111.173 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.22 119.35 38.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 2.3300000000000001 110.94 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.0 t -108.61 109.9 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 2.6400000000000001 111.129 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 72.2 t -134.35 144.97 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 2.1099999999999999 111.134 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -92.22 153.17 19.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 5.21 110.895 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.33 178.02 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 1.95 111.118 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -145.04 111.54 5.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 6.2000000000000002 110.9 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 63.73 -147.67 50.67 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.712 -0.756 . . . . 1.3899999999999999 112.504 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.54 112.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 2.0899999999999999 111.105 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -95.66 27.95 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 3.71 110.812 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.52 18.21 60.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 2.8399999999999999 112.46 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -106.61 -74.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.763 0.316 . . . . 6.9299999999999997 110.89 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.19 -65.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 5.3899999999999997 110.882 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -77.39 107.09 9.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 6.25 110.868 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.32 159.64 23.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 1.9199999999999999 111.118 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.84 113.83 2.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 8.0 110.818 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.96 -169.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 7.4699999999999998 110.907 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.99 97.82 2.11 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 3.3500000000000001 112.477 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -51.67 119.19 3.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 4.1500000000000004 110.859 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.19 7.05 62.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 2.2999999999999998 112.475 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -114.76 -126.39 4.19 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 1.6399999999999999 112.538 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 mp -89.16 93.9 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 3.79 111.129 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.8 pp -49.9 -26.9 4.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 4.0199999999999996 110.858 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 179.5 171.49 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 2.2000000000000002 111.107 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -160.14 106.26 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 4.0800000000000001 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -110.75 109.84 20.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 1.79 111.087 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.06 169.65 4.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 4.25 110.927 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.39 173.8 0.25 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 1.1499999999999999 112.443 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 179.62 3.58 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.689 2.259 . . . . 0.93000000000000005 112.353 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 154.12 -128.79 2.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 1.3600000000000001 112.529 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.08 141.12 52.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.927 0.394 . . . . 2.46 110.85 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.5 -76.54 0.95 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.721 . . . . 1.3 112.504 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.1 tt -104.92 16.41 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 4.04 111.13 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.88 -77.58 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 2.8300000000000001 112.473 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.94 2.22 81.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.775 -0.726 . . . . 2.3300000000000001 112.479 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.51 127.42 17.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.785 0.326 . . . . 2.21 110.873 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.87 146.39 50.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 2.8100000000000001 111.088 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -113.76 149.89 34.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 7.7599999999999998 110.834 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.97 147.56 44.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 5.5999999999999996 110.889 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.74 -35.84 10.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 5.6200000000000001 110.84 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 63.28 -82.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 7.75 110.853 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -134.87 35.21 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 6.4699999999999998 110.868 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.8 -5.58 6.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 4.5099999999999998 110.865 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.17 73.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 9.8100000000000005 110.87 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -105.36 124.62 49.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 10.98 110.96 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.47 153.45 27.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 3.1600000000000001 111.167 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.8 -172.51 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 2.54 111.148 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -50.27 -48.32 54.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 5.2999999999999998 110.826 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.5 p -76.82 -38.03 54.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 3.46 110.857 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.77 172.11 0.28 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 3.0600000000000001 112.494 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.45 -85.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 2.0600000000000001 112.472 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 88.3 m -79.36 98.34 6.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.815 0.341 . . . . 3.21 111.167 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -51.14 115.48 1.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 4.21 110.914 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -35.28 38.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 3.98 110.9 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -72.33 -53.6 11.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 6.5999999999999996 110.86 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 10.6 tp -51.86 -47.75 64.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 3.9199999999999999 110.933 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.38 -51.23 67.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 1.99 111.154 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.59 -48.88 74.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 1.9399999999999999 111.132 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.5 -20.49 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 1.9199999999999999 111.139 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -74.33 -46.25 42.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 3.52 110.891 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.75 -23.46 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 5.4800000000000004 110.859 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 21.7 mm -65.56 -52.08 55.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 2.46 111.118 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.96 -25.69 66.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 0.76000000000000001 112.438 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -51.33 70.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 3.54 110.887 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.26 46.14 1.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 2.1099999999999999 110.861 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 mt -156.12 22.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 2.8799999999999999 110.913 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.27 5.28 89.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 1.78 112.487 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 19.4 tp -120.27 68.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 4.3600000000000003 110.906 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -86.05 -101.83 0.74 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.765 -0.731 . . . . 3.7000000000000002 112.443 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -118.46 153.61 33.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.338 . . . . 2.29 110.858 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.3 m -135.86 -75.91 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 4.9800000000000004 110.844 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.62 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 4.3399999999999999 110.864 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -49.28 108.27 0.94 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.577 0.703 . . . . 3.3999999999999999 110.853 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 233' ' ' LYS . 53.7 Cg_endo -69.76 -179.82 3.18 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.658 2.238 . . . . 1.8600000000000001 112.337 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.53 42.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 5.5199999999999996 110.897 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -128.91 -175.78 3.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 2.4199999999999999 111.117 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 43.0 t -93.05 -17.72 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 3.7999999999999998 111.117 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -82.23 -41.53 20.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 5.9100000000000001 110.887 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -51.54 136.4 33.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.668 0.747 . . . . 5.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 77.77 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.258 . . . . 2.5899999999999999 112.355 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.0 p -156.92 160.36 39.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 3.3599999999999999 111.154 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -127.05 113.2 16.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 5.2199999999999998 110.952 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.02 128.41 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.467 . . . . 4.0499999999999998 110.919 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -51.71 121.95 7.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 4.5800000000000001 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.18 148.8 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 3.5699999999999998 111.168 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -54.98 113.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 4.0999999999999996 110.87 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.3 pp -76.75 -31.27 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 3.6699999999999999 111.117 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -36.04 78.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 3.1400000000000001 110.868 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 21.0 p -104.71 24.69 11.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 3.9300000000000002 111.155 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -51.78 134.34 30.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 6.9000000000000004 110.929 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -178.54 136.47 0.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 5.1600000000000001 110.838 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.65 152.7 3.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 3.0699999999999998 110.887 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.54 -170.95 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 3.7799999999999998 110.889 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 69.18 157.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 4.8399999999999999 111.079 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.27 -24.9 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 2.77 110.883 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -50.78 -29.9 12.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 3.04 110.83 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.24 -29.67 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 2.8999999999999999 111.123 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -83.1 -24.8 32.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 6.3899999999999997 110.852 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -81.42 -44.85 7.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.815 -0.707 . . . . 2.54 112.479 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 5.7 tp -54.58 -36.93 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 1.76 111.089 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -77.04 -49.72 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 3.48 110.913 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 3.7799999999999998 110.83 -179.778 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.805 0.336 . . . . 3.1400000000000001 111.138 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -134.4 147.26 50.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 5.2999999999999998 110.903 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -153.06 152.63 31.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 4.79 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.39 144.59 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 3.7999999999999998 111.109 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -142.78 20.03 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 4.4199999999999999 110.886 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -122.44 157.7 31.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 6.9299999999999997 110.91 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.92 106.41 3.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 8.3000000000000007 110.916 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.3 m -70.66 120.0 76.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.598 0.713 . . . . 4.6699999999999999 111.115 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -48.38 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.702 2.268 . . . . 2.6499999999999999 112.341 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -23.44 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 4.8200000000000003 110.906 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 23.8 mmt -124.77 -174.56 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 4.21 110.912 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.9 162.06 17.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 3.46 110.88 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -74.61 -20.91 59.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 7.29 110.891 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.51 -54.44 5.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 5.0599999999999996 110.864 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -55.31 -40.18 70.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 4.0599999999999996 110.886 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -74.35 -37.16 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 2.1200000000000001 111.121 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -62.68 -55.16 29.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 3.0099999999999998 110.878 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -65.89 -31.92 73.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 4.6299999999999999 110.933 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.94 -41.86 59.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 1.9399999999999999 111.105 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.6 mm -79.31 -43.16 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 3.4900000000000002 111.169 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.24 -30.25 49.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 4.5700000000000003 110.91 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -78.49 -27.3 46.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 4.0700000000000003 110.844 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.69 -33.03 63.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 2.5699999999999998 111.121 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -73.85 -25.8 60.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 4.7000000000000002 110.905 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -79.08 -52.79 7.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 2.9700000000000002 110.935 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.14 -42.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 2.98 111.098 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -75.54 -43.59 47.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 5.3799999999999999 110.925 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.0 t -62.6 -15.07 49.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 2.6699999999999999 110.894 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.34 -23.13 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 2.7999999999999998 110.883 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -32.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 3.6400000000000001 111.084 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.09 150.16 39.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.573 0.701 . . . . 3.5600000000000001 111.127 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -53.41 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.69 2.26 . . . . 3.2799999999999998 112.359 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tp 46.55 -165.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 4.8099999999999996 110.858 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.61 131.14 11.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 4.3700000000000001 110.862 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -115.47 144.93 43.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 7.5099999999999998 110.908 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.8 t -156.99 90.76 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 2.6299999999999999 110.853 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -91.11 107.13 19.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 3.6000000000000001 110.878 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.89 139.57 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 3.3799999999999999 111.098 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -64.27 -24.02 67.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 3.73 110.914 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.7 m -138.06 148.91 45.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.462 . . . . 3.6499999999999999 111.147 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.83 -173.28 19.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.756 -0.735 . . . . 1.8300000000000001 112.458 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.8 mtt -110.65 145.87 37.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 6.1399999999999997 110.843 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.43 130.05 36.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 2.1200000000000001 111.114 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.26 -22.6 66.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 3.54 110.864 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.0 mm -104.18 84.36 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 3.6699999999999999 111.164 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.34 115.24 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 2.6299999999999999 110.887 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.88 110.88 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 2.2400000000000002 111.126 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.3 t -138.97 139.96 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 2.6000000000000001 111.136 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -82.48 122.87 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 4.6500000000000004 110.87 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.99 178.38 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 2.5600000000000001 111.08 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -145.18 126.93 15.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 9.25 110.862 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.0 -134.1 32.04 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.752 -0.737 . . . . 1.79 112.516 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.62 113.42 20.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 2.9300000000000002 111.075 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -90.87 154.04 19.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 3.9199999999999999 110.89 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.96 -14.0 54.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 3.4100000000000001 112.483 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.22 23.5 5.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.774 0.321 . . . . 7.5700000000000003 110.865 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.0 t70 63.4 52.94 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 6.6500000000000004 110.865 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -127.59 79.68 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 5.5800000000000001 110.826 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.39 129.05 34.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 2.5 111.082 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.09 173.08 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 11.83 110.903 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -125.58 -2.5 7.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 6.0700000000000003 110.866 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 77.36 148.1 2.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 2.9500000000000002 112.501 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.41 153.71 2.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 6.9100000000000001 110.901 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.74 -1.41 87.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.737 -0.744 . . . . 3.0600000000000001 112.452 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.37 -141.27 3.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 2.8300000000000001 112.453 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.47 91.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 3.8700000000000001 111.127 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.8 pp -48.28 -29.49 3.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 4.04 110.912 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.62 178.0 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 2.9900000000000002 111.162 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -153.03 130.14 11.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 5.25 110.83 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -116.94 119.88 36.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 1.6399999999999999 111.106 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.38 165.27 9.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 3.8900000000000001 110.83 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.25 173.14 0.28 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.734 -0.746 . . . . 0.93000000000000005 112.495 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -169.53 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.617 2.212 . . . . 1.24 112.344 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.12 -146.13 16.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 1.3700000000000001 112.437 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.4 m -94.69 154.54 17.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 2.3700000000000001 110.867 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.62 -103.81 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 1.55 112.447 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.23 -23.8 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 2.8399999999999999 111.141 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -57.0 99.61 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.775 -0.726 . . . . 2.5899999999999999 112.514 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 113.62 -12.08 23.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 1.99 112.46 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -49.96 145.35 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.356 . . . . 2.6400000000000001 110.826 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -131.97 135.3 46.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 1.6299999999999999 111.082 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -124.76 117.86 25.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 3.79 110.854 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -100.98 101.76 12.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 4.21 110.838 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 50.63 93.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 5.7199999999999998 110.868 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.59 87.08 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 9.4900000000000002 110.882 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 34.3 t70 64.5 15.3 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 3.3799999999999999 110.876 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.72 -78.09 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 4.4699999999999998 110.885 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 178.41 124.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 5.4900000000000002 110.913 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -102.03 137.78 39.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 8.3800000000000008 110.928 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.11 169.05 25.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 2.8399999999999999 111.16 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.31 173.89 10.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 2.6200000000000001 111.161 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -50.55 -30.31 12.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 6.0599999999999996 110.858 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.04 -37.63 17.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 3.02 110.851 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -56.45 -178.03 0.37 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.703 -0.76 . . . . 3.8900000000000001 112.478 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.96 -64.18 3.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.765 -0.731 . . . . 3.0899999999999999 112.511 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.73 102.13 13.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 2.23 111.149 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -59.91 95.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 4.7000000000000002 110.865 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.68 -32.83 70.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 4.0300000000000002 110.934 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -66.56 -64.32 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 7.0800000000000001 110.868 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.16 -46.68 87.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 3.6800000000000002 110.916 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 74.3 m -54.49 -26.28 30.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 1.8 111.18 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.08 -42.73 75.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 1.8500000000000001 111.083 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.5 t -59.38 -46.88 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 1.8799999999999999 111.17 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -53.61 -31.83 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 3.3700000000000001 110.838 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -74.75 -42.9 57.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 5.5700000000000003 110.845 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 46.1 mm -51.1 -44.74 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 2.5 111.115 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.99 -32.66 52.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 1.0800000000000001 112.479 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -36.67 81.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 4.1399999999999997 110.853 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.98 29.06 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 3.04 110.861 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.0 mt -139.7 -52.69 0.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 3.3599999999999999 110.945 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -176.41 -151.0 8.53 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.739 . . . . 2.2599999999999998 112.497 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 68.69 -75.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 3.9900000000000002 110.928 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 110.88 -74.39 0.21 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 3.27 112.509 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -170.99 84.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 2.6400000000000001 110.853 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.15 171.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 4.6699999999999999 110.836 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -25.18 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 4.7800000000000002 110.828 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.6 108.74 1.1 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.595 0.712 . . . . 2.2599999999999998 110.808 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 162.19 43.02 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 2.46 112.336 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 58.36 22.56 9.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 6.3399999999999999 110.87 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -111.19 158.59 18.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 2.4300000000000002 111.071 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.86 -23.93 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 4.25 111.157 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -49.46 22.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 5.0300000000000002 110.881 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -52.34 136.68 40.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.65 0.738 . . . . 5.0300000000000002 110.859 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 93.9 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.685 2.257 . . . . 3.0800000000000001 112.323 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.9 t -156.96 153.38 27.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 4.2400000000000002 111.158 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -110.55 125.86 53.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 5.1500000000000004 110.908 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.03 96.25 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 5.1500000000000004 110.841 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -49.9 122.76 6.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 5.0999999999999996 110.953 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.3 p -120.22 153.49 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 3.6499999999999999 111.123 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.51 137.03 42.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 4.3200000000000003 110.911 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.07 -26.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 4.1299999999999999 111.111 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -64.9 -39.36 93.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 4.8499999999999996 110.88 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 -10.85 24.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 4.7699999999999996 111.105 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.58 120.51 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 5.1299999999999999 110.89 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 175.64 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 4.9199999999999999 110.917 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.29 150.98 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 3.21 110.867 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.83 -172.04 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 4.1799999999999997 110.868 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 66.59 165.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 4.7599999999999998 111.083 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -20.4 62.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 3.0899999999999999 110.892 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -51.07 -29.99 14.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 3.3599999999999999 110.825 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.2 -29.63 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 3.1600000000000001 111.156 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 35.8 mtt85 -90.95 -33.83 15.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 7.5 110.855 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.44 -25.8 21.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 2.0099999999999998 112.49 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.5 tp -87.45 -29.17 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.767 0.318 . . . . 2.4300000000000002 111.14 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -79.37 -37.75 36.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 3.8900000000000001 110.951 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 3.0099999999999998 110.853 -179.832 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.801 0.334 . . . . 3.3300000000000001 111.138 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.51 136.27 37.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 8.7100000000000009 110.889 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -127.9 119.21 25.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 9.7899999999999991 110.878 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.9 pt -107.99 148.28 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 4.0899999999999999 111.146 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -157.16 22.86 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 4.1100000000000003 110.856 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -142.03 153.87 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 5.1299999999999999 110.924 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -114.67 163.05 15.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 5.7000000000000002 110.933 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 86.1 m -120.29 133.86 24.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.598 0.713 . . . . 3.46 111.124 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -177.6 1.97 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.69 2.26 . . . . 3.1499999999999999 112.33 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 72.39 -68.64 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 4.5999999999999996 110.836 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.88 147.7 25.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 5.2599999999999998 110.857 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -59.36 168.15 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 3.75 110.907 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.06 -22.46 50.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 7.0199999999999996 110.849 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -63.29 -44.05 96.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 4.4000000000000004 110.928 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -60.15 -53.3 59.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 3.9500000000000002 110.856 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.76 -29.57 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 1.9099999999999999 111.117 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.3 -53.48 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 3.4500000000000002 110.826 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -69.97 -33.45 72.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 5.1299999999999999 110.933 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.01 -59.25 4.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 1.8700000000000001 111.148 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 pt -63.48 -28.36 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 4.4699999999999998 111.101 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -51.1 -59.29 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 6.6200000000000001 110.874 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -21.44 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 4.25 110.885 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.2 -54.75 39.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 2.2200000000000002 111.106 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -23.27 65.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 7.3899999999999997 110.875 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.04 -28.14 43.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 4.1799999999999997 110.921 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 90.0 t -68.45 -30.22 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 3.0 111.152 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -93.31 -52.89 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 4.8200000000000003 110.891 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 p -55.14 -23.04 19.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 2.6600000000000001 110.817 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.51 -23.64 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 4.4000000000000004 110.873 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.8 p -125.01 21.65 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 4.8300000000000001 111.134 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 134.13 25.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.586 0.707 . . . . 2.9100000000000001 111.117 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -25.56 28.61 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.703 2.269 . . . . 1.8899999999999999 112.352 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.91 109.57 0.34 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 4.5599999999999996 110.895 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -121.99 129.6 52.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 6.0700000000000003 110.852 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -138.02 154.27 49.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 13.880000000000001 110.867 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.19 126.37 49.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 4.2599999999999998 110.903 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -57.87 154.62 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 4.75 110.9 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.36 116.73 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 4.4199999999999999 111.127 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -39.24 58.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 4.4699999999999998 110.87 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.5 m -140.6 109.63 6.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 3.5499999999999998 111.129 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 162.48 -156.12 27.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 1.96 112.532 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -110.88 157.38 19.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 5.8899999999999997 110.872 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -133.28 153.63 51.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 2.1000000000000001 111.088 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.62 -25.64 27.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 3.1200000000000001 110.869 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.5 mt -121.39 137.41 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 3.29 111.113 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -117.21 120.64 38.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 2.23 110.904 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.1 t -96.3 121.68 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 2.75 111.1 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.9 t -147.87 141.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 2.5699999999999998 111.088 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -99.67 135.59 40.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 4.8499999999999996 110.863 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.63 133.18 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 2.21 111.075 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.33 156.69 18.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 6.3499999999999996 110.866 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.62 -137.27 31.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 1.3100000000000001 112.507 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.81 130.29 34.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 2.1600000000000001 111.107 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -88.58 6.96 35.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 3.7799999999999998 110.909 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.81 -17.35 55.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 2.54 112.481 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.37 33.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 5.6600000000000001 110.858 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.43 -167.75 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 4.6699999999999999 110.856 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -76.3 100.84 5.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 7.6600000000000001 110.858 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.5 128.44 28.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 2.3599999999999999 111.078 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -101.51 -168.98 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 7.3300000000000001 110.929 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -139.22 -41.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 4.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.33 -127.69 8.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 3.46 112.487 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -51.77 119.06 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.814 0.34 . . . . 4.4299999999999997 110.922 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.32 -33.52 5.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.715 -0.755 . . . . 3.0 112.515 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -109.63 -137.35 7.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.742 . . . . 2.5099999999999998 112.497 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.2 mm -72.1 135.82 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.348 . . . . 2.7999999999999998 111.155 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.62 -27.24 14.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 5.54 110.882 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.26 124.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 2.5800000000000001 111.038 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -117.3 171.53 7.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 3.96 110.861 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -176.95 110.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 1.8899999999999999 111.085 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.57 157.08 24.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 3.8399999999999999 110.863 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.18 178.33 0.23 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 1.28 112.477 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -172.99 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.656 2.237 . . . . 1.26 112.355 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 136.49 -127.59 4.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 2.0800000000000001 112.524 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.23 130.6 52.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 3.3300000000000001 110.855 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.22 -73.99 1.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.727 -0.749 . . . . 1.96 112.505 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 23.4 mt -82.92 -4.12 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 3.6800000000000002 111.13 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.4 117.61 9.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 2.4100000000000001 112.508 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.31 -7.64 74.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.786 -0.721 . . . . 2.2200000000000002 112.459 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.53 139.23 16.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 2.1400000000000001 110.868 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -117.15 140.12 49.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 1.8100000000000001 111.112 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.07 110.62 12.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 4.9299999999999997 110.842 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -116.48 111.74 20.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 4.0300000000000002 110.919 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.53 119.67 3.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 6.8700000000000001 110.816 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -50.13 -72.6 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 8.0800000000000001 110.889 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.11 87.69 4.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 5.3499999999999996 110.855 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -125.51 -82.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 4.25 110.889 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 172.65 81.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 6.0300000000000002 110.907 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -106.64 113.43 26.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 7.4699999999999998 110.926 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.4 m -156.85 133.28 9.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 3.7200000000000002 111.084 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.1 t -107.36 69.34 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 4.5300000000000002 111.128 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.74 -70.72 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 10.119999999999999 110.887 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.7 m -117.38 -73.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 4.3300000000000001 110.885 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.27 -1.73 0.76 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 7.0599999999999996 112.521 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.01 -160.89 0.17 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 4.3799999999999999 112.495 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.12 95.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.799 0.333 . . . . 2.7200000000000002 111.147 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.32 150.12 24.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 3.1099999999999999 110.874 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.5 mt -54.95 -44.73 74.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 3.5299999999999998 110.942 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -73.08 -37.17 66.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 6.5800000000000001 110.901 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 24.3 tp -64.75 -60.65 2.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 4.2199999999999998 110.909 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.5 m -57.47 -40.59 78.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 2.0800000000000001 111.144 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.44 -51.78 67.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 1.78 111.11 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 73.5 t -51.6 -42.35 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 2.1299999999999999 111.162 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -56.82 -47.93 79.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 3.4399999999999999 110.833 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -65.21 -41.97 93.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 4.6200000000000001 110.91 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 85.5 mt -58.62 -32.4 46.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 2.8799999999999999 111.115 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.93 -36.82 40.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 1.1100000000000001 112.495 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -76.42 -39.33 53.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.781 0.324 . . . . 4.1600000000000001 110.826 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.88 -12.19 61.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 2.1800000000000002 110.836 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.2 mp -114.83 19.8 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.6299999999999999 110.905 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.8 132.48 0.97 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 2.25 112.493 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 3.8399999999999999 110.909 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 145.18 -120.82 1.42 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.72 -0.752 . . . . 3.29 112.462 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.98 37.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.801 0.334 . . . . 3.6600000000000001 110.855 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.29 -75.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 6.1500000000000004 110.842 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.55 -168.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 6.2300000000000004 110.844 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.97 155.51 2.04 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.715 . . . . 2.6099999999999999 110.871 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -49.25 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.69 2.26 . . . . 2.02 112.36 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -71.72 -27.97 63.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 6.4000000000000004 110.876 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.35 168.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 2.9700000000000002 111.139 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.6 m -87.85 8.44 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 4.8300000000000001 111.108 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.72 0.72 33.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 5.3700000000000001 110.847 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.47 146.12 5.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.616 0.722 . . . . 6.0800000000000001 110.891 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.98 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.698 2.265 . . . . 3.8300000000000001 112.319 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.2 m -91.11 164.38 13.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 5.0300000000000002 111.147 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -62.57 124.98 22.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 5.6200000000000001 110.95 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.39 123.86 48.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 5.5800000000000001 110.907 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -54.68 123.14 12.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 8.1600000000000001 110.914 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.2 136.21 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 3.6899999999999999 111.138 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.52 123.81 18.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 3.2200000000000002 110.841 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.52 -20.56 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 3.8500000000000001 111.107 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.21 -15.91 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 3.2000000000000002 110.88 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.5 m -106.81 1.21 24.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 3.1299999999999999 111.113 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -51.87 133.82 31.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 6.1500000000000004 110.873 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -176.79 153.05 1.02 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 4.2000000000000002 110.887 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 52.9 tp -52.06 160.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 3.79 110.906 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -172.73 3.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 5.1900000000000004 110.865 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -93.1 -70.43 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 4.8499999999999996 111.113 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.55 -32.66 51.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 3.29 110.858 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -30.46 67.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 2.5299999999999998 110.856 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.51 -28.17 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 2.5699999999999998 111.091 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -82.09 -44.56 16.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 4.7800000000000002 110.885 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.89 62.53 3.25 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 2.3500000000000001 112.502 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.6 tp -179.7 -41.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 2.1299999999999999 111.144 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.14 -28.21 48.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 3.8700000000000001 110.901 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 2.5699999999999998 110.894 -179.793 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.6 m80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.753 0.311 . . . . 9.6699999999999999 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -117.74 147.67 42.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 9.9000000000000004 110.914 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mm -118.38 148.21 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 4.1699999999999999 111.102 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.42 144.36 27.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.145 -0.479 . . . . 2.6600000000000001 111.148 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -127.7 164.02 23.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 8.1099999999999994 110.913 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.9 117.77 2.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 5.2000000000000002 110.889 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 10.2 pt -108.71 148.51 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 3.9900000000000002 111.169 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -168.99 60.5 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 3.8599999999999999 110.853 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.64 135.65 25.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 6.5700000000000003 110.888 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -147.8 107.07 3.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 6.7599999999999998 110.939 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.1 p -94.24 158.59 35.64 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.63 0.729 . . . . 4.7599999999999998 111.081 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -178.53 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.713 2.275 . . . . 2.8300000000000001 112.342 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 56.1 24.01 7.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.445 . . . . 3.8900000000000001 110.834 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.2 mmm -165.28 131.29 2.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 4.5899999999999999 110.844 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -66.14 142.01 57.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 2.8500000000000001 110.896 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -61.38 -18.12 57.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 8.6899999999999995 110.848 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.39 -34.78 65.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 3.1099999999999999 110.848 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.5 -45.55 68.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 2.54 110.847 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.59 -39.08 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 1.79 111.142 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -55.99 -53.67 54.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 2.27 110.827 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -74.72 -32.63 62.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 4.4100000000000001 110.933 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.17 -57.93 7.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 1.72 111.049 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.2 mp -75.93 -41.15 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 3.2000000000000002 111.111 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -38.08 52.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 5.7000000000000002 110.882 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.45 -26.59 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 3.9100000000000001 110.866 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.61 63.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 1.6899999999999999 111.072 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -74.4 -30.42 61.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 6.5099999999999998 110.913 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -77.06 -55.11 5.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 3.2400000000000002 110.866 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.6 p -52.9 -27.42 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 2.9399999999999999 111.129 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -89.5 -53.76 4.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 4.75 110.925 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -58.98 -19.49 43.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 2.2799999999999998 110.89 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -50.93 -30.09 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 3.04 110.911 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.94 61.49 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 2.9100000000000001 111.074 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.27 140.55 11.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.598 0.713 . . . . 2.5699999999999998 111.123 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -12.54 33.11 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.641 2.227 . . . . 2.1600000000000001 112.391 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.3 mp -54.63 175.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 3.5800000000000001 110.917 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -118.23 -169.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 6.0899999999999999 110.888 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -130.69 134.39 46.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 8.6500000000000004 110.907 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -156.86 89.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 2.4700000000000002 110.868 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 97.95 7.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 5.3099999999999996 110.892 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.3 tt -83.49 130.59 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 5.3499999999999996 111.106 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -78.43 -28.48 46.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 4.5300000000000002 110.9 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.1 m -149.59 120.87 7.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 4.6100000000000003 111.144 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.87 85.34 0.99 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 2.9500000000000002 112.501 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.77 167.28 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.776 0.322 . . . . 10.970000000000001 110.901 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.57 -161.99 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 4.3200000000000003 111.11 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -50.77 -25.22 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 2.8199999999999998 110.852 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.1 mm -102.5 114.43 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 4.04 111.124 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.24 158.03 25.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 4.2800000000000002 110.918 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 41.7 t -148.03 111.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 2.5800000000000001 111.175 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.9 t -148.51 144.82 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 2.3900000000000001 111.099 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -104.71 136.68 43.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 4.46 110.921 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.41 168.38 19.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 2.2400000000000002 111.134 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.2 111.8 22.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 7.6200000000000001 110.903 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.39 -128.58 27.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 1.5 112.476 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.51 110.92 6.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.331 . . . . 2.6000000000000001 111.158 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -92.49 41.95 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 5.0300000000000002 110.879 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.9 -53.87 4.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 2.71 112.461 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -145.11 28.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 5.2000000000000002 110.871 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -107.08 -169.55 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 6.1699999999999999 110.864 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -104.83 90.3 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 5.9299999999999997 110.828 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.6 149.53 8.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 2.5899999999999999 111.09 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -120.8 -82.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 7.1799999999999997 110.91 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.97 -170.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 4.1699999999999999 110.856 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -97.59 -160.72 31.09 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.709 -0.758 . . . . 2.7999999999999998 112.508 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -52.97 118.6 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 6.9100000000000001 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 123.61 -54.38 0.72 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.743 -0.741 . . . . 2.4500000000000002 112.484 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.76 -137.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.738 -0.744 . . . . 1.99 112.473 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.3 mt -78.03 90.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.897 0.38 . . . . 4.0300000000000002 111.137 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.04 -33.49 52.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 5.5999999999999996 110.92 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.09 123.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 2.7000000000000002 111.091 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -138.56 113.8 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 4.6900000000000004 110.864 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -99.27 125.01 44.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 1.7 111.099 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -63.61 164.16 10.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 3.52 110.867 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.61 169.94 0.25 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.706 -0.759 . . . . 1.0800000000000001 112.527 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -169.37 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.753 2.302 . . . . 1.1100000000000001 112.332 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.7 -152.02 19.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 1.22 112.506 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m -91.88 148.55 22.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 3.0499999999999998 110.83 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.83 -102.47 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.732 . . . . 1.3799999999999999 112.467 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 72.9 mt -56.11 -35.43 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 2.8900000000000001 111.143 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -52.73 100.46 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 2.3100000000000001 112.456 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 104.33 21.65 9.22 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.759 -0.734 . . . . 2.1600000000000001 112.484 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -95.08 139.4 31.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 2.2799999999999998 110.872 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.67 140.4 34.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 1.7 111.052 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -128.65 110.52 12.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 6.4100000000000001 110.847 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -113.7 120.16 39.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 4.1699999999999999 110.9 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -58.99 123.99 18.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 6.7300000000000004 110.874 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -74.74 -48.83 23.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 7.7300000000000004 110.926 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.4 -16.66 56.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 3.8500000000000001 110.867 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 4.3799999999999999 110.896 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.85 95.93 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 5.6299999999999999 110.878 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -79.73 148.57 31.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 8.4700000000000006 110.933 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -148.47 174.31 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 2.6899999999999999 111.13 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.62 -171.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 2.54 111.13 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -63.93 -21.52 66.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 5.2400000000000002 110.876 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.3 m -90.61 -49.2 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 2.8300000000000001 110.848 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -52.09 172.37 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 2.96 112.516 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -51.73 -88.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 2.0 112.509 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 m -60.19 99.55 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.78 0.324 . . . . 2.6600000000000001 111.145 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.476 ' ND2' ' H ' ' A' ' 243' ' ' VAL . 1.9 m-20 -76.46 107.9 9.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 3.0800000000000001 110.891 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.38 -36.91 71.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 2.8199999999999998 110.905 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -71.13 -64.35 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 6.2800000000000002 110.827 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.3 tp -51.67 -49.51 62.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 3.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 96.4 m -55.32 -48.79 73.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 1.8700000000000001 111.143 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.82 -31.88 63.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 1.73 111.125 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.7 -31.87 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 1.75 111.16 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -75.12 -41.75 57.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 3.3500000000000001 110.868 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -71.0 -43.44 67.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 4.6500000000000004 110.876 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 9.9 tt -64.72 -29.88 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 3.54 111.153 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -68.7 -42.63 79.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 0.93999999999999995 112.48 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -65.19 -23.7 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.339 . . . . 3.27 110.904 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.79 30.38 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 2.0499999999999998 110.83 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -61.65 0.68 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 3.6800000000000002 110.951 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 179.7 32.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 2.1299999999999999 112.475 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.15 149.46 27.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.814 0.34 . . . . 3.21 110.919 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -78.16 -98.7 0.21 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.748 . . . . 3.3799999999999999 112.528 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -178.76 40.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.846 0.355 . . . . 2.9500000000000002 110.822 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.53 -71.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 4.5599999999999996 110.893 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 47.6 t 65.56 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 6.1600000000000001 110.864 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.22 156.84 75.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.588 0.708 . . . . 2.9300000000000002 110.889 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -49.12 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.679 2.252 . . . . 2.27 112.378 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -34.31 73.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 110.894 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.6 153.32 2.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 2.9100000000000001 111.104 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.9 t -87.51 7.7 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 4.9800000000000004 111.151 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -17.36 35.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 5.6299999999999999 110.892 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.94 143.31 15.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.635 0.731 . . . . 5.6600000000000001 110.915 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 76.57 1.14 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.628 2.219 . . . . 2.7799999999999998 112.33 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.6 t -157.05 168.8 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 3.5499999999999998 111.142 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -110.43 112.62 24.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 4.3600000000000003 110.924 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -140.69 147.46 39.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 4.2699999999999996 110.851 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -106.84 125.82 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 4.3399999999999999 110.905 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.476 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 7.1 p -121.26 154.72 25.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 3.4700000000000002 111.168 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.07 125.91 25.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 2.8300000000000001 110.897 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.63 -24.49 34.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 3.5899999999999999 111.106 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -60.29 -39.66 87.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 3.75 110.896 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 51.9 p -105.43 1.89 28.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 3.1699999999999999 111.187 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.02 111.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 4.8399999999999999 110.854 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -174.52 157.37 2.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 3.79 110.892 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.84 150.6 23.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 3.1099999999999999 110.893 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.5 t -154.58 -172.6 4.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 4.25 110.854 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 65.13 176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 3.9300000000000002 111.134 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.96 -22.08 66.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 3.71 110.888 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -50.77 -29.57 11.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 3.3900000000000001 110.91 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 1.1 tt -52.74 -29.56 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 3.1099999999999999 111.105 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -21.03 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 6.0999999999999996 110.905 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.97 -6.04 81.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 2.02 112.492 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.7 tp -106.98 -34.99 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 2.02 111.144 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -78.59 -37.38 42.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 4.1200000000000001 110.891 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.2 t -84.8 -47.45 10.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 4.0700000000000003 110.829 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 57.7 93.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 3.6200000000000001 110.931 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -137.37 -52.63 0.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 11.68 110.903 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 119.111 -0.827 . . . . 10.800000000000001 112.488 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.817 0.341 . . . . 9.0500000000000007 110.876 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.25 148.05 22.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 8.8699999999999992 110.923 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.3 mm -132.89 157.02 42.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 3.77 111.17 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.16 128.57 14.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 3.0899999999999999 111.159 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -128.67 159.53 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 5.4800000000000004 110.872 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -161.65 153.92 19.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 5.5 110.883 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 26.1 mt -107.79 148.91 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 2.6699999999999999 111.121 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -115.76 -75.02 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 3.8300000000000001 110.928 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 120' ' ' ASN . 1.5 m-80 -98.98 175.9 5.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 6.5899999999999999 110.906 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -144.04 163.32 33.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 7.3899999999999997 110.864 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p -76.88 113.77 33.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.59 0.709 . . . . 3.71 111.139 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.71 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.255 . . . . 2.8399999999999999 112.358 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -57.63 -28.46 63.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 3.4399999999999999 110.874 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -101.29 152.77 20.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 3.8500000000000001 110.869 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -60.95 143.52 54.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 3.3300000000000001 110.886 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.0 ptt-85 -56.83 -24.3 50.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 7.9199999999999999 110.867 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.76 -44.91 19.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 3.9399999999999999 110.924 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.12 -51.32 68.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 2.3599999999999999 110.884 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.6 -38.18 78.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 1.8799999999999999 111.171 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.81 -54.45 44.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 3.9700000000000002 110.879 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -73.55 -32.34 64.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 3.8100000000000001 110.911 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.94 -57.56 8.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 1.9099999999999999 111.091 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -76.76 -40.11 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 3.21 111.161 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -54.5 -30.77 54.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 4.8899999999999997 110.885 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -78.45 -25.21 45.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 4.7000000000000002 110.925 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.91 -34.19 65.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 1.97 111.118 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.82 -30.52 61.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 5.1500000000000004 110.904 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -55.72 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 4.6900000000000004 110.873 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.1 p -49.35 -34.01 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 3.1600000000000001 111.184 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -80.28 -54.44 5.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 7.96 110.932 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.8 t -55.22 -26.63 40.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 2.98 110.841 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -53.25 -39.38 63.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 3.6400000000000001 110.91 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 m -123.31 18.09 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 3.3100000000000001 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.4 p -144.83 152.93 53.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.708 . . . . 4.21 111.158 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -87.84 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.672 2.248 . . . . 3.5 112.313 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 53.18 -175.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 4.2199999999999998 110.911 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -142.35 138.14 31.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 4.6699999999999999 110.85 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -112.48 128.18 56.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 8.0099999999999998 110.898 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.6 t -156.77 89.62 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 2.29 110.868 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 131.84 39.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 3.3199999999999998 110.899 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.5 pt -148.88 124.78 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 3.4100000000000001 111.16 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -60.67 -23.67 65.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 5.3899999999999997 110.896 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.3 m -133.9 112.03 10.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 3.3399999999999999 111.163 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 170.62 -179.05 42.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.789 -0.72 . . . . 2.0899999999999999 112.514 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.6 mtm -110.67 127.54 55.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.32 . . . . 5.6500000000000004 110.888 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -122.95 130.06 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 1.97 111.097 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -19.66 64.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 3.1800000000000002 110.874 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 mm -103.5 84.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 4.0300000000000002 111.106 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -87.96 115.94 25.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 2.3799999999999999 110.919 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 94.7 t -100.71 110.27 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 2.3599999999999999 111.131 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 50.2 t -137.53 143.09 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 2.27 111.15 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -81.0 115.5 20.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 7.0499999999999998 110.868 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.08 154.83 18.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 3.0699999999999998 111.064 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.49 118.68 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 5.9800000000000004 110.885 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.88 -128.15 32.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 1.3500000000000001 112.505 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.65 119.05 23.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 2.9300000000000002 111.11 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -95.1 41.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 7.4000000000000004 110.87 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.93 -43.5 2.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 3.1000000000000001 112.462 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.23 61.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 5.6699999999999999 110.884 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.82 -168.42 2.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 4.0700000000000003 110.892 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -76.59 95.96 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 6.3600000000000003 110.892 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.93 138.1 58.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 2.4500000000000002 111.123 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -136.67 106.85 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 7.7199999999999998 110.925 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.67 168.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 4.21 110.834 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.96 -133.59 2.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 3.1200000000000001 112.467 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -51.45 119.04 3.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.759 0.314 . . . . 5.3300000000000001 110.901 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 114.06 28.65 3.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 4.79 112.492 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.17 -137.17 3.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 2.4399999999999999 112.488 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.0 mm -76.88 123.38 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.346 . . . . 2.7999999999999998 111.107 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.43 -12.06 26.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.469 . . . . 5.5899999999999999 110.932 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.77 132.57 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 2.8100000000000001 111.091 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.09 110.18 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 3.7200000000000002 110.905 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.87 112.02 14.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 1.79 111.113 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.9 170.12 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 3.7000000000000002 110.899 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.46 169.41 0.27 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.82999999999999996 112.476 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -171.18 0.44 Allowed 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.736 2.291 . . . . 0.92000000000000004 112.317 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.33 -145.71 16.56 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 1.1299999999999999 112.477 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.8 m -92.17 153.52 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 2.46 110.908 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.51 -107.32 0.41 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 1.46 112.497 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.18 -24.77 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 2.8500000000000001 111.111 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.09 96.95 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.736 -0.745 . . . . 2.4500000000000002 112.51 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 117.8 -16.55 12.26 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.772 -0.728 . . . . 2.04 112.475 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -50.43 145.04 6.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.821 0.343 . . . . 2.2799999999999998 110.882 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.57 133.45 42.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 1.8 111.101 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -121.77 109.96 15.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 3.3700000000000001 110.853 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -90.24 111.8 23.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 3.9700000000000002 110.888 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.51 99.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 5.96 110.829 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -75.56 69.93 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 9.5600000000000005 110.836 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 43.6 t0 64.67 20.4 12.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 3.8399999999999999 110.884 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.4 18.37 19.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 4.4000000000000004 110.862 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.09 153.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 7.1500000000000004 110.867 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -105.74 173.7 6.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 8.1300000000000008 110.899 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.13 172.86 17.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 2.75 111.092 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.74 -170.55 2.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 2.6299999999999999 111.113 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -61.66 -20.72 63.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 5.0899999999999999 110.872 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.42 -36.41 9.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 2.6800000000000002 110.883 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.94 -179.68 0.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.789 -0.72 . . . . 3.23 112.477 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -54.08 -91.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 2.3700000000000001 112.492 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 92.0 m -70.5 98.84 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.352 . . . . 2.8300000000000001 111.139 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.06 111.07 1.78 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 3.29 110.891 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.66 -34.21 67.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 3.0499999999999998 110.938 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -71.85 -64.86 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 6.79 110.882 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.7 -46.45 70.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 4.1399999999999997 110.906 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 77.3 m -54.91 -40.12 69.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 2.1299999999999999 111.145 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.85 -32.27 63.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 2.0499999999999998 111.081 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.53 -34.49 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 1.97 111.101 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -71.41 -38.85 71.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 3.27 110.872 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.44 -52.89 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 3.8999999999999999 110.859 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 9.9 tt -51.93 -32.53 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.484 . . . . 3.52 111.096 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.26 -34.14 46.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.752 . . . . 1.03 112.455 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -25.61 67.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.798 0.332 . . . . 3.8799999999999999 110.842 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.47 24.9 4.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 2.4199999999999999 110.842 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.43 -64.75 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 4.1900000000000004 110.916 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 170.87 48.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.726 . . . . 1.9399999999999999 112.496 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 56.4 mt -145.23 -74.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.389 . . . . 4.4400000000000004 110.886 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 57.1 -102.51 0.21 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 4.5999999999999996 112.495 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -119.32 119.27 33.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 2.7599999999999998 110.857 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 11.0 t -99.14 -80.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 4.5 110.874 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.19 -38.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 4.5499999999999998 110.872 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.41 107.41 0.72 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.61 0.719 . . . . 2.3900000000000001 110.828 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -44.42 2.11 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.647 2.231 . . . . 1.97 112.341 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -32.02 70.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 5.5599999999999996 110.881 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -71.63 170.65 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 2.9700000000000002 111.1 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.5 m -95.96 8.15 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 6.2400000000000002 111.092 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -89.18 3.14 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 4.3499999999999996 110.892 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 160.09 0.52 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.667 0.746 . . . . 10.65 110.849 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -30.33 22.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.66 2.24 . . . . 3.7400000000000002 112.353 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.8 p -84.84 169.33 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 3.8999999999999999 111.162 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -119.6 114.73 22.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 11.390000000000001 110.901 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.28 133.18 51.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 4.04 110.888 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -61.6 125.63 24.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 4.4100000000000001 110.929 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.06 155.27 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 3.2599999999999998 111.144 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.15 112.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 2.7400000000000002 110.928 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.2 pt -76.58 -13.89 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 4.3300000000000001 111.099 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.56 -26.85 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 4.4199999999999999 110.863 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 46.0 p -120.99 20.6 11.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 3.8100000000000001 111.096 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.66 148.5 40.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 5.0999999999999996 110.893 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 179.98 147.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 3.8999999999999999 110.919 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.0 tt -74.89 144.27 43.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 3.2999999999999998 110.905 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.9 m -154.6 -172.03 4.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 4.25 110.861 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 67.11 -171.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 3.7799999999999998 111.076 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.73 -23.59 30.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 3.54 110.861 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.87 -29.75 29.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 3.2999999999999998 110.875 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 17.8 tt -68.55 -31.25 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 2.8700000000000001 111.144 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -32.71 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 6.1299999999999999 110.861 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.61 -17.13 47.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 1.5600000000000001 112.477 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.0 tp -110.9 -35.81 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 2.3100000000000001 111.186 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -73.53 -24.75 60.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 3.1400000000000001 110.877 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 9.8 t -66.86 -27.47 67.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 3.0699999999999998 110.868 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 7.6 mp -51.98 -32.65 34.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 4.29 110.912 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -93.45 -34.87 13.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 15.380000000000001 110.925 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 119.183 -0.787 . . . . 12.300000000000001 112.516 -179.992 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.82 0.343 . . . . 9.0600000000000005 110.872 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -65.98 149.12 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 9.7100000000000009 110.915 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.59 164.11 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 3.0899999999999999 111.106 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.4 p -125.56 143.09 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 3.0699999999999998 111.146 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -152.05 141.42 21.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 5.0899999999999999 110.898 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.13 150.24 29.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 5.5300000000000002 110.871 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.7 mt -108.01 148.88 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 2.9199999999999999 111.151 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -102.68 -71.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 4.0599999999999996 110.868 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.27 172.48 7.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 6.8099999999999996 110.905 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -127.45 164.34 22.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 5.7199999999999998 110.949 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.41 129.21 42.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.566 0.698 . . . . 3.3300000000000001 111.127 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 133.55 25.83 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.678 2.252 . . . . 2.5899999999999999 112.346 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 t70 67.74 11.5 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 6.1299999999999999 110.864 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.5 tpt -106.09 152.54 23.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 4.0800000000000001 110.869 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -58.7 115.73 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 3.73 110.892 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -59.71 -20.18 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 6.04 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -80.15 -39.43 29.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.204 -0.453 . . . . 3.8700000000000001 110.9 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.51 -46.25 60.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 3.3100000000000001 110.897 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.98 -35.28 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.95 111.086 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.61 -54.61 37.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 3.0299999999999998 110.879 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -71.36 -32.38 68.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 3.8700000000000001 110.905 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.29 -51.96 49.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 1.6899999999999999 111.163 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.7 mp -82.73 -46.01 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 3.21 111.13 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -50.44 -45.49 55.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 7.3200000000000003 110.86 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -20.4 51.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 3.9500000000000002 110.883 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.6 -35.43 65.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 1.8100000000000001 111.093 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -72.42 -24.83 61.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 6.4900000000000002 110.894 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -31.5 60.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 4.5099999999999998 110.936 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.49 -30.93 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 3.29 111.108 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -94.57 -32.72 13.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 4.9699999999999998 110.92 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -63.68 -15.74 59.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 2.6000000000000001 110.857 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -83.0 -12.79 56.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 2.8300000000000001 110.946 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.6 p -118.84 -28.46 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 4.3899999999999997 111.136 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.0 t -107.22 141.65 23.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.581 0.705 . . . . 3.8500000000000001 111.19 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -6.07 17.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.656 2.238 . . . . 2.4100000000000001 112.347 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.2 tp -49.86 161.01 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 3.5299999999999998 110.915 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.28 138.06 54.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 6.25 110.915 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -114.38 128.65 56.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 10.58 110.896 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.27 99.86 4.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 2.6299999999999999 110.853 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 103.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 3.2000000000000002 110.877 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 tt -97.28 135.28 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 4.7800000000000002 111.115 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -102.52 41.71 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 3.9500000000000002 110.891 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.98 169.77 7.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 4.6299999999999999 111.119 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.08 -169.76 0.54 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 2.4300000000000002 112.486 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.3 mtm -108.48 148.19 30.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 7.9100000000000001 110.87 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.2 159.91 16.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 2.1600000000000001 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.87 -44.72 67.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 2.4300000000000002 110.906 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.1 pp -104.02 140.78 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 4.6100000000000003 111.114 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.2 115.27 17.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 2.3399999999999999 110.934 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.81 119.38 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 2.4900000000000002 111.133 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.7 t -138.47 140.91 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 2.1499999999999999 111.176 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.62 102.97 14.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 6.1600000000000001 110.854 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.67 177.35 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 2.23 111.108 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -135.64 111.74 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 4.7699999999999996 110.825 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 72.82 -135.78 22.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.737 . . . . 1.8799999999999999 112.497 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.16 110.96 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.334 . . . . 2.3399999999999999 111.081 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -70.61 -15.64 62.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 4.0499999999999998 110.871 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.04 -25.09 14.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 2.75 112.487 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -80.27 -74.81 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.351 . . . . 6.0300000000000002 110.872 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -178.68 33.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 7.0300000000000002 110.859 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -129.18 64.93 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 5.6600000000000001 110.825 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.26 145.43 30.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 2.5299999999999998 111.101 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -54.93 174.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 11.960000000000001 110.907 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -137.99 9.95 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 5.3700000000000001 110.881 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.91 139.81 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.708 -0.758 . . . . 2.9300000000000002 112.489 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 119.23 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.366 . . . . 4.0499999999999998 110.873 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 124.09 -18.48 7.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.718 -0.753 . . . . 2.8599999999999999 112.495 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -117.65 -125.96 3.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 2.1699999999999999 112.498 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.7 mp -79.23 93.27 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 2.8199999999999998 111.125 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.9 pp -50.43 -26.43 5.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 4.3799999999999999 110.906 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 179.45 168.9 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 2.8399999999999999 111.101 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.87 130.8 53.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 3.9199999999999999 110.867 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -142.1 103.71 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 1.73 111.072 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.28 165.53 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 3.9199999999999999 110.885 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -56.51 -176.74 0.31 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 0.97999999999999998 112.477 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.703 2.269 . . . . 0.87 112.313 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.13 -149.46 17.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 1.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.7 p -91.73 151.73 20.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 3.1299999999999999 110.823 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 50.35 -103.98 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 1.45 112.478 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 30.7 mm -57.02 -25.98 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.371 . . . . 3.5 111.142 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.33 100.1 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 2.5299999999999998 112.536 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.44 18.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.739 -0.743 . . . . 1.8700000000000001 112.469 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.22 145.17 8.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.778 0.323 . . . . 2.1200000000000001 110.844 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -136.95 128.69 28.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 1.8300000000000001 111.1 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.09 123.59 50.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 3.7200000000000002 110.85 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.52 143.83 41.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 5.5599999999999996 110.913 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.67 -77.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 5.79 110.879 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 66.94 41.22 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 7.5199999999999996 110.914 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.9 t0 66.18 47.5 1.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 3.3199999999999998 110.836 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.78 -77.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 4.5899999999999999 110.834 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.83 138.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 5.0499999999999998 110.873 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -106.28 138.95 41.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 10.93 110.92 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.45 165.68 35.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 2.2000000000000002 111.173 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -170.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 2.5699999999999998 111.162 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -57.24 -46.6 82.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 5.0499999999999998 110.888 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.54 -34.84 40.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 2.7200000000000002 110.901 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -50.87 170.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 3.1699999999999999 112.539 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -45.13 -83.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 2.2799999999999998 112.527 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.13 97.56 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 3.54 111.134 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -61.49 113.14 2.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 3.5299999999999998 110.897 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.57 -35.91 70.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 3.2999999999999998 110.975 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -71.34 -35.94 71.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 5.6799999999999997 110.867 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.78 -48.55 11.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 3.46 110.914 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 53.3 m -55.25 -28.83 55.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 2.0800000000000001 111.148 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.38 -46.06 67.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 1.6899999999999999 111.072 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.86 -42.71 93.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 1.9299999999999999 111.124 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -54.1 -34.66 60.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 3.3999999999999999 110.855 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -29.6 61.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 4.2999999999999998 110.894 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.3 mm -56.24 -59.87 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 2.6800000000000002 111.127 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.65 -31.75 79.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 1.05 112.487 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -44.49 86.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 3.75 110.895 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.75 24.95 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 2.27 110.879 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 mp -127.97 -38.5 1.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 3.3599999999999999 110.924 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 161.73 -54.74 0.31 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 2.1800000000000002 112.475 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.6 mt -73.2 -178.57 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 3.8999999999999999 110.913 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 156.31 -94.93 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 4.46 112.499 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -96.12 98.3 10.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.768 0.318 . . . . 2.0699999999999998 110.879 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.8 m -101.35 -75.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 5.1399999999999997 110.845 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.65 -33.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 4.8799999999999999 110.893 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -47.91 107.57 0.76 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.581 0.705 . . . . 3.1000000000000001 110.875 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -41.83 3.95 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 2.9399999999999999 112.376 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.42 46.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 5.6900000000000004 110.904 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -136.58 174.45 10.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 2.0099999999999998 111.119 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.46 7.6 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 4.0300000000000002 111.129 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -87.32 -48.47 7.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 6.0 110.877 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.8 139.86 21.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.741 . . . . 6.2999999999999998 110.882 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 79.1 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.713 2.275 . . . . 3.0600000000000001 112.311 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.5 t -157.02 118.61 3.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 3.79 111.144 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -70.22 131.05 43.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 4.2400000000000002 110.896 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -162.85 93.23 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 4.6200000000000001 110.923 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -50.87 119.64 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.448 . . . . 4.8499999999999996 110.929 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.1 t -114.82 152.09 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 3.5600000000000001 111.12 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.79 113.25 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 2.7599999999999998 110.893 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -57.42 -37.98 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 3.46 111.188 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.68 -28.41 68.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 4.0899999999999999 110.877 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 30.0 p -115.65 17.94 16.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 3.9100000000000001 111.15 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -82.53 121.69 27.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 6.4900000000000002 110.889 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -164.65 151.81 11.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 4.7000000000000002 110.835 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.07 139.1 42.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 3.75 110.871 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.35 -171.09 3.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 3.8999999999999999 110.829 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 70.7 165.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 4.5300000000000002 111.099 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -59.31 -20.46 54.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 2.6400000000000001 110.868 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -50.06 -29.4 8.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 3.6800000000000002 110.89 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 7.4 tt -51.98 -29.04 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 2.7599999999999998 111.11 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -83.4 -31.16 26.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 5.4100000000000001 110.866 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.74 -24.64 69.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 1.97 112.491 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 4.1 tp -102.88 -30.98 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 1.8899999999999999 111.144 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -61.67 -36.55 81.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 3.4199999999999999 110.907 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.8 t -64.43 -41.09 96.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 3.3399999999999999 110.863 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.7 mp -51.93 105.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 6.6399999999999997 110.921 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -156.67 -74.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 16.789999999999999 110.903 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.131 -0.816 . . . . 12.52 112.502 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.803 0.335 . . . . 9.7300000000000004 110.818 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -116.34 148.04 40.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 9.6699999999999999 110.958 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mp -118.73 145.83 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 3.6499999999999999 111.154 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.01 150.55 39.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 3.1000000000000001 111.178 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.84 162.62 39.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 5.1900000000000004 110.93 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -161.94 138.09 7.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 5.3499999999999996 110.86 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.0 pt -107.75 136.06 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 3.48 111.143 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -151.59 43.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 4.2800000000000002 110.948 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.76 151.41 51.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 6.4400000000000004 110.85 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -144.06 129.92 19.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 5.7800000000000002 110.94 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.58 159.5 58.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.616 0.722 . . . . 3.0600000000000001 111.144 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -86.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.68 2.253 . . . . 2.7999999999999998 112.338 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.92 75.58 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 4.2400000000000002 110.892 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.4 tpt -165.16 138.36 4.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 3.7599999999999998 110.863 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.27 120.01 8.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 4.1900000000000004 110.892 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -60.96 -19.37 60.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 6.0800000000000001 110.863 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -78.86 -29.24 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 3.1099999999999999 110.902 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.3 -44.82 24.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 2.8300000000000001 110.9 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.8 p -58.93 -43.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 2.3900000000000001 111.113 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.48 -45.7 76.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 3.1299999999999999 110.917 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -74.65 -32.49 62.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 3.2400000000000002 110.878 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.83 -44.58 63.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 2.0600000000000001 111.087 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.8 mm -83.06 -48.83 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.414 . . . . 3.23 111.136 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -50.62 -44.99 57.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 4.2199999999999998 110.889 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -78.22 -20.52 51.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 3.8500000000000001 110.931 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.34 -40.88 71.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 2.4900000000000002 111.126 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -48.24 34.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 5.1600000000000001 110.874 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -52.39 -28.65 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 4.5800000000000001 110.926 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.7 t -55.79 -56.43 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 3.1200000000000001 111.143 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -82.15 -40.72 21.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 5.1299999999999999 110.886 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.79 -24.45 35.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 2.25 110.867 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -75.28 -27.39 59.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 2.71 110.851 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.05 41.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 3.46 111.112 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 36.3 m -150.94 132.37 7.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.689 . . . . 2.6499999999999999 111.189 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 70.09 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.669 2.246 . . . . 2.9700000000000002 112.325 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 tp -138.29 -171.88 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 3.8500000000000001 110.863 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -128.23 142.34 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 5.9199999999999999 110.876 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.85 122.52 20.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 8.1199999999999992 110.844 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 t -156.82 112.21 2.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 3.0499999999999998 110.877 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.55 107.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 3.6200000000000001 110.949 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.6 mt -91.57 144.41 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 4.5999999999999996 111.142 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -94.7 22.86 5.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 5.1299999999999999 110.906 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.17 167.77 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 6.6900000000000004 111.129 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -79.37 -0.09 82.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 3.79 112.487 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 10.7 mtt -83.15 100.34 10.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.726 0.298 . . . . 7.71 110.859 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -148.36 129.83 14.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 2.6299999999999999 111.1 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.49 -26.53 41.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 2.77 110.847 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.4 pt -123.98 142.5 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.205 -0.452 . . . . 3.7799999999999998 111.154 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.461 ' C ' ' CD2' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -133.17 164.13 27.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 3.1400000000000001 110.894 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.6 t -121.93 115.64 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 2.4500000000000002 111.096 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.4 t -145.18 142.08 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 2.5 111.135 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -105.39 133.97 49.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 4.71 110.926 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.28 142.18 6.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 2.8700000000000001 111.076 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -107.25 167.21 10.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 5.8799999999999999 110.888 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.94 -141.08 25.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 1.8100000000000001 112.451 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.13 148.68 48.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 3.2599999999999998 111.072 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -115.68 22.25 13.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 4.4900000000000002 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.45 14.53 62.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.669 -0.777 . . . . 3.4100000000000001 112.49 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.56 -75.95 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.778 0.323 . . . . 6.3899999999999997 110.807 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.34 62.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 4.6699999999999999 110.872 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -137.7 42.57 2.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 7.6299999999999999 110.841 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 118.86 22.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.1699999999999999 111.095 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -179.07 98.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 9.4700000000000006 110.926 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.88 -175.77 4.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 5.75 110.855 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.42 106.97 2.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 3.0600000000000001 112.502 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -50.31 119.39 3.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.337 . . . . 5.54 110.896 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.76 -27.76 19.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.752 -0.737 . . . . 2.6800000000000002 112.505 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -81.48 -140.0 2.9 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 1.52 112.453 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.9 mm -80.63 92.46 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.36 . . . . 3.02 111.122 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 pp -44.81 -33.77 2.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 4.1200000000000001 110.918 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 179.96 179.79 0.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 2.7000000000000002 111.122 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.87 128.5 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 7.0499999999999998 110.891 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.08 123.65 38.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 1.8999999999999999 111.097 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.5 169.96 4.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 3.5600000000000001 110.839 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.34 177.16 0.32 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 0.97999999999999998 112.501 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 160.1 50.97 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.91000000000000003 112.314 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 152.49 -146.41 14.97 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 1.29 112.471 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 99.0 p -107.46 124.45 49.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.91 0.386 . . . . 2.5299999999999998 110.857 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.93 -57.65 3.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.699 -0.762 . . . . 1.78 112.506 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.6 22.08 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 3.0899999999999999 111.125 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.78 -114.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 3.1800000000000002 112.479 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -94.29 42.76 2.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 2.0699999999999998 112.499 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.35 127.14 30.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 1.98 110.868 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.72 131.77 34.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 2.46 111.145 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -125.45 137.73 53.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 3.9199999999999999 110.866 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -139.97 102.75 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 3.7999999999999998 110.884 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -52.39 120.98 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 6.7000000000000002 110.914 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -67.78 -29.19 68.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 8.1899999999999995 110.893 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -78.29 -19.36 53.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 4.7400000000000002 110.867 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -177.48 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 3.8599999999999999 110.907 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -118.35 109.51 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 5.8799999999999999 110.925 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -101.93 122.21 43.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 7.7800000000000002 110.943 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 p -135.64 174.41 10.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 2.3700000000000001 111.131 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -175.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 2.3100000000000001 111.157 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -51.75 -35.21 42.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 5.6200000000000001 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -60.37 2.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 2.1699999999999999 110.867 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.51 171.52 0.28 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 2.9500000000000002 112.508 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -52.28 -89.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 2.1899999999999999 112.466 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.12 108.81 2.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 2.3500000000000001 111.1 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.67 114.82 23.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 3.79 110.889 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.79 -35.87 45.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 2.9500000000000002 110.938 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -71.36 -60.76 2.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 6.6500000000000004 110.867 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.5 tp -52.11 -55.31 21.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.193 -0.458 . . . . 3.6800000000000002 110.882 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.1 m -54.88 -45.83 74.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 1.8 111.144 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.49 -32.07 62.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 1.8100000000000001 111.114 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.0 t -76.35 -30.07 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 2.27 111.148 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -65.47 -36.68 84.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 3.3599999999999999 110.826 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -66.88 -20.95 66.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 6.04 110.89 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.96 -42.87 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 2.5299999999999998 111.132 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.98 -38.13 36.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.725 -0.75 . . . . 0.95999999999999996 112.469 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -23.63 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 3.8300000000000001 110.842 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.4 p -109.97 17.78 20.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 4.0199999999999996 110.895 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.43 94.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 3.5699999999999998 110.906 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 58.73 -178.72 1.61 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 3.0899999999999999 112.477 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 71.04 -68.84 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 4.2599999999999998 110.888 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 98.63 -66.92 0.69 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.728 . . . . 3.2799999999999998 112.487 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -173.52 133.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 2.6000000000000001 110.871 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.0 m 63.21 163.32 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 6.3899999999999997 110.859 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 25.2 t -178.86 -64.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 7.1299999999999999 110.885 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.92 156.79 51.4 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 2.8100000000000001 110.862 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 165.66 30.22 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.686 2.258 . . . . 2.7000000000000002 112.349 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.68 28.4 4.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 6.1100000000000003 110.879 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -122.7 -169.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 2.7000000000000002 111.107 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.8 m -95.58 -29.29 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 4.1500000000000004 111.158 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.1 tpt -58.2 -23.66 56.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 5.0 110.828 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.18 150.71 29.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.683 0.754 . . . . 5.1299999999999999 110.859 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -48.69 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.657 2.238 . . . . 3.3199999999999998 112.342 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -85.61 138.83 31.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 4.4400000000000004 111.19 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.13 135.98 52.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 5.2300000000000004 110.924 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 102.89 8.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 5.5 110.877 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -51.65 131.34 29.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 4.5 110.905 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.78 132.8 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 3.48 111.17 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.99 132.61 23.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 2.9399999999999999 110.858 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -14.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 4.3300000000000001 111.178 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -71.26 -29.12 64.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 4.7000000000000002 110.863 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.92 -6.06 10.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 3.3199999999999998 111.142 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -51.94 127.36 20.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 6.8300000000000001 110.877 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -173.1 142.06 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 5.9100000000000001 110.823 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.53 170.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 3.9900000000000002 110.934 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.98 160.95 16.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 4.2599999999999998 110.843 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -61.83 -55.56 28.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 5.3499999999999996 111.1 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.49 -29.38 50.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 2.4100000000000001 110.898 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.08 -30.43 67.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 3.3500000000000001 110.896 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 60.6 mt -62.31 -30.8 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 3.8199999999999998 111.161 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -75.84 -28.17 58.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 4.9299999999999997 110.882 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.69 -3.41 88.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 1.4199999999999999 112.487 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 10.4 tp -120.93 -31.53 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.777 0.322 . . . . 1.79 111.115 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -78.67 -44.52 23.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 3.4100000000000001 110.96 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.69 -47.18 13.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 2.6200000000000001 110.867 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 63.4 98.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 3.52 110.936 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 1.4 t80 53.36 89.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 12.869999999999999 110.931 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 CA-C-O 119.177 -0.79 . . . . 8.9199999999999999 112.452 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.83 0.348 . . . . 9.7699999999999996 110.87 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -110.11 148.7 31.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 11.6 110.907 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.7 mm -120.18 152.77 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 3.9500000000000002 111.148 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 t -146.72 154.48 41.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 2.96 111.127 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -145.23 166.34 25.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 5.0599999999999996 110.977 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -161.8 138.21 8.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 4.8899999999999997 110.924 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.3 mt -108.07 148.42 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 3.2200000000000002 111.112 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -162.25 56.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 4.75 110.886 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 135.14 10.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 6.2300000000000004 110.936 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -147.7 106.51 3.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 7.5599999999999996 110.972 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.8 153.65 45.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.573 0.701 . . . . 4.8899999999999997 111.123 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -15.01 36.9 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 2.7799999999999998 112.327 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -51.45 -69.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 5.7400000000000002 110.905 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 34.7 mmt -107.79 160.35 15.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 4.3600000000000003 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.03 166.84 2.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 3.3100000000000001 110.893 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.51 -19.46 60.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 7.04 110.891 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.5 -38.67 33.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 3.1000000000000001 110.895 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -71.24 -41.15 70.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 2.5099999999999998 110.877 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.8 p -74.09 -27.88 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 1.8100000000000001 111.115 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -71.23 -53.87 12.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 2.6099999999999999 110.871 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -69.75 -32.45 70.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 3.6099999999999999 110.933 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.92 -58.2 6.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.512 . . . . 1.72 111.081 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mm -69.19 -45.47 79.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 3.48 111.126 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -34.54 31.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 5.75 110.84 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -78.71 -31.79 46.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 3.6299999999999999 110.914 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.48 65.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 2.2400000000000002 111.104 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -74.1 -27.87 61.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 6.9500000000000002 110.867 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -79.33 -50.9 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 3.1899999999999999 110.905 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.5 p -51.23 -41.96 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 3.21 111.086 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -49.63 17.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 4.7000000000000002 110.9 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.6 p -58.91 -19.9 46.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 2.4700000000000002 110.867 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -72.12 -17.11 62.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 3.1000000000000001 110.872 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.2 m -139.59 29.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 2.8700000000000001 111.147 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.3 p -148.48 152.26 38.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.57 0.7 . . . . 3.5800000000000001 111.173 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -14.98 36.98 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.668 2.245 . . . . 2.1099999999999999 112.379 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.02 163.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 4.1200000000000001 110.95 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -118.34 -172.39 2.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 6.25 110.926 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -135.64 119.99 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 7.96 110.867 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.4 t -140.7 89.95 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 3.0600000000000001 110.848 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 116.56 22.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 2.8300000000000001 110.92 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.79 116.82 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 3.5899999999999999 111.139 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -53.73 -27.76 30.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 4.4900000000000002 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.0 m -160.3 133.79 6.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 4.8200000000000003 111.155 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.94 -134.39 5.22 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 2.1200000000000001 112.526 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.8 138.22 31.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 10.93 110.828 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.31 130.06 16.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 2.4399999999999999 111.08 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.53 -28.35 37.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 2.8500000000000001 110.893 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.57 140.87 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 5.0999999999999996 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -120.18 114.01 21.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 2.4100000000000001 110.903 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.8 t -92.67 110.97 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 2.1499999999999999 111.104 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.2 t -143.22 139.98 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 2.0699999999999998 111.172 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -84.28 131.43 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 4.6699999999999999 110.936 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.41 176.64 5.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 2.7999999999999998 111.101 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.96 111.64 5.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 6.04 110.866 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.93 -127.02 27.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.766 -0.73 . . . . 1.4199999999999999 112.481 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.06 110.81 20.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 2.4199999999999999 111.105 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -90.52 66.54 6.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 3.9700000000000002 110.866 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.94 -91.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 3.1600000000000001 112.475 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.8 75.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 5.3499999999999996 110.863 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -157.36 -169.69 2.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 5.5099999999999998 110.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -78.53 95.57 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 4.7599999999999998 110.867 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.55 136.36 38.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 2.1099999999999999 111.109 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -112.78 -169.61 1.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 6.9699999999999998 110.862 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -141.79 164.6 29.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 4.0099999999999998 110.857 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.21 -156.08 17.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 2.6200000000000001 112.504 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.52 119.16 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 4.4500000000000002 110.927 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 133.71 -82.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.77 -0.728 . . . . 2.4300000000000002 112.496 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.33 -133.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 2.3900000000000001 112.493 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.1 mm -75.1 142.11 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 2.6499999999999999 111.107 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.5 -11.3 14.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 3.75 110.913 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.19 144.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 2.1600000000000001 111.089 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -143.64 117.09 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 3.6499999999999999 110.882 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.99 130.1 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 1.46 111.069 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.23 166.01 21.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 3.25 110.91 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.62 172.83 0.35 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.777 -0.725 . . . . 0.81999999999999995 112.478 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 172.08 13.3 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 0.81000000000000005 112.297 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 145.2 -154.97 26.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 1.02 112.47 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.4 p -88.78 135.44 33.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.936 0.398 . . . . 2.5800000000000001 110.844 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.72 -81.94 0.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 1.1399999999999999 112.496 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.71 50.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 3.5 111.157 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.1 -110.95 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 2.6400000000000001 112.462 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -90.78 41.45 2.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 2.4199999999999999 112.497 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.43 143.58 8.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 2.2999999999999998 110.873 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -121.52 130.98 53.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 1.72 111.124 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -122.03 126.67 49.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 3.79 110.876 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -139.45 150.35 45.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 4.3399999999999999 110.882 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 69.13 45.68 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 6.4800000000000004 110.867 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.29 58.99 1.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 8.1500000000000004 110.875 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.46 16.62 8.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 4.2699999999999996 110.84 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.57 -1.09 14.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 4.3099999999999996 110.942 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.75 150.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 7.3700000000000001 110.852 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -105.4 176.93 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 9.0600000000000005 110.904 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.26 172.89 17.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 2.5299999999999998 111.148 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.76 -173.39 2.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 2.0699999999999998 111.131 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -65.69 -20.33 66.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 5.3099999999999996 110.862 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -70.18 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 2.4300000000000002 110.856 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.66 -169.61 11.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 3.4100000000000001 112.457 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 49.29 -166.29 0.3 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 2.4500000000000002 112.483 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.87 99.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 2.46 111.144 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 214' ' ' LEU . 32.1 t30 -61.71 120.71 11.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 4.2000000000000002 110.849 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.88 -37.85 66.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 3.1299999999999999 110.842 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -71.58 -67.32 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 6.0 110.886 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.401 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 3.9 tp -48.31 -53.67 16.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 3.5800000000000001 110.931 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 37.5 m -55.21 -41.58 72.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 1.8100000000000001 111.113 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.54 -44.99 95.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 1.8700000000000001 111.12 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.77 -23.14 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 1.8700000000000001 111.14 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -72.65 -62.27 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 3.4700000000000002 110.857 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -55.37 26.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 4.6399999999999997 110.893 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.1 tt -51.55 -29.95 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 3.6099999999999999 111.143 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.98 -52.48 49.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 1.1000000000000001 112.479 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -72.12 -23.12 61.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 3.8199999999999998 110.83 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.12 -9.76 58.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 2.5699999999999998 110.847 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.13 -19.08 14.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 3.2000000000000002 110.903 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 145.23 -31.5 1.7 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 2.7400000000000002 112.477 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.9 179.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.343 . . . . 3.5699999999999998 110.958 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 173.79 66.89 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.68 -0.771 . . . . 2.7200000000000002 112.42 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 11.0 m80 63.47 106.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.349 . . . . 2.6499999999999999 110.872 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.2 t -80.91 -79.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 5.8899999999999997 110.855 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 175.93 -54.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 4.2199999999999998 110.848 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.95 126.63 34.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 2.7400000000000002 110.88 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -177.73 1.99 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.692 2.261 . . . . 2.3399999999999999 112.327 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.6 28.09 4.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 4.5199999999999996 110.9 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -115.36 178.71 4.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 2.2599999999999998 111.134 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 18.0 t -95.55 -9.44 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 4.1600000000000001 111.174 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 28.9 mmt -86.53 -38.48 17.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 5.8499999999999996 110.889 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.34 137.47 68.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.731 . . . . 5.3399999999999999 110.867 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 73.62 1.31 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.692 2.261 . . . . 2.6800000000000002 112.341 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.71 148.6 21.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 2.9700000000000002 111.158 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -113.32 112.76 24.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 3.8799999999999999 110.899 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 35.7 tttt -135.97 119.81 17.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 5.5599999999999996 110.918 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -51.71 132.0 30.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 4.0800000000000001 110.937 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 56.7 t -136.38 121.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 3.2200000000000002 111.12 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.02 130.96 26.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 4.0700000000000003 110.928 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 23.9 pt -56.67 -24.16 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 3.9500000000000002 111.151 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.5 -37.64 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 3.1200000000000001 110.872 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.4 m -104.02 27.98 7.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 3.7400000000000002 111.087 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -103.01 130.84 50.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 6.8899999999999997 110.844 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -163.88 139.73 6.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 5.8200000000000003 110.835 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.2 pp -52.4 170.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 4.3200000000000003 110.927 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.0 t -89.85 147.57 23.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 4.8600000000000003 110.893 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.51 -60.98 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 5.2699999999999996 111.095 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.48 -26.3 30.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 3.5 110.869 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.55 -34.74 74.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 3.4500000000000002 110.849 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.3 mt -55.17 -41.59 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 3.9399999999999999 111.132 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -14.3 61.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 5.3200000000000003 110.847 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -93.4 -14.48 53.57 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 1.6499999999999999 112.485 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 10.7 tp -110.32 -29.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 2.0800000000000001 111.089 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -67.83 -32.06 72.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 4.1799999999999997 110.915 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.2 t -63.71 -33.01 74.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 3.3100000000000001 110.843 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.84 129.87 35.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 4.71 110.91 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -123.08 -175.26 3.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 11.789999999999999 110.934 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 CA-C-O 119.157 -0.802 . . . . 14.279999999999999 112.471 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.791 0.329 . . . . 9.1400000000000006 110.866 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -73.09 148.95 43.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 9.5399999999999991 110.962 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.7 146.76 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 3.2599999999999998 111.148 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.2 p -114.06 147.7 38.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 2.9300000000000002 111.153 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -127.63 152.76 47.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 7.8899999999999997 110.883 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -160.24 123.32 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 8.2899999999999991 110.829 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.5 mt -108.16 131.94 57.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 2.8599999999999999 111.137 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -131.38 49.76 2.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 4.5999999999999996 110.86 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -179.87 126.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 6.0999999999999996 110.905 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -118.7 163.07 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 6.8200000000000003 110.922 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.3 m -86.63 131.57 45.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.63 0.728 . . . . 4.1600000000000001 111.074 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -48.91 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.697 2.264 . . . . 3.0499999999999998 112.393 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.36 54.57 2.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 4.3899999999999997 110.836 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -165.44 141.94 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 3.3900000000000001 110.918 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.29 135.54 57.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 4.5300000000000002 110.911 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -54.26 -25.59 24.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 7.04 110.878 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -78.27 -37.87 44.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 4.7199999999999998 110.887 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.51 -45.55 90.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 3.2000000000000002 110.84 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.4 p -74.32 -32.62 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 2.25 111.112 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.23 -54.35 11.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 3.6899999999999999 110.89 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -65.21 -32.17 73.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 4.5800000000000001 110.934 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.51 -57.75 8.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 1.8999999999999999 111.114 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.5 mm -70.16 -49.12 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 3.29 111.13 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -49.76 -46.06 50.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 5.1100000000000003 110.862 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -20.41 49.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 4.0 110.849 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.04 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 2.3100000000000001 111.089 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.23 -26.79 67.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 6.1600000000000001 110.883 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -28.92 66.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 4.1399999999999997 110.913 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.96 -56.03 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 2.9300000000000002 111.113 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -43.54 65.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 4.7999999999999998 110.942 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.6 t -56.01 -32.39 63.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 2.4199999999999999 110.887 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -51.59 -32.23 27.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 2.8399999999999999 110.913 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.2 m -138.93 36.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 3.1000000000000001 111.098 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.4 m -155.38 131.6 5.76 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.573 0.701 . . . . 2.71 111.12 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 72.13 1.47 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.675 2.25 . . . . 2.1600000000000001 112.323 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.04 130.32 23.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 3.6899999999999999 110.884 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.42 133.29 56.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 5.9900000000000002 110.886 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -99.53 131.25 45.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 8.6799999999999997 110.902 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.6 m -113.41 90.15 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 2.5299999999999998 110.832 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 122.21 19.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 3.6000000000000001 110.883 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 pp -144.63 161.49 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 3.7999999999999998 111.157 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.44 34.22 3.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 5.2199999999999998 110.9 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 t -161.66 142.98 11.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 4.5499999999999998 111.139 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 85.78 176.4 50.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.73 . . . . 1.96 112.502 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.98 164.06 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 6.46 110.845 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.71 144.51 47.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 2.1000000000000001 111.134 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.4 -26.81 32.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 2.4399999999999999 110.884 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.9 mm -104.1 135.35 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 3.5 111.139 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -133.17 118.26 18.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 2.2000000000000002 110.929 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 89.5 t -105.65 110.54 31.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 2.7000000000000002 111.131 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.96 145.43 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 2.2000000000000002 111.106 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -107.25 109.03 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 6.4500000000000002 110.879 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.67 178.76 4.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 2.1499999999999999 111.082 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.08 111.63 17.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 5.71 110.887 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.37 -123.75 16.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.717 -0.754 . . . . 1.6699999999999999 112.494 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.22 110.41 20.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 2.8999999999999999 111.122 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -79.39 58.76 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 3.9199999999999999 110.885 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.8 -63.69 2.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.702 -0.761 . . . . 4.2999999999999998 112.507 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -179.5 42.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.77 0.319 . . . . 7.6500000000000004 110.867 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -111.23 -78.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 4.9900000000000002 110.829 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -138.16 98.12 3.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 5.2699999999999996 110.837 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.85 113.61 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 2.5099999999999998 111.128 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -111.12 131.58 54.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 7.0599999999999996 110.904 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.82 171.06 13.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 4.3799999999999999 110.887 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.06 -162.18 27.95 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 2.8599999999999999 112.475 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -50.3 119.17 3.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 4.5899999999999999 110.887 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 128.06 -15.85 6.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 2.48 112.497 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -127.21 -133.75 3.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.71 -0.757 . . . . 1.6299999999999999 112.496 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.85 90.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 3.6600000000000001 111.138 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.8 pp -48.31 -31.71 6.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 3.8700000000000001 110.886 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 176.87 153.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 2.0800000000000001 111.124 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -142.92 106.27 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 4.6299999999999999 110.896 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -96.22 108.41 20.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 2.0499999999999998 111.085 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.43 168.81 5.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 3.8700000000000001 110.86 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.49 171.49 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.747 . . . . 0.88 112.526 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -170.62 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 0.84999999999999998 112.336 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 126.42 -152.01 18.2 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 1.1699999999999999 112.486 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.16 152.81 20.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 2.4100000000000001 110.835 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 50.83 -104.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 1.51 112.497 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 34.0 mm -54.8 -26.56 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 3.3399999999999999 111.124 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.85 108.03 1.69 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.659 -0.781 . . . . 2.4700000000000002 112.491 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 108.17 -24.33 23.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.792 -0.718 . . . . 1.8600000000000001 112.502 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -49.8 147.27 3.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 2.2000000000000002 110.887 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.85 145.79 30.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 2.1400000000000001 111.112 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -121.78 152.95 38.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 3.52 110.841 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -133.53 103.19 5.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 4.0700000000000003 110.861 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 47.39 70.62 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 5.7599999999999998 110.889 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.59 -48.82 63.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 7.3899999999999997 110.872 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -127.93 0.47 5.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 4.4299999999999997 110.862 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.72 -168.73 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 3.7799999999999998 110.915 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -114.96 160.07 19.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 7.2800000000000002 110.918 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -106.15 152.52 23.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 7.2800000000000002 110.892 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.09 174.03 16.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 2.4199999999999999 111.133 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.74 -172.28 3.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 2.7799999999999998 111.182 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -55.92 -32.85 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 6.6299999999999999 110.842 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -56.45 5.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 3.2400000000000002 110.814 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -49.3 155.28 1.97 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 2.8500000000000001 112.488 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.48 -58.75 7.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 2.3399999999999999 112.5 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.19 102.91 15.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 3.0699999999999998 111.167 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.14 121.66 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 3.8900000000000001 110.859 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -35.28 64.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 3.1299999999999999 110.901 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -71.96 -67.82 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 6.2800000000000002 110.87 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.9 tp -49.6 -47.34 49.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 3.2200000000000002 110.866 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 99.4 m -55.31 -44.2 75.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 2.1899999999999999 111.107 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.52 69.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 1.9099999999999999 111.071 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.3 t -72.82 -29.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 1.78 111.127 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -71.89 -39.39 69.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 2.98 110.826 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -74.31 -51.62 14.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 4.3399999999999999 110.932 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.0 tt -54.94 -27.32 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 3.4500000000000002 111.135 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.81 -27.41 62.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.776 -0.726 . . . . 0.90000000000000002 112.502 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -81.76 -43.88 17.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.757 0.313 . . . . 3.6400000000000001 110.837 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.5 p -86.53 52.26 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 1.9399999999999999 110.848 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 mt -159.12 -46.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 2.8599999999999999 110.887 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -172.51 -61.88 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 2.0800000000000001 112.496 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.6 mp -60.89 171.71 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 3.8500000000000001 110.926 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 177.46 65.08 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 2.7799999999999998 112.487 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.1 m170 64.22 157.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.32 . . . . 2.3799999999999999 110.853 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.6 t -163.86 -70.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 4.9299999999999997 110.863 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.7 -32.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 4.8499999999999996 110.871 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -45.2 105.81 0.49 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.677 0.751 . . . . 2.2400000000000002 110.834 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 233' ' ' LYS . 54.0 Cg_endo -69.69 175.67 7.73 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.722 2.281 . . . . 2.02 112.349 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.25 42.66 0.31 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 4.8300000000000001 110.869 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -135.18 151.06 50.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 2.2000000000000002 111.093 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.84 -14.59 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 3.6299999999999999 111.159 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -81.96 -39.66 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 6.3600000000000003 110.847 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -50.99 134.52 29.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.662 0.744 . . . . 5.0800000000000001 110.902 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 76.45 1.15 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.722 2.282 . . . . 3.0800000000000001 112.323 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.5 m -157.3 152.66 26.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 3.5699999999999998 111.137 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -111.72 112.32 23.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 6.4400000000000004 110.89 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.48 -169.15 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 5.2999999999999998 110.913 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -121.48 107.86 12.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 4.8300000000000001 110.901 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.93 154.58 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 4.2800000000000002 111.135 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -74.22 124.99 27.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 3.23 110.86 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 11.8 tt -76.47 -35.48 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 4.1699999999999999 111.113 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -53.48 -31.9 47.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 3.52 110.881 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.9 t -113.68 30.07 7.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 3.8199999999999998 111.109 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -52.05 134.47 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 7.0499999999999998 110.873 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -179.9 142.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 4.4800000000000004 110.926 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.21 147.8 47.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 3.48 110.866 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.1 -172.02 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 3.79 110.872 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 66.4 163.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 4.4900000000000002 111.118 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -57.67 -25.11 59.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 2.6800000000000002 110.815 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -51.62 -29.83 19.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 3.04 110.853 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 12.7 tt -50.88 -29.59 7.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 3.23 111.153 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -92.07 -40.15 11.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 6.9299999999999997 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.97 -20.51 41.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 1.95 112.462 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 8.2 tp -91.41 -32.83 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 2.23 111.128 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.19 -44.4 38.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 3.9399999999999999 110.957 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.45 -47.16 12.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 2.9399999999999999 110.883 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.5 tp 54.13 27.16 7.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 3.2000000000000002 110.926 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.77 29.46 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 9.8599999999999994 110.872 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 CA-C-O 119.133 -0.815 . . . . 9.3100000000000005 112.501 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.791 0.329 . . . . 8.8300000000000001 110.833 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -132.14 148.38 52.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 12.69 110.929 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -152.16 166.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 4.3700000000000001 111.141 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.2 p -144.63 140.71 28.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 2.5800000000000001 111.109 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -150.26 151.32 32.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 5.0199999999999996 110.938 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.83 161.63 29.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 6.25 110.92 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.4 mt -108.09 148.93 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 2.8100000000000001 111.082 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.15 -69.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 3.2200000000000002 110.901 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -98.59 176.89 5.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 6.4800000000000004 110.895 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -146.39 155.01 42.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 7.5 110.904 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.53 134.9 53.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.601 0.715 . . . . 3.1299999999999999 111.11 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 135.25 29.87 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.689 2.259 . . . . 2.6699999999999999 112.354 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.45 11.39 8.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 5.9000000000000004 110.865 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.48 147.32 29.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 3.9900000000000002 110.839 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -58.63 115.34 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 4.29 110.893 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -21.94 61.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 6.6900000000000004 110.862 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -80.55 -40.01 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 3.27 110.831 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.72 -47.87 61.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 2.8100000000000001 110.87 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.97 -40.8 90.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 1.8300000000000001 111.142 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.83 -54.07 33.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 3.1299999999999999 110.912 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -68.17 -32.28 72.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 3.8399999999999999 110.936 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.64 -41.07 54.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 1.9399999999999999 111.151 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.8 mm -83.62 -49.4 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 3.21 111.129 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -59.66 4.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 6.7300000000000004 110.841 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -29.86 61.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 6.0499999999999998 110.915 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.14 -33.37 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 1.8999999999999999 111.112 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.36 -24.66 60.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 4.7599999999999998 110.896 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.22 -54.02 6.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 3.3500000000000001 110.884 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.6 p -52.08 -28.81 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 3.2400000000000002 111.12 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -89.11 -55.44 3.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 5.0199999999999996 110.897 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 81.6 p -55.26 -22.56 18.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 2.5099999999999998 110.855 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.83 -29.78 12.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 3.0600000000000001 110.905 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -128.3 46.36 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 2.7200000000000002 111.137 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.46 142.35 13.52 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.619 0.723 . . . . 2.4700000000000002 111.113 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -11.91 31.79 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.702 2.268 . . . . 1.8400000000000001 112.345 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.2 167.2 4.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 4.0899999999999999 110.914 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.76 -172.95 2.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 7.1399999999999997 110.887 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -131.84 127.58 36.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 7.6200000000000001 110.9 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.97 89.92 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 3.0499999999999998 110.885 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 95.18 7.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 3.3500000000000001 110.918 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.81 133.19 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 4.04 111.13 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.1 -28.96 67.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 4.8399999999999999 110.916 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.62 174.32 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 3.9900000000000002 111.175 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.94 134.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.719 . . . . 2.27 112.487 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.1 mtm -68.99 160.33 31.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 7.6299999999999999 110.866 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.68 144.63 37.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 2.04 111.124 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.48 -33.54 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 2.3799999999999999 110.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.3 mm -103.99 94.47 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 4.0199999999999996 111.124 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -105.13 117.46 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 2.8500000000000001 110.86 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.2 t -102.25 109.24 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 2.7599999999999998 111.076 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.7 t -138.88 141.11 37.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 2.7400000000000002 111.187 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.91 152.76 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 4.4500000000000002 110.89 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.41 173.33 10.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 2.0099999999999998 111.112 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.67 120.0 13.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 6.0700000000000003 110.819 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 53.62 -134.77 42.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 1.9399999999999999 112.488 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.91 110.48 20.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 2.1200000000000001 111.061 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.23 56.38 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 3.9399999999999999 110.859 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.34 -58.94 3.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 2.6800000000000002 112.493 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -162.3 33.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 5.4699999999999998 110.847 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -110.74 -168.88 1.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 5.1399999999999997 110.878 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.75 114.89 16.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 7.7300000000000004 110.876 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.05 147.83 40.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 2.77 111.11 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -59.86 -170.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 11.31 110.875 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -137.92 165.39 26.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 5.25 110.87 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -50.82 133.35 31.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 3.8799999999999999 112.504 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 129.89 27.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 5.4900000000000002 110.934 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.87 -13.39 29.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 3.8399999999999999 112.459 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -108.58 -136.95 7.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 3.2799999999999998 112.514 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.7 mt -71.47 110.88 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 4.4699999999999998 111.174 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -42.55 55.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 4.7400000000000002 110.931 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.84 -179.74 0.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 3.1099999999999999 111.078 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -142.15 129.58 21.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 4.8300000000000001 110.843 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -115.76 121.63 43.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 1.78 111.059 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.28 165.8 8.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 3.8799999999999999 110.859 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.37 170.2 0.34 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.90000000000000002 112.478 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -170.3 0.38 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.738 2.292 . . . . 1.0 112.364 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.14 -149.14 18.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 1.23 112.497 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 99.3 p -92.24 155.56 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 2.3199999999999998 110.899 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.42 -104.4 0.15 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 1.3700000000000001 112.485 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 38.0 mt -61.31 -26.52 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 2.8399999999999999 111.121 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.15 99.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 2.6899999999999999 112.515 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 116.73 -18.9 12.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 1.76 112.456 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -49.83 137.57 16.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.826 0.345 . . . . 2.0099999999999998 110.883 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -131.39 149.93 52.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 2.0899999999999999 111.099 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.58 109.89 7.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 3.7799999999999998 110.83 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -107.84 125.81 51.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 7.1299999999999999 110.889 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 49.67 78.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 6.6299999999999999 110.871 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -76.61 60.79 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 8.5 110.901 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.6 26.6 16.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 5.3399999999999999 110.856 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -97.42 -42.54 7.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 3.7999999999999998 110.848 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 178.68 119.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 5.3700000000000001 110.871 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -106.76 124.71 50.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 10.51 110.923 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.1 159.92 38.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 2.1899999999999999 111.141 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.3 177.84 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 2.0800000000000001 111.146 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -55.39 -24.97 32.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 5.5800000000000001 110.865 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.98 -42.0 10.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 3.3399999999999999 110.861 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -57.21 -175.93 0.36 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 3.2400000000000002 112.503 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.4 -87.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.737 . . . . 2.4900000000000002 112.461 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 60.1 m -73.89 98.74 3.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.827 0.346 . . . . 2.7599999999999998 111.126 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -61.62 110.77 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 4.9100000000000001 110.846 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.33 -44.41 71.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.13 -0.487 . . . . 3.1499999999999999 110.907 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.96 -40.31 96.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 6.7999999999999998 110.896 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.44 -47.06 28.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 3.8199999999999998 110.904 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 24.0 m -55.54 -49.6 72.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 2.3399999999999999 111.141 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.84 -32.09 63.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 1.8799999999999999 111.076 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 62.9 t -80.77 -29.82 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 2.1699999999999999 111.066 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -73.56 -48.73 30.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 2.9700000000000002 110.871 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -63.59 -49.21 74.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 4.8399999999999999 110.884 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.6 tt -57.82 -25.41 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 3.71 111.162 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 -27.52 70.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 1.46 112.481 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -74.97 -28.67 60.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 4.9800000000000004 110.877 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.88 40.93 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 2.2000000000000002 110.859 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.72 -40.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 2.6400000000000001 110.922 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 147.85 122.32 1.29 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 2.54 112.46 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.6 tp -179.19 -63.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 4.9199999999999999 110.912 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 62.74 15.33 54.27 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 3.5299999999999998 112.475 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 17.5 m80 51.98 67.15 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 2.7999999999999998 110.833 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 65.1 m -51.89 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 5.6600000000000001 110.866 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 177.2 101.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 4.7400000000000002 110.888 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.65 85.17 7.29 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 3.6600000000000001 110.887 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -29.78 23.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 2.7799999999999998 112.325 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 8.38 43.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 6.6799999999999997 110.952 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -124.74 -177.49 3.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 2.6400000000000001 111.129 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 16.7 m -95.83 -7.6 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 5.5999999999999996 111.115 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.9 ttp -54.15 -27.22 32.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 6.1299999999999999 110.892 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.25 157.58 1.15 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.633 0.73 . . . . 5.1600000000000001 110.871 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.34 28.3 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.67 2.246 . . . . 2.6400000000000001 112.297 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.2 m -99.42 137.4 37.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 3.8799999999999999 111.185 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -63.14 142.07 58.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 4.9800000000000004 110.945 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 96.62 4.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 4.1299999999999999 110.919 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -61.59 125.84 25.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 4.7199999999999998 110.899 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.92 177.19 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 3.6299999999999999 111.136 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.1 128.45 34.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 2.79 110.878 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.0 tp -55.83 -25.29 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 4.3700000000000001 111.13 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -65.36 -39.4 92.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 3.6299999999999999 110.894 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 65.2 p -99.6 2.72 44.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 3.4199999999999999 111.154 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -51.91 108.32 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 5.4100000000000001 110.877 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -174.45 139.24 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 4.3700000000000001 110.832 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.59 151.75 4.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 3.52 110.917 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.1 -179.0 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 4.7400000000000002 110.848 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 64.55 -178.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 4.0499999999999998 111.119 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -23.23 51.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 2.7200000000000002 110.831 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -53.19 -30.12 35.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 3.0499999999999998 110.863 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.2 tt -65.1 -29.99 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 3.6299999999999999 111.11 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -99.04 -1.71 39.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 7.8499999999999996 110.885 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -90.17 17.85 51.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.693 -0.765 . . . . 1.8 112.532 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.87 -40.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 2.1000000000000001 111.1 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -24.77 56.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 3.5099999999999998 110.867 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.2 t -76.32 -24.74 54.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 2.3700000000000001 110.833 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.7 mp -82.97 142.28 31.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 5.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 55.14 26.59 8.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 12.859999999999999 110.869 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 CA-C-O 119.122 -0.821 . . . . 11.279999999999999 112.477 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.824 0.345 . . . . 9.0500000000000007 110.863 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -132.62 126.51 32.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 11.699999999999999 110.918 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 tp -116.8 163.88 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.508 . . . . 4.3799999999999999 111.103 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.6 p -146.42 155.99 42.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 3.46 111.127 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.47 136.7 52.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 8.2300000000000004 110.911 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -141.14 143.33 34.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 5.1500000000000004 110.864 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.5 mt -108.01 148.36 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 3.4700000000000002 111.162 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -111.9 -69.46 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 4.0300000000000002 110.914 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -107.36 -169.84 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 5.6699999999999999 110.877 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -146.62 140.73 26.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 7.0700000000000003 110.946 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 72.3 p -53.08 109.71 1.61 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.552 0.692 . . . . 3.5699999999999998 111.129 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 122' ' ' THR . 53.7 Cg_endo -69.8 -48.74 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.647 2.231 . . . . 3.0099999999999998 112.307 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.21 -33.55 75.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 4.6500000000000004 110.858 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.2 tpt -101.34 178.88 4.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 3.96 110.853 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -78.92 128.83 33.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 4.25 110.849 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -52.96 -28.12 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 6.8700000000000001 110.908 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.77 -32.49 40.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 3.2999999999999998 110.899 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -65.6 -43.05 90.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 2.7200000000000002 110.881 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.2 p -74.09 -35.54 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 2.0099999999999998 111.143 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.0 -44.4 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 2.48 110.846 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -71.76 -39.63 69.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 4.7300000000000004 110.932 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.16 -59.24 5.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 1.9199999999999999 111.168 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 pt -56.43 -29.4 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 3.9900000000000002 111.139 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.08 -57.64 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 5.0999999999999996 110.827 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.19 -25.64 42.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 3.9100000000000001 110.869 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.59 -43.75 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 2.2599999999999998 111.091 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -73.68 -23.93 59.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 4.8700000000000001 110.84 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -78.13 -31.41 49.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 3.5800000000000001 110.912 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.7 t -51.09 -56.2 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 3.1200000000000001 111.089 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -42.13 61.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 5.2300000000000004 110.917 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.67 -22.38 13.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 2.2400000000000002 110.841 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -57.62 -21.84 41.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 3.3599999999999999 110.909 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.51 62.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 3.2000000000000002 111.173 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.02 147.53 16.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.632 0.73 . . . . 2.6800000000000002 111.114 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -8.53 23.85 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.688 2.259 . . . . 2.8700000000000001 112.362 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 pp -66.22 -172.28 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 5.1699999999999999 110.923 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.77 -174.89 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 7.0700000000000003 110.899 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -132.32 122.34 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 7.9800000000000004 110.891 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.4 t -144.93 89.94 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 2.25 110.869 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -82.31 117.1 22.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 4.8499999999999996 110.894 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.2 159.84 42.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 3.7599999999999998 111.11 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -99.88 -27.96 13.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 3.8999999999999999 110.876 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.4 m -113.73 116.73 29.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 3.6299999999999999 111.088 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.33 147.35 6.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 2.0600000000000001 112.484 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.2 164.67 26.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.766 0.317 . . . . 6.8200000000000003 110.891 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.0 142.9 27.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 2.21 111.106 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -51.93 53.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 2.2400000000000002 110.859 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.9 pt -104.63 139.85 24.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 3.6499999999999999 111.141 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -135.44 162.94 31.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 3.1299999999999999 110.941 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.21 121.74 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 3.0600000000000001 111.095 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.5 p -139.43 163.31 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 3.7000000000000002 111.144 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -121.02 133.13 55.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 5.1299999999999999 110.892 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.86 167.73 20.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 1.9099999999999999 111.112 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.68 146.59 32.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 6.3499999999999996 110.878 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.37 -151.48 3.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 2.46 112.502 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.79 125.35 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 3.0299999999999998 111.088 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -112.39 43.54 1.6 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 4.1900000000000004 110.847 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.14 76.59 0.26 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 3.21 112.462 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.2 t70 63.86 47.71 3.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.736 0.303 . . . . 5.9400000000000004 110.825 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.2 -169.02 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 4.6500000000000004 110.851 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -76.83 124.08 27.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 6.7400000000000002 110.851 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.29 144.96 31.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 2.6400000000000001 111.131 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -130.32 -169.66 2.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 7.4500000000000002 110.887 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -151.28 -170.53 3.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 5.04 110.86 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -115.92 -153.13 10.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.758 . . . . 3.2200000000000002 112.445 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.71 133.61 25.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 3.9399999999999999 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 111.96 -18.97 23.6 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 2.4300000000000002 112.496 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -143.98 -129.09 2.21 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.747 -0.739 . . . . 1.5900000000000001 112.49 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.5 mm -77.2 125.45 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.89 0.376 . . . . 3.3700000000000001 111.144 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.89 -5.91 40.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 5.2800000000000002 110.911 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.6 123.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 2.8399999999999999 111.114 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 114.23 18.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 4.7800000000000002 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.64 117.5 24.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 1.52 111.075 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -64.41 170.79 3.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 4.2800000000000002 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.05 172.08 0.17 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.751 -0.737 . . . . 0.94999999999999996 112.489 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 172.23 13.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 0.87 112.333 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 159.35 -133.6 3.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 1.3899999999999999 112.507 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 34.5 t -134.09 128.42 34.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.367 . . . . 3.73 110.88 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 85.52 -70.36 3.08 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.741 -0.742 . . . . 2.04 112.486 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.7 -27.04 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.358 . . . . 4.1299999999999999 111.119 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.11 129.14 29.0 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 2.2999999999999998 112.525 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.69 -9.57 67.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 2.0800000000000001 112.511 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -51.19 157.61 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.8200000000000001 110.874 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.97 121.28 32.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 1.97 111.08 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -111.05 115.52 29.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 4.2300000000000004 110.838 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -143.94 150.23 38.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 4.2300000000000004 110.875 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.406 ' N ' ' HE1' ' A' ' 203' ' ' TRP . 0.9 OUTLIER 75.16 -168.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 7.1500000000000004 110.855 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.87 96.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 6.9100000000000001 110.923 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.2 t70 55.95 68.97 0.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 4.0800000000000001 110.888 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -174.75 -41.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 4.2699999999999996 110.879 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 11.7 t80 67.24 131.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 6.5599999999999996 110.885 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.406 ' HE1' ' N ' ' A' ' 198' ' ' ASP . 21.3 m95 -105.72 -174.91 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 8.2699999999999996 110.877 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 168.27 27.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 2.52 111.184 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -175.1 3.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 2.4399999999999999 111.143 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -52.76 -47.95 67.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 5.1799999999999997 110.909 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.4 p -78.39 -31.94 48.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 3.21 110.879 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -50.38 167.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 3.0299999999999998 112.483 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.83 -72.71 0.44 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 2.0600000000000001 112.502 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.3 98.64 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.796 0.332 . . . . 2.8500000000000001 111.133 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -69.57 132.39 46.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 5.7300000000000004 110.87 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -57.99 -41.3 82.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 4.46 110.908 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -70.74 -60.72 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 6.8300000000000001 110.899 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.43 -34.89 26.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 3.8100000000000001 110.898 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 82.5 m -79.91 -41.6 25.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 2.21 111.148 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.89 98.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 1.8899999999999999 111.102 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 53.5 t -51.27 -40.74 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 1.96 111.156 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -64.74 -36.41 84.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 3.3599999999999999 110.85 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -74.64 -45.75 42.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 4.4699999999999998 110.883 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.09 -37.04 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 3.3900000000000001 111.187 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.07 -37.78 36.94 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.686 -0.769 . . . . 0.72999999999999998 112.467 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -54.86 -40.64 69.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 3.3500000000000001 110.879 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.6 8.75 26.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 2.6000000000000001 110.879 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.33 88.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 3.4700000000000002 110.944 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 71.12 179.32 29.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.738 -0.744 . . . . 2.7999999999999998 112.51 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 54.3 -175.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 3.8300000000000001 110.896 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.8 -115.68 0.96 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 2.5800000000000001 112.464 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.44 142.82 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 2.25 110.881 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.83 -78.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 7.5999999999999996 110.845 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.51 -78.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 5.4400000000000004 110.882 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 153.21 48.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.599 0.714 . . . . 3.8900000000000001 110.858 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 233' ' ' LYS . 54.0 Cg_endo -69.73 -177.12 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.677 2.252 . . . . 2.8300000000000001 112.358 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.47 43.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 5.25 110.887 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -135.54 163.5 29.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 2.3999999999999999 111.101 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.16 7.4 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 4.0999999999999996 111.14 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -98.43 -26.08 14.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 4.7300000000000004 110.906 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.68 141.59 55.6 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.632 0.73 . . . . 5.1600000000000001 110.888 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 64.97 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.683 2.256 . . . . 2.6000000000000001 112.349 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.1 t -158.03 134.2 9.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 3.4500000000000002 111.169 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -76.3 127.49 32.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 5.6600000000000001 110.951 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -140.58 92.74 2.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 4.8799999999999999 110.915 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -62.41 125.61 24.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 4.5999999999999996 110.912 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.49 177.32 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.494 . . . . 3.5600000000000001 111.153 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -62.09 114.28 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 3.9100000000000001 110.845 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 18.4 tt -76.36 -32.75 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 4.04 111.172 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.43 -30.79 65.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 3.3900000000000001 110.866 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.56 28.05 9.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 4.6100000000000003 111.11 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -51.76 149.86 4.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 6.6799999999999997 110.913 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -179.71 156.2 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 5.1299999999999999 110.885 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.83 157.49 19.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 3.2799999999999998 110.955 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.65 -171.64 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 3.8399999999999999 110.904 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 68.72 160.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 4.3499999999999996 111.109 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.84 -21.48 56.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 3.2799999999999998 110.886 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.84 -29.74 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 4.04 110.886 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 1.2 tt -51.14 -29.53 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 2.5899999999999999 111.143 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -90.59 -34.07 15.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 5.8399999999999999 110.842 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.55 -17.07 47.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 1.6499999999999999 112.507 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 4.0 tp -99.95 -31.61 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 1.8600000000000001 111.179 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.78 -43.39 25.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 4.7000000000000002 110.899 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.6 t -85.6 -47.25 10.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 2.3199999999999998 110.841 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.1 mp 56.93 70.12 0.68 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 4.1900000000000004 110.902 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -142.13 93.3 2.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 12.09 110.875 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 CA-C-O 119.121 -0.822 . . . . 10.84 112.5 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.757 0.313 . . . . 8.1300000000000008 110.862 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -67.27 148.89 51.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 9.6099999999999994 110.936 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.6 mm -129.01 155.05 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 3.6499999999999999 111.16 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.47 117.71 7.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 2.96 111.136 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -131.95 145.83 51.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 4.7599999999999998 110.942 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -142.29 160.51 40.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 5.5800000000000001 110.9 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.3 mt -106.59 148.92 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 3.3799999999999999 111.172 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -106.77 -69.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 5.1100000000000003 110.86 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -118.37 174.88 5.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 6.6799999999999997 110.881 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -134.45 163.27 30.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 6.8399999999999999 110.918 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.51 131.86 40.75 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.546 0.688 . . . . 3.4399999999999999 111.114 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -19.43 36.14 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.702 2.268 . . . . 2.1499999999999999 112.334 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.64 -69.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 4.4800000000000004 110.874 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 38.0 mmm -101.19 168.12 9.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 4.4800000000000004 110.87 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -59.39 158.23 9.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 3.0800000000000001 110.892 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -70.78 -11.26 60.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 7.6399999999999997 110.888 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -79.73 -36.69 37.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 3.0899999999999999 110.886 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.07 -40.77 71.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 2.6800000000000002 110.866 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.3 -36.2 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 1.8999999999999999 111.107 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -66.34 -43.97 84.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 3.7799999999999998 110.855 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -48.98 23.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 4.1200000000000001 110.937 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.78 -26.88 66.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 2.4500000000000002 111.094 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mm -70.85 -50.93 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 3.4399999999999999 111.15 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -75.2 -22.7 57.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 4.8700000000000001 110.879 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -77.62 -29.92 52.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 3.8500000000000001 110.934 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.5 -52.08 62.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 1.96 111.039 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.09 -28.38 52.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 5.6299999999999999 110.887 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -70.49 -27.95 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 3.1400000000000001 110.898 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.4 t -51.08 -56.1 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 2.71 111.16 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -77.44 -29.06 52.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 5.1100000000000003 110.921 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 p -55.19 -41.61 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 2.6699999999999999 110.807 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.69 -16.19 62.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 3.29 110.9 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.79 39.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 2.9900000000000002 111.139 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 91.9 m -155.63 133.65 6.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.583 0.706 . . . . 2.7999999999999998 111.17 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 74.56 1.28 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.738 2.292 . . . . 2.3599999999999999 112.341 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tp -163.13 -169.65 2.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 4.3700000000000001 110.941 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -148.25 176.27 10.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 5.5999999999999996 110.875 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -135.81 120.03 17.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 8.3900000000000006 110.87 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 t -110.44 89.99 3.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 2.5699999999999998 110.843 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.16 93.4 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 3.3399999999999999 110.882 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.57 163.96 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 4.7199999999999998 111.155 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -103.01 -5.78 23.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 3.6200000000000001 110.891 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.57 175.73 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 5.0800000000000001 111.184 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.48 -165.55 1.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 3.0299999999999998 112.476 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.4 mtm -110.77 151.92 27.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 5.5800000000000001 110.867 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.35 130.14 55.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 2.1299999999999999 111.087 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.41 -20.82 62.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 2.54 110.883 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.0 mm -103.47 84.58 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 3.3900000000000001 111.144 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.72 117.72 24.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 2.5099999999999998 110.945 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 99.4 t -105.3 110.77 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 2.3399999999999999 111.085 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.6 t -127.07 143.2 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 2.25 111.15 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -97.77 100.21 11.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 9.4000000000000004 110.903 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.26 144.03 50.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 2.21 111.1 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.74 164.1 14.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 8.1400000000000006 110.849 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.52 -138.03 29.36 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.768 -0.729 . . . . 1.4399999999999999 112.502 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.23 128.24 33.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 2.2599999999999998 111.137 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -95.67 24.87 4.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 4.5099999999999998 110.887 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.8 -28.17 10.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.761 -0.733 . . . . 2.3199999999999998 112.481 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.46 34.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.817 0.341 . . . . 5.25 110.874 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.56 -173.84 2.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 110.903 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.61 118.83 26.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 7.2400000000000002 110.864 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.41 139.9 35.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 2.1800000000000002 111.086 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -154.02 88.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 8.4499999999999993 110.87 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -128.49 -168.42 1.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 5.5300000000000002 110.859 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.62 106.1 0.91 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.748 -0.739 . . . . 3.2799999999999998 112.477 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.94 119.11 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 6.1100000000000003 110.891 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.61 -24.52 21.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 2.29 112.494 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -82.88 -140.72 3.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.675 -0.774 . . . . 1.6699999999999999 112.51 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.62 110.53 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 2.9300000000000002 111.105 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -57.38 8.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.478 . . . . 4.9900000000000002 110.915 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.01 123.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 2.1200000000000001 111.093 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -95.3 153.58 17.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 4.3399999999999999 110.831 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -152.46 113.04 4.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 1.8700000000000001 111.06 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.67 157.4 24.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 3.8900000000000001 110.885 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.94 -171.0 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 1.29 112.497 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -169.86 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.731 2.287 . . . . 1.1599999999999999 112.338 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 125.37 -156.34 19.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 1.2 112.512 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.8 p -88.92 145.58 25.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 3.25 110.861 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.08 -102.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 1.45 112.43 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 82.0 mt -52.57 -27.73 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 2.7599999999999998 111.153 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.59 111.56 2.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 2.6600000000000001 112.474 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.43 -16.14 56.89 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 1.8100000000000001 112.507 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -49.94 138.41 15.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 2.2599999999999998 110.905 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -129.96 141.17 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 2.0299999999999998 111.097 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.77 144.57 46.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 3.8300000000000001 110.871 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -144.45 148.5 34.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 3.9100000000000001 110.903 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.5 t70 70.48 -75.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 5.8600000000000003 110.882 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 46.85 41.33 10.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 8.8300000000000001 110.919 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.5 t0 62.98 41.1 8.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 3.54 110.888 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -118.45 1.87 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 4.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.12 115.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 5.9100000000000001 110.899 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.11 170.19 8.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 8.0800000000000001 110.946 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.81 172.92 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 2.77 111.161 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.35 -170.15 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 2.21 111.161 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -76.77 -21.39 55.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 5.6799999999999997 110.853 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.9 t -61.08 -68.9 0.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 3.1600000000000001 110.843 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -132.9 -166.69 11.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.716 -0.754 . . . . 3.2799999999999998 112.481 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 50.07 -168.06 0.31 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.697 -0.763 . . . . 2.27 112.497 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -56.46 99.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 2.3900000000000001 111.114 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.0 103.76 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 3.3599999999999999 110.846 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.6 tt -57.51 -38.27 74.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 3.1600000000000001 110.901 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -71.47 -64.26 0.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 6.2800000000000002 110.837 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.7 tp -50.8 -53.68 29.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 3.1299999999999999 110.915 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 85.5 m -55.37 -44.24 75.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 1.9199999999999999 111.167 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.68 -43.91 76.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 1.8100000000000001 111.098 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.6 t -55.09 -41.87 61.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 1.75 111.14 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -60.23 -31.33 70.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 3.3599999999999999 110.857 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -74.62 -40.35 61.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 3.6600000000000001 110.884 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.4 mm -54.64 -43.35 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 2.4900000000000002 111.101 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.87 -50.47 7.83 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.733 -0.746 . . . . 0.95999999999999996 112.528 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.81 -31.69 62.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 3.25 110.865 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.9 p -95.24 22.11 7.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 2.3999999999999999 110.846 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 17.2 mt -142.31 18.03 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 3.5099999999999998 110.888 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.26 70.08 1.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 2.1400000000000001 112.499 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -130.28 169.47 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 4.7400000000000002 110.928 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -82.29 -120.89 0.62 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 3.5 112.45 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.87 33.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.331 . . . . 3.3900000000000001 110.819 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.0 m -153.09 -75.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 6.1399999999999997 110.832 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.0 t 57.7 -169.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 6.6799999999999997 110.888 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.06 160.29 0.87 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.632 0.729 . . . . 2.9199999999999999 110.851 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -14.84 36.46 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.639 2.226 . . . . 2.5099999999999998 112.346 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.74 -19.7 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 4.4900000000000002 110.889 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.57 170.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 2.3300000000000001 111.067 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.9 t -88.17 -1.37 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 3.9500000000000002 111.156 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -30.2 20.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 4.7999999999999998 110.897 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.53 137.69 31.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.638 0.732 . . . . 5.1299999999999999 110.877 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 77.97 1.02 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 3.04 112.375 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.1 p -156.41 168.03 28.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 3.3599999999999999 111.136 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -125.37 112.53 16.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 5.0300000000000002 110.922 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.01 153.02 48.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 3.29 110.888 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -111.13 102.47 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 4.4500000000000002 110.94 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.5 t -107.57 157.21 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 3.1800000000000002 111.146 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.92 135.32 40.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 3.6200000000000001 110.855 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 19.6 pt -58.17 -22.61 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 3.98 111.116 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -21.41 24.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 3.6299999999999999 110.903 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.9 m -100.73 -6.11 25.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 3.8399999999999999 111.116 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.06 158.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 6.8799999999999999 110.848 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -178.22 149.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 4.8700000000000001 110.879 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -83.87 150.82 25.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 3.8900000000000001 110.888 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.67 123.61 32.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 3.6699999999999999 110.894 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -44.73 -54.79 5.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 5.1399999999999997 111.067 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.08 -39.63 63.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 3.5899999999999999 110.895 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -71.68 -34.53 69.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 2.7599999999999998 110.905 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -30.84 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 2.8599999999999999 111.111 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -79.39 -35.38 40.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 6.9400000000000004 110.88 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -61.17 -16.72 49.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 1.73 112.479 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 7.5 tp -114.45 -36.27 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 1.95 111.172 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? -67.37 -50.71 58.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 4.75 110.881 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -47.18 56.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 2.8100000000000001 110.852 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.2 tp 54.73 26.05 7.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 3.6600000000000001 110.947 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.88 124.34 7.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 10.140000000000001 110.927 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 119.091 -0.838 . . . . 9.8599999999999994 112.5 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.803 0.335 . . . . 8.6799999999999997 110.828 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -85.19 146.14 27.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 10.33 110.919 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.92 145.58 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 3.54 111.094 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.23 137.43 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 2.8300000000000001 111.132 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -144.58 136.78 26.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 4.9900000000000002 110.908 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.27 133.63 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 5.1299999999999999 110.878 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 26.5 mt -108.05 141.61 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 3.7599999999999998 111.16 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -157.44 47.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 5.0099999999999998 110.83 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -147.23 143.72 28.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 6.7400000000000002 110.914 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -148.29 162.47 39.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 7.1900000000000004 110.934 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 123' ' ' PRO . 1.0 OUTLIER -87.8 156.73 52.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.562 0.696 . . . . 3.9500000000000002 111.164 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 122' ' ' THR . 53.7 Cg_endo -69.71 -52.18 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.664 2.243 . . . . 3.02 112.352 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -66.94 -46.0 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 5.4299999999999997 110.932 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 10.7 mmt -98.26 122.88 41.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 4.4400000000000004 110.888 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -56.2 171.78 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 4.4800000000000004 110.879 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -67.2 -10.56 51.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 7.0300000000000002 110.853 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -34.17 71.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 5.1799999999999997 110.902 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.31 -41.23 41.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 3.8100000000000001 110.875 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.17 -33.99 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 2.3199999999999998 111.113 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -49.92 -53.02 28.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 2.6499999999999999 110.847 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -76.16 -33.1 59.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 4.5599999999999996 110.924 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.38 -58.65 7.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 2.04 111.098 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.3 mm -67.78 -45.48 84.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 3.5099999999999998 111.093 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -50.3 -48.99 54.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 4.5700000000000003 110.854 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -76.83 -20.37 56.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 6.3399999999999999 110.885 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.01 -37.96 69.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 2.0899999999999999 111.141 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.31 -25.17 60.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 4.9400000000000004 110.901 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -73.63 -27.79 61.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 3.6899999999999999 110.932 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.94 -55.94 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 3.0 111.151 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -44.21 61.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 5.25 110.945 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.3 m -54.87 -24.87 25.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 3.46 110.855 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -58.08 -22.62 51.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 2.5299999999999998 110.899 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.5 m -140.3 37.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 2.8799999999999999 111.14 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.8 m -142.88 131.52 11.53 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.62 0.724 . . . . 2.4100000000000001 111.149 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 66.75 1.77 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 2.3199999999999998 112.305 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tp -140.62 166.25 25.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 3.4300000000000002 110.906 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -118.38 162.29 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 5.1699999999999999 110.905 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -135.8 119.84 17.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 8.0199999999999996 110.881 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 98.4 p -127.35 90.01 3.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 2.8300000000000001 110.894 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 120.13 12.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 3.1099999999999999 110.882 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.5 pt -148.03 156.93 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 4.0300000000000002 111.161 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -96.52 -24.33 16.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 3.9500000000000002 110.874 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.71 175.51 6.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 3.9700000000000002 111.148 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.46 -171.95 42.88 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.712 -0.756 . . . . 2.52 112.507 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mtt -110.65 157.09 20.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.794 0.33 . . . . 5.7699999999999996 110.846 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -137.08 146.57 45.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.96 111.094 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.75 -17.79 32.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 2.77 110.901 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.3 mm -104.31 84.47 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 3.5499999999999998 111.164 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.78 117.15 29.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 2.3300000000000001 110.902 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.71 110.75 30.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 2.4500000000000002 111.097 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.2 t -133.97 141.94 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 2.2799999999999998 111.158 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -80.81 145.7 31.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 4.6299999999999999 110.857 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.27 156.0 16.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 2.5099999999999998 111.094 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.62 140.1 31.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 6.2999999999999998 110.829 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.43 -136.4 35.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 1.8300000000000001 112.468 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.29 127.71 33.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 1.95 111.061 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -101.22 25.31 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 7.3799999999999999 110.865 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.19 92.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.807 -0.711 . . . . 2.7799999999999998 112.505 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.9 t0 63.71 59.03 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.341 . . . . 5.5 110.848 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -158.03 -170.5 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 4.1600000000000001 110.868 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -96.07 106.25 18.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 6.3399999999999999 110.866 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.03 159.17 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 2.1299999999999999 111.063 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.09 -74.06 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 7.2300000000000004 110.866 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -179.28 -74.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 4.2699999999999996 110.894 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.08 -155.06 24.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 3.0 112.501 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -59.43 123.06 15.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.844 0.354 . . . . 6.3600000000000003 110.864 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.38 90.6 0.64 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 3.2999999999999998 112.459 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.25 -140.59 11.02 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.794 -0.717 . . . . 2.3500000000000001 112.507 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.0 mt -72.06 92.24 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.893 0.378 . . . . 3.1000000000000001 111.187 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.8 pp -48.51 -28.96 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 4.2000000000000002 110.921 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 179.14 178.3 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 2.73 111.065 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -151.64 125.49 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 4.1299999999999999 110.885 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.93 104.9 8.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 1.46 111.13 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.09 165.81 8.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 4.4900000000000002 110.921 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.4 171.12 0.28 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.784 -0.722 . . . . 1.24 112.521 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -170.04 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.691 2.261 . . . . 1.3999999999999999 112.317 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.12 -112.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 1.46 112.459 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.87 135.24 43.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 2.8100000000000001 110.875 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.61 -86.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 1.1100000000000001 112.467 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 90.8 mt -71.76 -23.45 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 2.7999999999999998 111.097 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -58.46 117.3 10.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.749 . . . . 2.46 112.474 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.71 -14.6 64.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.723 -0.751 . . . . 1.78 112.494 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -51.63 128.64 23.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.812 0.339 . . . . 2.0299999999999998 110.862 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -117.27 148.76 41.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 1.6799999999999999 111.098 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -137.08 124.78 22.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 3.7400000000000002 110.835 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.35 143.41 35.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 5.4900000000000002 110.853 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -77.93 58.08 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 6.1500000000000004 110.899 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -73.18 -13.51 61.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 9.5999999999999996 110.882 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -127.5 7.11 6.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 6.2199999999999998 110.91 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -121.74 -34.98 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 6.0199999999999996 110.862 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.52 91.69 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 9.0199999999999996 110.898 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -104.51 122.53 45.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 10.48 110.938 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.11 162.53 38.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 2.5800000000000001 111.168 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.52 -170.21 1.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 2.71 111.136 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -47.17 -46.95 24.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 7.5800000000000001 110.849 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -59.22 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 2.9399999999999999 110.847 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.26 171.2 0.25 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.738 . . . . 3.29 112.448 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.99 -90.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.744 . . . . 2.0499999999999998 112.514 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.02 97.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.321 . . . . 2.1400000000000001 111.169 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -68.34 117.82 10.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 3.5600000000000001 110.873 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.35 -40.26 58.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 3.2200000000000002 110.914 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -71.45 -56.22 6.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 6.0199999999999996 110.909 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.34 -54.74 27.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 3.77 110.892 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 92.3 m -55.52 -38.42 69.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 1.9299999999999999 111.164 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.61 -50.66 69.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.99 111.071 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.01 -36.15 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 1.8999999999999999 111.129 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -59.73 -41.89 91.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 3.1299999999999999 110.873 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -66.71 -36.87 83.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 4.21 110.864 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.8 mm -57.85 -57.89 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 2.6000000000000001 111.171 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.34 -41.61 99.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 1.05 112.471 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.93 ' HE1' 'CO ' ' A' ' 264' ' ' ' CO' . 0.2 OUTLIER -52.17 -46.33 65.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 4.71 110.863 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.25 23.44 5.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 2.8199999999999998 110.807 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.96 87.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.185 -0.462 . . . . 3.8100000000000001 110.883 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 131.47 -81.87 0.32 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 3.8100000000000001 112.454 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.45 179.26 3.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 4.4699999999999998 110.953 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.44 120.22 1.32 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.732 -0.747 . . . . 3.3199999999999998 112.444 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.9 m80 63.34 91.35 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.815 0.341 . . . . 2.9199999999999999 110.886 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.9 t -98.12 -75.49 0.55 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.166 -0.47 . . . . 4.8399999999999999 110.918 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.0 t -178.99 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.508 . . . . 5.0 110.861 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.1 116.86 7.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.638 0.732 . . . . 2.6600000000000001 110.909 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -8.73 24.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.726 2.284 . . . . 2.54 112.319 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 -24.21 13.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 6.1600000000000001 110.882 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.9 169.08 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.5499999999999998 111.105 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.6 7.35 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 4.0199999999999996 111.142 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -89.26 -34.13 16.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 5.3700000000000001 110.884 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.94 138.34 95.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.677 0.751 . . . . 5.0599999999999996 110.815 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 87.4 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.655 2.237 . . . . 2.8199999999999998 112.35 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.08 139.49 14.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 3.1000000000000001 111.179 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.74 112.28 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 4.0999999999999996 110.916 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -129.26 -169.18 2.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 6.6399999999999997 110.881 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -114.53 79.57 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 4.3200000000000003 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.8 t -107.33 159.95 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 3.8100000000000001 111.119 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.84 112.88 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 5.4800000000000004 110.829 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.5 pp -76.69 -33.11 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 4.4800000000000004 111.124 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -72.26 -39.2 68.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 4.4699999999999998 110.88 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.13 17.97 13.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 3.7200000000000002 111.194 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -70.62 138.23 50.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 8.3800000000000008 110.853 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -154.38 134.18 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 4.7000000000000002 110.887 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.24 171.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 3.9399999999999999 110.94 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 97.7 p -89.58 -172.8 3.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 5.5700000000000003 110.842 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -85.76 -59.88 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 4.9100000000000001 111.157 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -37.2 62.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 3.8199999999999998 110.846 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -70.49 -29.77 66.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 3.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.82 -28.39 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 2.7599999999999998 111.124 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -87.73 -36.49 17.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 5.4000000000000004 110.908 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.82 -17.48 50.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.708 -0.758 . . . . 1.74 112.512 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.3 tp -109.59 -30.37 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 2.1899999999999999 111.141 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -77.65 -40.07 43.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 3.6800000000000002 110.901 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t -85.34 -47.16 10.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 3.3799999999999999 110.862 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.1 mp 60.89 68.3 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 4.3899999999999997 110.863 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -119.76 153.65 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.249 -0.432 . . . . 11.09 110.903 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 CA-C-O 119.119 -0.823 . . . . 10.630000000000001 112.483 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . 0.93 'CO ' ' HE1' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.807 0.337 . . . . 14.48 110.875 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -101.48 149.69 23.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 17.079999999999998 110.931 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.1 tp -146.44 168.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 6.3700000000000001 111.126 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.31 116.29 28.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 3.8900000000000001 111.152 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -139.67 136.57 34.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 5.7300000000000004 110.913 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.03 107.09 15.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 4.9199999999999999 110.823 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.1 mt -75.23 138.76 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 3.4700000000000002 111.142 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -98.3 -74.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 5.2800000000000002 110.863 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.35 145.47 47.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 6.9400000000000004 110.873 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -85.69 163.25 18.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 7.2999999999999998 110.911 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.7 p -100.87 137.94 19.91 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.557 0.694 . . . . 4.3300000000000001 111.163 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -171.49 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.684 2.256 . . . . 2.71 112.335 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 56.64 22.97 7.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 4.0599999999999996 110.887 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -165.28 142.82 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 5.4000000000000004 110.895 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.45 142.52 58.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 2.7000000000000002 110.885 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -56.03 -25.2 43.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 5.8399999999999999 110.855 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -75.69 -38.83 58.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 3.1200000000000001 110.943 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.26 -51.12 67.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 2.4700000000000002 110.903 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.1 -39.6 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 2.0899999999999999 111.164 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -68.12 -54.6 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 2.9500000000000002 110.882 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -62.16 -33.29 74.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 3.7999999999999998 110.93 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.21 -57.98 8.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 1.8799999999999999 111.098 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.6 mt -67.51 -49.27 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 3.3700000000000001 111.111 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -49.58 -46.82 49.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 4.8300000000000001 110.915 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -78.63 -29.02 45.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 4.0199999999999996 110.849 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.03 -54.14 48.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 2.5800000000000001 111.069 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -61.2 -40.63 94.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 5.5999999999999996 110.882 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -55.22 -28.07 50.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 2.8500000000000001 110.891 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.3 t -60.98 -49.48 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 2.8199999999999998 111.137 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -70.61 -48.46 55.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 5.04 110.959 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.05 -20.39 38.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 3.9300000000000002 110.87 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.11 -31.88 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 3.8100000000000001 110.894 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.59 51.19 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 2.9199999999999999 111.139 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.73 140.57 13.68 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.559 0.695 . . . . 2.79 111.123 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -38.17 8.17 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.654 2.236 . . . . 1.96 112.323 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.53 104.34 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 3.8900000000000001 110.899 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.22 129.47 49.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 5.8799999999999999 110.889 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -138.34 153.54 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 12.83 110.886 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.6 t -104.29 132.28 50.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 3.54 110.809 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.34 147.3 31.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 4.3899999999999997 110.962 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 58.1 mt -135.68 119.07 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 3.8700000000000001 111.153 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.13 -39.91 57.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 3.3399999999999999 110.924 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 95.7 m -137.27 109.42 7.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 3.5 111.131 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 173.05 -153.99 19.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 2.1499999999999999 112.494 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.98 135.61 51.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 6.3700000000000001 110.86 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.89 -175.15 2.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 2.0 111.041 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.33 -26.36 6.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 3.1099999999999999 110.902 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.4 pp -135.58 141.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 4.5199999999999996 111.166 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.39 165.47 24.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.455 . . . . 3.79 110.936 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.21 110.96 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 3.96 111.146 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.0 t -126.86 154.52 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 2.3199999999999998 111.158 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -123.05 137.73 54.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 4.5999999999999996 110.858 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.95 174.56 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 3.4700000000000002 111.102 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -125.71 169.4 12.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 5.46 110.852 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.43 -138.39 28.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 2.4399999999999999 112.518 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.07 129.96 35.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 3.0600000000000001 111.109 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -89.75 11.01 21.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 5.1500000000000004 110.899 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 58.85 18.4 39.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 4.0700000000000003 112.48 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -148.19 29.08 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.749 0.309 . . . . 7.1200000000000001 110.856 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.3 t70 64.37 47.41 3.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 6.7199999999999998 110.873 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -137.45 70.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 5.96 110.871 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.59 159.83 23.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 2.3900000000000001 111.077 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -98.07 -169.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 11.26 110.9 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -143.67 -39.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 4.8600000000000003 110.858 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.43 166.58 21.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.721 -0.752 . . . . 2.5499999999999998 112.524 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -50.12 118.74 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 4.5099999999999998 110.899 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.65 -55.12 0.75 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 2.8500000000000001 112.472 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.53 -118.78 4.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 1.9299999999999999 112.502 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.1 mm -74.1 140.19 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 2.7200000000000002 111.12 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -124.34 -5.12 7.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 4.0499999999999998 110.901 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 179.82 131.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 2.1499999999999999 111.109 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -113.58 143.08 45.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 5.0 110.819 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -154.14 129.97 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 1.5600000000000001 111.163 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.88 170.73 10.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 4.7599999999999998 110.858 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.99 171.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 1.03 112.481 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 160.51 49.45 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.692 2.261 . . . . 0.85999999999999999 112.374 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 157.05 -142.44 8.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.727 . . . . 1.1599999999999999 112.548 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 88.5 p -106.53 117.21 33.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 2.5699999999999998 110.838 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.14 -58.59 3.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 1.79 112.465 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 10.6 mt -93.37 21.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 3.7000000000000002 111.155 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.79 -115.79 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 3.0 112.51 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -88.43 44.95 3.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 2.1800000000000002 112.496 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.98 130.65 44.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 2.2200000000000002 110.813 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -107.49 109.63 21.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 2.1200000000000001 111.104 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -113.81 110.62 20.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 6.2400000000000002 110.816 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -103.26 118.92 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 3.8700000000000001 110.888 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -50.77 145.63 6.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 7.0199999999999996 110.883 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.22 -21.66 23.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 8.1999999999999993 110.862 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -94.69 -6.39 43.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 4.5 110.83 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -73.48 -25.25 60.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 4.0899999999999999 110.852 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 18.3 t80 67.59 128.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 6.3899999999999997 110.861 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -105.57 172.19 6.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 7.5800000000000001 110.963 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.17 173.29 17.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 2.0 111.127 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -170.74 0.36 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 2.7599999999999998 111.156 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -67.13 -21.1 65.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 5.4699999999999998 110.866 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.26 -33.5 9.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 2.54 110.878 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -54.19 177.17 0.3 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 3.4399999999999999 112.494 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.73 -88.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.733 -0.746 . . . . 2.54 112.473 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.9 m -76.33 98.54 4.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 2.5600000000000001 111.146 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.89 123.02 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 4.0999999999999996 110.838 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.4 tt -72.38 -35.85 68.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 3.3599999999999999 110.929 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -71.86 -34.79 69.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 6.9800000000000004 110.859 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -52.97 6.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 3.8300000000000001 110.922 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 94.4 m -55.07 -37.77 67.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 1.99 111.175 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.26 85.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.7 111.105 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.1 t -64.35 -39.94 87.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 2.0299999999999998 111.145 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -69.32 -43.17 74.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 3.7599999999999998 110.824 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -70.32 -56.37 6.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 3.8500000000000001 110.9 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 76.5 mt -50.48 -33.82 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 3.7599999999999998 111.119 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.8 -43.01 99.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 1.22 112.455 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -75.37 -29.14 59.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.836 0.35 . . . . 4.0199999999999996 110.906 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.49 -16.97 64.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 3.2000000000000002 110.83 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.98 -23.03 16.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 3.3999999999999999 110.935 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 136.37 69.18 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 2.23 112.468 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.0 mt -160.44 134.62 7.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 3.96 110.89 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -131.68 51.26 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 3.4900000000000002 112.5 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.8 m80 66.19 144.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 2.1899999999999999 110.878 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.5 t -122.09 -79.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 5.1900000000000004 110.861 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 175.15 -32.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 4.9299999999999997 110.906 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 86.1 m-20 -45.66 105.84 0.5 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.543 0.687 . . . . 3.29 110.907 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.4 Cg_endo -69.82 172.56 12.48 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.633 2.222 . . . . 2.8300000000000001 112.342 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.8 30.56 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 4.2400000000000002 110.947 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -126.73 172.21 10.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 2.1699999999999999 111.111 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 9.5 p -89.66 7.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 4.0800000000000001 111.155 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.9 mmm -88.02 -39.15 14.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 4.7800000000000002 110.837 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.52 143.29 20.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.661 0.743 . . . . 5.4299999999999997 110.886 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 70.41 1.6 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.704 2.269 . . . . 2.7999999999999998 112.336 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.06 165.99 33.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 3.3900000000000001 111.085 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -131.49 113.13 13.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 4.4000000000000004 110.9 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -132.01 139.57 48.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 3.6000000000000001 110.907 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -69.7 127.87 34.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 4.71 110.879 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.55 177.19 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 3.2999999999999998 111.131 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.55 125.34 27.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 3.1099999999999999 110.89 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 24.0 pt -57.09 -24.65 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 4.3799999999999999 111.115 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -77.81 -39.59 43.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 3.6699999999999999 110.888 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.81 34.12 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 4.8799999999999999 111.158 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.96 19.34 4.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 4.9199999999999999 110.878 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -84.28 149.82 25.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 4.5300000000000002 110.87 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.13 158.18 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 3.52 110.935 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.69 -172.71 4.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 4.2000000000000002 110.865 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 64.63 -177.16 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 3.7200000000000002 111.089 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -67.75 -22.05 65.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 3.5899999999999999 110.874 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -51.36 -30.01 17.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 3.4399999999999999 110.823 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -51.27 -29.96 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 2.4300000000000002 111.117 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -88.98 -31.42 18.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 7.2699999999999996 110.867 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.06 -18.27 40.45 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 1.78 112.482 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -101.4 -29.57 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 2.96 111.133 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -79.78 -32.64 40.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 3.8199999999999998 110.919 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 12.4 m -85.67 -46.92 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 3.4399999999999999 110.857 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.8 mp 58.34 40.98 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 5.2199999999999998 110.937 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -146.48 134.15 21.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 11.09 110.874 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 119.103 -0.832 . . . . 10.19 112.438 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 64.1 m80 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.797 0.332 . . . . 8.3200000000000003 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -78.61 148.28 33.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 9.3200000000000003 110.93 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.46 146.43 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 3.0600000000000001 111.133 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 p -127.2 157.96 38.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 3.3700000000000001 111.09 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.0 151.46 31.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 4.7000000000000002 110.953 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -137.99 127.95 25.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 5.7000000000000002 110.901 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 82.9 mt -108.2 143.96 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 3.0699999999999998 111.135 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -145.26 35.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 4.2000000000000002 110.856 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -133.23 152.56 51.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 5.9199999999999999 110.908 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -146.49 117.9 7.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 7.5700000000000003 110.949 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.5 t -82.17 114.22 49.42 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.63 0.729 . . . . 3.8799999999999999 111.13 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -44.03 2.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.698 2.265 . . . . 2.5099999999999998 112.315 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.6 -40.29 59.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 3.8900000000000001 110.841 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -101.38 159.68 15.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 4.0700000000000003 110.892 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.23 129.65 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.433 . . . . 3.9500000000000002 110.848 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -57.84 -22.68 49.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 7.5800000000000001 110.847 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.56 -32.09 47.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 3.3999999999999999 110.911 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.29 -43.85 48.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 2.9100000000000001 110.844 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.03 -36.42 77.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 1.97 111.12 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.62 -54.65 36.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 3.2599999999999998 110.854 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -69.45 -36.8 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 6.0899999999999999 110.892 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.17 -57.75 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 2.0 111.154 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 12.8 mt -68.4 -49.21 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 3.6000000000000001 111.166 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -51.95 -40.47 60.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 5.0099999999999998 110.867 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -78.2 -21.76 49.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 4.54 110.886 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.86 -53.11 60.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 1.8799999999999999 111.052 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -57.12 -23.97 50.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 7.0099999999999998 110.851 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -39.57 51.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 3.29 110.904 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.7 t -57.37 -44.69 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 3.1299999999999999 111.094 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -67.26 -59.34 3.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 11.539999999999999 110.92 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -56.23 -23.87 38.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 2.96 110.871 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -67.99 -12.39 60.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 3.73 110.848 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.84 30.39 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 3.5699999999999998 111.136 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.49 157.88 31.73 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.59 0.71 . . . . 3.6499999999999999 111.081 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -25.14 29.07 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.689 2.259 . . . . 2.6299999999999999 112.357 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.49 175.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 4.8499999999999996 110.91 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.32 -178.07 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 5.4900000000000002 110.926 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -135.63 151.75 50.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 8.2899999999999991 110.911 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.5 t -156.37 89.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 2.3599999999999999 110.825 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.43 137.52 54.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 2.9700000000000002 110.897 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.57 165.93 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 4.5700000000000003 111.139 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.07 -29.99 5.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 4.6900000000000004 110.887 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 91.7 m -117.78 110.3 17.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 3.5800000000000001 111.177 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 142.54 -171.31 24.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 2.0 112.489 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -110.47 157.81 19.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 5.75 110.864 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -146.99 141.89 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 2.3199999999999998 111.091 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.89 -15.67 62.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.428 . . . . 2.3700000000000001 110.892 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.6 mm -104.03 141.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 3.6600000000000001 111.111 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 tt -130.78 134.43 46.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 3.5299999999999998 110.94 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -124.86 110.76 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 2.3799999999999999 111.13 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.25 141.21 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 2.2599999999999998 111.152 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -81.19 152.72 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 4.9100000000000001 110.865 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -161.58 167.23 25.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 2.2799999999999998 111.06 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -139.54 117.74 11.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 6.4900000000000002 110.851 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.06 -137.85 17.2 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.738 . . . . 2.2000000000000002 112.503 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -80.55 110.34 15.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 2.73 111.139 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.08 56.9 3.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 4.5 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 52.0 27.23 21.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.73 . . . . 2.9500000000000002 112.465 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -163.08 -167.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.797 0.332 . . . . 6.0999999999999996 110.862 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -80.55 55.95 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 6.8200000000000003 110.894 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -137.93 34.67 2.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 8.1500000000000004 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.8 127.81 34.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 2.3100000000000001 111.149 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.81 -82.16 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 7.3600000000000003 110.861 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.78 -77.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 5.0199999999999996 110.853 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 126.36 -161.1 20.76 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.747 -0.74 . . . . 3.1499999999999999 112.469 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -53.32 119.3 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 4.4299999999999997 110.9 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.46 -14.03 62.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 2.5 112.465 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.87 -150.56 7.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 1.8799999999999999 112.497 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.3 mt -71.29 96.66 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 3.2400000000000002 111.146 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.4 pp -48.18 -29.65 3.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 4.1500000000000004 110.907 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 178.62 176.0 0.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 2.6699999999999999 111.09 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.35 120.77 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 3.9500000000000002 110.88 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -109.75 117.55 34.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 1.53 111.111 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -63.79 166.14 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 5.2199999999999998 110.876 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.92 172.61 0.27 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.729 -0.748 . . . . 0.93999999999999995 112.481 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -179.2 2.77 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.682 2.255 . . . . 0.98999999999999999 112.339 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.39 -136.88 8.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 1.28 112.5 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.2 p -108.72 130.97 55.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.924 0.392 . . . . 3.1499999999999999 110.872 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.36 -85.39 0.18 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.761 -0.733 . . . . 1.3899999999999999 112.451 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.09 -7.95 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 3.6099999999999999 111.137 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.97 -84.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 2.77 112.504 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -76.18 -2.35 72.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 2.48 112.504 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -49.03 114.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 2.2599999999999998 110.866 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -122.2 154.14 37.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 2.4900000000000002 111.106 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -133.14 149.52 52.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 3.6800000000000002 110.864 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -130.0 143.87 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 4.1399999999999997 110.847 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.88 -73.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 5.6299999999999999 110.884 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 63.8 -80.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 8.6300000000000008 110.909 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -14.04 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 6.2699999999999996 110.916 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -91.46 15.76 11.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 6.8200000000000003 110.917 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 67.23 122.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 7.6500000000000004 110.918 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.43 -170.64 1.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 8.5399999999999991 110.934 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.01 172.76 18.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 3.3500000000000001 111.181 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.78 -170.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 2.3100000000000001 111.163 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -57.17 -20.9 29.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 5.0899999999999999 110.851 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.32 -69.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 2.6099999999999999 110.838 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.51 -160.43 10.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.731 . . . . 4.2699999999999996 112.511 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 50.94 -161.85 1.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 3.3900000000000001 112.498 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 97.4 m -64.95 104.75 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 2.7599999999999998 111.177 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.89 141.76 58.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 3.6800000000000002 110.885 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.53 -54.21 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 3.4199999999999999 110.904 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -51.97 18.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 6.8300000000000001 110.936 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 12.3 tp -49.31 -38.45 27.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 3.0699999999999998 110.967 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 60.2 m -79.75 -42.66 24.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 1.77 111.127 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.65 -36.84 77.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 2.0600000000000001 111.138 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.01 -43.84 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 2.3599999999999999 111.145 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -54.2 -31.64 53.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 3.3300000000000001 110.888 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -33.11 64.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 3.8399999999999999 110.867 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 40.9 mm -55.32 -50.38 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 2.5499999999999998 111.129 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.95 -28.58 60.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 1.1100000000000001 112.453 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -47.52 75.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.33 . . . . 3.5499999999999998 110.832 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.98 29.23 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 2.0600000000000001 110.864 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.0 mt -132.24 -39.96 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 2.9199999999999999 110.933 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.61 -30.86 0.2 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 1.74 112.482 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.3 mp -90.75 90.51 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 3.98 110.936 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.1 -89.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.712 -0.756 . . . . 3.5 112.504 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -118.71 89.84 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 2.8799999999999999 110.887 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.46 172.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 5.9900000000000002 110.853 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 8.2 t -112.92 -27.33 8.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 4.21 110.879 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -51.77 112.49 3.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.724 . . . . 3.2799999999999998 110.84 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.8 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 2.1299999999999999 112.318 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -27.31 69.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 4.71 110.923 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -72.13 167.68 19.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 2.5699999999999998 111.092 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.0 m -95.49 -15.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 5.8499999999999996 111.165 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 9.0 tpt -58.22 -21.9 49.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 5.6100000000000003 110.876 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -52.22 137.38 38.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.652 0.739 . . . . 5.0099999999999998 110.858 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 76.52 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.693 2.262 . . . . 2.8599999999999999 112.35 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.8 t -157.32 167.67 29.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 4.0 111.193 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -115.14 112.22 22.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.263 -0.426 . . . . 5.1699999999999999 110.943 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -136.22 -169.6 2.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 3.4199999999999999 110.896 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -107.24 142.57 36.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 6.1900000000000004 110.917 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.7 t -149.47 143.05 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 3.1400000000000001 111.182 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.87 126.06 26.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 2.75 110.832 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.8 tt -58.09 -22.83 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 4.0 111.132 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.25 -31.28 12.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 3.6400000000000001 110.916 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.93 33.53 2.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 2.8500000000000001 111.137 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -104.21 129.08 52.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 6.04 110.916 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -176.55 129.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 4.0199999999999996 110.898 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.8 mt -58.44 114.65 2.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 5.1299999999999999 110.9 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.02 108.2 9.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 5.25 110.895 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 174.18 172.59 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 4.3499999999999996 111.1 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -18.64 49.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 3.23 110.915 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -52.4 -30.44 29.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 3.5899999999999999 110.868 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 68.6 mt -51.36 -29.0 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 4.0599999999999996 111.116 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -87.55 -33.13 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 5.8099999999999996 110.85 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.58 -14.66 77.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 2.0800000000000001 112.47 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 7.2 tp -92.29 -34.36 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.784 0.326 . . . . 2.23 111.137 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -79.31 -40.84 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 4.4199999999999999 110.941 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 t -79.9 -47.34 15.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 3.27 110.867 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 55.02 91.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 4.2400000000000002 110.905 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -54.92 120.3 6.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 13.6 110.983 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.141 -0.81 . . . . 10.94 112.532 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.812 0.339 . . . . 8.0099999999999998 110.904 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -116.57 135.31 53.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 10.59 110.932 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.71 171.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.134 -0.485 . . . . 3.5899999999999999 111.126 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.2 p -114.25 146.96 39.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 3.25 111.119 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -152.41 136.6 16.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 6.3300000000000001 110.941 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -161.45 145.77 13.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 5.7699999999999996 110.868 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.7 mt -108.07 148.81 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 2.5699999999999998 111.144 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -156.45 38.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 3.4700000000000002 110.907 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -135.39 148.81 49.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 6.5199999999999996 110.92 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -147.86 122.51 9.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 6.4400000000000004 110.891 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.56 147.38 41.89 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.55 0.69 . . . . 3.9199999999999999 111.118 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -168.02 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.652 2.235 . . . . 2.8300000000000001 112.339 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 73.82 -62.29 0.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 3.8999999999999999 110.84 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 36.2 mmt -100.92 137.26 39.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 4.4199999999999999 110.874 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.31 158.15 9.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 3.3300000000000001 110.896 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -52.57 -30.96 33.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 10.289999999999999 110.889 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.49 -45.38 72.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 2.8799999999999999 110.908 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.71 -44.72 93.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 2.3599999999999999 110.893 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.49 -37.02 49.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 2.0800000000000001 111.108 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -63.75 -54.5 34.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 2.7400000000000002 110.872 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -59.31 -33.47 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 3.79 110.927 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.15 71.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 1.9099999999999999 111.119 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.3 mm -83.13 -44.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 3.5800000000000001 111.17 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.69 -45.23 58.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 4.8600000000000003 110.923 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -78.09 -20.48 52.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 3.9100000000000001 110.907 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.03 -53.69 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 1.6000000000000001 111.099 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -36.11 75.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 4.7999999999999998 110.885 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -28.1 69.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 3.4700000000000002 110.893 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.28 -56.19 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 2.98 111.124 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -73.26 -34.41 65.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 4.9699999999999998 110.884 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.8 t -56.25 -23.49 36.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 2.48 110.874 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.28 -16.6 63.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 2.6000000000000001 110.885 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.2 t -114.41 -33.46 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 4.5999999999999996 111.121 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 t -107.19 146.0 32.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.614 0.721 . . . . 4.0 111.146 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -7.61 21.51 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 2.9100000000000001 112.313 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.23 150.34 3.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 3.54 110.965 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.59 -173.15 2.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 8.1099999999999994 110.923 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -135.56 119.83 17.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 8.1600000000000001 110.92 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -111.16 89.95 3.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 3.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.9 110.57 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 3.1899999999999999 110.878 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.33 162.84 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 4.0499999999999998 111.151 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -113.12 51.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 5.1600000000000001 110.851 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.7 t -175.63 160.17 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 4.9400000000000004 111.147 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.47 139.81 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 2.6800000000000002 112.491 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.82 164.3 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.357 . . . . 7.1200000000000001 110.86 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.02 136.77 23.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 2.2999999999999998 111.081 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.92 -45.48 64.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 2.54 110.867 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.7 pt -108.79 135.53 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 4.0599999999999996 111.079 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.19 125.46 29.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 3.9500000000000002 110.922 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 t -94.52 112.57 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 2.2200000000000002 111.117 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.1 t -145.03 144.42 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 2.2799999999999998 111.108 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -108.06 137.89 45.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 4.54 110.896 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.56 164.01 31.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 2.5899999999999999 111.105 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.32 126.42 52.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 6.25 110.85 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.72 -142.46 20.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.738 . . . . 1.3500000000000001 112.516 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.02 124.42 24.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 2.0899999999999999 111.134 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -89.62 76.64 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 3.8199999999999998 110.833 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.27 45.72 64.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 2.4199999999999999 112.499 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.78 88.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 6.6399999999999997 110.843 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -166.35 -74.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 4.3300000000000001 110.865 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -137.36 93.74 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 4.96 110.829 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.24 128.86 34.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 2.0299999999999998 111.116 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.66 -37.23 1.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 7.9000000000000004 110.918 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.13 168.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 6.1299999999999999 110.86 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.85 -148.49 7.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 3.8300000000000001 112.473 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.27 135.09 27.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 5.8600000000000003 110.838 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.98 -19.12 6.14 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.738 . . . . 5.0999999999999996 112.497 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.16 -107.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 3.02 112.535 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.4 mm -71.4 149.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.898 0.38 . . . . 3.8599999999999999 111.095 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.49 -18.66 10.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 5.46 110.884 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 175.64 124.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 2.7000000000000002 111.098 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -104.09 164.07 11.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 6.3799999999999999 110.818 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -179.68 109.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 1.7 111.098 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -71.11 150.8 45.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 5.3799999999999999 110.935 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.6 -167.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 1.1499999999999999 112.474 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 160.76 48.53 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.658 2.238 . . . . 1.6100000000000001 112.355 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 147.1 -163.45 28.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.742 . . . . 1.1299999999999999 112.49 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.08 140.67 29.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.895 0.378 . . . . 2.6499999999999999 110.841 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.25 -64.96 2.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.681 -0.771 . . . . 1.54 112.513 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.74 61.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.36 . . . . 4.0899999999999999 111.131 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -88.62 46.33 3.32 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 3.48 112.444 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.38 31.82 0.88 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 2.02 112.472 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -64.51 139.29 58.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.771 0.32 . . . . 2.9100000000000001 110.929 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.5 119.8 35.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 2.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -115.18 109.88 18.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 4.5700000000000003 110.859 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -113.0 101.66 9.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 3.6099999999999999 110.882 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.41 117.18 2.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 6.4000000000000004 110.857 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -64.22 -48.61 75.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 7.8200000000000003 110.942 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -50.16 -30.45 11.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 3.7999999999999998 110.895 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -169.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 3.7200000000000002 110.882 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -125.31 116.73 22.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 5.6500000000000004 110.869 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -105.06 97.41 7.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 8.3200000000000003 110.957 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.85 172.95 6.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 2.1200000000000001 111.11 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.42 173.57 6.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 2.1099999999999999 111.121 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -21.4 59.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.437 . . . . 10.42 110.891 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.05 -64.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 2.23 110.833 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.08 -177.14 14.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.772 -0.727 . . . . 3.4399999999999999 112.478 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 51.47 -170.88 0.31 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 2.4700000000000002 112.519 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -56.7 99.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 2.2799999999999998 111.134 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.11 111.66 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 3.9700000000000002 110.867 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.8 -35.65 71.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 3.2200000000000002 110.925 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -71.37 -62.43 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 6.0700000000000003 110.859 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.3 tp -51.34 -53.51 35.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 3.2599999999999998 110.917 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 23.3 m -55.58 -49.4 72.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 1.8799999999999999 111.142 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.63 -44.2 76.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 1.8500000000000001 111.075 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 23.7 t -66.4 -46.57 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 2.1200000000000001 111.104 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -54.02 -29.46 43.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 3.5699999999999998 110.856 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.59 -42.1 59.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 3.3599999999999999 110.879 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.5 mm -51.21 -32.95 13.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 2.6200000000000001 111.095 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.65 -55.36 8.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 1.1599999999999999 112.522 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -37.49 77.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 3.8700000000000001 110.811 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.0 p -65.23 -34.58 78.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 3.7400000000000002 110.878 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.1 mp -95.31 23.47 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 2.8399999999999999 110.902 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.44 98.89 0.27 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 1.95 112.513 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 18.7 tp -149.76 156.6 42.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.793 0.33 . . . . 4.4699999999999998 110.956 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.93 -109.16 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 3.77 112.497 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.3 147.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 2.79 110.875 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.27 -77.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 7.1399999999999997 110.894 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t 62.89 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 5.8799999999999999 110.886 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.0 159.49 68.47 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.635 0.731 . . . . 2.79 110.808 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -24.98 29.12 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 2.23 112.361 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.6 -31.11 12.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 4.8099999999999996 110.941 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -52.46 172.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 2.8399999999999999 111.093 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.38 7.48 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 3.4199999999999999 111.121 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -27.5 36.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 5.1600000000000001 110.875 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.447 ' O ' ' CG ' ' A' ' 237' ' ' PHE . 3.0 p90 -47.61 114.59 3.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.681 0.753 . . . . 10.52 110.888 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 61.68 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.669 2.246 . . . . 2.52 112.334 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.93 169.18 21.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 3.1899999999999999 111.113 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -109.13 113.01 25.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 4.4199999999999999 110.962 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -135.29 123.57 23.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 4.5499999999999998 110.902 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -66.58 141.37 57.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 4.4699999999999998 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 97.8 t -150.39 144.36 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 3.2200000000000002 111.103 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.56 126.93 21.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 3.1200000000000001 110.872 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.27 -25.38 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 4.7199999999999998 111.107 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.05 -39.5 23.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 3.8100000000000001 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.1 p -93.13 10.01 33.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 3.46 111.13 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -79.42 122.84 26.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 6.2300000000000004 110.864 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -163.81 148.02 10.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 4.0999999999999996 110.883 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.12 151.97 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 3.3199999999999998 110.929 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 6.3 t -89.2 -171.47 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 3.9100000000000001 110.9 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -84.06 -56.34 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 5.1799999999999997 111.12 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.71 -38.27 60.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 3.29 110.846 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.53 -29.05 65.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 3.02 110.858 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -27.56 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 2.6200000000000001 111.147 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.0 mtp85 -87.79 -23.43 24.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 5.5599999999999996 110.87 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.45 -22.96 64.17 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.718 -0.753 . . . . 2.4500000000000002 112.504 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.5 tp -92.87 -31.05 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.329 . . . . 2.2200000000000002 111.155 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -78.9 -42.55 26.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 4.0700000000000003 110.911 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.8 m -85.39 -46.0 11.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 4.6799999999999997 110.821 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.6 mp 58.89 77.82 0.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 6.2800000000000002 110.903 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.69 137.68 24.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 15.18 110.903 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 119.174 -0.792 . . . . 14.380000000000001 112.475 179.976 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.781 0.324 . . . . 15.27 110.898 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -73.41 147.21 44.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 18.59 110.873 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -132.92 169.94 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 7.4299999999999997 111.111 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.5 t -91.06 116.38 28.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 4.1699999999999999 111.112 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -142.08 136.53 30.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 5.8499999999999996 110.935 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -107.93 103.28 12.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 7.7000000000000002 110.917 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.7 mm -70.73 148.44 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 4.0 111.145 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -109.29 -75.09 0.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 5.1600000000000001 110.877 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -140.07 146.13 38.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 6.6699999999999999 110.883 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -92.5 163.26 13.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.207 -0.451 . . . . 7.5499999999999998 110.913 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.32 159.32 29.65 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.564 0.697 . . . . 4.7400000000000002 111.156 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.8 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.671 2.248 . . . . 2.8100000000000001 112.345 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 73.84 -63.39 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 4.4500000000000002 110.819 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.81 144.62 29.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 7.6799999999999997 110.881 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.09 161.82 15.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 4.0599999999999996 110.901 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -21.92 48.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 7.8099999999999996 110.859 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -79.78 -36.67 36.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 4.9900000000000002 110.895 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.0 -44.02 93.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 2.4399999999999999 110.887 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 p -74.58 -34.59 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 2.0299999999999998 111.077 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.66 -54.61 11.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 2.5800000000000001 110.852 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -62.82 -33.33 75.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 4.04 110.928 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.92 -58.73 6.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 1.5700000000000001 111.125 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 9.5 pt -65.69 -28.31 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 4.1699999999999999 111.119 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -48.25 -56.12 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 5.3499999999999996 110.851 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -26.17 44.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 3.7200000000000002 110.871 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.59 -33.97 64.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 1.9399999999999999 111.114 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -73.69 -30.75 63.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 7.2199999999999998 110.842 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -78.99 -29.12 43.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 4.6900000000000004 110.935 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -50.73 -42.52 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 2.9500000000000002 111.136 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -96.18 -44.88 7.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 4.8300000000000001 110.941 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.0 m -54.99 -24.99 26.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 4.3300000000000001 110.89 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -61.36 -21.39 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 2.6899999999999999 110.88 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.1 41.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 2.79 111.121 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.62 128.6 4.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.595 0.712 . . . . 2.8599999999999999 111.183 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 78.15 1.0 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.707 2.271 . . . . 2.7200000000000002 112.383 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.64 102.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 4.79 110.908 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.93 128.7 47.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 6.5300000000000002 110.882 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -138.81 152.41 47.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 12.33 110.895 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.01 152.23 23.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 4.7400000000000002 110.804 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -58.5 151.34 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 4.2400000000000002 110.863 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.0 mp -137.75 130.33 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 4.1699999999999999 111.161 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.15 -13.1 61.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 4.0700000000000003 110.901 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.0 -178.57 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 5.8600000000000003 111.122 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.18 48.22 2.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 3.8300000000000001 112.466 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.15 99.6 7.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.34 . . . . 8.0199999999999996 110.858 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.43 129.78 13.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.426 . . . . 2.2799999999999998 111.098 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -19.1 57.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 4.9500000000000002 110.844 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.2 pt -138.21 141.74 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 4.6200000000000001 111.126 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -114.21 118.65 34.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 2.2599999999999998 110.93 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 89.0 t -92.39 125.46 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 2.52 111.143 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.22 164.59 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 4.0499999999999998 111.123 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -137.52 101.09 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 9.2799999999999994 110.86 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -125.72 155.46 40.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 2.3999999999999999 111.107 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.93 127.4 53.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 6.1600000000000001 110.848 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.19 -144.51 13.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.691 -0.766 . . . . 1.46 112.505 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.7 123.04 18.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 2.23 111.088 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -95.15 25.4 4.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 4.0099999999999998 110.878 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.89 -23.03 30.86 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.694 -0.765 . . . . 2.4300000000000002 112.448 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -179.31 35.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 5.1900000000000004 110.886 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.98 -169.46 2.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 5.2999999999999998 110.886 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -77.05 114.55 15.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 4.9100000000000001 110.819 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.4 128.8 34.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 2.0800000000000001 111.101 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -131.21 170.66 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 7.1699999999999999 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -122.87 165.04 17.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 4.54 110.865 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.22 -142.09 1.49 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.725 -0.75 . . . . 3.3300000000000001 112.434 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -50.51 119.14 3.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 4.0899999999999999 110.926 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.11 -73.94 0.44 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.754 -0.736 . . . . 2.5899999999999999 112.47 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -89.67 -143.26 9.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.751 . . . . 1.8799999999999999 112.513 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.5 mm -71.29 133.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.889 0.376 . . . . 3.1499999999999999 111.113 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.47 -14.12 17.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 3.6899999999999999 110.946 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.88 125.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 2.6600000000000001 111.075 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -143.67 106.93 4.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 4.2699999999999996 110.915 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -100.34 142.31 32.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 1.4399999999999999 111.148 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.39 170.03 16.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 3.6499999999999999 110.915 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -53.96 176.67 0.3 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.687 -0.768 . . . . 0.93000000000000005 112.49 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -169.92 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.677 2.252 . . . . 1.28 112.367 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.54 -141.94 13.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 1.5700000000000001 112.51 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.1 m -127.03 146.26 50.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.928 0.394 . . . . 4.2000000000000002 110.873 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.22 -58.96 3.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.76 -0.733 . . . . 1.5 112.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.1 mm -106.12 -23.22 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.378 . . . . 3.4500000000000002 111.169 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.06 128.5 39.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 2.4900000000000002 112.509 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 89.8 -15.44 59.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 2.02 112.513 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -51.77 147.46 6.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 2.4300000000000002 110.871 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -121.34 109.39 14.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 1.99 111.093 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -96.99 110.46 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 5.0300000000000002 110.864 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -115.64 104.95 12.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 3.7200000000000002 110.886 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -51.7 113.45 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 7.2400000000000002 110.819 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.93 -41.18 77.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 7.2599999999999998 110.906 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.76 -51.06 59.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 4.4500000000000002 110.881 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -54.4 148.29 12.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 4.3399999999999999 110.862 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -89.27 121.44 31.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 8.0099999999999998 110.865 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -107.4 99.29 8.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 8.0600000000000005 110.912 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.2 t -157.1 134.14 10.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 5.3499999999999996 111.154 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.3 t -106.88 72.41 0.89 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 4.4199999999999999 111.135 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -82.66 -67.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 9.3100000000000005 110.86 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.5 m -114.23 -71.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 3.6299999999999999 110.843 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.41 4.75 1.32 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 5.4100000000000001 112.456 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.14 -161.43 0.97 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 3.1600000000000001 112.467 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.9 m -59.2 96.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 2.4300000000000002 111.14 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.38 127.41 35.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 2.9300000000000002 110.88 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -37.98 66.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 4.54 110.971 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -72.29 -32.49 66.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 6.4699999999999998 110.903 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.82 -60.04 2.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 3.7799999999999998 110.963 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -38.27 68.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 2.2799999999999998 111.166 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.96 74.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 1.97 111.087 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 58.7 t -49.18 -43.07 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 2.0099999999999998 111.109 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -36.66 71.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 4.1900000000000004 110.86 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.51 -42.83 58.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 3.9100000000000001 110.858 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 45.2 mm -50.06 -39.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 2.4700000000000002 111.111 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.11 -51.98 6.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.78 -0.724 . . . . 0.83999999999999997 112.499 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -55.49 -26.86 44.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 3.3199999999999998 110.867 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.27 24.73 4.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 2.25 110.905 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 mp -148.92 17.96 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 2.48 110.94 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 88.33 77.21 1.29 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.749 . . . . 1.8300000000000001 112.499 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -130.27 179.56 5.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.358 . . . . 4.1200000000000001 110.942 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.61 -123.73 3.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.805 -0.712 . . . . 3.4399999999999999 112.507 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.61 150.56 12.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 2.8199999999999998 110.815 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.3 m 61.0 -92.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 7.54 110.843 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 32.3 m 59.6 -86.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.499 . . . . 4.9699999999999998 110.847 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.5 155.96 75.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.611 0.719 . . . . 2.52 110.864 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 233' ' ' LYS . 53.6 Cg_endo -69.76 168.79 20.55 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.717 2.278 . . . . 2.7999999999999998 112.335 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.7 41.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 5.8600000000000003 110.868 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -130.85 153.79 48.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 2.2400000000000002 111.082 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 99.7 t -56.05 -25.74 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 5.2999999999999998 111.097 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.5 tpp -66.4 -18.2 65.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 5.8399999999999999 110.85 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -109.72 82.22 2.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.657 0.742 . . . . 5.4299999999999997 110.861 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 104.93 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.651 2.234 . . . . 4.9500000000000002 112.345 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.8 t -157.29 127.77 6.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 3.5099999999999998 111.136 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -61.82 120.92 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 4.79 110.938 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -162.61 140.9 8.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 4.21 110.892 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -58.59 125.24 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 5.8499999999999996 110.929 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.4 t -150.49 143.66 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 3.7000000000000002 111.117 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.51 122.02 8.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 4.0 110.902 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 22.3 pt -74.74 -23.9 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 4.9000000000000004 111.092 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -87.22 -23.71 24.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 5.5800000000000001 110.919 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.2 m -100.95 6.54 43.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 3.5600000000000001 111.176 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -50.24 132.8 24.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 5.4199999999999999 110.849 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -179.56 148.05 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 5.4900000000000002 110.87 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.32 171.07 11.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 3.6099999999999999 110.928 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.8 p -89.94 170.37 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 5.3799999999999999 110.895 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.84 -53.75 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 5.1699999999999999 111.099 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -18.84 51.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 3.0299999999999998 110.923 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.43 -36.34 73.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 2.7200000000000002 110.847 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.96 -32.17 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 4.0099999999999998 111.154 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -59.03 -26.11 64.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 11.31 110.863 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -98.97 45.17 1.61 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 2.2599999999999998 112.467 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 7.5 tp -176.69 -36.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.761 0.315 . . . . 2.2400000000000002 111.105 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.21 -44.27 26.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 4.3200000000000003 110.905 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.6 t -72.87 -29.04 62.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 3.0600000000000001 110.89 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.88 -64.16 1.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 4.4800000000000004 110.895 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -94.86 142.52 27.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 13.57 110.927 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.142 -0.81 . . . . 11.609999999999999 112.469 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.771 0.32 . . . . 13.56 110.851 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.74 148.82 52.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 15.630000000000001 110.912 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.2 tp -147.51 168.33 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 5.9500000000000002 111.091 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 p -93.28 116.69 29.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 3.6299999999999999 111.129 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -152.57 136.62 16.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 5.5599999999999996 110.941 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 45.4 ptt85 -123.1 127.55 48.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 6.9699999999999998 110.896 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.9 pt -107.59 148.53 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 3.77 111.141 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -149.02 -41.07 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 4.1699999999999999 110.882 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -96.2 150.38 20.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 6.5199999999999996 110.919 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -147.7 134.28 19.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 7.0800000000000001 110.902 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.04 146.85 18.29 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.613 0.72 . . . . 3.46 111.166 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 163.51 38.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 2.8500000000000001 112.327 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.54 16.13 9.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 3.8399999999999999 110.86 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.5 tpt -145.36 131.36 19.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 4.3700000000000001 110.867 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.34 135.22 57.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 3.6200000000000001 110.878 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -59.07 -20.16 50.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 6.7800000000000002 110.861 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -74.09 -30.5 62.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 3.8500000000000001 110.875 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.98 -44.94 75.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 3.4500000000000002 110.874 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.41 -28.33 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 2.2400000000000002 111.092 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -71.88 -47.97 49.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 3.23 110.841 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.57 -39.1 58.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 4.4800000000000004 110.9 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.73 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 2.1400000000000001 111.093 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.15 -28.55 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 5.2800000000000002 111.084 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -56.1 -41.23 74.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 4.1500000000000004 110.824 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.1 -19.65 46.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 3.8900000000000001 110.895 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.42 -38.54 34.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 2.3199999999999998 111.064 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.28 -25.71 58.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 7.3899999999999997 110.878 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -80.69 -51.15 9.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 3.0099999999999998 110.888 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.7 p -49.21 -42.28 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 3.4100000000000001 111.102 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -75.84 -50.8 14.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 4.8899999999999997 110.882 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 76.7 p -55.15 -24.96 29.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 2.25 110.859 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.99 -31.61 30.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 4.1900000000000004 110.854 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -119.24 45.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 3.0 111.167 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.46 135.44 8.3 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.565 0.698 . . . . 3.1699999999999999 111.124 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -23.74 30.31 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.697 2.265 . . . . 2.1400000000000001 112.346 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.71 113.4 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 4.4800000000000004 110.935 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.32 129.12 39.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 6.1600000000000001 110.918 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -137.52 154.48 49.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.441 . . . . 13.58 110.886 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.9 t -101.86 122.8 44.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 3.9500000000000002 110.845 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.25 142.27 43.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 3.6000000000000001 110.891 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 71.6 mt -113.24 117.6 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 3.8500000000000001 111.146 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.7 -39.84 59.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 5.4000000000000004 110.858 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 97.2 m -139.14 112.31 8.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 4.3700000000000001 111.14 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.25 -163.59 31.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.783 -0.722 . . . . 3.0299999999999998 112.481 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.73 143.85 38.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 5.79 110.91 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -113.12 160.44 18.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 2.48 111.088 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.45 -34.31 61.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 3.48 110.897 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 66.3 mt -104.7 141.04 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 3.6600000000000001 111.129 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -121.64 117.31 26.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 2.6800000000000002 110.93 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.0 t -95.45 110.99 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 2.9399999999999999 111.096 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.8 t -149.7 142.21 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 2.3500000000000001 111.123 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -80.4 152.8 28.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 5.2599999999999998 110.907 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.3 176.17 8.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 2.5 111.076 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -144.85 111.97 5.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 6.04 110.893 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.12 -125.3 27.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 1.3700000000000001 112.502 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.68 114.86 23.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.333 . . . . 3.0899999999999999 111.12 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -89.16 48.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 4.2400000000000002 110.923 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.85 45.81 5.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.731 . . . . 3.48 112.526 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.74 96.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.337 . . . . 8.3699999999999992 110.869 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.4 -74.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 4.6600000000000001 110.846 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -128.06 80.73 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 5.29 110.868 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.22 113.26 19.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 2.5499999999999998 111.084 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 141.31 43.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 6.9699999999999998 110.888 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 p30 178.69 -174.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 4.9900000000000002 110.86 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.65 106.04 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 3.5299999999999998 112.521 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.26 118.96 2.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 6.7800000000000002 110.919 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 121.16 -41.44 1.9 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.748 . . . . 3.0899999999999999 112.533 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -75.91 -114.03 0.12 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 1.8200000000000001 112.516 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.8 mm -92.44 135.18 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 3.21 111.102 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.94 -20.84 13.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 4.3200000000000003 110.892 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.62 124.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 2.2200000000000002 111.128 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -109.46 146.74 34.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 4.5300000000000002 110.842 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -155.76 122.34 5.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 1.54 111.119 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.67 169.45 18.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 3.5699999999999998 110.897 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.16 177.55 0.27 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.711 -0.757 . . . . 1.1499999999999999 112.485 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 153.12 69.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.73 2.287 . . . . 1.3400000000000001 112.331 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.79 175.2 27.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.746 -0.74 . . . . 1.6499999999999999 112.513 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 88.9 p -58.72 158.89 7.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 2.54 110.891 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.85 -102.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 1.49 112.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.64 -73.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 3.48 111.11 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 50.54 -132.63 30.76 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 2.7999999999999998 112.51 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -88.66 47.1 3.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 2.21 112.486 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.92 154.97 37.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 2.46 110.883 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.95 109.52 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 2.2200000000000002 111.02 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -111.44 109.89 20.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 4.5199999999999996 110.812 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -106.33 103.2 12.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 3.8599999999999999 110.871 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.66 101.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 7.5300000000000002 110.87 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.9 -29.15 26.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 7.1900000000000004 110.886 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -32.81 70.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 3.8500000000000001 110.838 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.84 -174.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 3.5 110.939 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -114.17 76.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 5.5700000000000003 110.844 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -73.6 147.52 43.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 8.1500000000000004 110.938 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.66 173.09 17.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 3.0499999999999998 111.143 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -173.86 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 2.71 111.117 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -55.64 -48.97 74.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 5.4900000000000002 110.84 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -81.92 -25.09 35.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 3.4199999999999999 110.835 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.8 -172.13 0.39 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 4.0499999999999998 112.474 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.47 -86.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 3.4500000000000002 112.511 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -93.63 109.51 21.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 2.8500000000000001 111.127 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -49.92 114.31 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 4.2000000000000002 110.911 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.54 -35.77 78.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 4.3600000000000003 110.934 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.9 -57.93 3.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 6.7300000000000004 110.928 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 14.8 tp -47.9 -45.41 30.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 2.98 110.889 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 24.8 m -59.37 -44.8 92.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 1.72 111.102 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.28 80.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 1.77 111.122 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.4 t -49.21 -50.47 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 2.1600000000000001 111.159 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.788 ' NE2' 'CO ' ' A' ' 264' ' ' ' CO' . 50.1 t60 -54.08 -33.63 58.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 3.3700000000000001 110.882 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.73 -41.57 59.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 3.98 110.855 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 39.1 mm -53.37 -37.93 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 2.6400000000000001 111.105 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.99 -53.56 5.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 0.92000000000000004 112.493 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -57.15 -24.92 57.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 3.4300000000000002 110.872 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.3 m -87.25 -17.58 32.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 2.1699999999999999 110.864 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.2 mp -120.82 24.83 10.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 2.7400000000000002 110.95 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.87 106.52 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 1.98 112.466 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.12 -67.01 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 5.1900000000000004 110.905 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 67.13 121.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 3.48 112.486 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -51.71 152.68 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 2.4199999999999999 110.866 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 73.7 m -134.05 -77.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 4.6100000000000003 110.856 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 8.2 t 178.09 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 6.2699999999999996 110.895 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -48.4 108.01 0.85 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.612 0.72 . . . . 2.8199999999999998 110.883 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 157.02 61.85 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.717 2.278 . . . . 2.04 112.314 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.14 17.9 8.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 7.04 110.927 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.46 175.45 5.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 2.4100000000000001 111.099 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 49.7 t -71.46 -18.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 6.1100000000000003 111.139 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -74.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 7.5599999999999996 110.823 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -128.36 65.14 69.89 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.658 0.742 . . . . 7.7400000000000002 110.903 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -169.88 0.36 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.669 2.246 . . . . 7.5199999999999996 112.367 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.49 155.37 40.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 3.3100000000000001 111.137 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -62.09 118.7 7.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 4.6699999999999999 110.912 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.64 -168.94 1.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 4.1799999999999997 110.922 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -132.75 102.55 5.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 4.8700000000000001 110.942 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.69 157.08 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 3.3999999999999999 111.108 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -58.63 114.64 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 2.6600000000000001 110.864 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -69.2 -25.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 4.71 111.118 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -28.6 32.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 4.46 110.895 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.29 13.27 32.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 3.25 111.153 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -51.28 164.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 6.4299999999999997 110.877 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -179.44 146.97 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 3.9100000000000001 110.863 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 40.7 tp -66.98 162.48 21.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 3.5600000000000001 110.91 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.77 145.22 25.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 5.5800000000000001 110.846 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.22 -71.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 4.25 111.115 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.09 -35.06 59.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 3.7000000000000002 110.841 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -70.82 -29.99 66.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 2.8799999999999999 110.85 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -51.58 -28.51 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 2.8700000000000001 111.106 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.8 mtp85 -79.88 -37.77 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 6.8499999999999996 110.824 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.36 58.88 3.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.741 -0.742 . . . . 2.4100000000000001 112.505 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 5.2 tp -177.89 -39.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.321 . . . . 2.5299999999999998 111.151 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -73.55 -30.89 63.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 4.8799999999999999 110.901 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -42.53 99.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 4.0 110.865 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.82 153.04 43.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 4.1399999999999997 110.941 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 60.39 98.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 14.789999999999999 110.906 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 119.136 -0.814 . . . . 10.869999999999999 112.495 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . 0.788 'CO ' ' NE2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.481 ' N ' ' HZ1' ' A' ' 148' ' ' LYS . 1.1 t60 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.791 0.329 . . . . 9.5299999999999994 110.865 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.7 143.56 49.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 10.5 110.922 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.7 153.77 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 3.5299999999999998 111.118 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.5 p -117.09 143.81 45.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 2.6699999999999999 111.142 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -146.96 136.67 23.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 4.8700000000000001 110.875 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -135.21 126.23 27.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 4.8799999999999999 110.859 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.1 pt -104.82 133.96 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 4.0 111.103 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -135.55 29.37 3.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 3.7000000000000002 110.904 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -112.86 151.33 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 6.46 110.926 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -147.69 145.23 28.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 7.0899999999999999 110.943 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.67 133.14 23.83 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.601 0.715 . . . . 4.3799999999999999 111.121 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -49.56 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.69 2.26 . . . . 3.02 112.329 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -30.99 15.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 4.3899999999999997 110.876 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 24.7 mtp -108.01 164.57 12.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 6.3300000000000001 110.906 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -86.55 161.53 18.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 3.8399999999999999 110.873 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -25.49 36.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 8.4800000000000004 110.909 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -80.07 -41.17 26.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 5.1699999999999999 110.883 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -55.66 -53.03 61.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 2.25 110.873 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.1 -37.57 79.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 2.54 111.161 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -61.44 -54.25 45.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 2.5499999999999998 110.845 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -70.37 -32.54 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 3.9900000000000002 110.955 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.24 -57.45 8.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 1.8600000000000001 111.079 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -76.06 -45.67 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 3.0800000000000001 111.129 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.61 -37.35 39.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 5.4299999999999997 110.856 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -78.53 -30.68 47.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 4.71 110.883 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.73 -35.96 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 1.73 111.073 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -74.51 -28.15 60.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 4.8200000000000003 110.878 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.34 -50.42 10.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 3.5699999999999998 110.932 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -50.09 -30.99 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 3.04 111.143 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -88.76 -43.48 11.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 5.0199999999999996 110.926 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 70.7 p -54.75 -24.79 23.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.6400000000000001 110.871 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.31 -24.43 43.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 3.1699999999999999 110.864 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -140.94 46.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 3.0 111.103 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 m -155.76 132.06 5.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 2.5099999999999998 111.142 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -8.36 23.4 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.712 2.275 . . . . 1.8 112.364 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.65 147.01 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 3.7200000000000002 110.891 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.481 ' HZ1' ' N ' ' A' ' 112' ' ' HIS . 0.0 OUTLIER -118.38 137.24 53.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 6.0 110.894 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -99.35 134.48 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 7.7000000000000002 110.923 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.4 t -123.87 89.91 3.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 2.2799999999999998 110.836 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.88 119.92 19.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 3.29 110.863 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.14 149.29 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 3.7599999999999998 111.086 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.43 -24.53 34.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 4.2699999999999996 110.893 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.2 m -139.77 132.16 28.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 4.2000000000000002 111.142 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.19 162.8 11.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.802 -0.713 . . . . 2.52 112.516 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 42.0 mtt -95.02 166.39 11.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 7.9800000000000004 110.902 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -142.86 163.49 32.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 2.23 111.093 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -25.53 65.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.7200000000000002 110.897 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.9 mm -104.02 84.54 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 4.1200000000000001 111.094 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -81.06 115.78 20.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 2.4100000000000001 110.945 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.84 107.98 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 3.3700000000000001 111.154 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.4 t -138.27 145.08 29.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 2.3100000000000001 111.066 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -93.11 129.48 39.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 4.9000000000000004 110.866 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -111.09 178.39 4.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 2.0699999999999998 111.117 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -144.02 112.24 6.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 5.29 110.866 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 58.66 -131.15 51.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 1.48 112.521 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.95 110.55 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 2.1400000000000001 111.096 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -85.36 53.64 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 4.2400000000000002 110.882 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 78.62 -57.74 4.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.733 -0.746 . . . . 3.0899999999999999 112.499 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -162.7 46.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 5.5599999999999996 110.882 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.31 -169.13 1.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 4.5999999999999996 110.869 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -76.75 96.4 4.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 4.6100000000000003 110.911 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.39 143.64 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 2.8199999999999998 111.11 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -155.75 139.18 15.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 8.0800000000000001 110.906 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.17 -175.47 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 4.7800000000000002 110.841 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.74 99.32 1.09 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 3.9199999999999999 112.464 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.04 118.95 2.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 4.2000000000000002 110.865 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.16 -34.74 5.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 3.7000000000000002 112.479 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.79 -147.63 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 2.0099999999999998 112.494 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.6 mm -71.62 89.47 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 3.6299999999999999 111.104 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.6 pp -45.2 -32.89 2.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 4.3399999999999999 110.919 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 178.61 167.91 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 2.54 111.12 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -146.52 106.3 3.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 3.8900000000000001 110.858 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -90.63 121.3 32.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 1.6799999999999999 111.106 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.94 151.68 42.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 3.9900000000000002 110.873 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.68 167.33 0.47 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 1.1799999999999999 112.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 154.37 67.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 1.0900000000000001 112.327 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 167.56 -110.03 0.37 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 1.78 112.48 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 93.3 p -131.28 142.25 50.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.401 . . . . 3.7200000000000002 110.806 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.08 -87.43 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 1.55 112.484 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 10.4 tt -91.94 14.93 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 4.29 111.124 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -55.71 -68.47 1.67 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.783 -0.723 . . . . 2.71 112.492 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -85.62 2.85 87.81 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 2.6499999999999999 112.453 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.14 139.4 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.812 0.339 . . . . 2.6200000000000001 110.849 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -134.31 154.68 51.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 1.9399999999999999 111.09 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -135.21 129.9 34.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 3.4399999999999999 110.833 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -108.8 106.18 16.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 4.3300000000000001 110.888 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.45 82.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 5.7599999999999998 110.845 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -51.33 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 8.2599999999999998 110.843 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.92 28.83 5.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 4.6399999999999997 110.853 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -95.04 -80.97 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 4.5599999999999996 110.895 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 174.27 134.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 5.5899999999999999 110.867 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 95.27 5.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 7.9199999999999999 110.917 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 2.6 m -157.04 120.32 4.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 3.9199999999999999 111.117 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.5 t -111.5 65.38 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 4.6699999999999999 111.169 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -88.47 -68.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 10.800000000000001 110.866 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.81 -43.32 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 4.0599999999999996 110.909 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -155.59 -112.76 0.42 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.751 . . . . 4.7999999999999998 112.469 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 40.63 -133.99 2.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 3.6099999999999999 112.475 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.49 97.05 9.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 2.9500000000000002 111.16 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.8 111.44 23.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 4.3899999999999997 110.899 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 13.2 tp -51.45 -31.44 23.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 5.7199999999999998 110.918 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.96 -68.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 5.0700000000000003 110.871 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.6 mp -76.89 -36.83 56.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 4.9400000000000004 110.876 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 70.2 m -54.56 -45.8 73.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 1.8799999999999999 111.173 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.5 -44.65 76.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 2.1499999999999999 111.101 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 29.4 t -51.35 -49.88 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 1.72 111.171 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -55.29 -33.77 63.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 3.25 110.832 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.52 -40.71 61.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 110.885 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 42.9 mm -50.78 -47.48 28.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 2.4300000000000002 111.116 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.98 -23.99 70.44 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 1.1599999999999999 112.495 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -49.44 70.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 3.8900000000000001 110.869 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 43.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 2.27 110.828 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.3 mt -144.33 -42.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 3.54 110.923 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 168.71 -38.0 0.21 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.787 -0.72 . . . . 2.3300000000000001 112.529 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.19 177.91 7.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 4.1200000000000001 110.922 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.42 -77.62 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.729 . . . . 3.48 112.477 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -143.11 113.98 7.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.865 0.364 . . . . 1.8300000000000001 110.866 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.1 t -92.35 -78.16 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 5.2400000000000002 110.902 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.4 t 176.85 -33.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 5.0999999999999996 110.853 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -49.55 108.13 0.92 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 2.4199999999999999 110.85 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.9 Cg_endo -69.79 167.78 23.48 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.688 2.259 . . . . 1.75 112.329 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.65 29.82 6.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 5.1699999999999999 110.931 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.73 -174.61 2.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 2.3300000000000001 111.101 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.56 -4.1 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 3.6899999999999999 111.112 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.6 tpt -83.25 -41.66 18.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 4.6100000000000003 110.849 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.32 149.83 6.91 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.659 0.742 . . . . 4.8399999999999999 110.893 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -7.23 20.5 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.685 2.256 . . . . 2.7200000000000002 112.351 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.7 t -84.86 138.01 32.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 3.6299999999999999 111.139 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -66.25 145.44 55.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 5.25 110.892 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.88 102.39 15.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 5.6299999999999999 110.888 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -91.8 44.37 1.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 7.1600000000000001 110.941 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.18 177.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 4.5700000000000003 111.141 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.79 126.26 26.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 3.1400000000000001 110.836 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 25.0 pt -76.42 -30.28 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 4.2699999999999996 111.106 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -65.86 -39.57 90.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 5.8899999999999997 110.853 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.6 t -94.71 -4.77 46.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 4.4199999999999999 111.116 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -51.84 144.18 11.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 6.3799999999999999 110.887 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -175.05 151.45 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 4.0700000000000003 110.857 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.45 145.3 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 3.1000000000000001 110.932 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.42 -172.24 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 4.1799999999999997 110.849 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 65.56 161.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 4.4800000000000004 111.118 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -22.89 51.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 3.2000000000000002 110.903 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -51.32 -29.75 16.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 3.6400000000000001 110.888 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 8.2 tt -50.74 -29.65 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 3.2400000000000002 111.164 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -92.34 -31.16 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 7.8499999999999996 110.827 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.06 -16.86 60.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.778 -0.725 . . . . 1.8500000000000001 112.494 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 8.4 tp -93.33 -31.47 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.776 0.322 . . . . 1.99 111.121 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -78.43 -48.2 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 5.4000000000000004 110.912 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.41 -47.24 43.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 2.79 110.876 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 56.04 93.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.514 . . . . 3.5299999999999998 110.907 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.68 34.32 1.28 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 11.300000000000001 110.894 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 119.128 -0.818 . . . . 10.09 112.496 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.812 0.339 . . . . 8.8000000000000007 110.835 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -109.45 148.84 30.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 10.15 110.938 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.2 mm -129.82 159.12 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 3.8300000000000001 111.109 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.99 142.28 27.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 2.9900000000000002 111.153 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -127.56 152.43 47.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 7.0 110.889 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -161.88 133.79 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 5.4100000000000001 110.904 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 86.8 mt -108.12 144.06 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 3.7200000000000002 111.122 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -108.96 -76.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 4.7599999999999998 110.881 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.81 -178.28 4.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 6.5599999999999996 110.9 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -140.85 163.23 33.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 6.1799999999999997 110.916 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.0 m -73.73 131.34 82.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.528 0.68 . . . . 3.9100000000000001 111.142 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -34.87 13.73 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.702 2.268 . . . . 2.6299999999999999 112.366 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -50.49 -53.73 27.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 4.9699999999999998 110.848 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 19.6 mmt -101.33 154.6 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 4.4900000000000002 110.888 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -59.1 149.09 28.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 3.6099999999999999 110.899 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -58.5 -20.87 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 5.4299999999999997 110.888 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.24 -37.28 61.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 3.7999999999999998 110.909 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -61.62 -52.2 65.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 3.0499999999999998 110.886 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.43 -30.0 43.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 1.8799999999999999 111.149 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.42 -48.73 47.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 3.3900000000000001 110.871 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -75.36 -33.56 61.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.461 . . . . 4.1299999999999999 110.925 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.45 -58.8 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 1.96 111.103 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 pp -68.34 -28.01 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 5.1500000000000004 111.107 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.61 -51.0 52.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 5.46 110.908 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -78.63 -32.07 47.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 3.9300000000000002 110.936 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.85 65.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 2.1699999999999999 111.111 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -73.96 -28.38 61.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 6.0 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.07 -51.34 9.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 4.29 110.913 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.9 p -51.15 -29.84 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 3.3599999999999999 111.141 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -85.91 -51.38 6.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 4.6600000000000001 110.918 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.6 p -60.98 -17.23 50.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 2.3300000000000001 110.894 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -50.4 -30.69 12.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 4.0300000000000002 110.936 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.6 m -133.39 36.42 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 2.9300000000000002 111.069 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.08 132.96 9.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.566 0.698 . . . . 2.5699999999999998 111.148 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 64.9 1.79 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.712 2.274 . . . . 2.1200000000000001 112.316 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mp -121.1 150.05 41.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 4.1399999999999997 110.899 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.0 174.34 6.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 5.4299999999999997 110.893 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -112.57 126.09 54.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 10.06 110.903 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.5 t -133.38 89.99 2.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 2.9199999999999999 110.869 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -81.75 121.94 27.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 3.3799999999999999 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.0 mt -137.48 113.21 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 4.2699999999999996 111.127 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.07 -28.92 27.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 4.0800000000000001 110.844 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 94.9 m -160.73 110.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 4.7999999999999998 111.13 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -173.32 -134.15 1.78 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.758 . . . . 2.3500000000000001 112.466 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 120.51 42.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.321 . . . . 6.29 110.89 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.94 129.41 43.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 2.6600000000000001 111.084 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.06 -18.73 28.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 2.4100000000000001 110.866 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.82 127.04 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 4.25 111.133 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.24 166.38 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 3.8999999999999999 110.938 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.24 110.09 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 4.2199999999999998 111.074 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.66 174.71 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 3.0600000000000001 111.123 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -106.78 125.06 50.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 6.29 110.904 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -125.71 148.34 49.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 2.48 111.12 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.63 111.57 13.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 5.4699999999999998 110.853 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.61 -139.56 16.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 1.6399999999999999 112.457 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.06 111.09 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 2.96 111.135 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -92.29 43.69 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 3.7999999999999998 110.823 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.83 95.53 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.721 -0.752 . . . . 3.0099999999999998 112.487 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.4 41.79 7.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.819 0.342 . . . . 6.3399999999999999 110.87 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.12 -168.81 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 4.4199999999999999 110.919 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -76.9 102.95 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 5.4000000000000004 110.853 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.73 112.3 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 2.0699999999999998 111.093 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -70.01 -168.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 7.29 110.868 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -131.95 -41.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 4.6900000000000004 110.915 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 123.22 -172.42 16.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 2.7000000000000002 112.504 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.06 118.8 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.331 . . . . 5.8700000000000001 110.883 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.62 -47.34 1.05 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 2.54 112.485 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -88.86 -121.01 1.83 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.717 -0.754 . . . . 1.53 112.477 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.32 148.51 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 4.5 111.152 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -29.55 7.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 4.6399999999999997 110.935 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.69 123.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 2.5 111.096 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -94.97 162.94 13.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 3.9700000000000002 110.891 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -173.23 105.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 1.8799999999999999 111.048 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.88 170.19 4.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 3.8399999999999999 110.867 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.09 165.87 1.13 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 1.45 112.458 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 165.24 31.71 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 1.03 112.367 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.04 -136.44 5.03 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 1.3799999999999999 112.47 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.89 121.26 44.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 4.29 110.832 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.21 -62.93 2.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.756 . . . . 1.98 112.505 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.7 mt -93.95 21.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 3.1800000000000002 111.138 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.7 -106.99 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 2.7200000000000002 112.483 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -92.07 37.66 3.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 2.3399999999999999 112.493 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -50.77 126.06 14.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.794 0.33 . . . . 2.1000000000000001 110.89 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.86 145.97 28.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 2.5299999999999998 111.098 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -139.79 107.69 5.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 4.0499999999999998 110.829 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -143.82 108.52 4.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 4.2800000000000002 110.883 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 t70 179.38 -82.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 8.2200000000000006 110.832 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.41 153.57 28.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 7.7300000000000004 110.913 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 64.69 125.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 6.4699999999999998 110.905 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 63.57 70.45 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 4.5700000000000003 110.909 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -45.78 157.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 6.3099999999999996 110.87 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -105.35 175.05 5.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 8.3699999999999992 110.905 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.28 173.44 16.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 2.0600000000000001 111.144 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -171.51 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 2.73 111.142 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -67.01 -21.76 65.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 6.1200000000000001 110.876 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.6 m -103.62 -24.71 13.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 2.9199999999999999 110.812 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -62.48 -160.43 0.18 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 3.02 112.503 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -60.6 -101.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 2.25 112.492 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.4 t -80.42 103.57 10.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 4.5300000000000002 111.105 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.512 ' ND2' ' H ' ' A' ' 243' ' ' VAL . 9.8 m-20 -50.38 116.37 1.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 3.71 110.929 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 11.5 tp -60.76 -39.29 88.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 4.0700000000000003 110.954 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -34.7 68.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 6.7699999999999996 110.881 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -55.07 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 3.98 110.944 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 98.4 m -54.97 -38.47 67.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 2.23 111.151 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.14 -32.25 61.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 2.04 111.086 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.0 t -70.64 -25.53 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 2.04 111.135 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -69.57 -61.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 3.1200000000000001 110.868 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.99 -50.02 75.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 4.7199999999999998 110.869 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 72.1 mt -51.42 -29.52 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 2.98 111.161 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.56 -44.36 16.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 0.80000000000000004 112.492 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.59 -34.33 76.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 3.6299999999999999 110.83 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -28.91 18.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 3.2000000000000002 110.903 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.3 mp -93.73 -24.64 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 2.6200000000000001 110.923 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 126.38 105.49 1.43 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 2.3599999999999999 112.489 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.37 -68.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 3.6499999999999999 110.866 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 73.31 31.59 61.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 3.4199999999999999 112.468 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 21.6 m80 64.47 155.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 2.2200000000000002 110.877 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 59.4 m -124.84 -78.14 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 4.8099999999999996 110.86 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.16 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 5.2699999999999996 110.884 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -47.44 106.64 0.62 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.577 0.703 . . . . 3.2999999999999998 110.865 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.3 21.94 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 2.1299999999999999 112.359 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.0 mptt 50.65 29.96 4.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 6.3499999999999996 110.934 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -130.59 -168.88 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 2.5800000000000001 111.101 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.3 t -50.42 -57.26 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 5.3499999999999996 111.13 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 9.8 mmt -59.41 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 4.0800000000000001 110.875 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.72 99.62 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.651 0.739 . . . . 5.7599999999999998 110.915 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 77.95 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.693 2.262 . . . . 4.0 112.283 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.4 p -145.46 125.53 13.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 3.7200000000000002 111.116 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -62.77 126.39 27.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 5.4400000000000004 110.875 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -150.69 92.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 5.0700000000000003 110.89 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -58.68 127.29 31.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 4.6200000000000001 110.91 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.512 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 7.6 p -135.97 154.32 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 3.5699999999999998 111.167 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.19 113.15 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 2.8199999999999998 110.835 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.0 tt -74.28 -34.5 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 3.3900000000000001 111.163 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -24.02 67.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 3.1099999999999999 110.914 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 14.6 19.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 3.5 111.168 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -51.36 156.97 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 6.4000000000000004 110.879 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -178.67 148.15 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 4.2800000000000002 110.88 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.14 161.11 2.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 3.7999999999999998 110.893 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.93 150.76 22.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 5.2400000000000002 110.874 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.96 -68.34 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 4.4299999999999997 111.106 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -53.31 -36.91 61.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 3.6000000000000001 110.853 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -70.96 -29.23 65.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 3.27 110.838 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -51.09 -28.6 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 2.6000000000000001 111.111 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -77.78 -37.19 49.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 6.2400000000000002 110.853 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -78.63 57.11 4.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 2.6600000000000001 112.488 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 4.9 tp -179.16 -40.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 2.1200000000000001 111.17 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -75.03 -45.07 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 3.5600000000000001 110.908 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.15 -47.2 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 3.0899999999999999 110.827 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.3 tp 51.16 30.58 5.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 3.7599999999999998 110.944 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -126.55 -59.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 11.23 110.946 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 119.146 -0.808 . . . . 10.66 112.505 179.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.1 m80 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.846 0.355 . . . . 8.5600000000000005 110.823 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -114.77 142.77 46.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 10.33 110.92 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.71 147.89 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 3.7599999999999998 111.134 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.8 p -130.01 148.07 51.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 2.9700000000000002 111.128 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -145.57 173.28 12.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 4.4500000000000002 110.962 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -160.5 125.89 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 8.7100000000000009 110.838 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.6 pt -108.17 121.63 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 4.0700000000000003 111.138 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -136.11 47.92 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 4.1600000000000001 110.88 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -137.5 153.23 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 6.6500000000000004 110.867 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -147.4 163.15 37.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 8.6600000000000001 110.883 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 p -125.37 151.72 70.3 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.712 . . . . 3.1899999999999999 111.155 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 169.08 19.75 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.713 2.276 . . . . 3.1800000000000002 112.337 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.1 t70 75.65 -52.06 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 6.0300000000000002 110.824 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -97.66 132.91 42.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 4.5899999999999999 110.895 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.99 155.75 10.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 4.0800000000000001 110.879 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.06 -23.12 12.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 5.9699999999999998 110.851 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -41.01 84.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 3.8999999999999999 110.91 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.36 -54.67 44.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 2.6000000000000001 110.874 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.21 -40.66 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 1.8300000000000001 111.111 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.13 -40.83 61.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 3.2999999999999998 110.875 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -74.61 -31.08 61.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 4.0700000000000003 110.932 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.24 -52.46 35.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 2.3199999999999998 111.096 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.02 -28.52 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 3.3300000000000001 111.152 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -50.98 -55.08 19.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 7.6799999999999997 110.869 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -78.25 -25.94 47.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 4.6600000000000001 110.874 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.82 -37.26 68.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 1.9399999999999999 111.1 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -27.03 61.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 4.6900000000000004 110.852 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.97 -48.81 13.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 3.9300000000000002 110.886 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.6 p -55.8 -27.07 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 3.0899999999999999 111.115 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -91.1 -54.37 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 11.48 110.933 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.5 p -59.22 -18.4 36.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 2.1600000000000001 110.841 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.2 -26.66 61.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 3.2000000000000002 110.921 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.85 -23.87 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 4.6799999999999997 111.114 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.57 145.26 30.67 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.56 0.695 . . . . 2.5699999999999998 111.15 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.58 23.97 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.676 2.251 . . . . 1.9099999999999999 112.308 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -51.6 158.2 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 3.8900000000000001 110.881 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.23 138.71 52.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 6.9199999999999999 110.918 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -101.54 139.25 37.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 7.6699999999999999 110.871 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.0 90.04 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 2.1600000000000001 110.849 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -77.81 122.77 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 4.8300000000000001 110.889 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 15.7 pt -140.18 163.79 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 3.5 111.14 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -109.59 28.9 8.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 3.7599999999999998 110.888 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.6 t -157.65 174.05 15.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 4.2000000000000002 111.145 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.62 -173.62 12.15 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.74 . . . . 2.0800000000000001 112.507 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.46 166.34 10.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 6.3300000000000001 110.873 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -144.62 146.94 32.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 2.1600000000000001 111.113 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -26.65 68.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 2.4399999999999999 110.879 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.8 mm -104.04 109.9 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 3.6800000000000002 111.173 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.22 119.35 38.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 2.3300000000000001 110.94 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.0 t -108.61 109.9 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 2.6400000000000001 111.129 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 72.2 t -134.35 144.97 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 2.1099999999999999 111.134 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -92.22 153.17 19.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 5.21 110.895 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.33 178.02 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 1.95 111.118 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -145.04 111.54 5.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 6.2000000000000002 110.9 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 63.73 -147.67 50.67 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.712 -0.756 . . . . 1.3899999999999999 112.504 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.54 112.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 2.0899999999999999 111.105 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -95.66 27.95 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 3.71 110.812 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.52 18.21 60.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 2.8399999999999999 112.46 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -106.61 -74.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.763 0.316 . . . . 6.9299999999999997 110.89 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.19 -65.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 5.3899999999999997 110.882 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -77.39 107.09 9.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 6.25 110.868 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.32 159.64 23.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 1.9199999999999999 111.118 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.84 113.83 2.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 8.0 110.818 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.96 -169.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 7.4699999999999998 110.907 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.99 97.82 2.11 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 3.3500000000000001 112.477 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -51.67 119.19 3.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 4.1500000000000004 110.859 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.19 7.05 62.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 2.2999999999999998 112.475 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -114.76 -126.39 4.19 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 1.6399999999999999 112.538 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 mp -89.16 93.9 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 3.79 111.129 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.8 pp -49.9 -26.9 4.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 4.0199999999999996 110.858 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 179.5 171.49 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 2.2000000000000002 111.107 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -160.14 106.26 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 4.0800000000000001 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -110.75 109.84 20.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 1.79 111.087 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.06 169.65 4.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 4.25 110.927 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.39 173.8 0.25 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 1.1499999999999999 112.443 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 179.62 3.58 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.689 2.259 . . . . 0.93000000000000005 112.353 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 154.12 -128.79 2.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 1.3600000000000001 112.529 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.08 141.12 52.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.927 0.394 . . . . 2.46 110.85 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.5 -76.54 0.95 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.721 . . . . 1.3 112.504 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.1 tt -104.92 16.41 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 4.04 111.13 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.88 -77.58 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 2.8300000000000001 112.473 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.94 2.22 81.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.775 -0.726 . . . . 2.3300000000000001 112.479 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.51 127.42 17.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.785 0.326 . . . . 2.21 110.873 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.87 146.39 50.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 2.8100000000000001 111.088 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -113.76 149.89 34.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 7.7599999999999998 110.834 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.97 147.56 44.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 5.5999999999999996 110.889 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.74 -35.84 10.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 5.6200000000000001 110.84 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 63.28 -82.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 7.75 110.853 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -134.87 35.21 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 6.4699999999999998 110.868 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.8 -5.58 6.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 4.5099999999999998 110.865 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.17 73.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 9.8100000000000005 110.87 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -105.36 124.62 49.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 10.98 110.96 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.47 153.45 27.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 3.1600000000000001 111.167 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.8 -172.51 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 2.54 111.148 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -50.27 -48.32 54.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 5.2999999999999998 110.826 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.5 p -76.82 -38.03 54.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 3.46 110.857 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.77 172.11 0.28 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 3.0600000000000001 112.494 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.45 -85.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 2.0600000000000001 112.472 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 88.3 m -79.36 98.34 6.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.815 0.341 . . . . 3.21 111.167 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -51.14 115.48 1.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 4.21 110.914 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -35.28 38.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 3.98 110.9 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -72.33 -53.6 11.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 6.5999999999999996 110.86 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 10.6 tp -51.86 -47.75 64.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 3.9199999999999999 110.933 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.38 -51.23 67.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 1.99 111.154 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.59 -48.88 74.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 1.9399999999999999 111.132 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.5 -20.49 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 1.9199999999999999 111.139 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -74.33 -46.25 42.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 3.52 110.891 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.75 -23.46 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 5.4800000000000004 110.859 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 21.7 mm -65.56 -52.08 55.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 2.46 111.118 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.96 -25.69 66.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 0.76000000000000001 112.438 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -51.33 70.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 3.54 110.887 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.26 46.14 1.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 2.1099999999999999 110.861 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 mt -156.12 22.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 2.8799999999999999 110.913 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.27 5.28 89.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 1.78 112.487 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 19.4 tp -120.27 68.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 4.3600000000000003 110.906 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -86.05 -101.83 0.74 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.765 -0.731 . . . . 3.7000000000000002 112.443 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -118.46 153.61 33.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.338 . . . . 2.29 110.858 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.3 m -135.86 -75.91 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 4.9800000000000004 110.844 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.62 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 4.3399999999999999 110.864 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -49.28 108.27 0.94 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.577 0.703 . . . . 3.3999999999999999 110.853 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 233' ' ' LYS . 53.7 Cg_endo -69.76 -179.82 3.18 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.658 2.238 . . . . 1.8600000000000001 112.337 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.53 42.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 5.5199999999999996 110.897 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -128.91 -175.78 3.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 2.4199999999999999 111.117 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 43.0 t -93.05 -17.72 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 3.7999999999999998 111.117 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -82.23 -41.53 20.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 5.9100000000000001 110.887 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -51.54 136.4 33.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.668 0.747 . . . . 5.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 77.77 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.258 . . . . 2.5899999999999999 112.355 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.0 p -156.92 160.36 39.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 3.3599999999999999 111.154 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -127.05 113.2 16.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 5.2199999999999998 110.952 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.02 128.41 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.467 . . . . 4.0499999999999998 110.919 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -51.71 121.95 7.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 4.5800000000000001 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.18 148.8 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 3.5699999999999998 111.168 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -54.98 113.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 4.0999999999999996 110.87 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.3 pp -76.75 -31.27 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 3.6699999999999999 111.117 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -36.04 78.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 3.1400000000000001 110.868 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 21.0 p -104.71 24.69 11.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 3.9300000000000002 111.155 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -51.78 134.34 30.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 6.9000000000000004 110.929 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -178.54 136.47 0.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 5.1600000000000001 110.838 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.65 152.7 3.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 3.0699999999999998 110.887 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.54 -170.95 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 3.7799999999999998 110.889 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 69.18 157.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 4.8399999999999999 111.079 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.27 -24.9 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 2.77 110.883 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -50.78 -29.9 12.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 3.04 110.83 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.24 -29.67 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 2.8999999999999999 111.123 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -83.1 -24.8 32.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 6.3899999999999997 110.852 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -81.42 -44.85 7.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.815 -0.707 . . . . 2.54 112.479 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 5.7 tp -54.58 -36.93 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 1.76 111.089 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -77.04 -49.72 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 3.48 110.913 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 57.7 m -59.37 -27.27 65.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 3.7799999999999998 110.83 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.7 mp -57.18 -25.92 59.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.104 -0.498 . . . . 4.1799999999999997 110.916 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -52.06 135.03 31.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 14.609999999999999 110.908 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 CA-C-O 119.127 -0.818 . . . . 12.01 112.467 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.857 0.36 . . . . 9.9900000000000002 110.807 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -123.31 142.57 50.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 11.49 110.95 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.01 145.62 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 3.6600000000000001 111.174 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.51 134.56 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 3.1400000000000001 111.138 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -134.4 147.26 50.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 5.2999999999999998 110.903 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -153.06 152.63 31.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 4.79 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.39 144.59 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 3.7999999999999998 111.109 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -142.78 20.03 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 4.4199999999999999 110.886 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -122.44 157.7 31.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 6.9299999999999997 110.91 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.92 106.41 3.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 8.3000000000000007 110.916 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.3 m -70.66 120.0 76.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.598 0.713 . . . . 4.6699999999999999 111.115 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -48.38 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.702 2.268 . . . . 2.6499999999999999 112.341 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -23.44 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 4.8200000000000003 110.906 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 23.8 mmt -124.77 -174.56 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 4.21 110.912 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.9 162.06 17.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 3.46 110.88 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -74.61 -20.91 59.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 7.29 110.891 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.51 -54.44 5.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 5.0599999999999996 110.864 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -55.31 -40.18 70.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 4.0599999999999996 110.886 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -74.35 -37.16 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 2.1200000000000001 111.121 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -62.68 -55.16 29.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 3.0099999999999998 110.878 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -65.89 -31.92 73.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 4.6299999999999999 110.933 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.94 -41.86 59.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 1.9399999999999999 111.105 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.6 mm -79.31 -43.16 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 3.4900000000000002 111.169 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.24 -30.25 49.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 4.5700000000000003 110.91 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -78.49 -27.3 46.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 4.0700000000000003 110.844 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.69 -33.03 63.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 2.5699999999999998 111.121 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -73.85 -25.8 60.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 4.7000000000000002 110.905 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -79.08 -52.79 7.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 2.9700000000000002 110.935 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.14 -42.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 2.98 111.098 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -75.54 -43.59 47.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 5.3799999999999999 110.925 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.0 t -62.6 -15.07 49.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 2.6699999999999999 110.894 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.34 -23.13 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 2.7999999999999998 110.883 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -32.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 3.6400000000000001 111.084 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.09 150.16 39.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.573 0.701 . . . . 3.5600000000000001 111.127 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -53.41 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.69 2.26 . . . . 3.2799999999999998 112.359 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tp 46.55 -165.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 4.8099999999999996 110.858 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.61 131.14 11.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 4.3700000000000001 110.862 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -115.47 144.93 43.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 7.5099999999999998 110.908 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.8 t -156.99 90.76 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 2.6299999999999999 110.853 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -91.11 107.13 19.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 3.6000000000000001 110.878 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.89 139.57 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 3.3799999999999999 111.098 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -64.27 -24.02 67.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 3.73 110.914 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.7 m -138.06 148.91 45.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.462 . . . . 3.6499999999999999 111.147 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.83 -173.28 19.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.756 -0.735 . . . . 1.8300000000000001 112.458 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.8 mtt -110.65 145.87 37.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 6.1399999999999997 110.843 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.43 130.05 36.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 2.1200000000000001 111.114 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.26 -22.6 66.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 3.54 110.864 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.0 mm -104.18 84.36 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 3.6699999999999999 111.164 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.34 115.24 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 2.6299999999999999 110.887 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.88 110.88 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 2.2400000000000002 111.126 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.3 t -138.97 139.96 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 2.6000000000000001 111.136 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -82.48 122.87 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 4.6500000000000004 110.87 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.99 178.38 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 2.5600000000000001 111.08 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -145.18 126.93 15.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 9.25 110.862 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.0 -134.1 32.04 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.752 -0.737 . . . . 1.79 112.516 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.62 113.42 20.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 2.9300000000000002 111.075 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -90.87 154.04 19.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 3.9199999999999999 110.89 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.96 -14.0 54.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 3.4100000000000001 112.483 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.22 23.5 5.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.774 0.321 . . . . 7.5700000000000003 110.865 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.0 t70 63.4 52.94 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 6.6500000000000004 110.865 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -127.59 79.68 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 5.5800000000000001 110.826 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.39 129.05 34.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 2.5 111.082 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.09 173.08 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 11.83 110.903 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -125.58 -2.5 7.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 6.0700000000000003 110.866 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 77.36 148.1 2.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 2.9500000000000002 112.501 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.41 153.71 2.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 6.9100000000000001 110.901 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.74 -1.41 87.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.737 -0.744 . . . . 3.0600000000000001 112.452 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.37 -141.27 3.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 2.8300000000000001 112.453 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.47 91.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 3.8700000000000001 111.127 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.8 pp -48.28 -29.49 3.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 4.04 110.912 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.62 178.0 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 2.9900000000000002 111.162 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -153.03 130.14 11.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 5.25 110.83 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -116.94 119.88 36.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 1.6399999999999999 111.106 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.38 165.27 9.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 3.8900000000000001 110.83 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.25 173.14 0.28 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.734 -0.746 . . . . 0.93000000000000005 112.495 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -169.53 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.617 2.212 . . . . 1.24 112.344 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.12 -146.13 16.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 1.3700000000000001 112.437 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.4 m -94.69 154.54 17.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 2.3700000000000001 110.867 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.62 -103.81 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 1.55 112.447 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.23 -23.8 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 2.8399999999999999 111.141 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -57.0 99.61 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.775 -0.726 . . . . 2.5899999999999999 112.514 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 113.62 -12.08 23.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 1.99 112.46 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -49.96 145.35 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.356 . . . . 2.6400000000000001 110.826 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -131.97 135.3 46.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 1.6299999999999999 111.082 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -124.76 117.86 25.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 3.79 110.854 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -100.98 101.76 12.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 4.21 110.838 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 50.63 93.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 5.7199999999999998 110.868 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.59 87.08 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 9.4900000000000002 110.882 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 34.3 t70 64.5 15.3 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 3.3799999999999999 110.876 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.72 -78.09 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 4.4699999999999998 110.885 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 178.41 124.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 5.4900000000000002 110.913 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -102.03 137.78 39.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 8.3800000000000008 110.928 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.11 169.05 25.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 2.8399999999999999 111.16 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.31 173.89 10.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 2.6200000000000001 111.161 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -50.55 -30.31 12.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 6.0599999999999996 110.858 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.04 -37.63 17.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 3.02 110.851 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -56.45 -178.03 0.37 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.703 -0.76 . . . . 3.8900000000000001 112.478 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.96 -64.18 3.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.765 -0.731 . . . . 3.0899999999999999 112.511 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.73 102.13 13.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 2.23 111.149 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -59.91 95.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 4.7000000000000002 110.865 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.68 -32.83 70.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 4.0300000000000002 110.934 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -66.56 -64.32 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 7.0800000000000001 110.868 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.16 -46.68 87.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 3.6800000000000002 110.916 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 74.3 m -54.49 -26.28 30.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 1.8 111.18 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.08 -42.73 75.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 1.8500000000000001 111.083 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.5 t -59.38 -46.88 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 1.8799999999999999 111.17 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -53.61 -31.83 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 3.3700000000000001 110.838 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -74.75 -42.9 57.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 5.5700000000000003 110.845 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 46.1 mm -51.1 -44.74 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 2.5 111.115 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.99 -32.66 52.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 1.0800000000000001 112.479 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -36.67 81.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 4.1399999999999997 110.853 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.98 29.06 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 3.04 110.861 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.0 mt -139.7 -52.69 0.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 3.3599999999999999 110.945 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -176.41 -151.0 8.53 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.739 . . . . 2.2599999999999998 112.497 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 68.69 -75.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 3.9900000000000002 110.928 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 110.88 -74.39 0.21 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 3.27 112.509 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -170.99 84.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 2.6400000000000001 110.853 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.15 171.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 4.6699999999999999 110.836 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -25.18 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 4.7800000000000002 110.828 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.6 108.74 1.1 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.595 0.712 . . . . 2.2599999999999998 110.808 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 162.19 43.02 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 2.46 112.336 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 58.36 22.56 9.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 6.3399999999999999 110.87 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -111.19 158.59 18.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 2.4300000000000002 111.071 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.86 -23.93 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 4.25 111.157 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -49.46 22.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 5.0300000000000002 110.881 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -52.34 136.68 40.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.65 0.738 . . . . 5.0300000000000002 110.859 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 93.9 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.685 2.257 . . . . 3.0800000000000001 112.323 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.9 t -156.96 153.38 27.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 4.2400000000000002 111.158 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -110.55 125.86 53.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 5.1500000000000004 110.908 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.03 96.25 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 5.1500000000000004 110.841 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -49.9 122.76 6.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 5.0999999999999996 110.953 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.3 p -120.22 153.49 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 3.6499999999999999 111.123 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.51 137.03 42.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 4.3200000000000003 110.911 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.07 -26.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 4.1299999999999999 111.111 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -64.9 -39.36 93.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 4.8499999999999996 110.88 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 -10.85 24.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 4.7699999999999996 111.105 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.58 120.51 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 5.1299999999999999 110.89 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 175.64 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 4.9199999999999999 110.917 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.29 150.98 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 3.21 110.867 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.83 -172.04 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 4.1799999999999997 110.868 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 66.59 165.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 4.7599999999999998 111.083 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -20.4 62.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 3.0899999999999999 110.892 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -51.07 -29.99 14.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 3.3599999999999999 110.825 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.2 -29.63 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 3.1600000000000001 111.156 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 35.8 mtt85 -90.95 -33.83 15.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 7.5 110.855 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.44 -25.8 21.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 2.0099999999999998 112.49 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.5 tp -87.45 -29.17 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.767 0.318 . . . . 2.4300000000000002 111.14 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -79.37 -37.75 36.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 3.8900000000000001 110.951 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.6 t -86.97 -32.88 19.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 3.0099999999999998 110.853 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.8 mp 54.18 87.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 5.3799999999999999 110.886 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -157.41 163.1 38.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 10.779999999999999 110.959 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 119.126 -0.819 . . . . 10.039999999999999 112.471 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 48.5 m80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.79 0.329 . . . . 18.07 110.819 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -125.03 149.24 47.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 14.44 110.949 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.64 152.52 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 5.4500000000000002 111.071 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.63 116.91 27.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 3.3300000000000001 111.138 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.51 136.27 37.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 8.7100000000000009 110.889 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -127.9 119.21 25.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 9.7899999999999991 110.878 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.9 pt -107.99 148.28 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 4.0899999999999999 111.146 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -157.16 22.86 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 4.1100000000000003 110.856 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -142.03 153.87 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 5.1299999999999999 110.924 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -114.67 163.05 15.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 5.7000000000000002 110.933 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 86.1 m -120.29 133.86 24.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.598 0.713 . . . . 3.46 111.124 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -177.6 1.97 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.69 2.26 . . . . 3.1499999999999999 112.33 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 72.39 -68.64 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 4.5999999999999996 110.836 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.88 147.7 25.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 5.2599999999999998 110.857 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -59.36 168.15 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 3.75 110.907 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.06 -22.46 50.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 7.0199999999999996 110.849 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -63.29 -44.05 96.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 4.4000000000000004 110.928 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -60.15 -53.3 59.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 3.9500000000000002 110.856 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.76 -29.57 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 1.9099999999999999 111.117 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.3 -53.48 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 3.4500000000000002 110.826 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -69.97 -33.45 72.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 5.1299999999999999 110.933 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.01 -59.25 4.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 1.8700000000000001 111.148 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 pt -63.48 -28.36 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 4.4699999999999998 111.101 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -51.1 -59.29 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 6.6200000000000001 110.874 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -21.44 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 4.25 110.885 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.2 -54.75 39.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 2.2200000000000002 111.106 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -23.27 65.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 7.3899999999999997 110.875 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.04 -28.14 43.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 4.1799999999999997 110.921 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 90.0 t -68.45 -30.22 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 3.0 111.152 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -93.31 -52.89 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 4.8200000000000003 110.891 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 p -55.14 -23.04 19.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 2.6600000000000001 110.817 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.51 -23.64 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 4.4000000000000004 110.873 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.8 p -125.01 21.65 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 4.8300000000000001 111.134 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 134.13 25.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.586 0.707 . . . . 2.9100000000000001 111.117 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -25.56 28.61 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.703 2.269 . . . . 1.8899999999999999 112.352 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.91 109.57 0.34 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 4.5599999999999996 110.895 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -121.99 129.6 52.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 6.0700000000000003 110.852 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -138.02 154.27 49.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 13.880000000000001 110.867 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.19 126.37 49.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 4.2599999999999998 110.903 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -57.87 154.62 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 4.75 110.9 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.36 116.73 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 4.4199999999999999 111.127 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -39.24 58.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 4.4699999999999998 110.87 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.5 m -140.6 109.63 6.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 3.5499999999999998 111.129 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 162.48 -156.12 27.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 1.96 112.532 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -110.88 157.38 19.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 5.8899999999999997 110.872 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -133.28 153.63 51.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 2.1000000000000001 111.088 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.62 -25.64 27.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 3.1200000000000001 110.869 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.5 mt -121.39 137.41 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 3.29 111.113 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -117.21 120.64 38.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 2.23 110.904 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.1 t -96.3 121.68 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 2.75 111.1 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.9 t -147.87 141.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 2.5699999999999998 111.088 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -99.67 135.59 40.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 4.8499999999999996 110.863 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.63 133.18 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 2.21 111.075 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.33 156.69 18.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 6.3499999999999996 110.866 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.62 -137.27 31.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 1.3100000000000001 112.507 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.81 130.29 34.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 2.1600000000000001 111.107 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -88.58 6.96 35.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 3.7799999999999998 110.909 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.81 -17.35 55.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 2.54 112.481 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.37 33.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 5.6600000000000001 110.858 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.43 -167.75 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 4.6699999999999999 110.856 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -76.3 100.84 5.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 7.6600000000000001 110.858 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.5 128.44 28.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 2.3599999999999999 111.078 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -101.51 -168.98 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 7.3300000000000001 110.929 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -139.22 -41.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 4.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.33 -127.69 8.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 3.46 112.487 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -51.77 119.06 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.814 0.34 . . . . 4.4299999999999997 110.922 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.32 -33.52 5.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.715 -0.755 . . . . 3.0 112.515 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -109.63 -137.35 7.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.742 . . . . 2.5099999999999998 112.497 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.2 mm -72.1 135.82 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.348 . . . . 2.7999999999999998 111.155 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.62 -27.24 14.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 5.54 110.882 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.26 124.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 2.5800000000000001 111.038 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -117.3 171.53 7.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 3.96 110.861 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -176.95 110.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 1.8899999999999999 111.085 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.57 157.08 24.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 3.8399999999999999 110.863 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.18 178.33 0.23 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 1.28 112.477 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -172.99 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.656 2.237 . . . . 1.26 112.355 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 136.49 -127.59 4.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 2.0800000000000001 112.524 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.23 130.6 52.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 3.3300000000000001 110.855 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.22 -73.99 1.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.727 -0.749 . . . . 1.96 112.505 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 23.4 mt -82.92 -4.12 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 3.6800000000000002 111.13 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.4 117.61 9.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 2.4100000000000001 112.508 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.31 -7.64 74.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.786 -0.721 . . . . 2.2200000000000002 112.459 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.53 139.23 16.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 2.1400000000000001 110.868 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -117.15 140.12 49.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 1.8100000000000001 111.112 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.07 110.62 12.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 4.9299999999999997 110.842 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -116.48 111.74 20.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 4.0300000000000002 110.919 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.53 119.67 3.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 6.8700000000000001 110.816 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -50.13 -72.6 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 8.0800000000000001 110.889 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.11 87.69 4.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 5.3499999999999996 110.855 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -125.51 -82.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 4.25 110.889 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 172.65 81.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 6.0300000000000002 110.907 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -106.64 113.43 26.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 7.4699999999999998 110.926 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.4 m -156.85 133.28 9.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 3.7200000000000002 111.084 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.1 t -107.36 69.34 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 4.5300000000000002 111.128 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.74 -70.72 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 10.119999999999999 110.887 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.7 m -117.38 -73.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 4.3300000000000001 110.885 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.27 -1.73 0.76 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 7.0599999999999996 112.521 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.01 -160.89 0.17 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 4.3799999999999999 112.495 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.12 95.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.799 0.333 . . . . 2.7200000000000002 111.147 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.32 150.12 24.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 3.1099999999999999 110.874 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.5 mt -54.95 -44.73 74.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 3.5299999999999998 110.942 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -73.08 -37.17 66.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 6.5800000000000001 110.901 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 24.3 tp -64.75 -60.65 2.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 4.2199999999999998 110.909 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.5 m -57.47 -40.59 78.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 2.0800000000000001 111.144 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.44 -51.78 67.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 1.78 111.11 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 73.5 t -51.6 -42.35 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 2.1299999999999999 111.162 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -56.82 -47.93 79.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 3.4399999999999999 110.833 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -65.21 -41.97 93.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 4.6200000000000001 110.91 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 85.5 mt -58.62 -32.4 46.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 2.8799999999999999 111.115 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.93 -36.82 40.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 1.1100000000000001 112.495 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -76.42 -39.33 53.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.781 0.324 . . . . 4.1600000000000001 110.826 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.88 -12.19 61.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 2.1800000000000002 110.836 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.2 mp -114.83 19.8 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.6299999999999999 110.905 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.8 132.48 0.97 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 2.25 112.493 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 3.8399999999999999 110.909 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 145.18 -120.82 1.42 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.72 -0.752 . . . . 3.29 112.462 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.98 37.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.801 0.334 . . . . 3.6600000000000001 110.855 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.29 -75.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 6.1500000000000004 110.842 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.55 -168.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 6.2300000000000004 110.844 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.97 155.51 2.04 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.715 . . . . 2.6099999999999999 110.871 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -49.25 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.69 2.26 . . . . 2.02 112.36 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -71.72 -27.97 63.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 6.4000000000000004 110.876 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.35 168.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 2.9700000000000002 111.139 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.6 m -87.85 8.44 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 4.8300000000000001 111.108 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.72 0.72 33.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 5.3700000000000001 110.847 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.47 146.12 5.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.616 0.722 . . . . 6.0800000000000001 110.891 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.98 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.698 2.265 . . . . 3.8300000000000001 112.319 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.2 m -91.11 164.38 13.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 5.0300000000000002 111.147 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -62.57 124.98 22.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 5.6200000000000001 110.95 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.39 123.86 48.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 5.5800000000000001 110.907 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -54.68 123.14 12.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 8.1600000000000001 110.914 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.2 136.21 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 3.6899999999999999 111.138 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.52 123.81 18.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 3.2200000000000002 110.841 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.52 -20.56 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 3.8500000000000001 111.107 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.21 -15.91 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 3.2000000000000002 110.88 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.5 m -106.81 1.21 24.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 3.1299999999999999 111.113 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -51.87 133.82 31.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 6.1500000000000004 110.873 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -176.79 153.05 1.02 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 4.2000000000000002 110.887 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 52.9 tp -52.06 160.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 3.79 110.906 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -172.73 3.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 5.1900000000000004 110.865 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -93.1 -70.43 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 4.8499999999999996 111.113 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.55 -32.66 51.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 3.29 110.858 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -30.46 67.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 2.5299999999999998 110.856 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.51 -28.17 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 2.5699999999999998 111.091 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -82.09 -44.56 16.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 4.7800000000000002 110.885 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.89 62.53 3.25 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 2.3500000000000001 112.502 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.6 tp -179.7 -41.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 2.1299999999999999 111.144 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.14 -28.21 48.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 3.8700000000000001 110.901 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.2 t -75.79 -25.04 56.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 2.5699999999999998 110.894 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.6 mp -51.81 -74.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 3.8799999999999999 110.966 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -88.32 -37.98 15.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 13.029999999999999 110.906 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 CA-C-O 119.096 -0.835 . . . . 11.35 112.478 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.782 0.325 . . . . 1.89 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.762 ' CD2' HG21 ' A' ' 159' ' ' ILE . 44.8 m-85 -127.7 164.02 23.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 8.11 110.913 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.9 117.77 2.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 4.26 110.889 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.561 ' CG2' HG21 ' A' ' 134' ' ' ILE . 10.2 pt -108.71 148.51 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 3.12 111.169 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -168.99 60.5 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 3.86 110.853 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.611 ' OD1' HG12 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -144.64 135.65 25.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 5.51 110.888 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -147.8 107.07 3.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 6.23 110.939 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.1 p -94.24 158.59 35.64 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.63 0.729 . . . . 3.79 111.081 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -178.53 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.713 2.275 . . . . 2.83 112.342 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 56.1 24.01 7.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.445 . . . . 3.89 110.834 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.2 mmm -165.28 131.29 2.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 3.74 110.844 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -66.14 142.01 57.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 2.8 110.896 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -61.38 -18.12 57.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 7.58 110.848 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.39 -34.78 65.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 3.11 110.848 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.5 -45.55 68.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 2.54 110.847 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.568 ' O ' HD12 ' A' ' 134' ' ' ILE . 7.5 p -66.59 -39.08 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.67 111.142 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -55.99 -53.67 54.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 2.27 110.827 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -74.72 -32.63 62.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 2.94 110.933 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.576 ' CB ' HD22 ' A' ' 212' ' ' LEU . . . -51.17 -57.93 7.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 0.69 111.049 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.568 HD12 ' O ' ' A' ' 130' ' ' VAL . 4.2 mp -75.93 -41.15 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 2.32 111.111 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -38.08 52.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 4.75 110.882 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.9 OUTLIER -78.45 -26.59 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 2.85 110.866 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.77 -32.61 63.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.89 111.072 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -74.4 -30.42 61.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 5.25 110.913 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -77.06 -55.11 5.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 2.6 110.866 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.505 HG11 ' CG2' ' A' ' 217' ' ' VAL . 3.6 p -52.9 -27.42 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 1.99 111.129 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -89.5 -53.76 4.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 3.82 110.925 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -58.98 -19.49 43.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 1.7 110.89 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -50.93 -30.09 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 2.31 110.911 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.66 HG11 ' CG1' ' A' ' 255' ' ' ILE . 3.5 m -134.94 61.49 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 2.08 111.074 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.718 HG23 HG13 ' A' ' 258' ' ' ILE . 0.1 OUTLIER -156.27 140.55 11.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.598 0.713 . . . . 1.67 111.123 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.656 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.9 Cg_endo -69.76 -12.54 33.11 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.641 2.227 . . . . 2.16 112.391 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.3 mp -54.63 175.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 2.69 110.917 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -118.23 -169.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 5.46 110.888 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -130.69 134.39 46.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 7.55 110.907 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -156.86 89.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 2.23 110.868 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 97.95 7.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 4.54 110.892 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 155' ' ' GLY . 14.3 tt -83.49 130.59 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 4.39 111.106 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -78.43 -28.48 46.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 3.82 110.9 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.436 ' O ' HD11 ' A' ' 152' ' ' ILE . 96.1 m -149.59 120.87 7.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 3.52 111.144 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.643 ' O ' HD13 ' A' ' 152' ' ' ILE . . . 118.87 85.34 0.99 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 2.28 112.501 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.77 167.28 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.776 0.322 . . . . 9.98 110.901 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.57 -161.99 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 2.91 111.11 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -50.77 -25.22 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 2.82 110.852 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.762 HG21 ' CD2' ' A' ' 116' ' ' TYR . 46.1 mm -102.5 114.43 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 3.07 111.124 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.24 158.03 25.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 2.97 110.918 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.774 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 41.7 t -148.03 111.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 1.63 111.175 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.9 t -148.51 144.82 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 1.12 111.099 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -104.71 136.68 43.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 3.28 110.921 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.512 ' HB1' ' ND1' ' A' ' 168' ' ' HIS . . . -142.41 168.38 19.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 1.29 111.134 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.2 111.8 22.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 6.27 110.903 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.39 -128.58 27.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 1.24 112.476 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.449 ' N ' ' HB2' ' A' ' 173' ' ' ALA . . . -71.51 110.92 6.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.331 . . . . 1.51 111.158 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.512 ' ND1' ' HB1' ' A' ' 164' ' ' ALA . 0.9 OUTLIER -92.49 41.95 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 3.89 110.879 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.9 -53.87 4.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 2.71 112.461 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -145.11 28.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 5.2 110.871 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -107.08 -169.55 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 6.17 110.864 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -104.83 90.3 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 4.89 110.828 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.449 ' HB2' ' N ' ' A' ' 167' ' ' ALA . . . -53.6 149.53 8.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 1.76 111.09 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -120.8 -82.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 6.02 110.91 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.97 -170.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 4.17 110.856 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -97.59 -160.72 31.09 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.709 -0.758 . . . . 2.1 112.508 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -52.97 118.6 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 5.7 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 123.61 -54.38 0.72 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.743 -0.741 . . . . 2.45 112.484 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.76 -137.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.738 -0.744 . . . . 1.76 112.473 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.3 mt -78.03 90.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.897 0.38 . . . . 2.88 111.137 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -53.04 -33.49 52.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 4.44 110.92 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.09 123.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 1.79 111.091 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -138.56 113.8 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 3.49 110.864 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -99.27 125.01 44.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 1.19 111.099 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -63.61 164.16 10.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 2.26 110.867 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.61 169.94 0.25 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.706 -0.759 . . . . 0.95 112.527 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -169.37 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.753 2.302 . . . . 1.04 112.332 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.7 -152.02 19.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 1.22 112.506 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m -91.88 148.55 22.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 2.36 110.83 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.83 -102.47 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.732 . . . . 1.36 112.467 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 72.9 mt -56.11 -35.43 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 1.85 111.143 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -52.73 100.46 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 2.31 112.456 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 104.33 21.65 9.22 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.759 -0.734 . . . . 1.21 112.484 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.404 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 15.7 m-20 -95.08 139.4 31.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 2.28 110.872 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.774 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -100.67 140.4 34.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 1.07 111.052 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -128.65 110.52 12.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 4.83 110.847 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -113.7 120.16 39.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 2.96 110.9 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -58.99 123.99 18.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 6.73 110.874 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -74.74 -48.83 23.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 7.73 110.926 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.4 -16.66 56.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 3.85 110.867 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 4.38 110.896 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.85 95.93 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 4.67 110.878 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.506 ' CZ3' HD21 ' A' ' 212' ' ' LEU . 5.1 m0 -79.73 148.57 31.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 7.17 110.933 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -148.47 174.31 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 2.57 111.13 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.62 -171.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 1.93 111.13 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -63.93 -21.52 66.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 4.52 110.876 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.3 m -90.61 -49.2 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 2.26 110.848 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -52.09 172.37 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 2.12 112.516 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -51.73 -88.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 1.5 112.509 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.429 HG21 ' HD1' ' A' ' 203' ' ' TRP . 14.8 m -60.19 99.55 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.78 0.324 . . . . 1.63 111.145 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 243' ' ' VAL . 1.9 m-20 -76.46 107.9 9.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 2.47 110.891 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.576 HD22 ' CB ' ' A' ' 133' ' ' ALA . 0.6 OUTLIER -57.38 -36.91 71.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 2.09 110.905 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.412 ' O ' HG23 ' A' ' 217' ' ' VAL . 11.0 m-85 -71.13 -64.35 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 4.93 110.827 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.547 HD13 HG12 ' A' ' 243' ' ' VAL . 5.3 tp -51.67 -49.51 62.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 2.04 110.965 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 96.4 m -55.32 -48.79 73.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.72 111.143 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.82 -31.88 63.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.69 111.125 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.632 HG21 ' CE1' ' A' ' 248' ' ' PHE . 60.4 t -77.7 -31.87 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.62 111.16 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -75.12 -41.75 57.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 2.04 110.868 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -71.0 -43.44 67.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 4.65 110.876 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 217' ' ' VAL . 9.9 tt -64.72 -29.88 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 2.13 111.153 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -68.7 -42.63 79.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 0.85 112.48 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -65.19 -23.7 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.339 . . . . 2.33 110.904 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.79 30.38 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 1.76 110.83 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -61.65 0.68 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 2.47 110.951 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 179.7 32.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 2.13 112.475 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.15 149.46 27.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.814 0.34 . . . . 2.53 110.919 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -78.16 -98.7 0.21 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.748 . . . . 2.63 112.528 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.76 40.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.846 0.355 . . . . 2.95 110.822 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 230' ' ' SER . 0.6 OUTLIER -179.53 -71.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 4.35 110.893 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 229' ' ' SER . 47.6 t 65.56 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 6.02 110.864 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.22 156.84 75.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.588 0.708 . . . . 2.93 110.889 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -49.12 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.679 2.252 . . . . 2.27 112.378 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -34.31 73.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 3.92 110.894 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 252' ' ' ALA . . . -51.6 153.32 2.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 2.23 111.104 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.725 HG13 ' HE2' ' A' ' 241' ' ' LYS . 3.9 t -87.51 7.7 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 4.05 111.151 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -17.36 35.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 4.67 110.892 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.94 143.31 15.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.635 0.731 . . . . 4.34 110.915 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 76.57 1.14 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.628 2.219 . . . . 2.29 112.33 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.6 t -157.05 168.8 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 2.43 111.142 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -110.43 112.62 24.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 3.81 110.924 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.725 ' HE2' HG13 ' A' ' 235' ' ' VAL . 8.2 pttt -140.69 147.46 39.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 3.45 110.851 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -106.84 125.82 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 3.43 110.905 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.547 HG12 HD13 ' A' ' 214' ' ' LEU . 7.1 p -121.26 154.72 25.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 2.22 111.168 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.07 125.91 25.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 2.83 110.897 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.63 -24.49 34.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 2.54 111.106 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -60.29 -39.66 87.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 3.75 110.896 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 51.9 p -105.43 1.89 28.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 2.4 111.187 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.632 ' CE1' HG21 ' A' ' 217' ' ' VAL . 2.7 t80 -52.02 111.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 3.94 110.854 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -174.52 157.37 2.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 3.1 110.892 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 251' ' ' SER . 0.4 OUTLIER -58.84 150.6 23.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 2.04 110.893 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.564 ' H ' HD23 ' A' ' 250' ' ' LEU . 1.5 t -154.58 -172.6 4.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 3.59 110.854 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.579 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . . . 65.13 176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 3.13 111.134 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.96 -22.08 66.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 3.71 110.888 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -50.77 -29.57 11.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 3.39 110.91 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.66 ' CG1' HG11 ' A' ' 144' ' ' VAL . 1.1 tt -52.74 -29.56 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 1.98 111.105 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -21.03 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 5.07 110.905 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.97 -6.04 81.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 1.73 112.492 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.718 HG13 HG23 ' A' ' 145' ' ' THR . 3.7 tp -106.98 -34.99 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 1.29 111.144 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -78.59 -37.38 42.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 3.67 110.891 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 2.98 110.829 -179.802 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.47 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.774 0.321 . . . . 2.36 111.159 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.64 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 33.7 p90 -128.67 159.53 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 4.87 110.872 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -161.65 153.92 19.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 4.42 110.883 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 26.1 mt -107.79 148.91 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 1.8 111.121 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.489 ' CB ' HG22 ' A' ' 162' ' ' VAL . 1.0 OUTLIER -115.76 -75.02 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 3.45 110.928 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -98.98 175.9 5.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 5.35 110.906 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -144.04 163.32 33.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 6.99 110.864 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.882 HG21 HD11 ' A' ' 212' ' ' LEU . 26.5 p -76.88 113.77 33.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.59 0.709 . . . . 2.87 111.139 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.71 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.255 . . . . 2.79 112.358 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -57.63 -28.46 63.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 3.44 110.874 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -101.29 152.77 20.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 3.06 110.869 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -60.95 143.52 54.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 3.33 110.886 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.0 ptt-85 -56.83 -24.3 50.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 6.98 110.867 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.76 -44.91 19.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 3.94 110.924 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.12 -51.32 68.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 2.36 110.884 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.633 ' O ' HD12 ' A' ' 134' ' ' ILE . 7.3 p -68.6 -38.18 78.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.91 111.171 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.81 -54.45 44.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 3.97 110.879 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -73.55 -32.34 64.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 2.66 110.911 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.94 -57.56 8.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.71 111.091 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.633 HD12 ' O ' ' A' ' 130' ' ' VAL . 3.7 mp -76.76 -40.11 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 2.38 111.161 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -54.5 -30.77 54.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 4.33 110.885 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 140' ' ' VAL . 1.5 mptp? -78.45 -25.21 45.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 3.73 110.925 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.91 -34.19 65.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 1.17 111.118 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.82 -30.52 61.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 4.0 110.904 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -55.72 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 3.8 110.873 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.754 HG11 HG22 ' A' ' 217' ' ' VAL . 5.1 p -49.35 -34.01 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.04 111.184 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.541 ' CZ2' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -80.28 -54.44 5.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 6.16 110.932 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.8 t -55.22 -26.63 40.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 2.44 110.841 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -53.25 -39.38 63.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 3.64 110.91 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 m -123.31 18.09 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 2.52 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.456 HG21 HG12 ' A' ' 258' ' ' ILE . 16.4 p -144.83 152.93 53.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.708 . . . . 3.07 111.158 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -87.84 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.672 2.248 . . . . 3.5 112.313 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 53.18 -175.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 3.35 110.911 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -142.35 138.14 31.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 4.03 110.85 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -112.48 128.18 56.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 6.95 110.898 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.6 t -156.77 89.62 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 1.89 110.868 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 131.84 39.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 2.38 110.899 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.424 HD12 ' HA3' ' A' ' 155' ' ' GLY . 10.5 pt -148.88 124.78 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 2.5 111.16 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -60.67 -23.67 65.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 4.15 110.896 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.3 m -133.9 112.03 10.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 2.9 111.163 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.424 ' HA3' HD12 ' A' ' 152' ' ' ILE . . . 170.62 -179.05 42.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.789 -0.72 . . . . 1.57 112.514 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.6 mtm -110.67 127.54 55.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.32 . . . . 4.95 110.888 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -122.95 130.06 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 1.08 111.097 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -19.66 64.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 3.18 110.874 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 mm -103.5 84.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 3.0 111.106 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.3 tm? -87.96 115.94 25.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 1.44 110.919 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.568 ' N ' HD22 ' A' ' 160' ' ' LEU . 94.7 t -100.71 110.27 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 1.63 111.131 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.554 ' CG2' HD11 ' A' ' 160' ' ' LEU . 50.2 t -137.53 143.09 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 1.16 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -81.0 115.5 20.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 5.49 110.868 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.675 ' HB1' ' NE2' ' A' ' 168' ' ' HIS . . . -101.08 154.83 18.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 1.9 111.064 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.49 118.68 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 5.21 110.885 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.88 -128.15 32.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 1.18 112.505 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.65 119.05 23.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 2.15 111.11 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.675 ' NE2' ' HB1' ' A' ' 164' ' ' ALA . 0.7 OUTLIER -95.1 41.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 5.77 110.87 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.93 -43.5 2.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 3.1 112.462 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.23 61.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 5.67 110.884 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.82 -168.42 2.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 4.07 110.892 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -76.59 95.96 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 5.17 110.892 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.93 138.1 58.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 1.85 111.123 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -136.67 106.85 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 6.45 110.925 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.67 168.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 4.03 110.834 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.96 -133.59 2.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 2.07 112.467 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -51.45 119.04 3.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.759 0.314 . . . . 4.4 110.901 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 114.06 28.65 3.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 4.79 112.492 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.17 -137.17 3.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 2.11 112.488 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.0 mm -76.88 123.38 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.346 . . . . 1.93 111.107 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.527 HD22 ' H ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -95.43 -12.06 26.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.469 . . . . 4.58 110.932 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.77 132.57 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 1.77 111.091 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.09 110.18 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 2.95 110.905 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.551 ' HB2' ' OE2' ' A' ' 219' ' ' GLU . . . -126.87 112.02 14.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.68 111.113 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.9 170.12 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 2.55 110.899 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.46 169.41 0.27 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.75 112.476 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -171.18 0.44 Allowed 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.736 2.291 . . . . 0.82 112.317 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.33 -145.71 16.56 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 1.13 112.477 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.8 m -92.17 153.52 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 1.95 110.908 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.51 -107.32 0.41 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 1.19 112.497 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.18 -24.77 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 2.1 111.111 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.09 96.95 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.736 -0.745 . . . . 2.45 112.51 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 117.8 -16.55 12.26 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.772 -0.728 . . . . 1.13 112.475 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.432 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 8.6 m-20 -50.43 145.04 6.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.821 0.343 . . . . 2.28 110.882 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -133.57 133.45 42.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.88 111.101 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -121.77 109.96 15.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 2.47 110.853 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -90.24 111.8 23.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 2.91 110.888 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.51 99.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 5.96 110.829 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -75.56 69.93 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 9.56 110.836 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 43.6 t0 64.67 20.4 12.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 3.84 110.884 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.4 18.37 19.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 4.4 110.862 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.09 153.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 6.01 110.867 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.409 ' CD1' HG22 ' A' ' 122' ' ' THR . 1.7 m-90 -105.74 173.7 6.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 6.87 110.899 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.419 HG21 ' H ' ' A' ' 209' ' ' GLY . 0.0 OUTLIER -157.13 172.86 17.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 2.13 111.092 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.74 -170.55 2.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 2.25 111.113 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.652 ' HB3' HD13 ' A' ' 245' ' ' ILE . 20.9 p-80 -61.66 -20.72 63.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 4.31 110.872 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.42 -36.41 9.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 2.09 110.883 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.94 -179.68 0.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.789 -0.72 . . . . 2.42 112.477 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.419 ' H ' HG21 ' A' ' 204' ' ' THR . . . -54.08 -91.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 1.77 112.492 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 92.0 m -70.5 98.84 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.352 . . . . 1.99 111.139 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.06 111.07 1.78 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 2.62 110.891 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.882 HD11 HG21 ' A' ' 122' ' ' THR . 0.6 OUTLIER -56.66 -34.21 67.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 2.22 110.938 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.424 ' CE2' HD12 ' A' ' 245' ' ' ILE . 9.7 m-85 -71.85 -64.86 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 5.41 110.882 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -53.7 -46.45 70.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 3.12 110.906 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 77.3 m -54.91 -40.12 69.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.93 111.145 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 134' ' ' ILE . . . -55.85 -32.27 63.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.081 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.754 HG22 HG11 ' A' ' 140' ' ' VAL . 29.5 t -82.53 -34.49 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.78 111.101 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -71.41 -38.85 71.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 2.06 110.872 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.551 ' OE2' ' HB2' ' A' ' 184' ' ' ALA . 1.6 tm-20 -74.44 -52.89 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 3.9 110.859 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 9.9 tt -51.93 -32.53 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.484 . . . . 2.09 111.096 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.26 -34.14 46.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.752 . . . . 0.97 112.455 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -25.61 67.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.798 0.332 . . . . 2.77 110.842 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.498 ' O ' HD22 ' A' ' 224' ' ' LEU . 0.4 OUTLIER -95.47 24.9 4.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 2.04 110.842 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 223' ' ' SER . 0.8 OUTLIER -135.43 -64.75 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 2.93 110.916 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.419 ' O ' HD23 ' A' ' 226' ' ' LEU . . . 170.87 48.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.726 . . . . 1.92 112.496 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.541 HD12 ' CZ2' ' A' ' 141' ' ' TRP . 56.4 mt -145.23 -74.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.389 . . . . 3.48 110.886 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 57.1 -102.51 0.21 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 4.42 112.495 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -119.32 119.27 33.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 2.27 110.857 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 11.0 t -99.14 -80.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 4.18 110.874 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.19 -38.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 4.27 110.872 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.702 ' OD2' ' HB1' ' A' ' 252' ' ' ALA . 0.5 OUTLIER -47.41 107.41 0.72 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.61 0.719 . . . . 2.39 110.828 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 54.2 Cg_endo -69.73 -44.42 2.11 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.647 2.231 . . . . 1.97 112.341 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -32.02 70.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 4.56 110.881 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . . . -71.63 170.65 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 2.63 111.1 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.5 m -95.96 8.15 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 5.18 111.092 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.425 ' CE ' HD22 ' A' ' 226' ' ' LEU . 1.2 tmm? -89.18 3.14 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 3.58 110.892 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 160.09 0.52 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.667 0.746 . . . . 8.75 110.849 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -30.33 22.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.66 2.24 . . . . 2.93 112.353 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.8 p -84.84 169.33 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 2.82 111.162 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -119.6 114.73 22.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 10.82 110.901 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.534 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.2 OUTLIER -126.28 133.18 51.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 3.28 110.888 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -61.6 125.63 24.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 3.29 110.929 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 241' ' ' LYS . 12.5 t -133.06 155.27 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 2.2 111.144 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.15 112.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 2.74 110.928 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.652 HD13 ' HB3' ' A' ' 206' ' ' HIS . 31.2 pt -76.58 -13.89 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 3.05 111.099 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.56 -26.85 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 3.43 110.863 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 46.0 p -120.99 20.6 11.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 2.89 111.096 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.66 148.5 40.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 3.79 110.893 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 179.98 147.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 3.18 110.919 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.613 HD23 ' N ' ' A' ' 251' ' ' SER . 7.0 tt -74.89 144.27 43.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 2.4 110.905 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.613 ' N ' HD23 ' A' ' 250' ' ' LEU . 14.9 m -154.6 -172.03 4.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 3.94 110.861 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.702 ' HB1' ' OD2' ' A' ' 231' ' ' ASP . . . 67.11 -171.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 2.91 111.076 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.73 -23.59 30.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 3.54 110.861 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 252' ' ' ALA . 4.2 m-20 -52.87 -29.75 29.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 3.3 110.875 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 252' ' ' ALA . 17.8 tt -68.55 -31.25 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 1.73 111.144 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -32.71 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 5.18 110.861 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.61 -17.13 47.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 1.56 112.477 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 145' ' ' THR . 6.0 tp -110.9 -35.81 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 1.04 111.186 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -73.53 -24.75 60.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 3.08 110.877 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 2.24 110.868 -179.779 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.4 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.81 0.338 . . . . 2.31 111.146 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.793 ' HB2' HD11 ' A' ' 159' ' ' ILE . 15.7 p90 -152.05 141.42 21.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 4.82 110.898 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.13 150.24 29.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 4.68 110.871 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.7 mt -108.01 148.88 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 1.86 111.151 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' CB ' HG22 ' A' ' 162' ' ' VAL . 38.4 t-20 -102.68 -71.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 3.65 110.868 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.27 172.48 7.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 5.67 110.905 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.677 ' HB2' HG11 ' A' ' 130' ' ' VAL . 18.3 p90 -127.45 164.34 22.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 5.42 110.949 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.553 ' OG1' HD11 ' A' ' 212' ' ' LEU . 0.7 OUTLIER -52.41 129.21 42.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.566 0.698 . . . . 2.55 111.127 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 133.55 25.83 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.678 2.252 . . . . 2.41 112.346 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 t70 67.74 11.5 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 6.13 110.864 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.5 tpt -106.09 152.54 23.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 3.14 110.869 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -58.7 115.73 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 3.73 110.892 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -59.71 -20.18 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 5.46 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -80.15 -39.43 29.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.204 -0.453 . . . . 3.87 110.9 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.51 -46.25 60.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 3.31 110.897 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.755 ' O ' HD12 ' A' ' 134' ' ' ILE . 13.9 p -65.98 -35.28 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.95 111.086 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.61 -54.61 37.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 3.03 110.879 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -71.36 -32.38 68.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 2.8 110.905 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -51.29 -51.96 49.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.7 111.163 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 130' ' ' VAL . 2.7 mp -82.73 -46.01 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 2.42 111.13 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -50.44 -45.49 55.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 6.55 110.86 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -20.4 51.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 3.03 110.883 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.6 -35.43 65.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.84 111.093 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -72.42 -24.83 61.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 5.19 110.894 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -31.5 60.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 3.45 110.936 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 217' ' ' VAL . 21.7 t -58.49 -30.93 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 2.03 111.108 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.755 ' O ' HG22 ' A' ' 145' ' ' THR . 0.7 OUTLIER -94.57 -32.72 13.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 4.0 110.92 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -63.68 -15.74 59.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 2.18 110.857 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -83.0 -12.79 56.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 2.17 110.946 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 258' ' ' ILE . 4.6 p -118.84 -28.46 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 3.28 111.136 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 141' ' ' TRP . 15.0 t -107.22 141.65 23.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.581 0.705 . . . . 2.78 111.19 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -6.07 17.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.656 2.238 . . . . 2.41 112.347 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.2 tp -49.86 161.01 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 2.45 110.915 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.28 138.06 54.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 5.41 110.915 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -114.38 128.65 56.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 8.85 110.896 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.27 99.86 4.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 2.1 110.853 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 103.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 2.41 110.877 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 tt -97.28 135.28 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 3.9 111.115 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -102.52 41.71 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 3.22 110.891 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.98 169.77 7.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 3.53 111.119 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.08 -169.76 0.54 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 1.99 112.486 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.3 mtm -108.48 148.19 30.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 6.81 110.87 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.2 159.91 16.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 1.14 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.87 -44.72 67.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 2.43 110.906 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' A' ' 116' ' ' TYR . 2.1 pp -104.02 140.78 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 3.53 111.114 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.632 HD11 ' CG2' ' A' ' 162' ' ' VAL . 1.0 OUTLIER -129.2 115.27 17.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 1.5 110.934 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.616 ' N ' HD22 ' A' ' 160' ' ' LEU . 93.1 t -94.81 119.38 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 1.44 111.133 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.632 ' CG2' HD11 ' A' ' 160' ' ' LEU . 11.7 t -138.47 140.91 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 1.14 111.176 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.62 102.97 14.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 4.7 110.854 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.67 177.35 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 1.71 111.108 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -135.64 111.74 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 3.88 110.825 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 72.82 -135.78 22.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.737 . . . . 1.61 112.497 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.16 110.96 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.334 . . . . 1.41 111.081 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -70.61 -15.64 62.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 3.13 110.871 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.04 -25.09 14.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 2.75 112.487 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -80.27 -74.81 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.351 . . . . 6.03 110.872 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -178.68 33.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 7.03 110.859 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -129.18 64.93 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 4.59 110.825 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.26 145.43 30.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 1.99 111.101 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -54.93 174.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 10.24 110.907 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -137.99 9.95 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 5.37 110.881 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.91 139.81 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.708 -0.758 . . . . 2.09 112.489 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 119.23 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.366 . . . . 3.43 110.873 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 124.09 -18.48 7.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.718 -0.753 . . . . 2.86 112.495 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -117.65 -125.96 3.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 1.88 112.498 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.407 ' H ' HD12 ' A' ' 180' ' ' ILE . 4.7 mp -79.23 93.27 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 1.93 111.125 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.9 pp -50.43 -26.43 5.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 3.56 110.906 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.725 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.45 168.9 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 1.88 111.101 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.87 130.8 53.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 3.06 110.867 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -142.1 103.71 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.98 111.072 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.28 165.53 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 2.53 110.885 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -56.51 -176.74 0.31 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 0.83 112.477 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.703 2.269 . . . . 0.81 112.313 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.13 -149.46 17.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 1.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.7 p -91.73 151.73 20.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 2.74 110.823 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 50.35 -103.98 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 1.15 112.478 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 30.7 mm -57.02 -25.98 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.371 . . . . 2.57 111.142 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.33 100.1 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 2.53 112.536 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.436 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . 115.2 -15.44 18.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.739 -0.743 . . . . 1.0 112.469 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.22 145.17 8.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.778 0.323 . . . . 2.12 110.844 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.54 ' HB3' HG22 ' A' ' 161' ' ' VAL . . . -136.95 128.69 28.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.88 111.1 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.423 ' CB ' ' HB1' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -113.09 123.59 50.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 2.71 110.85 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.52 143.83 41.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 4.03 110.913 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.67 -77.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 5.79 110.879 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 66.94 41.22 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 7.52 110.914 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.9 t0 66.18 47.5 1.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 3.32 110.836 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.78 -77.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 4.59 110.834 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.83 138.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 4.14 110.873 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -106.28 138.95 41.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 9.38 110.92 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.45 165.68 35.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 1.71 111.173 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -170.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 2.04 111.162 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -57.24 -46.6 82.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 4.32 110.888 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.54 -34.84 40.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 2.48 110.901 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -50.87 170.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 2.29 112.539 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -45.13 -83.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 1.73 112.527 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.13 97.56 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 2.35 111.134 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -61.49 113.14 2.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 3.35 110.897 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.553 HD11 ' OG1' ' A' ' 122' ' ' THR . 1.1 tt -71.57 -35.91 70.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 2.29 110.975 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.485 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 7.8 t80 -71.34 -35.94 71.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 4.48 110.867 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.428 HD12 ' CD1' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -81.78 -48.55 11.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 2.32 110.914 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.499 ' CG2' HD22 ' A' ' 181' ' ' LEU . 53.3 m -55.25 -28.83 55.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.98 111.148 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.424 ' HB1' ' HA ' ' A' ' 134' ' ' ILE . . . -69.38 -46.06 67.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.78 111.072 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.571 HG21 ' CE2' ' A' ' 248' ' ' PHE . 19.1 t -60.86 -42.71 93.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.84 111.124 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -54.1 -34.66 60.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 1.96 110.855 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -29.6 61.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 4.3 110.894 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.655 ' O ' HD13 ' A' ' 224' ' ' LEU . 51.3 mm -56.24 -59.87 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 1.52 111.127 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.65 -31.75 79.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.83 112.487 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -44.49 86.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 2.73 110.895 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.409 ' O ' HD12 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -95.75 24.95 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 1.68 110.879 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.655 HD13 ' O ' ' A' ' 220' ' ' ILE . 4.4 mp -127.97 -38.5 1.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 2.05 110.924 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 161.73 -54.74 0.31 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 2.18 112.475 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.732 HD12 ' HB ' ' A' ' 258' ' ' ILE . 1.6 mt -73.2 -178.57 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 3.31 110.913 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 156.31 -94.93 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 3.9 112.499 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -96.12 98.3 10.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.768 0.318 . . . . 2.07 110.879 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.8 m -101.35 -75.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 4.65 110.845 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.65 -33.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 4.52 110.893 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.503 ' CG ' ' HB1' ' A' ' 252' ' ' ALA . 12.7 m-20 -47.91 107.57 0.76 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.581 0.705 . . . . 3.1 110.875 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -41.83 3.95 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 2.94 112.376 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.42 46.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 4.88 110.904 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.718 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -136.58 174.45 10.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 1.69 111.119 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 235' ' ' VAL . 9.3 p -95.46 7.6 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 2.9 111.129 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.409 ' HB2' ' HE2' ' A' ' 236' ' ' MET . 1.8 mpp? -87.32 -48.47 7.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 5.12 110.877 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.8 139.86 21.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.741 . . . . 5.01 110.882 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 79.1 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.713 2.275 . . . . 2.52 112.311 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 239' ' ' THR . 4.5 t -157.02 118.61 3.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 2.74 111.144 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -70.22 131.05 43.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 3.43 110.896 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 243' ' ' VAL . 1.2 pttt -162.85 93.23 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 3.66 110.923 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -50.87 119.64 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.448 . . . . 3.75 110.929 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 241' ' ' LYS . 18.1 t -114.82 152.09 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 2.49 111.12 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.79 113.25 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 2.76 110.893 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -57.42 -37.98 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 2.37 111.188 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.68 -28.41 68.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 3.55 110.877 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 30.0 p -115.65 17.94 16.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 2.91 111.15 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.571 ' CE2' HG21 ' A' ' 217' ' ' VAL . 15.8 t80 -82.53 121.69 27.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 5.22 110.889 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -164.65 151.81 11.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 3.88 110.835 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.69 HD13 ' N ' ' A' ' 251' ' ' SER . 3.1 tm? -55.07 139.1 42.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 2.55 110.871 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.69 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.3 OUTLIER -150.35 -171.09 3.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 3.2 110.829 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.718 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 70.7 165.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 3.86 111.099 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -59.31 -20.46 54.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 2.64 110.868 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -50.06 -29.4 8.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 3.68 110.89 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.573 HD12 HD12 ' A' ' 250' ' ' LEU . 7.4 tt -51.98 -29.04 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 1.72 111.11 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -83.4 -31.16 26.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 4.77 110.866 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.74 -24.64 69.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 1.97 112.491 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.732 ' HB ' HD12 ' A' ' 226' ' ' LEU . 4.1 tp -102.88 -30.98 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 1.37 111.144 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -61.67 -36.55 81.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 2.9 110.907 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 3.34 110.863 -179.801 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.538 ' HB ' HD12 ' A' ' 152' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.834 0.349 . . . . 2.25 111.178 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.686 ' HB3' HD11 ' A' ' 159' ' ' ILE . 43.6 p90 -149.84 162.62 39.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 4.88 110.93 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -161.94 138.09 7.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 4.76 110.86 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 1.033 HG22 HG21 ' A' ' 161' ' ' VAL . 18.0 pt -107.75 136.06 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 2.6 111.143 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -151.59 43.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 3.46 110.948 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.76 151.41 51.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 5.27 110.85 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -144.06 129.92 19.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 5.34 110.94 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.58 159.5 58.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.616 0.722 . . . . 2.16 111.144 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -86.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.68 2.253 . . . . 2.32 112.338 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.92 75.58 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 4.24 110.892 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.4 tpt -165.16 138.36 4.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 2.9 110.863 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.27 120.01 8.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 4.19 110.892 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -60.96 -19.37 60.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 5.24 110.863 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -78.86 -29.24 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 3.11 110.902 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.3 -44.82 24.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 2.83 110.9 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.494 HG23 HD21 ' A' ' 212' ' ' LEU . 5.8 p -58.93 -43.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.92 111.113 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 130' ' ' VAL . 7.8 t70 -55.48 -45.7 76.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 3.13 110.917 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -74.65 -32.49 62.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 2.18 110.878 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -51.83 -44.58 63.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 1.18 111.087 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.62 HG21 HG21 ' A' ' 161' ' ' VAL . 2.8 mm -83.06 -48.83 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.414 . . . . 2.4 111.136 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -50.62 -44.99 57.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 3.55 110.889 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.763 ' O ' HG23 ' A' ' 140' ' ' VAL . 3.3 mttm -78.22 -20.52 51.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 3.04 110.931 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.754 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.34 -40.88 71.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 1.12 111.126 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -48.24 34.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 3.92 110.874 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -52.39 -28.65 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 3.62 110.926 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.792 HG11 HG11 ' A' ' 217' ' ' VAL . 97.7 t -55.79 -56.43 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 2.04 111.143 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -82.15 -40.72 21.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 3.94 110.886 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.79 -24.45 35.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 1.79 110.867 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -75.28 -27.39 59.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 2.55 110.851 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 250' ' ' LEU . 32.9 m -132.05 41.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 2.83 111.112 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 36.3 m -150.94 132.37 7.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.689 . . . . 1.97 111.189 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 70.09 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.669 2.246 . . . . 2.97 112.325 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.538 HD22 HD21 ' A' ' 224' ' ' LEU . 1.6 tp -138.29 -171.88 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 2.78 110.863 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -128.23 142.34 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 5.03 110.876 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.85 122.52 20.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 7.02 110.844 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 t -156.82 112.21 2.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 3.0 110.877 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.55 107.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 2.74 110.949 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 154' ' ' THR . 26.6 mt -91.57 144.41 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 3.56 111.142 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -94.7 22.86 5.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 5.13 110.906 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.54 ' H ' HG22 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -110.17 167.77 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 5.67 111.129 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 154' ' ' THR . . . -79.37 -0.09 82.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 2.64 112.487 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 10.7 mtt -83.15 100.34 10.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.726 0.298 . . . . 7.01 110.859 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -148.36 129.83 14.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 1.4 111.1 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.49 -26.53 41.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 2.77 110.847 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 116' ' ' TYR . 22.4 pt -123.98 142.5 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.205 -0.452 . . . . 2.52 111.154 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.774 HD23 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -133.17 164.13 27.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 2.22 110.894 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 1.033 HG21 HG22 ' A' ' 118' ' ' ILE . 8.6 t -121.93 115.64 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 1.52 111.096 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.774 HG23 HD23 ' A' ' 160' ' ' LEU . 39.4 t -145.18 142.08 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 1.41 111.135 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -105.39 133.97 49.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 3.56 110.926 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.28 142.18 6.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 1.89 111.076 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -107.25 167.21 10.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 4.9 110.888 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.94 -141.08 25.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 1.44 112.451 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.13 148.68 48.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 2.1 111.072 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -115.68 22.25 13.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 3.41 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.45 14.53 62.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.669 -0.777 . . . . 3.41 112.49 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.56 -75.95 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.778 0.323 . . . . 6.39 110.807 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.34 62.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 4.67 110.872 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -137.7 42.57 2.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 6.43 110.841 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 118.86 22.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 1.48 111.095 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -179.07 98.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 8.01 110.926 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.88 -175.77 4.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 5.75 110.855 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.42 106.97 2.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 2.03 112.502 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -50.31 119.39 3.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.337 . . . . 4.46 110.896 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.76 -27.76 19.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.752 -0.737 . . . . 2.68 112.505 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -81.48 -140.0 2.9 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 1.43 112.453 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.9 mm -80.63 92.46 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.36 . . . . 2.09 111.122 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.705 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.5 pp -44.81 -33.77 2.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 3.38 110.918 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.705 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.96 179.79 0.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 1.77 111.122 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.87 128.5 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 6.42 110.891 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.08 123.65 38.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.87 111.097 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.404 ' CB ' HG22 ' A' ' 191' ' ' ILE . 0.1 OUTLIER -64.5 169.96 4.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 2.42 110.839 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.34 177.16 0.32 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 0.85 112.501 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 160.1 50.97 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.77 112.314 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 152.49 -146.41 14.97 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 1.29 112.471 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 99.0 p -107.46 124.45 49.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.91 0.386 . . . . 2.03 110.857 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.93 -57.65 3.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.699 -0.762 . . . . 1.75 112.506 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 191' ' ' ILE . 12.6 mm -100.6 22.08 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 1.95 111.125 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.78 -114.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 3.18 112.479 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.425 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . -94.29 42.76 2.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 1.32 112.499 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.402 ' HA ' HD13 ' A' ' 160' ' ' LEU . 2.8 m-20 -61.35 127.14 30.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 1.98 110.868 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.779 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -88.72 131.77 34.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 1.38 111.145 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -125.45 137.73 53.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 2.83 110.866 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.491 ' HE1' ' HB1' ' A' ' 195' ' ' ALA . 59.4 m-85 -139.97 102.75 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 2.71 110.884 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -52.39 120.98 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 6.7 110.914 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -67.78 -29.19 68.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 8.19 110.893 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -78.29 -19.36 53.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 4.74 110.867 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -177.48 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 3.86 110.907 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -118.35 109.51 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 4.66 110.925 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -101.93 122.21 43.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 6.63 110.943 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 p -135.64 174.41 10.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 2.14 111.131 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -175.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 1.86 111.157 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -51.75 -35.21 42.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 4.68 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -60.37 2.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 2.08 110.867 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.51 171.52 0.28 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 2.2 112.508 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -52.28 -89.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 1.75 112.466 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.12 108.81 2.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 1.58 111.1 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.67 114.82 23.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 3.43 110.889 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.494 HD21 HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -51.79 -35.87 45.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 2.16 110.938 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.742 ' O ' HG23 ' A' ' 217' ' ' VAL . 13.4 m-85 -71.36 -60.76 2.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 5.29 110.867 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.751 HD12 ' CE1' ' A' ' 248' ' ' PHE . 4.5 tp -52.11 -55.31 21.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.193 -0.458 . . . . 2.67 110.882 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.1 m -54.88 -45.83 74.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.87 111.144 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.49 -32.07 62.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 1.11 111.114 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.792 HG11 HG11 ' A' ' 140' ' ' VAL . 13.0 t -76.35 -30.07 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 1.03 111.148 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -65.47 -36.68 84.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 2.09 110.826 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -66.88 -20.95 66.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 6.04 110.89 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.96 -42.87 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 1.74 111.132 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.98 -38.13 36.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.725 -0.75 . . . . 0.87 112.469 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -23.63 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 2.66 110.842 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.647 ' O ' HD12 ' A' ' 224' ' ' LEU . 17.4 p -109.97 17.78 20.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 2.74 110.895 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 223' ' ' SER . 0.2 OUTLIER -156.43 94.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 3.42 110.906 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 58.73 -178.72 1.61 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 2.43 112.477 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.542 HD22 ' SD ' ' A' ' 236' ' ' MET . 0.4 OUTLIER 71.04 -68.84 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 3.72 110.888 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 98.63 -66.92 0.69 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.728 . . . . 3.2 112.487 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -173.52 133.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 2.06 110.871 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.0 m 63.21 163.32 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 5.83 110.859 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 25.2 t -178.86 -64.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 6.06 110.885 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.92 156.79 51.4 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 2.61 110.862 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 165.66 30.22 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.686 2.258 . . . . 2.7 112.349 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.68 28.4 4.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 4.95 110.879 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -122.7 -169.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 2.45 111.107 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.8 m -95.58 -29.29 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 3.03 111.158 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.542 ' SD ' HD22 ' A' ' 226' ' ' LEU . 1.1 tpt -58.2 -23.66 56.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 4.08 110.828 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.18 150.71 29.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.683 0.754 . . . . 4.11 110.859 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -48.69 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.657 2.238 . . . . 2.59 112.342 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -85.61 138.83 31.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 3.53 111.19 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.13 135.98 52.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 4.33 110.924 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 102.89 8.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 4.56 110.877 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -51.65 131.34 29.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 3.34 110.905 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.78 132.8 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 2.4 111.17 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.99 132.61 23.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 2.94 110.858 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -14.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 3.33 111.178 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -71.26 -29.12 64.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 3.88 110.863 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.92 -6.06 10.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 2.36 111.142 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.751 ' CE1' HD12 ' A' ' 214' ' ' LEU . 7.5 t80 -51.94 127.36 20.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 5.37 110.877 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -173.1 142.06 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 4.89 110.823 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.562 HD11 HG12 ' A' ' 255' ' ' ILE . 0.7 OUTLIER -52.53 170.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 3.04 110.934 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.98 160.95 16.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 3.94 110.843 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.612 ' HA ' HD12 ' A' ' 255' ' ' ILE . . . -61.83 -55.56 28.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 4.15 111.1 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.49 -29.38 50.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 2.41 110.898 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.08 -30.43 67.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 3.35 110.896 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 252' ' ' ALA . 60.6 mt -62.31 -30.8 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 2.75 111.161 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -75.84 -28.17 58.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 4.4 110.882 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.69 -3.41 88.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 1.42 112.487 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 10.4 tp -120.93 -31.53 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.777 0.322 . . . . 0.97 111.115 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -78.67 -44.52 23.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 2.83 110.96 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 2.2 110.867 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.469 HG23 ' HA ' ' A' ' 157' ' ' ALA . 1.6 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.806 0.336 . . . . 1.94 111.127 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.591 ' HB2' HD11 ' A' ' 159' ' ' ILE . 51.3 p90 -145.23 166.34 25.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 4.77 110.977 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -161.8 138.21 8.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 3.97 110.924 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.3 mt -108.07 148.42 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 2.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -162.25 56.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 3.89 110.886 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -157.22 135.14 10.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 5.09 110.936 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -147.7 106.51 3.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 6.72 110.972 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.579 HG22 ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -90.8 153.65 45.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.573 0.701 . . . . 3.78 111.123 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.579 ' HD2' HG22 ' A' ' 122' ' ' THR . 53.8 Cg_endo -69.76 -15.01 36.9 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 2.37 112.327 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -51.45 -69.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 5.74 110.905 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 34.7 mmt -107.79 160.35 15.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 3.45 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.03 166.84 2.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 3.31 110.893 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.443 ' HA ' HG12 ' A' ' 130' ' ' VAL . 2.6 mpt_? -74.51 -19.46 60.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 6.05 110.891 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.5 -38.67 33.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 3.1 110.895 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 65.8 m-20 -71.24 -41.15 70.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 2.51 110.877 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.791 HG23 HD21 ' A' ' 212' ' ' LEU . 13.8 p -74.09 -27.88 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.81 111.115 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -71.23 -53.87 12.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 2.61 110.871 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -69.75 -32.45 70.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 2.54 110.933 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 129' ' ' ASP . . . -50.92 -58.2 6.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.512 . . . . 0.77 111.081 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.511 HG22 ' CE2' ' A' ' 138' ' ' PHE . 5.1 mm -69.19 -45.47 79.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 2.62 111.126 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -34.54 31.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 4.81 110.84 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -78.71 -31.79 46.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 2.55 110.914 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.474 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.95 -34.48 65.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.104 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 134' ' ' ILE . 54.5 m-85 -74.1 -27.87 61.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 5.29 110.867 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -79.33 -50.9 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 2.55 110.905 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.593 HG22 HD23 ' A' ' 250' ' ' LEU . 3.5 p -51.23 -41.96 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 1.97 111.086 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -49.63 17.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 3.79 110.9 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.6 p -58.91 -19.9 46.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 1.8 110.867 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -72.12 -17.11 62.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 2.27 110.872 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 255' ' ' ILE . 21.2 m -139.59 29.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 2.21 111.147 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.3 p -148.48 152.26 38.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.57 0.7 . . . . 2.52 111.173 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -14.98 36.98 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.668 2.245 . . . . 1.81 112.379 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.549 HD13 HD23 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -51.02 163.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 3.12 110.95 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -118.34 -172.39 2.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 5.3 110.926 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -135.64 119.99 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 6.9 110.867 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.4 t -140.7 89.95 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 2.09 110.848 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 116.56 22.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 2.16 110.92 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.418 HD11 ' O ' ' A' ' 156' ' ' MET . 1.0 OUTLIER -130.79 116.82 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 2.81 111.139 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -53.73 -27.76 30.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 3.3 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.0 m -160.3 133.79 6.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 4.24 111.155 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.94 -134.39 5.22 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 1.83 112.526 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.418 ' O ' HD11 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -89.8 138.22 31.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 10.0 110.828 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.469 ' HA ' HG23 ' A' ' 115' ' ' THR . . . -147.31 130.06 16.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 1.4 111.08 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.41 ' H ' HG23 ' A' ' 115' ' ' THR . 0.3 OUTLIER -80.53 -28.35 37.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 2.85 110.893 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.733 HG22 ' HA3' ' A' ' 193' ' ' GLY . 1.5 pp -122.57 140.87 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 3.82 111.114 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 160' ' ' LEU . 1.1 tm? -120.18 114.01 21.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 1.55 110.903 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.736 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 52.8 t -92.67 110.97 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 1.26 111.104 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.582 ' CG2' HD11 ' A' ' 160' ' ' LEU . 24.2 t -143.22 139.98 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 1.11 111.172 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -84.28 131.43 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 3.45 110.936 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.41 176.64 5.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 1.39 111.101 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.96 111.64 5.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 5.42 110.866 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.93 -127.02 27.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.766 -0.73 . . . . 1.2 112.481 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.06 110.81 20.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 1.37 111.105 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -90.52 66.54 6.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 3.02 110.866 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.94 -91.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 3.16 112.475 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.8 75.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 5.35 110.863 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -157.36 -169.69 2.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 5.51 110.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -78.53 95.57 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 4.02 110.867 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.55 136.36 38.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 1.3 111.109 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -112.78 -169.61 1.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 5.83 110.862 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -141.79 164.6 29.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 4.01 110.857 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.21 -156.08 17.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 1.82 112.504 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.52 119.16 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 3.74 110.927 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 133.71 -82.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.77 -0.728 . . . . 2.24 112.496 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.33 -133.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 1.96 112.493 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.537 HG22 ' H ' ' A' ' 182' ' ' ALA . 23.1 mm -75.1 142.11 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 1.79 111.107 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -109.5 -11.3 14.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 2.89 110.913 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.537 ' H ' HG22 ' A' ' 180' ' ' ILE . . . -178.19 144.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 1.28 111.089 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -143.64 117.09 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 2.77 110.882 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.99 130.1 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.79 111.069 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.23 166.01 21.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 2.08 110.91 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.62 172.83 0.35 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.777 -0.725 . . . . 0.74 112.478 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 172.08 13.3 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 0.81 112.297 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 145.2 -154.97 26.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 1.02 112.47 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.4 p -88.78 135.44 33.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.936 0.398 . . . . 2.18 110.844 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.72 -81.94 0.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.99 112.496 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 191' ' ' ILE . 1.9 mp -87.71 50.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 2.62 111.157 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.1 -110.95 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 2.64 112.462 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.733 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . -90.78 41.45 2.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 1.16 112.497 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.43 143.58 8.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 2.3 110.873 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.736 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -121.52 130.98 53.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 1.01 111.124 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -122.03 126.67 49.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 2.69 110.876 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -139.45 150.35 45.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 2.95 110.882 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 69.13 45.68 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 6.48 110.867 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.29 58.99 1.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 8.15 110.875 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.46 16.62 8.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 4.27 110.84 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.576 ' OE2' HG21 ' A' ' 210' ' ' THR . 0.2 OUTLIER -112.57 -1.09 14.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 4.31 110.942 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.75 150.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 6.06 110.852 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -105.4 176.93 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 7.71 110.904 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 205' ' ' THR . 0.2 OUTLIER -157.26 172.89 17.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 1.98 111.148 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 204' ' ' THR . 0.0 OUTLIER -94.76 -173.39 2.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 1.92 111.131 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.421 ' CG ' HG23 ' A' ' 245' ' ' ILE . 15.5 p80 -65.69 -20.33 66.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 4.45 110.862 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -70.18 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 2.22 110.856 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.66 -169.61 11.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 2.33 112.457 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 49.29 -166.29 0.3 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 1.6 112.483 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.576 HG21 ' OE2' ' A' ' 201' ' ' GLU . 0.9 OUTLIER -61.87 99.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 2.0 111.144 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 214' ' ' LEU . 32.1 t30 -61.71 120.71 11.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 3.52 110.849 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.791 HD21 HG23 ' A' ' 130' ' ' VAL . 0.3 OUTLIER -54.88 -37.85 66.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 2.35 110.842 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -71.58 -67.32 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 4.7 110.886 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.687 HD22 ' O ' ' A' ' 241' ' ' LYS . 3.9 tp -48.31 -53.67 16.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 2.53 110.931 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 37.5 m -55.21 -41.58 72.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.71 111.113 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.54 -44.99 95.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.7 111.12 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 248' ' ' PHE . 38.3 t -68.77 -23.14 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.67 111.14 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.643 ' HA ' HG12 ' A' ' 235' ' ' VAL . 19.7 t60 -72.65 -62.27 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 2.1 110.857 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.427 ' CD ' ' HB3' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -53.7 -55.37 26.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 4.64 110.893 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.1 tt -51.55 -29.95 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 2.21 111.143 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.98 -52.48 49.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.97 112.479 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -72.12 -23.12 61.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 2.73 110.83 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.12 -9.76 58.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 2.17 110.847 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.549 HD23 HD13 ' A' ' 147' ' ' LEU . 5.5 mp -104.13 -19.08 14.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.08 110.903 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 145.23 -31.5 1.7 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 2.74 112.477 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.67 HD23 ' CD1' ' A' ' 258' ' ' ILE . 0.5 OUTLIER -56.9 179.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.343 . . . . 3.06 110.958 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 173.79 66.89 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.68 -0.771 . . . . 2.72 112.42 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 11.0 m80 63.47 106.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.349 . . . . 2.01 110.872 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.2 t -80.91 -79.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 5.02 110.855 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 175.93 -54.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 3.86 110.848 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.95 126.63 34.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 2.74 110.88 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -177.73 1.99 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.692 2.261 . . . . 2.34 112.327 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.6 28.09 4.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 3.84 110.9 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -115.36 178.71 4.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 1.98 111.134 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.643 HG12 ' HA ' ' A' ' 218' ' ' HIS . 18.0 t -95.55 -9.44 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 3.48 111.174 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 28.9 mmt -86.53 -38.48 17.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 4.9 110.889 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.34 137.47 68.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.731 . . . . 4.07 110.867 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 73.62 1.31 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.692 2.261 . . . . 2.19 112.341 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.71 148.6 21.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 2.4 111.158 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -113.32 112.76 24.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 3.39 110.899 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.687 ' O ' HD22 ' A' ' 214' ' ' LEU . 35.7 tttt -135.97 119.81 17.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 4.35 110.918 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -51.71 132.0 30.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 3.05 110.937 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.646 HG21 HD13 ' A' ' 214' ' ' LEU . 56.7 t -136.38 121.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 2.09 111.12 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.02 130.96 26.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 4.07 110.928 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.421 HG23 ' CG ' ' A' ' 206' ' ' HIS . 23.9 pt -56.67 -24.16 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 2.86 111.151 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.5 -37.64 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 2.82 110.872 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.4 m -104.02 27.98 7.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 2.52 111.087 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.647 ' CE1' HD12 ' A' ' 214' ' ' LEU . 9.8 t80 -103.01 130.84 50.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 5.41 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -163.88 139.73 6.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 4.95 110.835 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.593 HD23 HG22 ' A' ' 140' ' ' VAL . 4.2 pp -52.4 170.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 3.04 110.927 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.0 t -89.85 147.57 23.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 3.84 110.893 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' A' ' 255' ' ' ILE . . . -63.51 -60.98 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 3.98 111.095 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.48 -26.3 30.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 3.5 110.869 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.55 -34.74 74.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 3.45 110.849 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 252' ' ' ALA . 38.3 mt -55.17 -41.59 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 2.76 111.132 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -14.3 61.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 4.42 110.847 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -93.4 -14.48 53.57 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 1.65 112.485 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.67 ' CD1' HD23 ' A' ' 226' ' ' LEU . 10.7 tp -110.32 -29.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 1.25 111.089 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -67.83 -32.06 72.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 3.81 110.915 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 2.91 110.843 -179.779 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.458 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 68.2 p . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.815 0.34 . . . . 2.06 111.153 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.68 ' CE2' HG21 ' A' ' 159' ' ' ILE . 1.6 t80 -127.63 152.76 47.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 7.52 110.883 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -160.24 123.32 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 6.87 110.829 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.57 HD11 HG21 ' A' ' 134' ' ' ILE . 60.5 mt -108.16 131.94 57.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 1.9 111.137 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -131.38 49.76 2.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 3.68 110.86 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -179.87 126.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 4.72 110.905 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -118.7 163.07 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 6.12 110.922 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.3 m -86.63 131.57 45.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.63 0.728 . . . . 2.92 111.074 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -48.91 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.697 2.264 . . . . 3.05 112.393 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.36 54.57 2.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 4.39 110.836 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -165.44 141.94 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 2.71 110.918 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.29 135.54 57.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 4.53 110.911 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -54.26 -25.59 24.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 5.97 110.878 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -78.27 -37.87 44.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 4.04 110.887 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -63.51 -45.55 90.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 3.2 110.84 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.595 ' HA ' HD13 ' A' ' 212' ' ' LEU . 13.4 p -74.32 -32.62 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.93 111.112 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.23 -54.35 11.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 3.69 110.89 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -65.21 -32.17 73.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 3.07 110.934 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 129' ' ' ASP . . . -52.51 -57.75 8.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.79 111.114 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.57 HG21 HD11 ' A' ' 118' ' ' ILE . 4.5 mm -70.16 -49.12 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 2.34 111.13 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -49.76 -46.06 50.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 4.03 110.862 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -20.41 49.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 2.97 110.849 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 134' ' ' ILE . . . -55.7 -50.04 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.95 111.089 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.23 -26.79 67.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 4.64 110.883 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -28.92 66.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 3.05 110.913 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.83 HG11 HG11 ' A' ' 217' ' ' VAL . 21.4 t -62.96 -56.03 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 1.9 111.113 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -43.54 65.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 3.89 110.942 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.6 t -56.01 -32.39 63.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 2.02 110.887 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' HG13 ' A' ' 144' ' ' VAL . 18.7 t-20 -51.59 -32.23 27.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 2.73 110.913 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.815 HG11 HD11 ' A' ' 255' ' ' ILE . 23.2 m -138.93 36.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 2.42 111.098 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.4 m -155.38 131.6 5.76 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.573 0.701 . . . . 2.34 111.12 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.659 ' O ' HD22 ' A' ' 147' ' ' LEU . 53.7 Cg_endo -69.77 72.13 1.47 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.675 2.25 . . . . 2.16 112.323 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.659 HD22 ' O ' ' A' ' 146' ' ' PRO . 0.8 OUTLIER -141.04 130.32 23.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 2.63 110.884 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.42 133.29 56.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 5.09 110.886 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -99.53 131.25 45.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 7.49 110.902 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.6 m -113.41 90.15 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 1.95 110.832 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 122.21 19.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 2.75 110.883 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.527 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.3 pp -144.63 161.49 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 2.75 111.157 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.44 34.22 3.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 4.21 110.9 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 t -161.66 142.98 11.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 3.73 111.139 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 85.78 176.4 50.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.73 . . . . 1.48 112.502 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.98 164.06 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 5.62 110.845 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -134.71 144.51 47.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 1.08 111.134 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.4 -26.81 32.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 2.44 110.884 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.68 HG21 ' CE2' ' A' ' 116' ' ' TYR . 42.9 mm -104.1 135.35 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 2.72 111.139 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.4 tm? -133.17 118.26 18.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 1.49 110.929 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.593 ' N ' HD22 ' A' ' 160' ' ' LEU . 89.5 t -105.65 110.54 31.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 1.47 111.131 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.558 ' CG2' HD11 ' A' ' 160' ' ' LEU . 55.9 t -133.96 145.43 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 1.12 111.106 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -107.25 109.03 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 4.95 110.879 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.683 ' HB3' ' OE2' ' A' ' 199' ' ' GLU . . . -101.67 178.76 4.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 1.41 111.082 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.08 111.63 17.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 4.92 110.887 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.37 -123.75 16.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.717 -0.754 . . . . 1.36 112.494 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 173' ' ' ALA . . . -87.22 110.41 20.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 1.49 111.122 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -79.39 58.76 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 3.09 110.885 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.8 -63.69 2.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.702 -0.761 . . . . 4.3 112.507 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -179.5 42.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.77 0.319 . . . . 7.65 110.867 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -111.23 -78.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 4.99 110.829 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -138.16 98.12 3.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 4.2 110.837 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 167' ' ' ALA . . . -81.85 113.61 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 1.73 111.128 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -111.12 131.58 54.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 5.88 110.904 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.82 171.06 13.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 4.38 110.887 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.06 -162.18 27.95 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 1.98 112.475 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -50.3 119.17 3.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 3.76 110.887 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 128.06 -15.85 6.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 2.48 112.497 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -127.21 -133.75 3.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.71 -0.757 . . . . 1.41 112.496 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.85 90.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 2.6 111.138 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.763 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -48.31 -31.71 6.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 3.07 110.886 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.763 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 176.87 153.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 1.22 111.124 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -142.92 106.27 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 3.5 110.896 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -96.22 108.41 20.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.93 111.085 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.43 168.81 5.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 2.63 110.86 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.49 171.49 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.747 . . . . 0.78 112.526 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -170.62 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 0.77 112.336 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 126.42 -152.01 18.2 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 1.17 112.486 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.16 152.81 20.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 1.99 110.835 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 50.83 -104.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 1.27 112.497 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 34.0 mm -54.8 -26.56 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 2.44 111.124 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.85 108.03 1.69 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.659 -0.781 . . . . 2.47 112.491 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 108.17 -24.33 23.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.792 -0.718 . . . . 0.96 112.502 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -49.8 147.27 3.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 2.2 110.887 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.85 145.79 30.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 1.12 111.112 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.553 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 60.7 m-70 -121.78 152.95 38.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 2.56 110.841 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.43 ' CE1' HG13 ' A' ' 161' ' ' VAL . 43.4 m-85 -133.53 103.19 5.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 2.81 110.861 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 47.39 70.62 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 5.76 110.889 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.683 ' OE2' ' HB3' ' A' ' 164' ' ' ALA . 4.4 mm-40 -51.59 -48.82 63.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 7.39 110.872 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -127.93 0.47 5.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 4.43 110.862 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.72 -168.73 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 3.78 110.915 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -114.96 160.07 19.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 5.83 110.918 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -106.15 152.52 23.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 6.17 110.892 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.09 174.03 16.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 1.74 111.133 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.447 HG23 ' OD2' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -80.74 -172.28 3.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 1.98 111.182 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.55 ' CG ' HG22 ' A' ' 245' ' ' ILE . 25.5 p80 -55.92 -32.85 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 5.42 110.842 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -56.45 5.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 2.35 110.814 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -49.3 155.28 1.97 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 2.06 112.488 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.48 -58.75 7.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 1.87 112.5 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.19 102.91 15.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 1.84 111.167 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.687 ' ND2' HD23 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -96.14 121.66 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 2.95 110.859 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -54.93 -35.28 64.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 2.24 110.901 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.414 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 34.0 t80 -71.96 -67.82 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 5.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.813 HD22 HG12 ' A' ' 243' ' ' VAL . 3.9 tp -49.6 -47.34 49.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 2.04 110.866 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 99.4 m -55.31 -44.2 75.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.52 69.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.82 111.071 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.83 HG11 HG11 ' A' ' 140' ' ' VAL . 39.3 t -72.82 -29.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.65 111.127 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -71.89 -39.39 69.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 1.73 110.826 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -74.31 -51.62 14.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 4.34 110.932 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.5 HG12 HD12 ' A' ' 224' ' ' LEU . 11.0 tt -54.94 -27.32 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 2.33 111.135 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.81 -27.41 62.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.776 -0.726 . . . . 0.9 112.502 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -81.76 -43.88 17.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.757 0.313 . . . . 2.63 110.837 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.5 p -86.53 52.26 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 1.54 110.848 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.5 HD12 HG12 ' A' ' 220' ' ' ILE . 1.4 mt -159.12 -46.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 2.05 110.887 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -172.51 -61.88 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 1.92 112.496 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.6 mp -60.89 171.71 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 3.04 110.926 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 177.46 65.08 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 2.78 112.487 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.1 m170 64.22 157.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.32 . . . . 2.38 110.853 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.6 t -163.86 -70.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 4.43 110.863 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.7 -32.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 4.67 110.871 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.429 ' HB2' ' HE1' ' A' ' 236' ' ' MET . 2.0 t0 -45.2 105.81 0.49 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.677 0.751 . . . . 2.24 110.834 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 233' ' ' LYS . 54.0 Cg_endo -69.69 175.67 7.73 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.722 2.281 . . . . 2.02 112.349 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.25 42.66 0.31 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 3.93 110.869 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -135.18 151.06 50.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 1.73 111.093 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.84 -14.59 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 2.92 111.159 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.429 ' HE1' ' HB2' ' A' ' 231' ' ' ASP . 6.0 tmm? -81.96 -39.66 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 5.38 110.847 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -50.99 134.52 29.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.662 0.744 . . . . 3.9 110.902 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 76.45 1.15 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.722 2.282 . . . . 2.61 112.323 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.5 m -157.3 152.66 26.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 2.82 111.137 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.405 ' HB3' HD21 ' A' ' 181' ' ' LEU . 9.8 p90 -111.72 112.32 23.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 4.91 110.89 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.48 -169.15 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 4.59 110.913 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -121.48 107.86 12.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 3.61 110.901 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.813 HG12 HD22 ' A' ' 214' ' ' LEU . 7.5 p -107.93 154.58 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 3.01 111.135 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -74.22 124.99 27.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 3.23 110.86 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.55 HG22 ' CG ' ' A' ' 206' ' ' HIS . 11.8 tt -76.47 -35.48 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 3.01 111.113 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -53.48 -31.9 47.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 3.51 110.881 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.9 t -113.68 30.07 7.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 2.97 111.109 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -52.05 134.47 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 5.94 110.873 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -179.9 142.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 3.52 110.926 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.21 147.8 47.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 2.36 110.866 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.1 -172.02 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 3.41 110.872 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.713 ' HB3' ' OD2' ' A' ' 254' ' ' ASP . . . 66.4 163.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 3.77 111.118 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -57.67 -25.11 59.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 2.68 110.815 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.713 ' OD2' ' HB3' ' A' ' 252' ' ' ALA . 2.2 p30 -51.62 -29.83 19.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 3.04 110.853 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.815 HD11 HG11 ' A' ' 144' ' ' VAL . 12.7 tt -50.88 -29.59 7.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 2.1 111.153 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -92.07 -40.15 11.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 6.33 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.97 -20.51 41.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 1.95 112.462 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 8.2 tp -91.41 -32.83 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 1.05 111.128 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.19 -44.4 38.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 3.4 110.957 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 2.78 110.883 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.51 ' C ' ' HB1' ' A' ' 157' ' ' ALA . 53.2 p . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.853 0.358 . . . . 2.08 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -150.26 151.32 32.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 4.41 110.938 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.83 161.63 29.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 5.01 110.92 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.556 HD11 ' HB ' ' A' ' 134' ' ' ILE . 23.4 mt -108.09 148.93 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 1.87 111.082 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.434 ' HB2' HG22 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -120.15 -69.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 3.03 110.901 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -98.59 176.89 5.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 5.42 110.895 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.533 ' HB3' HG11 ' A' ' 130' ' ' VAL . 25.9 m-85 -146.39 155.01 42.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 6.57 110.904 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.458 HG21 ' OD2' ' A' ' 198' ' ' ASP . 0.7 OUTLIER -53.53 134.9 53.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.601 0.715 . . . . 2.36 111.11 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 135.25 29.87 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.689 2.259 . . . . 2.64 112.354 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.45 11.39 8.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 5.9 110.865 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.48 147.32 29.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 3.09 110.839 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.472 ' O ' HG12 ' A' ' 130' ' ' VAL . 3.5 m-20 -58.63 115.34 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 3.49 110.893 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -21.94 61.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 5.71 110.862 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -80.55 -40.01 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 3.27 110.831 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.72 -47.87 61.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 2.81 110.87 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.741 HG23 HD21 ' A' ' 212' ' ' LEU . 7.3 p -63.97 -40.8 90.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.79 111.142 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.5 m-20 -51.83 -54.07 33.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 3.13 110.912 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -68.17 -32.28 72.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 2.6 110.936 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.416 ' CB ' HD22 ' A' ' 212' ' ' LEU . . . -50.64 -41.07 54.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 1.11 111.151 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.583 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 2.8 mm -83.62 -49.4 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 2.39 111.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -59.66 4.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 5.67 110.841 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -29.86 61.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 4.82 110.915 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 134' ' ' ILE . . . -56.14 -33.37 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.84 111.112 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.505 ' CE1' HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -73.36 -24.66 60.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 3.59 110.896 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.22 -54.02 6.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 2.56 110.884 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 250' ' ' LEU . 2.6 p -52.08 -28.81 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 1.88 111.12 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -89.11 -55.44 3.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 4.08 110.897 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 81.6 p -55.26 -22.56 18.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 1.61 110.855 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.83 -29.78 12.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 2.38 110.905 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.697 HG11 ' CG1' ' A' ' 255' ' ' ILE . 4.8 m -128.3 46.36 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 1.89 111.137 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.675 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -155.46 142.35 13.52 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.619 0.723 . . . . 1.58 111.113 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.675 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.5 Cg_endo -69.78 -11.91 31.79 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.702 2.268 . . . . 1.84 112.345 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.2 167.2 4.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 3.19 110.914 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.76 -172.95 2.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 6.12 110.887 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -131.84 127.58 36.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 6.55 110.9 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.97 89.92 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 2.45 110.885 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 95.18 7.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 2.53 110.918 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.655 HG22 ' H ' ' A' ' 154' ' ' THR . 2.0 mp -111.81 133.19 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 2.78 111.13 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.1 -28.96 67.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 4.29 110.916 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.655 ' H ' HG22 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -121.62 174.32 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 3.23 111.175 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.454 ' H ' HG22 ' A' ' 154' ' ' THR . . . 74.94 134.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.719 . . . . 2.27 112.487 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.1 mtm -68.99 160.33 31.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 6.73 110.866 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.51 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -139.68 144.63 37.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 1.24 111.124 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.48 -33.54 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 2.38 110.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.3 mm -103.99 94.47 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 3.14 111.124 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.617 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.1 tm? -105.13 117.46 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 1.88 110.86 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.617 ' N ' HD22 ' A' ' 160' ' ' LEU . 20.2 t -102.25 109.24 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 1.97 111.076 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.578 HG23 HD21 ' A' ' 160' ' ' LEU . 54.7 t -138.88 141.11 37.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 1.73 111.187 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.91 152.76 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 3.26 110.89 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.41 173.33 10.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 1.26 111.112 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.67 120.0 13.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 5.08 110.819 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 53.62 -134.77 42.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 1.72 112.488 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.91 110.48 20.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 1.49 111.061 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.23 56.38 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 2.93 110.859 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.34 -58.94 3.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 2.68 112.493 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -162.3 33.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 5.47 110.847 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -110.74 -168.88 1.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 5.14 110.878 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.75 114.89 16.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 6.11 110.876 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.05 147.83 40.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 1.84 111.11 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -59.86 -170.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 9.54 110.875 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -137.92 165.39 26.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 5.25 110.87 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -50.82 133.35 31.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 2.93 112.504 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 129.89 27.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 4.77 110.934 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.87 -13.39 29.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 3.84 112.459 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -108.58 -136.95 7.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 2.79 112.514 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.7 mt -71.47 110.88 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 3.21 111.174 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.572 HD22 ' H ' ' A' ' 181' ' ' LEU . 0.4 OUTLIER -50.51 -42.55 55.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 3.54 110.931 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 196' ' ' HIS . . . -178.84 -179.74 0.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 1.88 111.078 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -142.15 129.58 21.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 3.66 110.843 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -115.76 121.63 43.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.63 111.059 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.28 165.8 8.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 2.63 110.859 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.37 170.2 0.34 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.77 112.478 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -170.3 0.38 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.738 2.292 . . . . 0.98 112.364 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.14 -149.14 18.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 1.23 112.497 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 99.3 p -92.24 155.56 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 1.96 110.899 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.42 -104.4 0.15 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 1.14 112.485 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 38.0 mt -61.31 -26.52 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 1.98 111.121 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.15 99.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 2.69 112.515 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 116.73 -18.9 12.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 1.01 112.456 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.532 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 10.1 m-20 -49.83 137.57 16.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.826 0.345 . . . . 2.01 110.883 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -131.39 149.93 52.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.98 111.099 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.535 ' O ' ' HB3' ' A' ' 182' ' ' ALA . 20.3 m-70 -136.58 109.89 7.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 2.74 110.83 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -107.84 125.81 51.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 5.47 110.889 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.458 ' OD2' HG21 ' A' ' 122' ' ' THR . 11.5 m-20 49.67 78.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 6.63 110.871 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -76.61 60.79 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 8.5 110.901 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.6 26.6 16.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 5.34 110.856 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -97.42 -42.54 7.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 3.8 110.848 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 178.68 119.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 4.29 110.871 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -106.76 124.71 50.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 9.01 110.923 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.1 159.92 38.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 1.83 111.141 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.3 177.84 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 1.84 111.146 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -55.39 -24.97 32.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 4.86 110.865 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.98 -42.0 10.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 3.12 110.861 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -57.21 -175.93 0.36 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 2.35 112.503 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.4 -87.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.737 . . . . 1.92 112.461 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 60.1 m -73.89 98.74 3.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.827 0.346 . . . . 1.82 111.126 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -61.62 110.77 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 4.0 110.846 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.741 HD21 HG23 ' A' ' 130' ' ' VAL . 1.2 tt -69.33 -44.41 71.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.13 -0.487 . . . . 2.2 110.907 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 217' ' ' VAL . 14.1 m-85 -63.96 -40.31 96.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 5.36 110.896 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.44 -47.06 28.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 2.66 110.904 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 24.0 m -55.54 -49.6 72.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 1.21 111.141 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.84 -32.09 63.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.91 111.076 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 213' ' ' PHE . 62.9 t -80.77 -29.82 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.97 111.066 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -73.56 -48.73 30.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 1.78 110.871 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -63.59 -49.21 74.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 4.84 110.884 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.505 HD11 ' CE1' ' A' ' 138' ' ' PHE . 11.6 tt -57.82 -25.41 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 2.35 111.162 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 -27.52 70.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 1.29 112.481 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -74.97 -28.67 60.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 3.44 110.877 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.604 ' O ' HD12 ' A' ' 224' ' ' LEU . 0.7 OUTLIER -93.88 40.93 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 1.74 110.859 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 223' ' ' SER . 0.2 OUTLIER -159.72 -40.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 1.78 110.922 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 147.85 122.32 1.29 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 2.54 112.46 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.6 tp -179.19 -63.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 4.05 110.912 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 62.74 15.33 54.27 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 3.53 112.475 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 17.5 m80 51.98 67.15 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 2.24 110.833 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 65.1 m -51.89 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 5.13 110.866 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.464 ' N ' ' HE1' ' A' ' 236' ' ' MET . 0.3 OUTLIER 177.2 101.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 4.24 110.888 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.4 OUTLIER -146.65 85.17 7.29 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 3.66 110.887 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -29.78 23.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 2.78 112.325 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 8.38 43.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 5.5 110.952 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.797 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . . . -124.74 -177.49 3.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 2.29 111.129 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 241' ' ' LYS . 16.7 m -95.83 -7.6 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 4.62 111.115 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.464 ' HE1' ' N ' ' A' ' 230' ' ' SER . 1.9 ttp -54.15 -27.22 32.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 5.11 110.892 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.25 157.58 1.15 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.633 0.73 . . . . 3.92 110.871 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.34 28.3 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.67 2.246 . . . . 2.5 112.297 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.2 m -99.42 137.4 37.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 2.88 111.185 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -63.14 142.07 58.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 3.93 110.945 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.479 ' HB3' HG12 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -125.21 96.62 4.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 3.28 110.919 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -61.59 125.84 25.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 3.59 110.899 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.92 177.19 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 2.35 111.136 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.1 128.45 34.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 2.79 110.878 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.0 tp -55.83 -25.29 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 3.19 111.13 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -65.36 -39.4 92.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 2.97 110.894 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 65.2 p -99.6 2.72 44.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 2.46 111.154 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 217' ' ' VAL . 7.2 t80 -51.91 108.32 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 4.1 110.877 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -174.45 139.24 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 3.7 110.832 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.598 HD21 ' OD2' ' A' ' 254' ' ' ASP . 0.8 OUTLIER -52.59 151.75 4.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 2.41 110.917 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.586 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.4 OUTLIER -154.1 -179.0 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 3.98 110.848 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.658 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . . . 64.55 -178.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 3.29 111.119 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -23.23 51.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 2.72 110.831 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.598 ' OD2' HD21 ' A' ' 250' ' ' LEU . 5.1 t0 -53.19 -30.12 35.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 3.05 110.863 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.697 ' CG1' HG11 ' A' ' 144' ' ' VAL . 2.2 tt -65.1 -29.99 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 2.41 111.11 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -99.04 -1.71 39.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 7.09 110.885 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -90.17 17.85 51.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.693 -0.765 . . . . 1.69 112.532 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.46 HG12 HG23 ' A' ' 145' ' ' THR . 0.7 OUTLIER -134.87 -40.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 1.08 111.1 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -24.77 56.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 3.51 110.867 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 1.87 110.833 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.766 0.317 . . . . 2.22 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.409 ' CD2' HD11 ' A' ' 159' ' ' ILE . 0.1 OUTLIER -127.47 136.7 52.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 7.5 110.911 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -141.14 143.33 34.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 4.33 110.864 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.5 mt -108.01 148.36 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 2.48 111.162 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -111.9 -69.46 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 3.74 110.914 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -107.36 -169.84 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 4.72 110.877 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -146.62 140.73 26.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 6.27 110.946 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.632 HG23 HG21 ' A' ' 130' ' ' VAL . 72.3 p -53.08 109.71 1.61 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.552 0.692 . . . . 2.84 111.129 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 122' ' ' THR . 53.7 Cg_endo -69.8 -48.74 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.647 2.231 . . . . 2.85 112.307 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.21 -33.55 75.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 4.65 110.858 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.2 tpt -101.34 178.88 4.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 3.16 110.853 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -78.92 128.83 33.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 3.52 110.849 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -52.96 -28.12 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 6.17 110.908 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.77 -32.49 40.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 3.3 110.899 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -65.6 -43.05 90.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 2.72 110.881 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.632 HG21 HG23 ' A' ' 122' ' ' THR . 10.2 p -74.09 -35.54 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.02 111.143 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.0 -44.4 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 2.48 110.846 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -71.76 -39.63 69.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 3.67 110.932 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.671 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -56.16 -59.24 5.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.98 111.168 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.466 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 3.4 pt -56.43 -29.4 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 2.74 111.139 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.08 -57.64 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 4.24 110.827 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.664 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -79.19 -25.64 42.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 2.98 110.869 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.734 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.59 -43.75 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 1.28 111.091 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.415 ' HA ' HG21 ' A' ' 220' ' ' ILE . 37.0 t80 -73.68 -23.93 59.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 3.66 110.84 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -78.13 -31.41 49.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 2.95 110.912 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 136' ' ' LYS . 47.7 t -51.09 -56.2 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 1.97 111.089 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CE3' HD11 ' A' ' 250' ' ' LEU . 0.9 OUTLIER -73.64 -42.13 61.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 4.38 110.917 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.651 ' HB2' HD11 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -54.67 -22.38 13.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 1.7 110.841 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -57.62 -21.84 41.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 3.36 110.909 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.609 HG21 HG13 ' A' ' 255' ' ' ILE . 3.0 m -141.51 62.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 2.26 111.173 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.771 HG23 HG13 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -157.02 147.53 16.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.632 0.73 . . . . 1.84 111.114 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.734 ' HD2' HG22 ' A' ' 145' ' ' THR . 54.2 Cg_endo -69.75 -8.53 23.85 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.688 2.259 . . . . 2.48 112.362 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' A' ' 142' ' ' SER . 3.6 pp -66.22 -172.28 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 4.26 110.923 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.508 ' N ' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -144.77 -174.89 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 6.28 110.899 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -132.32 122.34 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 6.94 110.891 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.4 t -144.93 89.94 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 1.9 110.869 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -82.31 117.1 22.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 3.68 110.894 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.2 159.84 42.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 2.87 111.11 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -99.88 -27.96 13.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 3.9 110.876 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.4 m -113.73 116.73 29.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 3.08 111.088 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.33 147.35 6.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 2.06 112.484 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.2 164.67 26.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.766 0.317 . . . . 6.03 110.891 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.0 142.9 27.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 1.02 111.106 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -51.93 53.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 2.24 110.859 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.881 HG22 ' HA3' ' A' ' 193' ' ' GLY . 22.9 pt -104.63 139.85 24.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 2.57 111.141 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.742 HD22 ' C ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -135.44 162.94 31.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 2.0 110.941 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.598 ' N ' HD22 ' A' ' 160' ' ' LEU . 39.2 t -106.21 121.74 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.79 111.095 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.486 ' HB ' HD21 ' A' ' 160' ' ' LEU . 3.5 p -139.43 163.31 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 2.48 111.144 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -121.02 133.13 55.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 4.01 110.892 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.86 167.73 20.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 1.49 111.112 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.68 146.59 32.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 5.15 110.878 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.37 -151.48 3.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 2.19 112.502 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.79 125.35 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 2.06 111.088 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -112.39 43.54 1.6 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 2.84 110.847 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.14 76.59 0.26 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 3.21 112.462 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.2 t70 63.86 47.71 3.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.736 0.303 . . . . 5.94 110.825 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.422 ' OD2' HD11 ' A' ' 191' ' ' ILE . 0.3 OUTLIER -142.2 -169.02 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 4.65 110.851 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -76.83 124.08 27.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 5.46 110.851 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.29 144.96 31.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 1.96 111.131 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -130.32 -169.66 2.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 6.32 110.887 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -151.28 -170.53 3.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 5.04 110.86 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -115.92 -153.13 10.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.758 . . . . 2.42 112.445 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.71 133.61 25.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 3.37 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 111.96 -18.97 23.6 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 2.43 112.496 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -143.98 -129.09 2.21 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.747 -0.739 . . . . 1.41 112.49 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 182' ' ' ALA . 28.5 mm -77.2 125.45 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.89 0.376 . . . . 2.46 111.144 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.591 ' HG ' HG21 ' A' ' 210' ' ' THR . 0.3 OUTLIER -95.89 -5.91 40.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 4.12 110.911 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.488 ' H ' HG22 ' A' ' 180' ' ' ILE . . . -178.6 123.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 1.76 111.114 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 114.23 18.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 3.66 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.64 117.5 24.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.69 111.075 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -64.41 170.79 3.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 2.79 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.05 172.08 0.17 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.751 -0.737 . . . . 0.82 112.489 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 172.23 13.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 0.87 112.333 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 159.35 -133.6 3.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 1.25 112.507 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 34.5 t -134.09 128.42 34.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.367 . . . . 3.63 110.88 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 85.52 -70.36 3.08 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.741 -0.742 . . . . 1.86 112.486 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.422 HD11 ' OD2' ' A' ' 171' ' ' ASP . 0.5 OUTLIER -99.7 -27.04 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.358 . . . . 3.04 111.119 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.11 129.14 29.0 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 2.3 112.525 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.881 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . 85.69 -9.57 67.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 1.06 112.511 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.453 ' HA ' HD13 ' A' ' 160' ' ' LEU . 3.8 m-20 -51.19 157.61 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.82 110.874 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.753 ' HB1' ' CE2' ' A' ' 197' ' ' PHE . . . -125.97 121.28 32.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 1.16 111.08 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -111.05 115.52 29.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 3.08 110.838 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.753 ' CE2' ' HB1' ' A' ' 195' ' ' ALA . 50.1 m-85 -143.94 150.23 38.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 3.03 110.875 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.432 ' N ' ' HE1' ' A' ' 203' ' ' TRP . 0.9 OUTLIER 75.16 -168.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 7.15 110.855 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.87 96.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 6.91 110.923 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.2 t70 55.95 68.97 0.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 4.08 110.888 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -174.75 -41.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 4.27 110.879 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 11.7 t80 67.24 131.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 5.56 110.885 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.658 ' CH2' HG21 ' A' ' 215' ' ' THR . 21.3 m95 -105.72 -174.91 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 7.08 110.877 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 168.27 27.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 1.96 111.184 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -175.1 3.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 2.0 111.143 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -52.76 -47.95 67.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 4.44 110.909 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.4 p -78.39 -31.94 48.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 2.18 110.879 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -50.38 167.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 2.2 112.483 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.83 -72.71 0.44 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 1.62 112.502 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.591 HG21 ' HG ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -102.3 98.64 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.796 0.332 . . . . 1.8 111.133 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -69.57 132.39 46.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 4.44 110.87 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.2 tm? -57.99 -41.3 82.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 3.39 110.908 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.733 ' O ' HG23 ' A' ' 217' ' ' VAL . 8.0 t80 -70.74 -60.72 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 5.52 110.899 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.529 ' CD2' HG22 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -50.43 -34.89 26.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 3.01 110.898 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.658 HG21 ' CH2' ' A' ' 203' ' ' TRP . 82.5 m -79.91 -41.6 25.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 1.11 111.148 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.89 98.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 1.19 111.102 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.734 HG22 ' HA ' ' A' ' 137' ' ' ALA . 53.5 t -51.27 -40.74 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.82 111.156 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -64.74 -36.41 84.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 2.07 110.85 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -74.64 -45.75 42.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 4.47 110.883 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.463 HD12 ' HB1' ' A' ' 137' ' ' ALA . 91.3 mt -56.09 -37.04 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 2.09 111.187 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.07 -37.78 36.94 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.686 -0.769 . . . . 0.67 112.467 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -54.86 -40.64 69.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 2.34 110.879 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.6 8.75 26.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 2.14 110.879 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.484 ' O ' HD13 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -150.33 88.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 3.47 110.944 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 71.12 179.32 29.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.738 -0.744 . . . . 2.11 112.51 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 54.3 -175.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 3.03 110.896 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.404 ' C ' ' HE1' ' A' ' 236' ' ' MET . . . -145.8 -115.68 0.96 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 2.48 112.464 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.44 142.82 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 1.8 110.881 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.83 -78.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 6.61 110.845 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.51 -78.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 5.44 110.882 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 153.21 48.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.599 0.714 . . . . 3.89 110.858 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 233' ' ' LYS . 54.0 Cg_endo -69.73 -177.12 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.677 2.252 . . . . 2.83 112.358 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.47 43.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 4.32 110.887 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -135.54 163.5 29.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 1.77 111.101 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.447 HG23 HD11 ' A' ' 214' ' ' LEU . 9.8 p -87.16 7.4 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 3.14 111.14 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.404 ' HE1' ' C ' ' A' ' 227' ' ' GLY . 1.4 tmm? -98.43 -26.08 14.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 3.86 110.906 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.458 ' HB3' HG22 ' A' ' 239' ' ' THR . 0.1 OUTLIER -54.68 141.59 55.6 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.632 0.73 . . . . 3.95 110.888 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 64.97 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.683 2.256 . . . . 2.12 112.349 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.458 HG22 ' HB3' ' A' ' 237' ' ' PHE . 7.1 t -158.03 134.2 9.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 2.64 111.169 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -76.3 127.49 32.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 4.23 110.951 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.407 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.0 ptmt -140.58 92.74 2.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 4.17 110.915 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -62.41 125.61 24.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 3.44 110.912 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.529 HG22 ' CD2' ' A' ' 214' ' ' LEU . 16.7 m -137.49 177.32 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.494 . . . . 2.55 111.153 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -62.09 114.28 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 3.91 110.845 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 18.4 tt -76.36 -32.75 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 3.16 111.172 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.43 -30.79 65.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 3.19 110.866 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.56 28.05 9.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 3.44 111.11 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -51.76 149.86 4.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 5.34 110.913 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -179.71 156.2 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 4.37 110.885 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 251' ' ' SER . 0.4 OUTLIER -86.83 157.49 19.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 2.18 110.955 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.627 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.3 OUTLIER -154.65 -171.64 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 3.4 110.904 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 68.72 160.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 3.66 111.109 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.84 -21.48 56.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 3.28 110.886 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.84 -29.74 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 4.04 110.886 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.609 HG13 HG21 ' A' ' 144' ' ' VAL . 1.2 tt -51.14 -29.53 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 1.7 111.143 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -90.59 -34.07 15.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 5.19 110.842 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.55 -17.07 47.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 1.65 112.507 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.771 HG13 HG23 ' A' ' 145' ' ' THR . 4.0 tp -99.95 -31.61 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.9 111.179 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.78 -43.39 25.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 3.98 110.899 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 1.95 110.841 -179.791 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.818 0.342 . . . . 2.19 111.136 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.759 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 11.8 p90 -131.95 145.83 51.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 4.25 110.942 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -142.29 160.51 40.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 4.94 110.9 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 134' ' ' ILE . 21.3 mt -106.59 148.92 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 2.16 111.172 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.582 ' CB ' HG22 ' A' ' 162' ' ' VAL . 9.7 t-20 -106.77 -69.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 4.29 110.86 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -118.37 174.88 5.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 5.42 110.881 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -134.45 163.27 30.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 6.55 110.918 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.578 HG21 ' HB2' ' A' ' 203' ' ' TRP . 0.0 OUTLIER -88.51 131.86 40.75 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.546 0.688 . . . . 2.57 111.114 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -19.43 36.14 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.702 2.268 . . . . 2.15 112.334 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.64 -69.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 4.48 110.874 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 38.0 mmm -101.19 168.12 9.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 3.61 110.87 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -59.39 158.23 9.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 2.54 110.892 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.433 ' HA ' HG12 ' A' ' 130' ' ' VAL . 3.9 tmm_? -70.78 -11.26 60.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 6.57 110.888 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -79.73 -36.69 37.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 3.09 110.886 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.07 -40.77 71.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 2.68 110.866 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.522 HG23 HD11 ' A' ' 212' ' ' LEU . 8.8 p -74.3 -36.2 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.67 111.107 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -66.34 -43.97 84.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 3.78 110.855 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -48.98 23.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 3.32 110.937 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.547 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -59.78 -26.88 66.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 1.27 111.094 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.529 HG21 HD11 ' A' ' 118' ' ' ILE . 1.3 mm -70.85 -50.93 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 2.46 111.15 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -75.2 -22.7 57.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 4.14 110.879 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -77.62 -29.92 52.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 2.94 110.934 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 140' ' ' VAL . . . -63.5 -52.08 62.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.97 111.039 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.579 ' HA ' HG21 ' A' ' 220' ' ' ILE . 1.3 t80 -55.09 -28.38 52.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 4.24 110.887 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -70.49 -27.95 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 2.49 110.898 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.534 HG11 HG11 ' A' ' 217' ' ' VAL . 58.4 t -51.08 -56.1 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 1.74 111.16 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.442 ' CZ3' HD21 ' A' ' 250' ' ' LEU . 30.7 m95 -77.44 -29.06 52.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 3.97 110.921 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 p -55.19 -41.61 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 2.24 110.807 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.69 -16.19 62.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 2.77 110.9 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.822 HG11 HD11 ' A' ' 255' ' ' ILE . 31.5 m -135.79 39.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 2.32 111.139 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.447 HG23 ' HD2' ' A' ' 146' ' ' PRO . 91.9 m -155.63 133.65 6.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.583 0.706 . . . . 1.86 111.17 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.447 ' HD2' HG23 ' A' ' 145' ' ' THR . 54.1 Cg_endo -69.76 74.56 1.28 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.738 2.292 . . . . 2.36 112.341 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tp -163.13 -169.65 2.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 3.21 110.941 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -148.25 176.27 10.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 4.81 110.875 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -135.81 120.03 17.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 7.26 110.87 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 t -110.44 89.99 3.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 1.91 110.843 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.16 93.4 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 2.76 110.882 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.599 HD12 ' O ' ' A' ' 154' ' ' THR . 1.1 pt -131.57 163.96 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 3.58 111.155 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -103.01 -5.78 23.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 3.19 110.891 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.599 ' O ' HD12 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -95.57 175.73 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 4.13 111.184 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.48 -165.55 1.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 2.14 112.476 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.4 mtm -110.77 151.92 27.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 4.94 110.867 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.759 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -119.35 130.14 55.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 1.31 111.087 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.41 -20.82 62.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 2.54 110.883 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.0 mm -103.47 84.58 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 2.59 111.144 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.643 HD11 HG23 ' A' ' 162' ' ' VAL . 1.1 tm? -85.72 117.72 24.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 1.48 110.945 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.605 ' N ' HD22 ' A' ' 160' ' ' LEU . 99.4 t -105.3 110.77 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 1.49 111.085 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.643 HG23 HD11 ' A' ' 160' ' ' LEU . 47.6 t -127.07 143.2 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 1.19 111.15 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -97.77 100.21 11.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 7.54 110.903 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.518 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . . . -132.26 144.03 50.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 1.75 111.1 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.74 164.1 14.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 6.72 110.849 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.52 -138.03 29.36 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.768 -0.729 . . . . 1.16 112.502 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.23 128.24 33.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 1.47 111.137 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -95.67 24.87 4.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 3.18 110.887 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.8 -28.17 10.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.761 -0.733 . . . . 2.32 112.481 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.46 34.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.817 0.341 . . . . 5.25 110.874 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.56 -173.84 2.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 4.53 110.903 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.61 118.83 26.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 6.38 110.864 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.41 139.9 35.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.34 111.086 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -154.02 88.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 7.17 110.87 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -128.49 -168.42 1.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 5.53 110.859 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.62 106.1 0.91 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.748 -0.739 . . . . 2.17 112.477 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.94 119.11 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 4.96 110.891 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.61 -24.52 21.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 2.29 112.494 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -82.88 -140.72 3.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.675 -0.774 . . . . 1.46 112.51 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.62 110.53 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 1.91 111.105 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.578 HD22 ' H ' ' A' ' 181' ' ' LEU . 0.4 OUTLIER -50.42 -57.38 8.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.478 . . . . 3.79 110.915 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.01 123.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 1.46 111.093 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -95.3 153.58 17.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 3.21 110.831 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -152.46 113.04 4.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.69 111.06 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.67 157.4 24.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 2.54 110.885 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.94 -171.0 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 1.13 112.497 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -169.86 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.731 2.287 . . . . 1.03 112.338 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 125.37 -156.34 19.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 1.2 112.512 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.8 p -88.92 145.58 25.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 2.83 110.861 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.08 -102.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 1.17 112.43 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 82.0 mt -52.57 -27.73 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 2.07 111.153 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.59 111.56 2.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 2.66 112.474 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.43 -16.14 56.89 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 1.05 112.507 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -49.94 138.41 15.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 2.26 110.905 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 161' ' ' VAL . . . -129.96 141.17 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.93 111.097 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.518 ' NE2' ' HB3' ' A' ' 164' ' ' ALA . 0.1 OUTLIER -118.77 144.57 46.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 3.28 110.871 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -144.45 148.5 34.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 2.71 110.903 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.425 ' HB2' HG23 ' A' ' 122' ' ' THR . 25.5 t70 70.48 -75.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 5.86 110.882 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 46.85 41.33 10.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 8.83 110.919 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.5 t0 62.98 41.1 8.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 3.54 110.888 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -118.45 1.87 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 4.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.12 115.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 4.75 110.899 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.737 ' CZ3' HG21 ' A' ' 210' ' ' THR . 0.1 OUTLIER -100.11 170.19 8.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 6.94 110.946 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 205' ' ' THR . 0.2 OUTLIER -156.81 172.92 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 1.75 111.161 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 204' ' ' THR . 0.3 OUTLIER -75.35 -170.15 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 1.99 111.161 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.671 ' CB ' HG23 ' A' ' 245' ' ' ILE . 39.7 p-80 -76.77 -21.39 55.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 4.89 110.853 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.9 t -61.08 -68.9 0.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 2.08 110.843 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -132.9 -166.69 11.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.716 -0.754 . . . . 2.22 112.481 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 50.07 -168.06 0.31 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.697 -0.763 . . . . 1.63 112.497 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.737 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.3 m -56.46 99.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 1.54 111.114 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.0 103.76 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 2.55 110.846 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.576 ' O ' HD23 ' A' ' 212' ' ' LEU . 6.6 tt -57.51 -38.27 74.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 1.96 110.901 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.547 ' O ' HG23 ' A' ' 217' ' ' VAL . 11.6 t80 -71.47 -64.26 0.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 5.03 110.837 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.7 tp -50.8 -53.68 29.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 2.15 110.915 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 85.5 m -55.37 -44.24 75.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.91 111.167 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.68 -43.91 76.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.65 111.098 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 213' ' ' PHE . 24.6 t -55.09 -41.87 61.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.64 111.14 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -60.23 -31.33 70.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 2.22 110.857 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -74.62 -40.35 61.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 3.66 110.884 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.579 HG21 ' HA ' ' A' ' 138' ' ' PHE . 49.4 mm -54.64 -43.35 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.54 111.101 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.467 ' O ' HD23 ' A' ' 226' ' ' LEU . . . -75.87 -50.47 7.83 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.733 -0.746 . . . . 0.93 112.528 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.81 -31.69 62.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 2.29 110.865 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.9 p -95.24 22.11 7.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 2.04 110.846 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 220' ' ' ILE . 17.2 mt -142.31 18.03 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 2.3 110.888 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.606 ' O ' HD22 ' A' ' 226' ' ' LEU . . . 90.26 70.08 1.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 1.89 112.499 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.606 HD22 ' O ' ' A' ' 225' ' ' GLY . 2.8 mm? -130.28 169.47 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 3.58 110.928 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -82.29 -120.89 0.62 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 2.67 112.45 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.87 33.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.331 . . . . 3.39 110.819 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.0 m -153.09 -75.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 5.42 110.832 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.0 t 57.7 -169.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 6.34 110.888 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.06 160.29 0.87 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.632 0.729 . . . . 2.92 110.851 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -14.84 36.46 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.639 2.226 . . . . 2.51 112.346 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.74 -19.7 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 3.65 110.889 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.57 170.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 1.66 111.067 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 235' ' ' VAL . 7.9 t -88.17 -1.37 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 3.18 111.156 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -30.2 20.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 3.86 110.897 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.53 137.69 31.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.638 0.732 . . . . 3.96 110.877 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.41 ' O ' HG23 ' A' ' 239' ' ' THR . 53.8 Cg_endo -69.71 77.97 1.02 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 2.56 112.375 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 238' ' ' PRO . 1.1 p -156.41 168.03 28.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 2.55 111.136 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -125.37 112.53 16.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 3.76 110.922 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.01 153.02 48.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 2.7 110.888 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -111.13 102.47 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 3.49 110.94 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 244' ' ' ASP . 7.5 t -107.57 157.21 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 2.35 111.146 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 243' ' ' VAL . 0.7 OUTLIER -75.92 135.32 40.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 3.62 110.855 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.671 HG23 ' CB ' ' A' ' 206' ' ' HIS . 19.6 pt -58.17 -22.61 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 2.73 111.116 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -21.41 24.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 3.06 110.903 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.9 m -100.73 -6.11 25.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 2.74 111.116 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.06 158.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 5.34 110.848 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -178.22 149.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 4.34 110.879 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.951 HD12 HD12 ' A' ' 255' ' ' ILE . 1.8 tm? -83.87 150.82 25.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 2.49 110.888 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.785 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.4 OUTLIER -87.67 123.61 32.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 3.6 110.894 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -44.73 -54.79 5.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 4.01 111.067 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.08 -39.63 63.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 3.59 110.895 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -71.68 -34.53 69.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 2.76 110.905 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.951 HD12 HD12 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -50.75 -30.84 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 1.84 111.111 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -79.39 -35.38 40.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 6.1 110.88 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -61.17 -16.72 49.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 1.61 112.479 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 7.5 tp -114.45 -36.27 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.84 111.172 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? -67.37 -50.71 58.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 3.73 110.881 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 2.1 110.852 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.775 0.322 . . . . 2.04 111.132 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.45 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 30.2 p90 -144.58 136.78 26.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 4.61 110.908 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.27 133.63 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 4.49 110.878 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.647 HD13 ' HB ' ' A' ' 134' ' ' ILE . 26.5 mt -108.05 141.61 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 2.48 111.16 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -157.44 47.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 4.27 110.83 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.519 ' CG ' HG12 ' A' ' 161' ' ' VAL . 21.4 p-10 -147.23 143.72 28.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 5.63 110.914 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -148.29 162.47 39.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 6.44 110.934 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.545 HG23 HD11 ' A' ' 212' ' ' LEU . 1.0 OUTLIER -87.8 156.73 52.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.562 0.696 . . . . 3.2 111.164 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 122' ' ' THR . 53.7 Cg_endo -69.71 -52.18 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.664 2.243 . . . . 2.5 112.352 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -66.94 -46.0 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 5.43 110.932 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 10.7 mmt -98.26 122.88 41.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 3.63 110.888 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -56.2 171.78 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 4.48 110.879 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.59 ' HA ' HG12 ' A' ' 130' ' ' VAL . 14.5 ptt180 -67.2 -10.56 51.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 5.99 110.853 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -34.17 71.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 5.18 110.902 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.31 -41.23 41.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 3.81 110.875 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.832 HG23 HD21 ' A' ' 212' ' ' LEU . 9.7 p -74.17 -33.99 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 1.2 111.113 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -49.92 -53.02 28.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 2.65 110.847 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -76.16 -33.1 59.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 3.11 110.924 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.38 -58.65 7.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.8 111.098 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.681 HG12 HG22 ' A' ' 130' ' ' VAL . 5.3 mm -67.78 -45.48 84.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 2.74 111.093 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -50.3 -48.99 54.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 3.73 110.854 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -76.83 -20.37 56.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 5.36 110.885 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 134' ' ' ILE . . . -56.01 -37.96 69.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.9 111.141 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.31 -25.17 60.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 3.88 110.901 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -73.63 -27.79 61.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 3.16 110.932 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.711 HG21 ' CG2' ' A' ' 217' ' ' VAL . 21.6 t -58.94 -55.94 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 2.05 111.151 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -44.21 61.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 4.37 110.945 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.3 m -54.87 -24.87 25.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 2.63 110.855 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -58.08 -22.62 51.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 2.25 110.899 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.754 HG11 HD11 ' A' ' 255' ' ' ILE . 23.5 m -140.3 37.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 2.11 111.14 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.8 m -142.88 131.52 11.53 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.62 0.724 . . . . 1.71 111.149 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 66.75 1.77 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 2.32 112.305 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tp -140.62 166.25 25.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 2.55 110.906 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -118.38 162.29 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 4.43 110.905 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -135.8 119.84 17.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 6.91 110.881 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 98.4 p -127.35 90.01 3.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 2.26 110.894 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 120.13 12.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 2.56 110.882 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 154' ' ' THR . 5.5 pt -148.03 156.93 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 3.05 111.161 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -96.52 -24.33 16.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 3.95 110.874 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.662 ' O ' HD12 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -95.71 175.51 6.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 3.17 111.148 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.46 -171.95 42.88 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.712 -0.756 . . . . 1.86 112.507 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mtt -110.65 157.09 20.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.794 0.33 . . . . 5.1 110.846 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -137.08 146.57 45.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.01 111.094 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.75 -17.79 32.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 2.77 110.901 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.3 mm -104.31 84.47 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 2.58 111.164 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.587 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.2 tm? -91.78 117.15 29.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 1.42 110.902 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.587 ' N ' HD22 ' A' ' 160' ' ' LEU . 21.2 t -102.71 110.75 30.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 1.35 111.097 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.582 ' CG2' HD11 ' A' ' 160' ' ' LEU . 45.2 t -133.97 141.94 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 1.06 111.158 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -80.81 145.7 31.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 3.43 110.857 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.57 ' HB1' ' CD2' ' A' ' 168' ' ' HIS . . . -164.27 156.0 16.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 1.69 111.094 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.62 140.1 31.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 5.71 110.829 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.43 -136.4 35.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 1.58 112.468 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.29 127.71 33.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 1.34 111.061 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.57 ' CD2' ' HB1' ' A' ' 164' ' ' ALA . 5.5 m170 -101.22 25.31 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 6.12 110.865 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.19 92.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.807 -0.711 . . . . 2.78 112.505 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.9 t0 63.71 59.03 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.341 . . . . 5.5 110.848 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -158.03 -170.5 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 4.16 110.868 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -96.07 106.25 18.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 5.85 110.866 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.03 159.17 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 2.13 111.063 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.09 -74.06 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 6.07 110.866 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -179.28 -74.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 4.27 110.894 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.08 -155.06 24.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 2.43 112.501 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -59.43 123.06 15.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.844 0.354 . . . . 5.39 110.864 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.38 90.6 0.64 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 3.3 112.459 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.25 -140.59 11.02 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.794 -0.717 . . . . 1.54 112.507 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.0 mt -72.06 92.24 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.893 0.378 . . . . 2.17 111.187 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -48.51 -28.96 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 3.36 110.921 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.14 178.3 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.58 111.065 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -151.64 125.49 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 3.22 110.885 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.93 104.9 8.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.96 111.13 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.09 165.81 8.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 3.22 110.921 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.4 171.12 0.28 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.784 -0.722 . . . . 1.04 112.521 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -170.04 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.691 2.261 . . . . 1.17 112.317 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.12 -112.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 1.46 112.459 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.87 135.24 43.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 2.11 110.875 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.61 -86.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.95 112.467 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 90.8 mt -71.76 -23.45 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 2.07 111.097 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -58.46 117.3 10.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.749 . . . . 2.46 112.474 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.71 -14.6 64.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.723 -0.751 . . . . 0.81 112.494 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -51.63 128.64 23.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.812 0.339 . . . . 2.03 110.862 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -117.27 148.76 41.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.8 111.098 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.583 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 39.7 m-70 -137.08 124.78 22.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 2.63 110.835 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.509 ' CE2' HD23 ' A' ' 212' ' ' LEU . 0.2 OUTLIER -107.35 143.41 35.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 4.09 110.853 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -77.93 58.08 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 6.15 110.899 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -73.18 -13.51 61.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 9.6 110.882 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -127.5 7.11 6.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 6.22 110.91 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -121.74 -34.98 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 6.02 110.862 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.52 91.69 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 7.57 110.898 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -104.51 122.53 45.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 8.98 110.938 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.11 162.53 38.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 2.11 111.168 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.52 -170.21 1.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 2.3 111.136 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -47.17 -46.95 24.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 6.02 110.849 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -59.22 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 2.28 110.847 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.26 171.2 0.25 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.738 . . . . 2.5 112.448 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.99 -90.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.744 . . . . 1.55 112.514 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.02 97.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.321 . . . . 1.47 111.169 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -68.34 117.82 10.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 2.84 110.873 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.832 HD21 HG23 ' A' ' 130' ' ' VAL . 0.7 OUTLIER -51.35 -40.26 58.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 2.46 110.914 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -71.45 -56.22 6.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 4.78 110.909 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.52 HD21 ' CE1' ' A' ' 248' ' ' PHE . 0.1 OUTLIER -52.34 -54.74 27.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 2.75 110.892 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 92.3 m -55.52 -38.42 69.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.8 111.164 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.61 -50.66 69.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.071 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.711 ' CG2' HG21 ' A' ' 140' ' ' VAL . 39.3 t -57.01 -36.15 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.74 111.129 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -59.73 -41.89 91.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 2.07 110.873 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -66.71 -36.87 83.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 4.21 110.864 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.8 mm -57.85 -57.89 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 1.48 111.171 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.34 -41.61 99.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.83 112.471 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -46.33 65.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 3.2 110.863 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.25 23.44 5.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 2.34 110.807 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.96 87.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.185 -0.462 . . . . 3.81 110.883 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 131.47 -81.87 0.32 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 2.51 112.454 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.45 179.26 3.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 3.52 110.953 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.44 120.22 1.32 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.732 -0.747 . . . . 2.67 112.444 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 63.34 91.35 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.815 0.341 . . . . 1.82 110.886 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.9 t -98.12 -75.49 0.55 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.166 -0.47 . . . . 4.14 110.918 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.0 t -178.99 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.508 . . . . 4.37 110.861 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.1 116.86 7.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.638 0.732 . . . . 2.66 110.909 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -8.73 24.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.726 2.284 . . . . 2.54 112.319 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 -24.21 13.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 5.12 110.882 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.433 ' HB2' ' OG ' ' A' ' 251' ' ' SER . . . -61.9 169.08 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.01 111.105 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.44 ' O ' HG12 ' A' ' 235' ' ' VAL . 3.7 t -94.6 7.35 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 3.1 111.142 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -89.26 -34.13 16.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 4.51 110.884 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.94 138.34 95.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.677 0.751 . . . . 3.9 110.815 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 87.4 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.655 2.237 . . . . 2.26 112.35 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.08 139.49 14.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 2.64 111.179 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.74 112.28 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 3.78 110.916 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -129.26 -169.18 2.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 5.68 110.881 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -114.53 79.57 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 3.49 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 244' ' ' ASP . 3.8 t -107.33 159.95 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 2.78 111.119 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.421 ' N ' HG12 ' A' ' 243' ' ' VAL . 0.6 OUTLIER -48.84 112.88 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 5.48 110.829 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.5 pp -76.69 -33.11 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 3.34 111.124 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -72.26 -39.2 68.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 4.1 110.88 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.13 17.97 13.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 2.74 111.194 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.52 ' CE1' HD21 ' A' ' 214' ' ' LEU . 9.5 t80 -70.62 138.23 50.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 6.83 110.853 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -154.38 134.18 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 4.01 110.887 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.74 HD11 HD12 ' A' ' 255' ' ' ILE . 0.5 OUTLIER -53.24 171.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 2.94 110.94 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 97.7 p -89.58 -172.8 3.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 4.66 110.842 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -85.76 -59.88 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 3.89 111.157 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -37.2 62.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 3.82 110.846 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -70.49 -29.77 66.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 3.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.754 HD11 HG11 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -52.82 -28.39 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 1.99 111.124 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -87.73 -36.49 17.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 4.69 110.908 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.82 -17.48 50.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.708 -0.758 . . . . 1.73 112.512 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.3 tp -109.59 -30.37 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.97 111.141 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -77.65 -40.07 43.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 2.96 110.901 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 2.48 110.862 -179.794 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 149' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.78 0.324 . . . . 3.02 111.152 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.566 ' HB3' HD11 ' A' ' 159' ' ' ILE . 16.9 p90 -139.67 136.57 34.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 5.19 110.913 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.03 107.09 15.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 4.27 110.823 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.788 HG23 HG23 ' A' ' 161' ' ' VAL . 18.1 mt -75.23 138.76 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 2.36 111.142 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.66 ' HB2' HG22 ' A' ' 162' ' ' VAL . 4.0 m120 -98.3 -74.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 4.79 110.863 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.35 145.47 47.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 5.91 110.873 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -85.69 163.25 18.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 6.54 110.911 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.7 p -100.87 137.94 19.91 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.557 0.694 . . . . 3.34 111.163 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -171.49 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.684 2.256 . . . . 2.71 112.335 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 56.64 22.97 7.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 4.06 110.887 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -165.28 142.82 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 4.45 110.895 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.45 142.52 58.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 2.51 110.885 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -56.03 -25.2 43.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 5.12 110.855 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -75.69 -38.83 58.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 3.12 110.943 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.26 -51.12 67.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 2.47 110.903 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.611 ' O ' HD12 ' A' ' 134' ' ' ILE . 6.4 p -62.1 -39.6 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.83 111.164 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -68.12 -54.6 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 2.95 110.882 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -62.16 -33.29 74.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 2.68 110.93 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.596 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -63.21 -57.98 8.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.76 111.098 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 130' ' ' VAL . 6.6 mt -67.51 -49.27 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 2.49 111.111 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -49.58 -46.82 49.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 4.18 110.915 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 140' ' ' VAL . 10.4 mtpt -78.63 -29.02 45.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 3.02 110.849 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.688 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -56.03 -54.14 48.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 1.4 111.069 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.752 ' CZ ' HD11 ' A' ' 224' ' ' LEU . 1.3 t80 -61.2 -40.63 94.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 4.62 110.882 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -55.22 -28.07 50.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 2.85 110.891 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 136' ' ' LYS . 35.3 t -60.98 -49.48 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 1.79 111.137 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.678 ' HE1' HD12 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -70.61 -48.46 55.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 4.21 110.959 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.05 -20.39 38.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 3.53 110.87 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -50.11 -31.88 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 2.7 110.894 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.722 HG11 ' CG1' ' A' ' 255' ' ' ILE . 3.6 m -128.59 51.19 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 2.01 111.139 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.67 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -151.73 140.57 13.68 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.559 0.695 . . . . 1.78 111.123 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.8 Cg_endo -69.76 -38.17 8.17 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.654 2.236 . . . . 1.96 112.323 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.54 ' O ' HD12 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -49.53 104.34 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 2.96 110.899 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.22 129.47 49.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 4.77 110.889 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.507 ' HB3' HG23 ' A' ' 115' ' ' THR . 1.4 m-85 -138.34 153.54 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 11.19 110.886 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.6 t -104.29 132.28 50.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 2.77 110.809 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.34 147.3 31.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 3.42 110.962 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 58.1 mt -135.68 119.07 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 2.9 111.153 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.13 -39.91 57.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 3.01 110.924 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 95.7 m -137.27 109.42 7.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 2.99 111.131 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 173.05 -153.99 19.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 1.67 112.494 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.98 135.61 51.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 5.56 110.86 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.89 -175.15 2.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 2.0 111.041 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.33 -26.36 6.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 3.11 110.902 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 116' ' ' TYR . 1.4 pp -135.58 141.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 3.58 111.166 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 194' ' ' ASP . 0.5 OUTLIER -132.39 165.47 24.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.455 . . . . 2.17 110.936 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.788 HG23 HG23 ' A' ' 118' ' ' ILE . 2.0 m -125.21 110.96 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 2.81 111.146 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 119' ' ' ASN . 12.0 t -126.86 154.52 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 1.31 111.158 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -123.05 137.73 54.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 3.52 110.858 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.95 174.56 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 2.23 111.102 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -125.71 169.4 12.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 4.85 110.852 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.43 -138.39 28.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 2.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.07 129.96 35.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 1.83 111.109 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -89.75 11.01 21.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 3.89 110.899 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 58.85 18.4 39.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 4.07 112.48 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -148.19 29.08 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.749 0.309 . . . . 7.12 110.856 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.3 t70 64.37 47.41 3.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 6.72 110.873 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -137.45 70.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 5.15 110.871 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.59 159.83 23.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 2.17 111.077 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -98.07 -169.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 9.5 110.9 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -143.67 -39.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 4.86 110.858 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.43 166.58 21.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.721 -0.752 . . . . 1.76 112.524 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -50.12 118.74 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 3.61 110.899 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.65 -55.12 0.75 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 2.85 112.472 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.53 -118.78 4.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 1.67 112.502 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.1 mm -74.1 140.19 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 1.84 111.12 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.679 ' N ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -124.34 -5.12 7.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 2.99 110.901 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.512 ' N ' HD22 ' A' ' 181' ' ' LEU . . . 179.82 131.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 1.25 111.109 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -113.58 143.08 45.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 3.91 110.819 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -154.14 129.97 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 1.23 111.163 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.88 170.73 10.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 3.37 110.858 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.99 171.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.88 112.481 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 160.51 49.45 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.692 2.261 . . . . 0.85 112.374 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 157.05 -142.44 8.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.727 . . . . 1.16 112.548 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 88.5 p -106.53 117.21 33.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 1.97 110.838 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.14 -58.59 3.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 1.41 112.465 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 191' ' ' ILE . 10.6 mt -93.37 21.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 2.57 111.155 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.79 -115.79 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 3.0 112.51 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.549 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . -88.43 44.95 3.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 1.3 112.496 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.411 ' CG ' HD11 ' A' ' 160' ' ' LEU . 11.6 m-20 -64.98 130.65 44.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 2.22 110.813 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -107.49 109.63 21.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.04 111.104 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -113.81 110.62 20.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 4.84 110.816 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -103.26 118.92 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 2.7 110.888 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -50.77 145.63 6.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 7.02 110.883 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.22 -21.66 23.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 8.2 110.862 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -94.69 -6.39 43.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 4.5 110.83 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -73.48 -25.25 60.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 4.09 110.852 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 18.3 t80 67.59 128.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 5.17 110.861 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -105.57 172.19 6.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 6.39 110.963 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.17 173.29 17.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 1.7 111.127 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -170.74 0.36 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 2.2 111.156 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -67.13 -21.1 65.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 4.64 110.866 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.26 -33.5 9.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 2.12 110.878 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -54.19 177.17 0.3 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 2.59 112.494 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.73 -88.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.733 -0.746 . . . . 1.96 112.473 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.9 m -76.33 98.54 4.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 1.58 111.146 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.45 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.6 OUTLIER -72.89 123.02 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 3.19 110.838 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 133' ' ' ALA . 1.4 tt -72.38 -35.85 68.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 2.28 110.929 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.686 ' CZ ' HD23 ' A' ' 214' ' ' LEU . 2.9 p90 -71.86 -34.79 69.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 5.53 110.859 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.686 HD23 ' CZ ' ' A' ' 213' ' ' PHE . 0.1 OUTLIER -82.68 -52.97 6.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 2.92 110.922 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 94.4 m -55.07 -37.77 67.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.95 111.175 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.26 85.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.98 111.105 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.688 HG22 ' HA ' ' A' ' 137' ' ' ALA . 39.1 t -64.35 -39.94 87.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.02 111.145 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -69.32 -43.17 74.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 2.35 110.824 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -70.32 -56.37 6.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 3.85 110.9 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.461 HD12 ' HB1' ' A' ' 137' ' ' ALA . 76.5 mt -50.48 -33.82 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 2.47 111.119 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.8 -43.01 99.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 1.16 112.455 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -75.37 -29.14 59.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.836 0.35 . . . . 2.97 110.906 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.49 -16.97 64.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 2.48 110.83 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.752 HD11 ' CZ ' ' A' ' 138' ' ' PHE . 7.1 mp -96.98 -23.03 16.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 2.1 110.935 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 136.37 69.18 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 1.74 112.468 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.678 HD12 ' HE1' ' A' ' 141' ' ' TRP . 7.0 mt -160.44 134.62 7.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 3.39 110.89 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -131.68 51.26 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 3.49 112.5 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.8 m80 66.19 144.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 2.04 110.878 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.44 ' N ' ' HE3' ' A' ' 236' ' ' MET . 6.5 t -122.09 -79.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 4.55 110.861 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 175.15 -32.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 4.67 110.906 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 86.1 m-20 -45.66 105.84 0.5 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.543 0.687 . . . . 3.29 110.907 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.4 Cg_endo -69.82 172.56 12.48 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.633 2.222 . . . . 2.83 112.342 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.8 30.56 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 3.44 110.947 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -126.73 172.21 10.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 1.57 111.111 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 235' ' ' VAL . 9.5 p -89.66 7.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 3.09 111.155 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.657 ' CE ' HD22 ' A' ' 226' ' ' LEU . 1.9 mmm -88.02 -39.15 14.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 4.02 110.837 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.52 143.29 20.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.661 0.743 . . . . 4.19 110.886 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 70.41 1.6 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.704 2.269 . . . . 2.29 112.336 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.06 165.99 33.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 2.43 111.085 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -131.49 113.13 13.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 3.76 110.9 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -132.01 139.57 48.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 3.02 110.907 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -69.7 127.87 34.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 3.52 110.879 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.52 HG12 ' H ' ' A' ' 244' ' ' ASP . 0.3 OUTLIER -131.55 177.19 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 2.42 111.131 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.52 ' H ' HG12 ' A' ' 243' ' ' VAL . 0.3 OUTLIER -72.55 125.34 27.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 3.11 110.89 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 24.0 pt -57.09 -24.65 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 3.3 111.115 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -77.81 -39.59 43.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 2.98 110.888 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.81 34.12 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 3.69 111.158 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.96 19.34 4.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 3.93 110.878 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -84.28 149.82 25.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 3.63 110.87 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.646 HD21 ' OD2' ' A' ' 254' ' ' ASP . 0.3 OUTLIER -52.13 158.18 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 2.54 110.935 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.59 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.2 OUTLIER -154.69 -172.71 4.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 3.56 110.865 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 64.63 -177.16 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 2.98 111.089 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -67.75 -22.05 65.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 3.59 110.874 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.646 ' OD2' HD21 ' A' ' 250' ' ' LEU . 4.8 t0 -51.36 -30.01 17.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 3.44 110.823 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.722 ' CG1' HG11 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -51.27 -29.96 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 1.59 111.117 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -88.98 -31.42 18.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 6.45 110.867 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.06 -18.27 40.45 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 1.78 112.482 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.721 ' CG2' HG23 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -101.4 -29.57 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 1.62 111.133 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -79.78 -32.64 40.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 3.82 110.919 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 2.92 110.857 -179.832 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.445 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 28.8 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.842 0.353 . . . . 2.43 111.09 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.0 151.46 31.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 4.43 110.953 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -137.99 127.95 25.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 4.99 110.901 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 82.9 mt -108.2 143.96 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 2.21 111.135 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -145.26 35.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 3.4 110.856 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -133.23 152.56 51.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 4.75 110.908 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -146.49 117.9 7.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 7.32 110.949 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 122' ' ' THR . 4.5 t -82.17 114.22 49.42 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.63 0.729 . . . . 2.83 111.13 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -44.03 2.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.698 2.265 . . . . 2.23 112.315 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.6 -40.29 59.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 3.89 110.841 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -101.38 159.68 15.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 3.22 110.892 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.23 129.65 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.433 . . . . 3.95 110.848 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -57.84 -22.68 49.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 6.95 110.847 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.56 -32.09 47.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 3.4 110.911 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.29 -43.85 48.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 2.91 110.844 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.459 HG22 HD12 ' A' ' 134' ' ' ILE . 7.2 p -65.03 -36.42 77.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.94 111.12 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.62 -54.65 36.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 3.26 110.854 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -69.45 -36.8 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 4.64 110.892 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -55.17 -57.75 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.72 111.154 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.459 HD12 HG22 ' A' ' 130' ' ' VAL . 12.8 mt -68.4 -49.21 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 2.67 111.166 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -51.95 -40.47 60.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 4.16 110.867 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -78.2 -21.76 49.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 3.73 110.886 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.814 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.86 -53.11 60.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.92 111.052 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.497 ' CD1' HD12 ' A' ' 220' ' ' ILE . 39.7 m-85 -57.12 -23.97 50.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 5.67 110.851 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -39.57 51.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 2.65 110.904 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.709 HG12 HD12 ' A' ' 250' ' ' LEU . 33.7 t -57.37 -44.69 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 2.15 111.094 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.685 ' CE2' HD13 ' A' ' 224' ' ' LEU . 11.1 t90 -67.26 -59.34 3.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 9.63 110.92 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -56.23 -23.87 38.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 2.03 110.871 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -67.99 -12.39 60.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 2.86 110.848 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.84 30.39 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 2.88 111.136 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.592 HG21 HG13 ' A' ' 258' ' ' ILE . 0.8 OUTLIER -155.49 157.88 31.73 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.59 0.71 . . . . 2.24 111.081 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -25.14 29.07 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.689 2.259 . . . . 2.63 112.357 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.49 175.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 3.86 110.91 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.32 -178.07 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 4.6 110.926 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -135.63 151.75 50.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 7.17 110.911 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.5 t -156.37 89.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 1.93 110.825 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.43 137.52 54.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 2.31 110.897 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.543 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -143.57 165.93 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 3.46 111.139 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.07 -29.99 5.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 3.92 110.887 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 91.7 m -117.78 110.3 17.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 2.88 111.177 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 142.54 -171.31 24.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 1.57 112.489 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -110.47 157.81 19.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 5.15 110.864 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -146.99 141.89 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 1.22 111.091 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.89 -15.67 62.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.428 . . . . 2.37 110.892 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.514 HD13 ' HA3' ' A' ' 193' ' ' GLY . 39.6 mm -104.03 141.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 2.63 111.111 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 161' ' ' VAL . 4.0 tt -130.78 134.43 46.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.56 110.94 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.713 ' N ' HD23 ' A' ' 160' ' ' LEU . 55.9 t -124.86 110.76 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 1.32 111.13 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.593 HG23 ' CD2' ' A' ' 160' ' ' LEU . 24.4 t -143.25 141.21 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 1.11 111.152 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -81.19 152.72 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 3.71 110.865 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -161.58 167.23 25.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 1.32 111.06 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -139.54 117.74 11.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 5.26 110.851 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.06 -137.85 17.2 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.738 . . . . 1.9 112.503 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -80.55 110.34 15.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 1.97 111.139 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.08 56.9 3.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 3.95 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 52.0 27.23 21.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.73 . . . . 2.69 112.465 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -163.08 -167.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.797 0.332 . . . . 6.1 110.862 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -80.55 55.95 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 6.82 110.894 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -137.93 34.67 2.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 6.9 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.8 127.81 34.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 1.84 111.149 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.81 -82.16 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 6.19 110.861 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.78 -77.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 5.02 110.853 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 126.36 -161.1 20.76 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.747 -0.74 . . . . 2.4 112.469 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -53.32 119.3 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 3.69 110.9 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.46 -14.03 62.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 2.5 112.465 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.87 -150.56 7.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 1.78 112.497 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 182' ' ' ALA . 17.3 mt -71.29 96.66 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 1.99 111.146 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.756 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.4 pp -48.18 -29.65 3.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 3.29 110.907 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.756 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 178.62 176.0 0.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 1.56 111.09 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.35 120.77 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 3.26 110.88 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -109.75 117.55 34.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.63 111.111 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -63.79 166.14 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 3.72 110.876 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.92 172.61 0.27 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.729 -0.748 . . . . 0.84 112.481 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -179.2 2.77 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.682 2.255 . . . . 0.95 112.339 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.39 -136.88 8.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 1.28 112.5 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.2 p -108.72 130.97 55.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.924 0.392 . . . . 2.71 110.872 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.36 -85.39 0.18 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.761 -0.733 . . . . 1.25 112.451 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 191' ' ' ILE . 63.2 mt -71.09 -7.95 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 2.46 111.137 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.97 -84.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 2.77 112.504 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 159' ' ' ILE . . . -76.18 -2.35 72.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 1.22 112.504 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -49.03 114.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 2.26 110.866 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -122.2 154.14 37.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 1.6 111.106 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -133.14 149.52 52.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 2.76 110.864 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.457 ' CE2' HG13 ' A' ' 161' ' ' VAL . 18.6 m-85 -130.0 143.87 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 2.89 110.847 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 199' ' ' GLU . 0.3 OUTLIER -47.88 -73.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 5.63 110.884 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 198' ' ' ASP . 3.7 tt0 63.8 -80.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 8.63 110.909 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -14.04 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 6.27 110.916 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -91.46 15.76 11.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 6.82 110.917 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 67.23 122.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 6.37 110.918 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.43 -170.64 1.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 7.28 110.934 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.01 172.76 18.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 2.26 111.181 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.78 -170.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 2.09 111.163 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -57.17 -20.9 29.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 4.31 110.851 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.32 -69.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 2.31 110.838 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.51 -160.43 10.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.731 . . . . 3.05 112.511 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 50.94 -161.85 1.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 2.29 112.498 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 97.4 m -64.95 104.75 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 2.02 111.177 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.89 141.76 58.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 2.85 110.885 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -72.53 -54.21 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 2.61 110.904 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.731 ' O ' HG23 ' A' ' 217' ' ' VAL . 0.1 OUTLIER -72.31 -51.97 18.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 5.36 110.936 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.434 HD22 HG23 ' A' ' 243' ' ' VAL . 12.3 tp -49.31 -38.45 27.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 2.11 110.967 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.557 HG21 HD22 ' A' ' 181' ' ' LEU . 60.2 m -79.75 -42.66 24.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.78 111.127 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.65 -36.84 77.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.92 111.138 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 137' ' ' ALA . 45.7 t -68.01 -43.84 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 1.02 111.145 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -54.2 -31.64 53.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 2.01 110.888 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -33.11 64.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 3.84 110.867 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.572 ' O ' HD12 ' A' ' 224' ' ' LEU . 40.9 mm -55.32 -50.38 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 1.54 111.129 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.95 -28.58 60.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.93 112.453 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -47.52 75.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.33 . . . . 2.54 110.832 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.98 29.23 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.6 110.864 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.685 HD13 ' CE2' ' A' ' 141' ' ' TRP . 9.0 mt -132.24 -39.96 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 1.88 110.933 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.61 -30.86 0.2 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 1.74 112.482 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.497 HD13 ' HB ' ' A' ' 258' ' ' ILE . 1.3 mp -90.75 90.51 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 3.98 110.936 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.1 -89.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.712 -0.756 . . . . 3.5 112.504 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -118.71 89.84 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 1.94 110.887 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.46 172.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 5.66 110.853 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 8.2 t -112.92 -27.33 8.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 3.83 110.879 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.721 ' CG ' ' HB1' ' A' ' 252' ' ' ALA . 8.7 m-20 -51.77 112.49 3.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.724 . . . . 3.28 110.84 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.8 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 2.13 112.318 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -27.31 69.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 4.02 110.923 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.923 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -72.13 167.68 19.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 2.21 111.092 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.462 HG21 ' HE1' ' A' ' 248' ' ' PHE . 17.0 m -95.49 -15.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 5.08 111.165 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.408 ' SD ' HD21 ' A' ' 250' ' ' LEU . 9.0 tpt -58.22 -21.9 49.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 4.83 110.876 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -52.22 137.38 38.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.652 0.739 . . . . 3.76 110.858 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 76.52 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.693 2.262 . . . . 2.34 112.35 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.8 t -157.32 167.67 29.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 2.88 111.193 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -115.14 112.22 22.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.263 -0.426 . . . . 3.7 110.943 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -136.22 -169.6 2.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 2.82 110.896 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -107.24 142.57 36.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 5.27 110.917 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.434 HG23 HD22 ' A' ' 214' ' ' LEU . 98.7 t -149.47 143.05 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 2.36 111.182 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.87 126.06 26.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 2.75 110.832 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.8 tt -58.09 -22.83 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 3.09 111.132 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.25 -31.28 12.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 3.64 110.916 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.93 33.53 2.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 2.01 111.137 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.598 ' CE2' HG21 ' A' ' 217' ' ' VAL . 8.5 t80 -104.21 129.08 52.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 4.85 110.916 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -176.55 129.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 3.24 110.898 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 140' ' ' VAL . 3.8 mt -58.44 114.65 2.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 3.91 110.9 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 252' ' ' ALA . 0.1 OUTLIER -132.02 108.2 9.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 4.3 110.895 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.923 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 174.18 172.59 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 3.47 111.1 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -18.64 49.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 3.23 110.915 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.475 ' HB2' HD21 ' A' ' 226' ' ' LEU . 1.3 p30 -52.4 -30.44 29.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 3.59 110.868 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 68.6 mt -51.36 -29.0 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 2.85 111.116 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -87.55 -33.13 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 5.11 110.85 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.58 -14.66 77.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 2.08 112.47 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.592 HG13 HG21 ' A' ' 145' ' ' THR . 7.2 tp -92.29 -34.36 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.784 0.326 . . . . 1.7 111.137 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -79.31 -40.84 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 3.53 110.941 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 2.68 110.867 -179.799 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.2 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.841 0.353 . . . . 2.51 111.119 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.527 ' OH ' HD11 ' A' ' 118' ' ' ILE . 11.2 t80 -152.41 136.6 16.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 5.5 110.941 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -161.45 145.77 13.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 4.68 110.868 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.527 HD11 ' OH ' ' A' ' 116' ' ' TYR . 18.7 mt -108.07 148.81 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 1.75 111.144 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -156.45 38.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 2.8 110.907 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.455 ' OD1' HG12 ' A' ' 161' ' ' VAL . 6.3 p-10 -135.39 148.81 49.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 5.41 110.92 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -147.86 122.51 9.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 5.59 110.891 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.56 147.38 41.89 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.55 0.69 . . . . 2.94 111.118 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -168.02 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.652 2.235 . . . . 2.83 112.339 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 73.82 -62.29 0.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 3.9 110.84 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.455 ' SD ' HG23 ' A' ' 205' ' ' THR . 36.2 mmt -100.92 137.26 39.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 3.49 110.874 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.31 158.15 9.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 2.79 110.896 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -52.57 -30.96 33.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 9.15 110.889 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.49 -45.38 72.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 2.88 110.908 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.71 -44.72 93.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 2.36 110.893 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.565 ' HA ' HD13 ' A' ' 212' ' ' LEU . 7.3 p -73.49 -37.02 49.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.96 111.108 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -63.75 -54.5 34.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 2.74 110.872 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -59.31 -33.47 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 2.51 110.927 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.57 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -53.98 -46.15 71.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.87 111.119 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 2.3 mm -83.13 -44.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 2.71 111.17 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.69 -45.23 58.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 4.12 110.923 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.66 ' O ' HG23 ' A' ' 140' ' ' VAL . 31.7 mttt -78.09 -20.48 52.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 3.08 110.907 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.725 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -56.03 -53.69 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.86 111.099 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -36.11 75.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 3.8 110.885 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -28.1 69.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 3.11 110.893 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 136' ' ' LYS . 21.4 t -65.28 -56.19 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 1.84 111.124 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.642 ' O ' HG22 ' A' ' 145' ' ' THR . 1.0 OUTLIER -73.26 -34.41 65.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 3.99 110.884 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.8 t -56.25 -23.49 36.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 1.97 110.874 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.28 -16.6 63.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 2.13 110.885 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.428 HG21 HD22 ' A' ' 250' ' ' LEU . 13.2 t -114.41 -33.46 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 3.18 111.121 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 141' ' ' TRP . 1.4 t -107.19 146.0 32.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.614 0.721 . . . . 3.17 111.146 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -7.61 21.51 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 2.91 112.313 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.805 HD13 HD23 ' A' ' 224' ' ' LEU . 0.2 OUTLIER -51.23 150.34 3.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 2.69 110.965 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.59 -173.15 2.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 7.3 110.923 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -135.56 119.83 17.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 6.95 110.92 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -111.16 89.95 3.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 2.54 110.868 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.9 110.57 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 2.23 110.878 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.497 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.2 pp -146.33 162.84 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 3.06 111.151 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -113.12 51.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 4.36 110.851 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.7 t -175.63 160.17 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 4.3 111.147 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.47 139.81 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 2.19 112.491 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.82 164.3 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.357 . . . . 6.39 110.86 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.02 136.77 23.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 1.84 111.081 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.92 -45.48 64.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 2.54 110.867 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.612 HG22 ' HA3' ' A' ' 193' ' ' GLY . 1.7 pt -108.79 135.53 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 2.85 111.079 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.623 ' O ' HD23 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -133.19 125.46 29.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 2.77 110.922 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.778 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 3.4 t -94.52 112.57 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 1.36 111.117 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.585 ' CG2' HD21 ' A' ' 160' ' ' LEU . 53.1 t -145.03 144.42 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 1.27 111.108 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -108.06 137.89 45.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 3.34 110.896 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.519 ' HB3' ' HZ ' ' A' ' 174' ' ' PHE . . . -139.56 164.01 31.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 1.35 111.105 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.32 126.42 52.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 5.16 110.85 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.72 -142.46 20.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.738 . . . . 1.19 112.516 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.02 124.42 24.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 1.35 111.134 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -89.62 76.64 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 3.12 110.833 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.27 45.72 64.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 2.42 112.499 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.78 88.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 6.64 110.843 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -166.35 -74.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 4.33 110.865 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -137.36 93.74 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 4.08 110.829 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.24 128.86 34.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 1.42 111.116 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.519 ' HZ ' ' HB3' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -128.66 -37.23 1.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 6.59 110.918 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.13 168.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 6.13 110.86 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.85 -148.49 7.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 2.9 112.473 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.27 135.09 27.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 4.95 110.838 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.98 -19.12 6.14 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.738 . . . . 5.1 112.497 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.16 -107.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 3.02 112.535 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.406 HG22 ' H ' ' A' ' 182' ' ' ALA . 26.4 mm -71.4 149.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.898 0.38 . . . . 2.91 111.095 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 182' ' ' ALA . 1.4 mm? -115.49 -18.66 10.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 4.44 110.884 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . 175.64 124.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.83 111.098 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -104.09 164.07 11.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 5.0 110.818 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.519 ' HB2' ' CD ' ' A' ' 219' ' ' GLU . . . -179.68 109.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.89 111.098 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -71.11 150.8 45.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 3.93 110.935 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.6 -167.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 1.14 112.474 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 160.76 48.53 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.658 2.238 . . . . 1.37 112.355 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 147.1 -163.45 28.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.742 . . . . 1.13 112.49 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.08 140.67 29.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.895 0.378 . . . . 2.36 110.841 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.25 -64.96 2.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.681 -0.771 . . . . 1.34 112.513 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.689 HG23 ' CG ' ' A' ' 194' ' ' ASP . 3.7 mp -118.74 61.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.36 . . . . 2.82 111.131 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -88.62 46.33 3.32 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 3.48 112.444 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.612 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . 124.38 31.82 0.88 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 1.37 112.472 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.689 ' CG ' HG23 ' A' ' 191' ' ' ILE . 38.2 m-20 -64.51 139.29 58.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.771 0.32 . . . . 2.91 110.929 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.778 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -96.5 119.8 35.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 1.09 111.104 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -115.18 109.88 18.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 3.95 110.859 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -113.0 101.66 9.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 2.5 110.882 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.41 117.18 2.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 6.4 110.857 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -64.22 -48.61 75.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 7.82 110.942 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -50.16 -30.45 11.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 3.8 110.895 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.44 ' OE2' HD12 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -63.4 -169.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 3.72 110.882 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -125.31 116.73 22.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 4.38 110.869 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.557 ' CZ3' HG21 ' A' ' 215' ' ' THR . 56.1 m95 -105.06 97.41 7.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 7.1 110.957 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.85 172.95 6.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 1.86 111.11 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.455 HG23 ' SD ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -70.42 173.57 6.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 1.93 111.121 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.71 ' HD1' HG22 ' A' ' 245' ' ' ILE . 0.0 OUTLIER -59.12 -21.4 59.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.437 . . . . 9.22 110.891 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.05 -64.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.95 110.833 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.08 -177.14 14.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.772 -0.727 . . . . 2.38 112.478 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 51.47 -170.88 0.31 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 1.64 112.519 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -56.7 99.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 1.56 111.134 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.11 111.66 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 3.69 110.867 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.57 HD22 ' HB3' ' A' ' 133' ' ' ALA . 0.5 OUTLIER -57.8 -35.65 71.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 2.15 110.925 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.736 ' O ' HG23 ' A' ' 217' ' ' VAL . 13.1 m-85 -71.37 -62.43 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 4.75 110.859 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 241' ' ' LYS . 2.3 tp -51.34 -53.51 35.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 2.29 110.917 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.557 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 23.3 m -55.58 -49.4 72.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.78 111.142 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.63 -44.2 76.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.72 111.075 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.737 HG21 ' CE2' ' A' ' 248' ' ' PHE . 23.7 t -66.4 -46.57 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 1.02 111.104 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -54.02 -29.46 43.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 2.27 110.856 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.519 ' CD ' ' HB2' ' A' ' 184' ' ' ALA . 1.9 tt0 -74.59 -42.1 59.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 3.36 110.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.508 ' O ' HD13 ' A' ' 224' ' ' LEU . 49.5 mm -51.21 -32.95 13.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 1.64 111.095 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.65 -55.36 8.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 1.04 112.522 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -37.49 77.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 2.84 110.811 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.0 p -65.23 -34.58 78.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 2.97 110.878 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.805 HD23 HD13 ' A' ' 147' ' ' LEU . 7.1 mp -95.31 23.47 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 2.07 110.902 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.44 98.89 0.27 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 1.95 112.513 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 18.7 tp -149.76 156.6 42.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.793 0.33 . . . . 3.13 110.956 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.93 -109.16 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 2.82 112.497 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.3 147.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 2.37 110.875 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.27 -77.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 6.26 110.894 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t 62.89 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 5.53 110.886 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.0 159.49 68.47 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.635 0.731 . . . . 2.79 110.808 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -24.98 29.12 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 2.16 112.361 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.6 -31.11 12.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 4.12 110.941 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -52.46 172.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 2.23 111.093 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 235' ' ' VAL . 4.0 t -95.38 7.48 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 2.77 111.121 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -27.5 36.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 4.34 110.875 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.447 ' O ' ' CG ' ' A' ' 237' ' ' PHE . 3.0 p90 -47.61 114.59 3.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.681 0.753 . . . . 8.62 110.888 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 61.68 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.669 2.246 . . . . 2.03 112.334 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.93 169.18 21.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 2.4 111.113 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -109.13 113.01 25.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 3.38 110.962 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.613 ' O ' HD22 ' A' ' 214' ' ' LEU . 1.1 tttp -135.29 123.57 23.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 3.5 110.902 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -66.58 141.37 57.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 3.38 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 97.8 t -150.39 144.36 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 2.46 111.103 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.56 126.93 21.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 3.12 110.872 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.71 HG22 ' HD1' ' A' ' 206' ' ' HIS . 1.9 pp -65.27 -25.38 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 3.41 111.107 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.05 -39.5 23.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 3.81 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.1 p -93.13 10.01 33.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 2.56 111.13 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.737 ' CE2' HG21 ' A' ' 217' ' ' VAL . 23.8 t80 -79.42 122.84 26.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 4.9 110.864 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -163.81 148.02 10.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 3.36 110.883 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.702 ' CD2' HD12 ' A' ' 255' ' ' ILE . 0.6 OUTLIER -53.12 151.97 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 2.46 110.929 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.548 ' O ' HD23 ' A' ' 250' ' ' LEU . 6.3 t -89.2 -171.47 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 3.13 110.9 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -84.06 -56.34 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 4.18 111.12 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.71 -38.27 60.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 3.29 110.846 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.53 -29.05 65.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 3.02 110.858 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.702 HD12 ' CD2' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -54.3 -27.56 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.83 111.147 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.0 mtp85 -87.79 -23.43 24.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 4.74 110.87 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.45 -22.96 64.17 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.718 -0.753 . . . . 1.93 112.504 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.449 HD13 ' CD1' ' A' ' 141' ' ' TRP . 6.5 tp -92.87 -31.05 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.329 . . . . 1.41 111.155 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -78.9 -42.55 26.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 4.07 110.911 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 4.63 110.821 -179.789 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.678 HG23 ' H ' ' A' ' 158' ' ' ASP . 5.5 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.743 0.306 . . . . 3.11 111.112 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -142.08 136.53 30.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 5.28 110.935 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -107.93 103.28 12.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 6.75 110.917 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.426 HG21 ' CE1' ' A' ' 121' ' ' TYR . 23.7 mm -70.73 148.44 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 2.63 111.145 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.556 ' ND2' HD21 ' A' ' 160' ' ' LEU . 33.3 m-20 -109.29 -75.09 0.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 4.2 110.877 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -140.07 146.13 38.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 5.88 110.883 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.44 ' HB3' HG11 ' A' ' 130' ' ' VAL . 24.8 m-85 -92.5 163.26 13.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.207 -0.451 . . . . 6.61 110.913 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.32 159.32 29.65 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.564 0.697 . . . . 3.94 111.156 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.8 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.671 2.248 . . . . 2.81 112.345 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 73.84 -63.39 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 4.45 110.819 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.409 ' HE2' ' HB2' ' A' ' 203' ' ' TRP . 0.0 OUTLIER -100.81 144.62 29.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 6.65 110.881 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.09 161.82 15.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 3.5 110.901 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -21.92 48.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 7.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -79.78 -36.67 36.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 4.99 110.895 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 1.2 m-20 -64.0 -44.02 93.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 2.44 110.887 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.491 HG23 ' HG ' ' A' ' 212' ' ' LEU . 10.3 p -74.58 -34.59 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.92 111.077 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.66 -54.61 11.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 2.58 110.852 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -62.82 -33.33 75.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 2.93 110.928 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.692 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -56.92 -58.73 6.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.88 111.125 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 9.5 pt -65.69 -28.31 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 3.1 111.119 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -48.25 -56.12 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 4.33 110.851 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -78.83 -26.17 44.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 2.88 110.871 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 134' ' ' ILE . . . -55.59 -33.97 64.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.89 111.114 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -73.69 -30.75 63.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 5.83 110.842 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -78.99 -29.12 43.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 3.95 110.935 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.655 HG11 HG11 ' A' ' 217' ' ' VAL . 72.6 t -50.73 -42.52 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 1.75 111.136 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.586 ' HZ2' HD11 ' A' ' 226' ' ' LEU . 0.5 OUTLIER -96.18 -44.88 7.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 4.06 110.941 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.0 m -54.99 -24.99 26.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 3.41 110.89 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -61.36 -21.39 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 2.69 110.88 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.1 41.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 1.84 111.121 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.716 HG21 HD11 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -155.62 128.6 4.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.595 0.712 . . . . 1.93 111.183 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 78.15 1.0 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.707 2.271 . . . . 2.72 112.383 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.64 102.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 3.86 110.908 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.93 128.7 47.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 5.62 110.882 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -138.81 152.41 47.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 10.72 110.895 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.01 152.23 23.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 3.09 110.804 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -58.5 151.34 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 3.37 110.863 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.842 HG22 ' H ' ' A' ' 154' ' ' THR . 3.0 mp -137.75 130.33 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 3.2 111.161 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.15 -13.1 61.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 4.05 110.901 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.842 ' H ' HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -94.0 -178.57 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 4.77 111.122 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.18 48.22 2.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 3.01 112.466 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.15 99.6 7.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.34 . . . . 7.31 110.858 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.43 129.78 13.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.426 . . . . 1.68 111.098 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.678 ' H ' HG23 ' A' ' 115' ' ' THR . 0.8 OUTLIER -77.04 -19.1 57.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 4.95 110.844 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.758 HG22 ' CA ' ' A' ' 193' ' ' GLY . 8.2 pt -138.21 141.74 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 3.73 111.126 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.556 HD21 ' ND2' ' A' ' 119' ' ' ASN . 1.9 tm? -114.21 118.65 34.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 1.45 110.93 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 89.0 t -92.39 125.46 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 1.41 111.143 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 163' ' ' PHE . 2.3 p -138.22 164.59 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 2.84 111.123 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.4 ' H ' HG22 ' A' ' 162' ' ' VAL . 79.0 m-85 -137.52 101.09 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 7.41 110.86 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -125.72 155.46 40.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 1.34 111.107 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.93 127.4 53.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 5.57 110.848 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.19 -144.51 13.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.691 -0.766 . . . . 1.21 112.505 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.7 123.04 18.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 1.26 111.088 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -95.15 25.4 4.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 3.05 110.878 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.89 -23.03 30.86 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.694 -0.765 . . . . 2.43 112.448 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -179.31 35.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 5.19 110.886 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.98 -169.46 2.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 5.3 110.886 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -77.05 114.55 15.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 3.96 110.819 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.4 128.8 34.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 1.26 111.101 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -131.21 170.66 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 6.01 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -122.87 165.04 17.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 4.54 110.865 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.22 -142.09 1.49 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.725 -0.75 . . . . 2.4 112.434 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -50.51 119.14 3.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 3.53 110.926 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.11 -73.94 0.44 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.754 -0.736 . . . . 2.27 112.47 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -89.67 -143.26 9.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.751 . . . . 1.68 112.513 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.481 HG21 ' HB2' ' A' ' 183' ' ' HIS . 24.5 mm -71.29 133.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.889 0.376 . . . . 2.15 111.113 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 182' ' ' ALA . 0.4 OUTLIER -101.47 -14.12 17.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 2.78 110.946 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.582 ' N ' HD12 ' A' ' 181' ' ' LEU . . . -178.88 125.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 1.56 111.075 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.481 ' HB2' HG21 ' A' ' 180' ' ' ILE . 1.8 t-160 -143.67 106.93 4.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 3.41 110.915 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -100.34 142.31 32.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.79 111.148 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.39 170.03 16.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 2.41 110.915 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -53.96 176.67 0.3 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.687 -0.768 . . . . 0.8 112.49 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -169.92 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.677 2.252 . . . . 1.11 112.367 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.54 -141.94 13.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 1.57 112.51 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.1 m -127.03 146.26 50.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.928 0.394 . . . . 3.74 110.873 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.22 -58.96 3.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.76 -0.733 . . . . 1.26 112.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.1 mm -106.12 -23.22 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.378 . . . . 2.37 111.169 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.06 128.5 39.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 2.49 112.509 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.758 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . 89.8 -15.44 59.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 1.15 112.513 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -51.77 147.46 6.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 2.43 110.871 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -121.34 109.39 14.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.9 111.093 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -96.99 110.46 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 4.17 110.864 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.566 ' HE2' HG13 ' A' ' 161' ' ' VAL . 41.3 m-85 -115.64 104.95 12.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 2.66 110.886 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -51.7 113.45 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 7.24 110.819 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.93 -41.18 77.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 7.26 110.906 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.76 -51.06 59.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 4.45 110.881 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -54.4 148.29 12.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 4.34 110.862 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -89.27 121.44 31.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 6.47 110.865 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.646 ' HB3' HD23 ' A' ' 212' ' ' LEU . 39.3 m95 -107.4 99.29 8.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 6.9 110.912 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.2 t -157.1 134.14 10.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 4.85 111.154 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.3 t -106.88 72.41 0.89 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 4.07 111.135 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -82.66 -67.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 8.79 110.86 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.5 m -114.23 -71.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 3.14 110.843 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.41 4.75 1.32 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 3.8 112.456 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.14 -161.43 0.97 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 2.52 112.467 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.9 m -59.2 96.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 1.59 111.14 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.408 HD22 HD22 ' A' ' 214' ' ' LEU . 3.0 m-80 -88.38 127.41 35.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 2.79 110.88 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.646 HD23 ' HB3' ' A' ' 203' ' ' TRP . 0.7 OUTLIER -54.78 -37.98 66.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 3.57 110.971 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.699 ' O ' HG23 ' A' ' 217' ' ' VAL . 8.5 p90 -72.29 -32.49 66.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 5.02 110.903 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 211' ' ' ASN . 13.8 tp -74.82 -60.04 2.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 2.59 110.963 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.451 ' CG2' HD13 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -55.45 -38.27 68.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 1.16 111.166 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.96 74.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.94 111.087 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 213' ' ' PHE . 58.7 t -49.18 -43.07 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.83 111.109 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -36.66 71.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 3.15 110.86 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.51 -42.83 58.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 3.91 110.858 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.464 ' O ' HD13 ' A' ' 224' ' ' LEU . 45.2 mm -50.06 -39.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 1.38 111.111 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.717 ' O ' HD23 ' A' ' 226' ' ' LEU . . . -76.11 -51.98 6.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.78 -0.724 . . . . 0.75 112.499 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -55.49 -26.86 44.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 2.27 110.867 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.702 ' O ' HD12 ' A' ' 224' ' ' LEU . 0.3 OUTLIER -95.27 24.73 4.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 1.96 110.905 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 223' ' ' SER . 1.4 mp -148.92 17.96 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 1.84 110.94 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.512 ' O ' HD22 ' A' ' 226' ' ' LEU . . . 88.33 77.21 1.29 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.749 . . . . 1.69 112.499 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.717 HD23 ' O ' ' A' ' 221' ' ' GLY . 2.2 mm? -130.27 179.56 5.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.358 . . . . 3.11 110.942 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.61 -123.73 3.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.805 -0.712 . . . . 2.54 112.507 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.61 150.56 12.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 2.4 110.815 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.3 m 61.0 -92.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 6.76 110.843 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 32.3 m 59.6 -86.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.499 . . . . 4.56 110.847 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.5 155.96 75.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.611 0.719 . . . . 2.52 110.864 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 233' ' ' LYS . 53.6 Cg_endo -69.76 168.79 20.55 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.717 2.278 . . . . 2.8 112.335 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.7 41.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 4.89 110.868 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.639 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -130.85 153.79 48.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 2.24 111.082 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 99.7 t -56.05 -25.74 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 4.42 111.097 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.447 ' SD ' HD12 ' A' ' 226' ' ' LEU . 1.5 tpp -66.4 -18.2 65.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 4.84 110.85 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 239' ' ' THR . 10.0 t80 -109.72 82.22 2.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.657 0.742 . . . . 4.19 110.861 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 104.93 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.651 2.234 . . . . 4.06 112.345 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.416 HG21 ' CE2' ' A' ' 237' ' ' PHE . 1.8 t -157.29 127.77 6.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 2.65 111.136 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -61.82 120.92 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 3.73 110.938 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -162.61 140.9 8.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 3.03 110.892 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -58.59 125.24 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 4.9 110.929 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.4 t -150.49 143.66 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 2.57 111.117 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.51 122.02 8.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 4.0 110.902 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.607 HG22 ' CZ ' ' A' ' 213' ' ' PHE . 22.3 pt -74.74 -23.9 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 3.45 111.092 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -87.22 -23.71 24.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 4.29 110.919 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.2 m -100.95 6.54 43.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 2.64 111.176 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -50.24 132.8 24.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 4.16 110.849 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -179.56 148.05 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 4.76 110.87 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.721 HD11 HG13 ' A' ' 255' ' ' ILE . 0.5 OUTLIER -71.32 171.07 11.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 2.34 110.928 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.56 ' O ' HD12 ' A' ' 255' ' ' ILE . 5.8 p -89.94 170.37 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 4.54 110.895 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.84 -53.75 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 4.08 111.099 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -18.84 51.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 3.03 110.923 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.639 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -70.43 -36.34 73.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 2.72 110.847 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.721 HG13 HD11 ' A' ' 250' ' ' LEU . 2.1 mp -56.96 -32.17 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 3.03 111.154 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -59.03 -26.11 64.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 9.95 110.863 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -98.97 45.17 1.61 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 2.26 112.467 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.716 HD11 HG21 ' A' ' 145' ' ' THR . 7.5 tp -176.69 -36.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.761 0.315 . . . . 1.26 111.105 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.21 -44.27 26.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 4.32 110.905 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 2.35 110.89 -179.817 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.647 HG23 ' HB3' ' A' ' 149' ' ' PHE . 2.7 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.829 0.347 . . . . 2.65 111.129 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -152.57 136.62 16.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 4.88 110.941 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.666 ' CZ ' HD23 ' A' ' 160' ' ' LEU . 45.4 ptt85 -123.1 127.55 48.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 6.23 110.896 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.9 pt -107.59 148.53 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 2.64 111.141 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -149.02 -41.07 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 4.11 110.882 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.474 ' OD1' HG13 ' A' ' 162' ' ' VAL . 32.8 m120 -96.2 150.38 20.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 5.21 110.919 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -147.7 134.28 19.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 6.29 110.902 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.641 HG21 ' CD1' ' A' ' 203' ' ' TRP . 0.8 OUTLIER -53.04 146.85 18.29 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.613 0.72 . . . . 3.18 111.166 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 163.51 38.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 2.85 112.327 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.54 16.13 9.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 3.84 110.86 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.5 tpt -145.36 131.36 19.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 3.61 110.867 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.34 135.22 57.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 3.24 110.878 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -59.07 -20.16 50.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 5.7 110.861 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -74.09 -30.5 62.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 3.85 110.875 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.98 -44.94 75.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 3.45 110.874 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.472 ' HA ' HD21 ' A' ' 212' ' ' LEU . 7.1 p -68.41 -28.33 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 1.36 111.092 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -71.88 -47.97 49.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 3.23 110.841 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.57 -39.1 58.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 3.65 110.9 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 213' ' ' PHE . . . -52.95 -58.73 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 1.32 111.093 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 135' ' ' ARG . 2.8 pp -57.15 -28.55 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 4.39 111.084 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.641 ' N ' HD12 ' A' ' 134' ' ' ILE . 6.9 ttm-85 -56.1 -41.23 74.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 3.42 110.824 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -80.1 -19.65 46.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 3.03 110.895 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.42 -38.54 34.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 1.36 111.064 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.28 -25.71 58.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 5.85 110.878 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -80.69 -51.15 9.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 2.79 110.888 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 136' ' ' LYS . 3.7 p -49.21 -42.28 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 2.57 111.102 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.519 ' HH2' HD23 ' A' ' 226' ' ' LEU . 58.8 t-105 -75.84 -50.8 14.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 4.05 110.882 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 76.7 p -55.15 -24.96 29.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 1.8 110.859 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.99 -31.61 30.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 3.05 110.854 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.731 HG11 HG13 ' A' ' 255' ' ' ILE . 16.8 m -119.24 45.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 2.13 111.167 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.52 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -155.46 135.44 8.3 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.565 0.698 . . . . 2.12 111.124 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.52 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.4 Cg_endo -69.79 -23.74 30.31 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.697 2.265 . . . . 2.0 112.346 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.71 113.4 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 3.59 110.935 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.32 129.12 39.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 5.26 110.918 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.647 ' HB3' HG23 ' A' ' 115' ' ' THR . 0.5 OUTLIER -137.52 154.48 49.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.441 . . . . 11.84 110.886 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.9 t -101.86 122.8 44.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 3.0 110.845 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.25 142.27 43.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 2.59 110.891 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 71.6 mt -113.24 117.6 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 2.91 111.146 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.7 -39.84 59.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 5.4 110.858 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 97.2 m -139.14 112.31 8.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 3.8 111.14 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.25 -163.59 31.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.783 -0.722 . . . . 2.86 112.481 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.73 143.85 38.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 4.92 110.91 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.555 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -113.12 160.44 18.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 1.96 111.088 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.45 -34.31 61.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 3.48 110.897 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.723 HG23 ' O ' ' A' ' 193' ' ' GLY . 66.3 mt -104.7 141.04 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 2.56 111.129 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.666 HD23 ' CZ ' ' A' ' 117' ' ' ARG . 1.7 tm? -121.64 117.31 26.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 1.73 110.93 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.57 HG13 ' HE2' ' A' ' 197' ' ' PHE . 97.0 t -95.45 110.99 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 1.74 111.096 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.567 ' CG2' HD11 ' A' ' 160' ' ' LEU . 40.8 t -149.7 142.21 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 1.27 111.123 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -80.4 152.8 28.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 4.08 110.907 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.3 176.17 8.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 1.53 111.076 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -144.85 111.97 5.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 5.32 110.893 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.12 -125.3 27.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 1.33 112.502 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.68 114.86 23.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.333 . . . . 1.96 111.12 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -89.16 48.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 3.17 110.923 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.85 45.81 5.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.731 . . . . 3.48 112.526 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.74 96.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.337 . . . . 8.37 110.869 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.4 -74.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 4.66 110.846 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -128.06 80.73 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 4.26 110.868 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.22 113.26 19.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.75 111.084 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 141.31 43.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 5.81 110.888 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 p30 178.69 -174.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 4.99 110.86 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.65 106.04 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 2.5 112.521 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.26 118.96 2.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 5.82 110.919 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 121.16 -41.44 1.9 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.748 . . . . 3.09 112.533 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -75.91 -114.03 0.12 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 1.71 112.516 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.8 mm -92.44 135.18 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 2.01 111.102 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 182' ' ' ALA . 0.5 OUTLIER -106.94 -20.84 13.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 3.38 110.892 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.625 ' N ' HD12 ' A' ' 181' ' ' LEU . . . -179.62 124.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 1.61 111.128 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -109.46 146.74 34.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 3.38 110.842 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -155.76 122.34 5.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.72 111.119 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.67 169.45 18.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 2.41 110.897 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.16 177.55 0.27 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.711 -0.757 . . . . 1.07 112.485 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 153.12 69.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.73 2.287 . . . . 1.34 112.331 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.79 175.2 27.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.746 -0.74 . . . . 1.65 112.513 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 88.9 p -58.72 158.89 7.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 2.01 110.891 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.85 -102.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 1.23 112.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.64 -73.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 2.68 111.11 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 50.54 -132.63 30.76 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 2.8 112.51 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.723 ' O ' HG23 ' A' ' 159' ' ' ILE . . . -88.66 47.1 3.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 1.02 112.486 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.92 154.97 37.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 2.46 110.883 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -118.95 109.52 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 1.2 111.02 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -111.44 109.89 20.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 3.45 110.812 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.57 ' HE2' HG13 ' A' ' 161' ' ' VAL . 52.6 m-85 -106.33 103.2 12.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 2.68 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.66 101.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 7.53 110.87 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.9 -29.15 26.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 7.19 110.886 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -32.81 70.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 3.85 110.838 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.84 -174.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 3.5 110.939 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -114.17 76.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 4.46 110.844 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.647 ' CH2' HG21 ' A' ' 215' ' ' THR . 0.6 OUTLIER -73.6 147.52 43.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 7.01 110.938 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.436 HG21 ' H ' ' A' ' 209' ' ' GLY . 0.1 OUTLIER -156.66 173.09 17.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 1.74 111.143 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -173.86 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 2.42 111.117 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -55.64 -48.97 74.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 4.65 110.84 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -81.92 -25.09 35.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 2.89 110.835 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.8 -172.13 0.39 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 3.29 112.474 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.436 ' H ' HG21 ' A' ' 204' ' ' THR . . . -50.47 -86.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 2.77 112.511 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -93.63 109.51 21.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 1.6 111.127 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -49.92 114.31 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 3.7 110.911 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 212' ' ' LEU . 0.1 OUTLIER -61.54 -35.77 78.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 3.18 110.934 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.403 ' HB2' ' HB1' ' A' ' 133' ' ' ALA . 2.0 t80 -72.9 -57.93 3.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 5.39 110.928 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.819 HD22 HG12 ' A' ' 243' ' ' VAL . 14.8 tp -47.9 -45.41 30.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 2.09 110.889 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.647 HG21 ' CH2' ' A' ' 203' ' ' TRP . 24.8 m -59.37 -44.8 92.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.66 111.102 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.28 80.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.91 111.122 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.4 t -49.21 -50.47 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 1.05 111.159 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.58 ' HA ' HG13 ' A' ' 235' ' ' VAL . 50.1 t60 -54.08 -33.63 58.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 2.0 110.882 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.5 ' OE2' ' HB3' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -74.73 -41.57 59.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 3.98 110.855 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.458 ' O ' HD13 ' A' ' 224' ' ' LEU . 39.1 mm -53.37 -37.93 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 1.5 111.105 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.99 -53.56 5.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 0.81 112.493 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -57.15 -24.92 57.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 2.47 110.872 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.3 m -87.25 -17.58 32.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 1.59 110.864 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 220' ' ' ILE . 6.2 mp -120.82 24.83 10.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 1.87 110.95 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.87 106.52 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 1.98 112.466 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.812 HD11 ' HA ' ' A' ' 236' ' ' MET . 2.3 tm? -144.12 -67.01 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 4.1 110.905 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.486 ' N ' HD13 ' A' ' 226' ' ' LEU . . . 67.13 121.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 3.48 112.486 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -51.71 152.68 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 2.24 110.866 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 73.7 m -134.05 -77.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 3.99 110.856 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 8.2 t 178.09 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 5.33 110.895 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -48.4 108.01 0.85 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.612 0.72 . . . . 2.82 110.883 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 157.02 61.85 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.717 2.278 . . . . 1.85 112.314 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.14 17.9 8.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 5.83 110.927 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.46 175.45 5.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 2.41 111.099 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 218' ' ' HIS . 49.7 t -71.46 -18.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 5.05 111.139 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.812 ' HA ' HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -57.05 -74.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 6.46 110.823 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -128.36 65.14 69.89 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.658 0.742 . . . . 6.62 110.903 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -169.88 0.36 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.669 2.246 . . . . 6.01 112.367 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.49 155.37 40.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 2.54 111.137 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -62.09 118.7 7.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 3.95 110.912 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.64 -168.94 1.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 3.36 110.922 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -132.75 102.55 5.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 4.15 110.942 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.819 HG12 HD22 ' A' ' 214' ' ' LEU . 10.0 p -108.69 157.08 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 2.55 111.108 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -58.63 114.64 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 2.66 110.864 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -69.2 -25.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 3.52 111.118 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -28.6 32.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 3.87 110.895 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.29 13.27 32.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 2.38 111.153 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -51.28 164.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 5.03 110.877 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -179.44 146.97 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 3.37 110.863 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.675 HD23 ' CD1' ' A' ' 255' ' ' ILE . 40.7 tp -66.98 162.48 21.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 2.76 110.91 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.77 145.22 25.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 5.07 110.846 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -63.22 -71.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 3.26 111.115 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.09 -35.06 59.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 3.7 110.841 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -70.82 -29.99 66.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 2.88 110.85 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.731 HG13 HG11 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -51.58 -28.51 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 1.92 111.106 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.8 mtp85 -79.88 -37.77 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 5.82 110.824 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.36 58.88 3.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.741 -0.742 . . . . 2.41 112.505 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.417 HG21 ' CG2' ' A' ' 144' ' ' VAL . 5.2 tp -177.89 -39.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.321 . . . . 1.17 111.151 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -73.55 -30.89 63.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 4.26 110.901 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 3.52 110.865 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.629 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 30.5 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.782 0.325 . . . . 1.95 111.142 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -146.96 136.67 23.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 4.46 110.875 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -135.21 126.23 27.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 4.31 110.859 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.645 HG21 HG21 ' A' ' 134' ' ' ILE . 22.1 pt -104.82 133.96 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 3.11 111.103 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -135.55 29.37 3.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 3.29 110.904 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.86 151.33 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 5.42 110.926 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -147.69 145.23 28.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 6.55 110.943 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' ' 125' ' ' MET . 0.0 OUTLIER -119.67 133.14 23.83 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.601 0.715 . . . . 3.34 111.121 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -49.56 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.69 2.26 . . . . 3.02 112.329 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -30.99 15.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 4.39 110.876 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.495 ' SD ' HG22 ' A' ' 205' ' ' THR . 24.7 mtp -108.01 164.57 12.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 5.34 110.906 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -86.55 161.53 18.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 3.39 110.873 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -25.49 36.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 7.43 110.909 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -80.07 -41.17 26.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 5.17 110.883 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -55.66 -53.03 61.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 2.25 110.873 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.746 HG23 ' CD2' ' A' ' 212' ' ' LEU . 7.4 p -67.1 -37.57 79.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 1.12 111.161 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -61.44 -54.25 45.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 2.55 110.845 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -70.37 -32.54 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 2.8 110.955 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.24 -57.45 8.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.79 111.079 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.71 HD12 ' O ' ' A' ' 130' ' ' VAL . 3.0 mp -76.06 -45.67 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 2.09 111.129 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.61 -37.35 39.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 4.5 110.856 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -78.53 -30.68 47.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 3.95 110.883 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.535 ' HB1' HG13 ' A' ' 220' ' ' ILE . . . -55.73 -35.96 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.99 111.073 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -74.51 -28.15 60.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 3.62 110.878 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.34 -50.42 10.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 2.74 110.932 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.747 ' O ' HD12 ' A' ' 250' ' ' LEU . 6.2 p -50.09 -30.99 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 1.91 111.143 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -88.76 -43.48 11.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 3.8 110.926 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 70.7 p -54.75 -24.79 23.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.16 110.871 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.31 -24.43 43.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 2.71 110.864 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.845 HG11 HG12 ' A' ' 255' ' ' ILE . 4.5 m -140.94 46.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 2.1 111.103 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 m -155.76 132.06 5.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 1.56 111.142 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -8.36 23.4 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.712 2.275 . . . . 1.8 112.364 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.65 147.01 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 2.76 110.891 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 137.24 53.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 5.07 110.894 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -99.35 134.48 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 6.59 110.923 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.4 t -123.87 89.91 3.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.77 110.836 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.88 119.92 19.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 2.58 110.863 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.437 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -120.14 149.29 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 2.8 111.086 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.43 -24.53 34.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 3.69 110.893 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.2 m -139.77 132.16 28.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 3.49 111.142 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.19 162.8 11.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.802 -0.713 . . . . 2.45 112.516 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 42.0 mtt -95.02 166.39 11.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 7.38 110.902 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -142.86 163.49 32.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 1.15 111.093 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -25.53 65.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.72 110.897 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.414 HD13 ' HA3' ' A' ' 193' ' ' GLY . 44.9 mm -104.02 84.54 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 3.08 111.094 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.636 HD21 HG23 ' A' ' 162' ' ' VAL . 1.2 tm? -81.06 115.78 20.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 1.38 110.945 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.591 ' N ' HD22 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -105.84 107.98 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.97 111.154 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.636 HG23 HD21 ' A' ' 160' ' ' LEU . 69.4 t -138.27 145.08 29.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 1.3 111.066 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -93.11 129.48 39.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 3.63 110.866 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.513 ' HB3' ' OE2' ' A' ' 199' ' ' GLU . . . -111.09 178.39 4.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 1.26 111.117 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -144.02 112.24 6.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 4.55 110.866 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 58.66 -131.15 51.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 1.27 112.521 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . . . -86.95 110.55 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 1.35 111.096 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -85.36 53.64 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 3.16 110.882 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 78.62 -57.74 4.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.733 -0.746 . . . . 3.09 112.499 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -162.7 46.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 5.56 110.882 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.31 -169.13 1.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 4.6 110.869 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -76.75 96.4 4.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 3.79 110.911 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 167' ' ' ALA . . . -81.39 143.64 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 1.52 111.11 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -155.75 139.18 15.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 6.8 110.906 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.17 -175.47 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 4.78 110.841 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.74 99.32 1.09 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 2.69 112.464 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.04 118.95 2.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 3.68 110.865 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.16 -34.74 5.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 3.7 112.479 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.79 -147.63 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 2.0 112.494 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.6 mm -71.62 89.47 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 2.69 111.104 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.6 pp -45.2 -32.89 2.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 3.46 110.919 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.727 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 178.61 167.91 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.49 111.12 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -146.52 106.3 3.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 3.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -90.63 121.3 32.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.77 111.106 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.94 151.68 42.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 2.75 110.873 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.68 167.33 0.47 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 1.08 112.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 154.37 67.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 1.03 112.327 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 167.56 -110.03 0.37 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 1.78 112.48 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 93.3 p -131.28 142.25 50.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.401 . . . . 3.34 110.806 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.08 -87.43 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 1.4 112.484 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 191' ' ' ILE . 10.4 tt -91.94 14.93 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 3.49 111.124 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -55.71 -68.47 1.67 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.783 -0.723 . . . . 2.71 112.492 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.414 ' HA3' HD13 ' A' ' 159' ' ' ILE . . . -85.62 2.85 87.81 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 1.41 112.453 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.14 139.4 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.812 0.339 . . . . 2.62 110.849 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.553 ' HB1' ' HG3' ' A' ' 219' ' ' GLU . . . -134.31 154.68 51.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 1.04 111.09 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.534 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 48.1 m80 -135.21 129.9 34.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 2.5 110.833 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -108.8 106.18 16.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 3.1 110.888 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.45 82.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 5.76 110.845 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.513 ' OE2' ' HB3' ' A' ' 164' ' ' ALA . 1.5 mm-40 -51.33 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 8.26 110.843 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.92 28.83 5.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 4.64 110.853 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -95.04 -80.97 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 4.56 110.895 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 174.27 134.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 4.64 110.867 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 95.27 5.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 6.88 110.917 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 2.6 m -157.04 120.32 4.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 3.92 111.117 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.495 HG22 ' SD ' ' A' ' 125' ' ' MET . 4.5 t -111.5 65.38 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 4.56 111.169 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -88.47 -68.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 9.61 110.866 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.81 -43.32 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 3.24 110.909 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 242' ' ' TYR . . . -155.59 -112.76 0.42 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.751 . . . . 3.45 112.469 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 40.63 -133.99 2.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 2.66 112.475 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.49 97.05 9.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 1.89 111.16 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.8 111.44 23.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 3.46 110.899 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.746 ' CD2' HG23 ' A' ' 130' ' ' VAL . 13.2 tp -51.45 -31.44 23.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 4.57 110.918 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.96 -68.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 3.97 110.871 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.615 HD22 ' CB ' ' A' ' 241' ' ' LYS . 3.6 mp -76.89 -36.83 56.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 3.9 110.876 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.458 ' CG2' HD22 ' A' ' 181' ' ' LEU . 70.2 m -54.56 -45.8 73.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.73 111.173 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.5 -44.65 76.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.83 111.101 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.577 HG21 ' CZ ' ' A' ' 248' ' ' PHE . 29.4 t -51.35 -49.88 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.77 111.171 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -55.29 -33.77 63.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 1.92 110.832 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.553 ' HG3' ' HB1' ' A' ' 195' ' ' ALA . 1.7 tm-20 -74.52 -40.71 61.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 5.47 110.885 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.535 HG13 ' HB1' ' A' ' 137' ' ' ALA . 42.9 mm -50.78 -47.48 28.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 1.54 111.116 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.98 -23.99 70.44 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 0.97 112.495 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -49.44 70.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 2.86 110.869 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 43.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 1.87 110.828 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.3 mt -144.33 -42.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 2.39 110.923 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 168.71 -38.0 0.21 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.787 -0.72 . . . . 2.33 112.529 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.19 177.91 7.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 3.33 110.922 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.42 -77.62 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.729 . . . . 3.48 112.477 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -143.11 113.98 7.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.865 0.364 . . . . 1.8 110.866 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.1 t -92.35 -78.16 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 4.48 110.902 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.4 t 176.85 -33.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 4.42 110.853 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -49.55 108.13 0.92 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 2.42 110.85 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.9 Cg_endo -69.79 167.78 23.48 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.688 2.259 . . . . 1.74 112.329 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.65 29.82 6.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 4.24 110.931 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.73 -174.61 2.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 1.97 111.101 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 235' ' ' VAL . 11.6 t -93.56 -4.1 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 2.92 111.112 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.433 ' HE3' ' HA ' ' A' ' 236' ' ' MET . 1.6 tpt -83.25 -41.66 18.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 3.67 110.849 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.695 ' HB3' HG22 ' A' ' 239' ' ' THR . 0.1 OUTLIER -51.32 149.83 6.91 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.659 0.742 . . . . 3.65 110.893 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -7.23 20.5 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.685 2.256 . . . . 2.72 112.351 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.695 HG22 ' HB3' ' A' ' 237' ' ' PHE . 14.7 t -84.86 138.01 32.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 2.57 111.139 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -66.25 145.44 55.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 3.85 110.892 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.615 ' CB ' HD22 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -90.88 102.39 15.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 4.37 110.888 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.405 ' HB2' ' HA3' ' A' ' 208' ' ' GLY . 18.6 p90 -91.8 44.37 1.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 6.28 110.941 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.18 177.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 3.59 111.141 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.753 ' HB3' HG22 ' A' ' 247' ' ' THR . 0.5 OUTLIER -59.79 126.26 26.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 3.14 110.836 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 214' ' ' LEU . 25.0 pt -76.42 -30.28 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 3.47 111.106 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -65.86 -39.57 90.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 4.97 110.853 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.753 HG22 ' HB3' ' A' ' 244' ' ' ASP . 14.6 t -94.71 -4.77 46.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 3.3 111.116 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 217' ' ' VAL . 21.6 t80 -51.84 144.18 11.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 5.08 110.887 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -175.05 151.45 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 3.48 110.857 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 140' ' ' VAL . 0.8 OUTLIER -52.45 145.3 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 2.08 110.932 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.613 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.2 OUTLIER -154.42 -172.24 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 3.53 110.849 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 65.56 161.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 3.77 111.118 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -22.89 51.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 3.2 110.903 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -51.32 -29.75 16.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 3.64 110.888 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.845 HG12 HG11 ' A' ' 144' ' ' VAL . 8.2 tt -50.74 -29.65 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 2.15 111.164 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -92.34 -31.16 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 6.59 110.827 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.06 -16.86 60.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.778 -0.725 . . . . 1.84 112.494 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.425 ' CG2' HG23 ' A' ' 144' ' ' VAL . 8.4 tp -93.33 -31.47 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.776 0.322 . . . . 1.02 111.121 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -78.43 -48.2 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 4.68 110.912 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 2.67 110.876 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.815 0.34 . . . . 2.18 111.153 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.61 ' CD2' HD11 ' A' ' 159' ' ' ILE . 7.4 m-85 -127.56 152.43 47.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 6.56 110.889 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -161.88 133.79 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 4.45 110.904 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.584 HG23 ' CG2' ' A' ' 161' ' ' VAL . 86.8 mt -108.12 144.06 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 2.39 111.122 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -108.96 -76.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 3.68 110.881 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -124.81 -178.28 4.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 6.11 110.9 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.731 ' HB2' HG11 ' A' ' 130' ' ' VAL . 13.1 p90 -140.85 163.23 33.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 5.32 110.916 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.0 m -73.73 131.34 82.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.528 0.68 . . . . 2.94 111.142 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -34.87 13.73 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.702 2.268 . . . . 2.35 112.366 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -50.49 -53.73 27.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 4.97 110.848 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 19.6 mmt -101.33 154.6 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 3.66 110.888 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -59.1 149.09 28.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 2.97 110.899 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -58.5 -20.87 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 4.84 110.888 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.24 -37.28 61.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 3.8 110.909 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 11.7 m-20 -61.62 -52.2 65.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 3.05 110.886 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.731 HG11 ' HB2' ' A' ' 121' ' ' TYR . 3.8 p -69.43 -30.0 43.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 1.13 111.149 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.42 -48.73 47.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 3.39 110.871 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -75.36 -33.56 61.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.461 . . . . 2.99 110.925 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -51.45 -58.8 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.59 HD12 ' N ' ' A' ' 135' ' ' ARG . 2.9 pp -68.34 -28.01 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 4.14 111.107 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.59 ' N ' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -50.61 -51.0 52.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 4.75 110.908 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -78.63 -32.07 47.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 3.28 110.936 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.653 ' HB1' HD12 ' A' ' 220' ' ' ILE . . . -55.88 -34.85 65.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 1.25 111.111 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -73.96 -28.38 61.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 4.66 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.07 -51.34 9.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 3.55 110.913 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.9 p -51.15 -29.84 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 2.52 111.141 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -85.91 -51.38 6.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 3.84 110.918 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.6 p -60.98 -17.23 50.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 1.79 110.894 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -50.4 -30.69 12.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 3.03 110.936 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.749 HG11 ' CG1' ' A' ' 255' ' ' ILE . 33.6 m -133.39 36.42 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 2.03 111.069 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.704 HG21 HD11 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -146.08 132.96 9.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.566 0.698 . . . . 1.63 111.148 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 64.9 1.79 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.712 2.274 . . . . 2.12 112.316 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mp -121.1 150.05 41.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 3.06 110.899 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.0 174.34 6.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 4.64 110.893 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -112.57 126.09 54.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 8.43 110.903 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.5 t -133.38 89.99 2.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 2.26 110.869 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -81.75 121.94 27.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 2.66 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.461 HG22 ' H ' ' A' ' 154' ' ' THR . 38.0 mt -137.48 113.21 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 3.25 111.127 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.07 -28.92 27.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 4.08 110.844 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.461 ' H ' HG22 ' A' ' 152' ' ' ILE . 94.9 m -160.73 110.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 3.98 111.13 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -173.32 -134.15 1.78 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.758 . . . . 2.35 112.466 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 120.51 42.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.321 . . . . 5.6 110.89 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.94 129.41 43.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 1.45 111.084 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.06 -18.73 28.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 2.41 110.866 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.61 HD11 ' CD2' ' A' ' 116' ' ' TYR . 2.0 pp -138.82 127.04 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 3.19 111.133 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.409 ' H ' HD12 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -136.24 166.38 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 2.34 110.938 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.633 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 3.1 m -112.24 110.09 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 3.1 111.074 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 163' ' ' PHE . 0.4 OUTLIER -120.66 174.71 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 1.74 111.123 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.501 ' H ' HG22 ' A' ' 162' ' ' VAL . 47.7 p90 -106.78 125.06 50.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 5.32 110.904 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -125.71 148.34 49.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 1.63 111.12 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.63 111.57 13.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 4.56 110.853 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.61 -139.56 16.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 1.39 112.457 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.06 111.09 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 2.07 111.135 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -92.29 43.69 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 2.87 110.823 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.83 95.53 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.721 -0.752 . . . . 2.87 112.487 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.4 41.79 7.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.819 0.342 . . . . 6.34 110.87 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.12 -168.81 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 4.42 110.919 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -76.9 102.95 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 4.39 110.853 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.73 112.3 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 1.53 111.093 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -70.01 -168.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 6.08 110.868 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.53 ' HB3' HD12 ' A' ' 180' ' ' ILE . 4.6 t70 -131.95 -41.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 4.69 110.915 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 123.22 -172.42 16.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 1.74 112.504 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.06 118.8 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.331 . . . . 4.74 110.883 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.62 -47.34 1.05 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 2.54 112.485 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -88.86 -121.01 1.83 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.717 -0.754 . . . . 1.38 112.477 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 175' ' ' ASP . 2.0 mp -71.32 148.51 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 3.36 111.152 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.622 HD12 ' H ' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -113.8 -29.55 7.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 3.63 110.935 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.622 ' H ' HD12 ' A' ' 181' ' ' LEU . . . -178.69 123.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 1.63 111.096 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -94.97 162.94 13.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 3.14 110.891 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -173.23 105.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.99 111.048 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.88 170.19 4.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 2.73 110.867 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.09 165.87 1.13 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 1.23 112.458 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 165.24 31.71 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 0.99 112.367 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.04 -136.44 5.03 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 1.38 112.47 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.89 121.26 44.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 3.43 110.832 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.21 -62.93 2.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.756 . . . . 1.72 112.505 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 191' ' ' ILE . 11.7 mt -93.95 21.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 2.44 111.138 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.7 -106.99 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 2.72 112.483 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.492 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . -92.07 37.66 3.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 1.12 112.493 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -50.77 126.06 14.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.794 0.33 . . . . 2.1 110.89 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.82 ' HB1' ' CE2' ' A' ' 197' ' ' PHE . . . -101.86 145.97 28.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 1.24 111.098 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -139.79 107.69 5.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 3.04 110.829 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.82 ' CE2' ' HB1' ' A' ' 195' ' ' ALA . 10.2 m-85 -143.82 108.52 4.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 3.35 110.883 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 t70 179.38 -82.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 8.22 110.832 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.41 153.57 28.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 7.73 110.913 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 64.69 125.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 6.47 110.905 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 63.57 70.45 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 4.57 110.909 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -45.78 157.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 5.05 110.87 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.62 ' CZ3' HG21 ' A' ' 215' ' ' THR . 66.2 m95 -105.35 175.05 5.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 7.23 110.905 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.45 HG21 ' H ' ' A' ' 209' ' ' GLY . 0.0 OUTLIER -157.28 173.44 16.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 2.04 111.144 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -171.51 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 2.06 111.142 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -67.01 -21.76 65.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 5.02 110.876 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.6 m -103.62 -24.71 13.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 2.46 110.812 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -62.48 -160.43 0.18 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 2.25 112.503 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.45 ' H ' HG21 ' A' ' 204' ' ' THR . . . -60.6 -101.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 1.64 112.492 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 210' ' ' THR . 2.4 t -80.42 103.57 10.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 3.6 111.105 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 243' ' ' VAL . 9.8 m-20 -50.38 116.37 1.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 2.99 110.929 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 203' ' ' TRP . 11.5 tp -60.76 -39.29 88.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 3.07 110.954 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.521 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -72.39 -34.7 68.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 5.4 110.881 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -55.07 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 2.99 110.944 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.62 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 98.4 m -54.97 -38.47 67.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 1.14 111.151 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.14 -32.25 61.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.85 111.086 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 137' ' ' ALA . 5.0 t -70.64 -25.53 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.99 111.135 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -69.57 -61.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 1.84 110.868 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.406 ' CD ' ' HB3' ' A' ' 182' ' ' ALA . 3.4 mp0 -58.99 -50.02 75.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 4.72 110.869 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.653 HD12 ' HB1' ' A' ' 137' ' ' ALA . 72.1 mt -51.42 -29.52 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 2.02 111.161 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.56 -44.36 16.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 0.75 112.492 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.59 -34.33 76.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 2.59 110.83 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -28.91 18.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 2.36 110.903 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.3 mp -93.73 -24.64 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 2.34 110.923 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.526 ' O ' HD22 ' A' ' 226' ' ' LEU . . . 126.38 105.49 1.43 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 1.81 112.489 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.619 HD21 ' O ' ' A' ' 257' ' ' GLY . 0.2 OUTLIER -149.37 -68.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 3.25 110.866 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 73.31 31.59 61.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 3.42 112.468 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 21.6 m80 64.47 155.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 2.22 110.877 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 59.4 m -124.84 -78.14 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 4.36 110.86 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.16 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 4.49 110.884 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -47.44 106.64 0.62 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.577 0.703 . . . . 3.3 110.865 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.3 21.94 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 1.89 112.359 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.0 mptt 50.65 29.96 4.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 5.55 110.934 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.531 ' HB1' ' OD2' ' A' ' 254' ' ' ASP . . . -130.59 -168.88 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 2.18 111.101 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.451 ' HB ' ' HE2' ' A' ' 236' ' ' MET . 55.3 t -50.42 -57.26 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 4.45 111.13 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.451 ' HE2' ' HB ' ' A' ' 235' ' ' VAL . 9.8 mmt -59.41 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 3.4 110.875 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 238' ' ' PRO . 0.2 OUTLIER 63.72 99.62 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.651 0.739 . . . . 4.54 110.915 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 237' ' ' PHE . 53.4 Cg_endo -69.83 77.95 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.693 2.262 . . . . 3.36 112.283 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.4 p -145.46 125.53 13.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 2.69 111.116 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -62.77 126.39 27.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 4.42 110.875 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -150.69 92.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 4.18 110.89 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -58.68 127.29 31.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 3.46 110.91 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.557 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 7.6 p -135.97 154.32 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 2.41 111.167 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.19 113.15 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 2.82 110.835 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.0 tt -74.28 -34.5 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.55 111.163 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -24.02 67.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 2.85 110.914 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 14.6 19.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 2.57 111.168 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -51.36 156.97 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 5.13 110.879 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -178.67 148.15 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 3.56 110.88 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.14 161.11 2.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 2.89 110.893 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.429 ' OG ' HG23 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -88.93 150.76 22.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 4.78 110.874 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.434 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -68.96 -68.34 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 3.43 111.106 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -53.31 -36.91 61.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 3.6 110.853 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.531 ' OD2' ' HB1' ' A' ' 234' ' ' ALA . 25.0 m-20 -70.96 -29.23 65.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 3.27 110.838 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.749 ' CG1' HG11 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -51.09 -28.6 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.73 111.111 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -77.78 -37.19 49.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 5.7 110.853 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.619 ' O ' HD21 ' A' ' 226' ' ' LEU . . . -78.63 57.11 4.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 2.66 112.488 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.704 HD11 HG21 ' A' ' 145' ' ' THR . 4.9 tp -179.16 -40.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.86 111.17 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -75.03 -45.07 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 3.03 110.908 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 2.15 110.827 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.724 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 71.8 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.822 0.344 . . . . 2.06 111.128 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -145.57 173.28 12.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 4.22 110.962 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -160.5 125.89 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 7.24 110.838 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.718 HG21 HG13 ' A' ' 134' ' ' ILE . 1.6 pt -108.17 121.63 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 3.23 111.138 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -136.11 47.92 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 3.98 110.88 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.534 ' OD1' HG12 ' A' ' 161' ' ' VAL . 1.1 p-10 -137.5 153.23 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 5.62 110.867 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -147.4 163.15 37.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 7.8 110.883 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 p -125.37 151.72 70.3 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.712 . . . . 2.62 111.155 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 169.08 19.75 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.713 2.276 . . . . 3.18 112.337 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.1 t70 75.65 -52.06 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 6.03 110.824 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.749 ' HG2' HG23 ' A' ' 205' ' ' THR . 3.7 mpp? -97.66 132.91 42.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 3.43 110.895 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.99 155.75 10.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 3.48 110.879 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.06 -23.12 12.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 5.13 110.851 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -41.01 84.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 3.9 110.91 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.36 -54.67 44.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 2.6 110.874 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.504 ' O ' HD13 ' A' ' 134' ' ' ILE . 6.1 p -62.21 -40.66 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.84 111.111 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.13 -40.83 61.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 3.3 110.875 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -74.61 -31.08 61.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 2.92 110.932 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.24 -52.46 35.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 1.15 111.096 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.718 HG13 HG21 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -83.02 -28.52 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 2.27 111.152 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -50.98 -55.08 19.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 6.53 110.869 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -78.25 -25.94 47.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 3.62 110.874 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.665 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.82 -37.26 68.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.8 111.1 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -27.03 61.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 3.43 110.852 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.97 -48.81 13.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 2.97 110.886 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.461 ' O ' HD12 ' A' ' 250' ' ' LEU . 4.6 p -55.8 -27.07 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 2.13 111.115 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.705 ' HE1' HD11 ' A' ' 258' ' ' ILE . 21.4 t90 -91.1 -54.37 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 9.58 110.933 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.5 p -59.22 -18.4 36.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 1.71 110.841 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.2 -26.66 61.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 2.36 110.921 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.605 HG11 HD13 ' A' ' 250' ' ' LEU . 7.1 p -103.85 -23.87 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 3.55 111.114 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.731 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -106.57 145.26 30.67 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.56 0.695 . . . . 1.68 111.15 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.731 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.8 Cg_endo -69.76 -8.58 23.97 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.676 2.251 . . . . 1.91 112.308 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -51.6 158.2 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 2.94 110.881 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.23 138.71 52.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 6.14 110.918 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -101.54 139.25 37.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 6.57 110.871 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.71 ' HB3' HG22 ' A' ' 115' ' ' THR . 0.6 OUTLIER -143.0 90.04 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 1.66 110.849 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -77.81 122.77 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 3.9 110.889 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 154' ' ' THR . 15.7 pt -140.18 163.79 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 2.44 111.14 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -109.59 28.9 8.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 3.71 110.888 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.457 ' O ' HD12 ' A' ' 152' ' ' ILE . 14.6 t -157.65 174.05 15.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 3.6 111.145 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.62 -173.62 12.15 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.74 . . . . 1.58 112.507 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.46 166.34 10.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 5.56 110.873 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.724 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -144.62 146.94 32.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 1.14 111.113 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -26.65 68.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 2.44 110.879 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.8 mm -104.04 109.9 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 2.87 111.173 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.674 HD22 ' N ' ' A' ' 161' ' ' VAL . 0.9 OUTLIER -111.22 119.35 38.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 1.49 110.94 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.674 ' N ' HD22 ' A' ' 160' ' ' LEU . 16.0 t -108.61 109.9 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 1.52 111.129 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.65 HG23 HD21 ' A' ' 160' ' ' LEU . 72.2 t -134.35 144.97 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 1.28 111.134 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -92.22 153.17 19.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 3.93 110.895 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.537 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . . . -164.33 178.02 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 1.08 111.118 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -145.04 111.54 5.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 5.11 110.9 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 63.73 -147.67 50.67 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.712 -0.756 . . . . 1.13 112.504 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.54 112.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 1.26 111.105 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -95.66 27.95 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 2.87 110.812 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.52 18.21 60.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 2.84 112.46 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -106.61 -74.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.763 0.316 . . . . 6.93 110.89 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.19 -65.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 4.54 110.882 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -77.39 107.09 9.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 5.1 110.868 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.32 159.64 23.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 1.82 111.118 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.84 113.83 2.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 6.83 110.818 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.96 -169.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 7.47 110.907 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.99 97.82 2.11 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 2.3 112.477 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -51.67 119.19 3.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 3.5 110.859 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.19 7.05 62.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 2.3 112.475 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -114.76 -126.39 4.19 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 1.48 112.538 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 180' ' ' ILE . 3.6 mp -89.16 93.9 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 2.68 111.129 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -49.9 -26.9 4.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 3.14 110.858 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.5 171.49 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 1.31 111.107 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -160.14 106.26 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 3.05 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.409 ' HB1' ' OG ' ' A' ' 223' ' ' SER . . . -110.75 109.84 20.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.79 111.087 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.06 169.65 4.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 3.06 110.927 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.39 173.8 0.25 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.99 112.443 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 179.62 3.58 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.689 2.259 . . . . 0.93 112.353 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 154.12 -128.79 2.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 1.36 112.529 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.08 141.12 52.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.927 0.394 . . . . 2.0 110.85 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.5 -76.54 0.95 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.721 . . . . 1.15 112.504 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 191' ' ' ILE . 11.1 tt -104.92 16.41 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 3.05 111.13 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.88 -77.58 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 2.83 112.473 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.94 2.22 81.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.775 -0.726 . . . . 1.06 112.479 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.51 127.42 17.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.785 0.326 . . . . 2.21 110.873 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.87 146.39 50.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 1.44 111.088 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.537 ' CD2' ' HB3' ' A' ' 164' ' ' ALA . 32.7 t-80 -113.76 149.89 34.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 6.09 110.834 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.97 147.56 44.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 4.05 110.889 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.74 -35.84 10.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 5.62 110.84 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 63.28 -82.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 7.75 110.853 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -134.87 35.21 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 6.47 110.868 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.8 -5.58 6.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 4.51 110.865 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.17 73.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 8.53 110.87 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -105.36 124.62 49.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 9.44 110.96 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.465 HG21 ' N ' ' A' ' 209' ' ' GLY . 0.0 OUTLIER -157.47 153.45 27.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 2.38 111.167 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.749 HG23 ' HG2' ' A' ' 125' ' ' MET . 0.1 OUTLIER -87.8 -172.51 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 2.27 111.148 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.508 ' HB3' HG21 ' A' ' 245' ' ' ILE . 25.5 p-80 -50.27 -48.32 54.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 4.45 110.826 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.5 p -76.82 -38.03 54.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 2.75 110.857 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.77 172.11 0.28 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 2.26 112.494 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.465 ' N ' HG21 ' A' ' 204' ' ' THR . . . -47.45 -85.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 1.55 112.472 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 88.3 m -79.36 98.34 6.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.815 0.341 . . . . 2.27 111.167 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.411 HD22 HG12 ' A' ' 243' ' ' VAL . 51.3 t-20 -51.14 115.48 1.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 3.33 110.914 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -35.28 38.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 2.85 110.9 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.414 ' O ' HG23 ' A' ' 217' ' ' VAL . 39.5 t80 -72.33 -53.6 11.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 5.28 110.86 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.473 HD13 HG11 ' A' ' 243' ' ' VAL . 10.6 tp -51.86 -47.75 64.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 2.78 110.933 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.582 HG23 HD22 ' A' ' 181' ' ' LEU . 0.7 OUTLIER -55.38 -51.23 67.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 1.07 111.154 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.59 -48.88 74.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.71 111.132 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.665 HG22 ' HA ' ' A' ' 137' ' ' ALA . 49.0 t -61.5 -20.49 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.73 111.139 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -74.33 -46.25 42.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 2.02 110.891 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.75 -23.46 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 5.48 110.859 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 224' ' ' LEU . 21.7 mm -65.56 -52.08 55.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 1.32 111.118 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.96 -25.69 66.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 0.67 112.438 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -51.33 70.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 2.56 110.887 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.409 ' OG ' ' HB1' ' A' ' 184' ' ' ALA . 0.9 OUTLIER -91.26 46.14 1.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 1.9 110.861 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 220' ' ' ILE . 1.2 mt -156.12 22.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 1.94 110.913 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.27 5.28 89.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 1.78 112.487 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.473 ' HB2' HD13 ' A' ' 258' ' ' ILE . 19.4 tp -120.27 68.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 4.32 110.906 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -86.05 -101.83 0.74 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.765 -0.731 . . . . 3.7 112.443 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -118.46 153.61 33.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.338 . . . . 2.29 110.858 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.3 m -135.86 -75.91 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 4.37 110.844 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.62 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 3.66 110.864 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 30.7 m-20 -49.28 108.27 0.94 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.577 0.703 . . . . 3.4 110.853 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 233' ' ' LYS . 53.7 Cg_endo -69.76 -179.82 3.18 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.658 2.238 . . . . 1.86 112.337 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.53 42.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 4.6 110.897 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -128.91 -175.78 3.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 1.92 111.117 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 43.0 t -93.05 -17.72 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 3.03 111.117 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -82.23 -41.53 20.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 4.79 110.887 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -51.54 136.4 33.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.668 0.747 . . . . 3.8 110.915 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.453 ' O ' HG23 ' A' ' 239' ' ' THR . 54.1 Cg_endo -69.77 77.77 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.258 . . . . 2.1 112.355 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 238' ' ' PRO . 2.0 p -156.92 160.36 39.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 2.71 111.154 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -127.05 113.2 16.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 3.75 110.952 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.02 128.41 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.467 . . . . 3.19 110.919 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -51.71 121.95 7.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 3.4 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.473 HG11 HD13 ' A' ' 214' ' ' LEU . 11.3 p -122.18 148.8 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 2.71 111.168 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -54.98 113.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 4.1 110.87 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.508 HG21 ' HB3' ' A' ' 206' ' ' HIS . 1.3 pp -76.75 -31.27 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 2.62 111.117 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -36.04 78.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 2.82 110.868 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 21.0 p -104.71 24.69 11.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 2.78 111.155 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -51.78 134.34 30.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 5.77 110.929 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -178.54 136.47 0.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 4.24 110.838 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.646 HD22 HG13 ' A' ' 255' ' ' ILE . 0.4 OUTLIER -52.65 152.7 3.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 2.14 110.887 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 252' ' ' ALA . 0.1 OUTLIER -154.54 -170.95 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 3.23 110.889 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.667 ' HB3' ' OD2' ' A' ' 254' ' ' ASP . . . 69.18 157.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 4.14 111.079 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.27 -24.9 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 2.77 110.883 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.667 ' OD2' ' HB3' ' A' ' 252' ' ' ALA . 1.2 p30 -50.78 -29.9 12.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 3.04 110.83 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.646 HG13 HD22 ' A' ' 250' ' ' LEU . 17.8 tt -54.24 -29.67 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 1.97 111.123 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -83.1 -24.8 32.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 5.6 110.852 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -81.42 -44.85 7.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.815 -0.707 . . . . 2.54 112.479 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.705 HD11 ' HE1' ' A' ' 141' ' ' TRP . 5.7 tp -54.58 -36.93 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.82 111.089 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -77.04 -49.72 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 3.44 110.913 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 2.65 110.83 -179.778 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.805 0.336 . . . . 2.38 111.138 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -134.4 147.26 50.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 4.83 110.903 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -153.06 152.63 31.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 3.95 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.39 144.59 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 2.76 111.109 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.44 ' HB3' HG22 ' A' ' 162' ' ' VAL . 13.7 m-80 -142.78 20.03 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 3.66 110.886 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.444 ' OD1' HG12 ' A' ' 161' ' ' VAL . 6.6 p-10 -122.44 157.7 31.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 5.81 110.91 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.92 106.41 3.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 7.64 110.916 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.747 HG23 ' HB2' ' A' ' 203' ' ' TRP . 16.3 m -70.66 120.0 76.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.598 0.713 . . . . 3.38 111.115 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -48.38 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.702 2.268 . . . . 2.65 112.341 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -23.44 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 4.82 110.906 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.727 ' HE3' HG22 ' A' ' 204' ' ' THR . 23.8 mmt -124.77 -174.56 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 3.28 110.912 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.558 ' O ' HG12 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -86.9 162.06 17.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 3.01 110.88 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -74.61 -20.91 59.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 6.59 110.891 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.51 -54.44 5.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 5.06 110.864 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -55.31 -40.18 70.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 4.06 110.886 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 126' ' ' ASN . 9.3 p -74.35 -37.16 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.07 111.121 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -62.68 -55.16 29.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 3.01 110.878 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -65.89 -31.92 73.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 3.83 110.933 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -50.94 -41.86 59.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 1.08 111.105 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.582 HD12 ' CZ ' ' A' ' 197' ' ' PHE . 2.6 mm -79.31 -43.16 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 2.54 111.169 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.24 -30.25 49.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 3.93 110.91 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -78.49 -27.3 46.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 3.15 110.844 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.485 ' HB1' HG13 ' A' ' 220' ' ' ILE . . . -55.69 -33.03 63.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 1.21 111.121 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -73.85 -25.8 60.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 3.56 110.905 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -79.08 -52.79 7.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 2.43 110.935 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.14 -42.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 2.08 111.098 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.489 ' CE3' HD11 ' A' ' 250' ' ' LEU . 9.3 m95 -75.54 -43.59 47.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 4.12 110.925 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.0 t -62.6 -15.07 49.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 2.58 110.894 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.34 -23.13 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 2.8 110.883 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.489 HG11 HG12 ' A' ' 255' ' ' ILE . 0.0 OUTLIER -120.3 -32.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 2.63 111.084 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.498 HG21 HG12 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -107.09 150.16 39.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.573 0.701 . . . . 2.55 111.127 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -53.41 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.69 2.26 . . . . 3.28 112.359 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tp 46.55 -165.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 3.89 110.858 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.61 131.14 11.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 3.81 110.862 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -115.47 144.93 43.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 6.45 110.908 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.442 ' O ' HD13 ' A' ' 152' ' ' ILE . 11.8 t -156.99 90.76 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 2.29 110.853 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -91.11 107.13 19.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 2.77 110.878 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -122.89 139.57 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 2.43 111.098 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -64.27 -24.02 67.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 3.44 110.914 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.7 m -138.06 148.91 45.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.462 . . . . 3.05 111.147 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.83 -173.28 19.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.756 -0.735 . . . . 1.77 112.458 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.8 mtt -110.65 145.87 37.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 5.45 110.843 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.43 130.05 36.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 1.47 111.114 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.26 -22.6 66.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 3.54 110.864 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.0 mm -104.18 84.36 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 2.88 111.164 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.2 tm? -91.34 115.24 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 1.7 110.887 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.823 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 21.9 t -98.88 110.88 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 1.44 111.126 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.555 ' CG2' HD11 ' A' ' 160' ' ' LEU . 46.3 t -138.97 139.96 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 1.41 111.136 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -82.48 122.87 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 3.42 110.87 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.99 178.38 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 1.45 111.08 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -145.18 126.93 15.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 8.08 110.862 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.0 -134.1 32.04 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.752 -0.737 . . . . 1.44 112.516 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.62 113.42 20.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 1.58 111.075 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -90.87 154.04 19.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 3.49 110.89 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.96 -14.0 54.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 3.41 112.483 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.22 23.5 5.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.774 0.321 . . . . 7.57 110.865 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.0 t70 63.4 52.94 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 6.65 110.865 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -127.59 79.68 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 4.96 110.826 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.39 129.05 34.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 1.63 111.082 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.09 173.08 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 10.06 110.903 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.605 ' OD2' HD12 ' A' ' 180' ' ' ILE . 13.9 t70 -125.58 -2.5 7.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 6.07 110.866 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 77.36 148.1 2.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 2.16 112.501 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.41 153.71 2.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 5.95 110.901 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.74 -1.41 87.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.737 -0.744 . . . . 3.06 112.452 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.37 -141.27 3.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 2.49 112.453 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.605 HD12 ' OD2' ' A' ' 175' ' ' ASP . 2.8 mp -71.47 91.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 2.56 111.127 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -48.28 -29.49 3.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 3.23 110.912 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.747 ' N ' HD12 ' A' ' 181' ' ' LEU . . . -179.62 178.0 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.84 111.162 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.502 ' ND1' HG21 ' A' ' 180' ' ' ILE . 0.3 OUTLIER -153.03 130.14 11.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 4.15 110.83 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -116.94 119.88 36.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.64 111.106 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.38 165.27 9.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 2.54 110.83 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.25 173.14 0.28 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.734 -0.746 . . . . 0.9 112.495 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -169.53 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.617 2.212 . . . . 1.24 112.344 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.12 -146.13 16.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 1.37 112.437 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.4 m -94.69 154.54 17.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 1.86 110.867 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.62 -103.81 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 1.3 112.447 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.23 -23.8 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 2.06 111.141 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -57.0 99.61 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.775 -0.726 . . . . 2.59 112.514 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 113.62 -12.08 23.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 1.16 112.46 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.542 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 3.4 m-20 -49.96 145.35 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.356 . . . . 2.64 110.826 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.823 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -131.97 135.3 46.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.83 111.082 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -124.76 117.86 25.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 2.77 110.854 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.582 ' CZ ' HD12 ' A' ' 134' ' ' ILE . 8.0 m-85 -100.98 101.76 12.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 2.92 110.838 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.646 ' OD1' HG21 ' A' ' 210' ' ' THR . 0.6 OUTLIER 50.63 93.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 5.72 110.868 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.59 87.08 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 9.49 110.882 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 34.3 t70 64.5 15.3 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 3.38 110.876 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.72 -78.09 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 4.47 110.885 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 178.41 124.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 4.28 110.913 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.747 ' HB2' HG23 ' A' ' 122' ' ' THR . 1.4 m-90 -102.03 137.78 39.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 7.17 110.928 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.727 HG22 ' HE3' ' A' ' 125' ' ' MET . 0.0 OUTLIER -157.11 169.05 25.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 1.96 111.16 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.41 HG23 ' SD ' ' A' ' 125' ' ' MET . 0.6 OUTLIER -75.31 173.89 10.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 1.94 111.161 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -50.55 -30.31 12.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 5.14 110.858 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.04 -37.63 17.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 2.27 110.851 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -56.45 -178.03 0.37 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.703 -0.76 . . . . 3.0 112.478 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.96 -64.18 3.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.765 -0.731 . . . . 2.41 112.511 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.646 HG21 ' OD1' ' A' ' 198' ' ' ASP . 0.2 OUTLIER -97.73 102.13 13.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 1.89 111.149 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.697 HD21 HD22 ' A' ' 214' ' ' LEU . 12.9 p30 -59.91 95.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 4.37 110.865 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 212' ' ' LEU . 2.8 tm? -59.68 -32.83 70.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 2.88 110.934 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.511 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 24.8 m-85 -66.56 -64.32 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 5.68 110.868 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.697 HD22 HD21 ' A' ' 211' ' ' ASN . 2.9 tt -59.16 -46.68 87.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 2.59 110.916 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 74.3 m -54.49 -26.28 30.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.74 111.18 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.08 -42.73 75.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.76 111.083 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.5 t -59.38 -46.88 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.84 111.17 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -53.61 -31.83 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 2.04 110.838 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -74.75 -42.9 57.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 5.57 110.845 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 224' ' ' LEU . 46.1 mm -51.1 -44.74 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 1.7 111.115 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.99 -32.66 52.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.9 112.479 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -36.67 81.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 3.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.98 29.06 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 2.43 110.861 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 220' ' ' ILE . 9.0 mt -139.7 -52.69 0.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 2.44 110.945 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -176.41 -151.0 8.53 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.739 . . . . 2.26 112.497 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 68.69 -75.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 3.81 110.928 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 110.88 -74.39 0.21 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 2.92 112.509 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -170.99 84.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 2.01 110.853 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.15 171.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 4.54 110.836 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -25.18 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 4.15 110.828 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 0.7 OUTLIER -50.6 108.74 1.1 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.595 0.712 . . . . 2.26 110.808 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.6 Cg_endo -69.75 162.19 43.02 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 2.19 112.336 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 58.36 22.56 9.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 5.47 110.87 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -111.19 158.59 18.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 1.98 111.071 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.86 -23.93 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 3.39 111.157 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -49.46 22.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 4.18 110.881 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -52.34 136.68 40.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.65 0.738 . . . . 4.02 110.859 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 93.9 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.685 2.257 . . . . 2.54 112.323 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.9 t -156.96 153.38 27.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 3.22 111.158 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -110.55 125.86 53.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 3.78 110.908 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.03 96.25 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 4.09 110.841 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -49.9 122.76 6.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 4.16 110.953 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.3 p -120.22 153.49 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 2.76 111.123 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.51 137.03 42.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 4.32 110.911 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.07 -26.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 3.27 111.111 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -64.9 -39.36 93.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 4.32 110.88 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 -10.85 24.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 3.55 111.105 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.58 120.51 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 4.06 110.89 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 175.64 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 4.45 110.917 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.656 ' HB3' HD12 ' A' ' 255' ' ' ILE . 0.8 OUTLIER -87.29 150.98 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 2.23 110.867 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.648 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.2 OUTLIER -154.83 -172.04 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 3.51 110.868 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 66.59 165.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 3.96 111.083 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -20.4 62.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 3.09 110.892 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -51.07 -29.99 14.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 3.36 110.825 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.656 HD12 ' HB3' ' A' ' 250' ' ' LEU . 1.0 OUTLIER -51.2 -29.63 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 2.16 111.156 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 35.8 mtt85 -90.95 -33.83 15.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 6.43 110.855 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.44 -25.8 21.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 2.01 112.49 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.498 HG12 HG21 ' A' ' 145' ' ' THR . 6.5 tp -87.45 -29.17 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.767 0.318 . . . . 1.26 111.14 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -79.37 -37.75 36.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 3.34 110.951 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 2.13 110.853 -179.832 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.459 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.801 0.334 . . . . 2.88 111.138 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.497 ' CZ ' HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -137.51 136.27 37.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 8.06 110.889 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.531 ' HG2' ' HB3' ' A' ' 157' ' ' ALA . 29.5 ptt180 -127.9 119.21 25.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 8.92 110.878 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.9 pt -107.99 148.28 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 3.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -157.16 22.86 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 3.44 110.856 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -142.03 153.87 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 4.19 110.924 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -114.67 163.05 15.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 5.1 110.933 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.508 ' OG1' HD21 ' A' ' 212' ' ' LEU . 86.1 m -120.29 133.86 24.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.598 0.713 . . . . 2.9 111.124 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 122' ' ' THR . 53.2 Cg_endo -69.81 -177.6 1.97 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.69 2.26 . . . . 3.15 112.33 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 72.39 -68.64 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 4.6 110.836 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.88 147.7 25.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 4.34 110.857 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -59.36 168.15 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 3.75 110.907 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.06 -22.46 50.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 6.11 110.849 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -63.29 -44.05 96.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 4.31 110.928 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.663 ' OD2' HD12 ' A' ' 212' ' ' LEU . 26.3 t0 -60.15 -53.3 59.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 3.95 110.856 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.854 HG23 HD22 ' A' ' 212' ' ' LEU . 11.4 p -65.76 -29.57 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.86 111.117 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.3 -53.48 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 3.45 110.826 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -69.97 -33.45 72.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 3.64 110.933 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.68 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -54.01 -59.25 4.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.148 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.472 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 3.3 pt -63.48 -28.36 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 3.31 111.101 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -51.1 -59.29 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 5.76 110.874 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.776 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -80.45 -21.44 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 3.38 110.885 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.604 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.2 -54.75 39.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 1.17 111.106 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.511 ' HA ' HD13 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -67.25 -23.27 65.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 5.81 110.875 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.04 -28.14 43.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 3.4 110.921 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 136' ' ' LYS . 90.0 t -68.45 -30.22 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 2.02 111.152 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.616 ' HD1' HD22 ' A' ' 224' ' ' LEU . 15.3 t-105 -93.31 -52.89 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 3.97 110.891 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 p -55.14 -23.04 19.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 1.88 110.817 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.51 -23.64 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 3.71 110.873 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.577 HG21 HG13 ' A' ' 255' ' ' ILE . 9.8 p -125.01 21.65 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 3.58 111.134 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -128.32 134.13 25.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.586 0.707 . . . . 2.02 111.117 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 145' ' ' THR . 54.2 Cg_endo -69.73 -25.56 28.61 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.703 2.269 . . . . 1.89 112.352 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.91 109.57 0.34 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 3.63 110.895 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -121.99 129.6 52.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 5.19 110.852 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -138.02 154.27 49.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 12.16 110.867 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.19 126.37 49.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 3.35 110.903 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -57.87 154.62 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 3.5 110.9 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.36 116.73 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 3.53 111.127 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -39.24 58.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 3.7 110.87 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.5 m -140.6 109.63 6.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 3.06 111.129 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 162.48 -156.12 27.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 1.73 112.532 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -110.88 157.38 19.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 5.21 110.872 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.531 ' HB3' ' HG2' ' A' ' 117' ' ' ARG . . . -133.28 153.63 51.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 1.15 111.088 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.62 -25.64 27.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 3.12 110.869 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 193' ' ' GLY . 26.5 mt -121.39 137.41 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 2.4 111.113 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.65 HD11 ' CG2' ' A' ' 162' ' ' VAL . 1.3 tm? -117.21 120.64 38.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 1.4 110.904 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.639 ' N ' HD22 ' A' ' 160' ' ' LEU . 4.1 t -96.3 121.68 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 1.56 111.1 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.65 ' CG2' HD11 ' A' ' 160' ' ' LEU . 10.9 t -147.87 141.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.4 111.088 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -99.67 135.59 40.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 3.69 110.863 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.63 133.18 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 1.73 111.075 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.33 156.69 18.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 5.48 110.866 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.62 -137.27 31.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 1.09 112.507 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.81 130.29 34.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 1.16 111.107 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -88.58 6.96 35.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 2.63 110.909 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.81 -17.35 55.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 2.54 112.481 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.37 33.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 5.66 110.858 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.43 -167.75 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 4.67 110.856 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -76.3 100.84 5.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 6.2 110.858 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.5 128.44 28.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 1.36 111.078 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -101.51 -168.98 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 6.12 110.929 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -139.22 -41.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 4.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.33 -127.69 8.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 2.56 112.487 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -51.77 119.06 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.814 0.34 . . . . 3.75 110.922 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.32 -33.52 5.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.715 -0.755 . . . . 3.0 112.515 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -109.63 -137.35 7.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.742 . . . . 2.24 112.497 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.2 mm -72.1 135.82 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.348 . . . . 1.99 111.155 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.519 HD22 ' H ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -97.62 -27.24 14.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 4.44 110.882 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.539 ' HB2' ' HH2' ' A' ' 203' ' ' TRP . . . -179.26 124.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 1.81 111.038 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -117.3 171.53 7.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 2.89 110.861 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -176.95 110.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.77 111.085 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.57 157.08 24.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 2.57 110.863 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.18 178.33 0.23 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 1.07 112.477 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -172.99 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.656 2.237 . . . . 1.19 112.355 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 136.49 -127.59 4.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 2.08 112.524 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.23 130.6 52.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 2.5 110.855 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.22 -73.99 1.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.727 -0.749 . . . . 1.8 112.505 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 191' ' ' ILE . 23.4 mt -82.92 -4.12 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 2.74 111.13 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.4 117.61 9.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 2.41 112.508 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.704 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 85.31 -7.64 74.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.786 -0.721 . . . . 1.31 112.459 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.486 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 5.1 m-20 -50.53 139.23 16.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 2.14 110.868 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.62 ' HB1' ' HE1' ' A' ' 197' ' ' PHE . . . -117.15 140.12 49.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 1.32 111.112 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.07 110.62 12.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 4.15 110.842 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.62 ' HE1' ' HB1' ' A' ' 195' ' ' ALA . 12.5 m-85 -116.48 111.74 20.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 2.82 110.919 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.53 119.67 3.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 6.87 110.816 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -50.13 -72.6 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 8.08 110.889 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.11 87.69 4.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 5.35 110.855 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -125.51 -82.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 4.25 110.889 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 172.65 81.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 4.73 110.907 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.539 ' HH2' ' HB2' ' A' ' 182' ' ' ALA . 8.9 m95 -106.64 113.43 26.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 6.37 110.926 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.4 m -156.85 133.28 9.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 2.94 111.084 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.671 ' OG1' HD12 ' A' ' 245' ' ' ILE . 2.1 t -107.36 69.34 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 4.11 111.128 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.74 -70.72 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 9.06 110.887 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.7 m -117.38 -73.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 4.02 110.885 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.27 -1.73 0.76 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 5.44 112.521 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.01 -160.89 0.17 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 3.91 112.495 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.12 95.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.799 0.333 . . . . 2.09 111.147 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.406 ' HB3' ' HB ' ' A' ' 205' ' ' THR . 2.1 m-20 -104.32 150.12 24.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 2.93 110.874 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.854 HD22 HG23 ' A' ' 130' ' ' VAL . 2.5 mt -54.95 -44.73 74.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 2.67 110.942 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.708 ' O ' HG23 ' A' ' 217' ' ' VAL . 31.0 p90 -73.08 -37.17 66.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 5.12 110.901 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.426 HD13 HG11 ' A' ' 243' ' ' VAL . 24.3 tp -64.75 -60.65 2.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 3.02 110.909 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.5 m -57.47 -40.59 78.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 1.12 111.144 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.44 -51.78 67.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.83 111.11 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 213' ' ' PHE . 73.5 t -51.6 -42.35 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.95 111.162 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -56.82 -47.93 79.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 2.07 110.833 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -65.21 -41.97 93.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 4.62 110.91 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.535 HD12 ' HB1' ' A' ' 137' ' ' ALA . 85.5 mt -58.62 -32.4 46.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 1.97 111.115 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.93 -36.82 40.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 1.04 112.495 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -76.42 -39.33 53.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.781 0.324 . . . . 2.93 110.826 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.88 -12.19 61.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 1.8 110.836 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.616 HD22 ' HD1' ' A' ' 141' ' ' TRP . 2.2 mp -114.83 19.8 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.8 132.48 0.97 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 2.25 112.493 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.553 HD22 ' SD ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -179.93 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 3.67 110.909 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 145.18 -120.82 1.42 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.72 -0.752 . . . . 2.66 112.462 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.401 ' HA ' ' HE1' ' A' ' 236' ' ' MET . 0.3 OUTLIER -179.98 37.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.801 0.334 . . . . 3.66 110.855 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.29 -75.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 5.03 110.842 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.55 -168.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 5.59 110.844 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.97 155.51 2.04 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.715 . . . . 2.61 110.871 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -49.25 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.69 2.26 . . . . 2.02 112.36 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -71.72 -27.97 63.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 5.24 110.876 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.35 168.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 2.3 111.139 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.522 HG22 ' OG ' ' A' ' 251' ' ' SER . 17.6 m -87.85 8.44 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 3.76 111.108 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.553 ' SD ' HD22 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -80.72 0.72 33.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 4.38 110.847 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.47 146.12 5.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.616 0.722 . . . . 4.93 110.891 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.98 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.698 2.265 . . . . 3.01 112.319 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.2 m -91.11 164.38 13.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 4.06 111.147 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -62.57 124.98 22.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 4.58 110.95 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.39 123.86 48.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 4.58 110.907 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -54.68 123.14 12.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 7.38 110.914 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.426 HG11 HD13 ' A' ' 214' ' ' LEU . 14.6 p -148.2 136.21 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 2.46 111.138 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.52 123.81 18.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 3.22 110.841 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.671 HD12 ' OG1' ' A' ' 205' ' ' THR . 15.3 tt -60.52 -20.56 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 3.07 111.107 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.21 -15.91 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 3.2 110.88 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.5 m -106.81 1.21 24.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 2.1 111.113 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -51.87 133.82 31.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 4.83 110.873 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -176.79 153.05 1.02 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 3.26 110.887 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 52.9 tp -52.06 160.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 2.81 110.906 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.522 ' OG ' HG22 ' A' ' 235' ' ' VAL . 0.1 OUTLIER -88.81 -172.73 3.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 4.22 110.865 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -93.1 -70.43 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 3.83 111.113 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.55 -32.66 51.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 3.29 110.858 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -30.46 67.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 2.53 110.856 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.577 HG13 HG21 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -54.51 -28.17 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 1.7 111.091 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -82.09 -44.56 16.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 4.28 110.885 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.89 62.53 3.25 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 2.35 112.502 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.508 HD13 ' CZ2' ' A' ' 141' ' ' TRP . 3.6 tp -179.7 -41.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 1.02 111.144 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.559 ' HB2' HG22 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -78.14 -28.21 48.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 3.14 110.901 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 1.95 110.894 -179.793 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.6 m80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.753 0.311 . . . . 9.19 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.519 ' C ' HD13 ' A' ' 114' ' ' ILE . 74.1 m-85 -117.74 147.67 42.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 9.67 110.914 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.602 HG21 HD23 ' A' ' 147' ' ' LEU . 1.7 mm -118.38 148.21 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 3.5 111.102 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.42 144.36 27.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.145 -0.479 . . . . 1.89 111.148 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.762 ' CD2' HG21 ' A' ' 159' ' ' ILE . 44.8 m-85 -127.7 164.02 23.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 8.11 110.913 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.9 117.77 2.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 4.26 110.889 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.561 ' CG2' HG21 ' A' ' 134' ' ' ILE . 10.2 pt -108.71 148.51 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 3.12 111.169 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -168.99 60.5 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 3.86 110.853 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.611 ' OD1' HG12 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -144.64 135.65 25.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 5.51 110.888 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -147.8 107.07 3.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 6.23 110.939 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.1 p -94.24 158.59 35.64 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.63 0.729 . . . . 3.79 111.081 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -178.53 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.713 2.275 . . . . 2.83 112.342 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 56.1 24.01 7.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.445 . . . . 3.89 110.834 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.2 mmm -165.28 131.29 2.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 3.74 110.844 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -66.14 142.01 57.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 2.8 110.896 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -61.38 -18.12 57.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 7.58 110.848 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.39 -34.78 65.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 3.11 110.848 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.5 -45.55 68.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 2.54 110.847 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.568 ' O ' HD12 ' A' ' 134' ' ' ILE . 7.5 p -66.59 -39.08 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.67 111.142 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -55.99 -53.67 54.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 2.27 110.827 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -74.72 -32.63 62.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 2.94 110.933 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.576 ' CB ' HD22 ' A' ' 212' ' ' LEU . . . -51.17 -57.93 7.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 0.69 111.049 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.568 HD12 ' O ' ' A' ' 130' ' ' VAL . 4.2 mp -75.93 -41.15 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 2.32 111.111 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -38.08 52.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 4.75 110.882 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.9 OUTLIER -78.45 -26.59 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 2.85 110.866 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.77 -32.61 63.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.89 111.072 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -74.4 -30.42 61.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 5.25 110.913 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -77.06 -55.11 5.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 2.6 110.866 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.505 HG11 ' CG2' ' A' ' 217' ' ' VAL . 3.6 p -52.9 -27.42 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 1.99 111.129 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -89.5 -53.76 4.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 3.82 110.925 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -58.98 -19.49 43.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 1.7 110.89 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -50.93 -30.09 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 2.31 110.911 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.66 HG11 ' CG1' ' A' ' 255' ' ' ILE . 3.5 m -134.94 61.49 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 2.08 111.074 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.718 HG23 HG13 ' A' ' 258' ' ' ILE . 0.1 OUTLIER -156.27 140.55 11.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.598 0.713 . . . . 1.67 111.123 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.656 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.9 Cg_endo -69.76 -12.54 33.11 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.641 2.227 . . . . 2.16 112.391 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.602 HD23 HG21 ' A' ' 114' ' ' ILE . 7.3 mp -54.63 175.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 2.69 110.917 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -118.23 -169.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 5.46 110.888 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -130.69 134.39 46.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 7.55 110.907 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -156.86 89.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 2.23 110.868 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 97.95 7.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 4.54 110.892 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 155' ' ' GLY . 14.3 tt -83.49 130.59 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 4.39 111.106 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -78.43 -28.48 46.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 3.82 110.9 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.436 ' O ' HD11 ' A' ' 152' ' ' ILE . 96.1 m -149.59 120.87 7.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 3.52 111.144 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.643 ' O ' HD13 ' A' ' 152' ' ' ILE . . . 118.87 85.34 0.99 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 2.28 112.501 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.77 167.28 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.776 0.322 . . . . 9.98 110.901 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.57 -161.99 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 2.91 111.11 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -50.77 -25.22 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 2.82 110.852 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.762 HG21 ' CD2' ' A' ' 116' ' ' TYR . 46.1 mm -102.5 114.43 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 3.07 111.124 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.24 158.03 25.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 2.97 110.918 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.774 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 41.7 t -148.03 111.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 1.63 111.175 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.9 t -148.51 144.82 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 1.12 111.099 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -104.71 136.68 43.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 3.28 110.921 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.512 ' HB1' ' ND1' ' A' ' 168' ' ' HIS . . . -142.41 168.38 19.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 1.29 111.134 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.2 111.8 22.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 6.27 110.903 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.39 -128.58 27.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 1.24 112.476 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.449 ' N ' ' HB2' ' A' ' 173' ' ' ALA . . . -71.51 110.92 6.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.331 . . . . 1.51 111.158 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.512 ' ND1' ' HB1' ' A' ' 164' ' ' ALA . 0.9 OUTLIER -92.49 41.95 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 3.89 110.879 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.9 -53.87 4.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 2.71 112.461 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -145.11 28.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 5.2 110.871 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -107.08 -169.55 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 6.17 110.864 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -104.83 90.3 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 4.89 110.828 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.449 ' HB2' ' N ' ' A' ' 167' ' ' ALA . . . -53.6 149.53 8.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 1.76 111.09 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -120.8 -82.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 6.02 110.91 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.97 -170.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 4.17 110.856 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -97.59 -160.72 31.09 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.709 -0.758 . . . . 2.1 112.508 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -52.97 118.6 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 5.7 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 123.61 -54.38 0.72 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.743 -0.741 . . . . 2.45 112.484 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.76 -137.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.738 -0.744 . . . . 1.76 112.473 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.3 mt -78.03 90.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.897 0.38 . . . . 2.88 111.137 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -53.04 -33.49 52.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 4.44 110.92 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.09 123.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 1.79 111.091 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -138.56 113.8 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 3.49 110.864 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -99.27 125.01 44.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 1.19 111.099 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -63.61 164.16 10.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 2.26 110.867 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.61 169.94 0.25 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.706 -0.759 . . . . 0.95 112.527 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -169.37 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.753 2.302 . . . . 1.04 112.332 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.7 -152.02 19.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 1.22 112.506 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m -91.88 148.55 22.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 2.36 110.83 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.83 -102.47 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.732 . . . . 1.36 112.467 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 72.9 mt -56.11 -35.43 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 1.85 111.143 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -52.73 100.46 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 2.31 112.456 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 104.33 21.65 9.22 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.759 -0.734 . . . . 1.21 112.484 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.404 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 15.7 m-20 -95.08 139.4 31.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 2.28 110.872 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.774 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -100.67 140.4 34.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 1.07 111.052 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -128.65 110.52 12.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 4.83 110.847 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -113.7 120.16 39.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 2.96 110.9 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -58.99 123.99 18.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 6.73 110.874 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -74.74 -48.83 23.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 7.73 110.926 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.4 -16.66 56.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 3.85 110.867 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 4.38 110.896 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.85 95.93 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 4.67 110.878 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.506 ' CZ3' HD21 ' A' ' 212' ' ' LEU . 5.1 m0 -79.73 148.57 31.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 7.17 110.933 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -148.47 174.31 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 2.57 111.13 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.62 -171.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 1.93 111.13 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -63.93 -21.52 66.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 4.52 110.876 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.3 m -90.61 -49.2 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 2.26 110.848 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -52.09 172.37 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 2.12 112.516 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -51.73 -88.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 1.5 112.509 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.429 HG21 ' HD1' ' A' ' 203' ' ' TRP . 14.8 m -60.19 99.55 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.78 0.324 . . . . 1.63 111.145 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 243' ' ' VAL . 1.9 m-20 -76.46 107.9 9.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 2.47 110.891 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.576 HD22 ' CB ' ' A' ' 133' ' ' ALA . 0.6 OUTLIER -57.38 -36.91 71.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 2.09 110.905 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.412 ' O ' HG23 ' A' ' 217' ' ' VAL . 11.0 m-85 -71.13 -64.35 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 4.93 110.827 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.547 HD13 HG12 ' A' ' 243' ' ' VAL . 5.3 tp -51.67 -49.51 62.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 2.04 110.965 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 96.4 m -55.32 -48.79 73.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.72 111.143 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.82 -31.88 63.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.69 111.125 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.632 HG21 ' CE1' ' A' ' 248' ' ' PHE . 60.4 t -77.7 -31.87 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.62 111.16 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -75.12 -41.75 57.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 2.04 110.868 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -71.0 -43.44 67.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 4.65 110.876 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 217' ' ' VAL . 9.9 tt -64.72 -29.88 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 2.13 111.153 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -68.7 -42.63 79.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 0.85 112.48 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -65.19 -23.7 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.339 . . . . 2.33 110.904 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.79 30.38 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 1.76 110.83 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -61.65 0.68 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 2.47 110.951 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 179.7 32.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 2.13 112.475 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.15 149.46 27.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.814 0.34 . . . . 2.53 110.919 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -78.16 -98.7 0.21 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.748 . . . . 2.63 112.528 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.76 40.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.846 0.355 . . . . 2.95 110.822 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 230' ' ' SER . 0.6 OUTLIER -179.53 -71.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 4.35 110.893 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 229' ' ' SER . 47.6 t 65.56 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 6.02 110.864 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.22 156.84 75.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.588 0.708 . . . . 2.93 110.889 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -49.12 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.679 2.252 . . . . 2.27 112.378 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -34.31 73.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 3.92 110.894 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 252' ' ' ALA . . . -51.6 153.32 2.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 2.23 111.104 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.725 HG13 ' HE2' ' A' ' 241' ' ' LYS . 3.9 t -87.51 7.7 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 4.05 111.151 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -17.36 35.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 4.67 110.892 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.94 143.31 15.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.635 0.731 . . . . 4.34 110.915 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 76.57 1.14 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.628 2.219 . . . . 2.29 112.33 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.6 t -157.05 168.8 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 2.43 111.142 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -110.43 112.62 24.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 3.81 110.924 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.725 ' HE2' HG13 ' A' ' 235' ' ' VAL . 8.2 pttt -140.69 147.46 39.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 3.45 110.851 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -106.84 125.82 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 3.43 110.905 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.547 HG12 HD13 ' A' ' 214' ' ' LEU . 7.1 p -121.26 154.72 25.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 2.22 111.168 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.07 125.91 25.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 2.83 110.897 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.63 -24.49 34.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 2.54 111.106 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -60.29 -39.66 87.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 3.75 110.896 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 51.9 p -105.43 1.89 28.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 2.4 111.187 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.632 ' CE1' HG21 ' A' ' 217' ' ' VAL . 2.7 t80 -52.02 111.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 3.94 110.854 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -174.52 157.37 2.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 3.1 110.892 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 251' ' ' SER . 0.4 OUTLIER -58.84 150.6 23.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 2.04 110.893 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.564 ' H ' HD23 ' A' ' 250' ' ' LEU . 1.5 t -154.58 -172.6 4.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 3.59 110.854 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.579 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . . . 65.13 176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 3.13 111.134 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.96 -22.08 66.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 3.71 110.888 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -50.77 -29.57 11.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 3.39 110.91 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.66 ' CG1' HG11 ' A' ' 144' ' ' VAL . 1.1 tt -52.74 -29.56 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 1.98 111.105 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -21.03 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 5.07 110.905 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.97 -6.04 81.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 1.73 112.492 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.718 HG13 HG23 ' A' ' 145' ' ' THR . 3.7 tp -106.98 -34.99 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 1.29 111.144 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -78.59 -37.38 42.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 3.67 110.891 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.2 t -84.8 -47.45 10.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 2.98 110.829 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.698 HD13 ' O ' ' A' ' 258' ' ' ILE . 1.0 OUTLIER 57.7 93.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 3.47 110.931 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -137.37 -52.63 0.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 11.68 110.903 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 119.111 -0.827 . . . . 10.8 112.488 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.3 p80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.817 0.341 . . . . 8.07 110.876 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.698 ' O ' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -94.25 148.05 22.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 8.46 110.923 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.698 HD13 ' O ' ' A' ' 113' ' ' TYR . 12.3 mm -132.89 157.02 42.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 3.49 111.17 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.47 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -147.16 128.57 14.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 2.36 111.159 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.64 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 33.7 p90 -128.67 159.53 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 4.87 110.872 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -161.65 153.92 19.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 4.42 110.883 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 26.1 mt -107.79 148.91 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 1.8 111.121 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.489 ' CB ' HG22 ' A' ' 162' ' ' VAL . 1.0 OUTLIER -115.76 -75.02 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 3.45 110.928 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -98.98 175.9 5.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 5.35 110.906 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -144.04 163.32 33.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 6.99 110.864 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.882 HG21 HD11 ' A' ' 212' ' ' LEU . 26.5 p -76.88 113.77 33.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.59 0.709 . . . . 2.87 111.139 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.71 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.255 . . . . 2.79 112.358 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -57.63 -28.46 63.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 3.44 110.874 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -101.29 152.77 20.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 3.06 110.869 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -60.95 143.52 54.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 3.33 110.886 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.0 ptt-85 -56.83 -24.3 50.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 6.98 110.867 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.76 -44.91 19.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 3.94 110.924 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.12 -51.32 68.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 2.36 110.884 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.633 ' O ' HD12 ' A' ' 134' ' ' ILE . 7.3 p -68.6 -38.18 78.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.91 111.171 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.81 -54.45 44.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 3.97 110.879 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -73.55 -32.34 64.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 2.66 110.911 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.94 -57.56 8.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.71 111.091 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.633 HD12 ' O ' ' A' ' 130' ' ' VAL . 3.7 mp -76.76 -40.11 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 2.38 111.161 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -54.5 -30.77 54.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 4.33 110.885 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 140' ' ' VAL . 1.5 mptp? -78.45 -25.21 45.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 3.73 110.925 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.91 -34.19 65.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 1.17 111.118 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.82 -30.52 61.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 4.0 110.904 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -55.72 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 3.8 110.873 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.754 HG11 HG22 ' A' ' 217' ' ' VAL . 5.1 p -49.35 -34.01 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.04 111.184 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.541 ' CZ2' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -80.28 -54.44 5.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 6.16 110.932 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.8 t -55.22 -26.63 40.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 2.44 110.841 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -53.25 -39.38 63.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 3.64 110.91 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 m -123.31 18.09 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 2.52 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.456 HG21 HG12 ' A' ' 258' ' ' ILE . 16.4 p -144.83 152.93 53.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.708 . . . . 3.07 111.158 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -87.84 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.672 2.248 . . . . 3.5 112.313 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 53.18 -175.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 3.35 110.911 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -142.35 138.14 31.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 4.03 110.85 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -112.48 128.18 56.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 6.95 110.898 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.6 t -156.77 89.62 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 1.89 110.868 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 131.84 39.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 2.38 110.899 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.424 HD12 ' HA3' ' A' ' 155' ' ' GLY . 10.5 pt -148.88 124.78 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 2.5 111.16 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -60.67 -23.67 65.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 4.15 110.896 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.3 m -133.9 112.03 10.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 2.9 111.163 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.424 ' HA3' HD12 ' A' ' 152' ' ' ILE . . . 170.62 -179.05 42.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.789 -0.72 . . . . 1.57 112.514 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.6 mtm -110.67 127.54 55.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.32 . . . . 4.95 110.888 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -122.95 130.06 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 1.08 111.097 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -19.66 64.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 3.18 110.874 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 mm -103.5 84.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 3.0 111.106 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.3 tm? -87.96 115.94 25.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 1.44 110.919 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.568 ' N ' HD22 ' A' ' 160' ' ' LEU . 94.7 t -100.71 110.27 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 1.63 111.131 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.554 ' CG2' HD11 ' A' ' 160' ' ' LEU . 50.2 t -137.53 143.09 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 1.16 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -81.0 115.5 20.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 5.49 110.868 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.675 ' HB1' ' NE2' ' A' ' 168' ' ' HIS . . . -101.08 154.83 18.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 1.9 111.064 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.49 118.68 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 5.21 110.885 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.88 -128.15 32.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 1.18 112.505 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.65 119.05 23.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 2.15 111.11 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.675 ' NE2' ' HB1' ' A' ' 164' ' ' ALA . 0.7 OUTLIER -95.1 41.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 5.77 110.87 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.93 -43.5 2.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 3.1 112.462 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.23 61.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 5.67 110.884 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.82 -168.42 2.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 4.07 110.892 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -76.59 95.96 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 5.17 110.892 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.93 138.1 58.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 1.85 111.123 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -136.67 106.85 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 6.45 110.925 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.67 168.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 4.03 110.834 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.96 -133.59 2.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 2.07 112.467 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -51.45 119.04 3.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.759 0.314 . . . . 4.4 110.901 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 114.06 28.65 3.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 4.79 112.492 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.17 -137.17 3.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 2.11 112.488 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.0 mm -76.88 123.38 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.346 . . . . 1.93 111.107 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.527 HD22 ' H ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -95.43 -12.06 26.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.469 . . . . 4.58 110.932 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.77 132.57 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 1.77 111.091 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.09 110.18 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 2.95 110.905 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.551 ' HB2' ' OE2' ' A' ' 219' ' ' GLU . . . -126.87 112.02 14.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.68 111.113 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.9 170.12 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 2.55 110.899 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.46 169.41 0.27 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.75 112.476 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -171.18 0.44 Allowed 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.736 2.291 . . . . 0.82 112.317 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.33 -145.71 16.56 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 1.13 112.477 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.8 m -92.17 153.52 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 1.95 110.908 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.51 -107.32 0.41 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 1.19 112.497 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.18 -24.77 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 2.1 111.111 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.09 96.95 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.736 -0.745 . . . . 2.45 112.51 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 117.8 -16.55 12.26 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.772 -0.728 . . . . 1.13 112.475 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.432 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 8.6 m-20 -50.43 145.04 6.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.821 0.343 . . . . 2.28 110.882 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -133.57 133.45 42.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.88 111.101 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -121.77 109.96 15.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 2.47 110.853 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -90.24 111.8 23.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 2.91 110.888 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.51 99.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 5.96 110.829 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -75.56 69.93 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 9.56 110.836 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 43.6 t0 64.67 20.4 12.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 3.84 110.884 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.4 18.37 19.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 4.4 110.862 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.09 153.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 6.01 110.867 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.409 ' CD1' HG22 ' A' ' 122' ' ' THR . 1.7 m-90 -105.74 173.7 6.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 6.87 110.899 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.419 HG21 ' H ' ' A' ' 209' ' ' GLY . 0.0 OUTLIER -157.13 172.86 17.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 2.13 111.092 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.74 -170.55 2.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 2.25 111.113 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.652 ' HB3' HD13 ' A' ' 245' ' ' ILE . 20.9 p-80 -61.66 -20.72 63.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 4.31 110.872 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.42 -36.41 9.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 2.09 110.883 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.94 -179.68 0.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.789 -0.72 . . . . 2.42 112.477 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.419 ' H ' HG21 ' A' ' 204' ' ' THR . . . -54.08 -91.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 1.77 112.492 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 92.0 m -70.5 98.84 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.352 . . . . 1.99 111.139 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.06 111.07 1.78 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 2.62 110.891 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.882 HD11 HG21 ' A' ' 122' ' ' THR . 0.6 OUTLIER -56.66 -34.21 67.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 2.22 110.938 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.424 ' CE2' HD12 ' A' ' 245' ' ' ILE . 9.7 m-85 -71.85 -64.86 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 5.41 110.882 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -53.7 -46.45 70.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 3.12 110.906 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 77.3 m -54.91 -40.12 69.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.93 111.145 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 134' ' ' ILE . . . -55.85 -32.27 63.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.081 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.754 HG22 HG11 ' A' ' 140' ' ' VAL . 29.5 t -82.53 -34.49 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.78 111.101 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -71.41 -38.85 71.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 2.06 110.872 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.551 ' OE2' ' HB2' ' A' ' 184' ' ' ALA . 1.6 tm-20 -74.44 -52.89 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 3.9 110.859 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 9.9 tt -51.93 -32.53 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.484 . . . . 2.09 111.096 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.26 -34.14 46.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.752 . . . . 0.97 112.455 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -25.61 67.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.798 0.332 . . . . 2.77 110.842 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.498 ' O ' HD22 ' A' ' 224' ' ' LEU . 0.4 OUTLIER -95.47 24.9 4.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 2.04 110.842 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 223' ' ' SER . 0.8 OUTLIER -135.43 -64.75 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 2.93 110.916 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.419 ' O ' HD23 ' A' ' 226' ' ' LEU . . . 170.87 48.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.726 . . . . 1.92 112.496 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.541 HD12 ' CZ2' ' A' ' 141' ' ' TRP . 56.4 mt -145.23 -74.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.389 . . . . 3.48 110.886 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 57.1 -102.51 0.21 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 4.42 112.495 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -119.32 119.27 33.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 2.27 110.857 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 11.0 t -99.14 -80.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 4.18 110.874 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.19 -38.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 4.27 110.872 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.702 ' OD2' ' HB1' ' A' ' 252' ' ' ALA . 0.5 OUTLIER -47.41 107.41 0.72 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.61 0.719 . . . . 2.39 110.828 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 54.2 Cg_endo -69.73 -44.42 2.11 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.647 2.231 . . . . 1.97 112.341 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -32.02 70.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 4.56 110.881 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . . . -71.63 170.65 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 2.63 111.1 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.5 m -95.96 8.15 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 5.18 111.092 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.425 ' CE ' HD22 ' A' ' 226' ' ' LEU . 1.2 tmm? -89.18 3.14 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 3.58 110.892 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 160.09 0.52 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.667 0.746 . . . . 8.75 110.849 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -30.33 22.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.66 2.24 . . . . 2.93 112.353 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.8 p -84.84 169.33 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 2.82 111.162 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -119.6 114.73 22.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 10.82 110.901 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.534 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.2 OUTLIER -126.28 133.18 51.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 3.28 110.888 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -61.6 125.63 24.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 3.29 110.929 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 241' ' ' LYS . 12.5 t -133.06 155.27 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 2.2 111.144 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.15 112.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 2.74 110.928 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.652 HD13 ' HB3' ' A' ' 206' ' ' HIS . 31.2 pt -76.58 -13.89 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 3.05 111.099 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.56 -26.85 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 3.43 110.863 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 46.0 p -120.99 20.6 11.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 2.89 111.096 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.66 148.5 40.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 3.79 110.893 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 179.98 147.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 3.18 110.919 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.613 HD23 ' N ' ' A' ' 251' ' ' SER . 7.0 tt -74.89 144.27 43.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 2.4 110.905 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.613 ' N ' HD23 ' A' ' 250' ' ' LEU . 14.9 m -154.6 -172.03 4.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 3.94 110.861 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.702 ' HB1' ' OD2' ' A' ' 231' ' ' ASP . . . 67.11 -171.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 2.91 111.076 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.73 -23.59 30.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 3.54 110.861 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 252' ' ' ALA . 4.2 m-20 -52.87 -29.75 29.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 3.3 110.875 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 252' ' ' ALA . 17.8 tt -68.55 -31.25 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 1.73 111.144 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -32.71 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 5.18 110.861 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.61 -17.13 47.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 1.56 112.477 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 145' ' ' THR . 6.0 tp -110.9 -35.81 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 1.04 111.186 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -73.53 -24.75 60.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 3.08 110.877 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 9.8 t -66.86 -27.47 67.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 2.24 110.868 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 258' ' ' ILE . 7.6 mp -51.98 -32.65 34.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 4.29 110.912 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -93.45 -34.87 13.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 15.3 110.925 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 119.183 -0.787 . . . . 12.3 112.516 -179.992 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.537 ' N ' ' HZ2' ' A' ' 148' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.82 0.343 . . . . 8.38 110.872 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -65.98 149.12 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 9.27 110.915 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.697 HD13 HD21 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -115.59 164.11 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 2.88 111.106 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.412 ' N ' HG23 ' A' ' 114' ' ' ILE . 53.4 p -125.56 143.09 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 2.31 111.146 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.793 ' HB2' HD11 ' A' ' 159' ' ' ILE . 15.7 p90 -152.05 141.42 21.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 4.82 110.898 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.13 150.24 29.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 4.68 110.871 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.7 mt -108.01 148.88 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 1.86 111.151 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' CB ' HG22 ' A' ' 162' ' ' VAL . 38.4 t-20 -102.68 -71.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 3.65 110.868 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.27 172.48 7.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 5.67 110.905 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.677 ' HB2' HG11 ' A' ' 130' ' ' VAL . 18.3 p90 -127.45 164.34 22.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 5.42 110.949 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.553 ' OG1' HD11 ' A' ' 212' ' ' LEU . 0.7 OUTLIER -52.41 129.21 42.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.566 0.698 . . . . 2.55 111.127 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 133.55 25.83 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.678 2.252 . . . . 2.41 112.346 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 t70 67.74 11.5 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 6.13 110.864 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.5 tpt -106.09 152.54 23.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 3.14 110.869 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -58.7 115.73 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 3.73 110.892 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -59.71 -20.18 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 5.46 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -80.15 -39.43 29.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.204 -0.453 . . . . 3.87 110.9 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.51 -46.25 60.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 3.31 110.897 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.755 ' O ' HD12 ' A' ' 134' ' ' ILE . 13.9 p -65.98 -35.28 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.95 111.086 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.61 -54.61 37.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 3.03 110.879 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -71.36 -32.38 68.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 2.8 110.905 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -51.29 -51.96 49.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.7 111.163 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 130' ' ' VAL . 2.7 mp -82.73 -46.01 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 2.42 111.13 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -50.44 -45.49 55.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 6.55 110.86 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -20.4 51.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 3.03 110.883 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.6 -35.43 65.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.84 111.093 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -72.42 -24.83 61.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 5.19 110.894 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -31.5 60.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 3.45 110.936 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 217' ' ' VAL . 21.7 t -58.49 -30.93 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 2.03 111.108 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.755 ' O ' HG22 ' A' ' 145' ' ' THR . 0.7 OUTLIER -94.57 -32.72 13.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 4.0 110.92 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -63.68 -15.74 59.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 2.18 110.857 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -83.0 -12.79 56.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 2.17 110.946 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 258' ' ' ILE . 4.6 p -118.84 -28.46 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 3.28 111.136 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 141' ' ' TRP . 15.0 t -107.22 141.65 23.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.581 0.705 . . . . 2.78 111.19 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -6.07 17.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.656 2.238 . . . . 2.41 112.347 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.697 HD21 HD13 ' A' ' 114' ' ' ILE . 8.2 tp -49.86 161.01 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 2.45 110.915 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.537 ' HZ2' ' N ' ' A' ' 112' ' ' HIS . 0.0 OUTLIER -123.28 138.06 54.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 5.41 110.915 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.402 ' HA ' HG22 ' A' ' 114' ' ' ILE . 74.8 m-85 -114.38 128.65 56.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 8.85 110.896 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.27 99.86 4.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 2.1 110.853 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 103.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 2.41 110.877 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 tt -97.28 135.28 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 3.9 111.115 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -102.52 41.71 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 3.22 110.891 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.98 169.77 7.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 3.53 111.119 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.08 -169.76 0.54 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 1.99 112.486 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.3 mtm -108.48 148.19 30.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 6.81 110.87 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.2 159.91 16.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 1.14 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.87 -44.72 67.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 2.43 110.906 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' A' ' 116' ' ' TYR . 2.1 pp -104.02 140.78 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 3.53 111.114 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.632 HD11 ' CG2' ' A' ' 162' ' ' VAL . 1.0 OUTLIER -129.2 115.27 17.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 1.5 110.934 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.616 ' N ' HD22 ' A' ' 160' ' ' LEU . 93.1 t -94.81 119.38 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 1.44 111.133 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.632 ' CG2' HD11 ' A' ' 160' ' ' LEU . 11.7 t -138.47 140.91 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 1.14 111.176 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.62 102.97 14.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 4.7 110.854 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.67 177.35 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 1.71 111.108 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -135.64 111.74 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 3.88 110.825 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 72.82 -135.78 22.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.737 . . . . 1.61 112.497 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.16 110.96 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.334 . . . . 1.41 111.081 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -70.61 -15.64 62.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 3.13 110.871 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.04 -25.09 14.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 2.75 112.487 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -80.27 -74.81 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.351 . . . . 6.03 110.872 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -178.68 33.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 7.03 110.859 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -129.18 64.93 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 4.59 110.825 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.26 145.43 30.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 1.99 111.101 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -54.93 174.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 10.24 110.907 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -137.99 9.95 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 5.37 110.881 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.91 139.81 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.708 -0.758 . . . . 2.09 112.489 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 119.23 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.366 . . . . 3.43 110.873 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 124.09 -18.48 7.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.718 -0.753 . . . . 2.86 112.495 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -117.65 -125.96 3.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 1.88 112.498 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.407 ' H ' HD12 ' A' ' 180' ' ' ILE . 4.7 mp -79.23 93.27 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 1.93 111.125 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.9 pp -50.43 -26.43 5.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 3.56 110.906 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.725 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.45 168.9 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 1.88 111.101 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.87 130.8 53.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 3.06 110.867 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -142.1 103.71 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.98 111.072 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.28 165.53 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 2.53 110.885 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -56.51 -176.74 0.31 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 0.83 112.477 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.703 2.269 . . . . 0.81 112.313 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.13 -149.46 17.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 1.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.7 p -91.73 151.73 20.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 2.74 110.823 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 50.35 -103.98 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 1.15 112.478 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 30.7 mm -57.02 -25.98 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.371 . . . . 2.57 111.142 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.33 100.1 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 2.53 112.536 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.436 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . 115.2 -15.44 18.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.739 -0.743 . . . . 1.0 112.469 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.22 145.17 8.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.778 0.323 . . . . 2.12 110.844 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.54 ' HB3' HG22 ' A' ' 161' ' ' VAL . . . -136.95 128.69 28.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.88 111.1 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.423 ' CB ' ' HB1' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -113.09 123.59 50.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 2.71 110.85 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.52 143.83 41.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 4.03 110.913 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.67 -77.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 5.79 110.879 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 66.94 41.22 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 7.52 110.914 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.9 t0 66.18 47.5 1.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 3.32 110.836 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.78 -77.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 4.59 110.834 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.83 138.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 4.14 110.873 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -106.28 138.95 41.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 9.38 110.92 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.45 165.68 35.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 1.71 111.173 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -170.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 2.04 111.162 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -57.24 -46.6 82.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 4.32 110.888 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.54 -34.84 40.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 2.48 110.901 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -50.87 170.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 2.29 112.539 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -45.13 -83.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 1.73 112.527 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.13 97.56 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 2.35 111.134 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -61.49 113.14 2.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 3.35 110.897 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.553 HD11 ' OG1' ' A' ' 122' ' ' THR . 1.1 tt -71.57 -35.91 70.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 2.29 110.975 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.485 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 7.8 t80 -71.34 -35.94 71.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 4.48 110.867 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.428 HD12 ' CD1' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -81.78 -48.55 11.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 2.32 110.914 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.499 ' CG2' HD22 ' A' ' 181' ' ' LEU . 53.3 m -55.25 -28.83 55.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.98 111.148 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.424 ' HB1' ' HA ' ' A' ' 134' ' ' ILE . . . -69.38 -46.06 67.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.78 111.072 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.571 HG21 ' CE2' ' A' ' 248' ' ' PHE . 19.1 t -60.86 -42.71 93.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.84 111.124 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -54.1 -34.66 60.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 1.96 110.855 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -29.6 61.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 4.3 110.894 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.655 ' O ' HD13 ' A' ' 224' ' ' LEU . 51.3 mm -56.24 -59.87 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 1.52 111.127 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.65 -31.75 79.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.83 112.487 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -44.49 86.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 2.73 110.895 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.409 ' O ' HD12 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -95.75 24.95 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 1.68 110.879 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.655 HD13 ' O ' ' A' ' 220' ' ' ILE . 4.4 mp -127.97 -38.5 1.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 2.05 110.924 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 161.73 -54.74 0.31 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 2.18 112.475 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.732 HD12 ' HB ' ' A' ' 258' ' ' ILE . 1.6 mt -73.2 -178.57 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 3.31 110.913 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 156.31 -94.93 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 3.9 112.499 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -96.12 98.3 10.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.768 0.318 . . . . 2.07 110.879 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.8 m -101.35 -75.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 4.65 110.845 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.65 -33.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 4.52 110.893 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.503 ' CG ' ' HB1' ' A' ' 252' ' ' ALA . 12.7 m-20 -47.91 107.57 0.76 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.581 0.705 . . . . 3.1 110.875 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -41.83 3.95 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 2.94 112.376 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.42 46.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 4.88 110.904 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.718 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -136.58 174.45 10.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 1.69 111.119 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 235' ' ' VAL . 9.3 p -95.46 7.6 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 2.9 111.129 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.409 ' HB2' ' HE2' ' A' ' 236' ' ' MET . 1.8 mpp? -87.32 -48.47 7.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 5.12 110.877 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.8 139.86 21.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.741 . . . . 5.01 110.882 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 79.1 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.713 2.275 . . . . 2.52 112.311 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 239' ' ' THR . 4.5 t -157.02 118.61 3.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 2.74 111.144 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -70.22 131.05 43.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 3.43 110.896 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 243' ' ' VAL . 1.2 pttt -162.85 93.23 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 3.66 110.923 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -50.87 119.64 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.448 . . . . 3.75 110.929 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 241' ' ' LYS . 18.1 t -114.82 152.09 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 2.49 111.12 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.79 113.25 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 2.76 110.893 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -57.42 -37.98 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 2.37 111.188 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.68 -28.41 68.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 3.55 110.877 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 30.0 p -115.65 17.94 16.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 2.91 111.15 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.571 ' CE2' HG21 ' A' ' 217' ' ' VAL . 15.8 t80 -82.53 121.69 27.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 5.22 110.889 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -164.65 151.81 11.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 3.88 110.835 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.69 HD13 ' N ' ' A' ' 251' ' ' SER . 3.1 tm? -55.07 139.1 42.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 2.55 110.871 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.69 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.3 OUTLIER -150.35 -171.09 3.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 3.2 110.829 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.718 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 70.7 165.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 3.86 111.099 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -59.31 -20.46 54.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 2.64 110.868 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -50.06 -29.4 8.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 3.68 110.89 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.573 HD12 HD12 ' A' ' 250' ' ' LEU . 7.4 tt -51.98 -29.04 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 1.72 111.11 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -83.4 -31.16 26.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 4.77 110.866 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.74 -24.64 69.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 1.97 112.491 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.732 ' HB ' HD12 ' A' ' 226' ' ' LEU . 4.1 tp -102.88 -30.98 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 1.37 111.144 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -61.67 -36.55 81.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 2.9 110.907 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.8 t -64.43 -41.09 96.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 3.34 110.863 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.7 mp -51.93 105.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 6.64 110.921 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -156.67 -74.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 16.38 110.903 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.131 -0.816 . . . . 12.52 112.502 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.803 0.335 . . . . 9.05 110.818 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.579 ' C ' HD12 ' A' ' 114' ' ' ILE . 13.9 m-85 -116.34 148.04 40.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 9.01 110.958 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.579 HD12 ' C ' ' A' ' 113' ' ' TYR . 1.7 mp -118.73 145.83 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 3.45 111.154 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.538 ' HB ' HD12 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -143.01 150.55 39.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 2.25 111.178 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.686 ' HB3' HD11 ' A' ' 159' ' ' ILE . 43.6 p90 -149.84 162.62 39.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 4.88 110.93 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -161.94 138.09 7.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 4.76 110.86 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 1.033 HG22 HG21 ' A' ' 161' ' ' VAL . 18.0 pt -107.75 136.06 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 2.6 111.143 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -151.59 43.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 3.46 110.948 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.76 151.41 51.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 5.27 110.85 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -144.06 129.92 19.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 5.34 110.94 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.58 159.5 58.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.616 0.722 . . . . 2.16 111.144 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -86.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.68 2.253 . . . . 2.32 112.338 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.92 75.58 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 4.24 110.892 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.4 tpt -165.16 138.36 4.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 2.9 110.863 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.27 120.01 8.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 4.19 110.892 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -60.96 -19.37 60.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 5.24 110.863 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -78.86 -29.24 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 3.11 110.902 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.3 -44.82 24.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 2.83 110.9 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.494 HG23 HD21 ' A' ' 212' ' ' LEU . 5.8 p -58.93 -43.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.92 111.113 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 130' ' ' VAL . 7.8 t70 -55.48 -45.7 76.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 3.13 110.917 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -74.65 -32.49 62.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 2.18 110.878 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -51.83 -44.58 63.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 1.18 111.087 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.62 HG21 HG21 ' A' ' 161' ' ' VAL . 2.8 mm -83.06 -48.83 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.414 . . . . 2.4 111.136 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -50.62 -44.99 57.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 3.55 110.889 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.763 ' O ' HG23 ' A' ' 140' ' ' VAL . 3.3 mttm -78.22 -20.52 51.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 3.04 110.931 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.754 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.34 -40.88 71.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 1.12 111.126 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -48.24 34.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 3.92 110.874 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -52.39 -28.65 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 3.62 110.926 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.792 HG11 HG11 ' A' ' 217' ' ' VAL . 97.7 t -55.79 -56.43 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 2.04 111.143 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -82.15 -40.72 21.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 3.94 110.886 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.79 -24.45 35.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 1.79 110.867 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -75.28 -27.39 59.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 2.55 110.851 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 250' ' ' LEU . 32.9 m -132.05 41.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 2.83 111.112 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 36.3 m -150.94 132.37 7.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.689 . . . . 1.97 111.189 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 70.09 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.669 2.246 . . . . 2.97 112.325 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.538 HD22 HD21 ' A' ' 224' ' ' LEU . 1.6 tp -138.29 -171.88 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 2.78 110.863 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -128.23 142.34 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 5.03 110.876 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.85 122.52 20.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 7.02 110.844 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 t -156.82 112.21 2.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 3.0 110.877 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.55 107.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 2.74 110.949 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 154' ' ' THR . 26.6 mt -91.57 144.41 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 3.56 111.142 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -94.7 22.86 5.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 5.13 110.906 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.54 ' H ' HG22 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -110.17 167.77 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 5.67 111.129 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 154' ' ' THR . . . -79.37 -0.09 82.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 2.64 112.487 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 10.7 mtt -83.15 100.34 10.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.726 0.298 . . . . 7.01 110.859 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -148.36 129.83 14.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 1.4 111.1 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.49 -26.53 41.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 2.77 110.847 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 116' ' ' TYR . 22.4 pt -123.98 142.5 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.205 -0.452 . . . . 2.52 111.154 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.774 HD23 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -133.17 164.13 27.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 2.22 110.894 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 1.033 HG21 HG22 ' A' ' 118' ' ' ILE . 8.6 t -121.93 115.64 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 1.52 111.096 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.774 HG23 HD23 ' A' ' 160' ' ' LEU . 39.4 t -145.18 142.08 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 1.41 111.135 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -105.39 133.97 49.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 3.56 110.926 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.28 142.18 6.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 1.89 111.076 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -107.25 167.21 10.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 4.9 110.888 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.94 -141.08 25.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 1.44 112.451 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.13 148.68 48.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 2.1 111.072 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -115.68 22.25 13.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 3.41 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.45 14.53 62.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.669 -0.777 . . . . 3.41 112.49 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.56 -75.95 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.778 0.323 . . . . 6.39 110.807 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.34 62.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 4.67 110.872 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -137.7 42.57 2.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 6.43 110.841 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 118.86 22.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 1.48 111.095 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -179.07 98.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 8.01 110.926 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.88 -175.77 4.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 5.75 110.855 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.42 106.97 2.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 2.03 112.502 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -50.31 119.39 3.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.337 . . . . 4.46 110.896 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.76 -27.76 19.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.752 -0.737 . . . . 2.68 112.505 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -81.48 -140.0 2.9 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 1.43 112.453 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.9 mm -80.63 92.46 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.36 . . . . 2.09 111.122 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.705 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.5 pp -44.81 -33.77 2.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 3.38 110.918 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.705 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.96 179.79 0.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 1.77 111.122 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.87 128.5 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 6.42 110.891 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.08 123.65 38.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.87 111.097 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.404 ' CB ' HG22 ' A' ' 191' ' ' ILE . 0.1 OUTLIER -64.5 169.96 4.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 2.42 110.839 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.34 177.16 0.32 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 0.85 112.501 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 160.1 50.97 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.77 112.314 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 152.49 -146.41 14.97 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 1.29 112.471 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 99.0 p -107.46 124.45 49.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.91 0.386 . . . . 2.03 110.857 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.93 -57.65 3.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.699 -0.762 . . . . 1.75 112.506 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 191' ' ' ILE . 12.6 mm -100.6 22.08 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 1.95 111.125 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.78 -114.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 3.18 112.479 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.425 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . -94.29 42.76 2.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 1.32 112.499 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.402 ' HA ' HD13 ' A' ' 160' ' ' LEU . 2.8 m-20 -61.35 127.14 30.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 1.98 110.868 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.779 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -88.72 131.77 34.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 1.38 111.145 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -125.45 137.73 53.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 2.83 110.866 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.491 ' HE1' ' HB1' ' A' ' 195' ' ' ALA . 59.4 m-85 -139.97 102.75 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 2.71 110.884 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -52.39 120.98 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 6.7 110.914 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -67.78 -29.19 68.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 8.19 110.893 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -78.29 -19.36 53.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 4.74 110.867 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -177.48 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 3.86 110.907 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -118.35 109.51 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 4.66 110.925 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -101.93 122.21 43.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 6.63 110.943 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 p -135.64 174.41 10.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 2.14 111.131 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -175.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 1.86 111.157 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -51.75 -35.21 42.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 4.68 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -60.37 2.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 2.08 110.867 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.51 171.52 0.28 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 2.2 112.508 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -52.28 -89.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 1.75 112.466 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.12 108.81 2.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 1.58 111.1 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.67 114.82 23.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 3.43 110.889 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.494 HD21 HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -51.79 -35.87 45.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 2.16 110.938 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.742 ' O ' HG23 ' A' ' 217' ' ' VAL . 13.4 m-85 -71.36 -60.76 2.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 5.29 110.867 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.751 HD12 ' CE1' ' A' ' 248' ' ' PHE . 4.5 tp -52.11 -55.31 21.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.193 -0.458 . . . . 2.67 110.882 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.1 m -54.88 -45.83 74.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.87 111.144 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.49 -32.07 62.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 1.11 111.114 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.792 HG11 HG11 ' A' ' 140' ' ' VAL . 13.0 t -76.35 -30.07 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 1.03 111.148 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -65.47 -36.68 84.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 2.09 110.826 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -66.88 -20.95 66.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 6.04 110.89 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.96 -42.87 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 1.74 111.132 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.98 -38.13 36.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.725 -0.75 . . . . 0.87 112.469 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -23.63 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 2.66 110.842 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.647 ' O ' HD12 ' A' ' 224' ' ' LEU . 17.4 p -109.97 17.78 20.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 2.74 110.895 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 223' ' ' SER . 0.2 OUTLIER -156.43 94.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 3.42 110.906 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 58.73 -178.72 1.61 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 2.43 112.477 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.542 HD22 ' SD ' ' A' ' 236' ' ' MET . 0.4 OUTLIER 71.04 -68.84 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 3.72 110.888 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 98.63 -66.92 0.69 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.728 . . . . 3.2 112.487 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -173.52 133.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 2.06 110.871 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.0 m 63.21 163.32 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 5.83 110.859 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 25.2 t -178.86 -64.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 6.06 110.885 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.92 156.79 51.4 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 2.61 110.862 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 165.66 30.22 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.686 2.258 . . . . 2.7 112.349 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.68 28.4 4.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 4.95 110.879 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -122.7 -169.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 2.45 111.107 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.8 m -95.58 -29.29 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 3.03 111.158 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.542 ' SD ' HD22 ' A' ' 226' ' ' LEU . 1.1 tpt -58.2 -23.66 56.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 4.08 110.828 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.18 150.71 29.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.683 0.754 . . . . 4.11 110.859 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -48.69 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.657 2.238 . . . . 2.59 112.342 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -85.61 138.83 31.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 3.53 111.19 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.13 135.98 52.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 4.33 110.924 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 102.89 8.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 4.56 110.877 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -51.65 131.34 29.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 3.34 110.905 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.78 132.8 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 2.4 111.17 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.99 132.61 23.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 2.94 110.858 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -14.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 3.33 111.178 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -71.26 -29.12 64.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 3.88 110.863 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.92 -6.06 10.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 2.36 111.142 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.751 ' CE1' HD12 ' A' ' 214' ' ' LEU . 7.5 t80 -51.94 127.36 20.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 5.37 110.877 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -173.1 142.06 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 4.89 110.823 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.562 HD11 HG12 ' A' ' 255' ' ' ILE . 0.7 OUTLIER -52.53 170.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 3.04 110.934 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.98 160.95 16.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 3.94 110.843 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.612 ' HA ' HD12 ' A' ' 255' ' ' ILE . . . -61.83 -55.56 28.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 4.15 111.1 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.49 -29.38 50.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 2.41 110.898 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.08 -30.43 67.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 3.35 110.896 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 252' ' ' ALA . 60.6 mt -62.31 -30.8 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 2.75 111.161 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -75.84 -28.17 58.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 4.4 110.882 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.69 -3.41 88.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 1.42 112.487 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.659 ' O ' HD13 ' A' ' 261' ' ' LEU . 10.4 tp -120.93 -31.53 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.777 0.322 . . . . 0.97 111.115 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -78.67 -44.52 23.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 2.83 110.96 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.69 -47.18 13.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 2.2 110.867 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 258' ' ' ILE . 1.0 OUTLIER 63.4 98.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 3.38 110.936 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 1.4 t80 53.36 89.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 12.29 110.931 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 CA-C-O 119.177 -0.79 . . . . 8.55 112.452 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.83 0.348 . . . . 8.92 110.87 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -110.11 148.7 31.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 10.75 110.907 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.458 HG21 HD23 ' A' ' 147' ' ' LEU . 19.7 mm -120.18 152.77 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 3.45 111.148 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.469 HG23 ' HA ' ' A' ' 157' ' ' ALA . 1.6 t -146.72 154.48 41.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 1.94 111.127 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.591 ' HB2' HD11 ' A' ' 159' ' ' ILE . 51.3 p90 -145.23 166.34 25.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 4.77 110.977 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -161.8 138.21 8.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 3.97 110.924 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.3 mt -108.07 148.42 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 2.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -162.25 56.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 3.89 110.886 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -157.22 135.14 10.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 5.09 110.936 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -147.7 106.51 3.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 6.72 110.972 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.579 HG22 ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -90.8 153.65 45.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.573 0.701 . . . . 3.78 111.123 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.579 ' HD2' HG22 ' A' ' 122' ' ' THR . 53.8 Cg_endo -69.76 -15.01 36.9 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 2.37 112.327 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -51.45 -69.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 5.74 110.905 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 34.7 mmt -107.79 160.35 15.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 3.45 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.03 166.84 2.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 3.31 110.893 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.443 ' HA ' HG12 ' A' ' 130' ' ' VAL . 2.6 mpt_? -74.51 -19.46 60.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 6.05 110.891 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.5 -38.67 33.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 3.1 110.895 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 65.8 m-20 -71.24 -41.15 70.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 2.51 110.877 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.791 HG23 HD21 ' A' ' 212' ' ' LEU . 13.8 p -74.09 -27.88 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.81 111.115 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -71.23 -53.87 12.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 2.61 110.871 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -69.75 -32.45 70.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 2.54 110.933 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 129' ' ' ASP . . . -50.92 -58.2 6.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.512 . . . . 0.77 111.081 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.511 HG22 ' CE2' ' A' ' 138' ' ' PHE . 5.1 mm -69.19 -45.47 79.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 2.62 111.126 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -34.54 31.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 4.81 110.84 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -78.71 -31.79 46.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 2.55 110.914 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.474 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.95 -34.48 65.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.104 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 134' ' ' ILE . 54.5 m-85 -74.1 -27.87 61.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 5.29 110.867 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -79.33 -50.9 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 2.55 110.905 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.593 HG22 HD23 ' A' ' 250' ' ' LEU . 3.5 p -51.23 -41.96 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 1.97 111.086 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -49.63 17.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 3.79 110.9 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.6 p -58.91 -19.9 46.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 1.8 110.867 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -72.12 -17.11 62.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 2.27 110.872 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 255' ' ' ILE . 21.2 m -139.59 29.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 2.21 111.147 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.3 p -148.48 152.26 38.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.57 0.7 . . . . 2.52 111.173 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -14.98 36.98 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.668 2.245 . . . . 1.81 112.379 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.549 HD13 HD23 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -51.02 163.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 3.12 110.95 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -118.34 -172.39 2.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 5.3 110.926 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -135.64 119.99 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 6.9 110.867 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.4 t -140.7 89.95 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 2.09 110.848 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 116.56 22.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 2.16 110.92 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.418 HD11 ' O ' ' A' ' 156' ' ' MET . 1.0 OUTLIER -130.79 116.82 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 2.81 111.139 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -53.73 -27.76 30.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 3.3 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.0 m -160.3 133.79 6.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 4.24 111.155 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.94 -134.39 5.22 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 1.83 112.526 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.418 ' O ' HD11 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -89.8 138.22 31.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 10.0 110.828 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.469 ' HA ' HG23 ' A' ' 115' ' ' THR . . . -147.31 130.06 16.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 1.4 111.08 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.41 ' H ' HG23 ' A' ' 115' ' ' THR . 0.3 OUTLIER -80.53 -28.35 37.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 2.85 110.893 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.733 HG22 ' HA3' ' A' ' 193' ' ' GLY . 1.5 pp -122.57 140.87 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 3.82 111.114 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 160' ' ' LEU . 1.1 tm? -120.18 114.01 21.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 1.55 110.903 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.736 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 52.8 t -92.67 110.97 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 1.26 111.104 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.582 ' CG2' HD11 ' A' ' 160' ' ' LEU . 24.2 t -143.22 139.98 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 1.11 111.172 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -84.28 131.43 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 3.45 110.936 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.41 176.64 5.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 1.39 111.101 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.96 111.64 5.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 5.42 110.866 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.93 -127.02 27.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.766 -0.73 . . . . 1.2 112.481 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.06 110.81 20.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 1.37 111.105 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -90.52 66.54 6.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 3.02 110.866 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.94 -91.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 3.16 112.475 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.8 75.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 5.35 110.863 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -157.36 -169.69 2.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 5.51 110.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -78.53 95.57 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 4.02 110.867 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.55 136.36 38.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 1.3 111.109 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -112.78 -169.61 1.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 5.83 110.862 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -141.79 164.6 29.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 4.01 110.857 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.21 -156.08 17.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 1.82 112.504 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.52 119.16 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 3.74 110.927 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 133.71 -82.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.77 -0.728 . . . . 2.24 112.496 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.33 -133.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 1.96 112.493 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.537 HG22 ' H ' ' A' ' 182' ' ' ALA . 23.1 mm -75.1 142.11 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 1.79 111.107 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -109.5 -11.3 14.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 2.89 110.913 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.537 ' H ' HG22 ' A' ' 180' ' ' ILE . . . -178.19 144.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 1.28 111.089 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -143.64 117.09 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 2.77 110.882 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.99 130.1 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.79 111.069 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.23 166.01 21.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 2.08 110.91 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.62 172.83 0.35 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.777 -0.725 . . . . 0.74 112.478 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 172.08 13.3 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 0.81 112.297 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 145.2 -154.97 26.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 1.02 112.47 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.4 p -88.78 135.44 33.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.936 0.398 . . . . 2.18 110.844 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.72 -81.94 0.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.99 112.496 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 191' ' ' ILE . 1.9 mp -87.71 50.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 2.62 111.157 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.1 -110.95 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 2.64 112.462 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.733 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . -90.78 41.45 2.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 1.16 112.497 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.43 143.58 8.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 2.3 110.873 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.736 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -121.52 130.98 53.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 1.01 111.124 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -122.03 126.67 49.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 2.69 110.876 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -139.45 150.35 45.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 2.95 110.882 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 69.13 45.68 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 6.48 110.867 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.29 58.99 1.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 8.15 110.875 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.46 16.62 8.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 4.27 110.84 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.576 ' OE2' HG21 ' A' ' 210' ' ' THR . 0.2 OUTLIER -112.57 -1.09 14.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 4.31 110.942 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.75 150.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 6.06 110.852 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -105.4 176.93 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 7.71 110.904 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 205' ' ' THR . 0.2 OUTLIER -157.26 172.89 17.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 1.98 111.148 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 204' ' ' THR . 0.0 OUTLIER -94.76 -173.39 2.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 1.92 111.131 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.421 ' CG ' HG23 ' A' ' 245' ' ' ILE . 15.5 p80 -65.69 -20.33 66.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 4.45 110.862 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -70.18 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 2.22 110.856 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.66 -169.61 11.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 2.33 112.457 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 49.29 -166.29 0.3 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 1.6 112.483 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.576 HG21 ' OE2' ' A' ' 201' ' ' GLU . 0.9 OUTLIER -61.87 99.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 2.0 111.144 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 214' ' ' LEU . 32.1 t30 -61.71 120.71 11.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 3.52 110.849 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.791 HD21 HG23 ' A' ' 130' ' ' VAL . 0.3 OUTLIER -54.88 -37.85 66.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 2.35 110.842 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -71.58 -67.32 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 4.7 110.886 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.687 HD22 ' O ' ' A' ' 241' ' ' LYS . 3.9 tp -48.31 -53.67 16.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 2.53 110.931 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 37.5 m -55.21 -41.58 72.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.71 111.113 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.54 -44.99 95.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.7 111.12 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 248' ' ' PHE . 38.3 t -68.77 -23.14 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.67 111.14 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.643 ' HA ' HG12 ' A' ' 235' ' ' VAL . 19.7 t60 -72.65 -62.27 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 2.1 110.857 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.427 ' CD ' ' HB3' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -53.7 -55.37 26.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 4.64 110.893 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.1 tt -51.55 -29.95 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 2.21 111.143 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.98 -52.48 49.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.97 112.479 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -72.12 -23.12 61.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 2.73 110.83 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.12 -9.76 58.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 2.17 110.847 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.549 HD23 HD13 ' A' ' 147' ' ' LEU . 5.5 mp -104.13 -19.08 14.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.08 110.903 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 145.23 -31.5 1.7 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 2.74 112.477 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.67 HD23 ' CD1' ' A' ' 258' ' ' ILE . 0.5 OUTLIER -56.9 179.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.343 . . . . 3.06 110.958 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 173.79 66.89 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.68 -0.771 . . . . 2.72 112.42 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 11.0 m80 63.47 106.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.349 . . . . 2.01 110.872 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.2 t -80.91 -79.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 5.02 110.855 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 175.93 -54.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 3.86 110.848 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.95 126.63 34.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 2.74 110.88 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -177.73 1.99 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.692 2.261 . . . . 2.34 112.327 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.6 28.09 4.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 3.84 110.9 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -115.36 178.71 4.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 1.98 111.134 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.643 HG12 ' HA ' ' A' ' 218' ' ' HIS . 18.0 t -95.55 -9.44 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 3.48 111.174 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 28.9 mmt -86.53 -38.48 17.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 4.9 110.889 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.34 137.47 68.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.731 . . . . 4.07 110.867 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 73.62 1.31 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.692 2.261 . . . . 2.19 112.341 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.71 148.6 21.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 2.4 111.158 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -113.32 112.76 24.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 3.39 110.899 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.687 ' O ' HD22 ' A' ' 214' ' ' LEU . 35.7 tttt -135.97 119.81 17.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 4.35 110.918 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -51.71 132.0 30.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 3.05 110.937 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.646 HG21 HD13 ' A' ' 214' ' ' LEU . 56.7 t -136.38 121.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 2.09 111.12 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.02 130.96 26.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 4.07 110.928 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.421 HG23 ' CG ' ' A' ' 206' ' ' HIS . 23.9 pt -56.67 -24.16 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 2.86 111.151 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.5 -37.64 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 2.82 110.872 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.4 m -104.02 27.98 7.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 2.52 111.087 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.647 ' CE1' HD12 ' A' ' 214' ' ' LEU . 9.8 t80 -103.01 130.84 50.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 5.41 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -163.88 139.73 6.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 4.95 110.835 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.593 HD23 HG22 ' A' ' 140' ' ' VAL . 4.2 pp -52.4 170.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 3.04 110.927 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.0 t -89.85 147.57 23.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 3.84 110.893 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' A' ' 255' ' ' ILE . . . -63.51 -60.98 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 3.98 111.095 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.48 -26.3 30.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 3.5 110.869 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.55 -34.74 74.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 3.45 110.849 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 252' ' ' ALA . 38.3 mt -55.17 -41.59 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 2.76 111.132 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -14.3 61.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 4.42 110.847 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -93.4 -14.48 53.57 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 1.65 112.485 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.67 ' CD1' HD23 ' A' ' 226' ' ' LEU . 10.7 tp -110.32 -29.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 1.25 111.089 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -67.83 -32.06 72.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 3.81 110.915 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.2 t -63.71 -33.01 74.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 2.91 110.843 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.84 129.87 35.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 4.71 110.91 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -123.08 -175.26 3.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 11.44 110.934 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 CA-C-O 119.157 -0.802 . . . . 14.28 112.471 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.791 0.329 . . . . 8.23 110.866 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -73.09 148.95 43.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 8.84 110.962 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.7 146.76 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 2.8 111.148 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.458 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 68.2 p -114.06 147.7 38.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 2.06 111.153 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.68 ' CE2' HG21 ' A' ' 159' ' ' ILE . 1.6 t80 -127.63 152.76 47.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 7.52 110.883 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -160.24 123.32 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 6.87 110.829 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.57 HD11 HG21 ' A' ' 134' ' ' ILE . 60.5 mt -108.16 131.94 57.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 1.9 111.137 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -131.38 49.76 2.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 3.68 110.86 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -179.87 126.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 4.72 110.905 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -118.7 163.07 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 6.12 110.922 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.3 m -86.63 131.57 45.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.63 0.728 . . . . 2.92 111.074 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -48.91 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.697 2.264 . . . . 3.05 112.393 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.36 54.57 2.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 4.39 110.836 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -165.44 141.94 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 2.71 110.918 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.29 135.54 57.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 4.53 110.911 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -54.26 -25.59 24.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 5.97 110.878 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -78.27 -37.87 44.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 4.04 110.887 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -63.51 -45.55 90.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 3.2 110.84 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.595 ' HA ' HD13 ' A' ' 212' ' ' LEU . 13.4 p -74.32 -32.62 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.93 111.112 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.23 -54.35 11.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 3.69 110.89 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -65.21 -32.17 73.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 3.07 110.934 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 129' ' ' ASP . . . -52.51 -57.75 8.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.79 111.114 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.57 HG21 HD11 ' A' ' 118' ' ' ILE . 4.5 mm -70.16 -49.12 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 2.34 111.13 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -49.76 -46.06 50.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 4.03 110.862 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -20.41 49.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 2.97 110.849 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 134' ' ' ILE . . . -55.7 -50.04 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.95 111.089 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.23 -26.79 67.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 4.64 110.883 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -28.92 66.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 3.05 110.913 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.83 HG11 HG11 ' A' ' 217' ' ' VAL . 21.4 t -62.96 -56.03 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 1.9 111.113 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -43.54 65.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 3.89 110.942 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.6 t -56.01 -32.39 63.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 2.02 110.887 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' HG13 ' A' ' 144' ' ' VAL . 18.7 t-20 -51.59 -32.23 27.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 2.73 110.913 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.815 HG11 HD11 ' A' ' 255' ' ' ILE . 23.2 m -138.93 36.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 2.42 111.098 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.4 m -155.38 131.6 5.76 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.573 0.701 . . . . 2.34 111.12 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.659 ' O ' HD22 ' A' ' 147' ' ' LEU . 53.7 Cg_endo -69.77 72.13 1.47 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.675 2.25 . . . . 2.16 112.323 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.659 HD22 ' O ' ' A' ' 146' ' ' PRO . 0.8 OUTLIER -141.04 130.32 23.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 2.63 110.884 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.42 133.29 56.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 5.09 110.886 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -99.53 131.25 45.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 7.49 110.902 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.6 m -113.41 90.15 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 1.95 110.832 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 122.21 19.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 2.75 110.883 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.527 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.3 pp -144.63 161.49 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 2.75 111.157 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.44 34.22 3.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 4.21 110.9 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 t -161.66 142.98 11.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 3.73 111.139 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 85.78 176.4 50.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.73 . . . . 1.48 112.502 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.98 164.06 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 5.62 110.845 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -134.71 144.51 47.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 1.08 111.134 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.4 -26.81 32.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 2.44 110.884 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.68 HG21 ' CE2' ' A' ' 116' ' ' TYR . 42.9 mm -104.1 135.35 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 2.72 111.139 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.4 tm? -133.17 118.26 18.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 1.49 110.929 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.593 ' N ' HD22 ' A' ' 160' ' ' LEU . 89.5 t -105.65 110.54 31.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 1.47 111.131 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.558 ' CG2' HD11 ' A' ' 160' ' ' LEU . 55.9 t -133.96 145.43 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 1.12 111.106 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -107.25 109.03 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 4.95 110.879 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.683 ' HB3' ' OE2' ' A' ' 199' ' ' GLU . . . -101.67 178.76 4.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 1.41 111.082 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.08 111.63 17.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 4.92 110.887 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.37 -123.75 16.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.717 -0.754 . . . . 1.36 112.494 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 173' ' ' ALA . . . -87.22 110.41 20.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 1.49 111.122 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -79.39 58.76 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 3.09 110.885 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.8 -63.69 2.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.702 -0.761 . . . . 4.3 112.507 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -179.5 42.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.77 0.319 . . . . 7.65 110.867 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -111.23 -78.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 4.99 110.829 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -138.16 98.12 3.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 4.2 110.837 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 167' ' ' ALA . . . -81.85 113.61 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 1.73 111.128 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -111.12 131.58 54.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 5.88 110.904 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.82 171.06 13.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 4.38 110.887 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.06 -162.18 27.95 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 1.98 112.475 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -50.3 119.17 3.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 3.76 110.887 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 128.06 -15.85 6.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 2.48 112.497 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -127.21 -133.75 3.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.71 -0.757 . . . . 1.41 112.496 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.85 90.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 2.6 111.138 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.763 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -48.31 -31.71 6.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 3.07 110.886 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.763 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 176.87 153.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 1.22 111.124 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -142.92 106.27 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 3.5 110.896 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -96.22 108.41 20.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.93 111.085 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.43 168.81 5.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 2.63 110.86 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.49 171.49 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.747 . . . . 0.78 112.526 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -170.62 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 0.77 112.336 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 126.42 -152.01 18.2 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 1.17 112.486 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.16 152.81 20.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 1.99 110.835 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 50.83 -104.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 1.27 112.497 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 34.0 mm -54.8 -26.56 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 2.44 111.124 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.85 108.03 1.69 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.659 -0.781 . . . . 2.47 112.491 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 108.17 -24.33 23.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.792 -0.718 . . . . 0.96 112.502 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -49.8 147.27 3.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 2.2 110.887 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.85 145.79 30.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 1.12 111.112 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.553 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 60.7 m-70 -121.78 152.95 38.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 2.56 110.841 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.43 ' CE1' HG13 ' A' ' 161' ' ' VAL . 43.4 m-85 -133.53 103.19 5.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 2.81 110.861 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 47.39 70.62 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 5.76 110.889 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.683 ' OE2' ' HB3' ' A' ' 164' ' ' ALA . 4.4 mm-40 -51.59 -48.82 63.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 7.39 110.872 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -127.93 0.47 5.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 4.43 110.862 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.72 -168.73 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 3.78 110.915 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -114.96 160.07 19.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 5.83 110.918 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -106.15 152.52 23.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 6.17 110.892 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.09 174.03 16.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 1.74 111.133 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.447 HG23 ' OD2' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -80.74 -172.28 3.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 1.98 111.182 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.55 ' CG ' HG22 ' A' ' 245' ' ' ILE . 25.5 p80 -55.92 -32.85 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 5.42 110.842 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -56.45 5.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 2.35 110.814 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -49.3 155.28 1.97 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 2.06 112.488 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.48 -58.75 7.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 1.87 112.5 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.19 102.91 15.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 1.84 111.167 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.687 ' ND2' HD23 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -96.14 121.66 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 2.95 110.859 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -54.93 -35.28 64.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 2.24 110.901 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.414 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 34.0 t80 -71.96 -67.82 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 5.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.813 HD22 HG12 ' A' ' 243' ' ' VAL . 3.9 tp -49.6 -47.34 49.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 2.04 110.866 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 99.4 m -55.31 -44.2 75.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.52 69.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.82 111.071 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.83 HG11 HG11 ' A' ' 140' ' ' VAL . 39.3 t -72.82 -29.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.65 111.127 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -71.89 -39.39 69.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 1.73 110.826 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -74.31 -51.62 14.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 4.34 110.932 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.5 HG12 HD12 ' A' ' 224' ' ' LEU . 11.0 tt -54.94 -27.32 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 2.33 111.135 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.81 -27.41 62.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.776 -0.726 . . . . 0.9 112.502 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -81.76 -43.88 17.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.757 0.313 . . . . 2.63 110.837 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.5 p -86.53 52.26 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 1.54 110.848 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.5 HD12 HG12 ' A' ' 220' ' ' ILE . 1.4 mt -159.12 -46.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 2.05 110.887 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -172.51 -61.88 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 1.92 112.496 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.6 mp -60.89 171.71 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 3.04 110.926 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 177.46 65.08 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 2.78 112.487 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.1 m170 64.22 157.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.32 . . . . 2.38 110.853 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.6 t -163.86 -70.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 4.43 110.863 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.7 -32.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 4.67 110.871 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.429 ' HB2' ' HE1' ' A' ' 236' ' ' MET . 2.0 t0 -45.2 105.81 0.49 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.677 0.751 . . . . 2.24 110.834 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 233' ' ' LYS . 54.0 Cg_endo -69.69 175.67 7.73 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.722 2.281 . . . . 2.02 112.349 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.25 42.66 0.31 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 3.93 110.869 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -135.18 151.06 50.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 1.73 111.093 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.84 -14.59 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 2.92 111.159 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.429 ' HE1' ' HB2' ' A' ' 231' ' ' ASP . 6.0 tmm? -81.96 -39.66 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 5.38 110.847 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -50.99 134.52 29.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.662 0.744 . . . . 3.9 110.902 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 76.45 1.15 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.722 2.282 . . . . 2.61 112.323 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.5 m -157.3 152.66 26.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 2.82 111.137 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.405 ' HB3' HD21 ' A' ' 181' ' ' LEU . 9.8 p90 -111.72 112.32 23.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 4.91 110.89 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.48 -169.15 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 4.59 110.913 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -121.48 107.86 12.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 3.61 110.901 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.813 HG12 HD22 ' A' ' 214' ' ' LEU . 7.5 p -107.93 154.58 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 3.01 111.135 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -74.22 124.99 27.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 3.23 110.86 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.55 HG22 ' CG ' ' A' ' 206' ' ' HIS . 11.8 tt -76.47 -35.48 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 3.01 111.113 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -53.48 -31.9 47.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 3.51 110.881 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.9 t -113.68 30.07 7.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 2.97 111.109 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -52.05 134.47 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 5.94 110.873 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -179.9 142.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 3.52 110.926 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.21 147.8 47.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 2.36 110.866 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.1 -172.02 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 3.41 110.872 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.713 ' HB3' ' OD2' ' A' ' 254' ' ' ASP . . . 66.4 163.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 3.77 111.118 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -57.67 -25.11 59.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 2.68 110.815 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.713 ' OD2' ' HB3' ' A' ' 252' ' ' ALA . 2.2 p30 -51.62 -29.83 19.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 3.04 110.853 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.815 HD11 HG11 ' A' ' 144' ' ' VAL . 12.7 tt -50.88 -29.59 7.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 2.1 111.153 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -92.07 -40.15 11.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 6.33 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 261' ' ' LEU . . . -57.97 -20.51 41.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 1.95 112.462 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 8.2 tp -91.41 -32.83 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 1.05 111.128 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.19 -44.4 38.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 3.4 110.957 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.45 -47.16 12.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 2.78 110.883 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 257' ' ' GLY . 1.5 tp 54.13 27.16 7.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 3.2 110.926 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.77 29.46 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 9.68 110.872 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 CA-C-O 119.133 -0.815 . . . . 9.19 112.501 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.791 0.329 . . . . 8.56 110.833 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -132.14 148.38 52.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 12.05 110.929 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.405 HG23 ' N ' ' A' ' 115' ' ' THR . 0.7 OUTLIER -152.16 166.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 3.34 111.141 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.51 ' C ' ' HB1' ' A' ' 157' ' ' ALA . 53.2 p -144.63 140.71 28.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 2.08 111.109 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -150.26 151.32 32.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 4.41 110.938 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.83 161.63 29.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 5.01 110.92 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.556 HD11 ' HB ' ' A' ' 134' ' ' ILE . 23.4 mt -108.09 148.93 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 1.87 111.082 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.434 ' HB2' HG22 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -120.15 -69.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 3.03 110.901 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -98.59 176.89 5.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 5.42 110.895 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.533 ' HB3' HG11 ' A' ' 130' ' ' VAL . 25.9 m-85 -146.39 155.01 42.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 6.57 110.904 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.458 HG21 ' OD2' ' A' ' 198' ' ' ASP . 0.7 OUTLIER -53.53 134.9 53.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.601 0.715 . . . . 2.36 111.11 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 135.25 29.87 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.689 2.259 . . . . 2.64 112.354 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.45 11.39 8.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 5.9 110.865 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.48 147.32 29.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 3.09 110.839 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.472 ' O ' HG12 ' A' ' 130' ' ' VAL . 3.5 m-20 -58.63 115.34 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 3.49 110.893 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -21.94 61.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 5.71 110.862 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -80.55 -40.01 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 3.27 110.831 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.72 -47.87 61.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 2.81 110.87 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.741 HG23 HD21 ' A' ' 212' ' ' LEU . 7.3 p -63.97 -40.8 90.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.79 111.142 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.5 m-20 -51.83 -54.07 33.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 3.13 110.912 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -68.17 -32.28 72.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 2.6 110.936 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.416 ' CB ' HD22 ' A' ' 212' ' ' LEU . . . -50.64 -41.07 54.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 1.11 111.151 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.583 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 2.8 mm -83.62 -49.4 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 2.39 111.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -59.66 4.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 5.67 110.841 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -29.86 61.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 4.82 110.915 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 134' ' ' ILE . . . -56.14 -33.37 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.84 111.112 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.505 ' CE1' HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -73.36 -24.66 60.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 3.59 110.896 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.22 -54.02 6.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 2.56 110.884 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 250' ' ' LEU . 2.6 p -52.08 -28.81 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 1.88 111.12 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -89.11 -55.44 3.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 4.08 110.897 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 81.6 p -55.26 -22.56 18.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 1.61 110.855 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.83 -29.78 12.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 2.38 110.905 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.697 HG11 ' CG1' ' A' ' 255' ' ' ILE . 4.8 m -128.3 46.36 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 1.89 111.137 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.675 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -155.46 142.35 13.52 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.619 0.723 . . . . 1.58 111.113 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.675 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.5 Cg_endo -69.78 -11.91 31.79 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.702 2.268 . . . . 1.84 112.345 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.2 167.2 4.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 3.19 110.914 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.76 -172.95 2.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 6.12 110.887 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -131.84 127.58 36.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 6.55 110.9 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.97 89.92 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 2.45 110.885 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 95.18 7.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 2.53 110.918 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.655 HG22 ' H ' ' A' ' 154' ' ' THR . 2.0 mp -111.81 133.19 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 2.78 111.13 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.1 -28.96 67.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 4.29 110.916 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.655 ' H ' HG22 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -121.62 174.32 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 3.23 111.175 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.454 ' H ' HG22 ' A' ' 154' ' ' THR . . . 74.94 134.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.719 . . . . 2.27 112.487 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.1 mtm -68.99 160.33 31.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 6.73 110.866 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.51 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -139.68 144.63 37.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 1.24 111.124 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.48 -33.54 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 2.38 110.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.3 mm -103.99 94.47 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 3.14 111.124 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.617 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.1 tm? -105.13 117.46 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 1.88 110.86 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.617 ' N ' HD22 ' A' ' 160' ' ' LEU . 20.2 t -102.25 109.24 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 1.97 111.076 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.578 HG23 HD21 ' A' ' 160' ' ' LEU . 54.7 t -138.88 141.11 37.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 1.73 111.187 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.91 152.76 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 3.26 110.89 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.41 173.33 10.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 1.26 111.112 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.67 120.0 13.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 5.08 110.819 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 53.62 -134.77 42.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 1.72 112.488 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.91 110.48 20.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 1.49 111.061 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.23 56.38 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 2.93 110.859 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.34 -58.94 3.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 2.68 112.493 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -162.3 33.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 5.47 110.847 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -110.74 -168.88 1.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 5.14 110.878 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.75 114.89 16.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 6.11 110.876 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.05 147.83 40.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 1.84 111.11 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -59.86 -170.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 9.54 110.875 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -137.92 165.39 26.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 5.25 110.87 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -50.82 133.35 31.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 2.93 112.504 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 129.89 27.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 4.77 110.934 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.87 -13.39 29.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 3.84 112.459 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -108.58 -136.95 7.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 2.79 112.514 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.7 mt -71.47 110.88 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 3.21 111.174 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.572 HD22 ' H ' ' A' ' 181' ' ' LEU . 0.4 OUTLIER -50.51 -42.55 55.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 3.54 110.931 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 196' ' ' HIS . . . -178.84 -179.74 0.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 1.88 111.078 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -142.15 129.58 21.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 3.66 110.843 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -115.76 121.63 43.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.63 111.059 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.28 165.8 8.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 2.63 110.859 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.37 170.2 0.34 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.77 112.478 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -170.3 0.38 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.738 2.292 . . . . 0.98 112.364 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.14 -149.14 18.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 1.23 112.497 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 99.3 p -92.24 155.56 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 1.96 110.899 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.42 -104.4 0.15 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 1.14 112.485 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 38.0 mt -61.31 -26.52 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 1.98 111.121 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.15 99.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 2.69 112.515 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 116.73 -18.9 12.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 1.01 112.456 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.532 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 10.1 m-20 -49.83 137.57 16.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.826 0.345 . . . . 2.01 110.883 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -131.39 149.93 52.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.98 111.099 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.535 ' O ' ' HB3' ' A' ' 182' ' ' ALA . 20.3 m-70 -136.58 109.89 7.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 2.74 110.83 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -107.84 125.81 51.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 5.47 110.889 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.458 ' OD2' HG21 ' A' ' 122' ' ' THR . 11.5 m-20 49.67 78.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 6.63 110.871 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -76.61 60.79 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 8.5 110.901 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.6 26.6 16.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 5.34 110.856 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -97.42 -42.54 7.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 3.8 110.848 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 178.68 119.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 4.29 110.871 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -106.76 124.71 50.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 9.01 110.923 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.1 159.92 38.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 1.83 111.141 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.3 177.84 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 1.84 111.146 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -55.39 -24.97 32.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 4.86 110.865 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.98 -42.0 10.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 3.12 110.861 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -57.21 -175.93 0.36 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 2.35 112.503 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.4 -87.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.737 . . . . 1.92 112.461 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 60.1 m -73.89 98.74 3.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.827 0.346 . . . . 1.82 111.126 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -61.62 110.77 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 4.0 110.846 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.741 HD21 HG23 ' A' ' 130' ' ' VAL . 1.2 tt -69.33 -44.41 71.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.13 -0.487 . . . . 2.2 110.907 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 217' ' ' VAL . 14.1 m-85 -63.96 -40.31 96.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 5.36 110.896 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.44 -47.06 28.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 2.66 110.904 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 24.0 m -55.54 -49.6 72.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 1.21 111.141 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.84 -32.09 63.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.91 111.076 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 213' ' ' PHE . 62.9 t -80.77 -29.82 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.97 111.066 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -73.56 -48.73 30.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 1.78 110.871 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -63.59 -49.21 74.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 4.84 110.884 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.505 HD11 ' CE1' ' A' ' 138' ' ' PHE . 11.6 tt -57.82 -25.41 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 2.35 111.162 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 -27.52 70.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 1.29 112.481 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -74.97 -28.67 60.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 3.44 110.877 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.604 ' O ' HD12 ' A' ' 224' ' ' LEU . 0.7 OUTLIER -93.88 40.93 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 1.74 110.859 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 223' ' ' SER . 0.2 OUTLIER -159.72 -40.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 1.78 110.922 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 147.85 122.32 1.29 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 2.54 112.46 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.6 tp -179.19 -63.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 4.05 110.912 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 62.74 15.33 54.27 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 3.53 112.475 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 17.5 m80 51.98 67.15 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 2.24 110.833 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 65.1 m -51.89 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 5.13 110.866 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.464 ' N ' ' HE1' ' A' ' 236' ' ' MET . 0.3 OUTLIER 177.2 101.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 4.24 110.888 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.4 OUTLIER -146.65 85.17 7.29 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 3.66 110.887 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -29.78 23.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 2.78 112.325 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 8.38 43.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 5.5 110.952 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.797 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . . . -124.74 -177.49 3.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 2.29 111.129 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 241' ' ' LYS . 16.7 m -95.83 -7.6 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 4.62 111.115 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.464 ' HE1' ' N ' ' A' ' 230' ' ' SER . 1.9 ttp -54.15 -27.22 32.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 5.11 110.892 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.25 157.58 1.15 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.633 0.73 . . . . 3.92 110.871 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.34 28.3 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.67 2.246 . . . . 2.5 112.297 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.2 m -99.42 137.4 37.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 2.88 111.185 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -63.14 142.07 58.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 3.93 110.945 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.479 ' HB3' HG12 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -125.21 96.62 4.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 3.28 110.919 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -61.59 125.84 25.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 3.59 110.899 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.92 177.19 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 2.35 111.136 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.1 128.45 34.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 2.79 110.878 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.0 tp -55.83 -25.29 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 3.19 111.13 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -65.36 -39.4 92.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 2.97 110.894 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 65.2 p -99.6 2.72 44.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 2.46 111.154 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 217' ' ' VAL . 7.2 t80 -51.91 108.32 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 4.1 110.877 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -174.45 139.24 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 3.7 110.832 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.598 HD21 ' OD2' ' A' ' 254' ' ' ASP . 0.8 OUTLIER -52.59 151.75 4.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 2.41 110.917 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.586 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.4 OUTLIER -154.1 -179.0 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 3.98 110.848 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.658 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . . . 64.55 -178.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 3.29 111.119 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -23.23 51.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 2.72 110.831 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.598 ' OD2' HD21 ' A' ' 250' ' ' LEU . 5.1 t0 -53.19 -30.12 35.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 3.05 110.863 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.697 ' CG1' HG11 ' A' ' 144' ' ' VAL . 2.2 tt -65.1 -29.99 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 2.41 111.11 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -99.04 -1.71 39.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 7.09 110.885 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -90.17 17.85 51.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.693 -0.765 . . . . 1.69 112.532 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.46 HG12 HG23 ' A' ' 145' ' ' THR . 0.7 OUTLIER -134.87 -40.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 1.08 111.1 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -24.77 56.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 3.51 110.867 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.2 t -76.32 -24.74 54.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 1.87 110.833 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.7 mp -82.97 142.28 31.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 5.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 55.14 26.59 8.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 12.83 110.869 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 CA-C-O 119.122 -0.821 . . . . 11.15 112.477 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.824 0.345 . . . . 8.42 110.863 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -132.62 126.51 32.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 11.02 110.918 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 tp -116.8 163.88 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.508 . . . . 3.37 111.103 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.6 p -146.42 155.99 42.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 2.22 111.127 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.409 ' CD2' HD11 ' A' ' 159' ' ' ILE . 0.1 OUTLIER -127.47 136.7 52.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 7.5 110.911 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -141.14 143.33 34.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 4.33 110.864 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.5 mt -108.01 148.36 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 2.48 111.162 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -111.9 -69.46 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 3.74 110.914 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -107.36 -169.84 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 4.72 110.877 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -146.62 140.73 26.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 6.27 110.946 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.632 HG23 HG21 ' A' ' 130' ' ' VAL . 72.3 p -53.08 109.71 1.61 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.552 0.692 . . . . 2.84 111.129 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 122' ' ' THR . 53.7 Cg_endo -69.8 -48.74 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.647 2.231 . . . . 2.85 112.307 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.21 -33.55 75.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 4.65 110.858 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.2 tpt -101.34 178.88 4.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 3.16 110.853 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -78.92 128.83 33.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 3.52 110.849 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -52.96 -28.12 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 6.17 110.908 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.77 -32.49 40.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 3.3 110.899 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -65.6 -43.05 90.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 2.72 110.881 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.632 HG21 HG23 ' A' ' 122' ' ' THR . 10.2 p -74.09 -35.54 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.02 111.143 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.0 -44.4 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 2.48 110.846 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -71.76 -39.63 69.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 3.67 110.932 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.671 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -56.16 -59.24 5.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.98 111.168 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.466 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 3.4 pt -56.43 -29.4 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 2.74 111.139 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.08 -57.64 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 4.24 110.827 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.664 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -79.19 -25.64 42.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 2.98 110.869 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.734 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.59 -43.75 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 1.28 111.091 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.415 ' HA ' HG21 ' A' ' 220' ' ' ILE . 37.0 t80 -73.68 -23.93 59.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 3.66 110.84 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -78.13 -31.41 49.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 2.95 110.912 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 136' ' ' LYS . 47.7 t -51.09 -56.2 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 1.97 111.089 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CE3' HD11 ' A' ' 250' ' ' LEU . 0.9 OUTLIER -73.64 -42.13 61.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 4.38 110.917 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.651 ' HB2' HD11 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -54.67 -22.38 13.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 1.7 110.841 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -57.62 -21.84 41.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 3.36 110.909 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.609 HG21 HG13 ' A' ' 255' ' ' ILE . 3.0 m -141.51 62.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 2.26 111.173 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.771 HG23 HG13 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -157.02 147.53 16.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.632 0.73 . . . . 1.84 111.114 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.734 ' HD2' HG22 ' A' ' 145' ' ' THR . 54.2 Cg_endo -69.75 -8.53 23.85 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.688 2.259 . . . . 2.48 112.362 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' A' ' 142' ' ' SER . 3.6 pp -66.22 -172.28 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 4.26 110.923 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.508 ' N ' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -144.77 -174.89 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 6.28 110.899 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -132.32 122.34 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 6.94 110.891 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.4 t -144.93 89.94 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 1.9 110.869 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -82.31 117.1 22.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 3.68 110.894 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.2 159.84 42.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 2.87 111.11 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -99.88 -27.96 13.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 3.9 110.876 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.4 m -113.73 116.73 29.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 3.08 111.088 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.33 147.35 6.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 2.06 112.484 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.2 164.67 26.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.766 0.317 . . . . 6.03 110.891 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.0 142.9 27.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 1.02 111.106 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -51.93 53.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 2.24 110.859 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.881 HG22 ' HA3' ' A' ' 193' ' ' GLY . 22.9 pt -104.63 139.85 24.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 2.57 111.141 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.742 HD22 ' C ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -135.44 162.94 31.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 2.0 110.941 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.598 ' N ' HD22 ' A' ' 160' ' ' LEU . 39.2 t -106.21 121.74 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.79 111.095 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.486 ' HB ' HD21 ' A' ' 160' ' ' LEU . 3.5 p -139.43 163.31 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 2.48 111.144 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -121.02 133.13 55.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 4.01 110.892 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.86 167.73 20.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 1.49 111.112 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.68 146.59 32.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 5.15 110.878 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.37 -151.48 3.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 2.19 112.502 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.79 125.35 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 2.06 111.088 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -112.39 43.54 1.6 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 2.84 110.847 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.14 76.59 0.26 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 3.21 112.462 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.2 t70 63.86 47.71 3.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.736 0.303 . . . . 5.94 110.825 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.422 ' OD2' HD11 ' A' ' 191' ' ' ILE . 0.3 OUTLIER -142.2 -169.02 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 4.65 110.851 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -76.83 124.08 27.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 5.46 110.851 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.29 144.96 31.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 1.96 111.131 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -130.32 -169.66 2.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 6.32 110.887 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -151.28 -170.53 3.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 5.04 110.86 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -115.92 -153.13 10.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.758 . . . . 2.42 112.445 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.71 133.61 25.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 3.37 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 111.96 -18.97 23.6 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 2.43 112.496 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -143.98 -129.09 2.21 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.747 -0.739 . . . . 1.41 112.49 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 182' ' ' ALA . 28.5 mm -77.2 125.45 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.89 0.376 . . . . 2.46 111.144 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.591 ' HG ' HG21 ' A' ' 210' ' ' THR . 0.3 OUTLIER -95.89 -5.91 40.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 4.12 110.911 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.488 ' H ' HG22 ' A' ' 180' ' ' ILE . . . -178.6 123.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 1.76 111.114 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 114.23 18.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 3.66 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.64 117.5 24.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.69 111.075 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -64.41 170.79 3.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 2.79 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.05 172.08 0.17 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.751 -0.737 . . . . 0.82 112.489 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 172.23 13.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 0.87 112.333 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 159.35 -133.6 3.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 1.25 112.507 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 34.5 t -134.09 128.42 34.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.367 . . . . 3.63 110.88 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 85.52 -70.36 3.08 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.741 -0.742 . . . . 1.86 112.486 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.422 HD11 ' OD2' ' A' ' 171' ' ' ASP . 0.5 OUTLIER -99.7 -27.04 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.358 . . . . 3.04 111.119 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.11 129.14 29.0 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 2.3 112.525 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.881 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . 85.69 -9.57 67.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 1.06 112.511 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.453 ' HA ' HD13 ' A' ' 160' ' ' LEU . 3.8 m-20 -51.19 157.61 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.82 110.874 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.753 ' HB1' ' CE2' ' A' ' 197' ' ' PHE . . . -125.97 121.28 32.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 1.16 111.08 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -111.05 115.52 29.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 3.08 110.838 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.753 ' CE2' ' HB1' ' A' ' 195' ' ' ALA . 50.1 m-85 -143.94 150.23 38.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 3.03 110.875 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.432 ' N ' ' HE1' ' A' ' 203' ' ' TRP . 0.9 OUTLIER 75.16 -168.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 7.15 110.855 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.87 96.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 6.91 110.923 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.2 t70 55.95 68.97 0.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 4.08 110.888 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -174.75 -41.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 4.27 110.879 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 11.7 t80 67.24 131.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 5.56 110.885 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.658 ' CH2' HG21 ' A' ' 215' ' ' THR . 21.3 m95 -105.72 -174.91 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 7.08 110.877 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 168.27 27.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 1.96 111.184 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -175.1 3.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 2.0 111.143 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -52.76 -47.95 67.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 4.44 110.909 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.4 p -78.39 -31.94 48.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 2.18 110.879 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -50.38 167.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 2.2 112.483 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.83 -72.71 0.44 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 1.62 112.502 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.591 HG21 ' HG ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -102.3 98.64 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.796 0.332 . . . . 1.8 111.133 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -69.57 132.39 46.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 4.44 110.87 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.2 tm? -57.99 -41.3 82.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 3.39 110.908 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.733 ' O ' HG23 ' A' ' 217' ' ' VAL . 8.0 t80 -70.74 -60.72 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 5.52 110.899 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.529 ' CD2' HG22 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -50.43 -34.89 26.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 3.01 110.898 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.658 HG21 ' CH2' ' A' ' 203' ' ' TRP . 82.5 m -79.91 -41.6 25.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 1.11 111.148 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.89 98.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 1.19 111.102 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.734 HG22 ' HA ' ' A' ' 137' ' ' ALA . 53.5 t -51.27 -40.74 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.82 111.156 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -64.74 -36.41 84.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 2.07 110.85 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -74.64 -45.75 42.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 4.47 110.883 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.463 HD12 ' HB1' ' A' ' 137' ' ' ALA . 91.3 mt -56.09 -37.04 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 2.09 111.187 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.07 -37.78 36.94 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.686 -0.769 . . . . 0.67 112.467 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -54.86 -40.64 69.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 2.34 110.879 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.6 8.75 26.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 2.14 110.879 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.484 ' O ' HD13 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -150.33 88.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 3.47 110.944 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 71.12 179.32 29.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.738 -0.744 . . . . 2.11 112.51 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 54.3 -175.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 3.03 110.896 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.404 ' C ' ' HE1' ' A' ' 236' ' ' MET . . . -145.8 -115.68 0.96 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 2.48 112.464 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.44 142.82 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 1.8 110.881 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.83 -78.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 6.61 110.845 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.51 -78.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 5.44 110.882 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 153.21 48.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.599 0.714 . . . . 3.89 110.858 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 233' ' ' LYS . 54.0 Cg_endo -69.73 -177.12 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.677 2.252 . . . . 2.83 112.358 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.47 43.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 4.32 110.887 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -135.54 163.5 29.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 1.77 111.101 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.447 HG23 HD11 ' A' ' 214' ' ' LEU . 9.8 p -87.16 7.4 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 3.14 111.14 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.404 ' HE1' ' C ' ' A' ' 227' ' ' GLY . 1.4 tmm? -98.43 -26.08 14.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 3.86 110.906 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.458 ' HB3' HG22 ' A' ' 239' ' ' THR . 0.1 OUTLIER -54.68 141.59 55.6 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.632 0.73 . . . . 3.95 110.888 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 64.97 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.683 2.256 . . . . 2.12 112.349 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.458 HG22 ' HB3' ' A' ' 237' ' ' PHE . 7.1 t -158.03 134.2 9.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 2.64 111.169 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -76.3 127.49 32.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 4.23 110.951 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.407 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.0 ptmt -140.58 92.74 2.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 4.17 110.915 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -62.41 125.61 24.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 3.44 110.912 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.529 HG22 ' CD2' ' A' ' 214' ' ' LEU . 16.7 m -137.49 177.32 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.494 . . . . 2.55 111.153 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -62.09 114.28 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 3.91 110.845 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 18.4 tt -76.36 -32.75 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 3.16 111.172 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.43 -30.79 65.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 3.19 110.866 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.56 28.05 9.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 3.44 111.11 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -51.76 149.86 4.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 5.34 110.913 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -179.71 156.2 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 4.37 110.885 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 251' ' ' SER . 0.4 OUTLIER -86.83 157.49 19.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 2.18 110.955 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.627 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.3 OUTLIER -154.65 -171.64 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 3.4 110.904 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 68.72 160.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 3.66 111.109 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.84 -21.48 56.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 3.28 110.886 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.84 -29.74 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 4.04 110.886 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.609 HG13 HG21 ' A' ' 144' ' ' VAL . 1.2 tt -51.14 -29.53 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 1.7 111.143 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -90.59 -34.07 15.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 5.19 110.842 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.55 -17.07 47.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 1.65 112.507 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.771 HG13 HG23 ' A' ' 145' ' ' THR . 4.0 tp -99.95 -31.61 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.9 111.179 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.78 -43.39 25.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 3.98 110.899 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.416 ' C ' HD12 ' A' ' 261' ' ' LEU . 34.6 t -85.6 -47.25 10.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 1.95 110.841 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 260' ' ' SER . 1.1 mp 56.93 70.12 0.68 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 3.55 110.902 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -142.13 93.3 2.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 11.71 110.875 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 CA-C-O 119.121 -0.822 . . . . 10.84 112.5 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.757 0.313 . . . . 7.51 110.862 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.496 ' O ' HD13 ' A' ' 114' ' ' ILE . 3.1 m-85 -67.27 148.89 51.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 9.14 110.936 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 113' ' ' TYR . 18.6 mm -129.01 155.05 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 2.87 111.16 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.47 117.71 7.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 2.19 111.136 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.759 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 11.8 p90 -131.95 145.83 51.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 4.25 110.942 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -142.29 160.51 40.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 4.94 110.9 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 134' ' ' ILE . 21.3 mt -106.59 148.92 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 2.16 111.172 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.582 ' CB ' HG22 ' A' ' 162' ' ' VAL . 9.7 t-20 -106.77 -69.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 4.29 110.86 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -118.37 174.88 5.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 5.42 110.881 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -134.45 163.27 30.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 6.55 110.918 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.578 HG21 ' HB2' ' A' ' 203' ' ' TRP . 0.0 OUTLIER -88.51 131.86 40.75 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.546 0.688 . . . . 2.57 111.114 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -19.43 36.14 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.702 2.268 . . . . 2.15 112.334 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.64 -69.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 4.48 110.874 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 38.0 mmm -101.19 168.12 9.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 3.61 110.87 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -59.39 158.23 9.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 2.54 110.892 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.433 ' HA ' HG12 ' A' ' 130' ' ' VAL . 3.9 tmm_? -70.78 -11.26 60.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 6.57 110.888 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -79.73 -36.69 37.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 3.09 110.886 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.07 -40.77 71.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 2.68 110.866 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.522 HG23 HD11 ' A' ' 212' ' ' LEU . 8.8 p -74.3 -36.2 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.67 111.107 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -66.34 -43.97 84.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 3.78 110.855 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -48.98 23.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 3.32 110.937 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.547 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -59.78 -26.88 66.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 1.27 111.094 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.529 HG21 HD11 ' A' ' 118' ' ' ILE . 1.3 mm -70.85 -50.93 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 2.46 111.15 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -75.2 -22.7 57.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 4.14 110.879 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -77.62 -29.92 52.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 2.94 110.934 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 140' ' ' VAL . . . -63.5 -52.08 62.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.97 111.039 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.579 ' HA ' HG21 ' A' ' 220' ' ' ILE . 1.3 t80 -55.09 -28.38 52.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 4.24 110.887 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -70.49 -27.95 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 2.49 110.898 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.534 HG11 HG11 ' A' ' 217' ' ' VAL . 58.4 t -51.08 -56.1 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 1.74 111.16 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.442 ' CZ3' HD21 ' A' ' 250' ' ' LEU . 30.7 m95 -77.44 -29.06 52.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 3.97 110.921 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 p -55.19 -41.61 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 2.24 110.807 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.69 -16.19 62.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 2.77 110.9 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.822 HG11 HD11 ' A' ' 255' ' ' ILE . 31.5 m -135.79 39.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 2.32 111.139 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.447 HG23 ' HD2' ' A' ' 146' ' ' PRO . 91.9 m -155.63 133.65 6.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.583 0.706 . . . . 1.86 111.17 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.447 ' HD2' HG23 ' A' ' 145' ' ' THR . 54.1 Cg_endo -69.76 74.56 1.28 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.738 2.292 . . . . 2.36 112.341 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.479 HD21 HD11 ' A' ' 114' ' ' ILE . 2.8 tp -163.13 -169.65 2.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 3.21 110.941 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -148.25 176.27 10.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 4.81 110.875 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -135.81 120.03 17.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 7.26 110.87 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 t -110.44 89.99 3.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 1.91 110.843 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.16 93.4 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 2.76 110.882 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.599 HD12 ' O ' ' A' ' 154' ' ' THR . 1.1 pt -131.57 163.96 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 3.58 111.155 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -103.01 -5.78 23.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 3.19 110.891 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.599 ' O ' HD12 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -95.57 175.73 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 4.13 111.184 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.48 -165.55 1.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 2.14 112.476 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.4 mtm -110.77 151.92 27.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 4.94 110.867 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.759 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -119.35 130.14 55.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 1.31 111.087 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.41 -20.82 62.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 2.54 110.883 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.0 mm -103.47 84.58 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 2.59 111.144 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.643 HD11 HG23 ' A' ' 162' ' ' VAL . 1.1 tm? -85.72 117.72 24.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 1.48 110.945 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.605 ' N ' HD22 ' A' ' 160' ' ' LEU . 99.4 t -105.3 110.77 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 1.49 111.085 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.643 HG23 HD11 ' A' ' 160' ' ' LEU . 47.6 t -127.07 143.2 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 1.19 111.15 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -97.77 100.21 11.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 7.54 110.903 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.518 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . . . -132.26 144.03 50.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 1.75 111.1 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.74 164.1 14.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 6.72 110.849 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.52 -138.03 29.36 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.768 -0.729 . . . . 1.16 112.502 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.23 128.24 33.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 1.47 111.137 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -95.67 24.87 4.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 3.18 110.887 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.8 -28.17 10.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.761 -0.733 . . . . 2.32 112.481 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.46 34.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.817 0.341 . . . . 5.25 110.874 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.56 -173.84 2.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 4.53 110.903 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.61 118.83 26.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 6.38 110.864 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.41 139.9 35.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.34 111.086 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -154.02 88.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 7.17 110.87 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -128.49 -168.42 1.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 5.53 110.859 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.62 106.1 0.91 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.748 -0.739 . . . . 2.17 112.477 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.94 119.11 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 4.96 110.891 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.61 -24.52 21.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 2.29 112.494 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -82.88 -140.72 3.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.675 -0.774 . . . . 1.46 112.51 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.62 110.53 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 1.91 111.105 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.578 HD22 ' H ' ' A' ' 181' ' ' LEU . 0.4 OUTLIER -50.42 -57.38 8.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.478 . . . . 3.79 110.915 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.01 123.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 1.46 111.093 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -95.3 153.58 17.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 3.21 110.831 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -152.46 113.04 4.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.69 111.06 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.67 157.4 24.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 2.54 110.885 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.94 -171.0 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 1.13 112.497 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -169.86 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.731 2.287 . . . . 1.03 112.338 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 125.37 -156.34 19.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 1.2 112.512 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.8 p -88.92 145.58 25.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 2.83 110.861 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.08 -102.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 1.17 112.43 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 82.0 mt -52.57 -27.73 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 2.07 111.153 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.59 111.56 2.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 2.66 112.474 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.43 -16.14 56.89 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 1.05 112.507 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -49.94 138.41 15.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 2.26 110.905 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 161' ' ' VAL . . . -129.96 141.17 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.93 111.097 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.518 ' NE2' ' HB3' ' A' ' 164' ' ' ALA . 0.1 OUTLIER -118.77 144.57 46.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 3.28 110.871 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -144.45 148.5 34.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 2.71 110.903 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.425 ' HB2' HG23 ' A' ' 122' ' ' THR . 25.5 t70 70.48 -75.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 5.86 110.882 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 46.85 41.33 10.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 8.83 110.919 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.5 t0 62.98 41.1 8.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 3.54 110.888 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -118.45 1.87 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 4.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.12 115.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 4.75 110.899 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.737 ' CZ3' HG21 ' A' ' 210' ' ' THR . 0.1 OUTLIER -100.11 170.19 8.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 6.94 110.946 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 205' ' ' THR . 0.2 OUTLIER -156.81 172.92 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 1.75 111.161 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 204' ' ' THR . 0.3 OUTLIER -75.35 -170.15 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 1.99 111.161 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.671 ' CB ' HG23 ' A' ' 245' ' ' ILE . 39.7 p-80 -76.77 -21.39 55.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 4.89 110.853 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.9 t -61.08 -68.9 0.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 2.08 110.843 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -132.9 -166.69 11.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.716 -0.754 . . . . 2.22 112.481 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 50.07 -168.06 0.31 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.697 -0.763 . . . . 1.63 112.497 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.737 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.3 m -56.46 99.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 1.54 111.114 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.0 103.76 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 2.55 110.846 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.576 ' O ' HD23 ' A' ' 212' ' ' LEU . 6.6 tt -57.51 -38.27 74.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 1.96 110.901 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.547 ' O ' HG23 ' A' ' 217' ' ' VAL . 11.6 t80 -71.47 -64.26 0.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 5.03 110.837 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.7 tp -50.8 -53.68 29.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 2.15 110.915 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 85.5 m -55.37 -44.24 75.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.91 111.167 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.68 -43.91 76.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.65 111.098 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 213' ' ' PHE . 24.6 t -55.09 -41.87 61.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.64 111.14 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -60.23 -31.33 70.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 2.22 110.857 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -74.62 -40.35 61.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 3.66 110.884 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.579 HG21 ' HA ' ' A' ' 138' ' ' PHE . 49.4 mm -54.64 -43.35 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.54 111.101 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.467 ' O ' HD23 ' A' ' 226' ' ' LEU . . . -75.87 -50.47 7.83 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.733 -0.746 . . . . 0.93 112.528 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.81 -31.69 62.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 2.29 110.865 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.9 p -95.24 22.11 7.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 2.04 110.846 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 220' ' ' ILE . 17.2 mt -142.31 18.03 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 2.3 110.888 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.606 ' O ' HD22 ' A' ' 226' ' ' LEU . . . 90.26 70.08 1.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 1.89 112.499 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.606 HD22 ' O ' ' A' ' 225' ' ' GLY . 2.8 mm? -130.28 169.47 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 3.58 110.928 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -82.29 -120.89 0.62 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 2.67 112.45 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.87 33.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.331 . . . . 3.39 110.819 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.0 m -153.09 -75.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 5.42 110.832 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.0 t 57.7 -169.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 6.34 110.888 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.06 160.29 0.87 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.632 0.729 . . . . 2.92 110.851 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -14.84 36.46 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.639 2.226 . . . . 2.51 112.346 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.74 -19.7 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 3.65 110.889 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.57 170.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 1.66 111.067 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 235' ' ' VAL . 7.9 t -88.17 -1.37 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 3.18 111.156 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -30.2 20.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 3.86 110.897 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.53 137.69 31.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.638 0.732 . . . . 3.96 110.877 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.41 ' O ' HG23 ' A' ' 239' ' ' THR . 53.8 Cg_endo -69.71 77.97 1.02 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 2.56 112.375 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 238' ' ' PRO . 1.1 p -156.41 168.03 28.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 2.55 111.136 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -125.37 112.53 16.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 3.76 110.922 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.01 153.02 48.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 2.7 110.888 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -111.13 102.47 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 3.49 110.94 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 244' ' ' ASP . 7.5 t -107.57 157.21 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 2.35 111.146 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 243' ' ' VAL . 0.7 OUTLIER -75.92 135.32 40.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 3.62 110.855 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.671 HG23 ' CB ' ' A' ' 206' ' ' HIS . 19.6 pt -58.17 -22.61 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 2.73 111.116 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -21.41 24.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 3.06 110.903 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.9 m -100.73 -6.11 25.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 2.74 111.116 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.06 158.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 5.34 110.848 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -178.22 149.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 4.34 110.879 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.951 HD12 HD12 ' A' ' 255' ' ' ILE . 1.8 tm? -83.87 150.82 25.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 2.49 110.888 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.785 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.4 OUTLIER -87.67 123.61 32.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 3.6 110.894 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -44.73 -54.79 5.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 4.01 111.067 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.08 -39.63 63.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 3.59 110.895 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -71.68 -34.53 69.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 2.76 110.905 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.951 HD12 HD12 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -50.75 -30.84 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 1.84 111.111 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -79.39 -35.38 40.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 6.1 110.88 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -61.17 -16.72 49.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 1.61 112.479 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.713 ' O ' HD13 ' A' ' 261' ' ' LEU . 7.5 tp -114.45 -36.27 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.84 111.172 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? -67.37 -50.71 58.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 3.73 110.881 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -47.18 56.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 2.1 110.852 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.713 HD13 ' O ' ' A' ' 258' ' ' ILE . 1.2 tp 54.73 26.05 7.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 3.52 110.947 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.88 124.34 7.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 9.98 110.927 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 119.091 -0.838 . . . . 9.86 112.5 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.803 0.335 . . . . 8.09 110.828 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.55 ' C ' HD12 ' A' ' 114' ' ' ILE . 34.7 p90 -85.19 146.14 27.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 9.59 110.919 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.55 HD12 ' C ' ' A' ' 113' ' ' TYR . 1.6 mp -117.92 145.58 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 3.01 111.094 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.23 137.43 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 2.04 111.132 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.45 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 30.2 p90 -144.58 136.78 26.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 4.61 110.908 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.27 133.63 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 4.49 110.878 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.647 HD13 ' HB ' ' A' ' 134' ' ' ILE . 26.5 mt -108.05 141.61 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 2.48 111.16 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -157.44 47.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 4.27 110.83 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.519 ' CG ' HG12 ' A' ' 161' ' ' VAL . 21.4 p-10 -147.23 143.72 28.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 5.63 110.914 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -148.29 162.47 39.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 6.44 110.934 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.545 HG23 HD11 ' A' ' 212' ' ' LEU . 1.0 OUTLIER -87.8 156.73 52.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.562 0.696 . . . . 3.2 111.164 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 122' ' ' THR . 53.7 Cg_endo -69.71 -52.18 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.664 2.243 . . . . 2.5 112.352 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -66.94 -46.0 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 5.43 110.932 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 10.7 mmt -98.26 122.88 41.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 3.63 110.888 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -56.2 171.78 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 4.48 110.879 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.59 ' HA ' HG12 ' A' ' 130' ' ' VAL . 14.5 ptt180 -67.2 -10.56 51.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 5.99 110.853 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -34.17 71.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 5.18 110.902 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.31 -41.23 41.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 3.81 110.875 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.832 HG23 HD21 ' A' ' 212' ' ' LEU . 9.7 p -74.17 -33.99 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 1.2 111.113 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -49.92 -53.02 28.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 2.65 110.847 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -76.16 -33.1 59.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 3.11 110.924 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.38 -58.65 7.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.8 111.098 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.681 HG12 HG22 ' A' ' 130' ' ' VAL . 5.3 mm -67.78 -45.48 84.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 2.74 111.093 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -50.3 -48.99 54.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 3.73 110.854 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -76.83 -20.37 56.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 5.36 110.885 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 134' ' ' ILE . . . -56.01 -37.96 69.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.9 111.141 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.31 -25.17 60.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 3.88 110.901 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -73.63 -27.79 61.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 3.16 110.932 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.711 HG21 ' CG2' ' A' ' 217' ' ' VAL . 21.6 t -58.94 -55.94 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 2.05 111.151 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -44.21 61.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 4.37 110.945 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.3 m -54.87 -24.87 25.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 2.63 110.855 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -58.08 -22.62 51.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 2.25 110.899 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.754 HG11 HD11 ' A' ' 255' ' ' ILE . 23.5 m -140.3 37.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 2.11 111.14 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.8 m -142.88 131.52 11.53 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.62 0.724 . . . . 1.71 111.149 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 66.75 1.77 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 2.32 112.305 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tp -140.62 166.25 25.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 2.55 110.906 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -118.38 162.29 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 4.43 110.905 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -135.8 119.84 17.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 6.91 110.881 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 98.4 p -127.35 90.01 3.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 2.26 110.894 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 120.13 12.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 2.56 110.882 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 154' ' ' THR . 5.5 pt -148.03 156.93 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 3.05 111.161 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -96.52 -24.33 16.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 3.95 110.874 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.662 ' O ' HD12 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -95.71 175.51 6.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 3.17 111.148 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.46 -171.95 42.88 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.712 -0.756 . . . . 1.86 112.507 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mtt -110.65 157.09 20.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.794 0.33 . . . . 5.1 110.846 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -137.08 146.57 45.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.01 111.094 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.75 -17.79 32.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 2.77 110.901 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.3 mm -104.31 84.47 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 2.58 111.164 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.587 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.2 tm? -91.78 117.15 29.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 1.42 110.902 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.587 ' N ' HD22 ' A' ' 160' ' ' LEU . 21.2 t -102.71 110.75 30.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 1.35 111.097 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.582 ' CG2' HD11 ' A' ' 160' ' ' LEU . 45.2 t -133.97 141.94 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 1.06 111.158 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -80.81 145.7 31.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 3.43 110.857 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.57 ' HB1' ' CD2' ' A' ' 168' ' ' HIS . . . -164.27 156.0 16.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 1.69 111.094 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.62 140.1 31.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 5.71 110.829 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.43 -136.4 35.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 1.58 112.468 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.29 127.71 33.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 1.34 111.061 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.57 ' CD2' ' HB1' ' A' ' 164' ' ' ALA . 5.5 m170 -101.22 25.31 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 6.12 110.865 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.19 92.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.807 -0.711 . . . . 2.78 112.505 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.9 t0 63.71 59.03 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.341 . . . . 5.5 110.848 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -158.03 -170.5 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 4.16 110.868 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -96.07 106.25 18.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 5.85 110.866 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.03 159.17 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 2.13 111.063 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.09 -74.06 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 6.07 110.866 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -179.28 -74.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 4.27 110.894 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.08 -155.06 24.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 2.43 112.501 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -59.43 123.06 15.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.844 0.354 . . . . 5.39 110.864 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.38 90.6 0.64 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 3.3 112.459 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.25 -140.59 11.02 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.794 -0.717 . . . . 1.54 112.507 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.0 mt -72.06 92.24 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.893 0.378 . . . . 2.17 111.187 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -48.51 -28.96 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 3.36 110.921 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.14 178.3 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.58 111.065 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -151.64 125.49 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 3.22 110.885 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.93 104.9 8.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.96 111.13 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.09 165.81 8.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 3.22 110.921 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.4 171.12 0.28 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.784 -0.722 . . . . 1.04 112.521 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -170.04 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.691 2.261 . . . . 1.17 112.317 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.12 -112.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 1.46 112.459 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.87 135.24 43.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 2.11 110.875 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.61 -86.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.95 112.467 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 90.8 mt -71.76 -23.45 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 2.07 111.097 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -58.46 117.3 10.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.749 . . . . 2.46 112.474 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.71 -14.6 64.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.723 -0.751 . . . . 0.81 112.494 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -51.63 128.64 23.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.812 0.339 . . . . 2.03 110.862 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -117.27 148.76 41.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.8 111.098 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.583 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 39.7 m-70 -137.08 124.78 22.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 2.63 110.835 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.509 ' CE2' HD23 ' A' ' 212' ' ' LEU . 0.2 OUTLIER -107.35 143.41 35.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 4.09 110.853 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -77.93 58.08 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 6.15 110.899 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -73.18 -13.51 61.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 9.6 110.882 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -127.5 7.11 6.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 6.22 110.91 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -121.74 -34.98 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 6.02 110.862 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.52 91.69 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 7.57 110.898 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -104.51 122.53 45.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 8.98 110.938 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.11 162.53 38.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 2.11 111.168 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.52 -170.21 1.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 2.3 111.136 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -47.17 -46.95 24.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 6.02 110.849 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -59.22 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 2.28 110.847 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.26 171.2 0.25 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.738 . . . . 2.5 112.448 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.99 -90.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.744 . . . . 1.55 112.514 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.02 97.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.321 . . . . 1.47 111.169 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -68.34 117.82 10.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 2.84 110.873 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.832 HD21 HG23 ' A' ' 130' ' ' VAL . 0.7 OUTLIER -51.35 -40.26 58.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 2.46 110.914 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -71.45 -56.22 6.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 4.78 110.909 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.52 HD21 ' CE1' ' A' ' 248' ' ' PHE . 0.1 OUTLIER -52.34 -54.74 27.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 2.75 110.892 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 92.3 m -55.52 -38.42 69.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.8 111.164 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.61 -50.66 69.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.071 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.711 ' CG2' HG21 ' A' ' 140' ' ' VAL . 39.3 t -57.01 -36.15 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.74 111.129 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -59.73 -41.89 91.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 2.07 110.873 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -66.71 -36.87 83.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 4.21 110.864 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.8 mm -57.85 -57.89 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 1.48 111.171 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.34 -41.61 99.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.83 112.471 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.93 ' HE1' 'CO ' ' A' ' 264' ' ' ' CO' . 0.2 OUTLIER -52.17 -46.33 65.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 3.2 110.863 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.25 23.44 5.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 2.34 110.807 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.96 87.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.185 -0.462 . . . . 3.81 110.883 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 131.47 -81.87 0.32 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 2.51 112.454 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.45 179.26 3.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 3.52 110.953 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.44 120.22 1.32 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.732 -0.747 . . . . 2.67 112.444 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 63.34 91.35 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.815 0.341 . . . . 1.82 110.886 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.9 t -98.12 -75.49 0.55 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.166 -0.47 . . . . 4.14 110.918 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.0 t -178.99 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.508 . . . . 4.37 110.861 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.1 116.86 7.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.638 0.732 . . . . 2.66 110.909 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -8.73 24.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.726 2.284 . . . . 2.54 112.319 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 -24.21 13.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 5.12 110.882 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.433 ' HB2' ' OG ' ' A' ' 251' ' ' SER . . . -61.9 169.08 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.01 111.105 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.44 ' O ' HG12 ' A' ' 235' ' ' VAL . 3.7 t -94.6 7.35 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 3.1 111.142 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -89.26 -34.13 16.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 4.51 110.884 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.94 138.34 95.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.677 0.751 . . . . 3.9 110.815 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 87.4 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.655 2.237 . . . . 2.26 112.35 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.08 139.49 14.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 2.64 111.179 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.74 112.28 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 3.78 110.916 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -129.26 -169.18 2.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 5.68 110.881 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -114.53 79.57 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 3.49 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 244' ' ' ASP . 3.8 t -107.33 159.95 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 2.78 111.119 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.421 ' N ' HG12 ' A' ' 243' ' ' VAL . 0.6 OUTLIER -48.84 112.88 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 5.48 110.829 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.5 pp -76.69 -33.11 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 3.34 111.124 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -72.26 -39.2 68.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 4.1 110.88 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.13 17.97 13.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 2.74 111.194 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.52 ' CE1' HD21 ' A' ' 214' ' ' LEU . 9.5 t80 -70.62 138.23 50.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 6.83 110.853 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -154.38 134.18 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 4.01 110.887 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.74 HD11 HD12 ' A' ' 255' ' ' ILE . 0.5 OUTLIER -53.24 171.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 2.94 110.94 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 97.7 p -89.58 -172.8 3.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 4.66 110.842 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -85.76 -59.88 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 3.89 111.157 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -37.2 62.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 3.82 110.846 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -70.49 -29.77 66.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 3.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.754 HD11 HG11 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -52.82 -28.39 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 1.99 111.124 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -87.73 -36.49 17.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 4.69 110.908 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.82 -17.48 50.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.708 -0.758 . . . . 1.73 112.512 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.3 tp -109.59 -30.37 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.97 111.141 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -77.65 -40.07 43.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 2.96 110.901 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t -85.34 -47.16 10.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 2.48 110.862 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.1 mp 60.89 68.3 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 3.68 110.863 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -119.76 153.65 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.249 -0.432 . . . . 10.94 110.903 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 CA-C-O 119.119 -0.823 . . . . 10.63 112.483 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . 0.93 'CO ' ' HE1' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.807 0.337 . . . . 14.22 110.875 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -101.48 149.69 23.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 16.69 110.931 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 115' ' ' THR . 2.1 tp -146.44 168.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 6.09 111.126 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -92.31 116.29 28.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 3.02 111.152 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.566 ' HB3' HD11 ' A' ' 159' ' ' ILE . 16.9 p90 -139.67 136.57 34.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 5.19 110.913 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.03 107.09 15.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 4.27 110.823 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.788 HG23 HG23 ' A' ' 161' ' ' VAL . 18.1 mt -75.23 138.76 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 2.36 111.142 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.66 ' HB2' HG22 ' A' ' 162' ' ' VAL . 4.0 m120 -98.3 -74.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 4.79 110.863 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.35 145.47 47.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 5.91 110.873 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -85.69 163.25 18.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 6.54 110.911 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.7 p -100.87 137.94 19.91 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.557 0.694 . . . . 3.34 111.163 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -171.49 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.684 2.256 . . . . 2.71 112.335 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 56.64 22.97 7.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 4.06 110.887 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -165.28 142.82 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 4.45 110.895 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.45 142.52 58.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 2.51 110.885 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -56.03 -25.2 43.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 5.12 110.855 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -75.69 -38.83 58.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 3.12 110.943 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.26 -51.12 67.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 2.47 110.903 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.611 ' O ' HD12 ' A' ' 134' ' ' ILE . 6.4 p -62.1 -39.6 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.83 111.164 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -68.12 -54.6 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 2.95 110.882 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -62.16 -33.29 74.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 2.68 110.93 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.596 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -63.21 -57.98 8.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.76 111.098 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 130' ' ' VAL . 6.6 mt -67.51 -49.27 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 2.49 111.111 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -49.58 -46.82 49.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 4.18 110.915 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 140' ' ' VAL . 10.4 mtpt -78.63 -29.02 45.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 3.02 110.849 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.688 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -56.03 -54.14 48.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 1.4 111.069 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.752 ' CZ ' HD11 ' A' ' 224' ' ' LEU . 1.3 t80 -61.2 -40.63 94.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 4.62 110.882 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -55.22 -28.07 50.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 2.85 110.891 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 136' ' ' LYS . 35.3 t -60.98 -49.48 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 1.79 111.137 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.678 ' HE1' HD12 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -70.61 -48.46 55.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 4.21 110.959 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.05 -20.39 38.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 3.53 110.87 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -50.11 -31.88 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 2.7 110.894 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.722 HG11 ' CG1' ' A' ' 255' ' ' ILE . 3.6 m -128.59 51.19 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 2.01 111.139 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.67 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -151.73 140.57 13.68 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.559 0.695 . . . . 1.78 111.123 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.8 Cg_endo -69.76 -38.17 8.17 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.654 2.236 . . . . 1.96 112.323 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.54 ' O ' HD12 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -49.53 104.34 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 2.96 110.899 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.22 129.47 49.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 4.77 110.889 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.507 ' HB3' HG23 ' A' ' 115' ' ' THR . 1.4 m-85 -138.34 153.54 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 11.19 110.886 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.6 t -104.29 132.28 50.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 2.77 110.809 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.34 147.3 31.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 3.42 110.962 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 58.1 mt -135.68 119.07 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 2.9 111.153 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.13 -39.91 57.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 3.01 110.924 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 95.7 m -137.27 109.42 7.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 2.99 111.131 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 173.05 -153.99 19.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 1.67 112.494 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.98 135.61 51.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 5.56 110.86 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.89 -175.15 2.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 2.0 111.041 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.33 -26.36 6.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 3.11 110.902 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 116' ' ' TYR . 1.4 pp -135.58 141.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 3.58 111.166 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 194' ' ' ASP . 0.5 OUTLIER -132.39 165.47 24.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.455 . . . . 2.17 110.936 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.788 HG23 HG23 ' A' ' 118' ' ' ILE . 2.0 m -125.21 110.96 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 2.81 111.146 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 119' ' ' ASN . 12.0 t -126.86 154.52 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 1.31 111.158 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -123.05 137.73 54.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 3.52 110.858 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.95 174.56 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 2.23 111.102 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -125.71 169.4 12.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 4.85 110.852 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.43 -138.39 28.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 2.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.07 129.96 35.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 1.83 111.109 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -89.75 11.01 21.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 3.89 110.899 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 58.85 18.4 39.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 4.07 112.48 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -148.19 29.08 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.749 0.309 . . . . 7.12 110.856 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.3 t70 64.37 47.41 3.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 6.72 110.873 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -137.45 70.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 5.15 110.871 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.59 159.83 23.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 2.17 111.077 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -98.07 -169.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 9.5 110.9 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -143.67 -39.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 4.86 110.858 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.43 166.58 21.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.721 -0.752 . . . . 1.76 112.524 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -50.12 118.74 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 3.61 110.899 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.65 -55.12 0.75 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 2.85 112.472 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.53 -118.78 4.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 1.67 112.502 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.1 mm -74.1 140.19 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 1.84 111.12 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.679 ' N ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -124.34 -5.12 7.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 2.99 110.901 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.512 ' N ' HD22 ' A' ' 181' ' ' LEU . . . 179.82 131.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 1.25 111.109 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -113.58 143.08 45.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 3.91 110.819 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -154.14 129.97 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 1.23 111.163 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.88 170.73 10.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 3.37 110.858 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.99 171.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.88 112.481 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 160.51 49.45 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.692 2.261 . . . . 0.85 112.374 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 157.05 -142.44 8.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.727 . . . . 1.16 112.548 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 88.5 p -106.53 117.21 33.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 1.97 110.838 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.14 -58.59 3.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 1.41 112.465 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 191' ' ' ILE . 10.6 mt -93.37 21.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 2.57 111.155 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.79 -115.79 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 3.0 112.51 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.549 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . -88.43 44.95 3.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 1.3 112.496 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.411 ' CG ' HD11 ' A' ' 160' ' ' LEU . 11.6 m-20 -64.98 130.65 44.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 2.22 110.813 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -107.49 109.63 21.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.04 111.104 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -113.81 110.62 20.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 4.84 110.816 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -103.26 118.92 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 2.7 110.888 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -50.77 145.63 6.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 7.02 110.883 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.22 -21.66 23.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 8.2 110.862 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -94.69 -6.39 43.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 4.5 110.83 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -73.48 -25.25 60.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 4.09 110.852 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 18.3 t80 67.59 128.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 5.17 110.861 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -105.57 172.19 6.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 6.39 110.963 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.17 173.29 17.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 1.7 111.127 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -170.74 0.36 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 2.2 111.156 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -67.13 -21.1 65.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 4.64 110.866 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.26 -33.5 9.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 2.12 110.878 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -54.19 177.17 0.3 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 2.59 112.494 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.73 -88.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.733 -0.746 . . . . 1.96 112.473 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.9 m -76.33 98.54 4.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 1.58 111.146 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.45 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.6 OUTLIER -72.89 123.02 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 3.19 110.838 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 133' ' ' ALA . 1.4 tt -72.38 -35.85 68.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 2.28 110.929 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.686 ' CZ ' HD23 ' A' ' 214' ' ' LEU . 2.9 p90 -71.86 -34.79 69.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 5.53 110.859 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.686 HD23 ' CZ ' ' A' ' 213' ' ' PHE . 0.1 OUTLIER -82.68 -52.97 6.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 2.92 110.922 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 94.4 m -55.07 -37.77 67.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.95 111.175 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.26 85.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.98 111.105 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.688 HG22 ' HA ' ' A' ' 137' ' ' ALA . 39.1 t -64.35 -39.94 87.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.02 111.145 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -69.32 -43.17 74.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 2.35 110.824 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -70.32 -56.37 6.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 3.85 110.9 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.461 HD12 ' HB1' ' A' ' 137' ' ' ALA . 76.5 mt -50.48 -33.82 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 2.47 111.119 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.8 -43.01 99.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 1.16 112.455 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -75.37 -29.14 59.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.836 0.35 . . . . 2.97 110.906 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.49 -16.97 64.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 2.48 110.83 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.752 HD11 ' CZ ' ' A' ' 138' ' ' PHE . 7.1 mp -96.98 -23.03 16.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 2.1 110.935 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 136.37 69.18 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 1.74 112.468 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.678 HD12 ' HE1' ' A' ' 141' ' ' TRP . 7.0 mt -160.44 134.62 7.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 3.39 110.89 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -131.68 51.26 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 3.49 112.5 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.8 m80 66.19 144.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 2.04 110.878 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.44 ' N ' ' HE3' ' A' ' 236' ' ' MET . 6.5 t -122.09 -79.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 4.55 110.861 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 175.15 -32.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 4.67 110.906 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 86.1 m-20 -45.66 105.84 0.5 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.543 0.687 . . . . 3.29 110.907 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.4 Cg_endo -69.82 172.56 12.48 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.633 2.222 . . . . 2.83 112.342 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.8 30.56 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 3.44 110.947 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -126.73 172.21 10.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 1.57 111.111 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 235' ' ' VAL . 9.5 p -89.66 7.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 3.09 111.155 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.657 ' CE ' HD22 ' A' ' 226' ' ' LEU . 1.9 mmm -88.02 -39.15 14.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 4.02 110.837 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.52 143.29 20.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.661 0.743 . . . . 4.19 110.886 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 70.41 1.6 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.704 2.269 . . . . 2.29 112.336 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.06 165.99 33.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 2.43 111.085 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -131.49 113.13 13.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 3.76 110.9 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -132.01 139.57 48.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 3.02 110.907 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -69.7 127.87 34.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 3.52 110.879 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.52 HG12 ' H ' ' A' ' 244' ' ' ASP . 0.3 OUTLIER -131.55 177.19 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 2.42 111.131 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.52 ' H ' HG12 ' A' ' 243' ' ' VAL . 0.3 OUTLIER -72.55 125.34 27.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 3.11 110.89 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 24.0 pt -57.09 -24.65 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 3.3 111.115 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -77.81 -39.59 43.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 2.98 110.888 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.81 34.12 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 3.69 111.158 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.96 19.34 4.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 3.93 110.878 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -84.28 149.82 25.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 3.63 110.87 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.646 HD21 ' OD2' ' A' ' 254' ' ' ASP . 0.3 OUTLIER -52.13 158.18 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 2.54 110.935 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.59 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.2 OUTLIER -154.69 -172.71 4.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 3.56 110.865 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 64.63 -177.16 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 2.98 111.089 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -67.75 -22.05 65.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 3.59 110.874 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.646 ' OD2' HD21 ' A' ' 250' ' ' LEU . 4.8 t0 -51.36 -30.01 17.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 3.44 110.823 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.722 ' CG1' HG11 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -51.27 -29.96 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 1.59 111.117 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -88.98 -31.42 18.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 6.45 110.867 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.06 -18.27 40.45 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 1.78 112.482 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.721 ' CG2' HG23 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -101.4 -29.57 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 1.62 111.133 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -79.78 -32.64 40.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 3.82 110.919 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 12.4 m -85.67 -46.92 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 2.92 110.857 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.8 mp 58.34 40.98 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 4.13 110.937 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -146.48 134.15 21.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 10.82 110.874 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 119.103 -0.832 . . . . 10.19 112.438 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 64.1 m80 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.797 0.332 . . . . 7.67 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -78.61 148.28 33.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 8.79 110.93 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.46 146.43 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 2.82 111.133 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.445 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 28.8 p -127.2 157.96 38.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 2.43 111.09 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.0 151.46 31.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 4.43 110.953 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -137.99 127.95 25.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 4.99 110.901 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 82.9 mt -108.2 143.96 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 2.21 111.135 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -145.26 35.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 3.4 110.856 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -133.23 152.56 51.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 4.75 110.908 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -146.49 117.9 7.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 7.32 110.949 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 122' ' ' THR . 4.5 t -82.17 114.22 49.42 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.63 0.729 . . . . 2.83 111.13 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -44.03 2.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.698 2.265 . . . . 2.23 112.315 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.6 -40.29 59.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 3.89 110.841 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -101.38 159.68 15.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 3.22 110.892 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.23 129.65 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.433 . . . . 3.95 110.848 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -57.84 -22.68 49.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 6.95 110.847 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.56 -32.09 47.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 3.4 110.911 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.29 -43.85 48.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 2.91 110.844 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.459 HG22 HD12 ' A' ' 134' ' ' ILE . 7.2 p -65.03 -36.42 77.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.94 111.12 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.62 -54.65 36.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 3.26 110.854 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -69.45 -36.8 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 4.64 110.892 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -55.17 -57.75 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.72 111.154 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.459 HD12 HG22 ' A' ' 130' ' ' VAL . 12.8 mt -68.4 -49.21 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 2.67 111.166 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -51.95 -40.47 60.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 4.16 110.867 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -78.2 -21.76 49.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 3.73 110.886 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.814 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.86 -53.11 60.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.92 111.052 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.497 ' CD1' HD12 ' A' ' 220' ' ' ILE . 39.7 m-85 -57.12 -23.97 50.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 5.67 110.851 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -39.57 51.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 2.65 110.904 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.709 HG12 HD12 ' A' ' 250' ' ' LEU . 33.7 t -57.37 -44.69 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 2.15 111.094 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.685 ' CE2' HD13 ' A' ' 224' ' ' LEU . 11.1 t90 -67.26 -59.34 3.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 9.63 110.92 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -56.23 -23.87 38.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 2.03 110.871 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -67.99 -12.39 60.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 2.86 110.848 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.84 30.39 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 2.88 111.136 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.592 HG21 HG13 ' A' ' 258' ' ' ILE . 0.8 OUTLIER -155.49 157.88 31.73 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.59 0.71 . . . . 2.24 111.081 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -25.14 29.07 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.689 2.259 . . . . 2.63 112.357 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.49 175.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 3.86 110.91 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.32 -178.07 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 4.6 110.926 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -135.63 151.75 50.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 7.17 110.911 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.5 t -156.37 89.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 1.93 110.825 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.43 137.52 54.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 2.31 110.897 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.543 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -143.57 165.93 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 3.46 111.139 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.07 -29.99 5.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 3.92 110.887 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 91.7 m -117.78 110.3 17.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 2.88 111.177 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 142.54 -171.31 24.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 1.57 112.489 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -110.47 157.81 19.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 5.15 110.864 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -146.99 141.89 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 1.22 111.091 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.89 -15.67 62.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.428 . . . . 2.37 110.892 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.514 HD13 ' HA3' ' A' ' 193' ' ' GLY . 39.6 mm -104.03 141.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 2.63 111.111 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 161' ' ' VAL . 4.0 tt -130.78 134.43 46.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.56 110.94 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.713 ' N ' HD23 ' A' ' 160' ' ' LEU . 55.9 t -124.86 110.76 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 1.32 111.13 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.593 HG23 ' CD2' ' A' ' 160' ' ' LEU . 24.4 t -143.25 141.21 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 1.11 111.152 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -81.19 152.72 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 3.71 110.865 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -161.58 167.23 25.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 1.32 111.06 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -139.54 117.74 11.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 5.26 110.851 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.06 -137.85 17.2 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.738 . . . . 1.9 112.503 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -80.55 110.34 15.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 1.97 111.139 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.08 56.9 3.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 3.95 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 52.0 27.23 21.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.73 . . . . 2.69 112.465 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -163.08 -167.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.797 0.332 . . . . 6.1 110.862 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -80.55 55.95 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 6.82 110.894 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -137.93 34.67 2.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 6.9 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.8 127.81 34.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 1.84 111.149 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.81 -82.16 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 6.19 110.861 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.78 -77.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 5.02 110.853 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 126.36 -161.1 20.76 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.747 -0.74 . . . . 2.4 112.469 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -53.32 119.3 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 3.69 110.9 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.46 -14.03 62.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 2.5 112.465 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.87 -150.56 7.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 1.78 112.497 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 182' ' ' ALA . 17.3 mt -71.29 96.66 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 1.99 111.146 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.756 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.4 pp -48.18 -29.65 3.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 3.29 110.907 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.756 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 178.62 176.0 0.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 1.56 111.09 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.35 120.77 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 3.26 110.88 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -109.75 117.55 34.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.63 111.111 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -63.79 166.14 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 3.72 110.876 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.92 172.61 0.27 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.729 -0.748 . . . . 0.84 112.481 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -179.2 2.77 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.682 2.255 . . . . 0.95 112.339 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.39 -136.88 8.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 1.28 112.5 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.2 p -108.72 130.97 55.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.924 0.392 . . . . 2.71 110.872 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.36 -85.39 0.18 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.761 -0.733 . . . . 1.25 112.451 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 191' ' ' ILE . 63.2 mt -71.09 -7.95 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 2.46 111.137 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.97 -84.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 2.77 112.504 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 159' ' ' ILE . . . -76.18 -2.35 72.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 1.22 112.504 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -49.03 114.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 2.26 110.866 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -122.2 154.14 37.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 1.6 111.106 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -133.14 149.52 52.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 2.76 110.864 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.457 ' CE2' HG13 ' A' ' 161' ' ' VAL . 18.6 m-85 -130.0 143.87 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 2.89 110.847 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 199' ' ' GLU . 0.3 OUTLIER -47.88 -73.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 5.63 110.884 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 198' ' ' ASP . 3.7 tt0 63.8 -80.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 8.63 110.909 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -14.04 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 6.27 110.916 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -91.46 15.76 11.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 6.82 110.917 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 67.23 122.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 6.37 110.918 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.43 -170.64 1.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 7.28 110.934 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.01 172.76 18.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 2.26 111.181 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.78 -170.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 2.09 111.163 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -57.17 -20.9 29.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 4.31 110.851 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.32 -69.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 2.31 110.838 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.51 -160.43 10.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.731 . . . . 3.05 112.511 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 50.94 -161.85 1.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 2.29 112.498 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 97.4 m -64.95 104.75 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 2.02 111.177 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.89 141.76 58.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 2.85 110.885 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -72.53 -54.21 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 2.61 110.904 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.731 ' O ' HG23 ' A' ' 217' ' ' VAL . 0.1 OUTLIER -72.31 -51.97 18.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 5.36 110.936 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.434 HD22 HG23 ' A' ' 243' ' ' VAL . 12.3 tp -49.31 -38.45 27.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 2.11 110.967 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.557 HG21 HD22 ' A' ' 181' ' ' LEU . 60.2 m -79.75 -42.66 24.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.78 111.127 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.65 -36.84 77.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.92 111.138 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 137' ' ' ALA . 45.7 t -68.01 -43.84 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 1.02 111.145 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -54.2 -31.64 53.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 2.01 110.888 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -33.11 64.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 3.84 110.867 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.572 ' O ' HD12 ' A' ' 224' ' ' LEU . 40.9 mm -55.32 -50.38 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 1.54 111.129 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.95 -28.58 60.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.93 112.453 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -47.52 75.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.33 . . . . 2.54 110.832 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.98 29.23 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.6 110.864 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.685 HD13 ' CE2' ' A' ' 141' ' ' TRP . 9.0 mt -132.24 -39.96 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 1.88 110.933 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.61 -30.86 0.2 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 1.74 112.482 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.497 HD13 ' HB ' ' A' ' 258' ' ' ILE . 1.3 mp -90.75 90.51 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 3.98 110.936 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.1 -89.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.712 -0.756 . . . . 3.5 112.504 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -118.71 89.84 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 1.94 110.887 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.46 172.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 5.66 110.853 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 8.2 t -112.92 -27.33 8.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 3.83 110.879 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.721 ' CG ' ' HB1' ' A' ' 252' ' ' ALA . 8.7 m-20 -51.77 112.49 3.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.724 . . . . 3.28 110.84 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.8 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 2.13 112.318 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -27.31 69.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 4.02 110.923 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.923 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -72.13 167.68 19.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 2.21 111.092 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.462 HG21 ' HE1' ' A' ' 248' ' ' PHE . 17.0 m -95.49 -15.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 5.08 111.165 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.408 ' SD ' HD21 ' A' ' 250' ' ' LEU . 9.0 tpt -58.22 -21.9 49.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 4.83 110.876 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -52.22 137.38 38.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.652 0.739 . . . . 3.76 110.858 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 76.52 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.693 2.262 . . . . 2.34 112.35 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.8 t -157.32 167.67 29.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 2.88 111.193 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -115.14 112.22 22.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.263 -0.426 . . . . 3.7 110.943 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -136.22 -169.6 2.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 2.82 110.896 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -107.24 142.57 36.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 5.27 110.917 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.434 HG23 HD22 ' A' ' 214' ' ' LEU . 98.7 t -149.47 143.05 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 2.36 111.182 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.87 126.06 26.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 2.75 110.832 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.8 tt -58.09 -22.83 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 3.09 111.132 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.25 -31.28 12.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 3.64 110.916 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.93 33.53 2.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 2.01 111.137 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.598 ' CE2' HG21 ' A' ' 217' ' ' VAL . 8.5 t80 -104.21 129.08 52.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 4.85 110.916 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -176.55 129.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 3.24 110.898 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 140' ' ' VAL . 3.8 mt -58.44 114.65 2.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 3.91 110.9 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 252' ' ' ALA . 0.1 OUTLIER -132.02 108.2 9.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 4.3 110.895 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.923 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 174.18 172.59 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 3.47 111.1 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -18.64 49.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 3.23 110.915 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.475 ' HB2' HD21 ' A' ' 226' ' ' LEU . 1.3 p30 -52.4 -30.44 29.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 3.59 110.868 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 68.6 mt -51.36 -29.0 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 2.85 111.116 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -87.55 -33.13 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 5.11 110.85 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.503 ' O ' HD12 ' A' ' 261' ' ' LEU . . . -72.58 -14.66 77.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 2.08 112.47 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.714 ' O ' HD13 ' A' ' 261' ' ' LEU . 7.2 tp -92.29 -34.36 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.784 0.326 . . . . 1.7 111.137 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -79.31 -40.84 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 3.53 110.941 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 t -79.9 -47.34 15.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 2.68 110.867 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.714 HD13 ' O ' ' A' ' 258' ' ' ILE . 0.9 OUTLIER 55.02 91.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 4.24 110.905 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -54.92 120.3 6.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 12.97 110.983 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.141 -0.81 . . . . 10.94 112.532 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.812 0.339 . . . . 7.39 110.904 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -116.57 135.31 53.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 9.9 110.932 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.701 HD13 HD21 ' A' ' 147' ' ' LEU . 0.1 OUTLIER -115.71 171.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.134 -0.485 . . . . 3.06 111.126 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.2 p -114.25 146.96 39.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 2.51 111.119 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.527 ' OH ' HD11 ' A' ' 118' ' ' ILE . 11.2 t80 -152.41 136.6 16.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 5.5 110.941 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -161.45 145.77 13.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 4.68 110.868 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.527 HD11 ' OH ' ' A' ' 116' ' ' TYR . 18.7 mt -108.07 148.81 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 1.75 111.144 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -156.45 38.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 2.8 110.907 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.455 ' OD1' HG12 ' A' ' 161' ' ' VAL . 6.3 p-10 -135.39 148.81 49.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 5.41 110.92 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -147.86 122.51 9.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 5.59 110.891 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.56 147.38 41.89 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.55 0.69 . . . . 2.94 111.118 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -168.02 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.652 2.235 . . . . 2.83 112.339 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 73.82 -62.29 0.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 3.9 110.84 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.455 ' SD ' HG23 ' A' ' 205' ' ' THR . 36.2 mmt -100.92 137.26 39.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 3.49 110.874 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.31 158.15 9.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 2.79 110.896 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -52.57 -30.96 33.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 9.15 110.889 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.49 -45.38 72.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 2.88 110.908 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.71 -44.72 93.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 2.36 110.893 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.565 ' HA ' HD13 ' A' ' 212' ' ' LEU . 7.3 p -73.49 -37.02 49.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.96 111.108 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -63.75 -54.5 34.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 2.74 110.872 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -59.31 -33.47 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 2.51 110.927 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.57 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -53.98 -46.15 71.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.87 111.119 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 2.3 mm -83.13 -44.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 2.71 111.17 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.69 -45.23 58.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 4.12 110.923 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.66 ' O ' HG23 ' A' ' 140' ' ' VAL . 31.7 mttt -78.09 -20.48 52.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 3.08 110.907 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.725 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -56.03 -53.69 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.86 111.099 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -36.11 75.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 3.8 110.885 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -28.1 69.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 3.11 110.893 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 136' ' ' LYS . 21.4 t -65.28 -56.19 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 1.84 111.124 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.642 ' O ' HG22 ' A' ' 145' ' ' THR . 1.0 OUTLIER -73.26 -34.41 65.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 3.99 110.884 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.8 t -56.25 -23.49 36.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 1.97 110.874 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.28 -16.6 63.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 2.13 110.885 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.428 HG21 HD22 ' A' ' 250' ' ' LEU . 13.2 t -114.41 -33.46 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 3.18 111.121 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 141' ' ' TRP . 1.4 t -107.19 146.0 32.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.614 0.721 . . . . 3.17 111.146 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -7.61 21.51 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 2.91 112.313 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.805 HD13 HD23 ' A' ' 224' ' ' LEU . 0.2 OUTLIER -51.23 150.34 3.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 2.69 110.965 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.59 -173.15 2.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 7.3 110.923 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -135.56 119.83 17.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 6.95 110.92 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -111.16 89.95 3.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 2.54 110.868 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.9 110.57 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 2.23 110.878 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.497 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.2 pp -146.33 162.84 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 3.06 111.151 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -113.12 51.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 4.36 110.851 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.7 t -175.63 160.17 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 4.3 111.147 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.47 139.81 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 2.19 112.491 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.82 164.3 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.357 . . . . 6.39 110.86 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.02 136.77 23.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 1.84 111.081 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.92 -45.48 64.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 2.54 110.867 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.612 HG22 ' HA3' ' A' ' 193' ' ' GLY . 1.7 pt -108.79 135.53 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 2.85 111.079 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.623 ' O ' HD23 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -133.19 125.46 29.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 2.77 110.922 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.778 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 3.4 t -94.52 112.57 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 1.36 111.117 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.585 ' CG2' HD21 ' A' ' 160' ' ' LEU . 53.1 t -145.03 144.42 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 1.27 111.108 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -108.06 137.89 45.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 3.34 110.896 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.519 ' HB3' ' HZ ' ' A' ' 174' ' ' PHE . . . -139.56 164.01 31.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 1.35 111.105 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.32 126.42 52.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 5.16 110.85 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.72 -142.46 20.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.738 . . . . 1.19 112.516 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.02 124.42 24.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 1.35 111.134 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -89.62 76.64 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 3.12 110.833 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.27 45.72 64.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 2.42 112.499 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.78 88.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 6.64 110.843 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -166.35 -74.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 4.33 110.865 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -137.36 93.74 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 4.08 110.829 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.24 128.86 34.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 1.42 111.116 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.519 ' HZ ' ' HB3' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -128.66 -37.23 1.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 6.59 110.918 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.13 168.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 6.13 110.86 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.85 -148.49 7.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 2.9 112.473 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.27 135.09 27.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 4.95 110.838 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.98 -19.12 6.14 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.738 . . . . 5.1 112.497 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.16 -107.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 3.02 112.535 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.406 HG22 ' H ' ' A' ' 182' ' ' ALA . 26.4 mm -71.4 149.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.898 0.38 . . . . 2.91 111.095 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 182' ' ' ALA . 1.4 mm? -115.49 -18.66 10.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 4.44 110.884 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . 175.64 124.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.83 111.098 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -104.09 164.07 11.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 5.0 110.818 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.519 ' HB2' ' CD ' ' A' ' 219' ' ' GLU . . . -179.68 109.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.89 111.098 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -71.11 150.8 45.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 3.93 110.935 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.6 -167.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 1.14 112.474 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 160.76 48.53 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.658 2.238 . . . . 1.37 112.355 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 147.1 -163.45 28.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.742 . . . . 1.13 112.49 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.08 140.67 29.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.895 0.378 . . . . 2.36 110.841 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.25 -64.96 2.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.681 -0.771 . . . . 1.34 112.513 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.689 HG23 ' CG ' ' A' ' 194' ' ' ASP . 3.7 mp -118.74 61.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.36 . . . . 2.82 111.131 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -88.62 46.33 3.32 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 3.48 112.444 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.612 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . 124.38 31.82 0.88 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 1.37 112.472 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.689 ' CG ' HG23 ' A' ' 191' ' ' ILE . 38.2 m-20 -64.51 139.29 58.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.771 0.32 . . . . 2.91 110.929 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.778 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -96.5 119.8 35.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 1.09 111.104 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -115.18 109.88 18.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 3.95 110.859 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -113.0 101.66 9.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 2.5 110.882 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.41 117.18 2.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 6.4 110.857 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -64.22 -48.61 75.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 7.82 110.942 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -50.16 -30.45 11.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 3.8 110.895 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.44 ' OE2' HD12 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -63.4 -169.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 3.72 110.882 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -125.31 116.73 22.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 4.38 110.869 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.557 ' CZ3' HG21 ' A' ' 215' ' ' THR . 56.1 m95 -105.06 97.41 7.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 7.1 110.957 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.85 172.95 6.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 1.86 111.11 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.455 HG23 ' SD ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -70.42 173.57 6.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 1.93 111.121 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.71 ' HD1' HG22 ' A' ' 245' ' ' ILE . 0.0 OUTLIER -59.12 -21.4 59.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.437 . . . . 9.22 110.891 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.05 -64.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.95 110.833 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.08 -177.14 14.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.772 -0.727 . . . . 2.38 112.478 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 51.47 -170.88 0.31 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 1.64 112.519 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -56.7 99.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 1.56 111.134 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.11 111.66 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 3.69 110.867 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.57 HD22 ' HB3' ' A' ' 133' ' ' ALA . 0.5 OUTLIER -57.8 -35.65 71.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 2.15 110.925 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.736 ' O ' HG23 ' A' ' 217' ' ' VAL . 13.1 m-85 -71.37 -62.43 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 4.75 110.859 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 241' ' ' LYS . 2.3 tp -51.34 -53.51 35.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 2.29 110.917 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.557 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 23.3 m -55.58 -49.4 72.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.78 111.142 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.63 -44.2 76.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.72 111.075 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.737 HG21 ' CE2' ' A' ' 248' ' ' PHE . 23.7 t -66.4 -46.57 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 1.02 111.104 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -54.02 -29.46 43.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 2.27 110.856 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.519 ' CD ' ' HB2' ' A' ' 184' ' ' ALA . 1.9 tt0 -74.59 -42.1 59.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 3.36 110.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.508 ' O ' HD13 ' A' ' 224' ' ' LEU . 49.5 mm -51.21 -32.95 13.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 1.64 111.095 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.65 -55.36 8.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 1.04 112.522 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -37.49 77.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 2.84 110.811 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.0 p -65.23 -34.58 78.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 2.97 110.878 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.805 HD23 HD13 ' A' ' 147' ' ' LEU . 7.1 mp -95.31 23.47 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 2.07 110.902 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.44 98.89 0.27 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 1.95 112.513 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 18.7 tp -149.76 156.6 42.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.793 0.33 . . . . 3.13 110.956 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.93 -109.16 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 2.82 112.497 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.3 147.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 2.37 110.875 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.27 -77.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 6.26 110.894 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t 62.89 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 5.53 110.886 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.0 159.49 68.47 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.635 0.731 . . . . 2.79 110.808 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -24.98 29.12 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 2.16 112.361 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.6 -31.11 12.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 4.12 110.941 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -52.46 172.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 2.23 111.093 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 235' ' ' VAL . 4.0 t -95.38 7.48 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 2.77 111.121 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -27.5 36.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 4.34 110.875 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.447 ' O ' ' CG ' ' A' ' 237' ' ' PHE . 3.0 p90 -47.61 114.59 3.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.681 0.753 . . . . 8.62 110.888 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 61.68 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.669 2.246 . . . . 2.03 112.334 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.93 169.18 21.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 2.4 111.113 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -109.13 113.01 25.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 3.38 110.962 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.613 ' O ' HD22 ' A' ' 214' ' ' LEU . 1.1 tttp -135.29 123.57 23.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 3.5 110.902 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -66.58 141.37 57.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 3.38 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 97.8 t -150.39 144.36 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 2.46 111.103 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.56 126.93 21.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 3.12 110.872 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.71 HG22 ' HD1' ' A' ' 206' ' ' HIS . 1.9 pp -65.27 -25.38 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 3.41 111.107 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.05 -39.5 23.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 3.81 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.1 p -93.13 10.01 33.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 2.56 111.13 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.737 ' CE2' HG21 ' A' ' 217' ' ' VAL . 23.8 t80 -79.42 122.84 26.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 4.9 110.864 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -163.81 148.02 10.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 3.36 110.883 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.702 ' CD2' HD12 ' A' ' 255' ' ' ILE . 0.6 OUTLIER -53.12 151.97 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 2.46 110.929 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.548 ' O ' HD23 ' A' ' 250' ' ' LEU . 6.3 t -89.2 -171.47 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 3.13 110.9 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -84.06 -56.34 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 4.18 111.12 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.71 -38.27 60.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 3.29 110.846 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.53 -29.05 65.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 3.02 110.858 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.702 HD12 ' CD2' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -54.3 -27.56 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.83 111.147 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.0 mtp85 -87.79 -23.43 24.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 4.74 110.87 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.45 -22.96 64.17 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.718 -0.753 . . . . 1.93 112.504 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.449 HD13 ' CD1' ' A' ' 141' ' ' TRP . 6.5 tp -92.87 -31.05 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.329 . . . . 1.41 111.155 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -78.9 -42.55 26.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 4.07 110.911 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.423 ' C ' HD12 ' A' ' 261' ' ' LEU . 4.8 m -85.39 -46.0 11.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 4.63 110.821 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.423 HD12 ' C ' ' A' ' 260' ' ' SER . 1.6 mp 58.89 77.82 0.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 6.28 110.903 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.69 137.68 24.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 14.55 110.903 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 119.174 -0.792 . . . . 14.38 112.475 179.976 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.781 0.324 . . . . 15.23 110.898 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.751 ' O ' HD13 ' A' ' 114' ' ' ILE . 48.4 m-85 -73.41 147.21 44.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 17.96 110.873 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 113' ' ' TYR . 5.0 mm -132.92 169.94 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 6.73 111.111 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.678 HG23 ' H ' ' A' ' 158' ' ' ASP . 5.5 t -91.06 116.38 28.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 3.11 111.112 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -142.08 136.53 30.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 5.28 110.935 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -107.93 103.28 12.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 6.75 110.917 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.426 HG21 ' CE1' ' A' ' 121' ' ' TYR . 23.7 mm -70.73 148.44 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 2.63 111.145 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.556 ' ND2' HD21 ' A' ' 160' ' ' LEU . 33.3 m-20 -109.29 -75.09 0.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 4.2 110.877 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -140.07 146.13 38.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 5.88 110.883 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.44 ' HB3' HG11 ' A' ' 130' ' ' VAL . 24.8 m-85 -92.5 163.26 13.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.207 -0.451 . . . . 6.61 110.913 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.32 159.32 29.65 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.564 0.697 . . . . 3.94 111.156 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.8 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.671 2.248 . . . . 2.81 112.345 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 73.84 -63.39 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 4.45 110.819 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.409 ' HE2' ' HB2' ' A' ' 203' ' ' TRP . 0.0 OUTLIER -100.81 144.62 29.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 6.65 110.881 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.09 161.82 15.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 3.5 110.901 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -21.92 48.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 7.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -79.78 -36.67 36.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 4.99 110.895 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 1.2 m-20 -64.0 -44.02 93.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 2.44 110.887 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.491 HG23 ' HG ' ' A' ' 212' ' ' LEU . 10.3 p -74.58 -34.59 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.92 111.077 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.66 -54.61 11.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 2.58 110.852 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -62.82 -33.33 75.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 2.93 110.928 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.692 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -56.92 -58.73 6.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.88 111.125 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 9.5 pt -65.69 -28.31 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 3.1 111.119 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -48.25 -56.12 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 4.33 110.851 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -78.83 -26.17 44.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 2.88 110.871 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 134' ' ' ILE . . . -55.59 -33.97 64.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.89 111.114 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -73.69 -30.75 63.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 5.83 110.842 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -78.99 -29.12 43.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 3.95 110.935 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.655 HG11 HG11 ' A' ' 217' ' ' VAL . 72.6 t -50.73 -42.52 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 1.75 111.136 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.586 ' HZ2' HD11 ' A' ' 226' ' ' LEU . 0.5 OUTLIER -96.18 -44.88 7.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 4.06 110.941 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.574 ' OG ' HD11 ' A' ' 114' ' ' ILE . 68.0 m -54.99 -24.99 26.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 3.41 110.89 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -61.36 -21.39 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 2.69 110.88 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.1 41.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 1.84 111.121 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.716 HG21 HD11 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -155.62 128.6 4.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.595 0.712 . . . . 1.93 111.183 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 78.15 1.0 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.707 2.271 . . . . 2.72 112.383 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.64 102.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 3.86 110.908 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.93 128.7 47.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 5.62 110.882 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -138.81 152.41 47.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 10.72 110.895 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.01 152.23 23.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 3.09 110.804 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -58.5 151.34 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 3.37 110.863 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.842 HG22 ' H ' ' A' ' 154' ' ' THR . 3.0 mp -137.75 130.33 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 3.2 111.161 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.15 -13.1 61.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 4.05 110.901 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.842 ' H ' HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -94.0 -178.57 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 4.77 111.122 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.18 48.22 2.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 3.01 112.466 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.15 99.6 7.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.34 . . . . 7.31 110.858 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.43 129.78 13.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.426 . . . . 1.68 111.098 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.678 ' H ' HG23 ' A' ' 115' ' ' THR . 0.8 OUTLIER -77.04 -19.1 57.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 4.95 110.844 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.758 HG22 ' CA ' ' A' ' 193' ' ' GLY . 8.2 pt -138.21 141.74 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 3.73 111.126 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.556 HD21 ' ND2' ' A' ' 119' ' ' ASN . 1.9 tm? -114.21 118.65 34.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 1.45 110.93 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 89.0 t -92.39 125.46 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 1.41 111.143 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 163' ' ' PHE . 2.3 p -138.22 164.59 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 2.84 111.123 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.4 ' H ' HG22 ' A' ' 162' ' ' VAL . 79.0 m-85 -137.52 101.09 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 7.41 110.86 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -125.72 155.46 40.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 1.34 111.107 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.93 127.4 53.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 5.57 110.848 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.19 -144.51 13.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.691 -0.766 . . . . 1.21 112.505 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.7 123.04 18.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 1.26 111.088 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -95.15 25.4 4.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 3.05 110.878 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.89 -23.03 30.86 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.694 -0.765 . . . . 2.43 112.448 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -179.31 35.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 5.19 110.886 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.98 -169.46 2.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 5.3 110.886 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -77.05 114.55 15.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 3.96 110.819 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.4 128.8 34.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 1.26 111.101 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -131.21 170.66 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 6.01 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -122.87 165.04 17.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 4.54 110.865 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.22 -142.09 1.49 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.725 -0.75 . . . . 2.4 112.434 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -50.51 119.14 3.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 3.53 110.926 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.11 -73.94 0.44 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.754 -0.736 . . . . 2.27 112.47 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -89.67 -143.26 9.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.751 . . . . 1.68 112.513 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.481 HG21 ' HB2' ' A' ' 183' ' ' HIS . 24.5 mm -71.29 133.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.889 0.376 . . . . 2.15 111.113 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 182' ' ' ALA . 0.4 OUTLIER -101.47 -14.12 17.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 2.78 110.946 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.582 ' N ' HD12 ' A' ' 181' ' ' LEU . . . -178.88 125.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 1.56 111.075 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.481 ' HB2' HG21 ' A' ' 180' ' ' ILE . 1.8 t-160 -143.67 106.93 4.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 3.41 110.915 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -100.34 142.31 32.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.79 111.148 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.39 170.03 16.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 2.41 110.915 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -53.96 176.67 0.3 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.687 -0.768 . . . . 0.8 112.49 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -169.92 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.677 2.252 . . . . 1.11 112.367 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.54 -141.94 13.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 1.57 112.51 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.1 m -127.03 146.26 50.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.928 0.394 . . . . 3.74 110.873 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.22 -58.96 3.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.76 -0.733 . . . . 1.26 112.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.1 mm -106.12 -23.22 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.378 . . . . 2.37 111.169 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.06 128.5 39.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 2.49 112.509 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.758 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . 89.8 -15.44 59.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 1.15 112.513 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -51.77 147.46 6.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 2.43 110.871 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -121.34 109.39 14.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.9 111.093 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -96.99 110.46 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 4.17 110.864 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.566 ' HE2' HG13 ' A' ' 161' ' ' VAL . 41.3 m-85 -115.64 104.95 12.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 2.66 110.886 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -51.7 113.45 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 7.24 110.819 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.93 -41.18 77.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 7.26 110.906 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.76 -51.06 59.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 4.45 110.881 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -54.4 148.29 12.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 4.34 110.862 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -89.27 121.44 31.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 6.47 110.865 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.646 ' HB3' HD23 ' A' ' 212' ' ' LEU . 39.3 m95 -107.4 99.29 8.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 6.9 110.912 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.2 t -157.1 134.14 10.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 4.85 111.154 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.3 t -106.88 72.41 0.89 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 4.07 111.135 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -82.66 -67.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 8.79 110.86 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.5 m -114.23 -71.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 3.14 110.843 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.41 4.75 1.32 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 3.8 112.456 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.14 -161.43 0.97 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 2.52 112.467 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.9 m -59.2 96.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 1.59 111.14 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.408 HD22 HD22 ' A' ' 214' ' ' LEU . 3.0 m-80 -88.38 127.41 35.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 2.79 110.88 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.646 HD23 ' HB3' ' A' ' 203' ' ' TRP . 0.7 OUTLIER -54.78 -37.98 66.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 3.57 110.971 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.699 ' O ' HG23 ' A' ' 217' ' ' VAL . 8.5 p90 -72.29 -32.49 66.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 5.02 110.903 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 211' ' ' ASN . 13.8 tp -74.82 -60.04 2.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 2.59 110.963 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.451 ' CG2' HD13 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -55.45 -38.27 68.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 1.16 111.166 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.96 74.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.94 111.087 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 213' ' ' PHE . 58.7 t -49.18 -43.07 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.83 111.109 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -36.66 71.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 3.15 110.86 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.51 -42.83 58.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 3.91 110.858 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.464 ' O ' HD13 ' A' ' 224' ' ' LEU . 45.2 mm -50.06 -39.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 1.38 111.111 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.717 ' O ' HD23 ' A' ' 226' ' ' LEU . . . -76.11 -51.98 6.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.78 -0.724 . . . . 0.75 112.499 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -55.49 -26.86 44.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 2.27 110.867 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.702 ' O ' HD12 ' A' ' 224' ' ' LEU . 0.3 OUTLIER -95.27 24.73 4.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 1.96 110.905 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 223' ' ' SER . 1.4 mp -148.92 17.96 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 1.84 110.94 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.512 ' O ' HD22 ' A' ' 226' ' ' LEU . . . 88.33 77.21 1.29 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.749 . . . . 1.69 112.499 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.717 HD23 ' O ' ' A' ' 221' ' ' GLY . 2.2 mm? -130.27 179.56 5.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.358 . . . . 3.11 110.942 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.61 -123.73 3.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.805 -0.712 . . . . 2.54 112.507 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.61 150.56 12.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 2.4 110.815 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.3 m 61.0 -92.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 6.76 110.843 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 32.3 m 59.6 -86.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.499 . . . . 4.56 110.847 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.5 155.96 75.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.611 0.719 . . . . 2.52 110.864 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 233' ' ' LYS . 53.6 Cg_endo -69.76 168.79 20.55 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.717 2.278 . . . . 2.8 112.335 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.7 41.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 4.89 110.868 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.639 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -130.85 153.79 48.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 2.24 111.082 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 99.7 t -56.05 -25.74 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 4.42 111.097 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.447 ' SD ' HD12 ' A' ' 226' ' ' LEU . 1.5 tpp -66.4 -18.2 65.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 4.84 110.85 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 239' ' ' THR . 10.0 t80 -109.72 82.22 2.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.657 0.742 . . . . 4.19 110.861 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 104.93 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.651 2.234 . . . . 4.06 112.345 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.416 HG21 ' CE2' ' A' ' 237' ' ' PHE . 1.8 t -157.29 127.77 6.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 2.65 111.136 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -61.82 120.92 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 3.73 110.938 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -162.61 140.9 8.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 3.03 110.892 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -58.59 125.24 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 4.9 110.929 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.4 t -150.49 143.66 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 2.57 111.117 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.51 122.02 8.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 4.0 110.902 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.607 HG22 ' CZ ' ' A' ' 213' ' ' PHE . 22.3 pt -74.74 -23.9 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 3.45 111.092 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -87.22 -23.71 24.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 4.29 110.919 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.2 m -100.95 6.54 43.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 2.64 111.176 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -50.24 132.8 24.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 4.16 110.849 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -179.56 148.05 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 4.76 110.87 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.721 HD11 HG13 ' A' ' 255' ' ' ILE . 0.5 OUTLIER -71.32 171.07 11.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 2.34 110.928 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.56 ' O ' HD12 ' A' ' 255' ' ' ILE . 5.8 p -89.94 170.37 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 4.54 110.895 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.84 -53.75 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 4.08 111.099 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -18.84 51.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 3.03 110.923 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.639 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -70.43 -36.34 73.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 2.72 110.847 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.721 HG13 HD11 ' A' ' 250' ' ' LEU . 2.1 mp -56.96 -32.17 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 3.03 111.154 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -59.03 -26.11 64.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 9.95 110.863 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -98.97 45.17 1.61 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 2.26 112.467 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.716 HD11 HG21 ' A' ' 145' ' ' THR . 7.5 tp -176.69 -36.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.761 0.315 . . . . 1.26 111.105 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.21 -44.27 26.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 4.32 110.905 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.6 t -72.87 -29.04 62.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 2.35 110.89 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.88 -64.16 1.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 3.44 110.895 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -94.86 142.52 27.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 12.97 110.927 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.142 -0.81 . . . . 11.15 112.469 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.771 0.32 . . . . 12.63 110.851 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.74 148.82 52.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 14.89 110.912 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 149' ' ' PHE . 2.2 tp -147.51 168.33 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 5.7 111.091 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.647 HG23 ' HB3' ' A' ' 149' ' ' PHE . 2.7 p -93.28 116.69 29.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 2.65 111.129 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -152.57 136.62 16.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 4.88 110.941 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.666 ' CZ ' HD23 ' A' ' 160' ' ' LEU . 45.4 ptt85 -123.1 127.55 48.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 6.23 110.896 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.9 pt -107.59 148.53 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 2.64 111.141 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -149.02 -41.07 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 4.11 110.882 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.474 ' OD1' HG13 ' A' ' 162' ' ' VAL . 32.8 m120 -96.2 150.38 20.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 5.21 110.919 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -147.7 134.28 19.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 6.29 110.902 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.641 HG21 ' CD1' ' A' ' 203' ' ' TRP . 0.8 OUTLIER -53.04 146.85 18.29 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.613 0.72 . . . . 3.18 111.166 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 163.51 38.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 2.85 112.327 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.54 16.13 9.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 3.84 110.86 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.5 tpt -145.36 131.36 19.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 3.61 110.867 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.34 135.22 57.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 3.24 110.878 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -59.07 -20.16 50.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 5.7 110.861 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -74.09 -30.5 62.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 3.85 110.875 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.98 -44.94 75.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 3.45 110.874 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.472 ' HA ' HD21 ' A' ' 212' ' ' LEU . 7.1 p -68.41 -28.33 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 1.36 111.092 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -71.88 -47.97 49.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 3.23 110.841 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.57 -39.1 58.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 3.65 110.9 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 213' ' ' PHE . . . -52.95 -58.73 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 1.32 111.093 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 135' ' ' ARG . 2.8 pp -57.15 -28.55 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 4.39 111.084 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.641 ' N ' HD12 ' A' ' 134' ' ' ILE . 6.9 ttm-85 -56.1 -41.23 74.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 3.42 110.824 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -80.1 -19.65 46.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 3.03 110.895 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.42 -38.54 34.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 1.36 111.064 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.28 -25.71 58.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 5.85 110.878 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -80.69 -51.15 9.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 2.79 110.888 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 136' ' ' LYS . 3.7 p -49.21 -42.28 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 2.57 111.102 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.519 ' HH2' HD23 ' A' ' 226' ' ' LEU . 58.8 t-105 -75.84 -50.8 14.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 4.05 110.882 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 76.7 p -55.15 -24.96 29.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 1.8 110.859 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.99 -31.61 30.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 3.05 110.854 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.731 HG11 HG13 ' A' ' 255' ' ' ILE . 16.8 m -119.24 45.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 2.13 111.167 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.52 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -155.46 135.44 8.3 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.565 0.698 . . . . 2.12 111.124 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.52 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.4 Cg_endo -69.79 -23.74 30.31 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.697 2.265 . . . . 2.0 112.346 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.71 113.4 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 3.59 110.935 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.32 129.12 39.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 5.26 110.918 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.647 ' HB3' HG23 ' A' ' 115' ' ' THR . 0.5 OUTLIER -137.52 154.48 49.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.441 . . . . 11.84 110.886 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.9 t -101.86 122.8 44.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 3.0 110.845 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.25 142.27 43.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 2.59 110.891 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 71.6 mt -113.24 117.6 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 2.91 111.146 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.7 -39.84 59.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 5.4 110.858 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 97.2 m -139.14 112.31 8.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 3.8 111.14 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.25 -163.59 31.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.783 -0.722 . . . . 2.86 112.481 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.73 143.85 38.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 4.92 110.91 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.555 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -113.12 160.44 18.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 1.96 111.088 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.45 -34.31 61.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 3.48 110.897 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.723 HG23 ' O ' ' A' ' 193' ' ' GLY . 66.3 mt -104.7 141.04 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 2.56 111.129 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.666 HD23 ' CZ ' ' A' ' 117' ' ' ARG . 1.7 tm? -121.64 117.31 26.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 1.73 110.93 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.57 HG13 ' HE2' ' A' ' 197' ' ' PHE . 97.0 t -95.45 110.99 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 1.74 111.096 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.567 ' CG2' HD11 ' A' ' 160' ' ' LEU . 40.8 t -149.7 142.21 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 1.27 111.123 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -80.4 152.8 28.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 4.08 110.907 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.3 176.17 8.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 1.53 111.076 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -144.85 111.97 5.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 5.32 110.893 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.12 -125.3 27.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 1.33 112.502 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.68 114.86 23.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.333 . . . . 1.96 111.12 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -89.16 48.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 3.17 110.923 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.85 45.81 5.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.731 . . . . 3.48 112.526 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.74 96.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.337 . . . . 8.37 110.869 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.4 -74.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 4.66 110.846 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -128.06 80.73 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 4.26 110.868 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.22 113.26 19.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.75 111.084 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 141.31 43.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 5.81 110.888 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 p30 178.69 -174.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 4.99 110.86 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.65 106.04 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 2.5 112.521 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.26 118.96 2.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 5.82 110.919 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 121.16 -41.44 1.9 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.748 . . . . 3.09 112.533 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -75.91 -114.03 0.12 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 1.71 112.516 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.8 mm -92.44 135.18 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 2.01 111.102 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 182' ' ' ALA . 0.5 OUTLIER -106.94 -20.84 13.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 3.38 110.892 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.625 ' N ' HD12 ' A' ' 181' ' ' LEU . . . -179.62 124.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 1.61 111.128 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -109.46 146.74 34.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 3.38 110.842 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -155.76 122.34 5.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.72 111.119 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.67 169.45 18.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 2.41 110.897 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.16 177.55 0.27 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.711 -0.757 . . . . 1.07 112.485 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 153.12 69.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.73 2.287 . . . . 1.34 112.331 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.79 175.2 27.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.746 -0.74 . . . . 1.65 112.513 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 88.9 p -58.72 158.89 7.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 2.01 110.891 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.85 -102.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 1.23 112.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.64 -73.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 2.68 111.11 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 50.54 -132.63 30.76 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 2.8 112.51 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.723 ' O ' HG23 ' A' ' 159' ' ' ILE . . . -88.66 47.1 3.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 1.02 112.486 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.92 154.97 37.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 2.46 110.883 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -118.95 109.52 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 1.2 111.02 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -111.44 109.89 20.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 3.45 110.812 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.57 ' HE2' HG13 ' A' ' 161' ' ' VAL . 52.6 m-85 -106.33 103.2 12.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 2.68 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.66 101.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 7.53 110.87 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.9 -29.15 26.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 7.19 110.886 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -32.81 70.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 3.85 110.838 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.84 -174.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 3.5 110.939 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -114.17 76.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 4.46 110.844 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.647 ' CH2' HG21 ' A' ' 215' ' ' THR . 0.6 OUTLIER -73.6 147.52 43.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 7.01 110.938 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.436 HG21 ' H ' ' A' ' 209' ' ' GLY . 0.1 OUTLIER -156.66 173.09 17.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 1.74 111.143 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -173.86 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 2.42 111.117 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -55.64 -48.97 74.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 4.65 110.84 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -81.92 -25.09 35.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 2.89 110.835 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.8 -172.13 0.39 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 3.29 112.474 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.436 ' H ' HG21 ' A' ' 204' ' ' THR . . . -50.47 -86.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 2.77 112.511 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -93.63 109.51 21.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 1.6 111.127 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -49.92 114.31 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 3.7 110.911 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 212' ' ' LEU . 0.1 OUTLIER -61.54 -35.77 78.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 3.18 110.934 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.403 ' HB2' ' HB1' ' A' ' 133' ' ' ALA . 2.0 t80 -72.9 -57.93 3.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 5.39 110.928 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.819 HD22 HG12 ' A' ' 243' ' ' VAL . 14.8 tp -47.9 -45.41 30.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 2.09 110.889 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.647 HG21 ' CH2' ' A' ' 203' ' ' TRP . 24.8 m -59.37 -44.8 92.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.66 111.102 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.28 80.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.91 111.122 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.4 t -49.21 -50.47 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 1.05 111.159 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.841 ' HE2' 'CO ' ' A' ' 264' ' ' ' CO' . 50.1 t60 -54.08 -33.63 58.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 2.0 110.882 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.5 ' OE2' ' HB3' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -74.73 -41.57 59.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 3.98 110.855 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.458 ' O ' HD13 ' A' ' 224' ' ' LEU . 39.1 mm -53.37 -37.93 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 1.5 111.105 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.99 -53.56 5.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 0.81 112.493 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -57.15 -24.92 57.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 2.47 110.872 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.3 m -87.25 -17.58 32.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 1.59 110.864 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 220' ' ' ILE . 6.2 mp -120.82 24.83 10.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 1.87 110.95 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.87 106.52 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 1.98 112.466 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.812 HD11 ' HA ' ' A' ' 236' ' ' MET . 2.3 tm? -144.12 -67.01 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 4.1 110.905 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.486 ' N ' HD13 ' A' ' 226' ' ' LEU . . . 67.13 121.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 3.48 112.486 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -51.71 152.68 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 2.24 110.866 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 73.7 m -134.05 -77.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 3.99 110.856 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 8.2 t 178.09 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 5.33 110.895 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -48.4 108.01 0.85 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.612 0.72 . . . . 2.82 110.883 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 157.02 61.85 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.717 2.278 . . . . 1.85 112.314 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.14 17.9 8.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 5.83 110.927 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.46 175.45 5.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 2.41 111.099 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 218' ' ' HIS . 49.7 t -71.46 -18.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 5.05 111.139 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.812 ' HA ' HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -57.05 -74.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 6.46 110.823 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -128.36 65.14 69.89 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.658 0.742 . . . . 6.62 110.903 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -169.88 0.36 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.669 2.246 . . . . 6.01 112.367 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.49 155.37 40.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 2.54 111.137 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -62.09 118.7 7.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 3.95 110.912 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.64 -168.94 1.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 3.36 110.922 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -132.75 102.55 5.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 4.15 110.942 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.819 HG12 HD22 ' A' ' 214' ' ' LEU . 10.0 p -108.69 157.08 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 2.55 111.108 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -58.63 114.64 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 2.66 110.864 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -69.2 -25.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 3.52 111.118 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -28.6 32.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 3.87 110.895 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.29 13.27 32.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 2.38 111.153 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -51.28 164.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 5.03 110.877 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -179.44 146.97 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 3.37 110.863 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.675 HD23 ' CD1' ' A' ' 255' ' ' ILE . 40.7 tp -66.98 162.48 21.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 2.76 110.91 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.77 145.22 25.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 5.07 110.846 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -63.22 -71.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 3.26 111.115 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.09 -35.06 59.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 3.7 110.841 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -70.82 -29.99 66.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 2.88 110.85 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.731 HG13 HG11 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -51.58 -28.51 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 1.92 111.106 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.8 mtp85 -79.88 -37.77 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 5.82 110.824 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.36 58.88 3.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.741 -0.742 . . . . 2.41 112.505 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.417 HG21 ' CG2' ' A' ' 144' ' ' VAL . 5.2 tp -177.89 -39.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.321 . . . . 1.17 111.151 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -73.55 -30.89 63.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 4.26 110.901 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -42.53 99.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 3.52 110.865 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.82 153.04 43.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 4.08 110.941 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 60.39 98.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 14.13 110.906 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 119.136 -0.814 . . . . 10.05 112.495 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . 0.841 'CO ' ' HE2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.485 ' N ' ' HZ2' ' A' ' 148' ' ' LYS . 1.1 t60 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.791 0.329 . . . . 8.65 110.865 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.7 143.56 49.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 10.22 110.922 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.7 153.77 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 2.97 111.118 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.629 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 30.5 p -117.09 143.81 45.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 1.95 111.142 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -146.96 136.67 23.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 4.46 110.875 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -135.21 126.23 27.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 4.31 110.859 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.645 HG21 HG21 ' A' ' 134' ' ' ILE . 22.1 pt -104.82 133.96 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 3.11 111.103 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -135.55 29.37 3.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 3.29 110.904 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.86 151.33 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 5.42 110.926 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -147.69 145.23 28.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 6.55 110.943 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' ' 125' ' ' MET . 0.0 OUTLIER -119.67 133.14 23.83 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.601 0.715 . . . . 3.34 111.121 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -49.56 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.69 2.26 . . . . 3.02 112.329 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -30.99 15.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 4.39 110.876 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.495 ' SD ' HG22 ' A' ' 205' ' ' THR . 24.7 mtp -108.01 164.57 12.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 5.34 110.906 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -86.55 161.53 18.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 3.39 110.873 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -25.49 36.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 7.43 110.909 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -80.07 -41.17 26.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 5.17 110.883 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -55.66 -53.03 61.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 2.25 110.873 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.746 HG23 ' CD2' ' A' ' 212' ' ' LEU . 7.4 p -67.1 -37.57 79.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 1.12 111.161 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -61.44 -54.25 45.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 2.55 110.845 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -70.37 -32.54 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 2.8 110.955 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.24 -57.45 8.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.79 111.079 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.71 HD12 ' O ' ' A' ' 130' ' ' VAL . 3.0 mp -76.06 -45.67 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 2.09 111.129 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.61 -37.35 39.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 4.5 110.856 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -78.53 -30.68 47.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 3.95 110.883 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.535 ' HB1' HG13 ' A' ' 220' ' ' ILE . . . -55.73 -35.96 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.99 111.073 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -74.51 -28.15 60.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 3.62 110.878 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.34 -50.42 10.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 2.74 110.932 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.747 ' O ' HD12 ' A' ' 250' ' ' LEU . 6.2 p -50.09 -30.99 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 1.91 111.143 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -88.76 -43.48 11.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 3.8 110.926 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 70.7 p -54.75 -24.79 23.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.16 110.871 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.31 -24.43 43.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 2.71 110.864 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.845 HG11 HG12 ' A' ' 255' ' ' ILE . 4.5 m -140.94 46.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 2.1 111.103 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 m -155.76 132.06 5.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 1.56 111.142 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -8.36 23.4 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.712 2.275 . . . . 1.8 112.364 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.65 147.01 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 2.76 110.891 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.485 ' HZ2' ' N ' ' A' ' 112' ' ' HIS . 0.0 OUTLIER -118.38 137.24 53.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 5.07 110.894 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -99.35 134.48 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 6.59 110.923 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.4 t -123.87 89.91 3.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.77 110.836 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.88 119.92 19.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 2.58 110.863 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.437 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -120.14 149.29 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 2.8 111.086 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.43 -24.53 34.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 3.69 110.893 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.2 m -139.77 132.16 28.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 3.49 111.142 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.19 162.8 11.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.802 -0.713 . . . . 2.45 112.516 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 42.0 mtt -95.02 166.39 11.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 7.38 110.902 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -142.86 163.49 32.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 1.15 111.093 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -25.53 65.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.72 110.897 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.414 HD13 ' HA3' ' A' ' 193' ' ' GLY . 44.9 mm -104.02 84.54 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 3.08 111.094 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.636 HD21 HG23 ' A' ' 162' ' ' VAL . 1.2 tm? -81.06 115.78 20.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 1.38 110.945 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.591 ' N ' HD22 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -105.84 107.98 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.97 111.154 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.636 HG23 HD21 ' A' ' 160' ' ' LEU . 69.4 t -138.27 145.08 29.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 1.3 111.066 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -93.11 129.48 39.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 3.63 110.866 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.513 ' HB3' ' OE2' ' A' ' 199' ' ' GLU . . . -111.09 178.39 4.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 1.26 111.117 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -144.02 112.24 6.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 4.55 110.866 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 58.66 -131.15 51.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 1.27 112.521 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . . . -86.95 110.55 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 1.35 111.096 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -85.36 53.64 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 3.16 110.882 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 78.62 -57.74 4.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.733 -0.746 . . . . 3.09 112.499 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -162.7 46.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 5.56 110.882 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.31 -169.13 1.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 4.6 110.869 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -76.75 96.4 4.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 3.79 110.911 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 167' ' ' ALA . . . -81.39 143.64 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 1.52 111.11 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -155.75 139.18 15.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 6.8 110.906 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.17 -175.47 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 4.78 110.841 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.74 99.32 1.09 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 2.69 112.464 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.04 118.95 2.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 3.68 110.865 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.16 -34.74 5.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 3.7 112.479 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.79 -147.63 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 2.0 112.494 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.6 mm -71.62 89.47 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 2.69 111.104 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.6 pp -45.2 -32.89 2.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 3.46 110.919 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.727 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 178.61 167.91 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.49 111.12 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -146.52 106.3 3.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 3.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -90.63 121.3 32.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.77 111.106 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.94 151.68 42.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 2.75 110.873 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.68 167.33 0.47 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 1.08 112.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 154.37 67.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 1.03 112.327 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 167.56 -110.03 0.37 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 1.78 112.48 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 93.3 p -131.28 142.25 50.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.401 . . . . 3.34 110.806 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.08 -87.43 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 1.4 112.484 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 191' ' ' ILE . 10.4 tt -91.94 14.93 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 3.49 111.124 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -55.71 -68.47 1.67 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.783 -0.723 . . . . 2.71 112.492 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.414 ' HA3' HD13 ' A' ' 159' ' ' ILE . . . -85.62 2.85 87.81 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 1.41 112.453 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.14 139.4 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.812 0.339 . . . . 2.62 110.849 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.553 ' HB1' ' HG3' ' A' ' 219' ' ' GLU . . . -134.31 154.68 51.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 1.04 111.09 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.534 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 48.1 m80 -135.21 129.9 34.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 2.5 110.833 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -108.8 106.18 16.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 3.1 110.888 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.45 82.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 5.76 110.845 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.513 ' OE2' ' HB3' ' A' ' 164' ' ' ALA . 1.5 mm-40 -51.33 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 8.26 110.843 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.92 28.83 5.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 4.64 110.853 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -95.04 -80.97 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 4.56 110.895 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 174.27 134.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 4.64 110.867 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 95.27 5.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 6.88 110.917 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 2.6 m -157.04 120.32 4.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 3.92 111.117 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.495 HG22 ' SD ' ' A' ' 125' ' ' MET . 4.5 t -111.5 65.38 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 4.56 111.169 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -88.47 -68.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 9.61 110.866 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.81 -43.32 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 3.24 110.909 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 242' ' ' TYR . . . -155.59 -112.76 0.42 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.751 . . . . 3.45 112.469 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 40.63 -133.99 2.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 2.66 112.475 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.49 97.05 9.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 1.89 111.16 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.8 111.44 23.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 3.46 110.899 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.746 ' CD2' HG23 ' A' ' 130' ' ' VAL . 13.2 tp -51.45 -31.44 23.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 4.57 110.918 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.96 -68.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 3.97 110.871 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.615 HD22 ' CB ' ' A' ' 241' ' ' LYS . 3.6 mp -76.89 -36.83 56.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 3.9 110.876 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.458 ' CG2' HD22 ' A' ' 181' ' ' LEU . 70.2 m -54.56 -45.8 73.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.73 111.173 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.5 -44.65 76.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.83 111.101 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.577 HG21 ' CZ ' ' A' ' 248' ' ' PHE . 29.4 t -51.35 -49.88 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.77 111.171 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -55.29 -33.77 63.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 1.92 110.832 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.553 ' HG3' ' HB1' ' A' ' 195' ' ' ALA . 1.7 tm-20 -74.52 -40.71 61.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 5.47 110.885 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.535 HG13 ' HB1' ' A' ' 137' ' ' ALA . 42.9 mm -50.78 -47.48 28.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 1.54 111.116 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.98 -23.99 70.44 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 0.97 112.495 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -49.44 70.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 2.86 110.869 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 43.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 1.87 110.828 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.3 mt -144.33 -42.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 2.39 110.923 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 168.71 -38.0 0.21 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.787 -0.72 . . . . 2.33 112.529 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.19 177.91 7.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 3.33 110.922 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.42 -77.62 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.729 . . . . 3.48 112.477 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -143.11 113.98 7.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.865 0.364 . . . . 1.8 110.866 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.1 t -92.35 -78.16 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 4.48 110.902 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.4 t 176.85 -33.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 4.42 110.853 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -49.55 108.13 0.92 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 2.42 110.85 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.9 Cg_endo -69.79 167.78 23.48 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.688 2.259 . . . . 1.74 112.329 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.65 29.82 6.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 4.24 110.931 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.73 -174.61 2.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 1.97 111.101 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 235' ' ' VAL . 11.6 t -93.56 -4.1 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 2.92 111.112 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.433 ' HE3' ' HA ' ' A' ' 236' ' ' MET . 1.6 tpt -83.25 -41.66 18.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 3.67 110.849 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.695 ' HB3' HG22 ' A' ' 239' ' ' THR . 0.1 OUTLIER -51.32 149.83 6.91 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.659 0.742 . . . . 3.65 110.893 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -7.23 20.5 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.685 2.256 . . . . 2.72 112.351 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.695 HG22 ' HB3' ' A' ' 237' ' ' PHE . 14.7 t -84.86 138.01 32.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 2.57 111.139 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -66.25 145.44 55.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 3.85 110.892 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.615 ' CB ' HD22 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -90.88 102.39 15.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 4.37 110.888 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.405 ' HB2' ' HA3' ' A' ' 208' ' ' GLY . 18.6 p90 -91.8 44.37 1.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 6.28 110.941 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.18 177.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 3.59 111.141 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.753 ' HB3' HG22 ' A' ' 247' ' ' THR . 0.5 OUTLIER -59.79 126.26 26.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 3.14 110.836 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 214' ' ' LEU . 25.0 pt -76.42 -30.28 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 3.47 111.106 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -65.86 -39.57 90.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 4.97 110.853 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.753 HG22 ' HB3' ' A' ' 244' ' ' ASP . 14.6 t -94.71 -4.77 46.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 3.3 111.116 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 217' ' ' VAL . 21.6 t80 -51.84 144.18 11.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 5.08 110.887 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -175.05 151.45 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 3.48 110.857 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 140' ' ' VAL . 0.8 OUTLIER -52.45 145.3 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 2.08 110.932 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.613 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.2 OUTLIER -154.42 -172.24 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 3.53 110.849 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 65.56 161.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 3.77 111.118 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -22.89 51.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 3.2 110.903 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -51.32 -29.75 16.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 3.64 110.888 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.845 HG12 HG11 ' A' ' 144' ' ' VAL . 8.2 tt -50.74 -29.65 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 2.15 111.164 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -92.34 -31.16 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 6.59 110.827 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.06 -16.86 60.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.778 -0.725 . . . . 1.84 112.494 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.712 ' O ' HD13 ' A' ' 261' ' ' LEU . 8.4 tp -93.33 -31.47 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.776 0.322 . . . . 1.02 111.121 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -78.43 -48.2 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 4.68 110.912 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.41 -47.24 43.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 2.67 110.876 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 258' ' ' ILE . 0.9 OUTLIER 56.04 93.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.514 . . . . 3.43 110.907 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.68 34.32 1.28 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 10.63 110.894 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 119.128 -0.818 . . . . 10.09 112.496 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.812 0.339 . . . . 7.91 110.835 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.676 ' O ' HD13 ' A' ' 114' ' ' ILE . 29.7 m-85 -109.45 148.84 30.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 9.91 110.938 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 113' ' ' TYR . 11.2 mm -129.82 159.12 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 3.11 111.109 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.416 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -146.99 142.28 27.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 2.18 111.153 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.61 ' CD2' HD11 ' A' ' 159' ' ' ILE . 7.4 m-85 -127.56 152.43 47.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 6.56 110.889 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -161.88 133.79 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 4.45 110.904 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.584 HG23 ' CG2' ' A' ' 161' ' ' VAL . 86.8 mt -108.12 144.06 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 2.39 111.122 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -108.96 -76.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 3.68 110.881 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -124.81 -178.28 4.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 6.11 110.9 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.731 ' HB2' HG11 ' A' ' 130' ' ' VAL . 13.1 p90 -140.85 163.23 33.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 5.32 110.916 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.0 m -73.73 131.34 82.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.528 0.68 . . . . 2.94 111.142 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -34.87 13.73 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.702 2.268 . . . . 2.35 112.366 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -50.49 -53.73 27.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 4.97 110.848 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 19.6 mmt -101.33 154.6 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 3.66 110.888 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -59.1 149.09 28.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 2.97 110.899 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -58.5 -20.87 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 4.84 110.888 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.24 -37.28 61.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 3.8 110.909 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 11.7 m-20 -61.62 -52.2 65.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 3.05 110.886 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.731 HG11 ' HB2' ' A' ' 121' ' ' TYR . 3.8 p -69.43 -30.0 43.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 1.13 111.149 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.42 -48.73 47.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 3.39 110.871 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -75.36 -33.56 61.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.461 . . . . 2.99 110.925 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -51.45 -58.8 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.59 HD12 ' N ' ' A' ' 135' ' ' ARG . 2.9 pp -68.34 -28.01 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 4.14 111.107 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.59 ' N ' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -50.61 -51.0 52.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 4.75 110.908 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -78.63 -32.07 47.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 3.28 110.936 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.653 ' HB1' HD12 ' A' ' 220' ' ' ILE . . . -55.88 -34.85 65.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 1.25 111.111 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -73.96 -28.38 61.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 4.66 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.07 -51.34 9.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 3.55 110.913 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.9 p -51.15 -29.84 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 2.52 111.141 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -85.91 -51.38 6.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 3.84 110.918 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.6 p -60.98 -17.23 50.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 1.79 110.894 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -50.4 -30.69 12.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 3.03 110.936 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.749 HG11 ' CG1' ' A' ' 255' ' ' ILE . 33.6 m -133.39 36.42 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 2.03 111.069 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.704 HG21 HD11 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -146.08 132.96 9.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.566 0.698 . . . . 1.63 111.148 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 64.9 1.79 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.712 2.274 . . . . 2.12 112.316 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 114' ' ' ILE . 2.7 mp -121.1 150.05 41.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 3.06 110.899 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.0 174.34 6.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 4.64 110.893 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -112.57 126.09 54.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 8.43 110.903 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.5 t -133.38 89.99 2.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 2.26 110.869 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -81.75 121.94 27.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 2.66 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.461 HG22 ' H ' ' A' ' 154' ' ' THR . 38.0 mt -137.48 113.21 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 3.25 111.127 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.07 -28.92 27.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 4.08 110.844 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.461 ' H ' HG22 ' A' ' 152' ' ' ILE . 94.9 m -160.73 110.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 3.98 111.13 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -173.32 -134.15 1.78 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.758 . . . . 2.35 112.466 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 120.51 42.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.321 . . . . 5.6 110.89 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.94 129.41 43.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 1.45 111.084 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.06 -18.73 28.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 2.41 110.866 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.61 HD11 ' CD2' ' A' ' 116' ' ' TYR . 2.0 pp -138.82 127.04 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 3.19 111.133 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.409 ' H ' HD12 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -136.24 166.38 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 2.34 110.938 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.633 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 3.1 m -112.24 110.09 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 3.1 111.074 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 163' ' ' PHE . 0.4 OUTLIER -120.66 174.71 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 1.74 111.123 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.501 ' H ' HG22 ' A' ' 162' ' ' VAL . 47.7 p90 -106.78 125.06 50.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 5.32 110.904 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -125.71 148.34 49.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 1.63 111.12 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.63 111.57 13.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 4.56 110.853 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.61 -139.56 16.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 1.39 112.457 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.06 111.09 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 2.07 111.135 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -92.29 43.69 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 2.87 110.823 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.83 95.53 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.721 -0.752 . . . . 2.87 112.487 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.4 41.79 7.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.819 0.342 . . . . 6.34 110.87 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.12 -168.81 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 4.42 110.919 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -76.9 102.95 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 4.39 110.853 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.73 112.3 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 1.53 111.093 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -70.01 -168.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 6.08 110.868 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.53 ' HB3' HD12 ' A' ' 180' ' ' ILE . 4.6 t70 -131.95 -41.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 4.69 110.915 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 123.22 -172.42 16.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 1.74 112.504 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.06 118.8 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.331 . . . . 4.74 110.883 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.62 -47.34 1.05 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 2.54 112.485 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -88.86 -121.01 1.83 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.717 -0.754 . . . . 1.38 112.477 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 175' ' ' ASP . 2.0 mp -71.32 148.51 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 3.36 111.152 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.622 HD12 ' H ' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -113.8 -29.55 7.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 3.63 110.935 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.622 ' H ' HD12 ' A' ' 181' ' ' LEU . . . -178.69 123.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 1.63 111.096 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -94.97 162.94 13.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 3.14 110.891 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -173.23 105.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.99 111.048 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.88 170.19 4.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 2.73 110.867 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.09 165.87 1.13 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 1.23 112.458 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 165.24 31.71 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 0.99 112.367 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.04 -136.44 5.03 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 1.38 112.47 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.89 121.26 44.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 3.43 110.832 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.21 -62.93 2.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.756 . . . . 1.72 112.505 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 191' ' ' ILE . 11.7 mt -93.95 21.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 2.44 111.138 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.7 -106.99 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 2.72 112.483 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.492 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . -92.07 37.66 3.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 1.12 112.493 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -50.77 126.06 14.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.794 0.33 . . . . 2.1 110.89 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.82 ' HB1' ' CE2' ' A' ' 197' ' ' PHE . . . -101.86 145.97 28.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 1.24 111.098 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -139.79 107.69 5.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 3.04 110.829 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.82 ' CE2' ' HB1' ' A' ' 195' ' ' ALA . 10.2 m-85 -143.82 108.52 4.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 3.35 110.883 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 t70 179.38 -82.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 8.22 110.832 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.41 153.57 28.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 7.73 110.913 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 64.69 125.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 6.47 110.905 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 63.57 70.45 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 4.57 110.909 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -45.78 157.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 5.05 110.87 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.62 ' CZ3' HG21 ' A' ' 215' ' ' THR . 66.2 m95 -105.35 175.05 5.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 7.23 110.905 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.45 HG21 ' H ' ' A' ' 209' ' ' GLY . 0.0 OUTLIER -157.28 173.44 16.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 2.04 111.144 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -171.51 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 2.06 111.142 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -67.01 -21.76 65.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 5.02 110.876 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.6 m -103.62 -24.71 13.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 2.46 110.812 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -62.48 -160.43 0.18 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 2.25 112.503 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.45 ' H ' HG21 ' A' ' 204' ' ' THR . . . -60.6 -101.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 1.64 112.492 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 210' ' ' THR . 2.4 t -80.42 103.57 10.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 3.6 111.105 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 243' ' ' VAL . 9.8 m-20 -50.38 116.37 1.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 2.99 110.929 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 203' ' ' TRP . 11.5 tp -60.76 -39.29 88.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 3.07 110.954 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.521 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -72.39 -34.7 68.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 5.4 110.881 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -55.07 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 2.99 110.944 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.62 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 98.4 m -54.97 -38.47 67.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 1.14 111.151 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.14 -32.25 61.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.85 111.086 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 137' ' ' ALA . 5.0 t -70.64 -25.53 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.99 111.135 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -69.57 -61.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 1.84 110.868 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.406 ' CD ' ' HB3' ' A' ' 182' ' ' ALA . 3.4 mp0 -58.99 -50.02 75.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 4.72 110.869 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.653 HD12 ' HB1' ' A' ' 137' ' ' ALA . 72.1 mt -51.42 -29.52 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 2.02 111.161 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.56 -44.36 16.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 0.75 112.492 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.59 -34.33 76.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 2.59 110.83 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -28.91 18.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 2.36 110.903 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.3 mp -93.73 -24.64 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 2.34 110.923 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.526 ' O ' HD22 ' A' ' 226' ' ' LEU . . . 126.38 105.49 1.43 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 1.81 112.489 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.619 HD21 ' O ' ' A' ' 257' ' ' GLY . 0.2 OUTLIER -149.37 -68.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 3.25 110.866 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 73.31 31.59 61.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 3.42 112.468 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 21.6 m80 64.47 155.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 2.22 110.877 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 59.4 m -124.84 -78.14 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 4.36 110.86 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.16 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 4.49 110.884 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -47.44 106.64 0.62 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.577 0.703 . . . . 3.3 110.865 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.3 21.94 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 1.89 112.359 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.0 mptt 50.65 29.96 4.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 5.55 110.934 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.531 ' HB1' ' OD2' ' A' ' 254' ' ' ASP . . . -130.59 -168.88 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 2.18 111.101 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.451 ' HB ' ' HE2' ' A' ' 236' ' ' MET . 55.3 t -50.42 -57.26 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 4.45 111.13 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.451 ' HE2' ' HB ' ' A' ' 235' ' ' VAL . 9.8 mmt -59.41 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 3.4 110.875 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 238' ' ' PRO . 0.2 OUTLIER 63.72 99.62 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.651 0.739 . . . . 4.54 110.915 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 237' ' ' PHE . 53.4 Cg_endo -69.83 77.95 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.693 2.262 . . . . 3.36 112.283 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.4 p -145.46 125.53 13.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 2.69 111.116 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -62.77 126.39 27.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 4.42 110.875 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -150.69 92.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 4.18 110.89 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -58.68 127.29 31.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 3.46 110.91 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.557 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 7.6 p -135.97 154.32 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 2.41 111.167 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.19 113.15 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 2.82 110.835 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.0 tt -74.28 -34.5 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.55 111.163 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -24.02 67.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 2.85 110.914 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 14.6 19.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 2.57 111.168 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -51.36 156.97 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 5.13 110.879 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -178.67 148.15 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 3.56 110.88 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.14 161.11 2.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 2.89 110.893 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.429 ' OG ' HG23 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -88.93 150.76 22.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 4.78 110.874 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.434 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -68.96 -68.34 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 3.43 111.106 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -53.31 -36.91 61.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 3.6 110.853 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.531 ' OD2' ' HB1' ' A' ' 234' ' ' ALA . 25.0 m-20 -70.96 -29.23 65.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 3.27 110.838 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.749 ' CG1' HG11 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -51.09 -28.6 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.73 111.111 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -77.78 -37.19 49.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 5.7 110.853 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.619 ' O ' HD21 ' A' ' 226' ' ' LEU . . . -78.63 57.11 4.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 2.66 112.488 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.704 HD11 HG21 ' A' ' 145' ' ' THR . 4.9 tp -179.16 -40.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.86 111.17 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -75.03 -45.07 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 3.03 110.908 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.15 -47.2 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 2.15 110.827 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 258' ' ' ILE . 2.3 tp 51.16 30.58 5.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 3.76 110.944 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -126.55 -59.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 10.62 110.946 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 119.146 -0.808 . . . . 10.66 112.505 179.952 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.1 m80 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.846 0.355 . . . . 8.05 110.823 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -114.77 142.77 46.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 9.57 110.92 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.71 147.89 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 2.96 111.134 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.724 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 71.8 p -130.01 148.07 51.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 2.06 111.128 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -145.57 173.28 12.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 4.22 110.962 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -160.5 125.89 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 7.24 110.838 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.718 HG21 HG13 ' A' ' 134' ' ' ILE . 1.6 pt -108.17 121.63 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 3.23 111.138 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -136.11 47.92 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 3.98 110.88 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.534 ' OD1' HG12 ' A' ' 161' ' ' VAL . 1.1 p-10 -137.5 153.23 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 5.62 110.867 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -147.4 163.15 37.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 7.8 110.883 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 p -125.37 151.72 70.3 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.712 . . . . 2.62 111.155 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 169.08 19.75 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.713 2.276 . . . . 3.18 112.337 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.1 t70 75.65 -52.06 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 6.03 110.824 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.749 ' HG2' HG23 ' A' ' 205' ' ' THR . 3.7 mpp? -97.66 132.91 42.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 3.43 110.895 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.99 155.75 10.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 3.48 110.879 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.06 -23.12 12.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 5.13 110.851 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -41.01 84.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 3.9 110.91 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.36 -54.67 44.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 2.6 110.874 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.504 ' O ' HD13 ' A' ' 134' ' ' ILE . 6.1 p -62.21 -40.66 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.84 111.111 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.13 -40.83 61.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 3.3 110.875 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -74.61 -31.08 61.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 2.92 110.932 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.24 -52.46 35.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 1.15 111.096 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.718 HG13 HG21 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -83.02 -28.52 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 2.27 111.152 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -50.98 -55.08 19.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 6.53 110.869 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -78.25 -25.94 47.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 3.62 110.874 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.665 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.82 -37.26 68.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.8 111.1 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -27.03 61.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 3.43 110.852 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.97 -48.81 13.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 2.97 110.886 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.461 ' O ' HD12 ' A' ' 250' ' ' LEU . 4.6 p -55.8 -27.07 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 2.13 111.115 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.705 ' HE1' HD11 ' A' ' 258' ' ' ILE . 21.4 t90 -91.1 -54.37 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 9.58 110.933 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.5 p -59.22 -18.4 36.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 1.71 110.841 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.2 -26.66 61.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 2.36 110.921 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.605 HG11 HD13 ' A' ' 250' ' ' LEU . 7.1 p -103.85 -23.87 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 3.55 111.114 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.731 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -106.57 145.26 30.67 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.56 0.695 . . . . 1.68 111.15 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.731 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.8 Cg_endo -69.76 -8.58 23.97 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.676 2.251 . . . . 1.91 112.308 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -51.6 158.2 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 2.94 110.881 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.23 138.71 52.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 6.14 110.918 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -101.54 139.25 37.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 6.57 110.871 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.71 ' HB3' HG22 ' A' ' 115' ' ' THR . 0.6 OUTLIER -143.0 90.04 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 1.66 110.849 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -77.81 122.77 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 3.9 110.889 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 154' ' ' THR . 15.7 pt -140.18 163.79 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 2.44 111.14 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -109.59 28.9 8.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 3.71 110.888 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.457 ' O ' HD12 ' A' ' 152' ' ' ILE . 14.6 t -157.65 174.05 15.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 3.6 111.145 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.62 -173.62 12.15 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.74 . . . . 1.58 112.507 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.46 166.34 10.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 5.56 110.873 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.724 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -144.62 146.94 32.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 1.14 111.113 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -26.65 68.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 2.44 110.879 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.8 mm -104.04 109.9 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 2.87 111.173 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.674 HD22 ' N ' ' A' ' 161' ' ' VAL . 0.9 OUTLIER -111.22 119.35 38.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 1.49 110.94 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.674 ' N ' HD22 ' A' ' 160' ' ' LEU . 16.0 t -108.61 109.9 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 1.52 111.129 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.65 HG23 HD21 ' A' ' 160' ' ' LEU . 72.2 t -134.35 144.97 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 1.28 111.134 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -92.22 153.17 19.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 3.93 110.895 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.537 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . . . -164.33 178.02 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 1.08 111.118 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -145.04 111.54 5.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 5.11 110.9 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 63.73 -147.67 50.67 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.712 -0.756 . . . . 1.13 112.504 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.54 112.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 1.26 111.105 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -95.66 27.95 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 2.87 110.812 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.52 18.21 60.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 2.84 112.46 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -106.61 -74.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.763 0.316 . . . . 6.93 110.89 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.19 -65.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 4.54 110.882 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -77.39 107.09 9.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 5.1 110.868 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.32 159.64 23.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 1.82 111.118 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.84 113.83 2.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 6.83 110.818 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.96 -169.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 7.47 110.907 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.99 97.82 2.11 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 2.3 112.477 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -51.67 119.19 3.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 3.5 110.859 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.19 7.05 62.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 2.3 112.475 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -114.76 -126.39 4.19 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 1.48 112.538 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 180' ' ' ILE . 3.6 mp -89.16 93.9 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 2.68 111.129 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -49.9 -26.9 4.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 3.14 110.858 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.5 171.49 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 1.31 111.107 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -160.14 106.26 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 3.05 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.409 ' HB1' ' OG ' ' A' ' 223' ' ' SER . . . -110.75 109.84 20.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.79 111.087 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.06 169.65 4.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 3.06 110.927 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.39 173.8 0.25 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.99 112.443 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 179.62 3.58 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.689 2.259 . . . . 0.93 112.353 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 154.12 -128.79 2.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 1.36 112.529 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.08 141.12 52.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.927 0.394 . . . . 2.0 110.85 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.5 -76.54 0.95 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.721 . . . . 1.15 112.504 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 191' ' ' ILE . 11.1 tt -104.92 16.41 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 3.05 111.13 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.88 -77.58 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 2.83 112.473 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.94 2.22 81.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.775 -0.726 . . . . 1.06 112.479 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.51 127.42 17.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.785 0.326 . . . . 2.21 110.873 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.87 146.39 50.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 1.44 111.088 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.537 ' CD2' ' HB3' ' A' ' 164' ' ' ALA . 32.7 t-80 -113.76 149.89 34.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 6.09 110.834 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.97 147.56 44.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 4.05 110.889 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.74 -35.84 10.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 5.62 110.84 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 63.28 -82.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 7.75 110.853 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -134.87 35.21 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 6.47 110.868 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.8 -5.58 6.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 4.51 110.865 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.17 73.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 8.53 110.87 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -105.36 124.62 49.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 9.44 110.96 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.465 HG21 ' N ' ' A' ' 209' ' ' GLY . 0.0 OUTLIER -157.47 153.45 27.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 2.38 111.167 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.749 HG23 ' HG2' ' A' ' 125' ' ' MET . 0.1 OUTLIER -87.8 -172.51 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 2.27 111.148 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.508 ' HB3' HG21 ' A' ' 245' ' ' ILE . 25.5 p-80 -50.27 -48.32 54.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 4.45 110.826 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.5 p -76.82 -38.03 54.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 2.75 110.857 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.77 172.11 0.28 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 2.26 112.494 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.465 ' N ' HG21 ' A' ' 204' ' ' THR . . . -47.45 -85.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 1.55 112.472 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 88.3 m -79.36 98.34 6.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.815 0.341 . . . . 2.27 111.167 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.411 HD22 HG12 ' A' ' 243' ' ' VAL . 51.3 t-20 -51.14 115.48 1.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 3.33 110.914 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -35.28 38.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 2.85 110.9 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.414 ' O ' HG23 ' A' ' 217' ' ' VAL . 39.5 t80 -72.33 -53.6 11.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 5.28 110.86 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.473 HD13 HG11 ' A' ' 243' ' ' VAL . 10.6 tp -51.86 -47.75 64.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 2.78 110.933 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.582 HG23 HD22 ' A' ' 181' ' ' LEU . 0.7 OUTLIER -55.38 -51.23 67.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 1.07 111.154 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.59 -48.88 74.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.71 111.132 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.665 HG22 ' HA ' ' A' ' 137' ' ' ALA . 49.0 t -61.5 -20.49 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.73 111.139 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -74.33 -46.25 42.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 2.02 110.891 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.75 -23.46 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 5.48 110.859 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 224' ' ' LEU . 21.7 mm -65.56 -52.08 55.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 1.32 111.118 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.96 -25.69 66.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 0.67 112.438 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -51.33 70.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 2.56 110.887 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.409 ' OG ' ' HB1' ' A' ' 184' ' ' ALA . 0.9 OUTLIER -91.26 46.14 1.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 1.9 110.861 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 220' ' ' ILE . 1.2 mt -156.12 22.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 1.94 110.913 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.27 5.28 89.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 1.78 112.487 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.473 ' HB2' HD13 ' A' ' 258' ' ' ILE . 19.4 tp -120.27 68.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 4.32 110.906 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -86.05 -101.83 0.74 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.765 -0.731 . . . . 3.7 112.443 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -118.46 153.61 33.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.338 . . . . 2.29 110.858 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.3 m -135.86 -75.91 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 4.37 110.844 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.62 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 3.66 110.864 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 30.7 m-20 -49.28 108.27 0.94 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.577 0.703 . . . . 3.4 110.853 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 233' ' ' LYS . 53.7 Cg_endo -69.76 -179.82 3.18 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.658 2.238 . . . . 1.86 112.337 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.53 42.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 4.6 110.897 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -128.91 -175.78 3.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 1.92 111.117 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 43.0 t -93.05 -17.72 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 3.03 111.117 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -82.23 -41.53 20.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 4.79 110.887 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -51.54 136.4 33.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.668 0.747 . . . . 3.8 110.915 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.453 ' O ' HG23 ' A' ' 239' ' ' THR . 54.1 Cg_endo -69.77 77.77 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.258 . . . . 2.1 112.355 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 238' ' ' PRO . 2.0 p -156.92 160.36 39.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 2.71 111.154 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -127.05 113.2 16.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 3.75 110.952 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.02 128.41 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.467 . . . . 3.19 110.919 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -51.71 121.95 7.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 3.4 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.473 HG11 HD13 ' A' ' 214' ' ' LEU . 11.3 p -122.18 148.8 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 2.71 111.168 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -54.98 113.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 4.1 110.87 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.508 HG21 ' HB3' ' A' ' 206' ' ' HIS . 1.3 pp -76.75 -31.27 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 2.62 111.117 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -36.04 78.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 2.82 110.868 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 21.0 p -104.71 24.69 11.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 2.78 111.155 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -51.78 134.34 30.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 5.77 110.929 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -178.54 136.47 0.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 4.24 110.838 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.646 HD22 HG13 ' A' ' 255' ' ' ILE . 0.4 OUTLIER -52.65 152.7 3.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 2.14 110.887 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 252' ' ' ALA . 0.1 OUTLIER -154.54 -170.95 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 3.23 110.889 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.667 ' HB3' ' OD2' ' A' ' 254' ' ' ASP . . . 69.18 157.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 4.14 111.079 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.27 -24.9 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 2.77 110.883 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.667 ' OD2' ' HB3' ' A' ' 252' ' ' ALA . 1.2 p30 -50.78 -29.9 12.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 3.04 110.83 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.646 HG13 HD22 ' A' ' 250' ' ' LEU . 17.8 tt -54.24 -29.67 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 1.97 111.123 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -83.1 -24.8 32.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 5.6 110.852 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 261' ' ' LEU . . . -81.42 -44.85 7.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.815 -0.707 . . . . 2.54 112.479 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.705 HD11 ' HE1' ' A' ' 141' ' ' TRP . 5.7 tp -54.58 -36.93 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.82 111.089 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -77.04 -49.72 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 3.44 110.913 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 57.7 m -59.37 -27.27 65.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 2.65 110.83 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 257' ' ' GLY . 1.7 mp -57.18 -25.92 59.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.104 -0.498 . . . . 3.41 110.916 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -52.06 135.03 31.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 14.07 110.908 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 CA-C-O 119.127 -0.818 . . . . 12.01 112.467 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.857 0.36 . . . . 9.02 110.807 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.586 ' C ' HD12 ' A' ' 114' ' ' ILE . 13.3 p90 -123.31 142.57 50.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 10.77 110.95 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.586 HD12 ' C ' ' A' ' 113' ' ' TYR . 1.7 mp -120.01 145.62 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 3.47 111.174 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.51 134.56 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 2.38 111.138 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -134.4 147.26 50.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 4.83 110.903 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -153.06 152.63 31.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 3.95 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.39 144.59 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 2.76 111.109 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.44 ' HB3' HG22 ' A' ' 162' ' ' VAL . 13.7 m-80 -142.78 20.03 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 3.66 110.886 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.444 ' OD1' HG12 ' A' ' 161' ' ' VAL . 6.6 p-10 -122.44 157.7 31.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 5.81 110.91 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.92 106.41 3.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 7.64 110.916 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.747 HG23 ' HB2' ' A' ' 203' ' ' TRP . 16.3 m -70.66 120.0 76.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.598 0.713 . . . . 3.38 111.115 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -48.38 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.702 2.268 . . . . 2.65 112.341 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -23.44 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 4.82 110.906 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.727 ' HE3' HG22 ' A' ' 204' ' ' THR . 23.8 mmt -124.77 -174.56 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 3.28 110.912 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.558 ' O ' HG12 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -86.9 162.06 17.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 3.01 110.88 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -74.61 -20.91 59.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 6.59 110.891 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.51 -54.44 5.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 5.06 110.864 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -55.31 -40.18 70.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 4.06 110.886 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 126' ' ' ASN . 9.3 p -74.35 -37.16 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.07 111.121 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -62.68 -55.16 29.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 3.01 110.878 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -65.89 -31.92 73.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 3.83 110.933 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -50.94 -41.86 59.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 1.08 111.105 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.582 HD12 ' CZ ' ' A' ' 197' ' ' PHE . 2.6 mm -79.31 -43.16 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 2.54 111.169 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.24 -30.25 49.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 3.93 110.91 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -78.49 -27.3 46.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 3.15 110.844 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.485 ' HB1' HG13 ' A' ' 220' ' ' ILE . . . -55.69 -33.03 63.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 1.21 111.121 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -73.85 -25.8 60.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 3.56 110.905 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -79.08 -52.79 7.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 2.43 110.935 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.14 -42.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 2.08 111.098 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.489 ' CE3' HD11 ' A' ' 250' ' ' LEU . 9.3 m95 -75.54 -43.59 47.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 4.12 110.925 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.0 t -62.6 -15.07 49.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 2.58 110.894 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.34 -23.13 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 2.8 110.883 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.489 HG11 HG12 ' A' ' 255' ' ' ILE . 0.0 OUTLIER -120.3 -32.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 2.63 111.084 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.498 HG21 HG12 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -107.09 150.16 39.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.573 0.701 . . . . 2.55 111.127 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -53.41 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.69 2.26 . . . . 3.28 112.359 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tp 46.55 -165.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 3.89 110.858 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.61 131.14 11.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 3.81 110.862 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -115.47 144.93 43.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 6.45 110.908 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.442 ' O ' HD13 ' A' ' 152' ' ' ILE . 11.8 t -156.99 90.76 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 2.29 110.853 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -91.11 107.13 19.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 2.77 110.878 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -122.89 139.57 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 2.43 111.098 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -64.27 -24.02 67.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 3.44 110.914 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.7 m -138.06 148.91 45.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.462 . . . . 3.05 111.147 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.83 -173.28 19.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.756 -0.735 . . . . 1.77 112.458 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.8 mtt -110.65 145.87 37.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 5.45 110.843 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.43 130.05 36.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 1.47 111.114 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.26 -22.6 66.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 3.54 110.864 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.0 mm -104.18 84.36 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 2.88 111.164 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.2 tm? -91.34 115.24 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 1.7 110.887 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.823 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 21.9 t -98.88 110.88 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 1.44 111.126 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.555 ' CG2' HD11 ' A' ' 160' ' ' LEU . 46.3 t -138.97 139.96 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 1.41 111.136 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -82.48 122.87 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 3.42 110.87 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.99 178.38 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 1.45 111.08 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -145.18 126.93 15.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 8.08 110.862 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.0 -134.1 32.04 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.752 -0.737 . . . . 1.44 112.516 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.62 113.42 20.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 1.58 111.075 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -90.87 154.04 19.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 3.49 110.89 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.96 -14.0 54.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 3.41 112.483 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.22 23.5 5.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.774 0.321 . . . . 7.57 110.865 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.0 t70 63.4 52.94 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 6.65 110.865 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -127.59 79.68 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 4.96 110.826 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.39 129.05 34.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 1.63 111.082 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.09 173.08 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 10.06 110.903 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.605 ' OD2' HD12 ' A' ' 180' ' ' ILE . 13.9 t70 -125.58 -2.5 7.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 6.07 110.866 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 77.36 148.1 2.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 2.16 112.501 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.41 153.71 2.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 5.95 110.901 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.74 -1.41 87.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.737 -0.744 . . . . 3.06 112.452 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.37 -141.27 3.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 2.49 112.453 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.605 HD12 ' OD2' ' A' ' 175' ' ' ASP . 2.8 mp -71.47 91.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 2.56 111.127 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -48.28 -29.49 3.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 3.23 110.912 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.747 ' N ' HD12 ' A' ' 181' ' ' LEU . . . -179.62 178.0 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.84 111.162 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.502 ' ND1' HG21 ' A' ' 180' ' ' ILE . 0.3 OUTLIER -153.03 130.14 11.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 4.15 110.83 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -116.94 119.88 36.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.64 111.106 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.38 165.27 9.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 2.54 110.83 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.25 173.14 0.28 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.734 -0.746 . . . . 0.9 112.495 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -169.53 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.617 2.212 . . . . 1.24 112.344 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.12 -146.13 16.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 1.37 112.437 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.4 m -94.69 154.54 17.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 1.86 110.867 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.62 -103.81 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 1.3 112.447 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.23 -23.8 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 2.06 111.141 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -57.0 99.61 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.775 -0.726 . . . . 2.59 112.514 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 113.62 -12.08 23.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 1.16 112.46 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.542 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 3.4 m-20 -49.96 145.35 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.356 . . . . 2.64 110.826 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.823 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -131.97 135.3 46.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.83 111.082 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -124.76 117.86 25.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 2.77 110.854 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.582 ' CZ ' HD12 ' A' ' 134' ' ' ILE . 8.0 m-85 -100.98 101.76 12.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 2.92 110.838 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.646 ' OD1' HG21 ' A' ' 210' ' ' THR . 0.6 OUTLIER 50.63 93.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 5.72 110.868 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.59 87.08 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 9.49 110.882 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 34.3 t70 64.5 15.3 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 3.38 110.876 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.72 -78.09 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 4.47 110.885 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 178.41 124.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 4.28 110.913 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.747 ' HB2' HG23 ' A' ' 122' ' ' THR . 1.4 m-90 -102.03 137.78 39.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 7.17 110.928 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.727 HG22 ' HE3' ' A' ' 125' ' ' MET . 0.0 OUTLIER -157.11 169.05 25.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 1.96 111.16 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.41 HG23 ' SD ' ' A' ' 125' ' ' MET . 0.6 OUTLIER -75.31 173.89 10.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 1.94 111.161 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -50.55 -30.31 12.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 5.14 110.858 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.04 -37.63 17.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 2.27 110.851 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -56.45 -178.03 0.37 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.703 -0.76 . . . . 3.0 112.478 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.96 -64.18 3.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.765 -0.731 . . . . 2.41 112.511 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.646 HG21 ' OD1' ' A' ' 198' ' ' ASP . 0.2 OUTLIER -97.73 102.13 13.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 1.89 111.149 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.697 HD21 HD22 ' A' ' 214' ' ' LEU . 12.9 p30 -59.91 95.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 4.37 110.865 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 212' ' ' LEU . 2.8 tm? -59.68 -32.83 70.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 2.88 110.934 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.511 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 24.8 m-85 -66.56 -64.32 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 5.68 110.868 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.697 HD22 HD21 ' A' ' 211' ' ' ASN . 2.9 tt -59.16 -46.68 87.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 2.59 110.916 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 74.3 m -54.49 -26.28 30.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.74 111.18 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.08 -42.73 75.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.76 111.083 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.5 t -59.38 -46.88 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.84 111.17 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -53.61 -31.83 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 2.04 110.838 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -74.75 -42.9 57.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 5.57 110.845 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 224' ' ' LEU . 46.1 mm -51.1 -44.74 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 1.7 111.115 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.99 -32.66 52.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.9 112.479 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -36.67 81.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 3.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.98 29.06 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 2.43 110.861 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 220' ' ' ILE . 9.0 mt -139.7 -52.69 0.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 2.44 110.945 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -176.41 -151.0 8.53 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.739 . . . . 2.26 112.497 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 68.69 -75.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 3.81 110.928 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 110.88 -74.39 0.21 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 2.92 112.509 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -170.99 84.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 2.01 110.853 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.15 171.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 4.54 110.836 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -25.18 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 4.15 110.828 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 0.7 OUTLIER -50.6 108.74 1.1 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.595 0.712 . . . . 2.26 110.808 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.6 Cg_endo -69.75 162.19 43.02 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 2.19 112.336 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 58.36 22.56 9.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 5.47 110.87 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -111.19 158.59 18.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 1.98 111.071 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.86 -23.93 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 3.39 111.157 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -49.46 22.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 4.18 110.881 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -52.34 136.68 40.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.65 0.738 . . . . 4.02 110.859 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 93.9 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.685 2.257 . . . . 2.54 112.323 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.9 t -156.96 153.38 27.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 3.22 111.158 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -110.55 125.86 53.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 3.78 110.908 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.03 96.25 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 4.09 110.841 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -49.9 122.76 6.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 4.16 110.953 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.3 p -120.22 153.49 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 2.76 111.123 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.51 137.03 42.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 4.32 110.911 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.07 -26.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 3.27 111.111 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -64.9 -39.36 93.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 4.32 110.88 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 -10.85 24.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 3.55 111.105 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.58 120.51 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 4.06 110.89 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 175.64 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 4.45 110.917 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.656 ' HB3' HD12 ' A' ' 255' ' ' ILE . 0.8 OUTLIER -87.29 150.98 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 2.23 110.867 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.648 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.2 OUTLIER -154.83 -172.04 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 3.51 110.868 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 66.59 165.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 3.96 111.083 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -20.4 62.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 3.09 110.892 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -51.07 -29.99 14.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 3.36 110.825 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.656 HD12 ' HB3' ' A' ' 250' ' ' LEU . 1.0 OUTLIER -51.2 -29.63 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 2.16 111.156 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 35.8 mtt85 -90.95 -33.83 15.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 6.43 110.855 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.44 -25.8 21.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 2.01 112.49 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.498 HG12 HG21 ' A' ' 145' ' ' THR . 6.5 tp -87.45 -29.17 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.767 0.318 . . . . 1.26 111.14 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -79.37 -37.75 36.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 3.34 110.951 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.6 t -86.97 -32.88 19.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 2.13 110.853 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.8 mp 54.18 87.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 4.35 110.886 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -157.41 163.1 38.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 10.52 110.959 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 119.126 -0.819 . . . . 10.04 112.471 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 48.5 m80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.79 0.329 . . . . 16.46 110.819 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -125.03 149.24 47.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 13.76 110.949 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.731 HD13 ' HB2' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -152.64 152.52 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 5.3 111.071 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.459 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -88.63 116.91 27.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 2.88 111.138 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.497 ' CZ ' HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -137.51 136.27 37.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 8.06 110.889 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.531 ' HG2' ' HB3' ' A' ' 157' ' ' ALA . 29.5 ptt180 -127.9 119.21 25.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 8.92 110.878 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.9 pt -107.99 148.28 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 3.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -157.16 22.86 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 3.44 110.856 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -142.03 153.87 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 4.19 110.924 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -114.67 163.05 15.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 5.1 110.933 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.508 ' OG1' HD21 ' A' ' 212' ' ' LEU . 86.1 m -120.29 133.86 24.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.598 0.713 . . . . 2.9 111.124 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 122' ' ' THR . 53.2 Cg_endo -69.81 -177.6 1.97 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.69 2.26 . . . . 3.15 112.33 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 72.39 -68.64 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 4.6 110.836 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.88 147.7 25.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 4.34 110.857 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -59.36 168.15 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 3.75 110.907 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.06 -22.46 50.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 6.11 110.849 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -63.29 -44.05 96.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 4.31 110.928 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.663 ' OD2' HD12 ' A' ' 212' ' ' LEU . 26.3 t0 -60.15 -53.3 59.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 3.95 110.856 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.854 HG23 HD22 ' A' ' 212' ' ' LEU . 11.4 p -65.76 -29.57 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.86 111.117 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.3 -53.48 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 3.45 110.826 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -69.97 -33.45 72.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 3.64 110.933 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.68 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -54.01 -59.25 4.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.148 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.472 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 3.3 pt -63.48 -28.36 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 3.31 111.101 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -51.1 -59.29 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 5.76 110.874 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.776 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -80.45 -21.44 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 3.38 110.885 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.604 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.2 -54.75 39.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 1.17 111.106 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.511 ' HA ' HD13 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -67.25 -23.27 65.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 5.81 110.875 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.04 -28.14 43.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 3.4 110.921 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 136' ' ' LYS . 90.0 t -68.45 -30.22 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 2.02 111.152 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.616 ' HD1' HD22 ' A' ' 224' ' ' LEU . 15.3 t-105 -93.31 -52.89 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 3.97 110.891 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 p -55.14 -23.04 19.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 1.88 110.817 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.51 -23.64 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 3.71 110.873 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.577 HG21 HG13 ' A' ' 255' ' ' ILE . 9.8 p -125.01 21.65 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 3.58 111.134 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -128.32 134.13 25.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.586 0.707 . . . . 2.02 111.117 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 145' ' ' THR . 54.2 Cg_endo -69.73 -25.56 28.61 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.703 2.269 . . . . 1.89 112.352 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.91 109.57 0.34 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 3.63 110.895 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -121.99 129.6 52.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 5.19 110.852 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.731 ' HB2' HD13 ' A' ' 114' ' ' ILE . 2.6 m-85 -138.02 154.27 49.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 12.16 110.867 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.19 126.37 49.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 3.35 110.903 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -57.87 154.62 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 3.5 110.9 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.36 116.73 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 3.53 111.127 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -39.24 58.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 3.7 110.87 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.5 m -140.6 109.63 6.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 3.06 111.129 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 162.48 -156.12 27.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 1.73 112.532 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -110.88 157.38 19.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 5.21 110.872 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.531 ' HB3' ' HG2' ' A' ' 117' ' ' ARG . . . -133.28 153.63 51.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 1.15 111.088 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.62 -25.64 27.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 3.12 110.869 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 193' ' ' GLY . 26.5 mt -121.39 137.41 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 2.4 111.113 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.65 HD11 ' CG2' ' A' ' 162' ' ' VAL . 1.3 tm? -117.21 120.64 38.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 1.4 110.904 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.639 ' N ' HD22 ' A' ' 160' ' ' LEU . 4.1 t -96.3 121.68 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 1.56 111.1 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.65 ' CG2' HD11 ' A' ' 160' ' ' LEU . 10.9 t -147.87 141.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.4 111.088 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -99.67 135.59 40.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 3.69 110.863 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.63 133.18 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 1.73 111.075 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.33 156.69 18.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 5.48 110.866 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.62 -137.27 31.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 1.09 112.507 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.81 130.29 34.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 1.16 111.107 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -88.58 6.96 35.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 2.63 110.909 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.81 -17.35 55.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 2.54 112.481 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.37 33.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 5.66 110.858 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.43 -167.75 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 4.67 110.856 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -76.3 100.84 5.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 6.2 110.858 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.5 128.44 28.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 1.36 111.078 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -101.51 -168.98 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 6.12 110.929 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -139.22 -41.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 4.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.33 -127.69 8.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 2.56 112.487 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -51.77 119.06 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.814 0.34 . . . . 3.75 110.922 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.32 -33.52 5.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.715 -0.755 . . . . 3.0 112.515 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -109.63 -137.35 7.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.742 . . . . 2.24 112.497 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.2 mm -72.1 135.82 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.348 . . . . 1.99 111.155 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.519 HD22 ' H ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -97.62 -27.24 14.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 4.44 110.882 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.539 ' HB2' ' HH2' ' A' ' 203' ' ' TRP . . . -179.26 124.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 1.81 111.038 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -117.3 171.53 7.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 2.89 110.861 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -176.95 110.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.77 111.085 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.57 157.08 24.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 2.57 110.863 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.18 178.33 0.23 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 1.07 112.477 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -172.99 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.656 2.237 . . . . 1.19 112.355 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 136.49 -127.59 4.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 2.08 112.524 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.23 130.6 52.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 2.5 110.855 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.22 -73.99 1.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.727 -0.749 . . . . 1.8 112.505 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 191' ' ' ILE . 23.4 mt -82.92 -4.12 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 2.74 111.13 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.4 117.61 9.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 2.41 112.508 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.704 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 85.31 -7.64 74.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.786 -0.721 . . . . 1.31 112.459 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.486 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 5.1 m-20 -50.53 139.23 16.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 2.14 110.868 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.62 ' HB1' ' HE1' ' A' ' 197' ' ' PHE . . . -117.15 140.12 49.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 1.32 111.112 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.07 110.62 12.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 4.15 110.842 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.62 ' HE1' ' HB1' ' A' ' 195' ' ' ALA . 12.5 m-85 -116.48 111.74 20.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 2.82 110.919 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.53 119.67 3.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 6.87 110.816 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -50.13 -72.6 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 8.08 110.889 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.11 87.69 4.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 5.35 110.855 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -125.51 -82.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 4.25 110.889 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 172.65 81.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 4.73 110.907 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.539 ' HH2' ' HB2' ' A' ' 182' ' ' ALA . 8.9 m95 -106.64 113.43 26.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 6.37 110.926 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.4 m -156.85 133.28 9.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 2.94 111.084 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.671 ' OG1' HD12 ' A' ' 245' ' ' ILE . 2.1 t -107.36 69.34 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 4.11 111.128 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.74 -70.72 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 9.06 110.887 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.7 m -117.38 -73.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 4.02 110.885 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.27 -1.73 0.76 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 5.44 112.521 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.01 -160.89 0.17 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 3.91 112.495 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.12 95.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.799 0.333 . . . . 2.09 111.147 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.406 ' HB3' ' HB ' ' A' ' 205' ' ' THR . 2.1 m-20 -104.32 150.12 24.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 2.93 110.874 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.854 HD22 HG23 ' A' ' 130' ' ' VAL . 2.5 mt -54.95 -44.73 74.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 2.67 110.942 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.708 ' O ' HG23 ' A' ' 217' ' ' VAL . 31.0 p90 -73.08 -37.17 66.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 5.12 110.901 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.426 HD13 HG11 ' A' ' 243' ' ' VAL . 24.3 tp -64.75 -60.65 2.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 3.02 110.909 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.5 m -57.47 -40.59 78.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 1.12 111.144 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.44 -51.78 67.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.83 111.11 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 213' ' ' PHE . 73.5 t -51.6 -42.35 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.95 111.162 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -56.82 -47.93 79.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 2.07 110.833 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -65.21 -41.97 93.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 4.62 110.91 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.535 HD12 ' HB1' ' A' ' 137' ' ' ALA . 85.5 mt -58.62 -32.4 46.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 1.97 111.115 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.93 -36.82 40.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 1.04 112.495 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -76.42 -39.33 53.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.781 0.324 . . . . 2.93 110.826 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.88 -12.19 61.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 1.8 110.836 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.616 HD22 ' HD1' ' A' ' 141' ' ' TRP . 2.2 mp -114.83 19.8 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.8 132.48 0.97 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 2.25 112.493 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.553 HD22 ' SD ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -179.93 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 3.67 110.909 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 145.18 -120.82 1.42 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.72 -0.752 . . . . 2.66 112.462 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.401 ' HA ' ' HE1' ' A' ' 236' ' ' MET . 0.3 OUTLIER -179.98 37.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.801 0.334 . . . . 3.66 110.855 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.29 -75.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 5.03 110.842 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.55 -168.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 5.59 110.844 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.97 155.51 2.04 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.715 . . . . 2.61 110.871 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -49.25 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.69 2.26 . . . . 2.02 112.36 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -71.72 -27.97 63.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 5.24 110.876 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.35 168.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 2.3 111.139 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.522 HG22 ' OG ' ' A' ' 251' ' ' SER . 17.6 m -87.85 8.44 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 3.76 111.108 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.553 ' SD ' HD22 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -80.72 0.72 33.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 4.38 110.847 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.47 146.12 5.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.616 0.722 . . . . 4.93 110.891 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.98 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.698 2.265 . . . . 3.01 112.319 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.2 m -91.11 164.38 13.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 4.06 111.147 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -62.57 124.98 22.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 4.58 110.95 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.39 123.86 48.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 4.58 110.907 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -54.68 123.14 12.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 7.38 110.914 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.426 HG11 HD13 ' A' ' 214' ' ' LEU . 14.6 p -148.2 136.21 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 2.46 111.138 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.52 123.81 18.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 3.22 110.841 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.671 HD12 ' OG1' ' A' ' 205' ' ' THR . 15.3 tt -60.52 -20.56 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 3.07 111.107 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.21 -15.91 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 3.2 110.88 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.5 m -106.81 1.21 24.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 2.1 111.113 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -51.87 133.82 31.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 4.83 110.873 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -176.79 153.05 1.02 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 3.26 110.887 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 52.9 tp -52.06 160.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 2.81 110.906 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.522 ' OG ' HG22 ' A' ' 235' ' ' VAL . 0.1 OUTLIER -88.81 -172.73 3.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 4.22 110.865 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -93.1 -70.43 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 3.83 111.113 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.55 -32.66 51.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 3.29 110.858 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -30.46 67.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 2.53 110.856 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.577 HG13 HG21 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -54.51 -28.17 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 1.7 111.091 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -82.09 -44.56 16.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 4.28 110.885 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.89 62.53 3.25 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 2.35 112.502 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.508 HD13 ' CZ2' ' A' ' 141' ' ' TRP . 3.6 tp -179.7 -41.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 1.02 111.144 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.559 ' HB2' HG22 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -78.14 -28.21 48.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 3.14 110.901 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.2 t -75.79 -25.04 56.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 1.95 110.894 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 258' ' ' ILE . 6.6 mp -51.81 -74.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 3.37 110.966 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -88.32 -37.98 15.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 13.03 110.906 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 CA-C-O 119.096 -0.835 . . . . 11.35 112.478 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.782 0.325 . . . . 1.8899999999999999 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.762 ' CD2' HG21 ' A' ' 159' ' ' ILE . 44.8 m-85 -127.7 164.02 23.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 8.1099999999999994 110.913 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.9 117.77 2.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 4.2599999999999998 110.889 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.561 ' CG2' HG21 ' A' ' 134' ' ' ILE . 10.2 pt -108.71 148.51 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 3.1200000000000001 111.169 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -168.99 60.5 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 3.8599999999999999 110.853 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.611 ' OD1' HG12 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -144.64 135.65 25.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 5.5099999999999998 110.888 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -147.8 107.07 3.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 6.2300000000000004 110.939 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.1 p -94.24 158.59 35.64 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.63 0.729 . . . . 3.79 111.081 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -178.53 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.713 2.275 . . . . 2.8300000000000001 112.342 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 56.1 24.01 7.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.445 . . . . 3.8900000000000001 110.834 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.2 mmm -165.28 131.29 2.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 3.7400000000000002 110.844 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -66.14 142.01 57.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 2.7999999999999998 110.896 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -61.38 -18.12 57.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 7.5800000000000001 110.848 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.39 -34.78 65.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 3.1099999999999999 110.848 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.5 -45.55 68.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 2.54 110.847 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.568 ' O ' HD12 ' A' ' 134' ' ' ILE . 7.5 p -66.59 -39.08 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.67000000000000004 111.142 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -55.99 -53.67 54.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 2.27 110.827 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -74.72 -32.63 62.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 2.9399999999999999 110.933 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.576 ' CB ' HD22 ' A' ' 212' ' ' LEU . . . -51.17 -57.93 7.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 0.68999999999999995 111.049 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.568 HD12 ' O ' ' A' ' 130' ' ' VAL . 4.2 mp -75.93 -41.15 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 2.3199999999999998 111.111 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -38.08 52.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 4.75 110.882 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.9 OUTLIER -78.45 -26.59 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 2.8500000000000001 110.866 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.77 -32.61 63.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.89000000000000001 111.072 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -74.4 -30.42 61.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 5.25 110.913 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -77.06 -55.11 5.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 2.6000000000000001 110.866 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.505 HG11 ' CG2' ' A' ' 217' ' ' VAL . 3.6 p -52.9 -27.42 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 1.99 111.129 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -89.5 -53.76 4.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 3.8199999999999998 110.925 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -58.98 -19.49 43.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 1.7 110.89 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -50.93 -30.09 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 2.3100000000000001 110.911 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.66 HG11 ' CG1' ' A' ' 255' ' ' ILE . 3.5 m -134.94 61.49 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 2.0800000000000001 111.074 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.718 HG23 HG13 ' A' ' 258' ' ' ILE . 0.1 OUTLIER -156.27 140.55 11.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.598 0.713 . . . . 1.6699999999999999 111.123 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.656 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.9 Cg_endo -69.76 -12.54 33.11 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.641 2.227 . . . . 2.1600000000000001 112.391 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.3 mp -54.63 175.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 2.6899999999999999 110.917 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -118.23 -169.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 5.46 110.888 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -130.69 134.39 46.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 7.5499999999999998 110.907 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -156.86 89.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 2.23 110.868 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 97.95 7.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 4.54 110.892 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 155' ' ' GLY . 14.3 tt -83.49 130.59 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 4.3899999999999997 111.106 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -78.43 -28.48 46.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 3.8199999999999998 110.9 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.436 ' O ' HD11 ' A' ' 152' ' ' ILE . 96.1 m -149.59 120.87 7.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 3.52 111.144 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.643 ' O ' HD13 ' A' ' 152' ' ' ILE . . . 118.87 85.34 0.99 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 2.2799999999999998 112.501 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.77 167.28 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.776 0.322 . . . . 9.9800000000000004 110.901 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.57 -161.99 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 2.9100000000000001 111.11 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -50.77 -25.22 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 2.8199999999999998 110.852 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.762 HG21 ' CD2' ' A' ' 116' ' ' TYR . 46.1 mm -102.5 114.43 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 3.0699999999999998 111.124 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.24 158.03 25.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 2.9700000000000002 110.918 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.774 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 41.7 t -148.03 111.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 1.6299999999999999 111.175 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.9 t -148.51 144.82 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 1.1200000000000001 111.099 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -104.71 136.68 43.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 3.2799999999999998 110.921 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.512 ' HB1' ' ND1' ' A' ' 168' ' ' HIS . . . -142.41 168.38 19.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 1.29 111.134 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.2 111.8 22.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 6.2699999999999996 110.903 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.39 -128.58 27.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 1.24 112.476 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.449 ' N ' ' HB2' ' A' ' 173' ' ' ALA . . . -71.51 110.92 6.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.331 . . . . 1.51 111.158 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.512 ' ND1' ' HB1' ' A' ' 164' ' ' ALA . 0.9 OUTLIER -92.49 41.95 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 3.8900000000000001 110.879 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.9 -53.87 4.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 2.71 112.461 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -145.11 28.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 5.2000000000000002 110.871 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -107.08 -169.55 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 6.1699999999999999 110.864 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -104.83 90.3 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 4.8899999999999997 110.828 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.449 ' HB2' ' N ' ' A' ' 167' ' ' ALA . . . -53.6 149.53 8.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 1.76 111.09 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -120.8 -82.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 6.0199999999999996 110.91 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.97 -170.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 4.1699999999999999 110.856 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -97.59 -160.72 31.09 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.709 -0.758 . . . . 2.1000000000000001 112.508 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -52.97 118.6 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 5.7000000000000002 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 123.61 -54.38 0.72 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.743 -0.741 . . . . 2.4500000000000002 112.484 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.76 -137.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.738 -0.744 . . . . 1.76 112.473 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.3 mt -78.03 90.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.897 0.38 . . . . 2.8799999999999999 111.137 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.592 ' H ' HD22 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -53.04 -33.49 52.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 4.4400000000000004 110.92 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.09 123.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 1.79 111.091 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -138.56 113.8 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 3.4900000000000002 110.864 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -99.27 125.01 44.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 1.1899999999999999 111.099 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -63.61 164.16 10.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 2.2599999999999998 110.867 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.61 169.94 0.25 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.706 -0.759 . . . . 0.94999999999999996 112.527 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -169.37 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.753 2.302 . . . . 1.04 112.332 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.7 -152.02 19.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 1.22 112.506 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m -91.88 148.55 22.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 2.3599999999999999 110.83 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.83 -102.47 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.732 . . . . 1.3600000000000001 112.467 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 72.9 mt -56.11 -35.43 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 1.8500000000000001 111.143 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -52.73 100.46 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 2.3100000000000001 112.456 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 104.33 21.65 9.22 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.759 -0.734 . . . . 1.21 112.484 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.404 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 15.7 m-20 -95.08 139.4 31.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 2.2799999999999998 110.872 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.774 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -100.67 140.4 34.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 1.0700000000000001 111.052 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -128.65 110.52 12.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 4.8300000000000001 110.847 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -113.7 120.16 39.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 2.96 110.9 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -58.99 123.99 18.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 6.7300000000000004 110.874 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -74.74 -48.83 23.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 7.7300000000000004 110.926 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.4 -16.66 56.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 3.8500000000000001 110.867 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 4.3799999999999999 110.896 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.85 95.93 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 4.6699999999999999 110.878 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.506 ' CZ3' HD21 ' A' ' 212' ' ' LEU . 5.1 m0 -79.73 148.57 31.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 7.1699999999999999 110.933 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -148.47 174.31 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 2.5699999999999998 111.13 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.62 -171.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 1.9299999999999999 111.13 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -63.93 -21.52 66.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 4.5199999999999996 110.876 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.3 m -90.61 -49.2 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 2.2599999999999998 110.848 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -52.09 172.37 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 2.1200000000000001 112.516 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -51.73 -88.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 1.5 112.509 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.429 HG21 ' HD1' ' A' ' 203' ' ' TRP . 14.8 m -60.19 99.55 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.78 0.324 . . . . 1.6299999999999999 111.145 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 243' ' ' VAL . 1.9 m-20 -76.46 107.9 9.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 2.4700000000000002 110.891 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.576 HD22 ' CB ' ' A' ' 133' ' ' ALA . 0.6 OUTLIER -57.38 -36.91 71.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 2.0899999999999999 110.905 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.412 ' O ' HG23 ' A' ' 217' ' ' VAL . 11.0 m-85 -71.13 -64.35 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 4.9299999999999997 110.827 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.547 HD13 HG12 ' A' ' 243' ' ' VAL . 5.3 tp -51.67 -49.51 62.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 2.04 110.965 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 96.4 m -55.32 -48.79 73.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.71999999999999997 111.143 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.82 -31.88 63.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.68999999999999995 111.125 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.632 HG21 ' CE1' ' A' ' 248' ' ' PHE . 60.4 t -77.7 -31.87 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.62 111.16 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -75.12 -41.75 57.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 2.04 110.868 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -71.0 -43.44 67.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 4.6500000000000004 110.876 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 217' ' ' VAL . 9.9 tt -64.72 -29.88 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 2.1299999999999999 111.153 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -68.7 -42.63 79.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 0.84999999999999998 112.48 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -65.19 -23.7 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.339 . . . . 2.3300000000000001 110.904 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.79 30.38 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 1.76 110.83 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -61.65 0.68 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 2.4700000000000002 110.951 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 179.7 32.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 2.1299999999999999 112.475 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.15 149.46 27.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.814 0.34 . . . . 2.5299999999999998 110.919 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -78.16 -98.7 0.21 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.748 . . . . 2.6299999999999999 112.528 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -178.76 40.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.846 0.355 . . . . 2.9500000000000002 110.822 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 230' ' ' SER . 0.6 OUTLIER -179.53 -71.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 4.3499999999999996 110.893 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 229' ' ' SER . 47.6 t 65.56 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 6.0199999999999996 110.864 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.22 156.84 75.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.588 0.708 . . . . 2.9300000000000002 110.889 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -49.12 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.679 2.252 . . . . 2.27 112.378 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -34.31 73.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 3.9199999999999999 110.894 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 252' ' ' ALA . . . -51.6 153.32 2.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 2.23 111.104 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.725 HG13 ' HE2' ' A' ' 241' ' ' LYS . 3.9 t -87.51 7.7 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 4.0499999999999998 111.151 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -17.36 35.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 4.6699999999999999 110.892 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.94 143.31 15.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.635 0.731 . . . . 4.3399999999999999 110.915 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 76.57 1.14 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.628 2.219 . . . . 2.29 112.33 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.6 t -157.05 168.8 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 2.4300000000000002 111.142 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -110.43 112.62 24.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 3.8100000000000001 110.924 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.725 ' HE2' HG13 ' A' ' 235' ' ' VAL . 8.2 pttt -140.69 147.46 39.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 3.4500000000000002 110.851 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -106.84 125.82 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 3.4300000000000002 110.905 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.547 HG12 HD13 ' A' ' 214' ' ' LEU . 7.1 p -121.26 154.72 25.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 2.2200000000000002 111.168 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.07 125.91 25.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 2.8300000000000001 110.897 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.63 -24.49 34.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 2.54 111.106 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -60.29 -39.66 87.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 3.75 110.896 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 51.9 p -105.43 1.89 28.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 2.3999999999999999 111.187 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.632 ' CE1' HG21 ' A' ' 217' ' ' VAL . 2.7 t80 -52.02 111.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 3.9399999999999999 110.854 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -174.52 157.37 2.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 3.1000000000000001 110.892 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 251' ' ' SER . 0.4 OUTLIER -58.84 150.6 23.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 2.04 110.893 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.564 ' H ' HD23 ' A' ' 250' ' ' LEU . 1.5 t -154.58 -172.6 4.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 3.5899999999999999 110.854 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.579 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . . . 65.13 176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 3.1299999999999999 111.134 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.96 -22.08 66.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 3.71 110.888 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -50.77 -29.57 11.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 3.3900000000000001 110.91 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.66 ' CG1' HG11 ' A' ' 144' ' ' VAL . 1.1 tt -52.74 -29.56 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 1.98 111.105 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -21.03 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 5.0700000000000003 110.905 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.97 -6.04 81.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 1.73 112.492 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.718 HG13 HG23 ' A' ' 145' ' ' THR . 3.7 tp -106.98 -34.99 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 1.29 111.144 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -78.59 -37.38 42.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 3.6699999999999999 110.891 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 2.98 110.829 -179.802 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.47 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.774 0.321 . . . . 2.3599999999999999 111.159 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.64 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 33.7 p90 -128.67 159.53 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 4.8700000000000001 110.872 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -161.65 153.92 19.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 4.4199999999999999 110.883 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 26.1 mt -107.79 148.91 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 1.8 111.121 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.489 ' CB ' HG22 ' A' ' 162' ' ' VAL . 1.0 OUTLIER -115.76 -75.02 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 3.4500000000000002 110.928 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.411 HD22 ' N ' ' A' ' 120' ' ' ASN . 1.5 m-80 -98.98 175.9 5.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 5.3499999999999996 110.906 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -144.04 163.32 33.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 6.9900000000000002 110.864 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.882 HG21 HD11 ' A' ' 212' ' ' LEU . 26.5 p -76.88 113.77 33.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.59 0.709 . . . . 2.8700000000000001 111.139 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.71 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.255 . . . . 2.79 112.358 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -57.63 -28.46 63.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 3.4399999999999999 110.874 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -101.29 152.77 20.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 3.0600000000000001 110.869 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -60.95 143.52 54.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 3.3300000000000001 110.886 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.0 ptt-85 -56.83 -24.3 50.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 6.9800000000000004 110.867 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.76 -44.91 19.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 3.9399999999999999 110.924 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.12 -51.32 68.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 2.3599999999999999 110.884 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.633 ' O ' HD12 ' A' ' 134' ' ' ILE . 7.3 p -68.6 -38.18 78.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.91000000000000003 111.171 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.81 -54.45 44.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 3.9700000000000002 110.879 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -73.55 -32.34 64.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 2.6600000000000001 110.911 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.94 -57.56 8.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.70999999999999996 111.091 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.633 HD12 ' O ' ' A' ' 130' ' ' VAL . 3.7 mp -76.76 -40.11 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 2.3799999999999999 111.161 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -54.5 -30.77 54.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 4.3300000000000001 110.885 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 140' ' ' VAL . 1.5 mptp? -78.45 -25.21 45.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 3.73 110.925 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.91 -34.19 65.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 1.1699999999999999 111.118 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.82 -30.52 61.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 4.0 110.904 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -55.72 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 3.7999999999999998 110.873 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.754 HG11 HG22 ' A' ' 217' ' ' VAL . 5.1 p -49.35 -34.01 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.04 111.184 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.541 ' CZ2' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -80.28 -54.44 5.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 6.1600000000000001 110.932 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.8 t -55.22 -26.63 40.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 2.4399999999999999 110.841 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -53.25 -39.38 63.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 3.6400000000000001 110.91 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 m -123.31 18.09 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 2.52 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.456 HG21 HG12 ' A' ' 258' ' ' ILE . 16.4 p -144.83 152.93 53.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.708 . . . . 3.0699999999999998 111.158 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -87.84 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.672 2.248 . . . . 3.5 112.313 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 53.18 -175.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 3.3500000000000001 110.911 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -142.35 138.14 31.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 4.0300000000000002 110.85 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -112.48 128.18 56.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 6.9500000000000002 110.898 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.6 t -156.77 89.62 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 1.8899999999999999 110.868 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 131.84 39.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 2.3799999999999999 110.899 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.424 HD12 ' HA3' ' A' ' 155' ' ' GLY . 10.5 pt -148.88 124.78 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 2.5 111.16 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -60.67 -23.67 65.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 4.1500000000000004 110.896 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.3 m -133.9 112.03 10.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 2.8999999999999999 111.163 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.424 ' HA3' HD12 ' A' ' 152' ' ' ILE . . . 170.62 -179.05 42.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.789 -0.72 . . . . 1.5700000000000001 112.514 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.6 mtm -110.67 127.54 55.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.32 . . . . 4.9500000000000002 110.888 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -122.95 130.06 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 1.0800000000000001 111.097 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -19.66 64.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 3.1800000000000002 110.874 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 mm -103.5 84.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 3.0 111.106 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.3 tm? -87.96 115.94 25.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 1.4399999999999999 110.919 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.568 ' N ' HD22 ' A' ' 160' ' ' LEU . 94.7 t -100.71 110.27 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 1.6299999999999999 111.131 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.554 ' CG2' HD11 ' A' ' 160' ' ' LEU . 50.2 t -137.53 143.09 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 1.1599999999999999 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -81.0 115.5 20.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 5.4900000000000002 110.868 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.675 ' HB1' ' NE2' ' A' ' 168' ' ' HIS . . . -101.08 154.83 18.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 1.8999999999999999 111.064 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.49 118.68 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 5.21 110.885 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.88 -128.15 32.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 1.1799999999999999 112.505 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.65 119.05 23.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 2.1499999999999999 111.11 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.675 ' NE2' ' HB1' ' A' ' 164' ' ' ALA . 0.7 OUTLIER -95.1 41.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 5.7699999999999996 110.87 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.93 -43.5 2.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 3.1000000000000001 112.462 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.23 61.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 5.6699999999999999 110.884 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.82 -168.42 2.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 4.0700000000000003 110.892 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -76.59 95.96 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 5.1699999999999999 110.892 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.93 138.1 58.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 1.8500000000000001 111.123 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -136.67 106.85 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 6.4500000000000002 110.925 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.67 168.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 4.0300000000000002 110.834 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.96 -133.59 2.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 2.0699999999999998 112.467 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -51.45 119.04 3.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.759 0.314 . . . . 4.4000000000000004 110.901 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 114.06 28.65 3.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 4.79 112.492 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.17 -137.17 3.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 2.1099999999999999 112.488 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.0 mm -76.88 123.38 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.346 . . . . 1.9299999999999999 111.107 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.527 ' H ' HD22 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -95.43 -12.06 26.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.469 . . . . 4.5800000000000001 110.932 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.77 132.57 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 1.77 111.091 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.09 110.18 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 2.9500000000000002 110.905 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.551 ' HB2' ' OE2' ' A' ' 219' ' ' GLU . . . -126.87 112.02 14.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.68000000000000005 111.113 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.9 170.12 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 2.5499999999999998 110.899 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.46 169.41 0.27 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.75 112.476 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -171.18 0.44 Allowed 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.736 2.291 . . . . 0.81999999999999995 112.317 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.33 -145.71 16.56 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 1.1299999999999999 112.477 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.8 m -92.17 153.52 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 1.95 110.908 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.51 -107.32 0.41 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 1.1899999999999999 112.497 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.18 -24.77 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 2.1000000000000001 111.111 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.09 96.95 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.736 -0.745 . . . . 2.4500000000000002 112.51 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 117.8 -16.55 12.26 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.772 -0.728 . . . . 1.1299999999999999 112.475 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.432 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 8.6 m-20 -50.43 145.04 6.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.821 0.343 . . . . 2.2799999999999998 110.882 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -133.57 133.45 42.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.88 111.101 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -121.77 109.96 15.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 2.4700000000000002 110.853 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -90.24 111.8 23.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 2.9100000000000001 110.888 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.51 99.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 5.96 110.829 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -75.56 69.93 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 9.5600000000000005 110.836 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 43.6 t0 64.67 20.4 12.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 3.8399999999999999 110.884 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.4 18.37 19.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 4.4000000000000004 110.862 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.09 153.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 6.0099999999999998 110.867 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.409 ' CD1' HG22 ' A' ' 122' ' ' THR . 1.7 m-90 -105.74 173.7 6.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 6.8700000000000001 110.899 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.419 HG21 ' H ' ' A' ' 209' ' ' GLY . 0.0 OUTLIER -157.13 172.86 17.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 2.1299999999999999 111.092 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.74 -170.55 2.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 2.25 111.113 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.652 ' HB3' HD13 ' A' ' 245' ' ' ILE . 20.9 p-80 -61.66 -20.72 63.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 4.3099999999999996 110.872 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.42 -36.41 9.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 2.0899999999999999 110.883 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.94 -179.68 0.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.789 -0.72 . . . . 2.4199999999999999 112.477 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.419 ' H ' HG21 ' A' ' 204' ' ' THR . . . -54.08 -91.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 1.77 112.492 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 92.0 m -70.5 98.84 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.352 . . . . 1.99 111.139 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.06 111.07 1.78 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 2.6200000000000001 110.891 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.882 HD11 HG21 ' A' ' 122' ' ' THR . 0.6 OUTLIER -56.66 -34.21 67.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 2.2200000000000002 110.938 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.424 ' CE2' HD12 ' A' ' 245' ' ' ILE . 9.7 m-85 -71.85 -64.86 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 5.4100000000000001 110.882 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -53.7 -46.45 70.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 3.1200000000000001 110.906 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 77.3 m -54.91 -40.12 69.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.93000000000000005 111.145 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 134' ' ' ILE . . . -55.85 -32.27 63.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.081 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.754 HG22 HG11 ' A' ' 140' ' ' VAL . 29.5 t -82.53 -34.49 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.78000000000000003 111.101 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -71.41 -38.85 71.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 2.0600000000000001 110.872 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.551 ' OE2' ' HB2' ' A' ' 184' ' ' ALA . 1.6 tm-20 -74.44 -52.89 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 3.8999999999999999 110.859 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 9.9 tt -51.93 -32.53 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.484 . . . . 2.0899999999999999 111.096 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.26 -34.14 46.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.752 . . . . 0.96999999999999997 112.455 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -25.61 67.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.798 0.332 . . . . 2.77 110.842 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.498 ' O ' HD22 ' A' ' 224' ' ' LEU . 0.4 OUTLIER -95.47 24.9 4.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 2.04 110.842 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 223' ' ' SER . 0.8 OUTLIER -135.43 -64.75 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 2.9300000000000002 110.916 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.419 ' O ' HD23 ' A' ' 226' ' ' LEU . . . 170.87 48.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.726 . . . . 1.9199999999999999 112.496 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.541 HD12 ' CZ2' ' A' ' 141' ' ' TRP . 56.4 mt -145.23 -74.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.389 . . . . 3.48 110.886 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 57.1 -102.51 0.21 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 4.4199999999999999 112.495 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -119.32 119.27 33.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 2.27 110.857 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 11.0 t -99.14 -80.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 4.1799999999999997 110.874 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.19 -38.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 4.2699999999999996 110.872 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.702 ' OD2' ' HB1' ' A' ' 252' ' ' ALA . 0.5 OUTLIER -47.41 107.41 0.72 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.61 0.719 . . . . 2.3900000000000001 110.828 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 54.2 Cg_endo -69.73 -44.42 2.11 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.647 2.231 . . . . 1.97 112.341 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -32.02 70.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 4.5599999999999996 110.881 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . . . -71.63 170.65 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 2.6299999999999999 111.1 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.5 m -95.96 8.15 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 5.1799999999999997 111.092 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.425 ' CE ' HD22 ' A' ' 226' ' ' LEU . 1.2 tmm? -89.18 3.14 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 3.5800000000000001 110.892 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 160.09 0.52 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.667 0.746 . . . . 8.75 110.849 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -30.33 22.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.66 2.24 . . . . 2.9300000000000002 112.353 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.8 p -84.84 169.33 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 2.8199999999999998 111.162 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -119.6 114.73 22.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 10.82 110.901 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.534 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.2 OUTLIER -126.28 133.18 51.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 3.2799999999999998 110.888 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -61.6 125.63 24.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 3.29 110.929 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 241' ' ' LYS . 12.5 t -133.06 155.27 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 2.2000000000000002 111.144 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.15 112.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 2.7400000000000002 110.928 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.652 HD13 ' HB3' ' A' ' 206' ' ' HIS . 31.2 pt -76.58 -13.89 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 3.0499999999999998 111.099 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.56 -26.85 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 3.4300000000000002 110.863 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 46.0 p -120.99 20.6 11.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 2.8900000000000001 111.096 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.66 148.5 40.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 3.79 110.893 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 179.98 147.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 3.1800000000000002 110.919 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.613 HD23 ' N ' ' A' ' 251' ' ' SER . 7.0 tt -74.89 144.27 43.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 2.3999999999999999 110.905 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.613 ' N ' HD23 ' A' ' 250' ' ' LEU . 14.9 m -154.6 -172.03 4.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 3.9399999999999999 110.861 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.702 ' HB1' ' OD2' ' A' ' 231' ' ' ASP . . . 67.11 -171.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 2.9100000000000001 111.076 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.73 -23.59 30.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 3.54 110.861 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 252' ' ' ALA . 4.2 m-20 -52.87 -29.75 29.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 3.2999999999999998 110.875 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 252' ' ' ALA . 17.8 tt -68.55 -31.25 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 1.73 111.144 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -32.71 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 5.1799999999999997 110.861 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.61 -17.13 47.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 1.5600000000000001 112.477 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 145' ' ' THR . 6.0 tp -110.9 -35.81 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 1.04 111.186 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -73.53 -24.75 60.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 3.0800000000000001 110.877 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 2.2400000000000002 110.868 -179.779 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.4 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.81 0.338 . . . . 2.3100000000000001 111.146 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.793 ' HB2' HD11 ' A' ' 159' ' ' ILE . 15.7 p90 -152.05 141.42 21.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 4.8200000000000003 110.898 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.13 150.24 29.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 4.6799999999999997 110.871 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.7 mt -108.01 148.88 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 1.8600000000000001 111.151 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' CB ' HG22 ' A' ' 162' ' ' VAL . 38.4 t-20 -102.68 -71.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 3.6499999999999999 110.868 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.27 172.48 7.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 5.6699999999999999 110.905 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.677 ' HB2' HG11 ' A' ' 130' ' ' VAL . 18.3 p90 -127.45 164.34 22.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 5.4199999999999999 110.949 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.553 ' OG1' HD11 ' A' ' 212' ' ' LEU . 0.7 OUTLIER -52.41 129.21 42.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.566 0.698 . . . . 2.5499999999999998 111.127 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 133.55 25.83 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.678 2.252 . . . . 2.4100000000000001 112.346 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 t70 67.74 11.5 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 6.1299999999999999 110.864 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.5 tpt -106.09 152.54 23.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 3.1400000000000001 110.869 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -58.7 115.73 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 3.73 110.892 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -59.71 -20.18 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 5.46 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -80.15 -39.43 29.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.204 -0.453 . . . . 3.8700000000000001 110.9 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.51 -46.25 60.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 3.3100000000000001 110.897 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.755 ' O ' HD12 ' A' ' 134' ' ' ILE . 13.9 p -65.98 -35.28 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.94999999999999996 111.086 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.61 -54.61 37.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 3.0299999999999998 110.879 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -71.36 -32.38 68.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 2.7999999999999998 110.905 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -51.29 -51.96 49.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.69999999999999996 111.163 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 130' ' ' VAL . 2.7 mp -82.73 -46.01 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 2.4199999999999999 111.13 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -50.44 -45.49 55.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 6.5499999999999998 110.86 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -20.4 51.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 3.0299999999999998 110.883 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.6 -35.43 65.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.83999999999999997 111.093 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -72.42 -24.83 61.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 5.1900000000000004 110.894 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -31.5 60.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 3.4500000000000002 110.936 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 217' ' ' VAL . 21.7 t -58.49 -30.93 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 2.0299999999999998 111.108 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.755 ' O ' HG22 ' A' ' 145' ' ' THR . 0.7 OUTLIER -94.57 -32.72 13.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 4.0 110.92 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -63.68 -15.74 59.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 2.1800000000000002 110.857 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -83.0 -12.79 56.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 2.1699999999999999 110.946 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 258' ' ' ILE . 4.6 p -118.84 -28.46 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 3.2799999999999998 111.136 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 141' ' ' TRP . 15.0 t -107.22 141.65 23.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.581 0.705 . . . . 2.7799999999999998 111.19 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -6.07 17.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.656 2.238 . . . . 2.4100000000000001 112.347 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.2 tp -49.86 161.01 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 2.4500000000000002 110.915 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.28 138.06 54.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 5.4100000000000001 110.915 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -114.38 128.65 56.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 8.8499999999999996 110.896 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.27 99.86 4.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 2.1000000000000001 110.853 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 103.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 2.4100000000000001 110.877 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 tt -97.28 135.28 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 3.8999999999999999 111.115 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -102.52 41.71 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 3.2200000000000002 110.891 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.98 169.77 7.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 3.5299999999999998 111.119 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.08 -169.76 0.54 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 1.99 112.486 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.3 mtm -108.48 148.19 30.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 6.8099999999999996 110.87 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.2 159.91 16.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 1.1399999999999999 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.87 -44.72 67.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 2.4300000000000002 110.906 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' A' ' 116' ' ' TYR . 2.1 pp -104.02 140.78 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 3.5299999999999998 111.114 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.632 HD11 ' CG2' ' A' ' 162' ' ' VAL . 1.0 OUTLIER -129.2 115.27 17.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 1.5 110.934 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.616 ' N ' HD22 ' A' ' 160' ' ' LEU . 93.1 t -94.81 119.38 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 1.4399999999999999 111.133 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.632 ' CG2' HD11 ' A' ' 160' ' ' LEU . 11.7 t -138.47 140.91 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 1.1399999999999999 111.176 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.62 102.97 14.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 4.7000000000000002 110.854 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.67 177.35 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 1.71 111.108 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -135.64 111.74 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 3.8799999999999999 110.825 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 72.82 -135.78 22.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.737 . . . . 1.6100000000000001 112.497 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.16 110.96 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.334 . . . . 1.4099999999999999 111.081 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -70.61 -15.64 62.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 3.1299999999999999 110.871 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.04 -25.09 14.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 2.75 112.487 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -80.27 -74.81 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.351 . . . . 6.0300000000000002 110.872 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -178.68 33.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 7.0300000000000002 110.859 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -129.18 64.93 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 4.5899999999999999 110.825 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.26 145.43 30.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 1.99 111.101 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -54.93 174.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 10.24 110.907 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -137.99 9.95 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 5.3700000000000001 110.881 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.91 139.81 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.708 -0.758 . . . . 2.0899999999999999 112.489 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 119.23 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.366 . . . . 3.4300000000000002 110.873 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 124.09 -18.48 7.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.718 -0.753 . . . . 2.8599999999999999 112.495 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -117.65 -125.96 3.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 1.8799999999999999 112.498 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.407 ' H ' HD12 ' A' ' 180' ' ' ILE . 4.7 mp -79.23 93.27 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 1.9299999999999999 111.125 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.9 pp -50.43 -26.43 5.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 3.5600000000000001 110.906 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.725 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.45 168.9 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 1.8799999999999999 111.101 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.87 130.8 53.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 3.0600000000000001 110.867 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -142.1 103.71 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.97999999999999998 111.072 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.28 165.53 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 2.5299999999999998 110.885 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -56.51 -176.74 0.31 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 0.82999999999999996 112.477 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.703 2.269 . . . . 0.81000000000000005 112.313 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.13 -149.46 17.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 1.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.7 p -91.73 151.73 20.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 2.7400000000000002 110.823 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 50.35 -103.98 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 1.1499999999999999 112.478 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 30.7 mm -57.02 -25.98 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.371 . . . . 2.5699999999999998 111.142 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.33 100.1 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 2.5299999999999998 112.536 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.436 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . 115.2 -15.44 18.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.739 -0.743 . . . . 1.0 112.469 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.22 145.17 8.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.778 0.323 . . . . 2.1200000000000001 110.844 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.54 ' HB3' HG22 ' A' ' 161' ' ' VAL . . . -136.95 128.69 28.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.88 111.1 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.423 ' CB ' ' HB1' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -113.09 123.59 50.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 2.71 110.85 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.52 143.83 41.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 4.0300000000000002 110.913 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.67 -77.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 5.79 110.879 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 66.94 41.22 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 7.5199999999999996 110.914 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.9 t0 66.18 47.5 1.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 3.3199999999999998 110.836 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.78 -77.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 4.5899999999999999 110.834 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.83 138.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 4.1399999999999997 110.873 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -106.28 138.95 41.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 9.3800000000000008 110.92 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.45 165.68 35.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 1.71 111.173 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -170.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 2.04 111.162 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -57.24 -46.6 82.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 4.3200000000000003 110.888 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.54 -34.84 40.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 2.48 110.901 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -50.87 170.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 2.29 112.539 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -45.13 -83.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 1.73 112.527 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.13 97.56 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 2.3500000000000001 111.134 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -61.49 113.14 2.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 3.3500000000000001 110.897 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.553 HD11 ' OG1' ' A' ' 122' ' ' THR . 1.1 tt -71.57 -35.91 70.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 2.29 110.975 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.485 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 7.8 t80 -71.34 -35.94 71.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 4.4800000000000004 110.867 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.428 HD12 ' CD1' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -81.78 -48.55 11.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 2.3199999999999998 110.914 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.499 ' CG2' HD22 ' A' ' 181' ' ' LEU . 53.3 m -55.25 -28.83 55.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.97999999999999998 111.148 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.424 ' HB1' ' HA ' ' A' ' 134' ' ' ILE . . . -69.38 -46.06 67.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.78000000000000003 111.072 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.571 HG21 ' CE2' ' A' ' 248' ' ' PHE . 19.1 t -60.86 -42.71 93.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.83999999999999997 111.124 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -54.1 -34.66 60.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 1.96 110.855 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -29.6 61.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 4.2999999999999998 110.894 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.655 ' O ' HD13 ' A' ' 224' ' ' LEU . 51.3 mm -56.24 -59.87 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 1.52 111.127 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.65 -31.75 79.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.82999999999999996 112.487 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -44.49 86.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 2.73 110.895 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.409 ' O ' HD12 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -95.75 24.95 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 1.6799999999999999 110.879 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.655 HD13 ' O ' ' A' ' 220' ' ' ILE . 4.4 mp -127.97 -38.5 1.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 2.0499999999999998 110.924 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 161.73 -54.74 0.31 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 2.1800000000000002 112.475 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.732 HD12 ' HB ' ' A' ' 258' ' ' ILE . 1.6 mt -73.2 -178.57 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 3.3100000000000001 110.913 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 156.31 -94.93 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 3.8999999999999999 112.499 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -96.12 98.3 10.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.768 0.318 . . . . 2.0699999999999998 110.879 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.8 m -101.35 -75.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 4.6500000000000004 110.845 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.65 -33.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 4.5199999999999996 110.893 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.503 ' CG ' ' HB1' ' A' ' 252' ' ' ALA . 12.7 m-20 -47.91 107.57 0.76 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.581 0.705 . . . . 3.1000000000000001 110.875 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -41.83 3.95 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 2.9399999999999999 112.376 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.42 46.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 4.8799999999999999 110.904 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.718 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -136.58 174.45 10.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 1.6899999999999999 111.119 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.447 ' O ' HG22 ' A' ' 235' ' ' VAL . 9.3 p -95.46 7.6 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 2.8999999999999999 111.129 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.409 ' HB2' ' HE2' ' A' ' 236' ' ' MET . 1.8 mpp? -87.32 -48.47 7.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 5.1200000000000001 110.877 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.8 139.86 21.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.741 . . . . 5.0099999999999998 110.882 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 79.1 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.713 2.275 . . . . 2.52 112.311 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 239' ' ' THR . 4.5 t -157.02 118.61 3.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 2.7400000000000002 111.144 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -70.22 131.05 43.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 3.4300000000000002 110.896 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 243' ' ' VAL . 1.2 pttt -162.85 93.23 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 3.6600000000000001 110.923 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -50.87 119.64 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.448 . . . . 3.75 110.929 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 241' ' ' LYS . 18.1 t -114.82 152.09 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 2.4900000000000002 111.12 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.79 113.25 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 2.7599999999999998 110.893 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -57.42 -37.98 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 2.3700000000000001 111.188 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.68 -28.41 68.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 3.5499999999999998 110.877 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 30.0 p -115.65 17.94 16.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 2.9100000000000001 111.15 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.571 ' CE2' HG21 ' A' ' 217' ' ' VAL . 15.8 t80 -82.53 121.69 27.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 5.2199999999999998 110.889 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -164.65 151.81 11.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 3.8799999999999999 110.835 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.69 HD13 ' N ' ' A' ' 251' ' ' SER . 3.1 tm? -55.07 139.1 42.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 2.5499999999999998 110.871 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.69 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.3 OUTLIER -150.35 -171.09 3.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 3.2000000000000002 110.829 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.718 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 70.7 165.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 3.8599999999999999 111.099 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -59.31 -20.46 54.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 2.6400000000000001 110.868 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -50.06 -29.4 8.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 3.6800000000000002 110.89 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.573 HD12 HD12 ' A' ' 250' ' ' LEU . 7.4 tt -51.98 -29.04 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 1.72 111.11 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -83.4 -31.16 26.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 4.7699999999999996 110.866 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.74 -24.64 69.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 1.97 112.491 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.732 ' HB ' HD12 ' A' ' 226' ' ' LEU . 4.1 tp -102.88 -30.98 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 1.3700000000000001 111.144 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -61.67 -36.55 81.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 2.8999999999999999 110.907 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 3.3399999999999999 110.863 -179.801 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.538 ' HB ' HD12 ' A' ' 152' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.834 0.349 . . . . 2.25 111.178 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.686 ' HB3' HD11 ' A' ' 159' ' ' ILE . 43.6 p90 -149.84 162.62 39.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 4.8799999999999999 110.93 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -161.94 138.09 7.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 4.7599999999999998 110.86 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 1.033 HG22 HG21 ' A' ' 161' ' ' VAL . 18.0 pt -107.75 136.06 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 2.6000000000000001 111.143 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -151.59 43.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 3.46 110.948 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.76 151.41 51.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 5.2699999999999996 110.85 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -144.06 129.92 19.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 5.3399999999999999 110.94 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.58 159.5 58.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.616 0.722 . . . . 2.1600000000000001 111.144 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -86.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.68 2.253 . . . . 2.3199999999999998 112.338 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.92 75.58 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 4.2400000000000002 110.892 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.4 tpt -165.16 138.36 4.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 2.8999999999999999 110.863 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.27 120.01 8.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 4.1900000000000004 110.892 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -60.96 -19.37 60.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 5.2400000000000002 110.863 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -78.86 -29.24 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 3.1099999999999999 110.902 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.3 -44.82 24.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 2.8300000000000001 110.9 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.494 HG23 HD21 ' A' ' 212' ' ' LEU . 5.8 p -58.93 -43.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.92000000000000004 111.113 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 130' ' ' VAL . 7.8 t70 -55.48 -45.7 76.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 3.1299999999999999 110.917 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -74.65 -32.49 62.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 2.1800000000000002 110.878 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -51.83 -44.58 63.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 1.1799999999999999 111.087 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.62 HG21 HG21 ' A' ' 161' ' ' VAL . 2.8 mm -83.06 -48.83 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.414 . . . . 2.3999999999999999 111.136 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -50.62 -44.99 57.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 3.5499999999999998 110.889 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.763 ' O ' HG23 ' A' ' 140' ' ' VAL . 3.3 mttm -78.22 -20.52 51.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 3.04 110.931 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.754 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.34 -40.88 71.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 1.1200000000000001 111.126 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -48.24 34.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 3.9199999999999999 110.874 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -52.39 -28.65 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 3.6200000000000001 110.926 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.792 HG11 HG11 ' A' ' 217' ' ' VAL . 97.7 t -55.79 -56.43 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 2.04 111.143 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -82.15 -40.72 21.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 3.9399999999999999 110.886 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.79 -24.45 35.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 1.79 110.867 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -75.28 -27.39 59.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 2.5499999999999998 110.851 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 250' ' ' LEU . 32.9 m -132.05 41.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 2.8300000000000001 111.112 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 36.3 m -150.94 132.37 7.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.689 . . . . 1.97 111.189 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 70.09 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.669 2.246 . . . . 2.9700000000000002 112.325 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.538 HD22 HD21 ' A' ' 224' ' ' LEU . 1.6 tp -138.29 -171.88 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 2.7799999999999998 110.863 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -128.23 142.34 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 5.0300000000000002 110.876 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.85 122.52 20.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 7.0199999999999996 110.844 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 t -156.82 112.21 2.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 3.0 110.877 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.55 107.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 2.7400000000000002 110.949 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 154' ' ' THR . 26.6 mt -91.57 144.41 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 3.5600000000000001 111.142 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -94.7 22.86 5.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 5.1299999999999999 110.906 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.54 ' H ' HG22 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -110.17 167.77 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 5.6699999999999999 111.129 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 154' ' ' THR . . . -79.37 -0.09 82.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 2.6400000000000001 112.487 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 10.7 mtt -83.15 100.34 10.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.726 0.298 . . . . 7.0099999999999998 110.859 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -148.36 129.83 14.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 1.3999999999999999 111.1 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.49 -26.53 41.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 2.77 110.847 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 116' ' ' TYR . 22.4 pt -123.98 142.5 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.205 -0.452 . . . . 2.52 111.154 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.774 HD23 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -133.17 164.13 27.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 2.2200000000000002 110.894 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 1.033 HG21 HG22 ' A' ' 118' ' ' ILE . 8.6 t -121.93 115.64 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 1.52 111.096 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.774 HG23 HD23 ' A' ' 160' ' ' LEU . 39.4 t -145.18 142.08 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 1.4099999999999999 111.135 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -105.39 133.97 49.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 3.5600000000000001 110.926 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.28 142.18 6.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 1.8899999999999999 111.076 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -107.25 167.21 10.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 4.9000000000000004 110.888 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.94 -141.08 25.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 1.4399999999999999 112.451 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.13 148.68 48.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 2.1000000000000001 111.072 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -115.68 22.25 13.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 3.4100000000000001 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.45 14.53 62.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.669 -0.777 . . . . 3.4100000000000001 112.49 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.56 -75.95 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.778 0.323 . . . . 6.3899999999999997 110.807 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.34 62.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 4.6699999999999999 110.872 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -137.7 42.57 2.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 6.4299999999999997 110.841 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 118.86 22.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 1.48 111.095 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -179.07 98.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 8.0099999999999998 110.926 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.88 -175.77 4.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 5.75 110.855 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.42 106.97 2.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 2.0299999999999998 112.502 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -50.31 119.39 3.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.337 . . . . 4.46 110.896 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.76 -27.76 19.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.752 -0.737 . . . . 2.6800000000000002 112.505 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -81.48 -140.0 2.9 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 1.4299999999999999 112.453 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.9 mm -80.63 92.46 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.36 . . . . 2.0899999999999999 111.122 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.705 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.5 pp -44.81 -33.77 2.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 3.3799999999999999 110.918 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.705 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.96 179.79 0.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 1.77 111.122 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.87 128.5 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 6.4199999999999999 110.891 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.08 123.65 38.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.87 111.097 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.404 ' CB ' HG22 ' A' ' 191' ' ' ILE . 0.1 OUTLIER -64.5 169.96 4.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 2.4199999999999999 110.839 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.34 177.16 0.32 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 0.84999999999999998 112.501 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 160.1 50.97 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.77000000000000002 112.314 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 152.49 -146.41 14.97 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 1.29 112.471 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 99.0 p -107.46 124.45 49.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.91 0.386 . . . . 2.0299999999999998 110.857 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.93 -57.65 3.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.699 -0.762 . . . . 1.75 112.506 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.503 ' O ' HG22 ' A' ' 191' ' ' ILE . 12.6 mm -100.6 22.08 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 1.95 111.125 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.78 -114.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 3.1800000000000002 112.479 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.425 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . -94.29 42.76 2.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 1.3200000000000001 112.499 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.402 ' HA ' HD13 ' A' ' 160' ' ' LEU . 2.8 m-20 -61.35 127.14 30.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 1.98 110.868 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.779 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -88.72 131.77 34.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 1.3799999999999999 111.145 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -125.45 137.73 53.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 2.8300000000000001 110.866 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.491 ' HE1' ' HB1' ' A' ' 195' ' ' ALA . 59.4 m-85 -139.97 102.75 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 2.71 110.884 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -52.39 120.98 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 6.7000000000000002 110.914 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -67.78 -29.19 68.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 8.1899999999999995 110.893 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -78.29 -19.36 53.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 4.7400000000000002 110.867 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -177.48 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 3.8599999999999999 110.907 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -118.35 109.51 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 4.6600000000000001 110.925 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -101.93 122.21 43.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 6.6299999999999999 110.943 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 p -135.64 174.41 10.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 2.1400000000000001 111.131 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -175.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 1.8600000000000001 111.157 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -51.75 -35.21 42.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 4.6799999999999997 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -60.37 2.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 2.0800000000000001 110.867 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.51 171.52 0.28 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 2.2000000000000002 112.508 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -52.28 -89.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 1.75 112.466 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.12 108.81 2.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 1.5800000000000001 111.1 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.67 114.82 23.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 3.4300000000000002 110.889 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.494 HD21 HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -51.79 -35.87 45.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 2.1600000000000001 110.938 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.742 ' O ' HG23 ' A' ' 217' ' ' VAL . 13.4 m-85 -71.36 -60.76 2.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 5.29 110.867 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.751 HD12 ' CE1' ' A' ' 248' ' ' PHE . 4.5 tp -52.11 -55.31 21.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.193 -0.458 . . . . 2.6699999999999999 110.882 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.1 m -54.88 -45.83 74.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.87 111.144 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.49 -32.07 62.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 1.1100000000000001 111.114 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.792 HG11 HG11 ' A' ' 140' ' ' VAL . 13.0 t -76.35 -30.07 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 1.03 111.148 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -65.47 -36.68 84.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 2.0899999999999999 110.826 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -66.88 -20.95 66.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 6.04 110.89 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.96 -42.87 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 1.74 111.132 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.98 -38.13 36.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.725 -0.75 . . . . 0.87 112.469 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -23.63 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 2.6600000000000001 110.842 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.647 ' O ' HD12 ' A' ' 224' ' ' LEU . 17.4 p -109.97 17.78 20.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 2.7400000000000002 110.895 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 223' ' ' SER . 0.2 OUTLIER -156.43 94.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 3.4199999999999999 110.906 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 58.73 -178.72 1.61 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 2.4300000000000002 112.477 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.542 HD22 ' SD ' ' A' ' 236' ' ' MET . 0.4 OUTLIER 71.04 -68.84 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 3.7200000000000002 110.888 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 98.63 -66.92 0.69 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.728 . . . . 3.2000000000000002 112.487 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -173.52 133.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 2.0600000000000001 110.871 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.0 m 63.21 163.32 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 5.8300000000000001 110.859 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 25.2 t -178.86 -64.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 6.0599999999999996 110.885 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.92 156.79 51.4 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 2.6099999999999999 110.862 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 165.66 30.22 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.686 2.258 . . . . 2.7000000000000002 112.349 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.68 28.4 4.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 4.9500000000000002 110.879 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -122.7 -169.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 2.4500000000000002 111.107 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.8 m -95.58 -29.29 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 3.0299999999999998 111.158 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.542 ' SD ' HD22 ' A' ' 226' ' ' LEU . 1.1 tpt -58.2 -23.66 56.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 4.0800000000000001 110.828 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.18 150.71 29.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.683 0.754 . . . . 4.1100000000000003 110.859 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -48.69 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.657 2.238 . . . . 2.5899999999999999 112.342 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -85.61 138.83 31.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 3.5299999999999998 111.19 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.13 135.98 52.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 4.3300000000000001 110.924 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 102.89 8.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 4.5599999999999996 110.877 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -51.65 131.34 29.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 3.3399999999999999 110.905 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.78 132.8 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 2.3999999999999999 111.17 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.99 132.61 23.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 2.9399999999999999 110.858 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -14.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 3.3300000000000001 111.178 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -71.26 -29.12 64.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 3.8799999999999999 110.863 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.92 -6.06 10.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 2.3599999999999999 111.142 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.751 ' CE1' HD12 ' A' ' 214' ' ' LEU . 7.5 t80 -51.94 127.36 20.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 5.3700000000000001 110.877 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -173.1 142.06 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 4.8899999999999997 110.823 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.562 HD11 HG12 ' A' ' 255' ' ' ILE . 0.7 OUTLIER -52.53 170.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 3.04 110.934 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.98 160.95 16.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 3.9399999999999999 110.843 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.612 ' HA ' HD12 ' A' ' 255' ' ' ILE . . . -61.83 -55.56 28.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 4.1500000000000004 111.1 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.49 -29.38 50.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 2.4100000000000001 110.898 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.08 -30.43 67.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 3.3500000000000001 110.896 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 252' ' ' ALA . 60.6 mt -62.31 -30.8 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 2.75 111.161 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -75.84 -28.17 58.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 4.4000000000000004 110.882 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.69 -3.41 88.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 1.4199999999999999 112.487 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 10.4 tp -120.93 -31.53 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.777 0.322 . . . . 0.96999999999999997 111.115 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -78.67 -44.52 23.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 2.8300000000000001 110.96 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 2.2000000000000002 110.867 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.469 HG23 ' HA ' ' A' ' 157' ' ' ALA . 1.6 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.806 0.336 . . . . 1.9399999999999999 111.127 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.591 ' HB2' HD11 ' A' ' 159' ' ' ILE . 51.3 p90 -145.23 166.34 25.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 4.7699999999999996 110.977 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -161.8 138.21 8.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 3.9700000000000002 110.924 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.3 mt -108.07 148.42 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 2.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -162.25 56.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 3.8900000000000001 110.886 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 135.14 10.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 5.0899999999999999 110.936 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -147.7 106.51 3.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 6.7199999999999998 110.972 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.579 HG22 ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -90.8 153.65 45.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.573 0.701 . . . . 3.7799999999999998 111.123 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.579 ' HD2' HG22 ' A' ' 122' ' ' THR . 53.8 Cg_endo -69.76 -15.01 36.9 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 2.3700000000000001 112.327 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -51.45 -69.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 5.7400000000000002 110.905 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 34.7 mmt -107.79 160.35 15.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 3.4500000000000002 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.03 166.84 2.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 3.3100000000000001 110.893 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.443 ' HA ' HG12 ' A' ' 130' ' ' VAL . 2.6 mpt_? -74.51 -19.46 60.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 6.0499999999999998 110.891 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.5 -38.67 33.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 3.1000000000000001 110.895 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 65.8 m-20 -71.24 -41.15 70.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 2.5099999999999998 110.877 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.791 HG23 HD21 ' A' ' 212' ' ' LEU . 13.8 p -74.09 -27.88 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.81000000000000005 111.115 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -71.23 -53.87 12.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 2.6099999999999999 110.871 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -69.75 -32.45 70.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 2.54 110.933 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 129' ' ' ASP . . . -50.92 -58.2 6.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.512 . . . . 0.77000000000000002 111.081 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.511 HG22 ' CE2' ' A' ' 138' ' ' PHE . 5.1 mm -69.19 -45.47 79.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 2.6200000000000001 111.126 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -34.54 31.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 4.8099999999999996 110.84 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -78.71 -31.79 46.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 2.5499999999999998 110.914 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.474 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.95 -34.48 65.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.104 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 134' ' ' ILE . 54.5 m-85 -74.1 -27.87 61.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 5.29 110.867 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -79.33 -50.9 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 2.5499999999999998 110.905 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.593 HG22 HD23 ' A' ' 250' ' ' LEU . 3.5 p -51.23 -41.96 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 1.97 111.086 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -49.63 17.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 3.79 110.9 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.6 p -58.91 -19.9 46.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 1.8 110.867 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -72.12 -17.11 62.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 2.27 110.872 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 255' ' ' ILE . 21.2 m -139.59 29.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 2.21 111.147 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.3 p -148.48 152.26 38.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.57 0.7 . . . . 2.52 111.173 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -14.98 36.98 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.668 2.245 . . . . 1.8100000000000001 112.379 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.549 HD13 HD23 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -51.02 163.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 3.1200000000000001 110.95 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -118.34 -172.39 2.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 5.2999999999999998 110.926 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -135.64 119.99 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 6.9000000000000004 110.867 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.4 t -140.7 89.95 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 2.0899999999999999 110.848 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 116.56 22.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 2.1600000000000001 110.92 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.418 HD11 ' O ' ' A' ' 156' ' ' MET . 1.0 OUTLIER -130.79 116.82 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 2.8100000000000001 111.139 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -53.73 -27.76 30.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 3.2999999999999998 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.0 m -160.3 133.79 6.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 4.2400000000000002 111.155 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.94 -134.39 5.22 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 1.8300000000000001 112.526 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.418 ' O ' HD11 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -89.8 138.22 31.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 10.0 110.828 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.469 ' HA ' HG23 ' A' ' 115' ' ' THR . . . -147.31 130.06 16.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 1.3999999999999999 111.08 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.41 ' H ' HG23 ' A' ' 115' ' ' THR . 0.3 OUTLIER -80.53 -28.35 37.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 2.8500000000000001 110.893 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.733 HG22 ' HA3' ' A' ' 193' ' ' GLY . 1.5 pp -122.57 140.87 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 3.8199999999999998 111.114 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 160' ' ' LEU . 1.1 tm? -120.18 114.01 21.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 1.55 110.903 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.736 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 52.8 t -92.67 110.97 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 1.26 111.104 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.582 ' CG2' HD11 ' A' ' 160' ' ' LEU . 24.2 t -143.22 139.98 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 1.1100000000000001 111.172 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -84.28 131.43 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 3.4500000000000002 110.936 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.41 176.64 5.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 1.3899999999999999 111.101 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.96 111.64 5.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 5.4199999999999999 110.866 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.93 -127.02 27.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.766 -0.73 . . . . 1.2 112.481 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.06 110.81 20.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 1.3700000000000001 111.105 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -90.52 66.54 6.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 3.02 110.866 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.94 -91.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 3.1600000000000001 112.475 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.8 75.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 5.3499999999999996 110.863 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -157.36 -169.69 2.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 5.5099999999999998 110.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -78.53 95.57 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 4.0199999999999996 110.867 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.55 136.36 38.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 1.3 111.109 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -112.78 -169.61 1.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 5.8300000000000001 110.862 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -141.79 164.6 29.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 4.0099999999999998 110.857 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.21 -156.08 17.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 1.8200000000000001 112.504 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.52 119.16 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 3.7400000000000002 110.927 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 133.71 -82.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.77 -0.728 . . . . 2.2400000000000002 112.496 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.33 -133.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 1.96 112.493 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.537 HG22 ' H ' ' A' ' 182' ' ' ALA . 23.1 mm -75.1 142.11 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 1.79 111.107 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -109.5 -11.3 14.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 2.8900000000000001 110.913 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.537 ' H ' HG22 ' A' ' 180' ' ' ILE . . . -178.19 144.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 1.28 111.089 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -143.64 117.09 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 2.77 110.882 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.99 130.1 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.79000000000000004 111.069 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.23 166.01 21.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 2.0800000000000001 110.91 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.62 172.83 0.35 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.777 -0.725 . . . . 0.73999999999999999 112.478 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 172.08 13.3 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 0.81000000000000005 112.297 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 145.2 -154.97 26.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 1.02 112.47 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.4 p -88.78 135.44 33.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.936 0.398 . . . . 2.1800000000000002 110.844 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.72 -81.94 0.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.98999999999999999 112.496 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 191' ' ' ILE . 1.9 mp -87.71 50.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 2.6200000000000001 111.157 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.1 -110.95 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 2.6400000000000001 112.462 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.733 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . -90.78 41.45 2.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 1.1599999999999999 112.497 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.43 143.58 8.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 2.2999999999999998 110.873 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.736 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -121.52 130.98 53.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 1.01 111.124 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -122.03 126.67 49.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 2.6899999999999999 110.876 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -139.45 150.35 45.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 2.9500000000000002 110.882 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 69.13 45.68 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 6.4800000000000004 110.867 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.29 58.99 1.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 8.1500000000000004 110.875 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.46 16.62 8.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 4.2699999999999996 110.84 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.576 ' OE2' HG21 ' A' ' 210' ' ' THR . 0.2 OUTLIER -112.57 -1.09 14.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 4.3099999999999996 110.942 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.75 150.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 6.0599999999999996 110.852 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -105.4 176.93 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 7.71 110.904 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 205' ' ' THR . 0.2 OUTLIER -157.26 172.89 17.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 1.98 111.148 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 204' ' ' THR . 0.0 OUTLIER -94.76 -173.39 2.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 1.9199999999999999 111.131 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.421 ' CG ' HG23 ' A' ' 245' ' ' ILE . 15.5 p80 -65.69 -20.33 66.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 4.4500000000000002 110.862 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -70.18 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 2.2200000000000002 110.856 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.66 -169.61 11.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 2.3300000000000001 112.457 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 49.29 -166.29 0.3 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 1.6000000000000001 112.483 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.576 HG21 ' OE2' ' A' ' 201' ' ' GLU . 0.9 OUTLIER -61.87 99.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 2.0 111.144 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 214' ' ' LEU . 32.1 t30 -61.71 120.71 11.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 3.52 110.849 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.791 HD21 HG23 ' A' ' 130' ' ' VAL . 0.3 OUTLIER -54.88 -37.85 66.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 2.3500000000000001 110.842 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -71.58 -67.32 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 4.7000000000000002 110.886 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.687 HD22 ' O ' ' A' ' 241' ' ' LYS . 3.9 tp -48.31 -53.67 16.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 2.5299999999999998 110.931 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 37.5 m -55.21 -41.58 72.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.70999999999999996 111.113 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.54 -44.99 95.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.69999999999999996 111.12 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 248' ' ' PHE . 38.3 t -68.77 -23.14 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.67000000000000004 111.14 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.643 ' HA ' HG12 ' A' ' 235' ' ' VAL . 19.7 t60 -72.65 -62.27 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 2.1000000000000001 110.857 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.427 ' CD ' ' HB3' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -53.7 -55.37 26.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 4.6399999999999997 110.893 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.1 tt -51.55 -29.95 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 2.21 111.143 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.98 -52.48 49.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.96999999999999997 112.479 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -72.12 -23.12 61.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 2.73 110.83 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.12 -9.76 58.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 2.1699999999999999 110.847 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.549 HD23 HD13 ' A' ' 147' ' ' LEU . 5.5 mp -104.13 -19.08 14.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.0800000000000001 110.903 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 145.23 -31.5 1.7 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 2.7400000000000002 112.477 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.67 HD23 ' CD1' ' A' ' 258' ' ' ILE . 0.5 OUTLIER -56.9 179.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.343 . . . . 3.0600000000000001 110.958 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 173.79 66.89 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.68 -0.771 . . . . 2.7200000000000002 112.42 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 11.0 m80 63.47 106.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.349 . . . . 2.0099999999999998 110.872 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.2 t -80.91 -79.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 5.0199999999999996 110.855 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 175.93 -54.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 3.8599999999999999 110.848 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.95 126.63 34.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 2.7400000000000002 110.88 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -177.73 1.99 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.692 2.261 . . . . 2.3399999999999999 112.327 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.6 28.09 4.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 3.8399999999999999 110.9 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -115.36 178.71 4.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 1.98 111.134 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.643 HG12 ' HA ' ' A' ' 218' ' ' HIS . 18.0 t -95.55 -9.44 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 3.48 111.174 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 28.9 mmt -86.53 -38.48 17.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 4.9000000000000004 110.889 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.34 137.47 68.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.731 . . . . 4.0700000000000003 110.867 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 73.62 1.31 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.692 2.261 . . . . 2.1899999999999999 112.341 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.71 148.6 21.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 2.3999999999999999 111.158 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -113.32 112.76 24.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 3.3900000000000001 110.899 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.687 ' O ' HD22 ' A' ' 214' ' ' LEU . 35.7 tttt -135.97 119.81 17.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 4.3499999999999996 110.918 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -51.71 132.0 30.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 3.0499999999999998 110.937 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.646 HG21 HD13 ' A' ' 214' ' ' LEU . 56.7 t -136.38 121.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 2.0899999999999999 111.12 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.02 130.96 26.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 4.0700000000000003 110.928 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.421 HG23 ' CG ' ' A' ' 206' ' ' HIS . 23.9 pt -56.67 -24.16 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 2.8599999999999999 111.151 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.5 -37.64 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 2.8199999999999998 110.872 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.4 m -104.02 27.98 7.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 2.52 111.087 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.647 ' CE1' HD12 ' A' ' 214' ' ' LEU . 9.8 t80 -103.01 130.84 50.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 5.4100000000000001 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -163.88 139.73 6.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 4.9500000000000002 110.835 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.593 HD23 HG22 ' A' ' 140' ' ' VAL . 4.2 pp -52.4 170.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 3.04 110.927 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.0 t -89.85 147.57 23.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 3.8399999999999999 110.893 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' A' ' 255' ' ' ILE . . . -63.51 -60.98 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 3.98 111.095 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.48 -26.3 30.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 3.5 110.869 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.55 -34.74 74.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 3.4500000000000002 110.849 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 252' ' ' ALA . 38.3 mt -55.17 -41.59 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 2.7599999999999998 111.132 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -14.3 61.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 4.4199999999999999 110.847 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -93.4 -14.48 53.57 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 1.6499999999999999 112.485 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.67 ' CD1' HD23 ' A' ' 226' ' ' LEU . 10.7 tp -110.32 -29.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 1.25 111.089 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -67.83 -32.06 72.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 3.8100000000000001 110.915 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 2.9100000000000001 110.843 -179.779 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.458 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 68.2 p . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.815 0.34 . . . . 2.0600000000000001 111.153 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.68 ' CE2' HG21 ' A' ' 159' ' ' ILE . 1.6 t80 -127.63 152.76 47.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 7.5199999999999996 110.883 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -160.24 123.32 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 6.8700000000000001 110.829 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.57 HD11 HG21 ' A' ' 134' ' ' ILE . 60.5 mt -108.16 131.94 57.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 1.8999999999999999 111.137 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -131.38 49.76 2.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 3.6800000000000002 110.86 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -179.87 126.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 4.7199999999999998 110.905 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -118.7 163.07 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 6.1200000000000001 110.922 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.3 m -86.63 131.57 45.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.63 0.728 . . . . 2.9199999999999999 111.074 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -48.91 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.697 2.264 . . . . 3.0499999999999998 112.393 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.36 54.57 2.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 4.3899999999999997 110.836 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -165.44 141.94 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 2.71 110.918 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.29 135.54 57.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 4.5300000000000002 110.911 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -54.26 -25.59 24.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 5.9699999999999998 110.878 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -78.27 -37.87 44.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 4.04 110.887 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -63.51 -45.55 90.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 3.2000000000000002 110.84 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.595 ' HA ' HD13 ' A' ' 212' ' ' LEU . 13.4 p -74.32 -32.62 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.93000000000000005 111.112 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.23 -54.35 11.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 3.6899999999999999 110.89 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -65.21 -32.17 73.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 3.0699999999999998 110.934 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 129' ' ' ASP . . . -52.51 -57.75 8.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.79000000000000004 111.114 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.57 HG21 HD11 ' A' ' 118' ' ' ILE . 4.5 mm -70.16 -49.12 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 2.3399999999999999 111.13 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -49.76 -46.06 50.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 4.0300000000000002 110.862 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -20.41 49.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 2.9700000000000002 110.849 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 134' ' ' ILE . . . -55.7 -50.04 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.94999999999999996 111.089 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.23 -26.79 67.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 4.6399999999999997 110.883 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -28.92 66.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 3.0499999999999998 110.913 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.83 HG11 HG11 ' A' ' 217' ' ' VAL . 21.4 t -62.96 -56.03 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 1.8999999999999999 111.113 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -43.54 65.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 3.8900000000000001 110.942 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.6 t -56.01 -32.39 63.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 2.02 110.887 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' HG13 ' A' ' 144' ' ' VAL . 18.7 t-20 -51.59 -32.23 27.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 2.73 110.913 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.815 HG11 HD11 ' A' ' 255' ' ' ILE . 23.2 m -138.93 36.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 2.4199999999999999 111.098 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.4 m -155.38 131.6 5.76 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.573 0.701 . . . . 2.3399999999999999 111.12 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.659 ' O ' HD22 ' A' ' 147' ' ' LEU . 53.7 Cg_endo -69.77 72.13 1.47 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.675 2.25 . . . . 2.1600000000000001 112.323 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.659 HD22 ' O ' ' A' ' 146' ' ' PRO . 0.8 OUTLIER -141.04 130.32 23.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 2.6299999999999999 110.884 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.42 133.29 56.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 5.0899999999999999 110.886 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -99.53 131.25 45.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 7.4900000000000002 110.902 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.6 m -113.41 90.15 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 1.95 110.832 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 122.21 19.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 2.75 110.883 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.527 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.3 pp -144.63 161.49 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 2.75 111.157 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.44 34.22 3.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 4.21 110.9 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 t -161.66 142.98 11.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 3.73 111.139 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 85.78 176.4 50.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.73 . . . . 1.48 112.502 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.98 164.06 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 5.6200000000000001 110.845 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -134.71 144.51 47.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 1.0800000000000001 111.134 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.4 -26.81 32.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 2.4399999999999999 110.884 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.68 HG21 ' CE2' ' A' ' 116' ' ' TYR . 42.9 mm -104.1 135.35 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 2.7200000000000002 111.139 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.4 tm? -133.17 118.26 18.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 1.49 110.929 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.593 ' N ' HD22 ' A' ' 160' ' ' LEU . 89.5 t -105.65 110.54 31.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 1.47 111.131 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.558 ' CG2' HD11 ' A' ' 160' ' ' LEU . 55.9 t -133.96 145.43 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 1.1200000000000001 111.106 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -107.25 109.03 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 4.9500000000000002 110.879 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.683 ' HB3' ' OE2' ' A' ' 199' ' ' GLU . . . -101.67 178.76 4.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 1.4099999999999999 111.082 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.08 111.63 17.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 4.9199999999999999 110.887 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.37 -123.75 16.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.717 -0.754 . . . . 1.3600000000000001 112.494 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 173' ' ' ALA . . . -87.22 110.41 20.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 1.49 111.122 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -79.39 58.76 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 3.0899999999999999 110.885 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.8 -63.69 2.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.702 -0.761 . . . . 4.2999999999999998 112.507 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -179.5 42.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.77 0.319 . . . . 7.6500000000000004 110.867 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -111.23 -78.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 4.9900000000000002 110.829 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -138.16 98.12 3.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 4.2000000000000002 110.837 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 167' ' ' ALA . . . -81.85 113.61 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 1.73 111.128 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -111.12 131.58 54.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 5.8799999999999999 110.904 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.82 171.06 13.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 4.3799999999999999 110.887 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.06 -162.18 27.95 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 1.98 112.475 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -50.3 119.17 3.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 3.7599999999999998 110.887 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 128.06 -15.85 6.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 2.48 112.497 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -127.21 -133.75 3.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.71 -0.757 . . . . 1.4099999999999999 112.496 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.85 90.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 2.6000000000000001 111.138 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.763 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -48.31 -31.71 6.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 3.0699999999999998 110.886 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.763 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 176.87 153.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 1.22 111.124 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -142.92 106.27 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 3.5 110.896 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -96.22 108.41 20.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.93000000000000005 111.085 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.43 168.81 5.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 2.6299999999999999 110.86 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.49 171.49 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.747 . . . . 0.78000000000000003 112.526 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -170.62 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 0.77000000000000002 112.336 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 126.42 -152.01 18.2 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 1.1699999999999999 112.486 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.16 152.81 20.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 1.99 110.835 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 50.83 -104.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 1.27 112.497 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 34.0 mm -54.8 -26.56 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 2.4399999999999999 111.124 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.85 108.03 1.69 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.659 -0.781 . . . . 2.4700000000000002 112.491 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 108.17 -24.33 23.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.792 -0.718 . . . . 0.95999999999999996 112.502 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -49.8 147.27 3.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 2.2000000000000002 110.887 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.85 145.79 30.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 1.1200000000000001 111.112 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.553 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 28.4 m80 -121.78 152.95 38.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 2.5600000000000001 110.841 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.43 ' CE1' HG13 ' A' ' 161' ' ' VAL . 43.4 m-85 -133.53 103.19 5.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 2.8100000000000001 110.861 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 47.39 70.62 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 5.7599999999999998 110.889 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.683 ' OE2' ' HB3' ' A' ' 164' ' ' ALA . 4.4 mm-40 -51.59 -48.82 63.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 7.3899999999999997 110.872 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -127.93 0.47 5.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 4.4299999999999997 110.862 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.72 -168.73 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 3.7799999999999998 110.915 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -114.96 160.07 19.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 5.8300000000000001 110.918 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -106.15 152.52 23.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 6.1699999999999999 110.892 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.09 174.03 16.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 1.74 111.133 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.447 HG23 ' OD2' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -80.74 -172.28 3.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 1.98 111.182 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.55 ' CG ' HG22 ' A' ' 245' ' ' ILE . 25.5 p80 -55.92 -32.85 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 5.4199999999999999 110.842 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -56.45 5.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 2.3500000000000001 110.814 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -49.3 155.28 1.97 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 2.0600000000000001 112.488 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.48 -58.75 7.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 1.8700000000000001 112.5 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.19 102.91 15.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 1.8400000000000001 111.167 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.687 ' ND2' HD23 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -96.14 121.66 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 2.9500000000000002 110.859 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -54.93 -35.28 64.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 2.2400000000000002 110.901 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.414 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 34.0 t80 -71.96 -67.82 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 5.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.813 HD22 HG12 ' A' ' 243' ' ' VAL . 3.9 tp -49.6 -47.34 49.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 2.04 110.866 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 99.4 m -55.31 -44.2 75.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.52 69.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.81999999999999995 111.071 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.83 HG11 HG11 ' A' ' 140' ' ' VAL . 39.3 t -72.82 -29.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.65000000000000002 111.127 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -71.89 -39.39 69.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 1.73 110.826 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -74.31 -51.62 14.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 4.3399999999999999 110.932 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.5 HG12 HD12 ' A' ' 224' ' ' LEU . 11.0 tt -54.94 -27.32 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 2.3300000000000001 111.135 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.81 -27.41 62.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.776 -0.726 . . . . 0.90000000000000002 112.502 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -81.76 -43.88 17.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.757 0.313 . . . . 2.6299999999999999 110.837 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.5 p -86.53 52.26 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 1.54 110.848 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.5 HD12 HG12 ' A' ' 220' ' ' ILE . 1.4 mt -159.12 -46.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 2.0499999999999998 110.887 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -172.51 -61.88 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 1.9199999999999999 112.496 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.6 mp -60.89 171.71 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 3.04 110.926 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 177.46 65.08 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 2.7799999999999998 112.487 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.1 m170 64.22 157.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.32 . . . . 2.3799999999999999 110.853 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.6 t -163.86 -70.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 4.4299999999999997 110.863 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.7 -32.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 4.6699999999999999 110.871 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.429 ' HB2' ' HE1' ' A' ' 236' ' ' MET . 2.0 t0 -45.2 105.81 0.49 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.677 0.751 . . . . 2.2400000000000002 110.834 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 233' ' ' LYS . 54.0 Cg_endo -69.69 175.67 7.73 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.722 2.281 . . . . 2.02 112.349 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.25 42.66 0.31 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 3.9300000000000002 110.869 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -135.18 151.06 50.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 1.73 111.093 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.84 -14.59 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 2.9199999999999999 111.159 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.429 ' HE1' ' HB2' ' A' ' 231' ' ' ASP . 6.0 tmm? -81.96 -39.66 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 5.3799999999999999 110.847 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -50.99 134.52 29.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.662 0.744 . . . . 3.8999999999999999 110.902 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 76.45 1.15 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.722 2.282 . . . . 2.6099999999999999 112.323 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.5 m -157.3 152.66 26.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 2.8199999999999998 111.137 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.405 ' HB3' HD21 ' A' ' 181' ' ' LEU . 9.8 p90 -111.72 112.32 23.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 4.9100000000000001 110.89 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.48 -169.15 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 4.5899999999999999 110.913 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -121.48 107.86 12.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 3.6099999999999999 110.901 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.813 HG12 HD22 ' A' ' 214' ' ' LEU . 7.5 p -107.93 154.58 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 3.0099999999999998 111.135 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -74.22 124.99 27.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 3.23 110.86 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.55 HG22 ' CG ' ' A' ' 206' ' ' HIS . 11.8 tt -76.47 -35.48 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 3.0099999999999998 111.113 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -53.48 -31.9 47.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 3.5099999999999998 110.881 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.9 t -113.68 30.07 7.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 2.9700000000000002 111.109 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -52.05 134.47 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 5.9400000000000004 110.873 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -179.9 142.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 3.52 110.926 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.21 147.8 47.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 2.3599999999999999 110.866 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.1 -172.02 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 3.4100000000000001 110.872 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.713 ' HB3' ' OD2' ' A' ' 254' ' ' ASP . . . 66.4 163.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 3.77 111.118 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -57.67 -25.11 59.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 2.6800000000000002 110.815 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.713 ' OD2' ' HB3' ' A' ' 252' ' ' ALA . 2.2 p30 -51.62 -29.83 19.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 3.04 110.853 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.815 HD11 HG11 ' A' ' 144' ' ' VAL . 12.7 tt -50.88 -29.59 7.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 2.1000000000000001 111.153 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -92.07 -40.15 11.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 6.3300000000000001 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.97 -20.51 41.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 1.95 112.462 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 8.2 tp -91.41 -32.83 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 1.05 111.128 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.19 -44.4 38.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 3.3999999999999999 110.957 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 2.7799999999999998 110.883 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.51 ' C ' ' HB1' ' A' ' 157' ' ' ALA . 53.2 p . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.853 0.358 . . . . 2.0800000000000001 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -150.26 151.32 32.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 4.4100000000000001 110.938 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.83 161.63 29.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 5.0099999999999998 110.92 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.556 HD11 ' HB ' ' A' ' 134' ' ' ILE . 23.4 mt -108.09 148.93 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 1.8700000000000001 111.082 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.434 ' HB2' HG22 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -120.15 -69.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 3.0299999999999998 110.901 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -98.59 176.89 5.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 5.4199999999999999 110.895 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.533 ' HB3' HG11 ' A' ' 130' ' ' VAL . 25.9 m-85 -146.39 155.01 42.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 6.5700000000000003 110.904 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.458 HG21 ' OD2' ' A' ' 198' ' ' ASP . 0.7 OUTLIER -53.53 134.9 53.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.601 0.715 . . . . 2.3599999999999999 111.11 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 135.25 29.87 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.689 2.259 . . . . 2.6400000000000001 112.354 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.45 11.39 8.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 5.9000000000000004 110.865 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.48 147.32 29.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 3.0899999999999999 110.839 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.472 ' O ' HG12 ' A' ' 130' ' ' VAL . 3.5 m-20 -58.63 115.34 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 3.4900000000000002 110.893 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -21.94 61.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 5.71 110.862 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -80.55 -40.01 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 3.27 110.831 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.72 -47.87 61.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 2.8100000000000001 110.87 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.741 HG23 HD21 ' A' ' 212' ' ' LEU . 7.3 p -63.97 -40.8 90.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.79000000000000004 111.142 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.5 m-20 -51.83 -54.07 33.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 3.1299999999999999 110.912 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -68.17 -32.28 72.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 2.6000000000000001 110.936 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.416 ' CB ' HD22 ' A' ' 212' ' ' LEU . . . -50.64 -41.07 54.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 1.1100000000000001 111.151 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.583 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 2.8 mm -83.62 -49.4 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 2.3900000000000001 111.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -59.66 4.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 5.6699999999999999 110.841 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -29.86 61.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 4.8200000000000003 110.915 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 134' ' ' ILE . . . -56.14 -33.37 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.83999999999999997 111.112 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.505 ' CE1' HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -73.36 -24.66 60.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 3.5899999999999999 110.896 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.22 -54.02 6.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 2.5600000000000001 110.884 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 250' ' ' LEU . 2.6 p -52.08 -28.81 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 1.8799999999999999 111.12 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -89.11 -55.44 3.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 4.0800000000000001 110.897 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 81.6 p -55.26 -22.56 18.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 1.6100000000000001 110.855 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.83 -29.78 12.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 2.3799999999999999 110.905 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.697 HG11 ' CG1' ' A' ' 255' ' ' ILE . 4.8 m -128.3 46.36 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 1.8899999999999999 111.137 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.675 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -155.46 142.35 13.52 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.619 0.723 . . . . 1.5800000000000001 111.113 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.675 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.5 Cg_endo -69.78 -11.91 31.79 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.702 2.268 . . . . 1.8400000000000001 112.345 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.2 167.2 4.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 3.1899999999999999 110.914 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.76 -172.95 2.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 6.1200000000000001 110.887 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -131.84 127.58 36.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 6.5499999999999998 110.9 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.97 89.92 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 2.4500000000000002 110.885 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 95.18 7.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 2.5299999999999998 110.918 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.655 HG22 ' H ' ' A' ' 154' ' ' THR . 2.0 mp -111.81 133.19 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 2.7799999999999998 111.13 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.1 -28.96 67.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 4.29 110.916 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.655 ' H ' HG22 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -121.62 174.32 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 3.23 111.175 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.454 ' H ' HG22 ' A' ' 154' ' ' THR . . . 74.94 134.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.719 . . . . 2.27 112.487 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.1 mtm -68.99 160.33 31.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 6.7300000000000004 110.866 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.51 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -139.68 144.63 37.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 1.24 111.124 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.48 -33.54 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 2.3799999999999999 110.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.3 mm -103.99 94.47 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 3.1400000000000001 111.124 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.617 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.1 tm? -105.13 117.46 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 1.8799999999999999 110.86 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.617 ' N ' HD22 ' A' ' 160' ' ' LEU . 20.2 t -102.25 109.24 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 1.97 111.076 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.578 HG23 HD21 ' A' ' 160' ' ' LEU . 54.7 t -138.88 141.11 37.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 1.73 111.187 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.91 152.76 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 3.2599999999999998 110.89 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.41 173.33 10.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 1.26 111.112 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.67 120.0 13.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 5.0800000000000001 110.819 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 53.62 -134.77 42.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 1.72 112.488 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.91 110.48 20.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 1.49 111.061 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.23 56.38 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 2.9300000000000002 110.859 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.34 -58.94 3.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 2.6800000000000002 112.493 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -162.3 33.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 5.4699999999999998 110.847 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -110.74 -168.88 1.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 5.1399999999999997 110.878 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.75 114.89 16.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 6.1100000000000003 110.876 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.05 147.83 40.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 1.8400000000000001 111.11 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -59.86 -170.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 9.5399999999999991 110.875 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -137.92 165.39 26.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 5.25 110.87 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -50.82 133.35 31.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 2.9300000000000002 112.504 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 129.89 27.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 4.7699999999999996 110.934 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.87 -13.39 29.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 3.8399999999999999 112.459 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -108.58 -136.95 7.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 2.79 112.514 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.7 mt -71.47 110.88 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 3.21 111.174 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.572 ' H ' HD22 ' A' ' 181' ' ' LEU . 0.4 OUTLIER -50.51 -42.55 55.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 3.54 110.931 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 196' ' ' HIS . . . -178.84 -179.74 0.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 1.8799999999999999 111.078 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -142.15 129.58 21.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 3.6600000000000001 110.843 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -115.76 121.63 43.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.63 111.059 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.28 165.8 8.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 2.6299999999999999 110.859 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.37 170.2 0.34 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.77000000000000002 112.478 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -170.3 0.38 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.738 2.292 . . . . 0.97999999999999998 112.364 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.14 -149.14 18.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 1.23 112.497 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 99.3 p -92.24 155.56 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 1.96 110.899 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.42 -104.4 0.15 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 1.1399999999999999 112.485 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 38.0 mt -61.31 -26.52 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 1.98 111.121 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.15 99.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 2.6899999999999999 112.515 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 116.73 -18.9 12.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 1.01 112.456 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.532 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 10.1 m-20 -49.83 137.57 16.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.826 0.345 . . . . 2.0099999999999998 110.883 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -131.39 149.93 52.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.97999999999999998 111.099 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.535 ' O ' ' HB3' ' A' ' 182' ' ' ALA . 20.3 m-70 -136.58 109.89 7.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 2.7400000000000002 110.83 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -107.84 125.81 51.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 5.4699999999999998 110.889 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.458 ' OD2' HG21 ' A' ' 122' ' ' THR . 11.5 m-20 49.67 78.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 6.6299999999999999 110.871 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -76.61 60.79 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 8.5 110.901 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.6 26.6 16.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 5.3399999999999999 110.856 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -97.42 -42.54 7.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 3.7999999999999998 110.848 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 178.68 119.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 4.29 110.871 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -106.76 124.71 50.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 9.0099999999999998 110.923 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.1 159.92 38.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 1.8300000000000001 111.141 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.3 177.84 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 1.8400000000000001 111.146 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -55.39 -24.97 32.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 4.8600000000000003 110.865 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.98 -42.0 10.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 3.1200000000000001 110.861 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -57.21 -175.93 0.36 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 2.3500000000000001 112.503 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.4 -87.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.737 . . . . 1.9199999999999999 112.461 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 60.1 m -73.89 98.74 3.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.827 0.346 . . . . 1.8200000000000001 111.126 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -61.62 110.77 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 4.0 110.846 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.741 HD21 HG23 ' A' ' 130' ' ' VAL . 1.2 tt -69.33 -44.41 71.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.13 -0.487 . . . . 2.2000000000000002 110.907 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 217' ' ' VAL . 14.1 m-85 -63.96 -40.31 96.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 5.3600000000000003 110.896 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.44 -47.06 28.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 2.6600000000000001 110.904 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 24.0 m -55.54 -49.6 72.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 1.21 111.141 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.84 -32.09 63.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.91000000000000003 111.076 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 213' ' ' PHE . 62.9 t -80.77 -29.82 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.96999999999999997 111.066 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -73.56 -48.73 30.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 1.78 110.871 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -63.59 -49.21 74.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 4.8399999999999999 110.884 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.505 HD11 ' CE1' ' A' ' 138' ' ' PHE . 11.6 tt -57.82 -25.41 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 2.3500000000000001 111.162 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 -27.52 70.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 1.29 112.481 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -74.97 -28.67 60.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 3.4399999999999999 110.877 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.604 ' O ' HD12 ' A' ' 224' ' ' LEU . 0.7 OUTLIER -93.88 40.93 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 1.74 110.859 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 223' ' ' SER . 0.2 OUTLIER -159.72 -40.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 1.78 110.922 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 147.85 122.32 1.29 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 2.54 112.46 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.6 tp -179.19 -63.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 4.0499999999999998 110.912 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 62.74 15.33 54.27 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 3.5299999999999998 112.475 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 17.5 m80 51.98 67.15 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 2.2400000000000002 110.833 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 65.1 m -51.89 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 5.1299999999999999 110.866 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.464 ' N ' ' HE1' ' A' ' 236' ' ' MET . 0.3 OUTLIER 177.2 101.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 4.2400000000000002 110.888 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.4 OUTLIER -146.65 85.17 7.29 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 3.6600000000000001 110.887 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -29.78 23.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 2.7799999999999998 112.325 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 8.38 43.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 5.5 110.952 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.797 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . . . -124.74 -177.49 3.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 2.29 111.129 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 241' ' ' LYS . 16.7 m -95.83 -7.6 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 4.6200000000000001 111.115 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.464 ' HE1' ' N ' ' A' ' 230' ' ' SER . 1.9 ttp -54.15 -27.22 32.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 5.1100000000000003 110.892 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.25 157.58 1.15 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.633 0.73 . . . . 3.9199999999999999 110.871 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.34 28.3 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.67 2.246 . . . . 2.5 112.297 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.2 m -99.42 137.4 37.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 2.8799999999999999 111.185 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -63.14 142.07 58.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 3.9300000000000002 110.945 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.479 ' HB3' HG12 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -125.21 96.62 4.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 3.2799999999999998 110.919 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -61.59 125.84 25.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 3.5899999999999999 110.899 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.92 177.19 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 2.3500000000000001 111.136 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.1 128.45 34.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 2.79 110.878 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.0 tp -55.83 -25.29 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 3.1899999999999999 111.13 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -65.36 -39.4 92.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 2.9700000000000002 110.894 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 65.2 p -99.6 2.72 44.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 2.46 111.154 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 217' ' ' VAL . 7.2 t80 -51.91 108.32 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 4.0999999999999996 110.877 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -174.45 139.24 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 3.7000000000000002 110.832 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.598 HD21 ' OD2' ' A' ' 254' ' ' ASP . 0.8 OUTLIER -52.59 151.75 4.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 2.4100000000000001 110.917 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.586 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.4 OUTLIER -154.1 -179.0 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 3.98 110.848 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.658 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . . . 64.55 -178.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 3.29 111.119 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -23.23 51.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 2.7200000000000002 110.831 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.598 ' OD2' HD21 ' A' ' 250' ' ' LEU . 5.1 t0 -53.19 -30.12 35.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 3.0499999999999998 110.863 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.697 ' CG1' HG11 ' A' ' 144' ' ' VAL . 2.2 tt -65.1 -29.99 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 2.4100000000000001 111.11 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -99.04 -1.71 39.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 7.0899999999999999 110.885 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -90.17 17.85 51.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.693 -0.765 . . . . 1.6899999999999999 112.532 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.46 HG12 HG23 ' A' ' 145' ' ' THR . 0.7 OUTLIER -134.87 -40.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 1.0800000000000001 111.1 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -24.77 56.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 3.5099999999999998 110.867 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 1.8700000000000001 110.833 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.766 0.317 . . . . 2.2200000000000002 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.409 ' CD2' HD11 ' A' ' 159' ' ' ILE . 0.1 OUTLIER -127.47 136.7 52.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 7.5 110.911 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -141.14 143.33 34.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 4.3300000000000001 110.864 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.5 mt -108.01 148.36 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 2.48 111.162 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -111.9 -69.46 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 3.7400000000000002 110.914 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -107.36 -169.84 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 4.7199999999999998 110.877 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -146.62 140.73 26.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 6.2699999999999996 110.946 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.632 HG23 HG21 ' A' ' 130' ' ' VAL . 72.3 p -53.08 109.71 1.61 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.552 0.692 . . . . 2.8399999999999999 111.129 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 122' ' ' THR . 53.7 Cg_endo -69.8 -48.74 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.647 2.231 . . . . 2.8500000000000001 112.307 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.21 -33.55 75.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 4.6500000000000004 110.858 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.2 tpt -101.34 178.88 4.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 3.1600000000000001 110.853 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -78.92 128.83 33.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 3.52 110.849 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -52.96 -28.12 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 6.1699999999999999 110.908 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.77 -32.49 40.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 3.2999999999999998 110.899 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -65.6 -43.05 90.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 2.7200000000000002 110.881 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.632 HG21 HG23 ' A' ' 122' ' ' THR . 10.2 p -74.09 -35.54 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.02 111.143 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.0 -44.4 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 2.48 110.846 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -71.76 -39.63 69.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 3.6699999999999999 110.932 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.671 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -56.16 -59.24 5.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.97999999999999998 111.168 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.466 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 3.4 pt -56.43 -29.4 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 2.7400000000000002 111.139 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.08 -57.64 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 4.2400000000000002 110.827 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.664 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -79.19 -25.64 42.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 2.98 110.869 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.734 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.59 -43.75 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 1.28 111.091 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.415 ' HA ' HG21 ' A' ' 220' ' ' ILE . 37.0 t80 -73.68 -23.93 59.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 3.6600000000000001 110.84 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -78.13 -31.41 49.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 2.9500000000000002 110.912 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 136' ' ' LYS . 47.7 t -51.09 -56.2 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 1.97 111.089 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CE3' HD11 ' A' ' 250' ' ' LEU . 0.9 OUTLIER -73.64 -42.13 61.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 4.3799999999999999 110.917 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.651 ' HB2' HD11 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -54.67 -22.38 13.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 1.7 110.841 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -57.62 -21.84 41.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 3.3599999999999999 110.909 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.609 HG21 HG13 ' A' ' 255' ' ' ILE . 3.0 m -141.51 62.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 2.2599999999999998 111.173 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.771 HG23 HG13 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -157.02 147.53 16.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.632 0.73 . . . . 1.8400000000000001 111.114 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.734 ' HD2' HG22 ' A' ' 145' ' ' THR . 54.2 Cg_endo -69.75 -8.53 23.85 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.688 2.259 . . . . 2.48 112.362 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' A' ' 142' ' ' SER . 3.6 pp -66.22 -172.28 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 4.2599999999999998 110.923 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.508 ' N ' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -144.77 -174.89 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 6.2800000000000002 110.899 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -132.32 122.34 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 6.9400000000000004 110.891 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.4 t -144.93 89.94 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 1.8999999999999999 110.869 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -82.31 117.1 22.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 3.6800000000000002 110.894 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.2 159.84 42.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 2.8700000000000001 111.11 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -99.88 -27.96 13.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 3.8999999999999999 110.876 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.4 m -113.73 116.73 29.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 3.0800000000000001 111.088 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.33 147.35 6.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 2.0600000000000001 112.484 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.2 164.67 26.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.766 0.317 . . . . 6.0300000000000002 110.891 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.0 142.9 27.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 1.02 111.106 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -51.93 53.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 2.2400000000000002 110.859 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.881 HG22 ' HA3' ' A' ' 193' ' ' GLY . 22.9 pt -104.63 139.85 24.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 2.5699999999999998 111.141 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.742 ' C ' HD22 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -135.44 162.94 31.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 2.0 110.941 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.598 ' N ' HD22 ' A' ' 160' ' ' LEU . 39.2 t -106.21 121.74 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.79 111.095 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.486 ' HB ' HD21 ' A' ' 160' ' ' LEU . 3.5 p -139.43 163.31 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 2.48 111.144 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -121.02 133.13 55.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 4.0099999999999998 110.892 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.86 167.73 20.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 1.49 111.112 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.68 146.59 32.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 5.1500000000000004 110.878 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.37 -151.48 3.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 2.1899999999999999 112.502 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.79 125.35 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 2.0600000000000001 111.088 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -112.39 43.54 1.6 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 2.8399999999999999 110.847 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.14 76.59 0.26 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 3.21 112.462 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.2 t70 63.86 47.71 3.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.736 0.303 . . . . 5.9400000000000004 110.825 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.422 ' OD2' HD11 ' A' ' 191' ' ' ILE . 0.3 OUTLIER -142.2 -169.02 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 4.6500000000000004 110.851 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -76.83 124.08 27.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 5.46 110.851 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.29 144.96 31.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 1.96 111.131 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -130.32 -169.66 2.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 6.3200000000000003 110.887 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -151.28 -170.53 3.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 5.04 110.86 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -115.92 -153.13 10.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.758 . . . . 2.4199999999999999 112.445 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.71 133.61 25.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 3.3700000000000001 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 111.96 -18.97 23.6 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 2.4300000000000002 112.496 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -143.98 -129.09 2.21 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.747 -0.739 . . . . 1.4099999999999999 112.49 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 182' ' ' ALA . 28.5 mm -77.2 125.45 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.89 0.376 . . . . 2.46 111.144 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.591 ' HG ' HG21 ' A' ' 210' ' ' THR . 0.3 OUTLIER -95.89 -5.91 40.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 4.1200000000000001 110.911 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.488 ' H ' HG22 ' A' ' 180' ' ' ILE . . . -178.6 123.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 1.76 111.114 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 114.23 18.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 3.6600000000000001 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.64 117.5 24.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.68999999999999995 111.075 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -64.41 170.79 3.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 2.79 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.05 172.08 0.17 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.751 -0.737 . . . . 0.81999999999999995 112.489 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 172.23 13.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 0.87 112.333 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 159.35 -133.6 3.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 1.25 112.507 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 34.5 t -134.09 128.42 34.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.367 . . . . 3.6299999999999999 110.88 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 85.52 -70.36 3.08 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.741 -0.742 . . . . 1.8600000000000001 112.486 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.422 HD11 ' OD2' ' A' ' 171' ' ' ASP . 0.5 OUTLIER -99.7 -27.04 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.358 . . . . 3.04 111.119 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.11 129.14 29.0 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 2.2999999999999998 112.525 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.881 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . 85.69 -9.57 67.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 1.0600000000000001 112.511 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.453 ' HA ' HD13 ' A' ' 160' ' ' LEU . 3.8 m-20 -51.19 157.61 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.8200000000000001 110.874 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.753 ' HB1' ' CE2' ' A' ' 197' ' ' PHE . . . -125.97 121.28 32.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 1.1599999999999999 111.08 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -111.05 115.52 29.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 3.0800000000000001 110.838 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.753 ' CE2' ' HB1' ' A' ' 195' ' ' ALA . 50.1 m-85 -143.94 150.23 38.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 3.0299999999999998 110.875 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.432 ' N ' ' HE1' ' A' ' 203' ' ' TRP . 0.9 OUTLIER 75.16 -168.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 7.1500000000000004 110.855 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.87 96.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 6.9100000000000001 110.923 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.2 t70 55.95 68.97 0.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 4.0800000000000001 110.888 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -174.75 -41.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 4.2699999999999996 110.879 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 11.7 t80 67.24 131.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 5.5599999999999996 110.885 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.658 ' CH2' HG21 ' A' ' 215' ' ' THR . 21.3 m95 -105.72 -174.91 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 7.0800000000000001 110.877 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 168.27 27.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 1.96 111.184 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -175.1 3.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 2.0 111.143 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -52.76 -47.95 67.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 4.4400000000000004 110.909 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.4 p -78.39 -31.94 48.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 2.1800000000000002 110.879 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -50.38 167.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 2.2000000000000002 112.483 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.83 -72.71 0.44 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 1.6200000000000001 112.502 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.591 HG21 ' HG ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -102.3 98.64 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.796 0.332 . . . . 1.8 111.133 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -69.57 132.39 46.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 4.4400000000000004 110.87 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.2 tm? -57.99 -41.3 82.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 3.3900000000000001 110.908 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.733 ' O ' HG23 ' A' ' 217' ' ' VAL . 8.0 t80 -70.74 -60.72 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 5.5199999999999996 110.899 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.529 ' CD2' HG22 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -50.43 -34.89 26.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 3.0099999999999998 110.898 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.658 HG21 ' CH2' ' A' ' 203' ' ' TRP . 82.5 m -79.91 -41.6 25.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 1.1100000000000001 111.148 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.89 98.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 1.1899999999999999 111.102 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.734 HG22 ' HA ' ' A' ' 137' ' ' ALA . 53.5 t -51.27 -40.74 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.81999999999999995 111.156 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -64.74 -36.41 84.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 2.0699999999999998 110.85 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -74.64 -45.75 42.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 4.4699999999999998 110.883 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.463 HD12 ' HB1' ' A' ' 137' ' ' ALA . 91.3 mt -56.09 -37.04 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 2.0899999999999999 111.187 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.07 -37.78 36.94 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.686 -0.769 . . . . 0.67000000000000004 112.467 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -54.86 -40.64 69.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 2.3399999999999999 110.879 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.6 8.75 26.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 2.1400000000000001 110.879 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.484 ' O ' HD13 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -150.33 88.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 3.4700000000000002 110.944 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 71.12 179.32 29.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.738 -0.744 . . . . 2.1099999999999999 112.51 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 54.3 -175.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 3.0299999999999998 110.896 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.404 ' C ' ' HE1' ' A' ' 236' ' ' MET . . . -145.8 -115.68 0.96 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 2.48 112.464 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.44 142.82 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 1.8 110.881 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.83 -78.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 6.6100000000000003 110.845 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.51 -78.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 5.4400000000000004 110.882 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 153.21 48.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.599 0.714 . . . . 3.8900000000000001 110.858 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 233' ' ' LYS . 54.0 Cg_endo -69.73 -177.12 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.677 2.252 . . . . 2.8300000000000001 112.358 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.47 43.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 4.3200000000000003 110.887 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -135.54 163.5 29.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 1.77 111.101 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.447 HG23 HD11 ' A' ' 214' ' ' LEU . 9.8 p -87.16 7.4 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 3.1400000000000001 111.14 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.404 ' HE1' ' C ' ' A' ' 227' ' ' GLY . 1.4 tmm? -98.43 -26.08 14.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 3.8599999999999999 110.906 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.458 ' HB3' HG22 ' A' ' 239' ' ' THR . 0.1 OUTLIER -54.68 141.59 55.6 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.632 0.73 . . . . 3.9500000000000002 110.888 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 64.97 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.683 2.256 . . . . 2.1200000000000001 112.349 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.458 HG22 ' HB3' ' A' ' 237' ' ' PHE . 7.1 t -158.03 134.2 9.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 2.6400000000000001 111.169 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -76.3 127.49 32.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 4.2300000000000004 110.951 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.407 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.0 ptmt -140.58 92.74 2.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 4.1699999999999999 110.915 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -62.41 125.61 24.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 3.4399999999999999 110.912 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.529 HG22 ' CD2' ' A' ' 214' ' ' LEU . 16.7 m -137.49 177.32 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.494 . . . . 2.5499999999999998 111.153 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -62.09 114.28 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 3.9100000000000001 110.845 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 18.4 tt -76.36 -32.75 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 3.1600000000000001 111.172 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.43 -30.79 65.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 3.1899999999999999 110.866 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.56 28.05 9.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 3.4399999999999999 111.11 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -51.76 149.86 4.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 5.3399999999999999 110.913 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -179.71 156.2 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 4.3700000000000001 110.885 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 251' ' ' SER . 0.4 OUTLIER -86.83 157.49 19.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 2.1800000000000002 110.955 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.627 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.3 OUTLIER -154.65 -171.64 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 3.3999999999999999 110.904 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 68.72 160.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 3.6600000000000001 111.109 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.84 -21.48 56.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 3.2799999999999998 110.886 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.84 -29.74 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 4.04 110.886 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.609 HG13 HG21 ' A' ' 144' ' ' VAL . 1.2 tt -51.14 -29.53 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 1.7 111.143 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -90.59 -34.07 15.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 5.1900000000000004 110.842 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.55 -17.07 47.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 1.6499999999999999 112.507 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.771 HG13 HG23 ' A' ' 145' ' ' THR . 4.0 tp -99.95 -31.61 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.90000000000000002 111.179 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.78 -43.39 25.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 3.98 110.899 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 1.95 110.841 -179.791 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.818 0.342 . . . . 2.1899999999999999 111.136 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.759 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 11.8 p90 -131.95 145.83 51.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 4.25 110.942 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -142.29 160.51 40.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 4.9400000000000004 110.9 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 134' ' ' ILE . 21.3 mt -106.59 148.92 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 2.1600000000000001 111.172 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.582 ' CB ' HG22 ' A' ' 162' ' ' VAL . 23.2 t30 -106.77 -69.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 4.29 110.86 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -118.37 174.88 5.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 5.4199999999999999 110.881 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -134.45 163.27 30.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 6.5499999999999998 110.918 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.578 HG21 ' HB2' ' A' ' 203' ' ' TRP . 0.0 OUTLIER -88.51 131.86 40.75 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.546 0.688 . . . . 2.5699999999999998 111.114 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -19.43 36.14 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.702 2.268 . . . . 2.1499999999999999 112.334 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.64 -69.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 4.4800000000000004 110.874 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 38.0 mmm -101.19 168.12 9.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 3.6099999999999999 110.87 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -59.39 158.23 9.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 2.54 110.892 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.433 ' HA ' HG12 ' A' ' 130' ' ' VAL . 3.9 tmm_? -70.78 -11.26 60.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 6.5700000000000003 110.888 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -79.73 -36.69 37.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 3.0899999999999999 110.886 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.07 -40.77 71.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 2.6800000000000002 110.866 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.522 HG23 HD11 ' A' ' 212' ' ' LEU . 8.8 p -74.3 -36.2 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.67000000000000004 111.107 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -66.34 -43.97 84.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 3.7799999999999998 110.855 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -48.98 23.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 3.3199999999999998 110.937 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.547 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -59.78 -26.88 66.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 1.27 111.094 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.529 HG21 HD11 ' A' ' 118' ' ' ILE . 1.3 mm -70.85 -50.93 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 2.46 111.15 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -75.2 -22.7 57.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 4.1399999999999997 110.879 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -77.62 -29.92 52.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 2.9399999999999999 110.934 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 140' ' ' VAL . . . -63.5 -52.08 62.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.96999999999999997 111.039 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.579 ' HA ' HG21 ' A' ' 220' ' ' ILE . 1.3 t80 -55.09 -28.38 52.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 4.2400000000000002 110.887 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -70.49 -27.95 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 2.4900000000000002 110.898 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.534 HG11 HG11 ' A' ' 217' ' ' VAL . 58.4 t -51.08 -56.1 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 1.74 111.16 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.442 ' CZ3' HD21 ' A' ' 250' ' ' LEU . 30.7 m95 -77.44 -29.06 52.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 3.9700000000000002 110.921 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 p -55.19 -41.61 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 2.2400000000000002 110.807 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.69 -16.19 62.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 2.77 110.9 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.822 HG11 HD11 ' A' ' 255' ' ' ILE . 31.5 m -135.79 39.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 2.3199999999999998 111.139 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.447 HG23 ' HD2' ' A' ' 146' ' ' PRO . 91.9 m -155.63 133.65 6.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.583 0.706 . . . . 1.8600000000000001 111.17 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.447 ' HD2' HG23 ' A' ' 145' ' ' THR . 54.1 Cg_endo -69.76 74.56 1.28 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.738 2.292 . . . . 2.3599999999999999 112.341 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tp -163.13 -169.65 2.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 3.21 110.941 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -148.25 176.27 10.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 4.8099999999999996 110.875 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -135.81 120.03 17.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 7.2599999999999998 110.87 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 t -110.44 89.99 3.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 1.9099999999999999 110.843 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.16 93.4 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 2.7599999999999998 110.882 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.599 HD12 ' O ' ' A' ' 154' ' ' THR . 1.1 pt -131.57 163.96 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 3.5800000000000001 111.155 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -103.01 -5.78 23.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 3.1899999999999999 110.891 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.599 ' O ' HD12 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -95.57 175.73 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 4.1299999999999999 111.184 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.48 -165.55 1.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 2.1400000000000001 112.476 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.4 mtm -110.77 151.92 27.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 4.9400000000000004 110.867 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.759 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -119.35 130.14 55.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 1.3100000000000001 111.087 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.41 -20.82 62.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 2.54 110.883 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.0 mm -103.47 84.58 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 2.5899999999999999 111.144 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.643 HD11 HG23 ' A' ' 162' ' ' VAL . 1.1 tm? -85.72 117.72 24.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 1.48 110.945 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.605 ' N ' HD22 ' A' ' 160' ' ' LEU . 99.4 t -105.3 110.77 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 1.49 111.085 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.643 HG23 HD11 ' A' ' 160' ' ' LEU . 47.6 t -127.07 143.2 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 1.1899999999999999 111.15 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -97.77 100.21 11.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 7.54 110.903 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.518 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . . . -132.26 144.03 50.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 1.75 111.1 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.74 164.1 14.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 6.7199999999999998 110.849 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.52 -138.03 29.36 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.768 -0.729 . . . . 1.1599999999999999 112.502 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.23 128.24 33.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 1.47 111.137 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -95.67 24.87 4.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 3.1800000000000002 110.887 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.8 -28.17 10.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.761 -0.733 . . . . 2.3199999999999998 112.481 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.46 34.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.817 0.341 . . . . 5.25 110.874 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.56 -173.84 2.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 110.903 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.61 118.83 26.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 6.3799999999999999 110.864 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.41 139.9 35.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.3400000000000001 111.086 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -154.02 88.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 7.1699999999999999 110.87 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -128.49 -168.42 1.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 5.5300000000000002 110.859 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.62 106.1 0.91 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.748 -0.739 . . . . 2.1699999999999999 112.477 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.94 119.11 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 4.96 110.891 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.61 -24.52 21.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 2.29 112.494 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -82.88 -140.72 3.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.675 -0.774 . . . . 1.46 112.51 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.62 110.53 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 1.9099999999999999 111.105 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.578 ' H ' HD22 ' A' ' 181' ' ' LEU . 0.4 OUTLIER -50.42 -57.38 8.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.478 . . . . 3.79 110.915 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.01 123.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 1.46 111.093 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -95.3 153.58 17.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 3.21 110.831 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -152.46 113.04 4.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.68999999999999995 111.06 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.67 157.4 24.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 2.54 110.885 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.94 -171.0 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 1.1299999999999999 112.497 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -169.86 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.731 2.287 . . . . 1.03 112.338 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 125.37 -156.34 19.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 1.2 112.512 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.8 p -88.92 145.58 25.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 2.8300000000000001 110.861 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.08 -102.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 1.1699999999999999 112.43 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 82.0 mt -52.57 -27.73 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 2.0699999999999998 111.153 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.59 111.56 2.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 2.6600000000000001 112.474 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.43 -16.14 56.89 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 1.05 112.507 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -49.94 138.41 15.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 2.2599999999999998 110.905 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 161' ' ' VAL . . . -129.96 141.17 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.93000000000000005 111.097 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.518 ' NE2' ' HB3' ' A' ' 164' ' ' ALA . 0.1 OUTLIER -118.77 144.57 46.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 3.2799999999999998 110.871 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -144.45 148.5 34.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 2.71 110.903 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.425 ' HB2' HG23 ' A' ' 122' ' ' THR . 25.5 t70 70.48 -75.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 5.8600000000000003 110.882 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 46.85 41.33 10.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 8.8300000000000001 110.919 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.5 t0 62.98 41.1 8.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 3.54 110.888 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -118.45 1.87 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 4.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.12 115.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 4.75 110.899 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.737 ' CZ3' HG21 ' A' ' 210' ' ' THR . 0.1 OUTLIER -100.11 170.19 8.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 6.9400000000000004 110.946 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 205' ' ' THR . 0.2 OUTLIER -156.81 172.92 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 1.75 111.161 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 204' ' ' THR . 0.3 OUTLIER -75.35 -170.15 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 1.99 111.161 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.671 ' CB ' HG23 ' A' ' 245' ' ' ILE . 39.7 p-80 -76.77 -21.39 55.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 4.8899999999999997 110.853 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.9 t -61.08 -68.9 0.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 2.0800000000000001 110.843 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -132.9 -166.69 11.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.716 -0.754 . . . . 2.2200000000000002 112.481 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 50.07 -168.06 0.31 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.697 -0.763 . . . . 1.6299999999999999 112.497 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.737 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.3 m -56.46 99.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 1.54 111.114 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.0 103.76 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 2.5499999999999998 110.846 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.576 ' O ' HD23 ' A' ' 212' ' ' LEU . 6.6 tt -57.51 -38.27 74.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 1.96 110.901 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.547 ' O ' HG23 ' A' ' 217' ' ' VAL . 11.6 t80 -71.47 -64.26 0.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 5.0300000000000002 110.837 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.7 tp -50.8 -53.68 29.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 2.1499999999999999 110.915 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 85.5 m -55.37 -44.24 75.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.91000000000000003 111.167 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.68 -43.91 76.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.65000000000000002 111.098 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 213' ' ' PHE . 24.6 t -55.09 -41.87 61.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.64000000000000001 111.14 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -60.23 -31.33 70.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 2.2200000000000002 110.857 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -74.62 -40.35 61.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 3.6600000000000001 110.884 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.579 HG21 ' HA ' ' A' ' 138' ' ' PHE . 49.4 mm -54.64 -43.35 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.54 111.101 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.467 ' O ' HD23 ' A' ' 226' ' ' LEU . . . -75.87 -50.47 7.83 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.733 -0.746 . . . . 0.93000000000000005 112.528 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.81 -31.69 62.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 2.29 110.865 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.9 p -95.24 22.11 7.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 2.04 110.846 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 220' ' ' ILE . 17.2 mt -142.31 18.03 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 2.2999999999999998 110.888 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.606 ' O ' HD22 ' A' ' 226' ' ' LEU . . . 90.26 70.08 1.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 1.8899999999999999 112.499 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.606 HD22 ' O ' ' A' ' 225' ' ' GLY . 2.8 mm? -130.28 169.47 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 3.5800000000000001 110.928 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -82.29 -120.89 0.62 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 2.6699999999999999 112.45 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.87 33.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.331 . . . . 3.3900000000000001 110.819 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.0 m -153.09 -75.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 5.4199999999999999 110.832 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.0 t 57.7 -169.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 6.3399999999999999 110.888 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.06 160.29 0.87 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.632 0.729 . . . . 2.9199999999999999 110.851 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -14.84 36.46 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.639 2.226 . . . . 2.5099999999999998 112.346 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.74 -19.7 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 3.6499999999999999 110.889 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.57 170.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 1.6599999999999999 111.067 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 235' ' ' VAL . 7.9 t -88.17 -1.37 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 3.1800000000000002 111.156 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -30.2 20.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 3.8599999999999999 110.897 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.53 137.69 31.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.638 0.732 . . . . 3.96 110.877 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.41 ' O ' HG23 ' A' ' 239' ' ' THR . 53.8 Cg_endo -69.71 77.97 1.02 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 2.5600000000000001 112.375 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 238' ' ' PRO . 1.1 p -156.41 168.03 28.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 2.5499999999999998 111.136 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -125.37 112.53 16.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 3.7599999999999998 110.922 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.01 153.02 48.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 2.7000000000000002 110.888 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -111.13 102.47 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 3.4900000000000002 110.94 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 244' ' ' ASP . 7.5 t -107.57 157.21 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 2.3500000000000001 111.146 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 243' ' ' VAL . 0.7 OUTLIER -75.92 135.32 40.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 3.6200000000000001 110.855 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.671 HG23 ' CB ' ' A' ' 206' ' ' HIS . 19.6 pt -58.17 -22.61 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 2.73 111.116 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -21.41 24.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 3.0600000000000001 110.903 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.9 m -100.73 -6.11 25.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 2.7400000000000002 111.116 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.06 158.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 5.3399999999999999 110.848 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -178.22 149.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 4.3399999999999999 110.879 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.951 HD12 HD12 ' A' ' 255' ' ' ILE . 1.8 tm? -83.87 150.82 25.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 2.4900000000000002 110.888 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.785 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.4 OUTLIER -87.67 123.61 32.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 3.6000000000000001 110.894 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -44.73 -54.79 5.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 4.0099999999999998 111.067 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.08 -39.63 63.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 3.5899999999999999 110.895 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -71.68 -34.53 69.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 2.7599999999999998 110.905 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.951 HD12 HD12 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -50.75 -30.84 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 1.8400000000000001 111.111 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -79.39 -35.38 40.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 6.0999999999999996 110.88 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -61.17 -16.72 49.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 1.6100000000000001 112.479 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 7.5 tp -114.45 -36.27 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.83999999999999997 111.172 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? -67.37 -50.71 58.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 3.73 110.881 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 2.1000000000000001 110.852 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.775 0.322 . . . . 2.04 111.132 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.45 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 30.2 p90 -144.58 136.78 26.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 4.6100000000000003 110.908 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.27 133.63 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 4.4900000000000002 110.878 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.647 HD13 ' HB ' ' A' ' 134' ' ' ILE . 26.5 mt -108.05 141.61 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 2.48 111.16 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -157.44 47.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 4.2699999999999996 110.83 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.519 ' CG ' HG12 ' A' ' 161' ' ' VAL . 21.4 p-10 -147.23 143.72 28.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 5.6299999999999999 110.914 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -148.29 162.47 39.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 6.4400000000000004 110.934 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.545 HG23 HD11 ' A' ' 212' ' ' LEU . 1.0 OUTLIER -87.8 156.73 52.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.562 0.696 . . . . 3.2000000000000002 111.164 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 122' ' ' THR . 53.7 Cg_endo -69.71 -52.18 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.664 2.243 . . . . 2.5 112.352 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -66.94 -46.0 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 5.4299999999999997 110.932 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 10.7 mmt -98.26 122.88 41.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 3.6299999999999999 110.888 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -56.2 171.78 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 4.4800000000000004 110.879 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.59 ' HA ' HG12 ' A' ' 130' ' ' VAL . 14.5 ptt180 -67.2 -10.56 51.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 5.9900000000000002 110.853 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -34.17 71.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 5.1799999999999997 110.902 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.31 -41.23 41.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 3.8100000000000001 110.875 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.832 HG23 HD21 ' A' ' 212' ' ' LEU . 9.7 p -74.17 -33.99 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 1.2 111.113 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -49.92 -53.02 28.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 2.6499999999999999 110.847 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -76.16 -33.1 59.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 3.1099999999999999 110.924 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.38 -58.65 7.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.80000000000000004 111.098 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.681 HG12 HG22 ' A' ' 130' ' ' VAL . 5.3 mm -67.78 -45.48 84.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 2.7400000000000002 111.093 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -50.3 -48.99 54.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 3.73 110.854 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -76.83 -20.37 56.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 5.3600000000000003 110.885 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 134' ' ' ILE . . . -56.01 -37.96 69.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.90000000000000002 111.141 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.31 -25.17 60.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 3.8799999999999999 110.901 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -73.63 -27.79 61.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 3.1600000000000001 110.932 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.711 HG21 ' CG2' ' A' ' 217' ' ' VAL . 21.6 t -58.94 -55.94 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 2.0499999999999998 111.151 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -44.21 61.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 4.3700000000000001 110.945 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.3 m -54.87 -24.87 25.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 2.6299999999999999 110.855 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -58.08 -22.62 51.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 2.25 110.899 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.754 HG11 HD11 ' A' ' 255' ' ' ILE . 23.5 m -140.3 37.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 2.1099999999999999 111.14 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.8 m -142.88 131.52 11.53 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.62 0.724 . . . . 1.71 111.149 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 66.75 1.77 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 2.3199999999999998 112.305 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tp -140.62 166.25 25.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 2.5499999999999998 110.906 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -118.38 162.29 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 4.4299999999999997 110.905 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -135.8 119.84 17.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 6.9100000000000001 110.881 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 98.4 p -127.35 90.01 3.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 2.2599999999999998 110.894 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 120.13 12.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 2.5600000000000001 110.882 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 154' ' ' THR . 5.5 pt -148.03 156.93 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 3.0499999999999998 111.161 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -96.52 -24.33 16.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 3.9500000000000002 110.874 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.662 ' O ' HD12 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -95.71 175.51 6.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 3.1699999999999999 111.148 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.46 -171.95 42.88 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.712 -0.756 . . . . 1.8600000000000001 112.507 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mtt -110.65 157.09 20.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.794 0.33 . . . . 5.0999999999999996 110.846 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -137.08 146.57 45.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.01 111.094 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.75 -17.79 32.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 2.77 110.901 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.3 mm -104.31 84.47 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 2.5800000000000001 111.164 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.587 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.2 tm? -91.78 117.15 29.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 1.4199999999999999 110.902 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.587 ' N ' HD22 ' A' ' 160' ' ' LEU . 21.2 t -102.71 110.75 30.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 1.3500000000000001 111.097 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.582 ' CG2' HD11 ' A' ' 160' ' ' LEU . 45.2 t -133.97 141.94 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 1.0600000000000001 111.158 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -80.81 145.7 31.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 3.4300000000000002 110.857 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.57 ' HB1' ' CD2' ' A' ' 168' ' ' HIS . . . -164.27 156.0 16.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 1.6899999999999999 111.094 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.62 140.1 31.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 5.71 110.829 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.43 -136.4 35.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 1.5800000000000001 112.468 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.29 127.71 33.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 1.3400000000000001 111.061 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.57 ' CD2' ' HB1' ' A' ' 164' ' ' ALA . 5.5 m170 -101.22 25.31 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 6.1200000000000001 110.865 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.19 92.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.807 -0.711 . . . . 2.7799999999999998 112.505 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.9 t0 63.71 59.03 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.341 . . . . 5.5 110.848 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -158.03 -170.5 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 4.1600000000000001 110.868 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -96.07 106.25 18.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 5.8499999999999996 110.866 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.03 159.17 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 2.1299999999999999 111.063 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.09 -74.06 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 6.0700000000000003 110.866 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -179.28 -74.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 4.2699999999999996 110.894 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.08 -155.06 24.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 2.4300000000000002 112.501 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -59.43 123.06 15.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.844 0.354 . . . . 5.3899999999999997 110.864 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.38 90.6 0.64 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 3.2999999999999998 112.459 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.25 -140.59 11.02 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.794 -0.717 . . . . 1.54 112.507 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.0 mt -72.06 92.24 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.893 0.378 . . . . 2.1699999999999999 111.187 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -48.51 -28.96 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 3.3599999999999999 110.921 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.14 178.3 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.5800000000000001 111.065 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -151.64 125.49 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 3.2200000000000002 110.885 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.93 104.9 8.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.95999999999999996 111.13 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.09 165.81 8.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 3.2200000000000002 110.921 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.4 171.12 0.28 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.784 -0.722 . . . . 1.04 112.521 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -170.04 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.691 2.261 . . . . 1.1699999999999999 112.317 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.12 -112.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 1.46 112.459 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.87 135.24 43.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 2.1099999999999999 110.875 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.61 -86.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.94999999999999996 112.467 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 90.8 mt -71.76 -23.45 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 2.0699999999999998 111.097 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -58.46 117.3 10.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.749 . . . . 2.46 112.474 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.71 -14.6 64.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.723 -0.751 . . . . 0.81000000000000005 112.494 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -51.63 128.64 23.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.812 0.339 . . . . 2.0299999999999998 110.862 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -117.27 148.76 41.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.80000000000000004 111.098 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.583 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 39.7 m-70 -137.08 124.78 22.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 2.6299999999999999 110.835 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.509 ' CE2' HD23 ' A' ' 212' ' ' LEU . 0.2 OUTLIER -107.35 143.41 35.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 4.0899999999999999 110.853 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -77.93 58.08 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 6.1500000000000004 110.899 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -73.18 -13.51 61.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 9.5999999999999996 110.882 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -127.5 7.11 6.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 6.2199999999999998 110.91 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -121.74 -34.98 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 6.0199999999999996 110.862 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.52 91.69 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 7.5700000000000003 110.898 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -104.51 122.53 45.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 8.9800000000000004 110.938 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.11 162.53 38.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 2.1099999999999999 111.168 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.52 -170.21 1.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 2.2999999999999998 111.136 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -47.17 -46.95 24.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 6.0199999999999996 110.849 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -59.22 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 2.2799999999999998 110.847 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.26 171.2 0.25 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.738 . . . . 2.5 112.448 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.99 -90.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.744 . . . . 1.55 112.514 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.02 97.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.321 . . . . 1.47 111.169 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -68.34 117.82 10.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 2.8399999999999999 110.873 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.832 HD21 HG23 ' A' ' 130' ' ' VAL . 0.7 OUTLIER -51.35 -40.26 58.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 2.46 110.914 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -71.45 -56.22 6.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 4.7800000000000002 110.909 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.52 HD21 ' CE1' ' A' ' 248' ' ' PHE . 0.1 OUTLIER -52.34 -54.74 27.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 2.75 110.892 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 92.3 m -55.52 -38.42 69.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.80000000000000004 111.164 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.61 -50.66 69.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.071 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.711 ' CG2' HG21 ' A' ' 140' ' ' VAL . 39.3 t -57.01 -36.15 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.73999999999999999 111.129 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -59.73 -41.89 91.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 2.0699999999999998 110.873 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -66.71 -36.87 83.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 4.21 110.864 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.8 mm -57.85 -57.89 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 1.48 111.171 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.34 -41.61 99.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.82999999999999996 112.471 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -46.33 65.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 3.2000000000000002 110.863 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.25 23.44 5.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 2.3399999999999999 110.807 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.96 87.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.185 -0.462 . . . . 3.8100000000000001 110.883 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 131.47 -81.87 0.32 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 2.5099999999999998 112.454 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.45 179.26 3.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 3.52 110.953 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.44 120.22 1.32 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.732 -0.747 . . . . 2.6699999999999999 112.444 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.9 m80 63.34 91.35 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.815 0.341 . . . . 1.8200000000000001 110.886 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.9 t -98.12 -75.49 0.55 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.166 -0.47 . . . . 4.1399999999999997 110.918 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.0 t -178.99 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.508 . . . . 4.3700000000000001 110.861 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.1 116.86 7.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.638 0.732 . . . . 2.6600000000000001 110.909 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -8.73 24.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.726 2.284 . . . . 2.54 112.319 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 -24.21 13.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 5.1200000000000001 110.882 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.433 ' HB2' ' OG ' ' A' ' 251' ' ' SER . . . -61.9 169.08 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.0099999999999998 111.105 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.44 ' O ' HG12 ' A' ' 235' ' ' VAL . 3.7 t -94.6 7.35 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 3.1000000000000001 111.142 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -89.26 -34.13 16.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 4.5099999999999998 110.884 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.94 138.34 95.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.677 0.751 . . . . 3.8999999999999999 110.815 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 87.4 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.655 2.237 . . . . 2.2599999999999998 112.35 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.08 139.49 14.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 2.6400000000000001 111.179 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.74 112.28 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 3.7799999999999998 110.916 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -129.26 -169.18 2.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 5.6799999999999997 110.881 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -114.53 79.57 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 3.4900000000000002 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 244' ' ' ASP . 3.8 t -107.33 159.95 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 2.7799999999999998 111.119 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.421 ' N ' HG12 ' A' ' 243' ' ' VAL . 0.6 OUTLIER -48.84 112.88 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 5.4800000000000004 110.829 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.5 pp -76.69 -33.11 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 3.3399999999999999 111.124 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -72.26 -39.2 68.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 4.0999999999999996 110.88 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.13 17.97 13.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 2.7400000000000002 111.194 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.52 ' CE1' HD21 ' A' ' 214' ' ' LEU . 9.5 t80 -70.62 138.23 50.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 6.8300000000000001 110.853 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -154.38 134.18 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 4.0099999999999998 110.887 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.74 HD11 HD12 ' A' ' 255' ' ' ILE . 0.5 OUTLIER -53.24 171.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 2.9399999999999999 110.94 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 97.7 p -89.58 -172.8 3.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 4.6600000000000001 110.842 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -85.76 -59.88 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 3.8900000000000001 111.157 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -37.2 62.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 3.8199999999999998 110.846 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -70.49 -29.77 66.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 3.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.754 HD11 HG11 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -52.82 -28.39 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 1.99 111.124 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -87.73 -36.49 17.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 4.6900000000000004 110.908 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.82 -17.48 50.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.708 -0.758 . . . . 1.73 112.512 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.3 tp -109.59 -30.37 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.96999999999999997 111.141 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -77.65 -40.07 43.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 2.96 110.901 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 2.48 110.862 -179.794 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 149' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.78 0.324 . . . . 3.02 111.152 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.566 ' HB3' HD11 ' A' ' 159' ' ' ILE . 16.9 p90 -139.67 136.57 34.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 5.1900000000000004 110.913 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.03 107.09 15.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 4.2699999999999996 110.823 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.788 HG23 HG23 ' A' ' 161' ' ' VAL . 18.1 mt -75.23 138.76 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 2.3599999999999999 111.142 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.66 ' HB2' HG22 ' A' ' 162' ' ' VAL . 2.0 m-80 -98.3 -74.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 4.79 110.863 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.35 145.47 47.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 5.9100000000000001 110.873 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -85.69 163.25 18.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 6.54 110.911 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.7 p -100.87 137.94 19.91 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.557 0.694 . . . . 3.3399999999999999 111.163 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -171.49 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.684 2.256 . . . . 2.71 112.335 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 56.64 22.97 7.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 4.0599999999999996 110.887 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -165.28 142.82 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 4.4500000000000002 110.895 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.45 142.52 58.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 2.5099999999999998 110.885 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -56.03 -25.2 43.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 5.1200000000000001 110.855 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -75.69 -38.83 58.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 3.1200000000000001 110.943 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.26 -51.12 67.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 2.4700000000000002 110.903 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.611 ' O ' HD12 ' A' ' 134' ' ' ILE . 6.4 p -62.1 -39.6 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.82999999999999996 111.164 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -68.12 -54.6 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 2.9500000000000002 110.882 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -62.16 -33.29 74.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 2.6800000000000002 110.93 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.596 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -63.21 -57.98 8.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.76000000000000001 111.098 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 130' ' ' VAL . 6.6 mt -67.51 -49.27 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 2.4900000000000002 111.111 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -49.58 -46.82 49.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 4.1799999999999997 110.915 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 140' ' ' VAL . 10.4 mtpt -78.63 -29.02 45.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 3.02 110.849 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.688 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -56.03 -54.14 48.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 1.3999999999999999 111.069 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.752 ' CZ ' HD11 ' A' ' 224' ' ' LEU . 1.3 t80 -61.2 -40.63 94.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 4.6200000000000001 110.882 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -55.22 -28.07 50.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 2.8500000000000001 110.891 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 136' ' ' LYS . 35.3 t -60.98 -49.48 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 1.79 111.137 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.678 ' HE1' HD12 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -70.61 -48.46 55.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 4.21 110.959 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.05 -20.39 38.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 3.5299999999999998 110.87 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.11 -31.88 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 2.7000000000000002 110.894 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.722 HG11 ' CG1' ' A' ' 255' ' ' ILE . 3.6 m -128.59 51.19 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 2.0099999999999998 111.139 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.67 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -151.73 140.57 13.68 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.559 0.695 . . . . 1.78 111.123 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.8 Cg_endo -69.76 -38.17 8.17 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.654 2.236 . . . . 1.96 112.323 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.54 ' O ' HD12 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -49.53 104.34 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 2.96 110.899 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.22 129.47 49.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 4.7699999999999996 110.889 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.507 ' HB3' HG23 ' A' ' 115' ' ' THR . 1.4 m-85 -138.34 153.54 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 11.19 110.886 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.6 t -104.29 132.28 50.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 2.77 110.809 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.34 147.3 31.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 3.4199999999999999 110.962 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 58.1 mt -135.68 119.07 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 2.8999999999999999 111.153 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.13 -39.91 57.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 3.0099999999999998 110.924 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 95.7 m -137.27 109.42 7.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 2.9900000000000002 111.131 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 173.05 -153.99 19.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 1.6699999999999999 112.494 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.98 135.61 51.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 5.5599999999999996 110.86 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.89 -175.15 2.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 2.0 111.041 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.33 -26.36 6.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 3.1099999999999999 110.902 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 116' ' ' TYR . 1.4 pp -135.58 141.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 3.5800000000000001 111.166 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 194' ' ' ASP . 0.5 OUTLIER -132.39 165.47 24.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.455 . . . . 2.1699999999999999 110.936 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.788 HG23 HG23 ' A' ' 118' ' ' ILE . 2.0 m -125.21 110.96 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 2.8100000000000001 111.146 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 119' ' ' ASN . 12.0 t -126.86 154.52 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 1.3100000000000001 111.158 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -123.05 137.73 54.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 3.52 110.858 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.95 174.56 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 2.23 111.102 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -125.71 169.4 12.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 4.8499999999999996 110.852 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.43 -138.39 28.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 2.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.07 129.96 35.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 1.8300000000000001 111.109 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -89.75 11.01 21.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 3.8900000000000001 110.899 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 58.85 18.4 39.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 4.0700000000000003 112.48 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -148.19 29.08 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.749 0.309 . . . . 7.1200000000000001 110.856 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.3 t70 64.37 47.41 3.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 6.7199999999999998 110.873 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -137.45 70.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 5.1500000000000004 110.871 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.59 159.83 23.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 2.1699999999999999 111.077 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -98.07 -169.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 9.5 110.9 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -143.67 -39.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 4.8600000000000003 110.858 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.43 166.58 21.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.721 -0.752 . . . . 1.76 112.524 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -50.12 118.74 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 3.6099999999999999 110.899 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.65 -55.12 0.75 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 2.8500000000000001 112.472 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.53 -118.78 4.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 1.6699999999999999 112.502 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.1 mm -74.1 140.19 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 1.8400000000000001 111.12 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.679 ' N ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -124.34 -5.12 7.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 2.9900000000000002 110.901 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.512 ' N ' HD22 ' A' ' 181' ' ' LEU . . . 179.82 131.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 1.25 111.109 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -113.58 143.08 45.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 3.9100000000000001 110.819 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -154.14 129.97 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 1.23 111.163 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.88 170.73 10.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 3.3700000000000001 110.858 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.99 171.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.88 112.481 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 160.51 49.45 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.692 2.261 . . . . 0.84999999999999998 112.374 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 157.05 -142.44 8.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.727 . . . . 1.1599999999999999 112.548 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 88.5 p -106.53 117.21 33.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 1.97 110.838 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.14 -58.59 3.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 1.4099999999999999 112.465 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.524 ' O ' HG22 ' A' ' 191' ' ' ILE . 10.6 mt -93.37 21.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 2.5699999999999998 111.155 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.79 -115.79 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 3.0 112.51 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.549 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . -88.43 44.95 3.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 1.3 112.496 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.411 ' CG ' HD11 ' A' ' 160' ' ' LEU . 11.6 m-20 -64.98 130.65 44.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 2.2200000000000002 110.813 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -107.49 109.63 21.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.04 111.104 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -113.81 110.62 20.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 4.8399999999999999 110.816 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -103.26 118.92 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 2.7000000000000002 110.888 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -50.77 145.63 6.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 7.0199999999999996 110.883 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.22 -21.66 23.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 8.1999999999999993 110.862 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -94.69 -6.39 43.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 4.5 110.83 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -73.48 -25.25 60.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 4.0899999999999999 110.852 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 18.3 t80 67.59 128.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 5.1699999999999999 110.861 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -105.57 172.19 6.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 6.3899999999999997 110.963 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.17 173.29 17.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 1.7 111.127 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -170.74 0.36 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 2.2000000000000002 111.156 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -67.13 -21.1 65.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 4.6399999999999997 110.866 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.26 -33.5 9.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 2.1200000000000001 110.878 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -54.19 177.17 0.3 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 2.5899999999999999 112.494 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.73 -88.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.733 -0.746 . . . . 1.96 112.473 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.9 m -76.33 98.54 4.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 1.5800000000000001 111.146 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.45 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.6 OUTLIER -72.89 123.02 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 3.1899999999999999 110.838 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 133' ' ' ALA . 1.4 tt -72.38 -35.85 68.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 2.2799999999999998 110.929 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.686 ' CZ ' HD23 ' A' ' 214' ' ' LEU . 2.9 p90 -71.86 -34.79 69.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 5.5300000000000002 110.859 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.686 HD23 ' CZ ' ' A' ' 213' ' ' PHE . 0.1 OUTLIER -82.68 -52.97 6.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 2.9199999999999999 110.922 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 94.4 m -55.07 -37.77 67.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.94999999999999996 111.175 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.26 85.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.97999999999999998 111.105 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.688 HG22 ' HA ' ' A' ' 137' ' ' ALA . 39.1 t -64.35 -39.94 87.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.02 111.145 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -69.32 -43.17 74.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 2.3500000000000001 110.824 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -70.32 -56.37 6.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 3.8500000000000001 110.9 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.461 HD12 ' HB1' ' A' ' 137' ' ' ALA . 76.5 mt -50.48 -33.82 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 2.4700000000000002 111.119 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.8 -43.01 99.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 1.1599999999999999 112.455 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -75.37 -29.14 59.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.836 0.35 . . . . 2.9700000000000002 110.906 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.49 -16.97 64.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 2.48 110.83 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.752 HD11 ' CZ ' ' A' ' 138' ' ' PHE . 7.1 mp -96.98 -23.03 16.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 2.1000000000000001 110.935 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 136.37 69.18 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 1.74 112.468 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.678 HD12 ' HE1' ' A' ' 141' ' ' TRP . 7.0 mt -160.44 134.62 7.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 3.3900000000000001 110.89 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -131.68 51.26 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 3.4900000000000002 112.5 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.8 m80 66.19 144.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 2.04 110.878 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.44 ' N ' ' HE3' ' A' ' 236' ' ' MET . 6.5 t -122.09 -79.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 4.5499999999999998 110.861 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 175.15 -32.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 4.6699999999999999 110.906 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 86.1 m-20 -45.66 105.84 0.5 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.543 0.687 . . . . 3.29 110.907 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.4 Cg_endo -69.82 172.56 12.48 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.633 2.222 . . . . 2.8300000000000001 112.342 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.8 30.56 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 3.4399999999999999 110.947 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -126.73 172.21 10.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 1.5700000000000001 111.111 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.452 ' O ' HG22 ' A' ' 235' ' ' VAL . 9.5 p -89.66 7.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 3.0899999999999999 111.155 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.657 ' CE ' HD22 ' A' ' 226' ' ' LEU . 1.9 mmm -88.02 -39.15 14.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 4.0199999999999996 110.837 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.52 143.29 20.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.661 0.743 . . . . 4.1900000000000004 110.886 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 70.41 1.6 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.704 2.269 . . . . 2.29 112.336 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.06 165.99 33.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 2.4300000000000002 111.085 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -131.49 113.13 13.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 3.7599999999999998 110.9 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -132.01 139.57 48.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 3.02 110.907 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -69.7 127.87 34.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 3.52 110.879 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.52 HG12 ' H ' ' A' ' 244' ' ' ASP . 0.3 OUTLIER -131.55 177.19 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 2.4199999999999999 111.131 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.52 ' H ' HG12 ' A' ' 243' ' ' VAL . 0.3 OUTLIER -72.55 125.34 27.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 3.1099999999999999 110.89 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 24.0 pt -57.09 -24.65 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 3.2999999999999998 111.115 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -77.81 -39.59 43.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 2.98 110.888 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.81 34.12 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 3.6899999999999999 111.158 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.96 19.34 4.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 3.9300000000000002 110.878 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -84.28 149.82 25.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 3.6299999999999999 110.87 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.646 HD21 ' OD2' ' A' ' 254' ' ' ASP . 0.3 OUTLIER -52.13 158.18 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 2.54 110.935 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.59 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.2 OUTLIER -154.69 -172.71 4.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 3.5600000000000001 110.865 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 64.63 -177.16 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 2.98 111.089 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -67.75 -22.05 65.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 3.5899999999999999 110.874 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.646 ' OD2' HD21 ' A' ' 250' ' ' LEU . 4.8 t0 -51.36 -30.01 17.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 3.4399999999999999 110.823 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.722 ' CG1' HG11 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -51.27 -29.96 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 1.5900000000000001 111.117 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -88.98 -31.42 18.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 6.4500000000000002 110.867 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.06 -18.27 40.45 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 1.78 112.482 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.721 ' CG2' HG23 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -101.4 -29.57 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 1.6200000000000001 111.133 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -79.78 -32.64 40.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 3.8199999999999998 110.919 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 2.9199999999999999 110.857 -179.832 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.445 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 28.8 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.842 0.353 . . . . 2.4300000000000002 111.09 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.0 151.46 31.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 4.4299999999999997 110.953 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -137.99 127.95 25.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 4.9900000000000002 110.901 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 82.9 mt -108.2 143.96 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 2.21 111.135 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -145.26 35.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 3.3999999999999999 110.856 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -133.23 152.56 51.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 4.75 110.908 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -146.49 117.9 7.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 7.3200000000000003 110.949 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 122' ' ' THR . 4.5 t -82.17 114.22 49.42 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.63 0.729 . . . . 2.8300000000000001 111.13 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -44.03 2.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.698 2.265 . . . . 2.23 112.315 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.6 -40.29 59.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 3.8900000000000001 110.841 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -101.38 159.68 15.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 3.2200000000000002 110.892 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.23 129.65 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.433 . . . . 3.9500000000000002 110.848 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -57.84 -22.68 49.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 6.9500000000000002 110.847 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.56 -32.09 47.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 3.3999999999999999 110.911 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.29 -43.85 48.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 2.9100000000000001 110.844 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.459 HG22 HD12 ' A' ' 134' ' ' ILE . 7.2 p -65.03 -36.42 77.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.93999999999999995 111.12 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.62 -54.65 36.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 3.2599999999999998 110.854 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -69.45 -36.8 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 4.6399999999999997 110.892 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -55.17 -57.75 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.71999999999999997 111.154 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.459 HD12 HG22 ' A' ' 130' ' ' VAL . 12.8 mt -68.4 -49.21 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 2.6699999999999999 111.166 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -51.95 -40.47 60.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 4.1600000000000001 110.867 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -78.2 -21.76 49.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 3.73 110.886 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.814 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.86 -53.11 60.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.92000000000000004 111.052 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.497 ' CD1' HD12 ' A' ' 220' ' ' ILE . 39.7 m-85 -57.12 -23.97 50.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 5.6699999999999999 110.851 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -39.57 51.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 2.6499999999999999 110.904 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.709 HG12 HD12 ' A' ' 250' ' ' LEU . 33.7 t -57.37 -44.69 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 2.1499999999999999 111.094 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.685 ' CE2' HD13 ' A' ' 224' ' ' LEU . 11.1 t90 -67.26 -59.34 3.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 9.6300000000000008 110.92 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -56.23 -23.87 38.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 2.0299999999999998 110.871 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -67.99 -12.39 60.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 2.8599999999999999 110.848 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.84 30.39 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 2.8799999999999999 111.136 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.592 HG21 HG13 ' A' ' 258' ' ' ILE . 0.8 OUTLIER -155.49 157.88 31.73 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.59 0.71 . . . . 2.2400000000000002 111.081 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -25.14 29.07 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.689 2.259 . . . . 2.6299999999999999 112.357 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.49 175.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 3.8599999999999999 110.91 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.32 -178.07 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 4.5999999999999996 110.926 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -135.63 151.75 50.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 7.1699999999999999 110.911 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.5 t -156.37 89.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 1.9299999999999999 110.825 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.43 137.52 54.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 2.3100000000000001 110.897 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.543 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -143.57 165.93 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 3.46 111.139 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.07 -29.99 5.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 3.9199999999999999 110.887 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 91.7 m -117.78 110.3 17.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 2.8799999999999999 111.177 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 142.54 -171.31 24.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 1.5700000000000001 112.489 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -110.47 157.81 19.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 5.1500000000000004 110.864 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -146.99 141.89 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 1.22 111.091 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.89 -15.67 62.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.428 . . . . 2.3700000000000001 110.892 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.514 HD13 ' HA3' ' A' ' 193' ' ' GLY . 39.6 mm -104.03 141.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 2.6299999999999999 111.111 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 161' ' ' VAL . 4.0 tt -130.78 134.43 46.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.5600000000000001 110.94 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.713 ' N ' HD23 ' A' ' 160' ' ' LEU . 55.9 t -124.86 110.76 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 1.3200000000000001 111.13 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.593 HG23 ' CD2' ' A' ' 160' ' ' LEU . 24.4 t -143.25 141.21 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 1.1100000000000001 111.152 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -81.19 152.72 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 3.71 110.865 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -161.58 167.23 25.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 1.3200000000000001 111.06 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -139.54 117.74 11.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 5.2599999999999998 110.851 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.06 -137.85 17.2 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.738 . . . . 1.8999999999999999 112.503 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -80.55 110.34 15.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 1.97 111.139 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.08 56.9 3.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 3.9500000000000002 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 52.0 27.23 21.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.73 . . . . 2.6899999999999999 112.465 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -163.08 -167.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.797 0.332 . . . . 6.0999999999999996 110.862 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -80.55 55.95 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 6.8200000000000003 110.894 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -137.93 34.67 2.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 6.9000000000000004 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.8 127.81 34.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 1.8400000000000001 111.149 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.81 -82.16 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 6.1900000000000004 110.861 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.78 -77.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 5.0199999999999996 110.853 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 126.36 -161.1 20.76 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.747 -0.74 . . . . 2.3999999999999999 112.469 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -53.32 119.3 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 3.6899999999999999 110.9 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.46 -14.03 62.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 2.5 112.465 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.87 -150.56 7.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 1.78 112.497 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 182' ' ' ALA . 17.3 mt -71.29 96.66 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 1.99 111.146 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.756 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.4 pp -48.18 -29.65 3.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 3.29 110.907 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.756 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 178.62 176.0 0.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 1.5600000000000001 111.09 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.35 120.77 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 3.2599999999999998 110.88 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -109.75 117.55 34.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.63 111.111 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -63.79 166.14 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 3.7200000000000002 110.876 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.92 172.61 0.27 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.729 -0.748 . . . . 0.83999999999999997 112.481 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -179.2 2.77 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.682 2.255 . . . . 0.94999999999999996 112.339 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.39 -136.88 8.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 1.28 112.5 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.2 p -108.72 130.97 55.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.924 0.392 . . . . 2.71 110.872 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.36 -85.39 0.18 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.761 -0.733 . . . . 1.25 112.451 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 191' ' ' ILE . 63.2 mt -71.09 -7.95 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 2.46 111.137 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.97 -84.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 2.77 112.504 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 159' ' ' ILE . . . -76.18 -2.35 72.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 1.22 112.504 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -49.03 114.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 2.2599999999999998 110.866 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -122.2 154.14 37.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 1.6000000000000001 111.106 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -133.14 149.52 52.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 2.7599999999999998 110.864 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.457 ' CE2' HG13 ' A' ' 161' ' ' VAL . 18.6 m-85 -130.0 143.87 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 2.8900000000000001 110.847 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 199' ' ' GLU . 0.3 OUTLIER -47.88 -73.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 5.6299999999999999 110.884 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 198' ' ' ASP . 3.7 tt0 63.8 -80.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 8.6300000000000008 110.909 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -14.04 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 6.2699999999999996 110.916 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -91.46 15.76 11.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 6.8200000000000003 110.917 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 67.23 122.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 6.3700000000000001 110.918 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.43 -170.64 1.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 7.2800000000000002 110.934 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.01 172.76 18.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 2.2599999999999998 111.181 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.78 -170.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 2.0899999999999999 111.163 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -57.17 -20.9 29.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 4.3099999999999996 110.851 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.32 -69.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 2.3100000000000001 110.838 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.51 -160.43 10.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.731 . . . . 3.0499999999999998 112.511 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 50.94 -161.85 1.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 2.29 112.498 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 97.4 m -64.95 104.75 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 2.02 111.177 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.89 141.76 58.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 2.8500000000000001 110.885 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -72.53 -54.21 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 2.6099999999999999 110.904 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.731 ' O ' HG23 ' A' ' 217' ' ' VAL . 0.1 OUTLIER -72.31 -51.97 18.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 5.3600000000000003 110.936 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.434 HD22 HG23 ' A' ' 243' ' ' VAL . 12.3 tp -49.31 -38.45 27.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 2.1099999999999999 110.967 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.557 HG21 HD22 ' A' ' 181' ' ' LEU . 60.2 m -79.75 -42.66 24.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.78000000000000003 111.127 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.65 -36.84 77.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.92000000000000004 111.138 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 137' ' ' ALA . 45.7 t -68.01 -43.84 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 1.02 111.145 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -54.2 -31.64 53.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 2.0099999999999998 110.888 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -33.11 64.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 3.8399999999999999 110.867 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.572 ' O ' HD12 ' A' ' 224' ' ' LEU . 40.9 mm -55.32 -50.38 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 1.54 111.129 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.95 -28.58 60.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.93000000000000005 112.453 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -47.52 75.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.33 . . . . 2.54 110.832 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.98 29.23 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.6000000000000001 110.864 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.685 HD13 ' CE2' ' A' ' 141' ' ' TRP . 9.0 mt -132.24 -39.96 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 1.8799999999999999 110.933 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.61 -30.86 0.2 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 1.74 112.482 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.497 HD13 ' HB ' ' A' ' 258' ' ' ILE . 1.3 mp -90.75 90.51 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 3.98 110.936 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.1 -89.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.712 -0.756 . . . . 3.5 112.504 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -118.71 89.84 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 1.9399999999999999 110.887 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.46 172.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 5.6600000000000001 110.853 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 8.2 t -112.92 -27.33 8.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 3.8300000000000001 110.879 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.721 ' CG ' ' HB1' ' A' ' 252' ' ' ALA . 8.7 m-20 -51.77 112.49 3.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.724 . . . . 3.2799999999999998 110.84 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.8 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 2.1299999999999999 112.318 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -27.31 69.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 4.0199999999999996 110.923 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.923 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -72.13 167.68 19.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 2.21 111.092 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.462 HG21 ' HE1' ' A' ' 248' ' ' PHE . 17.0 m -95.49 -15.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 5.0800000000000001 111.165 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.408 ' SD ' HD21 ' A' ' 250' ' ' LEU . 9.0 tpt -58.22 -21.9 49.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 4.8300000000000001 110.876 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -52.22 137.38 38.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.652 0.739 . . . . 3.7599999999999998 110.858 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 76.52 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.693 2.262 . . . . 2.3399999999999999 112.35 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.8 t -157.32 167.67 29.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 2.8799999999999999 111.193 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -115.14 112.22 22.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.263 -0.426 . . . . 3.7000000000000002 110.943 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -136.22 -169.6 2.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 2.8199999999999998 110.896 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -107.24 142.57 36.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 5.2699999999999996 110.917 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.434 HG23 HD22 ' A' ' 214' ' ' LEU . 98.7 t -149.47 143.05 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 2.3599999999999999 111.182 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.87 126.06 26.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 2.75 110.832 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.8 tt -58.09 -22.83 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 3.0899999999999999 111.132 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.25 -31.28 12.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 3.6400000000000001 110.916 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.93 33.53 2.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 2.0099999999999998 111.137 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.598 ' CE2' HG21 ' A' ' 217' ' ' VAL . 8.5 t80 -104.21 129.08 52.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 4.8499999999999996 110.916 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -176.55 129.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 3.2400000000000002 110.898 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 140' ' ' VAL . 3.8 mt -58.44 114.65 2.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 3.9100000000000001 110.9 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 252' ' ' ALA . 0.1 OUTLIER -132.02 108.2 9.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 4.2999999999999998 110.895 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.923 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 174.18 172.59 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 3.4700000000000002 111.1 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -18.64 49.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 3.23 110.915 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.475 ' HB2' HD21 ' A' ' 226' ' ' LEU . 1.3 p30 -52.4 -30.44 29.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 3.5899999999999999 110.868 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 68.6 mt -51.36 -29.0 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 2.8500000000000001 111.116 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -87.55 -33.13 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 5.1100000000000003 110.85 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.58 -14.66 77.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 2.0800000000000001 112.47 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.592 HG13 HG21 ' A' ' 145' ' ' THR . 7.2 tp -92.29 -34.36 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.784 0.326 . . . . 1.7 111.137 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -79.31 -40.84 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 3.5299999999999998 110.941 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 2.6800000000000002 110.867 -179.799 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.2 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.841 0.353 . . . . 2.5099999999999998 111.119 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.527 ' OH ' HD11 ' A' ' 118' ' ' ILE . 11.2 t80 -152.41 136.6 16.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 5.5 110.941 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -161.45 145.77 13.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 4.6799999999999997 110.868 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.527 HD11 ' OH ' ' A' ' 116' ' ' TYR . 18.7 mt -108.07 148.81 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 1.75 111.144 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -156.45 38.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 2.7999999999999998 110.907 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.455 ' OD1' HG12 ' A' ' 161' ' ' VAL . 6.3 p-10 -135.39 148.81 49.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 5.4100000000000001 110.92 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -147.86 122.51 9.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 5.5899999999999999 110.891 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.56 147.38 41.89 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.55 0.69 . . . . 2.9399999999999999 111.118 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -168.02 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.652 2.235 . . . . 2.8300000000000001 112.339 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 73.82 -62.29 0.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 3.8999999999999999 110.84 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.455 ' SD ' HG23 ' A' ' 205' ' ' THR . 36.2 mmt -100.92 137.26 39.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 3.4900000000000002 110.874 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.31 158.15 9.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 2.79 110.896 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -52.57 -30.96 33.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 9.1500000000000004 110.889 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.49 -45.38 72.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 2.8799999999999999 110.908 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.71 -44.72 93.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 2.3599999999999999 110.893 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.565 ' HA ' HD13 ' A' ' 212' ' ' LEU . 7.3 p -73.49 -37.02 49.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.95999999999999996 111.108 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -63.75 -54.5 34.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 2.7400000000000002 110.872 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -59.31 -33.47 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 2.5099999999999998 110.927 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.57 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -53.98 -46.15 71.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.87 111.119 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 2.3 mm -83.13 -44.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 2.71 111.17 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.69 -45.23 58.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 4.1200000000000001 110.923 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.66 ' O ' HG23 ' A' ' 140' ' ' VAL . 31.7 mttt -78.09 -20.48 52.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 3.0800000000000001 110.907 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.725 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -56.03 -53.69 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.85999999999999999 111.099 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -36.11 75.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 3.7999999999999998 110.885 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -28.1 69.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 3.1099999999999999 110.893 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 136' ' ' LYS . 21.4 t -65.28 -56.19 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 1.8400000000000001 111.124 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.642 ' O ' HG22 ' A' ' 145' ' ' THR . 1.0 OUTLIER -73.26 -34.41 65.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 3.9900000000000002 110.884 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.8 t -56.25 -23.49 36.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 1.97 110.874 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.28 -16.6 63.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 2.1299999999999999 110.885 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.428 HG21 HD22 ' A' ' 250' ' ' LEU . 13.2 t -114.41 -33.46 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 3.1800000000000002 111.121 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 141' ' ' TRP . 1.4 t -107.19 146.0 32.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.614 0.721 . . . . 3.1699999999999999 111.146 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -7.61 21.51 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 2.9100000000000001 112.313 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.805 HD13 HD23 ' A' ' 224' ' ' LEU . 0.2 OUTLIER -51.23 150.34 3.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 2.6899999999999999 110.965 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.59 -173.15 2.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 7.2999999999999998 110.923 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -135.56 119.83 17.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 6.9500000000000002 110.92 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -111.16 89.95 3.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 2.54 110.868 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.9 110.57 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 2.23 110.878 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.497 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.2 pp -146.33 162.84 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 3.0600000000000001 111.151 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -113.12 51.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 4.3600000000000003 110.851 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.7 t -175.63 160.17 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 4.2999999999999998 111.147 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.47 139.81 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 2.1899999999999999 112.491 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.82 164.3 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.357 . . . . 6.3899999999999997 110.86 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.02 136.77 23.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 1.8400000000000001 111.081 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.92 -45.48 64.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 2.54 110.867 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.612 HG22 ' HA3' ' A' ' 193' ' ' GLY . 1.7 pt -108.79 135.53 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 2.8500000000000001 111.079 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -133.19 125.46 29.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 2.77 110.922 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.778 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 3.4 t -94.52 112.57 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 1.3600000000000001 111.117 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.585 ' CG2' HD21 ' A' ' 160' ' ' LEU . 53.1 t -145.03 144.42 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 1.27 111.108 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -108.06 137.89 45.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 3.3399999999999999 110.896 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.519 ' HB3' ' HZ ' ' A' ' 174' ' ' PHE . . . -139.56 164.01 31.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 1.3500000000000001 111.105 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.32 126.42 52.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 5.1600000000000001 110.85 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.72 -142.46 20.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.738 . . . . 1.1899999999999999 112.516 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.02 124.42 24.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 1.3500000000000001 111.134 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -89.62 76.64 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 3.1200000000000001 110.833 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.27 45.72 64.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 2.4199999999999999 112.499 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.78 88.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 6.6399999999999997 110.843 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -166.35 -74.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 4.3300000000000001 110.865 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -137.36 93.74 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 4.0800000000000001 110.829 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.24 128.86 34.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 1.4199999999999999 111.116 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.519 ' HZ ' ' HB3' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -128.66 -37.23 1.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 6.5899999999999999 110.918 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.13 168.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 6.1299999999999999 110.86 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.85 -148.49 7.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 2.8999999999999999 112.473 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.27 135.09 27.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 4.9500000000000002 110.838 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.98 -19.12 6.14 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.738 . . . . 5.0999999999999996 112.497 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.16 -107.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 3.02 112.535 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.406 HG22 ' H ' ' A' ' 182' ' ' ALA . 26.4 mm -71.4 149.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.898 0.38 . . . . 2.9100000000000001 111.095 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 182' ' ' ALA . 1.4 mm? -115.49 -18.66 10.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 4.4400000000000004 110.884 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . 175.64 124.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.8300000000000001 111.098 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -104.09 164.07 11.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 5.0 110.818 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.519 ' HB2' ' CD ' ' A' ' 219' ' ' GLU . . . -179.68 109.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.89000000000000001 111.098 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -71.11 150.8 45.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 3.9300000000000002 110.935 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.6 -167.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 1.1399999999999999 112.474 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 160.76 48.53 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.658 2.238 . . . . 1.3700000000000001 112.355 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 147.1 -163.45 28.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.742 . . . . 1.1299999999999999 112.49 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.08 140.67 29.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.895 0.378 . . . . 2.3599999999999999 110.841 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.25 -64.96 2.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.681 -0.771 . . . . 1.3400000000000001 112.513 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.689 HG23 ' CG ' ' A' ' 194' ' ' ASP . 3.7 mp -118.74 61.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.36 . . . . 2.8199999999999998 111.131 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -88.62 46.33 3.32 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 3.48 112.444 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.612 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . 124.38 31.82 0.88 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 1.3700000000000001 112.472 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.689 ' CG ' HG23 ' A' ' 191' ' ' ILE . 38.2 m-20 -64.51 139.29 58.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.771 0.32 . . . . 2.9100000000000001 110.929 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.778 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -96.5 119.8 35.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 1.0900000000000001 111.104 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -115.18 109.88 18.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 3.9500000000000002 110.859 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -113.0 101.66 9.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 2.5 110.882 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.41 117.18 2.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 6.4000000000000004 110.857 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -64.22 -48.61 75.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 7.8200000000000003 110.942 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -50.16 -30.45 11.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 3.7999999999999998 110.895 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.44 ' OE2' HD12 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -63.4 -169.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 3.7200000000000002 110.882 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -125.31 116.73 22.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 4.3799999999999999 110.869 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.557 ' CZ3' HG21 ' A' ' 215' ' ' THR . 56.1 m95 -105.06 97.41 7.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 7.0999999999999996 110.957 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.85 172.95 6.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 1.8600000000000001 111.11 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.455 HG23 ' SD ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -70.42 173.57 6.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 1.9299999999999999 111.121 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.71 ' HD1' HG22 ' A' ' 245' ' ' ILE . 0.0 OUTLIER -59.12 -21.4 59.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.437 . . . . 9.2200000000000006 110.891 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.05 -64.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.95 110.833 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.08 -177.14 14.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.772 -0.727 . . . . 2.3799999999999999 112.478 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 51.47 -170.88 0.31 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 1.6399999999999999 112.519 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -56.7 99.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 1.5600000000000001 111.134 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.11 111.66 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 3.6899999999999999 110.867 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.57 HD22 ' HB3' ' A' ' 133' ' ' ALA . 0.5 OUTLIER -57.8 -35.65 71.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 2.1499999999999999 110.925 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.736 ' O ' HG23 ' A' ' 217' ' ' VAL . 13.1 m-85 -71.37 -62.43 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 4.75 110.859 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 241' ' ' LYS . 2.3 tp -51.34 -53.51 35.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 2.29 110.917 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.557 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 23.3 m -55.58 -49.4 72.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.78000000000000003 111.142 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.63 -44.2 76.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.71999999999999997 111.075 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.737 HG21 ' CE2' ' A' ' 248' ' ' PHE . 23.7 t -66.4 -46.57 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 1.02 111.104 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -54.02 -29.46 43.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 2.27 110.856 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.519 ' CD ' ' HB2' ' A' ' 184' ' ' ALA . 1.9 tt0 -74.59 -42.1 59.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 3.3599999999999999 110.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.508 ' O ' HD13 ' A' ' 224' ' ' LEU . 49.5 mm -51.21 -32.95 13.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 1.6399999999999999 111.095 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.65 -55.36 8.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 1.04 112.522 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -37.49 77.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 2.8399999999999999 110.811 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.0 p -65.23 -34.58 78.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 2.9700000000000002 110.878 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.805 HD23 HD13 ' A' ' 147' ' ' LEU . 7.1 mp -95.31 23.47 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 2.0699999999999998 110.902 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.44 98.89 0.27 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 1.95 112.513 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 18.7 tp -149.76 156.6 42.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.793 0.33 . . . . 3.1299999999999999 110.956 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.93 -109.16 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 2.8199999999999998 112.497 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.3 147.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 2.3700000000000001 110.875 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.27 -77.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 6.2599999999999998 110.894 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t 62.89 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 5.5300000000000002 110.886 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.0 159.49 68.47 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.635 0.731 . . . . 2.79 110.808 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -24.98 29.12 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 2.1600000000000001 112.361 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.6 -31.11 12.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 4.1200000000000001 110.941 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -52.46 172.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 2.23 111.093 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 235' ' ' VAL . 4.0 t -95.38 7.48 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 2.77 111.121 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -27.5 36.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 4.3399999999999999 110.875 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.447 ' O ' ' CG ' ' A' ' 237' ' ' PHE . 3.0 p90 -47.61 114.59 3.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.681 0.753 . . . . 8.6199999999999992 110.888 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 61.68 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.669 2.246 . . . . 2.0299999999999998 112.334 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.93 169.18 21.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 2.3999999999999999 111.113 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -109.13 113.01 25.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 3.3799999999999999 110.962 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.613 ' O ' HD22 ' A' ' 214' ' ' LEU . 1.1 tttp -135.29 123.57 23.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 3.5 110.902 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -66.58 141.37 57.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 3.3799999999999999 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 97.8 t -150.39 144.36 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 2.46 111.103 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.56 126.93 21.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 3.1200000000000001 110.872 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.71 HG22 ' HD1' ' A' ' 206' ' ' HIS . 1.9 pp -65.27 -25.38 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 3.4100000000000001 111.107 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.05 -39.5 23.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 3.8100000000000001 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.1 p -93.13 10.01 33.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 2.5600000000000001 111.13 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.737 ' CE2' HG21 ' A' ' 217' ' ' VAL . 23.8 t80 -79.42 122.84 26.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 4.9000000000000004 110.864 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -163.81 148.02 10.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 3.3599999999999999 110.883 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.702 ' CD2' HD12 ' A' ' 255' ' ' ILE . 0.6 OUTLIER -53.12 151.97 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 2.46 110.929 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.548 ' O ' HD23 ' A' ' 250' ' ' LEU . 6.3 t -89.2 -171.47 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 3.1299999999999999 110.9 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -84.06 -56.34 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 4.1799999999999997 111.12 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.71 -38.27 60.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 3.29 110.846 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.53 -29.05 65.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 3.02 110.858 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.702 HD12 ' CD2' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -54.3 -27.56 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.8300000000000001 111.147 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.0 mtp85 -87.79 -23.43 24.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 4.7400000000000002 110.87 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.45 -22.96 64.17 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.718 -0.753 . . . . 1.9299999999999999 112.504 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.449 HD13 ' CD1' ' A' ' 141' ' ' TRP . 6.5 tp -92.87 -31.05 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.329 . . . . 1.4099999999999999 111.155 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -78.9 -42.55 26.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 4.0700000000000003 110.911 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 4.6299999999999999 110.821 -179.789 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.678 HG23 ' H ' ' A' ' 158' ' ' ASP . 5.5 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.743 0.306 . . . . 3.1099999999999999 111.112 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -142.08 136.53 30.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 5.2800000000000002 110.935 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -107.93 103.28 12.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 6.75 110.917 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.426 HG21 ' CE1' ' A' ' 121' ' ' TYR . 23.7 mm -70.73 148.44 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 2.6299999999999999 111.145 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.556 ' ND2' HD21 ' A' ' 160' ' ' LEU . 33.3 m-20 -109.29 -75.09 0.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 4.2000000000000002 110.877 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -140.07 146.13 38.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 5.8799999999999999 110.883 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.44 ' HB3' HG11 ' A' ' 130' ' ' VAL . 24.8 m-85 -92.5 163.26 13.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.207 -0.451 . . . . 6.6100000000000003 110.913 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.32 159.32 29.65 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.564 0.697 . . . . 3.9399999999999999 111.156 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.8 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.671 2.248 . . . . 2.8100000000000001 112.345 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 73.84 -63.39 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 4.4500000000000002 110.819 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.409 ' HE2' ' HB2' ' A' ' 203' ' ' TRP . 0.0 OUTLIER -100.81 144.62 29.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 6.6500000000000004 110.881 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.09 161.82 15.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 3.5 110.901 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -21.92 48.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 7.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -79.78 -36.67 36.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 4.9900000000000002 110.895 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 1.2 m-20 -64.0 -44.02 93.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 2.4399999999999999 110.887 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.491 HG23 ' HG ' ' A' ' 212' ' ' LEU . 10.3 p -74.58 -34.59 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.92000000000000004 111.077 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.66 -54.61 11.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 2.5800000000000001 110.852 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -62.82 -33.33 75.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 2.9300000000000002 110.928 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.692 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -56.92 -58.73 6.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.88 111.125 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 9.5 pt -65.69 -28.31 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 3.1000000000000001 111.119 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -48.25 -56.12 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 4.3300000000000001 110.851 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -78.83 -26.17 44.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 2.8799999999999999 110.871 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 134' ' ' ILE . . . -55.59 -33.97 64.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.89000000000000001 111.114 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -73.69 -30.75 63.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 5.8300000000000001 110.842 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -78.99 -29.12 43.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 3.9500000000000002 110.935 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.655 HG11 HG11 ' A' ' 217' ' ' VAL . 72.6 t -50.73 -42.52 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 1.75 111.136 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.586 ' HZ2' HD11 ' A' ' 226' ' ' LEU . 0.5 OUTLIER -96.18 -44.88 7.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 4.0599999999999996 110.941 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.0 m -54.99 -24.99 26.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 3.4100000000000001 110.89 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -61.36 -21.39 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 2.6899999999999999 110.88 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.1 41.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 1.8400000000000001 111.121 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.716 HG21 HD11 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -155.62 128.6 4.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.595 0.712 . . . . 1.9299999999999999 111.183 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 78.15 1.0 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.707 2.271 . . . . 2.7200000000000002 112.383 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.64 102.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 3.8599999999999999 110.908 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.93 128.7 47.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 5.6200000000000001 110.882 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -138.81 152.41 47.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 10.720000000000001 110.895 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.01 152.23 23.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 3.0899999999999999 110.804 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -58.5 151.34 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 3.3700000000000001 110.863 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.842 HG22 ' H ' ' A' ' 154' ' ' THR . 3.0 mp -137.75 130.33 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 3.2000000000000002 111.161 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.15 -13.1 61.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 4.0499999999999998 110.901 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.842 ' H ' HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -94.0 -178.57 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 4.7699999999999996 111.122 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.18 48.22 2.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 3.0099999999999998 112.466 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.15 99.6 7.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.34 . . . . 7.3099999999999996 110.858 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.43 129.78 13.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.426 . . . . 1.6799999999999999 111.098 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.678 ' H ' HG23 ' A' ' 115' ' ' THR . 0.8 OUTLIER -77.04 -19.1 57.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 4.9500000000000002 110.844 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.758 HG22 ' CA ' ' A' ' 193' ' ' GLY . 8.2 pt -138.21 141.74 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 3.73 111.126 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.556 HD21 ' ND2' ' A' ' 119' ' ' ASN . 1.9 tm? -114.21 118.65 34.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 1.45 110.93 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 89.0 t -92.39 125.46 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 1.4099999999999999 111.143 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 163' ' ' PHE . 2.3 p -138.22 164.59 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 2.8399999999999999 111.123 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.4 ' H ' HG22 ' A' ' 162' ' ' VAL . 79.0 m-85 -137.52 101.09 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 7.4100000000000001 110.86 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -125.72 155.46 40.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 1.3400000000000001 111.107 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.93 127.4 53.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 5.5700000000000003 110.848 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.19 -144.51 13.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.691 -0.766 . . . . 1.21 112.505 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.7 123.04 18.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 1.26 111.088 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -95.15 25.4 4.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 3.0499999999999998 110.878 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.89 -23.03 30.86 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.694 -0.765 . . . . 2.4300000000000002 112.448 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -179.31 35.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 5.1900000000000004 110.886 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.98 -169.46 2.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 5.2999999999999998 110.886 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -77.05 114.55 15.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 3.96 110.819 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.4 128.8 34.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 1.26 111.101 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -131.21 170.66 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 6.0099999999999998 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -122.87 165.04 17.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 4.54 110.865 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.22 -142.09 1.49 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.725 -0.75 . . . . 2.3999999999999999 112.434 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -50.51 119.14 3.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 3.5299999999999998 110.926 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.11 -73.94 0.44 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.754 -0.736 . . . . 2.27 112.47 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -89.67 -143.26 9.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.751 . . . . 1.6799999999999999 112.513 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.481 HG21 ' HB2' ' A' ' 183' ' ' HIS . 24.5 mm -71.29 133.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.889 0.376 . . . . 2.1499999999999999 111.113 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 182' ' ' ALA . 0.4 OUTLIER -101.47 -14.12 17.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 2.7799999999999998 110.946 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.582 ' N ' HD12 ' A' ' 181' ' ' LEU . . . -178.88 125.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 1.5600000000000001 111.075 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.481 ' HB2' HG21 ' A' ' 180' ' ' ILE . 1.8 t-160 -143.67 106.93 4.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 3.4100000000000001 110.915 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -100.34 142.31 32.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.79000000000000004 111.148 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.39 170.03 16.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 2.4100000000000001 110.915 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -53.96 176.67 0.3 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.687 -0.768 . . . . 0.80000000000000004 112.49 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -169.92 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.677 2.252 . . . . 1.1100000000000001 112.367 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.54 -141.94 13.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 1.5700000000000001 112.51 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.1 m -127.03 146.26 50.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.928 0.394 . . . . 3.7400000000000002 110.873 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.22 -58.96 3.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.76 -0.733 . . . . 1.26 112.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.1 mm -106.12 -23.22 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.378 . . . . 2.3700000000000001 111.169 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.06 128.5 39.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 2.4900000000000002 112.509 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.758 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . 89.8 -15.44 59.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 1.1499999999999999 112.513 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -51.77 147.46 6.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 2.4300000000000002 110.871 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -121.34 109.39 14.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.90000000000000002 111.093 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -96.99 110.46 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 4.1699999999999999 110.864 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.566 ' HE2' HG13 ' A' ' 161' ' ' VAL . 41.3 m-85 -115.64 104.95 12.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 2.6600000000000001 110.886 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -51.7 113.45 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 7.2400000000000002 110.819 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.93 -41.18 77.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 7.2599999999999998 110.906 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.76 -51.06 59.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 4.4500000000000002 110.881 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -54.4 148.29 12.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 4.3399999999999999 110.862 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -89.27 121.44 31.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 6.4699999999999998 110.865 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.646 ' HB3' HD23 ' A' ' 212' ' ' LEU . 39.3 m95 -107.4 99.29 8.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 6.9000000000000004 110.912 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.2 t -157.1 134.14 10.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 4.8499999999999996 111.154 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.3 t -106.88 72.41 0.89 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 4.0700000000000003 111.135 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -82.66 -67.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 8.7899999999999991 110.86 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.5 m -114.23 -71.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 3.1400000000000001 110.843 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.41 4.75 1.32 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 3.7999999999999998 112.456 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.14 -161.43 0.97 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 2.52 112.467 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.9 m -59.2 96.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 1.5900000000000001 111.14 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.408 HD22 HD22 ' A' ' 214' ' ' LEU . 3.0 m-80 -88.38 127.41 35.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 2.79 110.88 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.646 HD23 ' HB3' ' A' ' 203' ' ' TRP . 0.7 OUTLIER -54.78 -37.98 66.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 3.5699999999999998 110.971 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.699 ' O ' HG23 ' A' ' 217' ' ' VAL . 8.5 p90 -72.29 -32.49 66.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 5.0199999999999996 110.903 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 211' ' ' ASN . 13.8 tp -74.82 -60.04 2.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 2.5899999999999999 110.963 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.451 ' CG2' HD13 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -55.45 -38.27 68.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 1.1599999999999999 111.166 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.96 74.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.93999999999999995 111.087 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 213' ' ' PHE . 58.7 t -49.18 -43.07 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.82999999999999996 111.109 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -36.66 71.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 3.1499999999999999 110.86 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.51 -42.83 58.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 3.9100000000000001 110.858 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.464 ' O ' HD13 ' A' ' 224' ' ' LEU . 45.2 mm -50.06 -39.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 1.3799999999999999 111.111 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.717 ' O ' HD23 ' A' ' 226' ' ' LEU . . . -76.11 -51.98 6.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.78 -0.724 . . . . 0.75 112.499 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -55.49 -26.86 44.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 2.27 110.867 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.702 ' O ' HD12 ' A' ' 224' ' ' LEU . 0.3 OUTLIER -95.27 24.73 4.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 1.96 110.905 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 223' ' ' SER . 1.4 mp -148.92 17.96 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 1.8400000000000001 110.94 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.512 ' O ' HD22 ' A' ' 226' ' ' LEU . . . 88.33 77.21 1.29 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.749 . . . . 1.6899999999999999 112.499 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.717 HD23 ' O ' ' A' ' 221' ' ' GLY . 2.2 mm? -130.27 179.56 5.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.358 . . . . 3.1099999999999999 110.942 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.61 -123.73 3.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.805 -0.712 . . . . 2.54 112.507 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.61 150.56 12.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 2.3999999999999999 110.815 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.3 m 61.0 -92.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 6.7599999999999998 110.843 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 32.3 m 59.6 -86.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.499 . . . . 4.5599999999999996 110.847 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.5 155.96 75.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.611 0.719 . . . . 2.52 110.864 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 233' ' ' LYS . 53.6 Cg_endo -69.76 168.79 20.55 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.717 2.278 . . . . 2.7999999999999998 112.335 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.7 41.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 4.8899999999999997 110.868 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.639 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -130.85 153.79 48.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 2.2400000000000002 111.082 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 99.7 t -56.05 -25.74 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 4.4199999999999999 111.097 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.447 ' SD ' HD12 ' A' ' 226' ' ' LEU . 1.5 tpp -66.4 -18.2 65.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 4.8399999999999999 110.85 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 239' ' ' THR . 10.0 t80 -109.72 82.22 2.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.657 0.742 . . . . 4.1900000000000004 110.861 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 104.93 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.651 2.234 . . . . 4.0599999999999996 112.345 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.416 HG21 ' CE2' ' A' ' 237' ' ' PHE . 1.8 t -157.29 127.77 6.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 2.6499999999999999 111.136 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -61.82 120.92 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 3.73 110.938 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -162.61 140.9 8.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 3.0299999999999998 110.892 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -58.59 125.24 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 4.9000000000000004 110.929 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.4 t -150.49 143.66 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 2.5699999999999998 111.117 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.51 122.02 8.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 4.0 110.902 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.607 HG22 ' CZ ' ' A' ' 213' ' ' PHE . 22.3 pt -74.74 -23.9 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 3.4500000000000002 111.092 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -87.22 -23.71 24.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 4.29 110.919 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.2 m -100.95 6.54 43.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 2.6400000000000001 111.176 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -50.24 132.8 24.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 4.1600000000000001 110.849 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -179.56 148.05 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 4.7599999999999998 110.87 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.721 HD11 HG13 ' A' ' 255' ' ' ILE . 0.5 OUTLIER -71.32 171.07 11.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 2.3399999999999999 110.928 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.56 ' O ' HD12 ' A' ' 255' ' ' ILE . 5.8 p -89.94 170.37 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 4.54 110.895 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.84 -53.75 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 4.0800000000000001 111.099 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -18.84 51.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 3.0299999999999998 110.923 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.639 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -70.43 -36.34 73.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 2.7200000000000002 110.847 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.721 HG13 HD11 ' A' ' 250' ' ' LEU . 2.1 mp -56.96 -32.17 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 3.0299999999999998 111.154 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -59.03 -26.11 64.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 9.9499999999999993 110.863 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -98.97 45.17 1.61 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 2.2599999999999998 112.467 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.716 HD11 HG21 ' A' ' 145' ' ' THR . 7.5 tp -176.69 -36.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.761 0.315 . . . . 1.26 111.105 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.21 -44.27 26.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 4.3200000000000003 110.905 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 2.3500000000000001 110.89 -179.817 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.647 HG23 ' HB3' ' A' ' 149' ' ' PHE . 2.7 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.829 0.347 . . . . 2.6499999999999999 111.129 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -152.57 136.62 16.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 4.8799999999999999 110.941 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.666 ' CZ ' HD23 ' A' ' 160' ' ' LEU . 45.4 ptt85 -123.1 127.55 48.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 6.2300000000000004 110.896 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.9 pt -107.59 148.53 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 2.6400000000000001 111.141 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -149.02 -41.07 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 4.1100000000000003 110.882 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.474 ' OD1' HG13 ' A' ' 162' ' ' VAL . 32.8 m120 -96.2 150.38 20.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 5.21 110.919 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -147.7 134.28 19.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 6.29 110.902 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.641 HG21 ' CD1' ' A' ' 203' ' ' TRP . 0.8 OUTLIER -53.04 146.85 18.29 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.613 0.72 . . . . 3.1800000000000002 111.166 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 163.51 38.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 2.8500000000000001 112.327 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.54 16.13 9.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 3.8399999999999999 110.86 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.5 tpt -145.36 131.36 19.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 3.6099999999999999 110.867 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.34 135.22 57.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 3.2400000000000002 110.878 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -59.07 -20.16 50.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 5.7000000000000002 110.861 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -74.09 -30.5 62.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 3.8500000000000001 110.875 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.98 -44.94 75.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 3.4500000000000002 110.874 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.472 ' HA ' HD21 ' A' ' 212' ' ' LEU . 7.1 p -68.41 -28.33 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 1.3600000000000001 111.092 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -71.88 -47.97 49.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 3.23 110.841 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.57 -39.1 58.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 3.6499999999999999 110.9 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 213' ' ' PHE . . . -52.95 -58.73 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 1.3200000000000001 111.093 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 135' ' ' ARG . 2.8 pp -57.15 -28.55 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 4.3899999999999997 111.084 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.641 ' N ' HD12 ' A' ' 134' ' ' ILE . 6.9 ttm-85 -56.1 -41.23 74.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 3.4199999999999999 110.824 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -80.1 -19.65 46.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 3.0299999999999998 110.895 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.42 -38.54 34.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 1.3600000000000001 111.064 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.28 -25.71 58.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 5.8499999999999996 110.878 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -80.69 -51.15 9.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 2.79 110.888 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 136' ' ' LYS . 3.7 p -49.21 -42.28 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 2.5699999999999998 111.102 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.519 ' HH2' HD23 ' A' ' 226' ' ' LEU . 58.8 t-105 -75.84 -50.8 14.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 4.0499999999999998 110.882 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 76.7 p -55.15 -24.96 29.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 1.8 110.859 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.99 -31.61 30.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 3.0499999999999998 110.854 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.731 HG11 HG13 ' A' ' 255' ' ' ILE . 16.8 m -119.24 45.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 2.1299999999999999 111.167 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.52 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -155.46 135.44 8.3 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.565 0.698 . . . . 2.1200000000000001 111.124 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.52 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.4 Cg_endo -69.79 -23.74 30.31 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.697 2.265 . . . . 2.0 112.346 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.71 113.4 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 3.5899999999999999 110.935 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.32 129.12 39.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 5.2599999999999998 110.918 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.647 ' HB3' HG23 ' A' ' 115' ' ' THR . 0.5 OUTLIER -137.52 154.48 49.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.441 . . . . 11.84 110.886 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.9 t -101.86 122.8 44.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 3.0 110.845 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.25 142.27 43.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 2.5899999999999999 110.891 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 71.6 mt -113.24 117.6 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 2.9100000000000001 111.146 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.7 -39.84 59.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 5.4000000000000004 110.858 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 97.2 m -139.14 112.31 8.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 3.7999999999999998 111.14 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.25 -163.59 31.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.783 -0.722 . . . . 2.8599999999999999 112.481 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.73 143.85 38.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 4.9199999999999999 110.91 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.555 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -113.12 160.44 18.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 1.96 111.088 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.45 -34.31 61.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 3.48 110.897 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.723 HG23 ' O ' ' A' ' 193' ' ' GLY . 66.3 mt -104.7 141.04 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 2.5600000000000001 111.129 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.666 HD23 ' CZ ' ' A' ' 117' ' ' ARG . 1.7 tm? -121.64 117.31 26.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 1.73 110.93 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.57 HG13 ' HE2' ' A' ' 197' ' ' PHE . 97.0 t -95.45 110.99 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 1.74 111.096 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.567 ' CG2' HD11 ' A' ' 160' ' ' LEU . 40.8 t -149.7 142.21 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 1.27 111.123 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -80.4 152.8 28.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 4.0800000000000001 110.907 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.3 176.17 8.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 1.53 111.076 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -144.85 111.97 5.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 5.3200000000000003 110.893 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.12 -125.3 27.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 1.3300000000000001 112.502 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.68 114.86 23.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.333 . . . . 1.96 111.12 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -89.16 48.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 3.1699999999999999 110.923 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.85 45.81 5.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.731 . . . . 3.48 112.526 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.74 96.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.337 . . . . 8.3699999999999992 110.869 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.4 -74.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 4.6600000000000001 110.846 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -128.06 80.73 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 4.2599999999999998 110.868 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.22 113.26 19.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.75 111.084 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 141.31 43.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 5.8099999999999996 110.888 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 p30 178.69 -174.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 4.9900000000000002 110.86 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.65 106.04 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 2.5 112.521 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.26 118.96 2.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 5.8200000000000003 110.919 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 121.16 -41.44 1.9 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.748 . . . . 3.0899999999999999 112.533 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -75.91 -114.03 0.12 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 1.71 112.516 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.8 mm -92.44 135.18 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 2.0099999999999998 111.102 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 182' ' ' ALA . 0.5 OUTLIER -106.94 -20.84 13.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 3.3799999999999999 110.892 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.625 ' N ' HD12 ' A' ' 181' ' ' LEU . . . -179.62 124.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 1.6100000000000001 111.128 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -109.46 146.74 34.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 3.3799999999999999 110.842 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -155.76 122.34 5.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.71999999999999997 111.119 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.67 169.45 18.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 2.4100000000000001 110.897 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.16 177.55 0.27 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.711 -0.757 . . . . 1.0700000000000001 112.485 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 153.12 69.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.73 2.287 . . . . 1.3400000000000001 112.331 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.79 175.2 27.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.746 -0.74 . . . . 1.6499999999999999 112.513 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 88.9 p -58.72 158.89 7.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 2.0099999999999998 110.891 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.85 -102.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 1.23 112.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.64 -73.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 2.6800000000000002 111.11 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 50.54 -132.63 30.76 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 2.7999999999999998 112.51 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.723 ' O ' HG23 ' A' ' 159' ' ' ILE . . . -88.66 47.1 3.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 1.02 112.486 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.92 154.97 37.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 2.46 110.883 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -118.95 109.52 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 1.2 111.02 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -111.44 109.89 20.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 3.4500000000000002 110.812 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.57 ' HE2' HG13 ' A' ' 161' ' ' VAL . 52.6 m-85 -106.33 103.2 12.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 2.6800000000000002 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.66 101.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 7.5300000000000002 110.87 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.9 -29.15 26.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 7.1900000000000004 110.886 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -32.81 70.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 3.8500000000000001 110.838 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.84 -174.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 3.5 110.939 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -114.17 76.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 4.46 110.844 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.647 ' CH2' HG21 ' A' ' 215' ' ' THR . 0.6 OUTLIER -73.6 147.52 43.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 7.0099999999999998 110.938 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.436 HG21 ' H ' ' A' ' 209' ' ' GLY . 0.1 OUTLIER -156.66 173.09 17.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 1.74 111.143 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -173.86 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 2.4199999999999999 111.117 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -55.64 -48.97 74.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 4.6500000000000004 110.84 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -81.92 -25.09 35.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 2.8900000000000001 110.835 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.8 -172.13 0.39 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 3.29 112.474 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.436 ' H ' HG21 ' A' ' 204' ' ' THR . . . -50.47 -86.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 2.77 112.511 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -93.63 109.51 21.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 1.6000000000000001 111.127 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -49.92 114.31 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 3.7000000000000002 110.911 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 212' ' ' LEU . 0.1 OUTLIER -61.54 -35.77 78.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 3.1800000000000002 110.934 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.403 ' HB2' ' HB1' ' A' ' 133' ' ' ALA . 2.0 t80 -72.9 -57.93 3.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 5.3899999999999997 110.928 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.819 HD22 HG12 ' A' ' 243' ' ' VAL . 14.8 tp -47.9 -45.41 30.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 2.0899999999999999 110.889 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.647 HG21 ' CH2' ' A' ' 203' ' ' TRP . 24.8 m -59.37 -44.8 92.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.66000000000000003 111.102 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.28 80.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.91000000000000003 111.122 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.4 t -49.21 -50.47 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 1.05 111.159 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.58 ' HA ' HG13 ' A' ' 235' ' ' VAL . 50.1 t60 -54.08 -33.63 58.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 2.0 110.882 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.5 ' OE2' ' HB3' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -74.73 -41.57 59.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 3.98 110.855 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.458 ' O ' HD13 ' A' ' 224' ' ' LEU . 39.1 mm -53.37 -37.93 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 1.5 111.105 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.99 -53.56 5.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 0.81000000000000005 112.493 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -57.15 -24.92 57.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 2.4700000000000002 110.872 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.3 m -87.25 -17.58 32.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 1.5900000000000001 110.864 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 220' ' ' ILE . 6.2 mp -120.82 24.83 10.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 1.8700000000000001 110.95 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.87 106.52 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 1.98 112.466 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.812 HD11 ' HA ' ' A' ' 236' ' ' MET . 2.3 tm? -144.12 -67.01 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 4.0999999999999996 110.905 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.486 ' N ' HD13 ' A' ' 226' ' ' LEU . . . 67.13 121.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 3.48 112.486 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -51.71 152.68 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 2.2400000000000002 110.866 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 73.7 m -134.05 -77.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 3.9900000000000002 110.856 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 8.2 t 178.09 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 5.3300000000000001 110.895 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -48.4 108.01 0.85 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.612 0.72 . . . . 2.8199999999999998 110.883 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 157.02 61.85 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.717 2.278 . . . . 1.8500000000000001 112.314 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.14 17.9 8.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 5.8300000000000001 110.927 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.46 175.45 5.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 2.4100000000000001 111.099 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 218' ' ' HIS . 49.7 t -71.46 -18.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 5.0499999999999998 111.139 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.812 ' HA ' HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -57.05 -74.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 6.46 110.823 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -128.36 65.14 69.89 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.658 0.742 . . . . 6.6200000000000001 110.903 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -169.88 0.36 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.669 2.246 . . . . 6.0099999999999998 112.367 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.49 155.37 40.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 2.54 111.137 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -62.09 118.7 7.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 3.9500000000000002 110.912 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.64 -168.94 1.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 3.3599999999999999 110.922 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -132.75 102.55 5.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 4.1500000000000004 110.942 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.819 HG12 HD22 ' A' ' 214' ' ' LEU . 10.0 p -108.69 157.08 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 2.5499999999999998 111.108 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -58.63 114.64 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 2.6600000000000001 110.864 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -69.2 -25.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 3.52 111.118 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -28.6 32.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 3.8700000000000001 110.895 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.29 13.27 32.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 2.3799999999999999 111.153 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -51.28 164.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 5.0300000000000002 110.877 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -179.44 146.97 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 3.3700000000000001 110.863 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.675 HD23 ' CD1' ' A' ' 255' ' ' ILE . 40.7 tp -66.98 162.48 21.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 2.7599999999999998 110.91 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.77 145.22 25.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 5.0700000000000003 110.846 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -63.22 -71.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 3.2599999999999998 111.115 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.09 -35.06 59.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 3.7000000000000002 110.841 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -70.82 -29.99 66.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 2.8799999999999999 110.85 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.731 HG13 HG11 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -51.58 -28.51 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 1.9199999999999999 111.106 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.8 mtp85 -79.88 -37.77 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 5.8200000000000003 110.824 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.36 58.88 3.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.741 -0.742 . . . . 2.4100000000000001 112.505 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.417 HG21 ' CG2' ' A' ' 144' ' ' VAL . 5.2 tp -177.89 -39.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.321 . . . . 1.1699999999999999 111.151 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -73.55 -30.89 63.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 4.2599999999999998 110.901 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 3.52 110.865 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.629 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 30.5 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.782 0.325 . . . . 1.95 111.142 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -146.96 136.67 23.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 4.46 110.875 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -135.21 126.23 27.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 4.3099999999999996 110.859 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.645 HG21 HG21 ' A' ' 134' ' ' ILE . 22.1 pt -104.82 133.96 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 3.1099999999999999 111.103 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -135.55 29.37 3.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 3.29 110.904 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -112.86 151.33 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 5.4199999999999999 110.926 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -147.69 145.23 28.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 6.5499999999999998 110.943 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' ' 125' ' ' MET . 0.0 OUTLIER -119.67 133.14 23.83 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.601 0.715 . . . . 3.3399999999999999 111.121 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -49.56 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.69 2.26 . . . . 3.02 112.329 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -30.99 15.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 4.3899999999999997 110.876 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.495 ' SD ' HG22 ' A' ' 205' ' ' THR . 24.7 mtp -108.01 164.57 12.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 5.3399999999999999 110.906 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -86.55 161.53 18.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 3.3900000000000001 110.873 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -25.49 36.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 7.4299999999999997 110.909 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -80.07 -41.17 26.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 5.1699999999999999 110.883 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -55.66 -53.03 61.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 2.25 110.873 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.746 HG23 ' CD2' ' A' ' 212' ' ' LEU . 7.4 p -67.1 -37.57 79.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 1.1200000000000001 111.161 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -61.44 -54.25 45.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 2.5499999999999998 110.845 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -70.37 -32.54 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 2.7999999999999998 110.955 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.24 -57.45 8.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.79000000000000004 111.079 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.71 HD12 ' O ' ' A' ' 130' ' ' VAL . 3.0 mp -76.06 -45.67 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 2.0899999999999999 111.129 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.61 -37.35 39.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 4.5 110.856 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -78.53 -30.68 47.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 3.9500000000000002 110.883 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.535 ' HB1' HG13 ' A' ' 220' ' ' ILE . . . -55.73 -35.96 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.98999999999999999 111.073 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -74.51 -28.15 60.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 3.6200000000000001 110.878 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.34 -50.42 10.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 2.7400000000000002 110.932 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.747 ' O ' HD12 ' A' ' 250' ' ' LEU . 6.2 p -50.09 -30.99 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 1.9099999999999999 111.143 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -88.76 -43.48 11.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 3.7999999999999998 110.926 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 70.7 p -54.75 -24.79 23.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.1600000000000001 110.871 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.31 -24.43 43.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 2.71 110.864 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.845 HG11 HG12 ' A' ' 255' ' ' ILE . 4.5 m -140.94 46.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 2.1000000000000001 111.103 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 m -155.76 132.06 5.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 1.5600000000000001 111.142 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -8.36 23.4 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.712 2.275 . . . . 1.8 112.364 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.65 147.01 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 2.7599999999999998 110.891 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 137.24 53.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 5.0700000000000003 110.894 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -99.35 134.48 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 6.5899999999999999 110.923 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.4 t -123.87 89.91 3.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.77 110.836 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.88 119.92 19.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 2.5800000000000001 110.863 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.437 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -120.14 149.29 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 2.7999999999999998 111.086 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.43 -24.53 34.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 3.6899999999999999 110.893 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.2 m -139.77 132.16 28.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 3.4900000000000002 111.142 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.19 162.8 11.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.802 -0.713 . . . . 2.4500000000000002 112.516 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 42.0 mtt -95.02 166.39 11.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 7.3799999999999999 110.902 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -142.86 163.49 32.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 1.1499999999999999 111.093 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -25.53 65.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.7200000000000002 110.897 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.414 HD13 ' HA3' ' A' ' 193' ' ' GLY . 44.9 mm -104.02 84.54 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 3.0800000000000001 111.094 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.636 HD21 HG23 ' A' ' 162' ' ' VAL . 1.2 tm? -81.06 115.78 20.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 1.3799999999999999 110.945 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.591 ' N ' HD22 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -105.84 107.98 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.97 111.154 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.636 HG23 HD21 ' A' ' 160' ' ' LEU . 69.4 t -138.27 145.08 29.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 1.3 111.066 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -93.11 129.48 39.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 3.6299999999999999 110.866 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.513 ' HB3' ' OE2' ' A' ' 199' ' ' GLU . . . -111.09 178.39 4.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 1.26 111.117 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -144.02 112.24 6.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 4.5499999999999998 110.866 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 58.66 -131.15 51.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 1.27 112.521 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . . . -86.95 110.55 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 1.3500000000000001 111.096 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -85.36 53.64 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 3.1600000000000001 110.882 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 78.62 -57.74 4.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.733 -0.746 . . . . 3.0899999999999999 112.499 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -162.7 46.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 5.5599999999999996 110.882 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.31 -169.13 1.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 4.5999999999999996 110.869 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -76.75 96.4 4.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 3.79 110.911 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 167' ' ' ALA . . . -81.39 143.64 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 1.52 111.11 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -155.75 139.18 15.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 6.7999999999999998 110.906 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.17 -175.47 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 4.7800000000000002 110.841 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.74 99.32 1.09 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 2.6899999999999999 112.464 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.04 118.95 2.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 3.6800000000000002 110.865 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.16 -34.74 5.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 3.7000000000000002 112.479 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.79 -147.63 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 2.0 112.494 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.6 mm -71.62 89.47 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 2.6899999999999999 111.104 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.6 pp -45.2 -32.89 2.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 3.46 110.919 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.727 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 178.61 167.91 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.49 111.12 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -146.52 106.3 3.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 3.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -90.63 121.3 32.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.77000000000000002 111.106 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.94 151.68 42.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 2.75 110.873 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.68 167.33 0.47 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 1.0800000000000001 112.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 154.37 67.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 1.03 112.327 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 167.56 -110.03 0.37 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 1.78 112.48 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 93.3 p -131.28 142.25 50.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.401 . . . . 3.3399999999999999 110.806 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.08 -87.43 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 1.3999999999999999 112.484 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 191' ' ' ILE . 10.4 tt -91.94 14.93 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 3.4900000000000002 111.124 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -55.71 -68.47 1.67 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.783 -0.723 . . . . 2.71 112.492 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.414 ' HA3' HD13 ' A' ' 159' ' ' ILE . . . -85.62 2.85 87.81 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 1.4099999999999999 112.453 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.14 139.4 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.812 0.339 . . . . 2.6200000000000001 110.849 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.553 ' HB1' ' HG3' ' A' ' 219' ' ' GLU . . . -134.31 154.68 51.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 1.04 111.09 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.534 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 48.1 m80 -135.21 129.9 34.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 2.5 110.833 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -108.8 106.18 16.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 3.1000000000000001 110.888 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.45 82.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 5.7599999999999998 110.845 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.513 ' OE2' ' HB3' ' A' ' 164' ' ' ALA . 1.5 mm-40 -51.33 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 8.2599999999999998 110.843 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.92 28.83 5.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 4.6399999999999997 110.853 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -95.04 -80.97 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 4.5599999999999996 110.895 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 174.27 134.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 4.6399999999999997 110.867 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 95.27 5.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 6.8799999999999999 110.917 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 2.6 m -157.04 120.32 4.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 3.9199999999999999 111.117 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.495 HG22 ' SD ' ' A' ' 125' ' ' MET . 4.5 t -111.5 65.38 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 4.5599999999999996 111.169 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -88.47 -68.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 9.6099999999999994 110.866 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.81 -43.32 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 3.2400000000000002 110.909 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 242' ' ' TYR . . . -155.59 -112.76 0.42 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.751 . . . . 3.4500000000000002 112.469 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 40.63 -133.99 2.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 2.6600000000000001 112.475 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.49 97.05 9.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 1.8899999999999999 111.16 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.8 111.44 23.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 3.46 110.899 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.746 ' CD2' HG23 ' A' ' 130' ' ' VAL . 13.2 tp -51.45 -31.44 23.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 4.5700000000000003 110.918 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.96 -68.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 3.9700000000000002 110.871 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.615 HD22 ' CB ' ' A' ' 241' ' ' LYS . 3.6 mp -76.89 -36.83 56.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 3.8999999999999999 110.876 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.458 ' CG2' HD22 ' A' ' 181' ' ' LEU . 70.2 m -54.56 -45.8 73.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.72999999999999998 111.173 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.5 -44.65 76.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.82999999999999996 111.101 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.577 HG21 ' CZ ' ' A' ' 248' ' ' PHE . 29.4 t -51.35 -49.88 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.77000000000000002 111.171 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -55.29 -33.77 63.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 1.9199999999999999 110.832 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.553 ' HG3' ' HB1' ' A' ' 195' ' ' ALA . 1.7 tm-20 -74.52 -40.71 61.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 110.885 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.535 HG13 ' HB1' ' A' ' 137' ' ' ALA . 42.9 mm -50.78 -47.48 28.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 1.54 111.116 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.98 -23.99 70.44 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 0.96999999999999997 112.495 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -49.44 70.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 2.8599999999999999 110.869 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 43.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 1.8700000000000001 110.828 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.3 mt -144.33 -42.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 2.3900000000000001 110.923 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 168.71 -38.0 0.21 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.787 -0.72 . . . . 2.3300000000000001 112.529 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.19 177.91 7.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 3.3300000000000001 110.922 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.42 -77.62 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.729 . . . . 3.48 112.477 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -143.11 113.98 7.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.865 0.364 . . . . 1.8 110.866 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.1 t -92.35 -78.16 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 4.4800000000000004 110.902 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.4 t 176.85 -33.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 4.4199999999999999 110.853 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -49.55 108.13 0.92 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 2.4199999999999999 110.85 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.9 Cg_endo -69.79 167.78 23.48 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.688 2.259 . . . . 1.74 112.329 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.65 29.82 6.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 4.2400000000000002 110.931 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.73 -174.61 2.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 1.97 111.101 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 235' ' ' VAL . 11.6 t -93.56 -4.1 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 2.9199999999999999 111.112 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.433 ' HA ' ' HE3' ' A' ' 236' ' ' MET . 1.6 tpt -83.25 -41.66 18.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 3.6699999999999999 110.849 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.695 ' HB3' HG22 ' A' ' 239' ' ' THR . 0.1 OUTLIER -51.32 149.83 6.91 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.659 0.742 . . . . 3.6499999999999999 110.893 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -7.23 20.5 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.685 2.256 . . . . 2.7200000000000002 112.351 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.695 HG22 ' HB3' ' A' ' 237' ' ' PHE . 14.7 t -84.86 138.01 32.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 2.5699999999999998 111.139 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -66.25 145.44 55.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 3.8500000000000001 110.892 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.615 ' CB ' HD22 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -90.88 102.39 15.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 4.3700000000000001 110.888 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.405 ' HB2' ' HA3' ' A' ' 208' ' ' GLY . 18.6 p90 -91.8 44.37 1.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 6.2800000000000002 110.941 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.18 177.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 3.5899999999999999 111.141 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.753 ' HB3' HG22 ' A' ' 247' ' ' THR . 0.5 OUTLIER -59.79 126.26 26.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 3.1400000000000001 110.836 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 214' ' ' LEU . 25.0 pt -76.42 -30.28 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 3.4700000000000002 111.106 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -65.86 -39.57 90.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 4.9699999999999998 110.853 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.753 HG22 ' HB3' ' A' ' 244' ' ' ASP . 14.6 t -94.71 -4.77 46.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 3.2999999999999998 111.116 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 217' ' ' VAL . 21.6 t80 -51.84 144.18 11.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 5.0800000000000001 110.887 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -175.05 151.45 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 3.48 110.857 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 140' ' ' VAL . 0.8 OUTLIER -52.45 145.3 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 2.0800000000000001 110.932 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.613 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.2 OUTLIER -154.42 -172.24 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 3.5299999999999998 110.849 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 65.56 161.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 3.77 111.118 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -22.89 51.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 3.2000000000000002 110.903 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -51.32 -29.75 16.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 3.6400000000000001 110.888 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.845 HG12 HG11 ' A' ' 144' ' ' VAL . 8.2 tt -50.74 -29.65 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 2.1499999999999999 111.164 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -92.34 -31.16 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 6.5899999999999999 110.827 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.06 -16.86 60.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.778 -0.725 . . . . 1.8400000000000001 112.494 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.425 ' CG2' HG23 ' A' ' 144' ' ' VAL . 8.4 tp -93.33 -31.47 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.776 0.322 . . . . 1.02 111.121 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -78.43 -48.2 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 4.6799999999999997 110.912 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 2.6699999999999999 110.876 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.815 0.34 . . . . 2.1800000000000002 111.153 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.61 ' CD2' HD11 ' A' ' 159' ' ' ILE . 7.4 m-85 -127.56 152.43 47.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 6.5599999999999996 110.889 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -161.88 133.79 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 4.4500000000000002 110.904 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.584 HG23 ' CG2' ' A' ' 161' ' ' VAL . 86.8 mt -108.12 144.06 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 2.3900000000000001 111.122 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -108.96 -76.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 3.6800000000000002 110.881 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.81 -178.28 4.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 6.1100000000000003 110.9 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.731 ' HB2' HG11 ' A' ' 130' ' ' VAL . 13.1 p90 -140.85 163.23 33.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 5.3200000000000003 110.916 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.0 m -73.73 131.34 82.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.528 0.68 . . . . 2.9399999999999999 111.142 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -34.87 13.73 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.702 2.268 . . . . 2.3500000000000001 112.366 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -50.49 -53.73 27.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 4.9699999999999998 110.848 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 19.6 mmt -101.33 154.6 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 3.6600000000000001 110.888 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -59.1 149.09 28.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 2.9700000000000002 110.899 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -58.5 -20.87 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 4.8399999999999999 110.888 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.24 -37.28 61.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 3.7999999999999998 110.909 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 11.7 m-20 -61.62 -52.2 65.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 3.0499999999999998 110.886 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.731 HG11 ' HB2' ' A' ' 121' ' ' TYR . 3.8 p -69.43 -30.0 43.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 1.1299999999999999 111.149 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.42 -48.73 47.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 3.3900000000000001 110.871 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -75.36 -33.56 61.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.461 . . . . 2.9900000000000002 110.925 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -51.45 -58.8 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.59 HD12 ' N ' ' A' ' 135' ' ' ARG . 2.9 pp -68.34 -28.01 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 4.1399999999999997 111.107 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.59 ' N ' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -50.61 -51.0 52.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 4.75 110.908 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -78.63 -32.07 47.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 3.2799999999999998 110.936 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.653 ' HB1' HD12 ' A' ' 220' ' ' ILE . . . -55.88 -34.85 65.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 1.25 111.111 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -73.96 -28.38 61.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 4.6600000000000001 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.07 -51.34 9.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 3.5499999999999998 110.913 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.9 p -51.15 -29.84 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 2.52 111.141 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -85.91 -51.38 6.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 3.8399999999999999 110.918 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.6 p -60.98 -17.23 50.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 1.79 110.894 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -50.4 -30.69 12.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 3.0299999999999998 110.936 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.749 HG11 ' CG1' ' A' ' 255' ' ' ILE . 33.6 m -133.39 36.42 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 2.0299999999999998 111.069 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.704 HG21 HD11 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -146.08 132.96 9.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.566 0.698 . . . . 1.6299999999999999 111.148 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 64.9 1.79 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.712 2.274 . . . . 2.1200000000000001 112.316 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mp -121.1 150.05 41.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 3.0600000000000001 110.899 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.0 174.34 6.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 4.6399999999999997 110.893 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -112.57 126.09 54.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 8.4299999999999997 110.903 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.5 t -133.38 89.99 2.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 2.2599999999999998 110.869 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -81.75 121.94 27.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 2.6600000000000001 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.461 HG22 ' H ' ' A' ' 154' ' ' THR . 38.0 mt -137.48 113.21 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 3.25 111.127 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.07 -28.92 27.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 4.0800000000000001 110.844 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.461 ' H ' HG22 ' A' ' 152' ' ' ILE . 94.9 m -160.73 110.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 3.98 111.13 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -173.32 -134.15 1.78 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.758 . . . . 2.3500000000000001 112.466 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 120.51 42.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.321 . . . . 5.5999999999999996 110.89 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.94 129.41 43.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 1.45 111.084 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.06 -18.73 28.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 2.4100000000000001 110.866 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.61 HD11 ' CD2' ' A' ' 116' ' ' TYR . 2.0 pp -138.82 127.04 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 3.1899999999999999 111.133 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.409 ' H ' HD12 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -136.24 166.38 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 2.3399999999999999 110.938 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.633 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 3.1 m -112.24 110.09 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 3.1000000000000001 111.074 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 163' ' ' PHE . 0.4 OUTLIER -120.66 174.71 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 1.74 111.123 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.501 ' H ' HG22 ' A' ' 162' ' ' VAL . 47.7 p90 -106.78 125.06 50.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 5.3200000000000003 110.904 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.418 ' HB2' ' HD2' ' A' ' 196' ' ' HIS . . . -125.71 148.34 49.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 1.6299999999999999 111.12 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.63 111.57 13.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 4.5599999999999996 110.853 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.61 -139.56 16.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 1.3899999999999999 112.457 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.06 111.09 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 2.0699999999999998 111.135 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -92.29 43.69 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 2.8700000000000001 110.823 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.83 95.53 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.721 -0.752 . . . . 2.8700000000000001 112.487 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.4 41.79 7.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.819 0.342 . . . . 6.3399999999999999 110.87 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.12 -168.81 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 4.4199999999999999 110.919 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -76.9 102.95 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 4.3899999999999997 110.853 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.73 112.3 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 1.53 111.093 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -70.01 -168.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 6.0800000000000001 110.868 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.53 ' HB3' HD12 ' A' ' 180' ' ' ILE . 4.6 t70 -131.95 -41.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 4.6900000000000004 110.915 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 123.22 -172.42 16.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 1.74 112.504 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.06 118.8 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.331 . . . . 4.7400000000000002 110.883 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.62 -47.34 1.05 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 2.54 112.485 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -88.86 -121.01 1.83 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.717 -0.754 . . . . 1.3799999999999999 112.477 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 175' ' ' ASP . 2.0 mp -71.32 148.51 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 3.3599999999999999 111.152 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.622 HD12 ' H ' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -113.8 -29.55 7.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 3.6299999999999999 110.935 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.622 ' H ' HD12 ' A' ' 181' ' ' LEU . . . -178.69 123.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 1.6299999999999999 111.096 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -94.97 162.94 13.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 3.1400000000000001 110.891 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -173.23 105.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.98999999999999999 111.048 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.88 170.19 4.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 2.73 110.867 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.09 165.87 1.13 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 1.23 112.458 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 165.24 31.71 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 0.98999999999999999 112.367 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.04 -136.44 5.03 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 1.3799999999999999 112.47 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.89 121.26 44.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 3.4300000000000002 110.832 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.21 -62.93 2.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.756 . . . . 1.72 112.505 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.525 ' O ' HG22 ' A' ' 191' ' ' ILE . 11.7 mt -93.95 21.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 2.4399999999999999 111.138 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.7 -106.99 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 2.7200000000000002 112.483 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.492 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . -92.07 37.66 3.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 1.1200000000000001 112.493 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -50.77 126.06 14.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.794 0.33 . . . . 2.1000000000000001 110.89 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.82 ' HB1' ' CE2' ' A' ' 197' ' ' PHE . . . -101.86 145.97 28.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 1.24 111.098 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.418 ' HD2' ' HB2' ' A' ' 164' ' ' ALA . 73.8 m80 -139.79 107.69 5.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 3.04 110.829 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.82 ' CE2' ' HB1' ' A' ' 195' ' ' ALA . 10.2 m-85 -143.82 108.52 4.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 3.3500000000000001 110.883 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 t70 179.38 -82.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 8.2200000000000006 110.832 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.41 153.57 28.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 7.7300000000000004 110.913 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 64.69 125.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 6.4699999999999998 110.905 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 63.57 70.45 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 4.5700000000000003 110.909 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -45.78 157.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 5.0499999999999998 110.87 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.62 ' CZ3' HG21 ' A' ' 215' ' ' THR . 66.2 m95 -105.35 175.05 5.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 7.2300000000000004 110.905 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.45 HG21 ' H ' ' A' ' 209' ' ' GLY . 0.0 OUTLIER -157.28 173.44 16.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 2.04 111.144 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -171.51 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 2.0600000000000001 111.142 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -67.01 -21.76 65.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 5.0199999999999996 110.876 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.6 m -103.62 -24.71 13.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 2.46 110.812 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -62.48 -160.43 0.18 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 2.25 112.503 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.45 ' H ' HG21 ' A' ' 204' ' ' THR . . . -60.6 -101.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 1.6399999999999999 112.492 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 210' ' ' THR . 2.4 t -80.42 103.57 10.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 3.6000000000000001 111.105 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 243' ' ' VAL . 9.8 m-20 -50.38 116.37 1.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 2.9900000000000002 110.929 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 203' ' ' TRP . 11.5 tp -60.76 -39.29 88.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 3.0699999999999998 110.954 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.521 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -72.39 -34.7 68.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 5.4000000000000004 110.881 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -55.07 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 2.9900000000000002 110.944 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.62 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 98.4 m -54.97 -38.47 67.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 1.1399999999999999 111.151 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.14 -32.25 61.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.84999999999999998 111.086 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 137' ' ' ALA . 5.0 t -70.64 -25.53 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.98999999999999999 111.135 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -69.57 -61.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 1.8400000000000001 110.868 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.406 ' CD ' ' HB3' ' A' ' 182' ' ' ALA . 3.4 mp0 -58.99 -50.02 75.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 4.7199999999999998 110.869 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.653 HD12 ' HB1' ' A' ' 137' ' ' ALA . 72.1 mt -51.42 -29.52 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 2.02 111.161 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.56 -44.36 16.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 0.75 112.492 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.59 -34.33 76.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 2.5899999999999999 110.83 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -28.91 18.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 2.3599999999999999 110.903 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.3 mp -93.73 -24.64 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 2.3399999999999999 110.923 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.526 ' O ' HD22 ' A' ' 226' ' ' LEU . . . 126.38 105.49 1.43 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 1.8100000000000001 112.489 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.619 HD21 ' O ' ' A' ' 257' ' ' GLY . 0.2 OUTLIER -149.37 -68.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 3.25 110.866 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 73.31 31.59 61.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 3.4199999999999999 112.468 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 21.6 m80 64.47 155.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 2.2200000000000002 110.877 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 59.4 m -124.84 -78.14 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 4.3600000000000003 110.86 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.16 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 4.4900000000000002 110.884 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -47.44 106.64 0.62 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.577 0.703 . . . . 3.2999999999999998 110.865 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.3 21.94 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 1.8899999999999999 112.359 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.0 mptt 50.65 29.96 4.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 5.5499999999999998 110.934 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.531 ' HB1' ' OD2' ' A' ' 254' ' ' ASP . . . -130.59 -168.88 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 2.1800000000000002 111.101 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.451 ' HB ' ' HE2' ' A' ' 236' ' ' MET . 55.3 t -50.42 -57.26 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 4.4500000000000002 111.13 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.451 ' HE2' ' HB ' ' A' ' 235' ' ' VAL . 9.8 mmt -59.41 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 3.3999999999999999 110.875 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 238' ' ' PRO . 0.2 OUTLIER 63.72 99.62 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.651 0.739 . . . . 4.54 110.915 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 237' ' ' PHE . 53.4 Cg_endo -69.83 77.95 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.693 2.262 . . . . 3.3599999999999999 112.283 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.4 p -145.46 125.53 13.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 2.6899999999999999 111.116 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -62.77 126.39 27.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 4.4199999999999999 110.875 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -150.69 92.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 4.1799999999999997 110.89 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -58.68 127.29 31.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 3.46 110.91 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.557 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 7.6 p -135.97 154.32 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 2.4100000000000001 111.167 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.19 113.15 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 2.8199999999999998 110.835 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.0 tt -74.28 -34.5 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.5499999999999998 111.163 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -24.02 67.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 2.8500000000000001 110.914 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 14.6 19.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 2.5699999999999998 111.168 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -51.36 156.97 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 5.1299999999999999 110.879 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -178.67 148.15 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 3.5600000000000001 110.88 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.14 161.11 2.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 2.8900000000000001 110.893 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.429 ' OG ' HG23 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -88.93 150.76 22.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 4.7800000000000002 110.874 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.434 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -68.96 -68.34 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 3.4300000000000002 111.106 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -53.31 -36.91 61.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 3.6000000000000001 110.853 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.531 ' OD2' ' HB1' ' A' ' 234' ' ' ALA . 25.0 m-20 -70.96 -29.23 65.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 3.27 110.838 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.749 ' CG1' HG11 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -51.09 -28.6 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.73 111.111 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -77.78 -37.19 49.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 5.7000000000000002 110.853 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.619 ' O ' HD21 ' A' ' 226' ' ' LEU . . . -78.63 57.11 4.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 2.6600000000000001 112.488 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.704 HD11 HG21 ' A' ' 145' ' ' THR . 4.9 tp -179.16 -40.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.85999999999999999 111.17 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -75.03 -45.07 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 3.0299999999999998 110.908 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 2.1499999999999999 110.827 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.724 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 71.8 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.822 0.344 . . . . 2.0600000000000001 111.128 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -145.57 173.28 12.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 4.2199999999999998 110.962 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -160.5 125.89 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 7.2400000000000002 110.838 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.718 HG21 HG13 ' A' ' 134' ' ' ILE . 1.6 pt -108.17 121.63 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 3.23 111.138 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -136.11 47.92 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 3.98 110.88 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.534 ' OD1' HG12 ' A' ' 161' ' ' VAL . 1.1 p-10 -137.5 153.23 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 5.6200000000000001 110.867 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -147.4 163.15 37.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 7.7999999999999998 110.883 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 p -125.37 151.72 70.3 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.712 . . . . 2.6200000000000001 111.155 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 169.08 19.75 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.713 2.276 . . . . 3.1800000000000002 112.337 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.1 t70 75.65 -52.06 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 6.0300000000000002 110.824 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.749 ' HG2' HG23 ' A' ' 205' ' ' THR . 3.7 mpp? -97.66 132.91 42.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 3.4300000000000002 110.895 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.99 155.75 10.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 3.48 110.879 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.06 -23.12 12.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 5.1299999999999999 110.851 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -41.01 84.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 3.8999999999999999 110.91 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.36 -54.67 44.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 2.6000000000000001 110.874 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.504 ' O ' HD13 ' A' ' 134' ' ' ILE . 6.1 p -62.21 -40.66 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.83999999999999997 111.111 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.13 -40.83 61.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 3.2999999999999998 110.875 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -74.61 -31.08 61.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 2.9199999999999999 110.932 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.24 -52.46 35.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 1.1499999999999999 111.096 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.718 HG13 HG21 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -83.02 -28.52 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 2.27 111.152 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -50.98 -55.08 19.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 6.5300000000000002 110.869 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -78.25 -25.94 47.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 3.6200000000000001 110.874 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.665 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.82 -37.26 68.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.80000000000000004 111.1 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -27.03 61.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 3.4300000000000002 110.852 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.97 -48.81 13.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 2.9700000000000002 110.886 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.461 ' O ' HD12 ' A' ' 250' ' ' LEU . 4.6 p -55.8 -27.07 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 2.1299999999999999 111.115 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.705 ' HE1' HD11 ' A' ' 258' ' ' ILE . 21.4 t90 -91.1 -54.37 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 9.5800000000000001 110.933 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.5 p -59.22 -18.4 36.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 1.71 110.841 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.2 -26.66 61.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 2.3599999999999999 110.921 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.605 HG11 HD13 ' A' ' 250' ' ' LEU . 7.1 p -103.85 -23.87 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 3.5499999999999998 111.114 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.731 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -106.57 145.26 30.67 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.56 0.695 . . . . 1.6799999999999999 111.15 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.731 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.8 Cg_endo -69.76 -8.58 23.97 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.676 2.251 . . . . 1.9099999999999999 112.308 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -51.6 158.2 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 2.9399999999999999 110.881 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.23 138.71 52.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 6.1399999999999997 110.918 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -101.54 139.25 37.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 6.5700000000000003 110.871 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.71 ' HB3' HG22 ' A' ' 115' ' ' THR . 0.6 OUTLIER -143.0 90.04 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 1.6599999999999999 110.849 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -77.81 122.77 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 3.8999999999999999 110.889 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 154' ' ' THR . 15.7 pt -140.18 163.79 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 2.4399999999999999 111.14 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -109.59 28.9 8.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 3.71 110.888 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.457 ' O ' HD12 ' A' ' 152' ' ' ILE . 14.6 t -157.65 174.05 15.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 3.6000000000000001 111.145 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.62 -173.62 12.15 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.74 . . . . 1.5800000000000001 112.507 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.46 166.34 10.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 5.5599999999999996 110.873 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.724 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -144.62 146.94 32.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 1.1399999999999999 111.113 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -26.65 68.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 2.4399999999999999 110.879 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.8 mm -104.04 109.9 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 2.8700000000000001 111.173 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.674 HD22 ' N ' ' A' ' 161' ' ' VAL . 0.9 OUTLIER -111.22 119.35 38.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 1.49 110.94 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.674 ' N ' HD22 ' A' ' 160' ' ' LEU . 16.0 t -108.61 109.9 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 1.52 111.129 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.65 HG23 HD21 ' A' ' 160' ' ' LEU . 72.2 t -134.35 144.97 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 1.28 111.134 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -92.22 153.17 19.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 3.9300000000000002 110.895 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.537 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . . . -164.33 178.02 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 1.0800000000000001 111.118 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -145.04 111.54 5.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 5.1100000000000003 110.9 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 63.73 -147.67 50.67 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.712 -0.756 . . . . 1.1299999999999999 112.504 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.54 112.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 1.26 111.105 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -95.66 27.95 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 2.8700000000000001 110.812 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.52 18.21 60.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 2.8399999999999999 112.46 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -106.61 -74.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.763 0.316 . . . . 6.9299999999999997 110.89 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.19 -65.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 4.54 110.882 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -77.39 107.09 9.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 5.0999999999999996 110.868 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.32 159.64 23.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 1.8200000000000001 111.118 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.84 113.83 2.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 6.8300000000000001 110.818 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.96 -169.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 7.4699999999999998 110.907 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.99 97.82 2.11 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 2.2999999999999998 112.477 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -51.67 119.19 3.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 3.5 110.859 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.19 7.05 62.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 2.2999999999999998 112.475 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -114.76 -126.39 4.19 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 1.48 112.538 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 180' ' ' ILE . 3.6 mp -89.16 93.9 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 2.6800000000000002 111.129 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -49.9 -26.9 4.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 3.1400000000000001 110.858 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.5 171.49 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 1.3100000000000001 111.107 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -160.14 106.26 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 3.0499999999999998 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.409 ' HB1' ' OG ' ' A' ' 223' ' ' SER . . . -110.75 109.84 20.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.79000000000000004 111.087 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.06 169.65 4.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 3.0600000000000001 110.927 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.39 173.8 0.25 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.98999999999999999 112.443 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 179.62 3.58 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.689 2.259 . . . . 0.93000000000000005 112.353 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 154.12 -128.79 2.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 1.3600000000000001 112.529 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.08 141.12 52.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.927 0.394 . . . . 2.0 110.85 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.5 -76.54 0.95 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.721 . . . . 1.1499999999999999 112.504 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 191' ' ' ILE . 11.1 tt -104.92 16.41 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 3.0499999999999998 111.13 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.88 -77.58 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 2.8300000000000001 112.473 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.94 2.22 81.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.775 -0.726 . . . . 1.0600000000000001 112.479 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.51 127.42 17.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.785 0.326 . . . . 2.21 110.873 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.87 146.39 50.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 1.4399999999999999 111.088 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.537 ' CD2' ' HB3' ' A' ' 164' ' ' ALA . 32.7 t-80 -113.76 149.89 34.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 6.0899999999999999 110.834 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.97 147.56 44.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 4.0499999999999998 110.889 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.74 -35.84 10.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 5.6200000000000001 110.84 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 63.28 -82.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 7.75 110.853 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -134.87 35.21 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 6.4699999999999998 110.868 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.8 -5.58 6.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 4.5099999999999998 110.865 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.17 73.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 8.5299999999999994 110.87 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -105.36 124.62 49.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 9.4399999999999995 110.96 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.465 HG21 ' N ' ' A' ' 209' ' ' GLY . 0.0 OUTLIER -157.47 153.45 27.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 2.3799999999999999 111.167 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.749 HG23 ' HG2' ' A' ' 125' ' ' MET . 0.1 OUTLIER -87.8 -172.51 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 2.27 111.148 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.508 ' HB3' HG21 ' A' ' 245' ' ' ILE . 25.5 p-80 -50.27 -48.32 54.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 4.4500000000000002 110.826 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.5 p -76.82 -38.03 54.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 2.75 110.857 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.77 172.11 0.28 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 2.2599999999999998 112.494 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.465 ' N ' HG21 ' A' ' 204' ' ' THR . . . -47.45 -85.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 1.55 112.472 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 88.3 m -79.36 98.34 6.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.815 0.341 . . . . 2.27 111.167 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.411 HD22 HG12 ' A' ' 243' ' ' VAL . 51.3 t-20 -51.14 115.48 1.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 3.3300000000000001 110.914 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -35.28 38.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 2.8500000000000001 110.9 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.414 ' O ' HG23 ' A' ' 217' ' ' VAL . 39.5 t80 -72.33 -53.6 11.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 5.2800000000000002 110.86 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.473 HD13 HG11 ' A' ' 243' ' ' VAL . 10.6 tp -51.86 -47.75 64.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 2.7799999999999998 110.933 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.582 HG23 HD22 ' A' ' 181' ' ' LEU . 0.7 OUTLIER -55.38 -51.23 67.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 1.0700000000000001 111.154 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.59 -48.88 74.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.70999999999999996 111.132 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.665 HG22 ' HA ' ' A' ' 137' ' ' ALA . 49.0 t -61.5 -20.49 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.72999999999999998 111.139 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -74.33 -46.25 42.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 2.02 110.891 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.75 -23.46 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 5.4800000000000004 110.859 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 224' ' ' LEU . 21.7 mm -65.56 -52.08 55.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 1.3200000000000001 111.118 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.96 -25.69 66.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 0.67000000000000004 112.438 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -51.33 70.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 2.5600000000000001 110.887 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.409 ' OG ' ' HB1' ' A' ' 184' ' ' ALA . 0.9 OUTLIER -91.26 46.14 1.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 1.8999999999999999 110.861 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 220' ' ' ILE . 1.2 mt -156.12 22.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 1.9399999999999999 110.913 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.27 5.28 89.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 1.78 112.487 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.473 ' HB2' HD13 ' A' ' 258' ' ' ILE . 19.4 tp -120.27 68.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 4.3200000000000003 110.906 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -86.05 -101.83 0.74 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.765 -0.731 . . . . 3.7000000000000002 112.443 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -118.46 153.61 33.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.338 . . . . 2.29 110.858 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.3 m -135.86 -75.91 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 4.3700000000000001 110.844 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.62 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 3.6600000000000001 110.864 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 30.7 m-20 -49.28 108.27 0.94 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.577 0.703 . . . . 3.3999999999999999 110.853 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 233' ' ' LYS . 53.7 Cg_endo -69.76 -179.82 3.18 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.658 2.238 . . . . 1.8600000000000001 112.337 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.53 42.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 4.5999999999999996 110.897 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -128.91 -175.78 3.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 1.9199999999999999 111.117 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 43.0 t -93.05 -17.72 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 3.0299999999999998 111.117 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -82.23 -41.53 20.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 4.79 110.887 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -51.54 136.4 33.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.668 0.747 . . . . 3.7999999999999998 110.915 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.453 ' O ' HG23 ' A' ' 239' ' ' THR . 54.1 Cg_endo -69.77 77.77 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.258 . . . . 2.1000000000000001 112.355 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 238' ' ' PRO . 2.0 p -156.92 160.36 39.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 2.71 111.154 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -127.05 113.2 16.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 3.75 110.952 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.02 128.41 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.467 . . . . 3.1899999999999999 110.919 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -51.71 121.95 7.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 3.3999999999999999 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.473 HG11 HD13 ' A' ' 214' ' ' LEU . 11.3 p -122.18 148.8 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 2.71 111.168 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -54.98 113.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 4.0999999999999996 110.87 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.508 HG21 ' HB3' ' A' ' 206' ' ' HIS . 1.3 pp -76.75 -31.27 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 2.6200000000000001 111.117 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -36.04 78.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 2.8199999999999998 110.868 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 21.0 p -104.71 24.69 11.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 2.7799999999999998 111.155 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -51.78 134.34 30.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 5.7699999999999996 110.929 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -178.54 136.47 0.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 4.2400000000000002 110.838 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.646 HD22 HG13 ' A' ' 255' ' ' ILE . 0.4 OUTLIER -52.65 152.7 3.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 2.1400000000000001 110.887 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 252' ' ' ALA . 0.1 OUTLIER -154.54 -170.95 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 3.23 110.889 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.667 ' HB3' ' OD2' ' A' ' 254' ' ' ASP . . . 69.18 157.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 4.1399999999999997 111.079 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.27 -24.9 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 2.77 110.883 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.667 ' OD2' ' HB3' ' A' ' 252' ' ' ALA . 1.2 p30 -50.78 -29.9 12.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 3.04 110.83 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.646 HG13 HD22 ' A' ' 250' ' ' LEU . 17.8 tt -54.24 -29.67 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 1.97 111.123 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -83.1 -24.8 32.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 5.5999999999999996 110.852 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -81.42 -44.85 7.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.815 -0.707 . . . . 2.54 112.479 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.705 HD11 ' HE1' ' A' ' 141' ' ' TRP . 5.7 tp -54.58 -36.93 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.81999999999999995 111.089 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -77.04 -49.72 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 3.4399999999999999 110.913 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 2.6499999999999999 110.83 -179.778 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.805 0.336 . . . . 2.3799999999999999 111.138 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -134.4 147.26 50.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 4.8300000000000001 110.903 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -153.06 152.63 31.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 3.9500000000000002 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.39 144.59 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 2.7599999999999998 111.109 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.44 ' HB3' HG22 ' A' ' 162' ' ' VAL . 13.7 m-80 -142.78 20.03 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 3.6600000000000001 110.886 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.444 ' OD1' HG12 ' A' ' 161' ' ' VAL . 6.6 p-10 -122.44 157.7 31.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 5.8099999999999996 110.91 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.92 106.41 3.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 7.6399999999999997 110.916 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.747 HG23 ' HB2' ' A' ' 203' ' ' TRP . 16.3 m -70.66 120.0 76.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.598 0.713 . . . . 3.3799999999999999 111.115 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -48.38 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.702 2.268 . . . . 2.6499999999999999 112.341 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -23.44 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 4.8200000000000003 110.906 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.727 ' HE3' HG22 ' A' ' 204' ' ' THR . 23.8 mmt -124.77 -174.56 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 3.2799999999999998 110.912 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.558 ' O ' HG12 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -86.9 162.06 17.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 3.0099999999999998 110.88 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -74.61 -20.91 59.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 6.5899999999999999 110.891 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.51 -54.44 5.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 5.0599999999999996 110.864 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -55.31 -40.18 70.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 4.0599999999999996 110.886 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 126' ' ' ASN . 9.3 p -74.35 -37.16 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.0700000000000001 111.121 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -62.68 -55.16 29.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 3.0099999999999998 110.878 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -65.89 -31.92 73.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 3.8300000000000001 110.933 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -50.94 -41.86 59.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 1.0800000000000001 111.105 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.582 HD12 ' CZ ' ' A' ' 197' ' ' PHE . 2.6 mm -79.31 -43.16 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 2.54 111.169 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.24 -30.25 49.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 3.9300000000000002 110.91 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -78.49 -27.3 46.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 3.1499999999999999 110.844 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.485 ' HB1' HG13 ' A' ' 220' ' ' ILE . . . -55.69 -33.03 63.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 1.21 111.121 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -73.85 -25.8 60.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 3.5600000000000001 110.905 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -79.08 -52.79 7.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 2.4300000000000002 110.935 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.14 -42.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 2.0800000000000001 111.098 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.489 ' CE3' HD11 ' A' ' 250' ' ' LEU . 9.3 m95 -75.54 -43.59 47.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 4.1200000000000001 110.925 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.0 t -62.6 -15.07 49.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 2.5800000000000001 110.894 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.34 -23.13 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 2.7999999999999998 110.883 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.489 HG11 HG12 ' A' ' 255' ' ' ILE . 0.0 OUTLIER -120.3 -32.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 2.6299999999999999 111.084 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.498 HG21 HG12 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -107.09 150.16 39.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.573 0.701 . . . . 2.5499999999999998 111.127 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -53.41 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.69 2.26 . . . . 3.2799999999999998 112.359 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tp 46.55 -165.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 3.8900000000000001 110.858 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.61 131.14 11.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 3.8100000000000001 110.862 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -115.47 144.93 43.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 6.4500000000000002 110.908 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.442 ' O ' HD13 ' A' ' 152' ' ' ILE . 11.8 t -156.99 90.76 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 2.29 110.853 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -91.11 107.13 19.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 2.77 110.878 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -122.89 139.57 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 2.4300000000000002 111.098 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -64.27 -24.02 67.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 3.4399999999999999 110.914 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.7 m -138.06 148.91 45.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.462 . . . . 3.0499999999999998 111.147 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.83 -173.28 19.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.756 -0.735 . . . . 1.77 112.458 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.8 mtt -110.65 145.87 37.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 5.4500000000000002 110.843 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.43 130.05 36.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 1.47 111.114 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.26 -22.6 66.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 3.54 110.864 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.0 mm -104.18 84.36 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 2.8799999999999999 111.164 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.2 tm? -91.34 115.24 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 1.7 110.887 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.823 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 21.9 t -98.88 110.88 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 1.4399999999999999 111.126 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.555 ' CG2' HD11 ' A' ' 160' ' ' LEU . 46.3 t -138.97 139.96 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 1.4099999999999999 111.136 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -82.48 122.87 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 3.4199999999999999 110.87 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.99 178.38 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 1.45 111.08 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -145.18 126.93 15.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 8.0800000000000001 110.862 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.0 -134.1 32.04 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.752 -0.737 . . . . 1.4399999999999999 112.516 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.62 113.42 20.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 1.5800000000000001 111.075 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -90.87 154.04 19.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 3.4900000000000002 110.89 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.96 -14.0 54.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 3.4100000000000001 112.483 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.22 23.5 5.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.774 0.321 . . . . 7.5700000000000003 110.865 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.0 t70 63.4 52.94 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 6.6500000000000004 110.865 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -127.59 79.68 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 4.96 110.826 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.39 129.05 34.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 1.6299999999999999 111.082 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.09 173.08 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 10.06 110.903 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.605 ' OD2' HD12 ' A' ' 180' ' ' ILE . 13.9 t70 -125.58 -2.5 7.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 6.0700000000000003 110.866 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 77.36 148.1 2.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 2.1600000000000001 112.501 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.41 153.71 2.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 5.9500000000000002 110.901 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.74 -1.41 87.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.737 -0.744 . . . . 3.0600000000000001 112.452 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.37 -141.27 3.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 2.4900000000000002 112.453 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.702 HG21 ' CD2' ' A' ' 183' ' ' HIS . 2.8 mp -71.47 91.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 2.5600000000000001 111.127 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -48.28 -29.49 3.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 3.23 110.912 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.747 ' N ' HD12 ' A' ' 181' ' ' LEU . . . -179.62 178.0 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.8400000000000001 111.162 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.702 ' CD2' HG21 ' A' ' 180' ' ' ILE . 1.0 OUTLIER -153.03 130.14 11.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 4.1500000000000004 110.83 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -116.94 119.88 36.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.64000000000000001 111.106 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.38 165.27 9.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 2.54 110.83 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.25 173.14 0.28 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.734 -0.746 . . . . 0.90000000000000002 112.495 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -169.53 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.617 2.212 . . . . 1.24 112.344 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.12 -146.13 16.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 1.3700000000000001 112.437 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.4 m -94.69 154.54 17.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 1.8600000000000001 110.867 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.62 -103.81 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 1.3 112.447 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.23 -23.8 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 2.0600000000000001 111.141 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -57.0 99.61 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.775 -0.726 . . . . 2.5899999999999999 112.514 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 113.62 -12.08 23.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 1.1599999999999999 112.46 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.542 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 3.4 m-20 -49.96 145.35 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.356 . . . . 2.6400000000000001 110.826 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.823 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -131.97 135.3 46.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.82999999999999996 111.082 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -124.76 117.86 25.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 2.77 110.854 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.582 ' CZ ' HD12 ' A' ' 134' ' ' ILE . 8.0 m-85 -100.98 101.76 12.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 2.9199999999999999 110.838 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.646 ' OD1' HG21 ' A' ' 210' ' ' THR . 0.6 OUTLIER 50.63 93.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 5.7199999999999998 110.868 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.59 87.08 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 9.4900000000000002 110.882 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 34.3 t70 64.5 15.3 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 3.3799999999999999 110.876 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.72 -78.09 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 4.4699999999999998 110.885 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 178.41 124.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 4.2800000000000002 110.913 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.747 ' HB2' HG23 ' A' ' 122' ' ' THR . 1.4 m-90 -102.03 137.78 39.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 7.1699999999999999 110.928 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.727 HG22 ' HE3' ' A' ' 125' ' ' MET . 0.0 OUTLIER -157.11 169.05 25.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 1.96 111.16 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.41 HG23 ' SD ' ' A' ' 125' ' ' MET . 0.6 OUTLIER -75.31 173.89 10.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 1.9399999999999999 111.161 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -50.55 -30.31 12.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 5.1399999999999997 110.858 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.04 -37.63 17.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 2.27 110.851 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -56.45 -178.03 0.37 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.703 -0.76 . . . . 3.0 112.478 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.96 -64.18 3.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.765 -0.731 . . . . 2.4100000000000001 112.511 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.646 HG21 ' OD1' ' A' ' 198' ' ' ASP . 0.2 OUTLIER -97.73 102.13 13.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 1.8899999999999999 111.149 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.697 HD21 HD22 ' A' ' 214' ' ' LEU . 12.9 p30 -59.91 95.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 4.3700000000000001 110.865 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.491 ' C ' HD13 ' A' ' 212' ' ' LEU . 2.8 tm? -59.68 -32.83 70.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 2.8799999999999999 110.934 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.511 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 24.8 m-85 -66.56 -64.32 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 5.6799999999999997 110.868 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.697 HD22 HD21 ' A' ' 211' ' ' ASN . 2.9 tt -59.16 -46.68 87.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 2.5899999999999999 110.916 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 74.3 m -54.49 -26.28 30.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.73999999999999999 111.18 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.08 -42.73 75.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.76000000000000001 111.083 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.5 t -59.38 -46.88 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.83999999999999997 111.17 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -53.61 -31.83 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 2.04 110.838 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -74.75 -42.9 57.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 5.5700000000000003 110.845 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 224' ' ' LEU . 46.1 mm -51.1 -44.74 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 1.7 111.115 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.99 -32.66 52.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.90000000000000002 112.479 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -36.67 81.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 3.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.98 29.06 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 2.4300000000000002 110.861 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 220' ' ' ILE . 9.0 mt -139.7 -52.69 0.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 2.4399999999999999 110.945 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -176.41 -151.0 8.53 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.739 . . . . 2.2599999999999998 112.497 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 68.69 -75.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 3.8100000000000001 110.928 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 110.88 -74.39 0.21 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 2.9199999999999999 112.509 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -170.99 84.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 2.0099999999999998 110.853 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.15 171.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 4.54 110.836 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -25.18 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 4.1500000000000004 110.828 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 0.7 OUTLIER -50.6 108.74 1.1 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.595 0.712 . . . . 2.2599999999999998 110.808 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.6 Cg_endo -69.75 162.19 43.02 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 2.1899999999999999 112.336 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 58.36 22.56 9.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 5.4699999999999998 110.87 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -111.19 158.59 18.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 1.98 111.071 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.86 -23.93 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 3.3900000000000001 111.157 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -49.46 22.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 4.1799999999999997 110.881 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -52.34 136.68 40.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.65 0.738 . . . . 4.0199999999999996 110.859 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 93.9 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.685 2.257 . . . . 2.54 112.323 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.9 t -156.96 153.38 27.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 3.2200000000000002 111.158 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -110.55 125.86 53.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 3.7799999999999998 110.908 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.03 96.25 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 4.0899999999999999 110.841 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -49.9 122.76 6.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 4.1600000000000001 110.953 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.3 p -120.22 153.49 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 2.7599999999999998 111.123 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.51 137.03 42.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 4.3200000000000003 110.911 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.07 -26.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 3.27 111.111 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -64.9 -39.36 93.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 4.3200000000000003 110.88 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 -10.85 24.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 3.5499999999999998 111.105 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.58 120.51 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 4.0599999999999996 110.89 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 175.64 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 4.4500000000000002 110.917 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.656 ' HB3' HD12 ' A' ' 255' ' ' ILE . 0.8 OUTLIER -87.29 150.98 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 2.23 110.867 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.648 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.2 OUTLIER -154.83 -172.04 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 3.5099999999999998 110.868 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 66.59 165.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 3.96 111.083 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -20.4 62.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 3.0899999999999999 110.892 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -51.07 -29.99 14.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 3.3599999999999999 110.825 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.656 HD12 ' HB3' ' A' ' 250' ' ' LEU . 1.0 OUTLIER -51.2 -29.63 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 2.1600000000000001 111.156 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 35.8 mtt85 -90.95 -33.83 15.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 6.4299999999999997 110.855 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.44 -25.8 21.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 2.0099999999999998 112.49 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.498 HG12 HG21 ' A' ' 145' ' ' THR . 6.5 tp -87.45 -29.17 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.767 0.318 . . . . 1.26 111.14 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -79.37 -37.75 36.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 3.3399999999999999 110.951 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 2.1299999999999999 110.853 -179.832 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.459 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.801 0.334 . . . . 2.8799999999999999 111.138 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.497 ' CZ ' HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -137.51 136.27 37.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 8.0600000000000005 110.889 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.531 ' HG2' ' HB3' ' A' ' 157' ' ' ALA . 29.5 ptt180 -127.9 119.21 25.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 8.9199999999999999 110.878 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.9 pt -107.99 148.28 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 3.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -157.16 22.86 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 3.4399999999999999 110.856 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.533 HD21 HG12 ' A' ' 161' ' ' VAL . 2.5 p30 -142.03 153.87 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 4.1900000000000004 110.924 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -114.67 163.05 15.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 5.0999999999999996 110.933 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.508 ' OG1' HD21 ' A' ' 212' ' ' LEU . 86.1 m -120.29 133.86 24.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.598 0.713 . . . . 2.8999999999999999 111.124 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 122' ' ' THR . 53.2 Cg_endo -69.81 -177.6 1.97 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.69 2.26 . . . . 3.1499999999999999 112.33 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 72.39 -68.64 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 4.5999999999999996 110.836 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.88 147.7 25.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 4.3399999999999999 110.857 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -59.36 168.15 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 3.75 110.907 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.06 -22.46 50.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 6.1100000000000003 110.849 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -63.29 -44.05 96.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 4.3099999999999996 110.928 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.663 ' OD2' HD12 ' A' ' 212' ' ' LEU . 26.3 t0 -60.15 -53.3 59.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 3.9500000000000002 110.856 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.854 HG23 HD22 ' A' ' 212' ' ' LEU . 11.4 p -65.76 -29.57 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.85999999999999999 111.117 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.3 -53.48 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 3.4500000000000002 110.826 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -69.97 -33.45 72.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 3.6400000000000001 110.933 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.68 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -54.01 -59.25 4.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.148 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.472 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 3.3 pt -63.48 -28.36 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 3.3100000000000001 111.101 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -51.1 -59.29 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 5.7599999999999998 110.874 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.776 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -80.45 -21.44 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 3.3799999999999999 110.885 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.604 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.2 -54.75 39.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 1.1699999999999999 111.106 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.511 ' HA ' HD13 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -67.25 -23.27 65.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 5.8099999999999996 110.875 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.04 -28.14 43.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 3.3999999999999999 110.921 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 136' ' ' LYS . 90.0 t -68.45 -30.22 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 2.02 111.152 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.616 ' HD1' HD22 ' A' ' 224' ' ' LEU . 15.3 t-105 -93.31 -52.89 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 3.9700000000000002 110.891 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 p -55.14 -23.04 19.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 1.8799999999999999 110.817 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.51 -23.64 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 3.71 110.873 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.577 HG21 HG13 ' A' ' 255' ' ' ILE . 9.8 p -125.01 21.65 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 3.5800000000000001 111.134 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -128.32 134.13 25.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.586 0.707 . . . . 2.02 111.117 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 145' ' ' THR . 54.2 Cg_endo -69.73 -25.56 28.61 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.703 2.269 . . . . 1.8899999999999999 112.352 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.91 109.57 0.34 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 3.6299999999999999 110.895 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -121.99 129.6 52.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 5.1900000000000004 110.852 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -138.02 154.27 49.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 12.16 110.867 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.19 126.37 49.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 3.3500000000000001 110.903 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -57.87 154.62 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 3.5 110.9 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.36 116.73 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 3.5299999999999998 111.127 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -39.24 58.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 3.7000000000000002 110.87 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.5 m -140.6 109.63 6.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 3.0600000000000001 111.129 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 162.48 -156.12 27.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 1.73 112.532 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -110.88 157.38 19.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 5.21 110.872 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.531 ' HB3' ' HG2' ' A' ' 117' ' ' ARG . . . -133.28 153.63 51.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 1.1499999999999999 111.088 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.62 -25.64 27.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 3.1200000000000001 110.869 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 193' ' ' GLY . 26.5 mt -121.39 137.41 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 2.3999999999999999 111.113 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.65 HD11 ' CG2' ' A' ' 162' ' ' VAL . 1.3 tm? -117.21 120.64 38.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 1.3999999999999999 110.904 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.639 ' N ' HD22 ' A' ' 160' ' ' LEU . 4.1 t -96.3 121.68 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 1.5600000000000001 111.1 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.65 ' CG2' HD11 ' A' ' 160' ' ' LEU . 10.9 t -147.87 141.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.3999999999999999 111.088 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -99.67 135.59 40.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 3.6899999999999999 110.863 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.63 133.18 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 1.73 111.075 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.33 156.69 18.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 5.4800000000000004 110.866 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.62 -137.27 31.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 1.0900000000000001 112.507 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.81 130.29 34.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 1.1599999999999999 111.107 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -88.58 6.96 35.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 2.6299999999999999 110.909 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.81 -17.35 55.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 2.54 112.481 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.37 33.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 5.6600000000000001 110.858 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.43 -167.75 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 4.6699999999999999 110.856 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -76.3 100.84 5.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 6.2000000000000002 110.858 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.5 128.44 28.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 1.3600000000000001 111.078 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -101.51 -168.98 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 6.1200000000000001 110.929 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -139.22 -41.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 4.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.33 -127.69 8.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 2.5600000000000001 112.487 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -51.77 119.06 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.814 0.34 . . . . 3.75 110.922 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.32 -33.52 5.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.715 -0.755 . . . . 3.0 112.515 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -109.63 -137.35 7.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.742 . . . . 2.2400000000000002 112.497 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.2 mm -72.1 135.82 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.348 . . . . 1.99 111.155 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.519 ' H ' HD22 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -97.62 -27.24 14.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 4.4400000000000004 110.882 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.539 ' HB2' ' HH2' ' A' ' 203' ' ' TRP . . . -179.26 124.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 1.8100000000000001 111.038 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -117.3 171.53 7.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 2.8900000000000001 110.861 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -176.95 110.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.77000000000000002 111.085 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.57 157.08 24.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 2.5699999999999998 110.863 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.18 178.33 0.23 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 1.0700000000000001 112.477 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -172.99 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.656 2.237 . . . . 1.1899999999999999 112.355 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 136.49 -127.59 4.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 2.0800000000000001 112.524 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.23 130.6 52.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 2.5 110.855 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.22 -73.99 1.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.727 -0.749 . . . . 1.8 112.505 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 191' ' ' ILE . 23.4 mt -82.92 -4.12 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 2.7400000000000002 111.13 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.4 117.61 9.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 2.4100000000000001 112.508 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.704 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 85.31 -7.64 74.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.786 -0.721 . . . . 1.3100000000000001 112.459 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.486 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 5.1 m-20 -50.53 139.23 16.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 2.1400000000000001 110.868 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.62 ' HB1' ' HE1' ' A' ' 197' ' ' PHE . . . -117.15 140.12 49.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 1.3200000000000001 111.112 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.07 110.62 12.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 4.1500000000000004 110.842 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.62 ' HE1' ' HB1' ' A' ' 195' ' ' ALA . 12.5 m-85 -116.48 111.74 20.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 2.8199999999999998 110.919 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.53 119.67 3.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 6.8700000000000001 110.816 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -50.13 -72.6 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 8.0800000000000001 110.889 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.11 87.69 4.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 5.3499999999999996 110.855 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -125.51 -82.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 4.25 110.889 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 172.65 81.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 4.7300000000000004 110.907 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.539 ' HH2' ' HB2' ' A' ' 182' ' ' ALA . 8.9 m95 -106.64 113.43 26.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 6.3700000000000001 110.926 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.4 m -156.85 133.28 9.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 2.9399999999999999 111.084 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.671 ' OG1' HD12 ' A' ' 245' ' ' ILE . 2.1 t -107.36 69.34 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 4.1100000000000003 111.128 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.74 -70.72 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 9.0600000000000005 110.887 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.7 m -117.38 -73.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 4.0199999999999996 110.885 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.27 -1.73 0.76 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 5.4400000000000004 112.521 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.01 -160.89 0.17 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 3.9100000000000001 112.495 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.12 95.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.799 0.333 . . . . 2.0899999999999999 111.147 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.406 ' HB3' ' HB ' ' A' ' 205' ' ' THR . 2.1 m-20 -104.32 150.12 24.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 2.9300000000000002 110.874 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.854 HD22 HG23 ' A' ' 130' ' ' VAL . 2.5 mt -54.95 -44.73 74.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 2.6699999999999999 110.942 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.708 ' O ' HG23 ' A' ' 217' ' ' VAL . 31.0 p90 -73.08 -37.17 66.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 5.1200000000000001 110.901 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.426 HD13 HG11 ' A' ' 243' ' ' VAL . 24.3 tp -64.75 -60.65 2.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 3.02 110.909 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.5 m -57.47 -40.59 78.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 1.1200000000000001 111.144 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.44 -51.78 67.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.82999999999999996 111.11 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 213' ' ' PHE . 73.5 t -51.6 -42.35 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.94999999999999996 111.162 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -56.82 -47.93 79.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 2.0699999999999998 110.833 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -65.21 -41.97 93.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 4.6200000000000001 110.91 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.535 HD12 ' HB1' ' A' ' 137' ' ' ALA . 85.5 mt -58.62 -32.4 46.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 1.97 111.115 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.93 -36.82 40.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 1.04 112.495 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -76.42 -39.33 53.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.781 0.324 . . . . 2.9300000000000002 110.826 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.88 -12.19 61.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 1.8 110.836 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.616 HD22 ' HD1' ' A' ' 141' ' ' TRP . 2.2 mp -114.83 19.8 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.8 132.48 0.97 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 2.25 112.493 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.553 HD22 ' SD ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -179.93 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 3.6699999999999999 110.909 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 145.18 -120.82 1.42 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.72 -0.752 . . . . 2.6600000000000001 112.462 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.401 ' HA ' ' HE1' ' A' ' 236' ' ' MET . 0.3 OUTLIER -179.98 37.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.801 0.334 . . . . 3.6600000000000001 110.855 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.29 -75.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 5.0300000000000002 110.842 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.55 -168.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 5.5899999999999999 110.844 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.97 155.51 2.04 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.715 . . . . 2.6099999999999999 110.871 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -49.25 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.69 2.26 . . . . 2.02 112.36 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -71.72 -27.97 63.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 5.2400000000000002 110.876 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.35 168.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 2.2999999999999998 111.139 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.522 HG22 ' OG ' ' A' ' 251' ' ' SER . 17.6 m -87.85 8.44 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 3.7599999999999998 111.108 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.553 ' SD ' HD22 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -80.72 0.72 33.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 4.3799999999999999 110.847 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.47 146.12 5.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.616 0.722 . . . . 4.9299999999999997 110.891 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.98 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.698 2.265 . . . . 3.0099999999999998 112.319 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.2 m -91.11 164.38 13.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 4.0599999999999996 111.147 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -62.57 124.98 22.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 4.5800000000000001 110.95 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.39 123.86 48.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 4.5800000000000001 110.907 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -54.68 123.14 12.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 7.3799999999999999 110.914 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.426 HG11 HD13 ' A' ' 214' ' ' LEU . 14.6 p -148.2 136.21 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 2.46 111.138 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.52 123.81 18.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 3.2200000000000002 110.841 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.671 HD12 ' OG1' ' A' ' 205' ' ' THR . 15.3 tt -60.52 -20.56 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 3.0699999999999998 111.107 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.21 -15.91 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 3.2000000000000002 110.88 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.5 m -106.81 1.21 24.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 2.1000000000000001 111.113 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -51.87 133.82 31.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 4.8300000000000001 110.873 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -176.79 153.05 1.02 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 3.2599999999999998 110.887 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 52.9 tp -52.06 160.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 2.8100000000000001 110.906 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.522 ' OG ' HG22 ' A' ' 235' ' ' VAL . 0.1 OUTLIER -88.81 -172.73 3.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 4.2199999999999998 110.865 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -93.1 -70.43 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 3.8300000000000001 111.113 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.55 -32.66 51.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 3.29 110.858 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -30.46 67.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 2.5299999999999998 110.856 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.577 HG13 HG21 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -54.51 -28.17 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 1.7 111.091 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -82.09 -44.56 16.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 4.2800000000000002 110.885 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.89 62.53 3.25 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 2.3500000000000001 112.502 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.508 HD13 ' CZ2' ' A' ' 141' ' ' TRP . 3.6 tp -179.7 -41.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 1.02 111.144 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.559 ' HB2' HG22 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -78.14 -28.21 48.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 3.1400000000000001 110.901 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 1.95 110.894 -179.793 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.6 m80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.753 0.311 . . . . 9.1899999999999995 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.519 ' C ' HD13 ' A' ' 114' ' ' ILE . 74.1 m-85 -117.74 147.67 42.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 9.6699999999999999 110.914 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.602 HG21 HD23 ' A' ' 147' ' ' LEU . 1.7 mm -118.38 148.21 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 3.5 111.102 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.42 144.36 27.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.145 -0.479 . . . . 1.8899999999999999 111.148 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.762 ' CD2' HG21 ' A' ' 159' ' ' ILE . 44.8 m-85 -127.7 164.02 23.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 8.1099999999999994 110.913 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.9 117.77 2.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 4.2599999999999998 110.889 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.561 ' CG2' HG21 ' A' ' 134' ' ' ILE . 10.2 pt -108.71 148.51 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 3.1200000000000001 111.169 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -168.99 60.5 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 3.8599999999999999 110.853 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.611 ' OD1' HG12 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -144.64 135.65 25.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 5.5099999999999998 110.888 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -147.8 107.07 3.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 6.2300000000000004 110.939 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.1 p -94.24 158.59 35.64 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.63 0.729 . . . . 3.79 111.081 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -178.53 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.713 2.275 . . . . 2.8300000000000001 112.342 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 56.1 24.01 7.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.445 . . . . 3.8900000000000001 110.834 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.2 mmm -165.28 131.29 2.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 3.7400000000000002 110.844 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -66.14 142.01 57.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 2.7999999999999998 110.896 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -61.38 -18.12 57.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 7.5800000000000001 110.848 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.39 -34.78 65.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 3.1099999999999999 110.848 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.5 -45.55 68.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 2.54 110.847 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.568 ' O ' HD12 ' A' ' 134' ' ' ILE . 7.5 p -66.59 -39.08 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.67000000000000004 111.142 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -55.99 -53.67 54.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 2.27 110.827 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -74.72 -32.63 62.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 2.9399999999999999 110.933 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.576 ' CB ' HD22 ' A' ' 212' ' ' LEU . . . -51.17 -57.93 7.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 0.68999999999999995 111.049 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.568 HD12 ' O ' ' A' ' 130' ' ' VAL . 4.2 mp -75.93 -41.15 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 2.3199999999999998 111.111 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -38.08 52.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 4.75 110.882 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.9 OUTLIER -78.45 -26.59 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 2.8500000000000001 110.866 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.77 -32.61 63.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.89000000000000001 111.072 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -74.4 -30.42 61.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 5.25 110.913 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -77.06 -55.11 5.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 2.6000000000000001 110.866 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.505 HG11 ' CG2' ' A' ' 217' ' ' VAL . 3.6 p -52.9 -27.42 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 1.99 111.129 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -89.5 -53.76 4.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 3.8199999999999998 110.925 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -58.98 -19.49 43.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 1.7 110.89 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -50.93 -30.09 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 2.3100000000000001 110.911 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.66 HG11 ' CG1' ' A' ' 255' ' ' ILE . 3.5 m -134.94 61.49 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 2.0800000000000001 111.074 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.718 HG23 HG13 ' A' ' 258' ' ' ILE . 0.1 OUTLIER -156.27 140.55 11.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.598 0.713 . . . . 1.6699999999999999 111.123 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.656 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.9 Cg_endo -69.76 -12.54 33.11 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.641 2.227 . . . . 2.1600000000000001 112.391 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.602 HD23 HG21 ' A' ' 114' ' ' ILE . 7.3 mp -54.63 175.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 2.6899999999999999 110.917 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -118.23 -169.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 5.46 110.888 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -130.69 134.39 46.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 7.5499999999999998 110.907 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -156.86 89.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 2.23 110.868 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 97.95 7.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 4.54 110.892 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 155' ' ' GLY . 14.3 tt -83.49 130.59 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 4.3899999999999997 111.106 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -78.43 -28.48 46.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 3.8199999999999998 110.9 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.436 ' O ' HD11 ' A' ' 152' ' ' ILE . 96.1 m -149.59 120.87 7.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 3.52 111.144 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.643 ' O ' HD13 ' A' ' 152' ' ' ILE . . . 118.87 85.34 0.99 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 2.2799999999999998 112.501 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.77 167.28 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.776 0.322 . . . . 9.9800000000000004 110.901 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.57 -161.99 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 2.9100000000000001 111.11 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -50.77 -25.22 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 2.8199999999999998 110.852 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.762 HG21 ' CD2' ' A' ' 116' ' ' TYR . 46.1 mm -102.5 114.43 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 3.0699999999999998 111.124 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.24 158.03 25.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 2.9700000000000002 110.918 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.774 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 41.7 t -148.03 111.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 1.6299999999999999 111.175 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.9 t -148.51 144.82 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 1.1200000000000001 111.099 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -104.71 136.68 43.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 3.2799999999999998 110.921 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.512 ' HB1' ' ND1' ' A' ' 168' ' ' HIS . . . -142.41 168.38 19.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 1.29 111.134 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.2 111.8 22.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 6.2699999999999996 110.903 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.39 -128.58 27.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 1.24 112.476 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.449 ' N ' ' HB2' ' A' ' 173' ' ' ALA . . . -71.51 110.92 6.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.331 . . . . 1.51 111.158 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.512 ' ND1' ' HB1' ' A' ' 164' ' ' ALA . 0.9 OUTLIER -92.49 41.95 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 3.8900000000000001 110.879 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.9 -53.87 4.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 2.71 112.461 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -145.11 28.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 5.2000000000000002 110.871 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -107.08 -169.55 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 6.1699999999999999 110.864 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -104.83 90.3 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 4.8899999999999997 110.828 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.449 ' HB2' ' N ' ' A' ' 167' ' ' ALA . . . -53.6 149.53 8.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 1.76 111.09 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -120.8 -82.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 6.0199999999999996 110.91 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.97 -170.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 4.1699999999999999 110.856 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -97.59 -160.72 31.09 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.709 -0.758 . . . . 2.1000000000000001 112.508 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -52.97 118.6 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 5.7000000000000002 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 123.61 -54.38 0.72 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.743 -0.741 . . . . 2.4500000000000002 112.484 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.76 -137.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.738 -0.744 . . . . 1.76 112.473 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.3 mt -78.03 90.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.897 0.38 . . . . 2.8799999999999999 111.137 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.592 ' H ' HD22 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -53.04 -33.49 52.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 4.4400000000000004 110.92 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.09 123.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 1.79 111.091 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -138.56 113.8 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 3.4900000000000002 110.864 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -99.27 125.01 44.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 1.1899999999999999 111.099 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -63.61 164.16 10.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 2.2599999999999998 110.867 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.61 169.94 0.25 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.706 -0.759 . . . . 0.94999999999999996 112.527 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -169.37 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.753 2.302 . . . . 1.04 112.332 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.7 -152.02 19.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 1.22 112.506 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m -91.88 148.55 22.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 2.3599999999999999 110.83 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.83 -102.47 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.732 . . . . 1.3600000000000001 112.467 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 72.9 mt -56.11 -35.43 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 1.8500000000000001 111.143 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -52.73 100.46 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 2.3100000000000001 112.456 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 104.33 21.65 9.22 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.759 -0.734 . . . . 1.21 112.484 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.404 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 15.7 m-20 -95.08 139.4 31.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 2.2799999999999998 110.872 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.774 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -100.67 140.4 34.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 1.0700000000000001 111.052 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -128.65 110.52 12.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 4.8300000000000001 110.847 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -113.7 120.16 39.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 2.96 110.9 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -58.99 123.99 18.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 6.7300000000000004 110.874 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -74.74 -48.83 23.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 7.7300000000000004 110.926 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.4 -16.66 56.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 3.8500000000000001 110.867 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 4.3799999999999999 110.896 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.85 95.93 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 4.6699999999999999 110.878 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.506 ' CZ3' HD21 ' A' ' 212' ' ' LEU . 5.1 m0 -79.73 148.57 31.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 7.1699999999999999 110.933 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -148.47 174.31 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 2.5699999999999998 111.13 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.62 -171.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 1.9299999999999999 111.13 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -63.93 -21.52 66.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 4.5199999999999996 110.876 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.3 m -90.61 -49.2 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 2.2599999999999998 110.848 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -52.09 172.37 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 2.1200000000000001 112.516 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -51.73 -88.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 1.5 112.509 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.429 HG21 ' HD1' ' A' ' 203' ' ' TRP . 14.8 m -60.19 99.55 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.78 0.324 . . . . 1.6299999999999999 111.145 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 243' ' ' VAL . 1.9 m-20 -76.46 107.9 9.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 2.4700000000000002 110.891 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.576 HD22 ' CB ' ' A' ' 133' ' ' ALA . 0.6 OUTLIER -57.38 -36.91 71.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 2.0899999999999999 110.905 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.412 ' O ' HG23 ' A' ' 217' ' ' VAL . 11.0 m-85 -71.13 -64.35 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 4.9299999999999997 110.827 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.547 HD13 HG12 ' A' ' 243' ' ' VAL . 5.3 tp -51.67 -49.51 62.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 2.04 110.965 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 96.4 m -55.32 -48.79 73.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.71999999999999997 111.143 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.82 -31.88 63.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.68999999999999995 111.125 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.632 HG21 ' CE1' ' A' ' 248' ' ' PHE . 60.4 t -77.7 -31.87 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.62 111.16 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -75.12 -41.75 57.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 2.04 110.868 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -71.0 -43.44 67.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 4.6500000000000004 110.876 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 217' ' ' VAL . 9.9 tt -64.72 -29.88 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 2.1299999999999999 111.153 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -68.7 -42.63 79.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 0.84999999999999998 112.48 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -65.19 -23.7 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.339 . . . . 2.3300000000000001 110.904 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.79 30.38 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 1.76 110.83 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -61.65 0.68 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 2.4700000000000002 110.951 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 179.7 32.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 2.1299999999999999 112.475 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.15 149.46 27.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.814 0.34 . . . . 2.5299999999999998 110.919 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -78.16 -98.7 0.21 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.748 . . . . 2.6299999999999999 112.528 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -178.76 40.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.846 0.355 . . . . 2.9500000000000002 110.822 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 230' ' ' SER . 0.6 OUTLIER -179.53 -71.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 4.3499999999999996 110.893 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 229' ' ' SER . 47.6 t 65.56 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 6.0199999999999996 110.864 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.22 156.84 75.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.588 0.708 . . . . 2.9300000000000002 110.889 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -49.12 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.679 2.252 . . . . 2.27 112.378 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -34.31 73.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 3.9199999999999999 110.894 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 252' ' ' ALA . . . -51.6 153.32 2.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 2.23 111.104 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.725 HG13 ' HE2' ' A' ' 241' ' ' LYS . 3.9 t -87.51 7.7 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 4.0499999999999998 111.151 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -17.36 35.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 4.6699999999999999 110.892 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.94 143.31 15.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.635 0.731 . . . . 4.3399999999999999 110.915 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 76.57 1.14 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.628 2.219 . . . . 2.29 112.33 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.6 t -157.05 168.8 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 2.4300000000000002 111.142 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -110.43 112.62 24.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 3.8100000000000001 110.924 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.725 ' HE2' HG13 ' A' ' 235' ' ' VAL . 8.2 pttt -140.69 147.46 39.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 3.4500000000000002 110.851 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -106.84 125.82 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 3.4300000000000002 110.905 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.547 HG12 HD13 ' A' ' 214' ' ' LEU . 7.1 p -121.26 154.72 25.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 2.2200000000000002 111.168 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.07 125.91 25.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 2.8300000000000001 110.897 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.63 -24.49 34.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 2.54 111.106 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -60.29 -39.66 87.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 3.75 110.896 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 51.9 p -105.43 1.89 28.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 2.3999999999999999 111.187 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.632 ' CE1' HG21 ' A' ' 217' ' ' VAL . 2.7 t80 -52.02 111.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 3.9399999999999999 110.854 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -174.52 157.37 2.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 3.1000000000000001 110.892 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 251' ' ' SER . 0.4 OUTLIER -58.84 150.6 23.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 2.04 110.893 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.564 ' H ' HD23 ' A' ' 250' ' ' LEU . 1.5 t -154.58 -172.6 4.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 3.5899999999999999 110.854 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.579 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . . . 65.13 176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 3.1299999999999999 111.134 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.96 -22.08 66.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 3.71 110.888 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -50.77 -29.57 11.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 3.3900000000000001 110.91 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.66 ' CG1' HG11 ' A' ' 144' ' ' VAL . 1.1 tt -52.74 -29.56 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 1.98 111.105 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -21.03 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 5.0700000000000003 110.905 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.97 -6.04 81.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 1.73 112.492 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.718 HG13 HG23 ' A' ' 145' ' ' THR . 3.7 tp -106.98 -34.99 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 1.29 111.144 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -78.59 -37.38 42.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 3.6699999999999999 110.891 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.2 t -84.8 -47.45 10.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 2.98 110.829 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.698 HD13 ' O ' ' A' ' 258' ' ' ILE . 1.0 OUTLIER 57.7 93.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 3.4700000000000002 110.931 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -137.37 -52.63 0.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 11.68 110.903 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 119.111 -0.827 . . . . 10.800000000000001 112.488 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.817 0.341 . . . . 8.0700000000000003 110.876 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.698 ' O ' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -94.25 148.05 22.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 8.4600000000000009 110.923 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.698 HD13 ' O ' ' A' ' 113' ' ' TYR . 12.3 mm -132.89 157.02 42.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 3.4900000000000002 111.17 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.47 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -147.16 128.57 14.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 2.3599999999999999 111.159 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.64 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 33.7 p90 -128.67 159.53 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 4.8700000000000001 110.872 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -161.65 153.92 19.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 4.4199999999999999 110.883 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 26.1 mt -107.79 148.91 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 1.8 111.121 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.489 ' CB ' HG22 ' A' ' 162' ' ' VAL . 1.0 OUTLIER -115.76 -75.02 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 3.4500000000000002 110.928 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.411 HD22 ' N ' ' A' ' 120' ' ' ASN . 1.5 m-80 -98.98 175.9 5.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 5.3499999999999996 110.906 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -144.04 163.32 33.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 6.9900000000000002 110.864 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.882 HG21 HD11 ' A' ' 212' ' ' LEU . 26.5 p -76.88 113.77 33.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.59 0.709 . . . . 2.8700000000000001 111.139 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.71 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.255 . . . . 2.79 112.358 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -57.63 -28.46 63.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 3.4399999999999999 110.874 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -101.29 152.77 20.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 3.0600000000000001 110.869 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -60.95 143.52 54.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 3.3300000000000001 110.886 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.0 ptt-85 -56.83 -24.3 50.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 6.9800000000000004 110.867 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.76 -44.91 19.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 3.9399999999999999 110.924 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.12 -51.32 68.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 2.3599999999999999 110.884 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.633 ' O ' HD12 ' A' ' 134' ' ' ILE . 7.3 p -68.6 -38.18 78.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.91000000000000003 111.171 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.81 -54.45 44.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 3.9700000000000002 110.879 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -73.55 -32.34 64.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 2.6600000000000001 110.911 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.94 -57.56 8.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.70999999999999996 111.091 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.633 HD12 ' O ' ' A' ' 130' ' ' VAL . 3.7 mp -76.76 -40.11 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 2.3799999999999999 111.161 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -54.5 -30.77 54.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 4.3300000000000001 110.885 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 140' ' ' VAL . 1.5 mptp? -78.45 -25.21 45.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 3.73 110.925 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.91 -34.19 65.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 1.1699999999999999 111.118 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.82 -30.52 61.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 4.0 110.904 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -55.72 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 3.7999999999999998 110.873 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.754 HG11 HG22 ' A' ' 217' ' ' VAL . 5.1 p -49.35 -34.01 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.04 111.184 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.541 ' CZ2' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -80.28 -54.44 5.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 6.1600000000000001 110.932 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.8 t -55.22 -26.63 40.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 2.4399999999999999 110.841 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -53.25 -39.38 63.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 3.6400000000000001 110.91 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 m -123.31 18.09 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 2.52 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.456 HG21 HG12 ' A' ' 258' ' ' ILE . 16.4 p -144.83 152.93 53.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.708 . . . . 3.0699999999999998 111.158 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -87.84 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.672 2.248 . . . . 3.5 112.313 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 53.18 -175.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 3.3500000000000001 110.911 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -142.35 138.14 31.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 4.0300000000000002 110.85 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -112.48 128.18 56.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 6.9500000000000002 110.898 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.6 t -156.77 89.62 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 1.8899999999999999 110.868 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 131.84 39.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 2.3799999999999999 110.899 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.424 HD12 ' HA3' ' A' ' 155' ' ' GLY . 10.5 pt -148.88 124.78 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 2.5 111.16 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -60.67 -23.67 65.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 4.1500000000000004 110.896 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.3 m -133.9 112.03 10.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 2.8999999999999999 111.163 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.424 ' HA3' HD12 ' A' ' 152' ' ' ILE . . . 170.62 -179.05 42.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.789 -0.72 . . . . 1.5700000000000001 112.514 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.6 mtm -110.67 127.54 55.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.32 . . . . 4.9500000000000002 110.888 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -122.95 130.06 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 1.0800000000000001 111.097 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -19.66 64.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 3.1800000000000002 110.874 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 mm -103.5 84.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 3.0 111.106 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.3 tm? -87.96 115.94 25.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 1.4399999999999999 110.919 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.568 ' N ' HD22 ' A' ' 160' ' ' LEU . 94.7 t -100.71 110.27 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 1.6299999999999999 111.131 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.554 ' CG2' HD11 ' A' ' 160' ' ' LEU . 50.2 t -137.53 143.09 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 1.1599999999999999 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -81.0 115.5 20.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 5.4900000000000002 110.868 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.675 ' HB1' ' NE2' ' A' ' 168' ' ' HIS . . . -101.08 154.83 18.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 1.8999999999999999 111.064 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.49 118.68 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 5.21 110.885 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.88 -128.15 32.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 1.1799999999999999 112.505 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.65 119.05 23.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 2.1499999999999999 111.11 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.675 ' NE2' ' HB1' ' A' ' 164' ' ' ALA . 0.7 OUTLIER -95.1 41.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 5.7699999999999996 110.87 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.93 -43.5 2.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 3.1000000000000001 112.462 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.23 61.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 5.6699999999999999 110.884 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.82 -168.42 2.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 4.0700000000000003 110.892 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -76.59 95.96 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 5.1699999999999999 110.892 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.93 138.1 58.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 1.8500000000000001 111.123 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -136.67 106.85 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 6.4500000000000002 110.925 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.67 168.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 4.0300000000000002 110.834 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.96 -133.59 2.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 2.0699999999999998 112.467 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -51.45 119.04 3.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.759 0.314 . . . . 4.4000000000000004 110.901 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 114.06 28.65 3.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 4.79 112.492 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.17 -137.17 3.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 2.1099999999999999 112.488 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.0 mm -76.88 123.38 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.346 . . . . 1.9299999999999999 111.107 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.527 ' H ' HD22 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -95.43 -12.06 26.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.469 . . . . 4.5800000000000001 110.932 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.77 132.57 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 1.77 111.091 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.09 110.18 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 2.9500000000000002 110.905 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.551 ' HB2' ' OE2' ' A' ' 219' ' ' GLU . . . -126.87 112.02 14.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.68000000000000005 111.113 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.9 170.12 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 2.5499999999999998 110.899 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.46 169.41 0.27 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.75 112.476 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -171.18 0.44 Allowed 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.736 2.291 . . . . 0.81999999999999995 112.317 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.33 -145.71 16.56 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 1.1299999999999999 112.477 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.8 m -92.17 153.52 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 1.95 110.908 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.51 -107.32 0.41 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 1.1899999999999999 112.497 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.18 -24.77 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 2.1000000000000001 111.111 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.09 96.95 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.736 -0.745 . . . . 2.4500000000000002 112.51 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 117.8 -16.55 12.26 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.772 -0.728 . . . . 1.1299999999999999 112.475 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.432 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 8.6 m-20 -50.43 145.04 6.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.821 0.343 . . . . 2.2799999999999998 110.882 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -133.57 133.45 42.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.88 111.101 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -121.77 109.96 15.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 2.4700000000000002 110.853 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -90.24 111.8 23.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 2.9100000000000001 110.888 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.51 99.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 5.96 110.829 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -75.56 69.93 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 9.5600000000000005 110.836 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 43.6 t0 64.67 20.4 12.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 3.8399999999999999 110.884 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.4 18.37 19.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 4.4000000000000004 110.862 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.09 153.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 6.0099999999999998 110.867 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.409 ' CD1' HG22 ' A' ' 122' ' ' THR . 1.7 m-90 -105.74 173.7 6.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 6.8700000000000001 110.899 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.419 HG21 ' H ' ' A' ' 209' ' ' GLY . 0.0 OUTLIER -157.13 172.86 17.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 2.1299999999999999 111.092 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.74 -170.55 2.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 2.25 111.113 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.652 ' HB3' HD13 ' A' ' 245' ' ' ILE . 20.9 p-80 -61.66 -20.72 63.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 4.3099999999999996 110.872 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.42 -36.41 9.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 2.0899999999999999 110.883 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.94 -179.68 0.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.789 -0.72 . . . . 2.4199999999999999 112.477 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.419 ' H ' HG21 ' A' ' 204' ' ' THR . . . -54.08 -91.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 1.77 112.492 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 92.0 m -70.5 98.84 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.352 . . . . 1.99 111.139 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.06 111.07 1.78 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 2.6200000000000001 110.891 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.882 HD11 HG21 ' A' ' 122' ' ' THR . 0.6 OUTLIER -56.66 -34.21 67.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 2.2200000000000002 110.938 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.424 ' CE2' HD12 ' A' ' 245' ' ' ILE . 9.7 m-85 -71.85 -64.86 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 5.4100000000000001 110.882 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -53.7 -46.45 70.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 3.1200000000000001 110.906 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 77.3 m -54.91 -40.12 69.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.93000000000000005 111.145 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 134' ' ' ILE . . . -55.85 -32.27 63.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.081 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.754 HG22 HG11 ' A' ' 140' ' ' VAL . 29.5 t -82.53 -34.49 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.78000000000000003 111.101 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -71.41 -38.85 71.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 2.0600000000000001 110.872 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.551 ' OE2' ' HB2' ' A' ' 184' ' ' ALA . 1.6 tm-20 -74.44 -52.89 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 3.8999999999999999 110.859 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 9.9 tt -51.93 -32.53 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.484 . . . . 2.0899999999999999 111.096 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.26 -34.14 46.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.752 . . . . 0.96999999999999997 112.455 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -25.61 67.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.798 0.332 . . . . 2.77 110.842 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.498 ' O ' HD22 ' A' ' 224' ' ' LEU . 0.4 OUTLIER -95.47 24.9 4.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 2.04 110.842 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 223' ' ' SER . 0.8 OUTLIER -135.43 -64.75 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 2.9300000000000002 110.916 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.419 ' O ' HD23 ' A' ' 226' ' ' LEU . . . 170.87 48.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.726 . . . . 1.9199999999999999 112.496 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.541 HD12 ' CZ2' ' A' ' 141' ' ' TRP . 56.4 mt -145.23 -74.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.389 . . . . 3.48 110.886 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 57.1 -102.51 0.21 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 4.4199999999999999 112.495 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -119.32 119.27 33.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 2.27 110.857 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 11.0 t -99.14 -80.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 4.1799999999999997 110.874 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.19 -38.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 4.2699999999999996 110.872 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.702 ' OD2' ' HB1' ' A' ' 252' ' ' ALA . 0.5 OUTLIER -47.41 107.41 0.72 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.61 0.719 . . . . 2.3900000000000001 110.828 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 54.2 Cg_endo -69.73 -44.42 2.11 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.647 2.231 . . . . 1.97 112.341 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -32.02 70.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 4.5599999999999996 110.881 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . . . -71.63 170.65 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 2.6299999999999999 111.1 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.5 m -95.96 8.15 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 5.1799999999999997 111.092 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.425 ' CE ' HD22 ' A' ' 226' ' ' LEU . 1.2 tmm? -89.18 3.14 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 3.5800000000000001 110.892 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 160.09 0.52 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.667 0.746 . . . . 8.75 110.849 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -30.33 22.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.66 2.24 . . . . 2.9300000000000002 112.353 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.8 p -84.84 169.33 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 2.8199999999999998 111.162 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -119.6 114.73 22.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 10.82 110.901 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.534 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.2 OUTLIER -126.28 133.18 51.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 3.2799999999999998 110.888 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -61.6 125.63 24.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 3.29 110.929 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 241' ' ' LYS . 12.5 t -133.06 155.27 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 2.2000000000000002 111.144 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.15 112.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 2.7400000000000002 110.928 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.652 HD13 ' HB3' ' A' ' 206' ' ' HIS . 31.2 pt -76.58 -13.89 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 3.0499999999999998 111.099 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.56 -26.85 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 3.4300000000000002 110.863 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 46.0 p -120.99 20.6 11.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 2.8900000000000001 111.096 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.66 148.5 40.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 3.79 110.893 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 179.98 147.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 3.1800000000000002 110.919 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.613 HD23 ' N ' ' A' ' 251' ' ' SER . 7.0 tt -74.89 144.27 43.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 2.3999999999999999 110.905 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.613 ' N ' HD23 ' A' ' 250' ' ' LEU . 14.9 m -154.6 -172.03 4.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 3.9399999999999999 110.861 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.702 ' HB1' ' OD2' ' A' ' 231' ' ' ASP . . . 67.11 -171.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 2.9100000000000001 111.076 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.73 -23.59 30.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 3.54 110.861 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 252' ' ' ALA . 4.2 m-20 -52.87 -29.75 29.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 3.2999999999999998 110.875 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 252' ' ' ALA . 17.8 tt -68.55 -31.25 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 1.73 111.144 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -32.71 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 5.1799999999999997 110.861 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.61 -17.13 47.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 1.5600000000000001 112.477 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 145' ' ' THR . 6.0 tp -110.9 -35.81 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 1.04 111.186 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -73.53 -24.75 60.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 3.0800000000000001 110.877 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 9.8 t -66.86 -27.47 67.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 2.2400000000000002 110.868 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 258' ' ' ILE . 7.6 mp -51.98 -32.65 34.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 4.29 110.912 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -93.45 -34.87 13.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 15.300000000000001 110.925 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 119.183 -0.787 . . . . 12.300000000000001 112.516 -179.992 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.537 ' N ' ' HZ2' ' A' ' 148' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.82 0.343 . . . . 8.3800000000000008 110.872 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -65.98 149.12 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 9.2699999999999996 110.915 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.697 HD13 HD21 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -115.59 164.11 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 2.8799999999999999 111.106 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.412 ' N ' HG23 ' A' ' 114' ' ' ILE . 53.4 p -125.56 143.09 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 2.3100000000000001 111.146 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.793 ' HB2' HD11 ' A' ' 159' ' ' ILE . 15.7 p90 -152.05 141.42 21.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 4.8200000000000003 110.898 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.13 150.24 29.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 4.6799999999999997 110.871 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.7 mt -108.01 148.88 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 1.8600000000000001 111.151 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' CB ' HG22 ' A' ' 162' ' ' VAL . 38.4 t-20 -102.68 -71.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 3.6499999999999999 110.868 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.27 172.48 7.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 5.6699999999999999 110.905 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.677 ' HB2' HG11 ' A' ' 130' ' ' VAL . 18.3 p90 -127.45 164.34 22.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 5.4199999999999999 110.949 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.553 ' OG1' HD11 ' A' ' 212' ' ' LEU . 0.7 OUTLIER -52.41 129.21 42.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.566 0.698 . . . . 2.5499999999999998 111.127 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 133.55 25.83 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.678 2.252 . . . . 2.4100000000000001 112.346 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 t70 67.74 11.5 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 6.1299999999999999 110.864 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.5 tpt -106.09 152.54 23.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 3.1400000000000001 110.869 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -58.7 115.73 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 3.73 110.892 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -59.71 -20.18 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 5.46 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -80.15 -39.43 29.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.204 -0.453 . . . . 3.8700000000000001 110.9 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.51 -46.25 60.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 3.3100000000000001 110.897 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.755 ' O ' HD12 ' A' ' 134' ' ' ILE . 13.9 p -65.98 -35.28 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.94999999999999996 111.086 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.61 -54.61 37.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 3.0299999999999998 110.879 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -71.36 -32.38 68.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 2.7999999999999998 110.905 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -51.29 -51.96 49.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.69999999999999996 111.163 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 130' ' ' VAL . 2.7 mp -82.73 -46.01 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 2.4199999999999999 111.13 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -50.44 -45.49 55.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 6.5499999999999998 110.86 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -20.4 51.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 3.0299999999999998 110.883 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.6 -35.43 65.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.83999999999999997 111.093 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -72.42 -24.83 61.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 5.1900000000000004 110.894 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -31.5 60.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 3.4500000000000002 110.936 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 217' ' ' VAL . 21.7 t -58.49 -30.93 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 2.0299999999999998 111.108 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.755 ' O ' HG22 ' A' ' 145' ' ' THR . 0.7 OUTLIER -94.57 -32.72 13.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 4.0 110.92 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -63.68 -15.74 59.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 2.1800000000000002 110.857 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -83.0 -12.79 56.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 2.1699999999999999 110.946 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 258' ' ' ILE . 4.6 p -118.84 -28.46 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 3.2799999999999998 111.136 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 141' ' ' TRP . 15.0 t -107.22 141.65 23.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.581 0.705 . . . . 2.7799999999999998 111.19 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -6.07 17.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.656 2.238 . . . . 2.4100000000000001 112.347 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.697 HD21 HD13 ' A' ' 114' ' ' ILE . 8.2 tp -49.86 161.01 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 2.4500000000000002 110.915 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.537 ' HZ2' ' N ' ' A' ' 112' ' ' HIS . 0.0 OUTLIER -123.28 138.06 54.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 5.4100000000000001 110.915 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.402 ' HA ' HG22 ' A' ' 114' ' ' ILE . 74.8 m-85 -114.38 128.65 56.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 8.8499999999999996 110.896 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.27 99.86 4.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 2.1000000000000001 110.853 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 103.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 2.4100000000000001 110.877 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 tt -97.28 135.28 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 3.8999999999999999 111.115 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -102.52 41.71 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 3.2200000000000002 110.891 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.98 169.77 7.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 3.5299999999999998 111.119 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.08 -169.76 0.54 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 1.99 112.486 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.3 mtm -108.48 148.19 30.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 6.8099999999999996 110.87 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.2 159.91 16.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 1.1399999999999999 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.87 -44.72 67.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 2.4300000000000002 110.906 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' A' ' 116' ' ' TYR . 2.1 pp -104.02 140.78 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 3.5299999999999998 111.114 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.632 HD11 ' CG2' ' A' ' 162' ' ' VAL . 1.0 OUTLIER -129.2 115.27 17.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 1.5 110.934 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.616 ' N ' HD22 ' A' ' 160' ' ' LEU . 93.1 t -94.81 119.38 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 1.4399999999999999 111.133 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.632 ' CG2' HD11 ' A' ' 160' ' ' LEU . 11.7 t -138.47 140.91 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 1.1399999999999999 111.176 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.62 102.97 14.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 4.7000000000000002 110.854 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.67 177.35 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 1.71 111.108 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -135.64 111.74 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 3.8799999999999999 110.825 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 72.82 -135.78 22.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.737 . . . . 1.6100000000000001 112.497 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.16 110.96 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.334 . . . . 1.4099999999999999 111.081 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -70.61 -15.64 62.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 3.1299999999999999 110.871 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.04 -25.09 14.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 2.75 112.487 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -80.27 -74.81 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.351 . . . . 6.0300000000000002 110.872 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -178.68 33.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 7.0300000000000002 110.859 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -129.18 64.93 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 4.5899999999999999 110.825 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.26 145.43 30.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 1.99 111.101 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -54.93 174.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 10.24 110.907 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -137.99 9.95 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 5.3700000000000001 110.881 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.91 139.81 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.708 -0.758 . . . . 2.0899999999999999 112.489 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 119.23 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.366 . . . . 3.4300000000000002 110.873 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 124.09 -18.48 7.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.718 -0.753 . . . . 2.8599999999999999 112.495 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -117.65 -125.96 3.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 1.8799999999999999 112.498 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.407 ' H ' HD12 ' A' ' 180' ' ' ILE . 4.7 mp -79.23 93.27 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 1.9299999999999999 111.125 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.9 pp -50.43 -26.43 5.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 3.5600000000000001 110.906 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.725 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.45 168.9 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 1.8799999999999999 111.101 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.87 130.8 53.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 3.0600000000000001 110.867 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -142.1 103.71 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.97999999999999998 111.072 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.28 165.53 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 2.5299999999999998 110.885 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -56.51 -176.74 0.31 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 0.82999999999999996 112.477 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.703 2.269 . . . . 0.81000000000000005 112.313 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.13 -149.46 17.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 1.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.7 p -91.73 151.73 20.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 2.7400000000000002 110.823 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 50.35 -103.98 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 1.1499999999999999 112.478 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 30.7 mm -57.02 -25.98 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.371 . . . . 2.5699999999999998 111.142 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.33 100.1 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 2.5299999999999998 112.536 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.436 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . 115.2 -15.44 18.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.739 -0.743 . . . . 1.0 112.469 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.22 145.17 8.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.778 0.323 . . . . 2.1200000000000001 110.844 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.54 ' HB3' HG22 ' A' ' 161' ' ' VAL . . . -136.95 128.69 28.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.88 111.1 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.423 ' CB ' ' HB1' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -113.09 123.59 50.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 2.71 110.85 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.52 143.83 41.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 4.0300000000000002 110.913 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.67 -77.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 5.79 110.879 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 66.94 41.22 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 7.5199999999999996 110.914 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.9 t0 66.18 47.5 1.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 3.3199999999999998 110.836 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.78 -77.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 4.5899999999999999 110.834 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.83 138.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 4.1399999999999997 110.873 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -106.28 138.95 41.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 9.3800000000000008 110.92 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.45 165.68 35.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 1.71 111.173 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -170.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 2.04 111.162 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -57.24 -46.6 82.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 4.3200000000000003 110.888 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.54 -34.84 40.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 2.48 110.901 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -50.87 170.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 2.29 112.539 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -45.13 -83.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 1.73 112.527 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.13 97.56 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 2.3500000000000001 111.134 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -61.49 113.14 2.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 3.3500000000000001 110.897 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.553 HD11 ' OG1' ' A' ' 122' ' ' THR . 1.1 tt -71.57 -35.91 70.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 2.29 110.975 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.485 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 7.8 t80 -71.34 -35.94 71.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 4.4800000000000004 110.867 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.428 HD12 ' CD1' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -81.78 -48.55 11.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 2.3199999999999998 110.914 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.499 ' CG2' HD22 ' A' ' 181' ' ' LEU . 53.3 m -55.25 -28.83 55.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.97999999999999998 111.148 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.424 ' HB1' ' HA ' ' A' ' 134' ' ' ILE . . . -69.38 -46.06 67.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.78000000000000003 111.072 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.571 HG21 ' CE2' ' A' ' 248' ' ' PHE . 19.1 t -60.86 -42.71 93.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.83999999999999997 111.124 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -54.1 -34.66 60.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 1.96 110.855 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -29.6 61.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 4.2999999999999998 110.894 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.655 ' O ' HD13 ' A' ' 224' ' ' LEU . 51.3 mm -56.24 -59.87 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 1.52 111.127 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.65 -31.75 79.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.82999999999999996 112.487 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -44.49 86.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 2.73 110.895 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.409 ' O ' HD12 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -95.75 24.95 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 1.6799999999999999 110.879 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.655 HD13 ' O ' ' A' ' 220' ' ' ILE . 4.4 mp -127.97 -38.5 1.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 2.0499999999999998 110.924 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 161.73 -54.74 0.31 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 2.1800000000000002 112.475 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.732 HD12 ' HB ' ' A' ' 258' ' ' ILE . 1.6 mt -73.2 -178.57 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 3.3100000000000001 110.913 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 156.31 -94.93 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 3.8999999999999999 112.499 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -96.12 98.3 10.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.768 0.318 . . . . 2.0699999999999998 110.879 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.8 m -101.35 -75.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 4.6500000000000004 110.845 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.65 -33.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 4.5199999999999996 110.893 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.503 ' CG ' ' HB1' ' A' ' 252' ' ' ALA . 12.7 m-20 -47.91 107.57 0.76 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.581 0.705 . . . . 3.1000000000000001 110.875 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -41.83 3.95 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 2.9399999999999999 112.376 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.42 46.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 4.8799999999999999 110.904 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.718 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -136.58 174.45 10.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 1.6899999999999999 111.119 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.447 ' O ' HG22 ' A' ' 235' ' ' VAL . 9.3 p -95.46 7.6 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 2.8999999999999999 111.129 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.409 ' HB2' ' HE2' ' A' ' 236' ' ' MET . 1.8 mpp? -87.32 -48.47 7.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 5.1200000000000001 110.877 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.8 139.86 21.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.741 . . . . 5.0099999999999998 110.882 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 79.1 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.713 2.275 . . . . 2.52 112.311 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 239' ' ' THR . 4.5 t -157.02 118.61 3.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 2.7400000000000002 111.144 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -70.22 131.05 43.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 3.4300000000000002 110.896 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 243' ' ' VAL . 1.2 pttt -162.85 93.23 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 3.6600000000000001 110.923 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -50.87 119.64 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.448 . . . . 3.75 110.929 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 241' ' ' LYS . 18.1 t -114.82 152.09 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 2.4900000000000002 111.12 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.79 113.25 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 2.7599999999999998 110.893 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -57.42 -37.98 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 2.3700000000000001 111.188 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.68 -28.41 68.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 3.5499999999999998 110.877 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 30.0 p -115.65 17.94 16.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 2.9100000000000001 111.15 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.571 ' CE2' HG21 ' A' ' 217' ' ' VAL . 15.8 t80 -82.53 121.69 27.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 5.2199999999999998 110.889 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -164.65 151.81 11.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 3.8799999999999999 110.835 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.69 HD13 ' N ' ' A' ' 251' ' ' SER . 3.1 tm? -55.07 139.1 42.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 2.5499999999999998 110.871 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.69 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.3 OUTLIER -150.35 -171.09 3.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 3.2000000000000002 110.829 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.718 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 70.7 165.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 3.8599999999999999 111.099 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -59.31 -20.46 54.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 2.6400000000000001 110.868 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -50.06 -29.4 8.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 3.6800000000000002 110.89 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.573 HD12 HD12 ' A' ' 250' ' ' LEU . 7.4 tt -51.98 -29.04 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 1.72 111.11 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -83.4 -31.16 26.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 4.7699999999999996 110.866 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.74 -24.64 69.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 1.97 112.491 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.732 ' HB ' HD12 ' A' ' 226' ' ' LEU . 4.1 tp -102.88 -30.98 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 1.3700000000000001 111.144 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -61.67 -36.55 81.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 2.8999999999999999 110.907 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.8 t -64.43 -41.09 96.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 3.3399999999999999 110.863 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.7 mp -51.93 105.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 6.6399999999999997 110.921 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -156.67 -74.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 16.379999999999999 110.903 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.131 -0.816 . . . . 12.52 112.502 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.803 0.335 . . . . 9.0500000000000007 110.818 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.579 ' C ' HD12 ' A' ' 114' ' ' ILE . 13.9 m-85 -116.34 148.04 40.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 9.0099999999999998 110.958 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.579 HD12 ' C ' ' A' ' 113' ' ' TYR . 1.7 mp -118.73 145.83 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 3.4500000000000002 111.154 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.538 ' HB ' HD12 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -143.01 150.55 39.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 2.25 111.178 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.686 ' HB3' HD11 ' A' ' 159' ' ' ILE . 43.6 p90 -149.84 162.62 39.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 4.8799999999999999 110.93 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -161.94 138.09 7.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 4.7599999999999998 110.86 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 1.033 HG22 HG21 ' A' ' 161' ' ' VAL . 18.0 pt -107.75 136.06 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 2.6000000000000001 111.143 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -151.59 43.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 3.46 110.948 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.76 151.41 51.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 5.2699999999999996 110.85 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -144.06 129.92 19.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 5.3399999999999999 110.94 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.58 159.5 58.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.616 0.722 . . . . 2.1600000000000001 111.144 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -86.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.68 2.253 . . . . 2.3199999999999998 112.338 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.92 75.58 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 4.2400000000000002 110.892 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.4 tpt -165.16 138.36 4.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 2.8999999999999999 110.863 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.27 120.01 8.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 4.1900000000000004 110.892 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -60.96 -19.37 60.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 5.2400000000000002 110.863 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -78.86 -29.24 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 3.1099999999999999 110.902 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.3 -44.82 24.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 2.8300000000000001 110.9 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.494 HG23 HD21 ' A' ' 212' ' ' LEU . 5.8 p -58.93 -43.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.92000000000000004 111.113 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 130' ' ' VAL . 7.8 t70 -55.48 -45.7 76.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 3.1299999999999999 110.917 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -74.65 -32.49 62.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 2.1800000000000002 110.878 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -51.83 -44.58 63.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 1.1799999999999999 111.087 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.62 HG21 HG21 ' A' ' 161' ' ' VAL . 2.8 mm -83.06 -48.83 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.414 . . . . 2.3999999999999999 111.136 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -50.62 -44.99 57.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 3.5499999999999998 110.889 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.763 ' O ' HG23 ' A' ' 140' ' ' VAL . 3.3 mttm -78.22 -20.52 51.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 3.04 110.931 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.754 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.34 -40.88 71.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 1.1200000000000001 111.126 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -48.24 34.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 3.9199999999999999 110.874 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -52.39 -28.65 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 3.6200000000000001 110.926 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.792 HG11 HG11 ' A' ' 217' ' ' VAL . 97.7 t -55.79 -56.43 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 2.04 111.143 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -82.15 -40.72 21.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 3.9399999999999999 110.886 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.79 -24.45 35.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 1.79 110.867 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -75.28 -27.39 59.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 2.5499999999999998 110.851 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 250' ' ' LEU . 32.9 m -132.05 41.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 2.8300000000000001 111.112 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 36.3 m -150.94 132.37 7.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.689 . . . . 1.97 111.189 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 70.09 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.669 2.246 . . . . 2.9700000000000002 112.325 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.538 HD22 HD21 ' A' ' 224' ' ' LEU . 1.6 tp -138.29 -171.88 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 2.7799999999999998 110.863 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -128.23 142.34 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 5.0300000000000002 110.876 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.85 122.52 20.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 7.0199999999999996 110.844 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 t -156.82 112.21 2.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 3.0 110.877 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.55 107.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 2.7400000000000002 110.949 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 154' ' ' THR . 26.6 mt -91.57 144.41 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 3.5600000000000001 111.142 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -94.7 22.86 5.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 5.1299999999999999 110.906 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.54 ' H ' HG22 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -110.17 167.77 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 5.6699999999999999 111.129 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 154' ' ' THR . . . -79.37 -0.09 82.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 2.6400000000000001 112.487 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 10.7 mtt -83.15 100.34 10.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.726 0.298 . . . . 7.0099999999999998 110.859 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -148.36 129.83 14.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 1.3999999999999999 111.1 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.49 -26.53 41.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 2.77 110.847 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 116' ' ' TYR . 22.4 pt -123.98 142.5 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.205 -0.452 . . . . 2.52 111.154 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.774 HD23 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -133.17 164.13 27.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 2.2200000000000002 110.894 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 1.033 HG21 HG22 ' A' ' 118' ' ' ILE . 8.6 t -121.93 115.64 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 1.52 111.096 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.774 HG23 HD23 ' A' ' 160' ' ' LEU . 39.4 t -145.18 142.08 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 1.4099999999999999 111.135 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -105.39 133.97 49.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 3.5600000000000001 110.926 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.28 142.18 6.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 1.8899999999999999 111.076 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -107.25 167.21 10.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 4.9000000000000004 110.888 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.94 -141.08 25.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 1.4399999999999999 112.451 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.13 148.68 48.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 2.1000000000000001 111.072 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -115.68 22.25 13.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 3.4100000000000001 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.45 14.53 62.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.669 -0.777 . . . . 3.4100000000000001 112.49 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.56 -75.95 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.778 0.323 . . . . 6.3899999999999997 110.807 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.34 62.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 4.6699999999999999 110.872 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -137.7 42.57 2.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 6.4299999999999997 110.841 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 118.86 22.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 1.48 111.095 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -179.07 98.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 8.0099999999999998 110.926 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.88 -175.77 4.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 5.75 110.855 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.42 106.97 2.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 2.0299999999999998 112.502 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -50.31 119.39 3.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.337 . . . . 4.46 110.896 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.76 -27.76 19.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.752 -0.737 . . . . 2.6800000000000002 112.505 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -81.48 -140.0 2.9 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 1.4299999999999999 112.453 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.9 mm -80.63 92.46 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.36 . . . . 2.0899999999999999 111.122 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.705 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.5 pp -44.81 -33.77 2.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 3.3799999999999999 110.918 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.705 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.96 179.79 0.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 1.77 111.122 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.87 128.5 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 6.4199999999999999 110.891 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.08 123.65 38.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.87 111.097 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.404 ' CB ' HG22 ' A' ' 191' ' ' ILE . 0.1 OUTLIER -64.5 169.96 4.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 2.4199999999999999 110.839 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.34 177.16 0.32 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 0.84999999999999998 112.501 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 160.1 50.97 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.77000000000000002 112.314 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 152.49 -146.41 14.97 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 1.29 112.471 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 99.0 p -107.46 124.45 49.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.91 0.386 . . . . 2.0299999999999998 110.857 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.93 -57.65 3.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.699 -0.762 . . . . 1.75 112.506 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.503 ' O ' HG22 ' A' ' 191' ' ' ILE . 12.6 mm -100.6 22.08 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 1.95 111.125 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.78 -114.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 3.1800000000000002 112.479 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.425 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . -94.29 42.76 2.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 1.3200000000000001 112.499 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.402 ' HA ' HD13 ' A' ' 160' ' ' LEU . 2.8 m-20 -61.35 127.14 30.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 1.98 110.868 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.779 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -88.72 131.77 34.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 1.3799999999999999 111.145 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -125.45 137.73 53.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 2.8300000000000001 110.866 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.491 ' HE1' ' HB1' ' A' ' 195' ' ' ALA . 59.4 m-85 -139.97 102.75 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 2.71 110.884 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -52.39 120.98 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 6.7000000000000002 110.914 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -67.78 -29.19 68.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 8.1899999999999995 110.893 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -78.29 -19.36 53.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 4.7400000000000002 110.867 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -177.48 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 3.8599999999999999 110.907 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -118.35 109.51 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 4.6600000000000001 110.925 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -101.93 122.21 43.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 6.6299999999999999 110.943 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 p -135.64 174.41 10.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 2.1400000000000001 111.131 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -175.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 1.8600000000000001 111.157 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -51.75 -35.21 42.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 4.6799999999999997 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -60.37 2.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 2.0800000000000001 110.867 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.51 171.52 0.28 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 2.2000000000000002 112.508 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -52.28 -89.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 1.75 112.466 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.12 108.81 2.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 1.5800000000000001 111.1 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.67 114.82 23.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 3.4300000000000002 110.889 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.494 HD21 HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -51.79 -35.87 45.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 2.1600000000000001 110.938 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.742 ' O ' HG23 ' A' ' 217' ' ' VAL . 13.4 m-85 -71.36 -60.76 2.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 5.29 110.867 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.751 HD12 ' CE1' ' A' ' 248' ' ' PHE . 4.5 tp -52.11 -55.31 21.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.193 -0.458 . . . . 2.6699999999999999 110.882 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.1 m -54.88 -45.83 74.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.87 111.144 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.49 -32.07 62.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 1.1100000000000001 111.114 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.792 HG11 HG11 ' A' ' 140' ' ' VAL . 13.0 t -76.35 -30.07 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 1.03 111.148 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -65.47 -36.68 84.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 2.0899999999999999 110.826 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -66.88 -20.95 66.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 6.04 110.89 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.96 -42.87 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 1.74 111.132 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.98 -38.13 36.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.725 -0.75 . . . . 0.87 112.469 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -23.63 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 2.6600000000000001 110.842 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.647 ' O ' HD12 ' A' ' 224' ' ' LEU . 17.4 p -109.97 17.78 20.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 2.7400000000000002 110.895 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 223' ' ' SER . 0.2 OUTLIER -156.43 94.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 3.4199999999999999 110.906 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 58.73 -178.72 1.61 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 2.4300000000000002 112.477 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.542 HD22 ' SD ' ' A' ' 236' ' ' MET . 0.4 OUTLIER 71.04 -68.84 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 3.7200000000000002 110.888 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 98.63 -66.92 0.69 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.728 . . . . 3.2000000000000002 112.487 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -173.52 133.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 2.0600000000000001 110.871 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.0 m 63.21 163.32 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 5.8300000000000001 110.859 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 25.2 t -178.86 -64.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 6.0599999999999996 110.885 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.92 156.79 51.4 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 2.6099999999999999 110.862 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 165.66 30.22 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.686 2.258 . . . . 2.7000000000000002 112.349 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.68 28.4 4.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 4.9500000000000002 110.879 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -122.7 -169.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 2.4500000000000002 111.107 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.8 m -95.58 -29.29 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 3.0299999999999998 111.158 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.542 ' SD ' HD22 ' A' ' 226' ' ' LEU . 1.1 tpt -58.2 -23.66 56.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 4.0800000000000001 110.828 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.18 150.71 29.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.683 0.754 . . . . 4.1100000000000003 110.859 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -48.69 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.657 2.238 . . . . 2.5899999999999999 112.342 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -85.61 138.83 31.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 3.5299999999999998 111.19 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.13 135.98 52.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 4.3300000000000001 110.924 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 102.89 8.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 4.5599999999999996 110.877 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -51.65 131.34 29.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 3.3399999999999999 110.905 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.78 132.8 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 2.3999999999999999 111.17 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.99 132.61 23.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 2.9399999999999999 110.858 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -14.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 3.3300000000000001 111.178 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -71.26 -29.12 64.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 3.8799999999999999 110.863 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.92 -6.06 10.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 2.3599999999999999 111.142 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.751 ' CE1' HD12 ' A' ' 214' ' ' LEU . 7.5 t80 -51.94 127.36 20.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 5.3700000000000001 110.877 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -173.1 142.06 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 4.8899999999999997 110.823 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.562 HD11 HG12 ' A' ' 255' ' ' ILE . 0.7 OUTLIER -52.53 170.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 3.04 110.934 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.98 160.95 16.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 3.9399999999999999 110.843 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.612 ' HA ' HD12 ' A' ' 255' ' ' ILE . . . -61.83 -55.56 28.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 4.1500000000000004 111.1 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.49 -29.38 50.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 2.4100000000000001 110.898 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.08 -30.43 67.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 3.3500000000000001 110.896 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 252' ' ' ALA . 60.6 mt -62.31 -30.8 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 2.75 111.161 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -75.84 -28.17 58.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 4.4000000000000004 110.882 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.69 -3.41 88.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 1.4199999999999999 112.487 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.659 ' O ' HD13 ' A' ' 261' ' ' LEU . 10.4 tp -120.93 -31.53 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.777 0.322 . . . . 0.96999999999999997 111.115 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -78.67 -44.52 23.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 2.8300000000000001 110.96 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.69 -47.18 13.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 2.2000000000000002 110.867 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 258' ' ' ILE . 1.0 OUTLIER 63.4 98.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 3.3799999999999999 110.936 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 1.4 t80 53.36 89.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 12.289999999999999 110.931 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 CA-C-O 119.177 -0.79 . . . . 8.5500000000000007 112.452 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.83 0.348 . . . . 8.9199999999999999 110.87 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -110.11 148.7 31.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 10.75 110.907 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.458 HG21 HD23 ' A' ' 147' ' ' LEU . 19.7 mm -120.18 152.77 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 3.4500000000000002 111.148 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.469 HG23 ' HA ' ' A' ' 157' ' ' ALA . 1.6 t -146.72 154.48 41.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 1.9399999999999999 111.127 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.591 ' HB2' HD11 ' A' ' 159' ' ' ILE . 51.3 p90 -145.23 166.34 25.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 4.7699999999999996 110.977 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -161.8 138.21 8.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 3.9700000000000002 110.924 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.3 mt -108.07 148.42 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 2.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -162.25 56.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 3.8900000000000001 110.886 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 135.14 10.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 5.0899999999999999 110.936 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -147.7 106.51 3.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 6.7199999999999998 110.972 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.579 HG22 ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -90.8 153.65 45.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.573 0.701 . . . . 3.7799999999999998 111.123 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.579 ' HD2' HG22 ' A' ' 122' ' ' THR . 53.8 Cg_endo -69.76 -15.01 36.9 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 2.3700000000000001 112.327 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -51.45 -69.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 5.7400000000000002 110.905 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 34.7 mmt -107.79 160.35 15.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 3.4500000000000002 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.03 166.84 2.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 3.3100000000000001 110.893 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.443 ' HA ' HG12 ' A' ' 130' ' ' VAL . 2.6 mpt_? -74.51 -19.46 60.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 6.0499999999999998 110.891 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.5 -38.67 33.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 3.1000000000000001 110.895 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 65.8 m-20 -71.24 -41.15 70.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 2.5099999999999998 110.877 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.791 HG23 HD21 ' A' ' 212' ' ' LEU . 13.8 p -74.09 -27.88 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.81000000000000005 111.115 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -71.23 -53.87 12.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 2.6099999999999999 110.871 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -69.75 -32.45 70.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 2.54 110.933 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 129' ' ' ASP . . . -50.92 -58.2 6.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.512 . . . . 0.77000000000000002 111.081 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.511 HG22 ' CE2' ' A' ' 138' ' ' PHE . 5.1 mm -69.19 -45.47 79.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 2.6200000000000001 111.126 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -34.54 31.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 4.8099999999999996 110.84 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -78.71 -31.79 46.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 2.5499999999999998 110.914 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.474 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.95 -34.48 65.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.104 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 134' ' ' ILE . 54.5 m-85 -74.1 -27.87 61.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 5.29 110.867 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -79.33 -50.9 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 2.5499999999999998 110.905 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.593 HG22 HD23 ' A' ' 250' ' ' LEU . 3.5 p -51.23 -41.96 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 1.97 111.086 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -49.63 17.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 3.79 110.9 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.6 p -58.91 -19.9 46.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 1.8 110.867 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -72.12 -17.11 62.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 2.27 110.872 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 255' ' ' ILE . 21.2 m -139.59 29.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 2.21 111.147 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.3 p -148.48 152.26 38.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.57 0.7 . . . . 2.52 111.173 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -14.98 36.98 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.668 2.245 . . . . 1.8100000000000001 112.379 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.549 HD13 HD23 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -51.02 163.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 3.1200000000000001 110.95 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -118.34 -172.39 2.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 5.2999999999999998 110.926 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -135.64 119.99 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 6.9000000000000004 110.867 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.4 t -140.7 89.95 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 2.0899999999999999 110.848 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 116.56 22.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 2.1600000000000001 110.92 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.418 HD11 ' O ' ' A' ' 156' ' ' MET . 1.0 OUTLIER -130.79 116.82 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 2.8100000000000001 111.139 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -53.73 -27.76 30.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 3.2999999999999998 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.0 m -160.3 133.79 6.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 4.2400000000000002 111.155 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.94 -134.39 5.22 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 1.8300000000000001 112.526 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.418 ' O ' HD11 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -89.8 138.22 31.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 10.0 110.828 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.469 ' HA ' HG23 ' A' ' 115' ' ' THR . . . -147.31 130.06 16.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 1.3999999999999999 111.08 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.41 ' H ' HG23 ' A' ' 115' ' ' THR . 0.3 OUTLIER -80.53 -28.35 37.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 2.8500000000000001 110.893 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.733 HG22 ' HA3' ' A' ' 193' ' ' GLY . 1.5 pp -122.57 140.87 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 3.8199999999999998 111.114 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 160' ' ' LEU . 1.1 tm? -120.18 114.01 21.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 1.55 110.903 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.736 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 52.8 t -92.67 110.97 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 1.26 111.104 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.582 ' CG2' HD11 ' A' ' 160' ' ' LEU . 24.2 t -143.22 139.98 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 1.1100000000000001 111.172 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -84.28 131.43 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 3.4500000000000002 110.936 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.41 176.64 5.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 1.3899999999999999 111.101 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.96 111.64 5.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 5.4199999999999999 110.866 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.93 -127.02 27.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.766 -0.73 . . . . 1.2 112.481 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.06 110.81 20.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 1.3700000000000001 111.105 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -90.52 66.54 6.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 3.02 110.866 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.94 -91.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 3.1600000000000001 112.475 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.8 75.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 5.3499999999999996 110.863 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -157.36 -169.69 2.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 5.5099999999999998 110.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -78.53 95.57 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 4.0199999999999996 110.867 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.55 136.36 38.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 1.3 111.109 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -112.78 -169.61 1.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 5.8300000000000001 110.862 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -141.79 164.6 29.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 4.0099999999999998 110.857 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.21 -156.08 17.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 1.8200000000000001 112.504 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.52 119.16 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 3.7400000000000002 110.927 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 133.71 -82.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.77 -0.728 . . . . 2.2400000000000002 112.496 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.33 -133.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 1.96 112.493 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.537 HG22 ' H ' ' A' ' 182' ' ' ALA . 23.1 mm -75.1 142.11 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 1.79 111.107 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -109.5 -11.3 14.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 2.8900000000000001 110.913 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.537 ' H ' HG22 ' A' ' 180' ' ' ILE . . . -178.19 144.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 1.28 111.089 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -143.64 117.09 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 2.77 110.882 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.99 130.1 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.79000000000000004 111.069 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.23 166.01 21.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 2.0800000000000001 110.91 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.62 172.83 0.35 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.777 -0.725 . . . . 0.73999999999999999 112.478 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 172.08 13.3 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 0.81000000000000005 112.297 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 145.2 -154.97 26.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 1.02 112.47 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.4 p -88.78 135.44 33.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.936 0.398 . . . . 2.1800000000000002 110.844 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.72 -81.94 0.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.98999999999999999 112.496 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 191' ' ' ILE . 1.9 mp -87.71 50.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 2.6200000000000001 111.157 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.1 -110.95 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 2.6400000000000001 112.462 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.733 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . -90.78 41.45 2.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 1.1599999999999999 112.497 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.43 143.58 8.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 2.2999999999999998 110.873 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.736 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -121.52 130.98 53.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 1.01 111.124 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -122.03 126.67 49.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 2.6899999999999999 110.876 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -139.45 150.35 45.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 2.9500000000000002 110.882 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 69.13 45.68 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 6.4800000000000004 110.867 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.29 58.99 1.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 8.1500000000000004 110.875 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.46 16.62 8.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 4.2699999999999996 110.84 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.576 ' OE2' HG21 ' A' ' 210' ' ' THR . 0.2 OUTLIER -112.57 -1.09 14.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 4.3099999999999996 110.942 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.75 150.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 6.0599999999999996 110.852 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -105.4 176.93 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 7.71 110.904 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 205' ' ' THR . 0.2 OUTLIER -157.26 172.89 17.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 1.98 111.148 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 204' ' ' THR . 0.0 OUTLIER -94.76 -173.39 2.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 1.9199999999999999 111.131 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.421 ' CG ' HG23 ' A' ' 245' ' ' ILE . 15.5 p80 -65.69 -20.33 66.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 4.4500000000000002 110.862 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -70.18 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 2.2200000000000002 110.856 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.66 -169.61 11.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 2.3300000000000001 112.457 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 49.29 -166.29 0.3 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 1.6000000000000001 112.483 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.576 HG21 ' OE2' ' A' ' 201' ' ' GLU . 0.9 OUTLIER -61.87 99.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 2.0 111.144 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 214' ' ' LEU . 32.1 t30 -61.71 120.71 11.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 3.52 110.849 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.791 HD21 HG23 ' A' ' 130' ' ' VAL . 0.3 OUTLIER -54.88 -37.85 66.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 2.3500000000000001 110.842 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -71.58 -67.32 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 4.7000000000000002 110.886 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.687 HD22 ' O ' ' A' ' 241' ' ' LYS . 3.9 tp -48.31 -53.67 16.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 2.5299999999999998 110.931 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 37.5 m -55.21 -41.58 72.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.70999999999999996 111.113 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.54 -44.99 95.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.69999999999999996 111.12 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 248' ' ' PHE . 38.3 t -68.77 -23.14 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.67000000000000004 111.14 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.643 ' HA ' HG12 ' A' ' 235' ' ' VAL . 19.7 t60 -72.65 -62.27 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 2.1000000000000001 110.857 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.427 ' CD ' ' HB3' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -53.7 -55.37 26.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 4.6399999999999997 110.893 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.1 tt -51.55 -29.95 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 2.21 111.143 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.98 -52.48 49.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.96999999999999997 112.479 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -72.12 -23.12 61.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 2.73 110.83 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.12 -9.76 58.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 2.1699999999999999 110.847 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.549 HD23 HD13 ' A' ' 147' ' ' LEU . 5.5 mp -104.13 -19.08 14.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.0800000000000001 110.903 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 145.23 -31.5 1.7 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 2.7400000000000002 112.477 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.67 HD23 ' CD1' ' A' ' 258' ' ' ILE . 0.5 OUTLIER -56.9 179.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.343 . . . . 3.0600000000000001 110.958 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 173.79 66.89 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.68 -0.771 . . . . 2.7200000000000002 112.42 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 11.0 m80 63.47 106.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.349 . . . . 2.0099999999999998 110.872 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.2 t -80.91 -79.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 5.0199999999999996 110.855 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 175.93 -54.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 3.8599999999999999 110.848 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.95 126.63 34.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 2.7400000000000002 110.88 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -177.73 1.99 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.692 2.261 . . . . 2.3399999999999999 112.327 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.6 28.09 4.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 3.8399999999999999 110.9 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -115.36 178.71 4.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 1.98 111.134 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.643 HG12 ' HA ' ' A' ' 218' ' ' HIS . 18.0 t -95.55 -9.44 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 3.48 111.174 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 28.9 mmt -86.53 -38.48 17.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 4.9000000000000004 110.889 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.34 137.47 68.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.731 . . . . 4.0700000000000003 110.867 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 73.62 1.31 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.692 2.261 . . . . 2.1899999999999999 112.341 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.71 148.6 21.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 2.3999999999999999 111.158 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -113.32 112.76 24.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 3.3900000000000001 110.899 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.687 ' O ' HD22 ' A' ' 214' ' ' LEU . 35.7 tttt -135.97 119.81 17.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 4.3499999999999996 110.918 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -51.71 132.0 30.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 3.0499999999999998 110.937 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.646 HG21 HD13 ' A' ' 214' ' ' LEU . 56.7 t -136.38 121.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 2.0899999999999999 111.12 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.02 130.96 26.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 4.0700000000000003 110.928 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.421 HG23 ' CG ' ' A' ' 206' ' ' HIS . 23.9 pt -56.67 -24.16 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 2.8599999999999999 111.151 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.5 -37.64 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 2.8199999999999998 110.872 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.4 m -104.02 27.98 7.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 2.52 111.087 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.647 ' CE1' HD12 ' A' ' 214' ' ' LEU . 9.8 t80 -103.01 130.84 50.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 5.4100000000000001 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -163.88 139.73 6.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 4.9500000000000002 110.835 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.593 HD23 HG22 ' A' ' 140' ' ' VAL . 4.2 pp -52.4 170.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 3.04 110.927 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.0 t -89.85 147.57 23.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 3.8399999999999999 110.893 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' A' ' 255' ' ' ILE . . . -63.51 -60.98 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 3.98 111.095 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.48 -26.3 30.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 3.5 110.869 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.55 -34.74 74.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 3.4500000000000002 110.849 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 252' ' ' ALA . 38.3 mt -55.17 -41.59 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 2.7599999999999998 111.132 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -14.3 61.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 4.4199999999999999 110.847 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -93.4 -14.48 53.57 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 1.6499999999999999 112.485 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.67 ' CD1' HD23 ' A' ' 226' ' ' LEU . 10.7 tp -110.32 -29.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 1.25 111.089 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -67.83 -32.06 72.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 3.8100000000000001 110.915 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.2 t -63.71 -33.01 74.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 2.9100000000000001 110.843 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.84 129.87 35.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 4.71 110.91 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -123.08 -175.26 3.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 11.44 110.934 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 CA-C-O 119.157 -0.802 . . . . 14.279999999999999 112.471 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.791 0.329 . . . . 8.2300000000000004 110.866 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -73.09 148.95 43.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 8.8399999999999999 110.962 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.7 146.76 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 2.7999999999999998 111.148 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.458 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 68.2 p -114.06 147.7 38.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 2.0600000000000001 111.153 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.68 ' CE2' HG21 ' A' ' 159' ' ' ILE . 1.6 t80 -127.63 152.76 47.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 7.5199999999999996 110.883 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -160.24 123.32 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 6.8700000000000001 110.829 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.57 HD11 HG21 ' A' ' 134' ' ' ILE . 60.5 mt -108.16 131.94 57.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 1.8999999999999999 111.137 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -131.38 49.76 2.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 3.6800000000000002 110.86 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -179.87 126.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 4.7199999999999998 110.905 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -118.7 163.07 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 6.1200000000000001 110.922 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.3 m -86.63 131.57 45.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.63 0.728 . . . . 2.9199999999999999 111.074 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -48.91 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.697 2.264 . . . . 3.0499999999999998 112.393 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.36 54.57 2.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 4.3899999999999997 110.836 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -165.44 141.94 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 2.71 110.918 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.29 135.54 57.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 4.5300000000000002 110.911 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -54.26 -25.59 24.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 5.9699999999999998 110.878 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -78.27 -37.87 44.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 4.04 110.887 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -63.51 -45.55 90.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 3.2000000000000002 110.84 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.595 ' HA ' HD13 ' A' ' 212' ' ' LEU . 13.4 p -74.32 -32.62 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.93000000000000005 111.112 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.23 -54.35 11.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 3.6899999999999999 110.89 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -65.21 -32.17 73.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 3.0699999999999998 110.934 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 129' ' ' ASP . . . -52.51 -57.75 8.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.79000000000000004 111.114 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.57 HG21 HD11 ' A' ' 118' ' ' ILE . 4.5 mm -70.16 -49.12 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 2.3399999999999999 111.13 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -49.76 -46.06 50.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 4.0300000000000002 110.862 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -20.41 49.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 2.9700000000000002 110.849 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 134' ' ' ILE . . . -55.7 -50.04 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.94999999999999996 111.089 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.23 -26.79 67.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 4.6399999999999997 110.883 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -28.92 66.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 3.0499999999999998 110.913 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.83 HG11 HG11 ' A' ' 217' ' ' VAL . 21.4 t -62.96 -56.03 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 1.8999999999999999 111.113 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -43.54 65.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 3.8900000000000001 110.942 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.6 t -56.01 -32.39 63.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 2.02 110.887 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' HG13 ' A' ' 144' ' ' VAL . 18.7 t-20 -51.59 -32.23 27.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 2.73 110.913 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.815 HG11 HD11 ' A' ' 255' ' ' ILE . 23.2 m -138.93 36.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 2.4199999999999999 111.098 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.4 m -155.38 131.6 5.76 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.573 0.701 . . . . 2.3399999999999999 111.12 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.659 ' O ' HD22 ' A' ' 147' ' ' LEU . 53.7 Cg_endo -69.77 72.13 1.47 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.675 2.25 . . . . 2.1600000000000001 112.323 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.659 HD22 ' O ' ' A' ' 146' ' ' PRO . 0.8 OUTLIER -141.04 130.32 23.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 2.6299999999999999 110.884 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.42 133.29 56.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 5.0899999999999999 110.886 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -99.53 131.25 45.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 7.4900000000000002 110.902 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.6 m -113.41 90.15 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 1.95 110.832 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 122.21 19.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 2.75 110.883 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.527 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.3 pp -144.63 161.49 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 2.75 111.157 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.44 34.22 3.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 4.21 110.9 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 t -161.66 142.98 11.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 3.73 111.139 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 85.78 176.4 50.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.73 . . . . 1.48 112.502 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.98 164.06 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 5.6200000000000001 110.845 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -134.71 144.51 47.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 1.0800000000000001 111.134 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.4 -26.81 32.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 2.4399999999999999 110.884 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.68 HG21 ' CE2' ' A' ' 116' ' ' TYR . 42.9 mm -104.1 135.35 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 2.7200000000000002 111.139 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.4 tm? -133.17 118.26 18.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 1.49 110.929 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.593 ' N ' HD22 ' A' ' 160' ' ' LEU . 89.5 t -105.65 110.54 31.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 1.47 111.131 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.558 ' CG2' HD11 ' A' ' 160' ' ' LEU . 55.9 t -133.96 145.43 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 1.1200000000000001 111.106 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -107.25 109.03 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 4.9500000000000002 110.879 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.683 ' HB3' ' OE2' ' A' ' 199' ' ' GLU . . . -101.67 178.76 4.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 1.4099999999999999 111.082 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.08 111.63 17.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 4.9199999999999999 110.887 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.37 -123.75 16.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.717 -0.754 . . . . 1.3600000000000001 112.494 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 173' ' ' ALA . . . -87.22 110.41 20.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 1.49 111.122 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -79.39 58.76 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 3.0899999999999999 110.885 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.8 -63.69 2.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.702 -0.761 . . . . 4.2999999999999998 112.507 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -179.5 42.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.77 0.319 . . . . 7.6500000000000004 110.867 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -111.23 -78.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 4.9900000000000002 110.829 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -138.16 98.12 3.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 4.2000000000000002 110.837 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 167' ' ' ALA . . . -81.85 113.61 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 1.73 111.128 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -111.12 131.58 54.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 5.8799999999999999 110.904 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.82 171.06 13.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 4.3799999999999999 110.887 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.06 -162.18 27.95 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 1.98 112.475 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -50.3 119.17 3.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 3.7599999999999998 110.887 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 128.06 -15.85 6.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 2.48 112.497 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -127.21 -133.75 3.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.71 -0.757 . . . . 1.4099999999999999 112.496 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.85 90.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 2.6000000000000001 111.138 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.763 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -48.31 -31.71 6.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 3.0699999999999998 110.886 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.763 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 176.87 153.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 1.22 111.124 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -142.92 106.27 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 3.5 110.896 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -96.22 108.41 20.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.93000000000000005 111.085 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.43 168.81 5.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 2.6299999999999999 110.86 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.49 171.49 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.747 . . . . 0.78000000000000003 112.526 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -170.62 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 0.77000000000000002 112.336 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 126.42 -152.01 18.2 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 1.1699999999999999 112.486 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.16 152.81 20.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 1.99 110.835 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 50.83 -104.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 1.27 112.497 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 34.0 mm -54.8 -26.56 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 2.4399999999999999 111.124 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.85 108.03 1.69 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.659 -0.781 . . . . 2.4700000000000002 112.491 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 108.17 -24.33 23.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.792 -0.718 . . . . 0.95999999999999996 112.502 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -49.8 147.27 3.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 2.2000000000000002 110.887 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.85 145.79 30.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 1.1200000000000001 111.112 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.553 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 28.4 m80 -121.78 152.95 38.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 2.5600000000000001 110.841 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.43 ' CE1' HG13 ' A' ' 161' ' ' VAL . 43.4 m-85 -133.53 103.19 5.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 2.8100000000000001 110.861 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 47.39 70.62 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 5.7599999999999998 110.889 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.683 ' OE2' ' HB3' ' A' ' 164' ' ' ALA . 4.4 mm-40 -51.59 -48.82 63.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 7.3899999999999997 110.872 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -127.93 0.47 5.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 4.4299999999999997 110.862 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.72 -168.73 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 3.7799999999999998 110.915 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -114.96 160.07 19.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 5.8300000000000001 110.918 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -106.15 152.52 23.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 6.1699999999999999 110.892 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.09 174.03 16.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 1.74 111.133 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.447 HG23 ' OD2' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -80.74 -172.28 3.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 1.98 111.182 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.55 ' CG ' HG22 ' A' ' 245' ' ' ILE . 25.5 p80 -55.92 -32.85 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 5.4199999999999999 110.842 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -56.45 5.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 2.3500000000000001 110.814 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -49.3 155.28 1.97 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 2.0600000000000001 112.488 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.48 -58.75 7.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 1.8700000000000001 112.5 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.19 102.91 15.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 1.8400000000000001 111.167 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.687 ' ND2' HD23 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -96.14 121.66 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 2.9500000000000002 110.859 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -54.93 -35.28 64.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 2.2400000000000002 110.901 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.414 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 34.0 t80 -71.96 -67.82 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 5.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.813 HD22 HG12 ' A' ' 243' ' ' VAL . 3.9 tp -49.6 -47.34 49.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 2.04 110.866 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 99.4 m -55.31 -44.2 75.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.52 69.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.81999999999999995 111.071 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.83 HG11 HG11 ' A' ' 140' ' ' VAL . 39.3 t -72.82 -29.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.65000000000000002 111.127 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -71.89 -39.39 69.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 1.73 110.826 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -74.31 -51.62 14.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 4.3399999999999999 110.932 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.5 HG12 HD12 ' A' ' 224' ' ' LEU . 11.0 tt -54.94 -27.32 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 2.3300000000000001 111.135 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.81 -27.41 62.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.776 -0.726 . . . . 0.90000000000000002 112.502 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -81.76 -43.88 17.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.757 0.313 . . . . 2.6299999999999999 110.837 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.5 p -86.53 52.26 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 1.54 110.848 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.5 HD12 HG12 ' A' ' 220' ' ' ILE . 1.4 mt -159.12 -46.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 2.0499999999999998 110.887 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -172.51 -61.88 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 1.9199999999999999 112.496 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.6 mp -60.89 171.71 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 3.04 110.926 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 177.46 65.08 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 2.7799999999999998 112.487 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.1 m170 64.22 157.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.32 . . . . 2.3799999999999999 110.853 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.6 t -163.86 -70.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 4.4299999999999997 110.863 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.7 -32.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 4.6699999999999999 110.871 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.429 ' HB2' ' HE1' ' A' ' 236' ' ' MET . 2.0 t0 -45.2 105.81 0.49 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.677 0.751 . . . . 2.2400000000000002 110.834 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 233' ' ' LYS . 54.0 Cg_endo -69.69 175.67 7.73 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.722 2.281 . . . . 2.02 112.349 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.25 42.66 0.31 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 3.9300000000000002 110.869 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -135.18 151.06 50.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 1.73 111.093 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.84 -14.59 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 2.9199999999999999 111.159 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.429 ' HE1' ' HB2' ' A' ' 231' ' ' ASP . 6.0 tmm? -81.96 -39.66 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 5.3799999999999999 110.847 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -50.99 134.52 29.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.662 0.744 . . . . 3.8999999999999999 110.902 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 76.45 1.15 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.722 2.282 . . . . 2.6099999999999999 112.323 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.5 m -157.3 152.66 26.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 2.8199999999999998 111.137 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.405 ' HB3' HD21 ' A' ' 181' ' ' LEU . 9.8 p90 -111.72 112.32 23.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 4.9100000000000001 110.89 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.48 -169.15 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 4.5899999999999999 110.913 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -121.48 107.86 12.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 3.6099999999999999 110.901 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.813 HG12 HD22 ' A' ' 214' ' ' LEU . 7.5 p -107.93 154.58 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 3.0099999999999998 111.135 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -74.22 124.99 27.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 3.23 110.86 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.55 HG22 ' CG ' ' A' ' 206' ' ' HIS . 11.8 tt -76.47 -35.48 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 3.0099999999999998 111.113 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -53.48 -31.9 47.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 3.5099999999999998 110.881 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.9 t -113.68 30.07 7.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 2.9700000000000002 111.109 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -52.05 134.47 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 5.9400000000000004 110.873 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -179.9 142.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 3.52 110.926 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.21 147.8 47.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 2.3599999999999999 110.866 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.1 -172.02 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 3.4100000000000001 110.872 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.713 ' HB3' ' OD2' ' A' ' 254' ' ' ASP . . . 66.4 163.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 3.77 111.118 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -57.67 -25.11 59.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 2.6800000000000002 110.815 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.713 ' OD2' ' HB3' ' A' ' 252' ' ' ALA . 2.2 p30 -51.62 -29.83 19.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 3.04 110.853 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.815 HD11 HG11 ' A' ' 144' ' ' VAL . 12.7 tt -50.88 -29.59 7.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 2.1000000000000001 111.153 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -92.07 -40.15 11.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 6.3300000000000001 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 261' ' ' LEU . . . -57.97 -20.51 41.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 1.95 112.462 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 8.2 tp -91.41 -32.83 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 1.05 111.128 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.19 -44.4 38.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 3.3999999999999999 110.957 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.45 -47.16 12.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 2.7799999999999998 110.883 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 257' ' ' GLY . 1.5 tp 54.13 27.16 7.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 3.2000000000000002 110.926 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.77 29.46 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 9.6799999999999997 110.872 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 CA-C-O 119.133 -0.815 . . . . 9.1899999999999995 112.501 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.791 0.329 . . . . 8.5600000000000005 110.833 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -132.14 148.38 52.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 12.050000000000001 110.929 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.405 HG23 ' N ' ' A' ' 115' ' ' THR . 0.7 OUTLIER -152.16 166.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 3.3399999999999999 111.141 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.51 ' C ' ' HB1' ' A' ' 157' ' ' ALA . 53.2 p -144.63 140.71 28.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 2.0800000000000001 111.109 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -150.26 151.32 32.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 4.4100000000000001 110.938 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.83 161.63 29.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 5.0099999999999998 110.92 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.556 HD11 ' HB ' ' A' ' 134' ' ' ILE . 23.4 mt -108.09 148.93 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 1.8700000000000001 111.082 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.434 ' HB2' HG22 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -120.15 -69.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 3.0299999999999998 110.901 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -98.59 176.89 5.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 5.4199999999999999 110.895 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.533 ' HB3' HG11 ' A' ' 130' ' ' VAL . 25.9 m-85 -146.39 155.01 42.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 6.5700000000000003 110.904 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.458 HG21 ' OD2' ' A' ' 198' ' ' ASP . 0.7 OUTLIER -53.53 134.9 53.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.601 0.715 . . . . 2.3599999999999999 111.11 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 135.25 29.87 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.689 2.259 . . . . 2.6400000000000001 112.354 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.45 11.39 8.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 5.9000000000000004 110.865 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.48 147.32 29.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 3.0899999999999999 110.839 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.472 ' O ' HG12 ' A' ' 130' ' ' VAL . 3.5 m-20 -58.63 115.34 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 3.4900000000000002 110.893 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -21.94 61.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 5.71 110.862 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -80.55 -40.01 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 3.27 110.831 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.72 -47.87 61.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 2.8100000000000001 110.87 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.741 HG23 HD21 ' A' ' 212' ' ' LEU . 7.3 p -63.97 -40.8 90.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.79000000000000004 111.142 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.5 m-20 -51.83 -54.07 33.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 3.1299999999999999 110.912 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -68.17 -32.28 72.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 2.6000000000000001 110.936 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.416 ' CB ' HD22 ' A' ' 212' ' ' LEU . . . -50.64 -41.07 54.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 1.1100000000000001 111.151 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.583 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 2.8 mm -83.62 -49.4 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 2.3900000000000001 111.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -59.66 4.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 5.6699999999999999 110.841 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -29.86 61.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 4.8200000000000003 110.915 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 134' ' ' ILE . . . -56.14 -33.37 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.83999999999999997 111.112 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.505 ' CE1' HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -73.36 -24.66 60.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 3.5899999999999999 110.896 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.22 -54.02 6.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 2.5600000000000001 110.884 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 250' ' ' LEU . 2.6 p -52.08 -28.81 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 1.8799999999999999 111.12 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -89.11 -55.44 3.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 4.0800000000000001 110.897 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 81.6 p -55.26 -22.56 18.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 1.6100000000000001 110.855 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.83 -29.78 12.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 2.3799999999999999 110.905 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.697 HG11 ' CG1' ' A' ' 255' ' ' ILE . 4.8 m -128.3 46.36 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 1.8899999999999999 111.137 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.675 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -155.46 142.35 13.52 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.619 0.723 . . . . 1.5800000000000001 111.113 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.675 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.5 Cg_endo -69.78 -11.91 31.79 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.702 2.268 . . . . 1.8400000000000001 112.345 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.2 167.2 4.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 3.1899999999999999 110.914 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.76 -172.95 2.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 6.1200000000000001 110.887 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -131.84 127.58 36.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 6.5499999999999998 110.9 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.97 89.92 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 2.4500000000000002 110.885 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 95.18 7.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 2.5299999999999998 110.918 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.655 HG22 ' H ' ' A' ' 154' ' ' THR . 2.0 mp -111.81 133.19 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 2.7799999999999998 111.13 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.1 -28.96 67.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 4.29 110.916 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.655 ' H ' HG22 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -121.62 174.32 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 3.23 111.175 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.454 ' H ' HG22 ' A' ' 154' ' ' THR . . . 74.94 134.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.719 . . . . 2.27 112.487 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.1 mtm -68.99 160.33 31.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 6.7300000000000004 110.866 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.51 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -139.68 144.63 37.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 1.24 111.124 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.48 -33.54 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 2.3799999999999999 110.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.3 mm -103.99 94.47 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 3.1400000000000001 111.124 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.617 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.1 tm? -105.13 117.46 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 1.8799999999999999 110.86 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.617 ' N ' HD22 ' A' ' 160' ' ' LEU . 20.2 t -102.25 109.24 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 1.97 111.076 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.578 HG23 HD21 ' A' ' 160' ' ' LEU . 54.7 t -138.88 141.11 37.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 1.73 111.187 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.91 152.76 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 3.2599999999999998 110.89 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.41 173.33 10.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 1.26 111.112 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.67 120.0 13.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 5.0800000000000001 110.819 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 53.62 -134.77 42.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 1.72 112.488 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.91 110.48 20.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 1.49 111.061 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.23 56.38 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 2.9300000000000002 110.859 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.34 -58.94 3.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 2.6800000000000002 112.493 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -162.3 33.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 5.4699999999999998 110.847 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -110.74 -168.88 1.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 5.1399999999999997 110.878 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.75 114.89 16.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 6.1100000000000003 110.876 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.05 147.83 40.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 1.8400000000000001 111.11 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -59.86 -170.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 9.5399999999999991 110.875 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -137.92 165.39 26.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 5.25 110.87 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -50.82 133.35 31.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 2.9300000000000002 112.504 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 129.89 27.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 4.7699999999999996 110.934 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.87 -13.39 29.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 3.8399999999999999 112.459 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -108.58 -136.95 7.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 2.79 112.514 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.7 mt -71.47 110.88 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 3.21 111.174 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.572 ' H ' HD22 ' A' ' 181' ' ' LEU . 0.4 OUTLIER -50.51 -42.55 55.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 3.54 110.931 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 196' ' ' HIS . . . -178.84 -179.74 0.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 1.8799999999999999 111.078 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -142.15 129.58 21.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 3.6600000000000001 110.843 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -115.76 121.63 43.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.63 111.059 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.28 165.8 8.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 2.6299999999999999 110.859 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.37 170.2 0.34 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.77000000000000002 112.478 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -170.3 0.38 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.738 2.292 . . . . 0.97999999999999998 112.364 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.14 -149.14 18.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 1.23 112.497 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 99.3 p -92.24 155.56 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 1.96 110.899 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.42 -104.4 0.15 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 1.1399999999999999 112.485 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 38.0 mt -61.31 -26.52 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 1.98 111.121 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.15 99.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 2.6899999999999999 112.515 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 116.73 -18.9 12.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 1.01 112.456 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.532 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 10.1 m-20 -49.83 137.57 16.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.826 0.345 . . . . 2.0099999999999998 110.883 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -131.39 149.93 52.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.97999999999999998 111.099 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.535 ' O ' ' HB3' ' A' ' 182' ' ' ALA . 20.3 m-70 -136.58 109.89 7.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 2.7400000000000002 110.83 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -107.84 125.81 51.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 5.4699999999999998 110.889 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.458 ' OD2' HG21 ' A' ' 122' ' ' THR . 11.5 m-20 49.67 78.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 6.6299999999999999 110.871 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -76.61 60.79 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 8.5 110.901 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.6 26.6 16.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 5.3399999999999999 110.856 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -97.42 -42.54 7.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 3.7999999999999998 110.848 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 178.68 119.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 4.29 110.871 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -106.76 124.71 50.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 9.0099999999999998 110.923 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.1 159.92 38.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 1.8300000000000001 111.141 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.3 177.84 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 1.8400000000000001 111.146 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -55.39 -24.97 32.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 4.8600000000000003 110.865 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.98 -42.0 10.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 3.1200000000000001 110.861 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -57.21 -175.93 0.36 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 2.3500000000000001 112.503 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.4 -87.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.737 . . . . 1.9199999999999999 112.461 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 60.1 m -73.89 98.74 3.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.827 0.346 . . . . 1.8200000000000001 111.126 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -61.62 110.77 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 4.0 110.846 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.741 HD21 HG23 ' A' ' 130' ' ' VAL . 1.2 tt -69.33 -44.41 71.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.13 -0.487 . . . . 2.2000000000000002 110.907 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 217' ' ' VAL . 14.1 m-85 -63.96 -40.31 96.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 5.3600000000000003 110.896 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.44 -47.06 28.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 2.6600000000000001 110.904 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 24.0 m -55.54 -49.6 72.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 1.21 111.141 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.84 -32.09 63.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.91000000000000003 111.076 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 213' ' ' PHE . 62.9 t -80.77 -29.82 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.96999999999999997 111.066 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -73.56 -48.73 30.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 1.78 110.871 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -63.59 -49.21 74.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 4.8399999999999999 110.884 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.505 HD11 ' CE1' ' A' ' 138' ' ' PHE . 11.6 tt -57.82 -25.41 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 2.3500000000000001 111.162 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 -27.52 70.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 1.29 112.481 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -74.97 -28.67 60.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 3.4399999999999999 110.877 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.604 ' O ' HD12 ' A' ' 224' ' ' LEU . 0.7 OUTLIER -93.88 40.93 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 1.74 110.859 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 223' ' ' SER . 0.2 OUTLIER -159.72 -40.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 1.78 110.922 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 147.85 122.32 1.29 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 2.54 112.46 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.6 tp -179.19 -63.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 4.0499999999999998 110.912 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 62.74 15.33 54.27 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 3.5299999999999998 112.475 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 17.5 m80 51.98 67.15 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 2.2400000000000002 110.833 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 65.1 m -51.89 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 5.1299999999999999 110.866 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.464 ' N ' ' HE1' ' A' ' 236' ' ' MET . 0.3 OUTLIER 177.2 101.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 4.2400000000000002 110.888 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.4 OUTLIER -146.65 85.17 7.29 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 3.6600000000000001 110.887 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -29.78 23.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 2.7799999999999998 112.325 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 8.38 43.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 5.5 110.952 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.797 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . . . -124.74 -177.49 3.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 2.29 111.129 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 241' ' ' LYS . 16.7 m -95.83 -7.6 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 4.6200000000000001 111.115 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.464 ' HE1' ' N ' ' A' ' 230' ' ' SER . 1.9 ttp -54.15 -27.22 32.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 5.1100000000000003 110.892 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.25 157.58 1.15 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.633 0.73 . . . . 3.9199999999999999 110.871 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.34 28.3 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.67 2.246 . . . . 2.5 112.297 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.2 m -99.42 137.4 37.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 2.8799999999999999 111.185 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -63.14 142.07 58.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 3.9300000000000002 110.945 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.479 ' HB3' HG12 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -125.21 96.62 4.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 3.2799999999999998 110.919 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -61.59 125.84 25.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 3.5899999999999999 110.899 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.92 177.19 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 2.3500000000000001 111.136 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.1 128.45 34.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 2.79 110.878 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.0 tp -55.83 -25.29 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 3.1899999999999999 111.13 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -65.36 -39.4 92.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 2.9700000000000002 110.894 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 65.2 p -99.6 2.72 44.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 2.46 111.154 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 217' ' ' VAL . 7.2 t80 -51.91 108.32 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 4.0999999999999996 110.877 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -174.45 139.24 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 3.7000000000000002 110.832 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.598 HD21 ' OD2' ' A' ' 254' ' ' ASP . 0.8 OUTLIER -52.59 151.75 4.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 2.4100000000000001 110.917 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.586 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.4 OUTLIER -154.1 -179.0 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 3.98 110.848 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.658 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . . . 64.55 -178.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 3.29 111.119 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -23.23 51.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 2.7200000000000002 110.831 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.598 ' OD2' HD21 ' A' ' 250' ' ' LEU . 5.1 t0 -53.19 -30.12 35.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 3.0499999999999998 110.863 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.697 ' CG1' HG11 ' A' ' 144' ' ' VAL . 2.2 tt -65.1 -29.99 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 2.4100000000000001 111.11 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -99.04 -1.71 39.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 7.0899999999999999 110.885 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -90.17 17.85 51.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.693 -0.765 . . . . 1.6899999999999999 112.532 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.46 HG12 HG23 ' A' ' 145' ' ' THR . 0.7 OUTLIER -134.87 -40.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 1.0800000000000001 111.1 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -24.77 56.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 3.5099999999999998 110.867 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.2 t -76.32 -24.74 54.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 1.8700000000000001 110.833 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.7 mp -82.97 142.28 31.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 5.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 55.14 26.59 8.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 12.83 110.869 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 CA-C-O 119.122 -0.821 . . . . 11.15 112.477 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.824 0.345 . . . . 8.4199999999999999 110.863 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -132.62 126.51 32.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 11.02 110.918 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 tp -116.8 163.88 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.508 . . . . 3.3700000000000001 111.103 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.6 p -146.42 155.99 42.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 2.2200000000000002 111.127 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.409 ' CD2' HD11 ' A' ' 159' ' ' ILE . 0.1 OUTLIER -127.47 136.7 52.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 7.5 110.911 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -141.14 143.33 34.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 4.3300000000000001 110.864 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.5 mt -108.01 148.36 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 2.48 111.162 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -111.9 -69.46 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 3.7400000000000002 110.914 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -107.36 -169.84 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 4.7199999999999998 110.877 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -146.62 140.73 26.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 6.2699999999999996 110.946 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.632 HG23 HG21 ' A' ' 130' ' ' VAL . 72.3 p -53.08 109.71 1.61 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.552 0.692 . . . . 2.8399999999999999 111.129 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 122' ' ' THR . 53.7 Cg_endo -69.8 -48.74 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.647 2.231 . . . . 2.8500000000000001 112.307 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.21 -33.55 75.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 4.6500000000000004 110.858 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.2 tpt -101.34 178.88 4.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 3.1600000000000001 110.853 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -78.92 128.83 33.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 3.52 110.849 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -52.96 -28.12 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 6.1699999999999999 110.908 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.77 -32.49 40.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 3.2999999999999998 110.899 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -65.6 -43.05 90.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 2.7200000000000002 110.881 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.632 HG21 HG23 ' A' ' 122' ' ' THR . 10.2 p -74.09 -35.54 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.02 111.143 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.0 -44.4 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 2.48 110.846 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -71.76 -39.63 69.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 3.6699999999999999 110.932 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.671 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -56.16 -59.24 5.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.97999999999999998 111.168 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.466 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 3.4 pt -56.43 -29.4 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 2.7400000000000002 111.139 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.08 -57.64 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 4.2400000000000002 110.827 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.664 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -79.19 -25.64 42.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 2.98 110.869 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.734 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.59 -43.75 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 1.28 111.091 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.415 ' HA ' HG21 ' A' ' 220' ' ' ILE . 37.0 t80 -73.68 -23.93 59.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 3.6600000000000001 110.84 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -78.13 -31.41 49.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 2.9500000000000002 110.912 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 136' ' ' LYS . 47.7 t -51.09 -56.2 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 1.97 111.089 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CE3' HD11 ' A' ' 250' ' ' LEU . 0.9 OUTLIER -73.64 -42.13 61.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 4.3799999999999999 110.917 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.651 ' HB2' HD11 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -54.67 -22.38 13.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 1.7 110.841 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -57.62 -21.84 41.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 3.3599999999999999 110.909 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.609 HG21 HG13 ' A' ' 255' ' ' ILE . 3.0 m -141.51 62.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 2.2599999999999998 111.173 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.771 HG23 HG13 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -157.02 147.53 16.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.632 0.73 . . . . 1.8400000000000001 111.114 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.734 ' HD2' HG22 ' A' ' 145' ' ' THR . 54.2 Cg_endo -69.75 -8.53 23.85 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.688 2.259 . . . . 2.48 112.362 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' A' ' 142' ' ' SER . 3.6 pp -66.22 -172.28 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 4.2599999999999998 110.923 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.508 ' N ' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -144.77 -174.89 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 6.2800000000000002 110.899 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -132.32 122.34 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 6.9400000000000004 110.891 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.4 t -144.93 89.94 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 1.8999999999999999 110.869 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -82.31 117.1 22.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 3.6800000000000002 110.894 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.2 159.84 42.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 2.8700000000000001 111.11 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -99.88 -27.96 13.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 3.8999999999999999 110.876 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.4 m -113.73 116.73 29.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 3.0800000000000001 111.088 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.33 147.35 6.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 2.0600000000000001 112.484 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.2 164.67 26.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.766 0.317 . . . . 6.0300000000000002 110.891 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.0 142.9 27.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 1.02 111.106 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -51.93 53.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 2.2400000000000002 110.859 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.881 HG22 ' HA3' ' A' ' 193' ' ' GLY . 22.9 pt -104.63 139.85 24.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 2.5699999999999998 111.141 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.742 ' C ' HD22 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -135.44 162.94 31.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 2.0 110.941 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.598 ' N ' HD22 ' A' ' 160' ' ' LEU . 39.2 t -106.21 121.74 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.79 111.095 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.486 ' HB ' HD21 ' A' ' 160' ' ' LEU . 3.5 p -139.43 163.31 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 2.48 111.144 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -121.02 133.13 55.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 4.0099999999999998 110.892 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.86 167.73 20.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 1.49 111.112 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.68 146.59 32.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 5.1500000000000004 110.878 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.37 -151.48 3.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 2.1899999999999999 112.502 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.79 125.35 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 2.0600000000000001 111.088 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -112.39 43.54 1.6 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 2.8399999999999999 110.847 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.14 76.59 0.26 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 3.21 112.462 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.2 t70 63.86 47.71 3.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.736 0.303 . . . . 5.9400000000000004 110.825 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.422 ' OD2' HD11 ' A' ' 191' ' ' ILE . 0.3 OUTLIER -142.2 -169.02 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 4.6500000000000004 110.851 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -76.83 124.08 27.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 5.46 110.851 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.29 144.96 31.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 1.96 111.131 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -130.32 -169.66 2.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 6.3200000000000003 110.887 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -151.28 -170.53 3.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 5.04 110.86 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -115.92 -153.13 10.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.758 . . . . 2.4199999999999999 112.445 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.71 133.61 25.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 3.3700000000000001 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 111.96 -18.97 23.6 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 2.4300000000000002 112.496 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -143.98 -129.09 2.21 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.747 -0.739 . . . . 1.4099999999999999 112.49 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 182' ' ' ALA . 28.5 mm -77.2 125.45 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.89 0.376 . . . . 2.46 111.144 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.591 ' HG ' HG21 ' A' ' 210' ' ' THR . 0.3 OUTLIER -95.89 -5.91 40.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 4.1200000000000001 110.911 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.488 ' H ' HG22 ' A' ' 180' ' ' ILE . . . -178.6 123.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 1.76 111.114 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 114.23 18.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 3.6600000000000001 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.64 117.5 24.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.68999999999999995 111.075 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -64.41 170.79 3.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 2.79 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.05 172.08 0.17 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.751 -0.737 . . . . 0.81999999999999995 112.489 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 172.23 13.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 0.87 112.333 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 159.35 -133.6 3.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 1.25 112.507 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 34.5 t -134.09 128.42 34.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.367 . . . . 3.6299999999999999 110.88 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 85.52 -70.36 3.08 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.741 -0.742 . . . . 1.8600000000000001 112.486 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.422 HD11 ' OD2' ' A' ' 171' ' ' ASP . 0.5 OUTLIER -99.7 -27.04 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.358 . . . . 3.04 111.119 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.11 129.14 29.0 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 2.2999999999999998 112.525 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.881 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . 85.69 -9.57 67.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 1.0600000000000001 112.511 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.453 ' HA ' HD13 ' A' ' 160' ' ' LEU . 3.8 m-20 -51.19 157.61 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.8200000000000001 110.874 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.753 ' HB1' ' CE2' ' A' ' 197' ' ' PHE . . . -125.97 121.28 32.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 1.1599999999999999 111.08 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -111.05 115.52 29.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 3.0800000000000001 110.838 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.753 ' CE2' ' HB1' ' A' ' 195' ' ' ALA . 50.1 m-85 -143.94 150.23 38.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 3.0299999999999998 110.875 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.432 ' N ' ' HE1' ' A' ' 203' ' ' TRP . 0.9 OUTLIER 75.16 -168.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 7.1500000000000004 110.855 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.87 96.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 6.9100000000000001 110.923 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.2 t70 55.95 68.97 0.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 4.0800000000000001 110.888 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -174.75 -41.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 4.2699999999999996 110.879 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 11.7 t80 67.24 131.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 5.5599999999999996 110.885 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.658 ' CH2' HG21 ' A' ' 215' ' ' THR . 21.3 m95 -105.72 -174.91 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 7.0800000000000001 110.877 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 168.27 27.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 1.96 111.184 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -175.1 3.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 2.0 111.143 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -52.76 -47.95 67.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 4.4400000000000004 110.909 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.4 p -78.39 -31.94 48.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 2.1800000000000002 110.879 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -50.38 167.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 2.2000000000000002 112.483 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.83 -72.71 0.44 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 1.6200000000000001 112.502 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.591 HG21 ' HG ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -102.3 98.64 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.796 0.332 . . . . 1.8 111.133 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -69.57 132.39 46.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 4.4400000000000004 110.87 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.2 tm? -57.99 -41.3 82.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 3.3900000000000001 110.908 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.733 ' O ' HG23 ' A' ' 217' ' ' VAL . 8.0 t80 -70.74 -60.72 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 5.5199999999999996 110.899 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.529 ' CD2' HG22 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -50.43 -34.89 26.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 3.0099999999999998 110.898 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.658 HG21 ' CH2' ' A' ' 203' ' ' TRP . 82.5 m -79.91 -41.6 25.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 1.1100000000000001 111.148 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.89 98.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 1.1899999999999999 111.102 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.734 HG22 ' HA ' ' A' ' 137' ' ' ALA . 53.5 t -51.27 -40.74 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.81999999999999995 111.156 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -64.74 -36.41 84.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 2.0699999999999998 110.85 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -74.64 -45.75 42.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 4.4699999999999998 110.883 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.463 HD12 ' HB1' ' A' ' 137' ' ' ALA . 91.3 mt -56.09 -37.04 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 2.0899999999999999 111.187 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.07 -37.78 36.94 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.686 -0.769 . . . . 0.67000000000000004 112.467 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -54.86 -40.64 69.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 2.3399999999999999 110.879 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.6 8.75 26.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 2.1400000000000001 110.879 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.484 ' O ' HD13 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -150.33 88.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 3.4700000000000002 110.944 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 71.12 179.32 29.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.738 -0.744 . . . . 2.1099999999999999 112.51 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 54.3 -175.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 3.0299999999999998 110.896 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.404 ' C ' ' HE1' ' A' ' 236' ' ' MET . . . -145.8 -115.68 0.96 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 2.48 112.464 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.44 142.82 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 1.8 110.881 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.83 -78.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 6.6100000000000003 110.845 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.51 -78.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 5.4400000000000004 110.882 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 153.21 48.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.599 0.714 . . . . 3.8900000000000001 110.858 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 233' ' ' LYS . 54.0 Cg_endo -69.73 -177.12 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.677 2.252 . . . . 2.8300000000000001 112.358 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.47 43.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 4.3200000000000003 110.887 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -135.54 163.5 29.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 1.77 111.101 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.447 HG23 HD11 ' A' ' 214' ' ' LEU . 9.8 p -87.16 7.4 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 3.1400000000000001 111.14 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.404 ' HE1' ' C ' ' A' ' 227' ' ' GLY . 1.4 tmm? -98.43 -26.08 14.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 3.8599999999999999 110.906 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.458 ' HB3' HG22 ' A' ' 239' ' ' THR . 0.1 OUTLIER -54.68 141.59 55.6 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.632 0.73 . . . . 3.9500000000000002 110.888 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 64.97 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.683 2.256 . . . . 2.1200000000000001 112.349 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.458 HG22 ' HB3' ' A' ' 237' ' ' PHE . 7.1 t -158.03 134.2 9.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 2.6400000000000001 111.169 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -76.3 127.49 32.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 4.2300000000000004 110.951 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.407 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.0 ptmt -140.58 92.74 2.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 4.1699999999999999 110.915 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -62.41 125.61 24.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 3.4399999999999999 110.912 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.529 HG22 ' CD2' ' A' ' 214' ' ' LEU . 16.7 m -137.49 177.32 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.494 . . . . 2.5499999999999998 111.153 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -62.09 114.28 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 3.9100000000000001 110.845 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 18.4 tt -76.36 -32.75 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 3.1600000000000001 111.172 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.43 -30.79 65.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 3.1899999999999999 110.866 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.56 28.05 9.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 3.4399999999999999 111.11 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -51.76 149.86 4.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 5.3399999999999999 110.913 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -179.71 156.2 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 4.3700000000000001 110.885 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 251' ' ' SER . 0.4 OUTLIER -86.83 157.49 19.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 2.1800000000000002 110.955 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.627 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.3 OUTLIER -154.65 -171.64 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 3.3999999999999999 110.904 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 68.72 160.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 3.6600000000000001 111.109 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.84 -21.48 56.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 3.2799999999999998 110.886 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.84 -29.74 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 4.04 110.886 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.609 HG13 HG21 ' A' ' 144' ' ' VAL . 1.2 tt -51.14 -29.53 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 1.7 111.143 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -90.59 -34.07 15.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 5.1900000000000004 110.842 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.55 -17.07 47.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 1.6499999999999999 112.507 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.771 HG13 HG23 ' A' ' 145' ' ' THR . 4.0 tp -99.95 -31.61 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.90000000000000002 111.179 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.78 -43.39 25.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 3.98 110.899 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.416 ' C ' HD12 ' A' ' 261' ' ' LEU . 34.6 t -85.6 -47.25 10.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 1.95 110.841 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 260' ' ' SER . 1.1 mp 56.93 70.12 0.68 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 3.5499999999999998 110.902 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -142.13 93.3 2.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 11.710000000000001 110.875 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 CA-C-O 119.121 -0.822 . . . . 10.84 112.5 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.757 0.313 . . . . 7.5099999999999998 110.862 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.496 ' O ' HD13 ' A' ' 114' ' ' ILE . 3.1 m-85 -67.27 148.89 51.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 9.1400000000000006 110.936 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 113' ' ' TYR . 18.6 mm -129.01 155.05 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 2.8700000000000001 111.16 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.47 117.71 7.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 2.1899999999999999 111.136 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.759 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 11.8 p90 -131.95 145.83 51.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 4.25 110.942 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -142.29 160.51 40.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 4.9400000000000004 110.9 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 134' ' ' ILE . 21.3 mt -106.59 148.92 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 2.1600000000000001 111.172 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.582 ' CB ' HG22 ' A' ' 162' ' ' VAL . 23.2 t30 -106.77 -69.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 4.29 110.86 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -118.37 174.88 5.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 5.4199999999999999 110.881 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -134.45 163.27 30.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 6.5499999999999998 110.918 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.578 HG21 ' HB2' ' A' ' 203' ' ' TRP . 0.0 OUTLIER -88.51 131.86 40.75 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.546 0.688 . . . . 2.5699999999999998 111.114 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -19.43 36.14 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.702 2.268 . . . . 2.1499999999999999 112.334 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.64 -69.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 4.4800000000000004 110.874 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 38.0 mmm -101.19 168.12 9.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 3.6099999999999999 110.87 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -59.39 158.23 9.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 2.54 110.892 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.433 ' HA ' HG12 ' A' ' 130' ' ' VAL . 3.9 tmm_? -70.78 -11.26 60.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 6.5700000000000003 110.888 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -79.73 -36.69 37.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 3.0899999999999999 110.886 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.07 -40.77 71.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 2.6800000000000002 110.866 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.522 HG23 HD11 ' A' ' 212' ' ' LEU . 8.8 p -74.3 -36.2 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.67000000000000004 111.107 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -66.34 -43.97 84.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 3.7799999999999998 110.855 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -48.98 23.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 3.3199999999999998 110.937 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.547 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -59.78 -26.88 66.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 1.27 111.094 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.529 HG21 HD11 ' A' ' 118' ' ' ILE . 1.3 mm -70.85 -50.93 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 2.46 111.15 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -75.2 -22.7 57.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 4.1399999999999997 110.879 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -77.62 -29.92 52.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 2.9399999999999999 110.934 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 140' ' ' VAL . . . -63.5 -52.08 62.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.96999999999999997 111.039 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.579 ' HA ' HG21 ' A' ' 220' ' ' ILE . 1.3 t80 -55.09 -28.38 52.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 4.2400000000000002 110.887 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -70.49 -27.95 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 2.4900000000000002 110.898 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.534 HG11 HG11 ' A' ' 217' ' ' VAL . 58.4 t -51.08 -56.1 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 1.74 111.16 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.442 ' CZ3' HD21 ' A' ' 250' ' ' LEU . 30.7 m95 -77.44 -29.06 52.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 3.9700000000000002 110.921 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 p -55.19 -41.61 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 2.2400000000000002 110.807 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.69 -16.19 62.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 2.77 110.9 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.822 HG11 HD11 ' A' ' 255' ' ' ILE . 31.5 m -135.79 39.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 2.3199999999999998 111.139 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.447 HG23 ' HD2' ' A' ' 146' ' ' PRO . 91.9 m -155.63 133.65 6.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.583 0.706 . . . . 1.8600000000000001 111.17 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.447 ' HD2' HG23 ' A' ' 145' ' ' THR . 54.1 Cg_endo -69.76 74.56 1.28 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.738 2.292 . . . . 2.3599999999999999 112.341 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.479 HD21 HD11 ' A' ' 114' ' ' ILE . 2.8 tp -163.13 -169.65 2.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 3.21 110.941 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -148.25 176.27 10.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 4.8099999999999996 110.875 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -135.81 120.03 17.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 7.2599999999999998 110.87 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 t -110.44 89.99 3.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 1.9099999999999999 110.843 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.16 93.4 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 2.7599999999999998 110.882 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.599 HD12 ' O ' ' A' ' 154' ' ' THR . 1.1 pt -131.57 163.96 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 3.5800000000000001 111.155 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -103.01 -5.78 23.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 3.1899999999999999 110.891 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.599 ' O ' HD12 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -95.57 175.73 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 4.1299999999999999 111.184 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.48 -165.55 1.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 2.1400000000000001 112.476 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.4 mtm -110.77 151.92 27.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 4.9400000000000004 110.867 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.759 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -119.35 130.14 55.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 1.3100000000000001 111.087 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.41 -20.82 62.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 2.54 110.883 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.0 mm -103.47 84.58 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 2.5899999999999999 111.144 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.643 HD11 HG23 ' A' ' 162' ' ' VAL . 1.1 tm? -85.72 117.72 24.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 1.48 110.945 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.605 ' N ' HD22 ' A' ' 160' ' ' LEU . 99.4 t -105.3 110.77 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 1.49 111.085 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.643 HG23 HD11 ' A' ' 160' ' ' LEU . 47.6 t -127.07 143.2 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 1.1899999999999999 111.15 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -97.77 100.21 11.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 7.54 110.903 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.518 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . . . -132.26 144.03 50.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 1.75 111.1 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.74 164.1 14.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 6.7199999999999998 110.849 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.52 -138.03 29.36 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.768 -0.729 . . . . 1.1599999999999999 112.502 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.23 128.24 33.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 1.47 111.137 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -95.67 24.87 4.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 3.1800000000000002 110.887 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.8 -28.17 10.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.761 -0.733 . . . . 2.3199999999999998 112.481 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.46 34.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.817 0.341 . . . . 5.25 110.874 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.56 -173.84 2.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 110.903 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.61 118.83 26.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 6.3799999999999999 110.864 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.41 139.9 35.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.3400000000000001 111.086 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -154.02 88.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 7.1699999999999999 110.87 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -128.49 -168.42 1.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 5.5300000000000002 110.859 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.62 106.1 0.91 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.748 -0.739 . . . . 2.1699999999999999 112.477 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.94 119.11 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 4.96 110.891 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.61 -24.52 21.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 2.29 112.494 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -82.88 -140.72 3.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.675 -0.774 . . . . 1.46 112.51 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.62 110.53 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 1.9099999999999999 111.105 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.578 ' H ' HD22 ' A' ' 181' ' ' LEU . 0.4 OUTLIER -50.42 -57.38 8.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.478 . . . . 3.79 110.915 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -179.01 123.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 1.46 111.093 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -95.3 153.58 17.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 3.21 110.831 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -152.46 113.04 4.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.68999999999999995 111.06 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.67 157.4 24.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 2.54 110.885 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.94 -171.0 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 1.1299999999999999 112.497 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -169.86 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.731 2.287 . . . . 1.03 112.338 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 125.37 -156.34 19.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 1.2 112.512 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.8 p -88.92 145.58 25.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 2.8300000000000001 110.861 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.08 -102.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 1.1699999999999999 112.43 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 82.0 mt -52.57 -27.73 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 2.0699999999999998 111.153 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.59 111.56 2.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 2.6600000000000001 112.474 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.43 -16.14 56.89 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 1.05 112.507 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -49.94 138.41 15.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 2.2599999999999998 110.905 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 161' ' ' VAL . . . -129.96 141.17 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.93000000000000005 111.097 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.518 ' NE2' ' HB3' ' A' ' 164' ' ' ALA . 0.1 OUTLIER -118.77 144.57 46.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 3.2799999999999998 110.871 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -144.45 148.5 34.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 2.71 110.903 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.425 ' HB2' HG23 ' A' ' 122' ' ' THR . 25.5 t70 70.48 -75.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 5.8600000000000003 110.882 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 46.85 41.33 10.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 8.8300000000000001 110.919 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.5 t0 62.98 41.1 8.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 3.54 110.888 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -118.45 1.87 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 4.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.12 115.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 4.75 110.899 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.737 ' CZ3' HG21 ' A' ' 210' ' ' THR . 0.1 OUTLIER -100.11 170.19 8.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 6.9400000000000004 110.946 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 205' ' ' THR . 0.2 OUTLIER -156.81 172.92 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 1.75 111.161 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 204' ' ' THR . 0.3 OUTLIER -75.35 -170.15 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 1.99 111.161 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.671 ' CB ' HG23 ' A' ' 245' ' ' ILE . 39.7 p-80 -76.77 -21.39 55.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 4.8899999999999997 110.853 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.9 t -61.08 -68.9 0.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 2.0800000000000001 110.843 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -132.9 -166.69 11.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.716 -0.754 . . . . 2.2200000000000002 112.481 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 50.07 -168.06 0.31 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.697 -0.763 . . . . 1.6299999999999999 112.497 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.737 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.3 m -56.46 99.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 1.54 111.114 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.0 103.76 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 2.5499999999999998 110.846 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.576 ' O ' HD23 ' A' ' 212' ' ' LEU . 6.6 tt -57.51 -38.27 74.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 1.96 110.901 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.547 ' O ' HG23 ' A' ' 217' ' ' VAL . 11.6 t80 -71.47 -64.26 0.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 5.0300000000000002 110.837 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.7 tp -50.8 -53.68 29.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 2.1499999999999999 110.915 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 85.5 m -55.37 -44.24 75.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.91000000000000003 111.167 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.68 -43.91 76.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.65000000000000002 111.098 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 213' ' ' PHE . 24.6 t -55.09 -41.87 61.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.64000000000000001 111.14 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -60.23 -31.33 70.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 2.2200000000000002 110.857 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -74.62 -40.35 61.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 3.6600000000000001 110.884 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.579 HG21 ' HA ' ' A' ' 138' ' ' PHE . 49.4 mm -54.64 -43.35 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.54 111.101 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.467 ' O ' HD23 ' A' ' 226' ' ' LEU . . . -75.87 -50.47 7.83 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.733 -0.746 . . . . 0.93000000000000005 112.528 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.81 -31.69 62.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 2.29 110.865 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.9 p -95.24 22.11 7.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 2.04 110.846 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 220' ' ' ILE . 17.2 mt -142.31 18.03 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 2.2999999999999998 110.888 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.606 ' O ' HD22 ' A' ' 226' ' ' LEU . . . 90.26 70.08 1.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 1.8899999999999999 112.499 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.606 HD22 ' O ' ' A' ' 225' ' ' GLY . 2.8 mm? -130.28 169.47 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 3.5800000000000001 110.928 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -82.29 -120.89 0.62 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 2.6699999999999999 112.45 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.87 33.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.331 . . . . 3.3900000000000001 110.819 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.0 m -153.09 -75.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 5.4199999999999999 110.832 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.0 t 57.7 -169.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 6.3399999999999999 110.888 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.06 160.29 0.87 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.632 0.729 . . . . 2.9199999999999999 110.851 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -14.84 36.46 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.639 2.226 . . . . 2.5099999999999998 112.346 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.74 -19.7 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 3.6499999999999999 110.889 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.57 170.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 1.6599999999999999 111.067 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 235' ' ' VAL . 7.9 t -88.17 -1.37 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 3.1800000000000002 111.156 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -30.2 20.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 3.8599999999999999 110.897 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.53 137.69 31.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.638 0.732 . . . . 3.96 110.877 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.41 ' O ' HG23 ' A' ' 239' ' ' THR . 53.8 Cg_endo -69.71 77.97 1.02 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 2.5600000000000001 112.375 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 238' ' ' PRO . 1.1 p -156.41 168.03 28.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 2.5499999999999998 111.136 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -125.37 112.53 16.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 3.7599999999999998 110.922 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.01 153.02 48.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 2.7000000000000002 110.888 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -111.13 102.47 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 3.4900000000000002 110.94 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 244' ' ' ASP . 7.5 t -107.57 157.21 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 2.3500000000000001 111.146 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 243' ' ' VAL . 0.7 OUTLIER -75.92 135.32 40.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 3.6200000000000001 110.855 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.671 HG23 ' CB ' ' A' ' 206' ' ' HIS . 19.6 pt -58.17 -22.61 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 2.73 111.116 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -21.41 24.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 3.0600000000000001 110.903 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.9 m -100.73 -6.11 25.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 2.7400000000000002 111.116 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.06 158.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 5.3399999999999999 110.848 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -178.22 149.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 4.3399999999999999 110.879 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.951 HD12 HD12 ' A' ' 255' ' ' ILE . 1.8 tm? -83.87 150.82 25.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 2.4900000000000002 110.888 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.785 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.4 OUTLIER -87.67 123.61 32.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 3.6000000000000001 110.894 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -44.73 -54.79 5.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 4.0099999999999998 111.067 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.08 -39.63 63.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 3.5899999999999999 110.895 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -71.68 -34.53 69.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 2.7599999999999998 110.905 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.951 HD12 HD12 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -50.75 -30.84 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 1.8400000000000001 111.111 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -79.39 -35.38 40.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 6.0999999999999996 110.88 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -61.17 -16.72 49.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 1.6100000000000001 112.479 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.713 ' O ' HD13 ' A' ' 261' ' ' LEU . 7.5 tp -114.45 -36.27 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.83999999999999997 111.172 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? -67.37 -50.71 58.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 3.73 110.881 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -47.18 56.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 2.1000000000000001 110.852 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.713 HD13 ' O ' ' A' ' 258' ' ' ILE . 1.2 tp 54.73 26.05 7.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 3.52 110.947 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.88 124.34 7.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 9.9800000000000004 110.927 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 119.091 -0.838 . . . . 9.8599999999999994 112.5 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.803 0.335 . . . . 8.0899999999999999 110.828 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.55 ' C ' HD12 ' A' ' 114' ' ' ILE . 34.7 p90 -85.19 146.14 27.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 9.5899999999999999 110.919 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.55 HD12 ' C ' ' A' ' 113' ' ' TYR . 1.6 mp -117.92 145.58 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 3.0099999999999998 111.094 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.23 137.43 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 2.04 111.132 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.45 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 30.2 p90 -144.58 136.78 26.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 4.6100000000000003 110.908 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.27 133.63 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 4.4900000000000002 110.878 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.647 HD13 ' HB ' ' A' ' 134' ' ' ILE . 26.5 mt -108.05 141.61 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 2.48 111.16 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -157.44 47.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 4.2699999999999996 110.83 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.519 ' CG ' HG12 ' A' ' 161' ' ' VAL . 21.4 p-10 -147.23 143.72 28.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 5.6299999999999999 110.914 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -148.29 162.47 39.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 6.4400000000000004 110.934 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.545 HG23 HD11 ' A' ' 212' ' ' LEU . 1.0 OUTLIER -87.8 156.73 52.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.562 0.696 . . . . 3.2000000000000002 111.164 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 122' ' ' THR . 53.7 Cg_endo -69.71 -52.18 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.664 2.243 . . . . 2.5 112.352 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -66.94 -46.0 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 5.4299999999999997 110.932 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 10.7 mmt -98.26 122.88 41.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 3.6299999999999999 110.888 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -56.2 171.78 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 4.4800000000000004 110.879 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.59 ' HA ' HG12 ' A' ' 130' ' ' VAL . 14.5 ptt180 -67.2 -10.56 51.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 5.9900000000000002 110.853 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -34.17 71.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 5.1799999999999997 110.902 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.31 -41.23 41.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 3.8100000000000001 110.875 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.832 HG23 HD21 ' A' ' 212' ' ' LEU . 9.7 p -74.17 -33.99 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 1.2 111.113 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -49.92 -53.02 28.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 2.6499999999999999 110.847 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -76.16 -33.1 59.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 3.1099999999999999 110.924 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.38 -58.65 7.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.80000000000000004 111.098 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.681 HG12 HG22 ' A' ' 130' ' ' VAL . 5.3 mm -67.78 -45.48 84.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 2.7400000000000002 111.093 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -50.3 -48.99 54.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 3.73 110.854 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -76.83 -20.37 56.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 5.3600000000000003 110.885 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 134' ' ' ILE . . . -56.01 -37.96 69.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.90000000000000002 111.141 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.31 -25.17 60.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 3.8799999999999999 110.901 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -73.63 -27.79 61.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 3.1600000000000001 110.932 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.711 HG21 ' CG2' ' A' ' 217' ' ' VAL . 21.6 t -58.94 -55.94 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 2.0499999999999998 111.151 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -44.21 61.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 4.3700000000000001 110.945 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.3 m -54.87 -24.87 25.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 2.6299999999999999 110.855 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -58.08 -22.62 51.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 2.25 110.899 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.754 HG11 HD11 ' A' ' 255' ' ' ILE . 23.5 m -140.3 37.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 2.1099999999999999 111.14 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.8 m -142.88 131.52 11.53 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.62 0.724 . . . . 1.71 111.149 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 66.75 1.77 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 2.3199999999999998 112.305 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tp -140.62 166.25 25.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 2.5499999999999998 110.906 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -118.38 162.29 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 4.4299999999999997 110.905 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -135.8 119.84 17.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 6.9100000000000001 110.881 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 98.4 p -127.35 90.01 3.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 2.2599999999999998 110.894 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 120.13 12.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 2.5600000000000001 110.882 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 154' ' ' THR . 5.5 pt -148.03 156.93 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 3.0499999999999998 111.161 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -96.52 -24.33 16.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 3.9500000000000002 110.874 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.662 ' O ' HD12 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -95.71 175.51 6.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 3.1699999999999999 111.148 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.46 -171.95 42.88 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.712 -0.756 . . . . 1.8600000000000001 112.507 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mtt -110.65 157.09 20.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.794 0.33 . . . . 5.0999999999999996 110.846 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -137.08 146.57 45.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.01 111.094 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.75 -17.79 32.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 2.77 110.901 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.3 mm -104.31 84.47 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 2.5800000000000001 111.164 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.587 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.2 tm? -91.78 117.15 29.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 1.4199999999999999 110.902 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.587 ' N ' HD22 ' A' ' 160' ' ' LEU . 21.2 t -102.71 110.75 30.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 1.3500000000000001 111.097 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.582 ' CG2' HD11 ' A' ' 160' ' ' LEU . 45.2 t -133.97 141.94 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 1.0600000000000001 111.158 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -80.81 145.7 31.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 3.4300000000000002 110.857 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.57 ' HB1' ' CD2' ' A' ' 168' ' ' HIS . . . -164.27 156.0 16.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 1.6899999999999999 111.094 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.62 140.1 31.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 5.71 110.829 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.43 -136.4 35.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 1.5800000000000001 112.468 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.29 127.71 33.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 1.3400000000000001 111.061 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.57 ' CD2' ' HB1' ' A' ' 164' ' ' ALA . 5.5 m170 -101.22 25.31 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 6.1200000000000001 110.865 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.19 92.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.807 -0.711 . . . . 2.7799999999999998 112.505 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.9 t0 63.71 59.03 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.341 . . . . 5.5 110.848 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -158.03 -170.5 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 4.1600000000000001 110.868 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -96.07 106.25 18.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 5.8499999999999996 110.866 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.03 159.17 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 2.1299999999999999 111.063 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.09 -74.06 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 6.0700000000000003 110.866 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -179.28 -74.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 4.2699999999999996 110.894 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.08 -155.06 24.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 2.4300000000000002 112.501 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -59.43 123.06 15.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.844 0.354 . . . . 5.3899999999999997 110.864 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.38 90.6 0.64 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 3.2999999999999998 112.459 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.25 -140.59 11.02 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.794 -0.717 . . . . 1.54 112.507 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.0 mt -72.06 92.24 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.893 0.378 . . . . 2.1699999999999999 111.187 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -48.51 -28.96 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 3.3599999999999999 110.921 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.14 178.3 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.5800000000000001 111.065 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -151.64 125.49 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 3.2200000000000002 110.885 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.93 104.9 8.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.95999999999999996 111.13 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.09 165.81 8.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 3.2200000000000002 110.921 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.4 171.12 0.28 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.784 -0.722 . . . . 1.04 112.521 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -170.04 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.691 2.261 . . . . 1.1699999999999999 112.317 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.12 -112.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 1.46 112.459 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.87 135.24 43.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 2.1099999999999999 110.875 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.61 -86.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.94999999999999996 112.467 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 90.8 mt -71.76 -23.45 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 2.0699999999999998 111.097 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -58.46 117.3 10.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.749 . . . . 2.46 112.474 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.71 -14.6 64.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.723 -0.751 . . . . 0.81000000000000005 112.494 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -51.63 128.64 23.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.812 0.339 . . . . 2.0299999999999998 110.862 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -117.27 148.76 41.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.80000000000000004 111.098 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.583 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 39.7 m-70 -137.08 124.78 22.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 2.6299999999999999 110.835 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.509 ' CE2' HD23 ' A' ' 212' ' ' LEU . 0.2 OUTLIER -107.35 143.41 35.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 4.0899999999999999 110.853 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -77.93 58.08 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 6.1500000000000004 110.899 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -73.18 -13.51 61.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 9.5999999999999996 110.882 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -127.5 7.11 6.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 6.2199999999999998 110.91 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -121.74 -34.98 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 6.0199999999999996 110.862 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.52 91.69 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 7.5700000000000003 110.898 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -104.51 122.53 45.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 8.9800000000000004 110.938 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.11 162.53 38.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 2.1099999999999999 111.168 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.52 -170.21 1.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 2.2999999999999998 111.136 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -47.17 -46.95 24.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 6.0199999999999996 110.849 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -59.22 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 2.2799999999999998 110.847 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.26 171.2 0.25 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.738 . . . . 2.5 112.448 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.99 -90.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.744 . . . . 1.55 112.514 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.02 97.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.321 . . . . 1.47 111.169 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -68.34 117.82 10.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 2.8399999999999999 110.873 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.832 HD21 HG23 ' A' ' 130' ' ' VAL . 0.7 OUTLIER -51.35 -40.26 58.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 2.46 110.914 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -71.45 -56.22 6.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 4.7800000000000002 110.909 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.52 HD21 ' CE1' ' A' ' 248' ' ' PHE . 0.1 OUTLIER -52.34 -54.74 27.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 2.75 110.892 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 92.3 m -55.52 -38.42 69.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.80000000000000004 111.164 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.61 -50.66 69.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.071 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.711 ' CG2' HG21 ' A' ' 140' ' ' VAL . 39.3 t -57.01 -36.15 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.73999999999999999 111.129 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -59.73 -41.89 91.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 2.0699999999999998 110.873 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -66.71 -36.87 83.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 4.21 110.864 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.8 mm -57.85 -57.89 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 1.48 111.171 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.34 -41.61 99.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.82999999999999996 112.471 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.93 ' HE1' 'CO ' ' A' ' 264' ' ' ' CO' . 0.2 OUTLIER -52.17 -46.33 65.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 3.2000000000000002 110.863 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.25 23.44 5.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 2.3399999999999999 110.807 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.96 87.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.185 -0.462 . . . . 3.8100000000000001 110.883 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 131.47 -81.87 0.32 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 2.5099999999999998 112.454 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.45 179.26 3.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 3.52 110.953 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.44 120.22 1.32 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.732 -0.747 . . . . 2.6699999999999999 112.444 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.9 m80 63.34 91.35 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.815 0.341 . . . . 1.8200000000000001 110.886 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.9 t -98.12 -75.49 0.55 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.166 -0.47 . . . . 4.1399999999999997 110.918 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.0 t -178.99 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.508 . . . . 4.3700000000000001 110.861 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.1 116.86 7.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.638 0.732 . . . . 2.6600000000000001 110.909 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -8.73 24.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.726 2.284 . . . . 2.54 112.319 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 -24.21 13.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 5.1200000000000001 110.882 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.433 ' HB2' ' OG ' ' A' ' 251' ' ' SER . . . -61.9 169.08 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.0099999999999998 111.105 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.44 ' O ' HG12 ' A' ' 235' ' ' VAL . 3.7 t -94.6 7.35 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 3.1000000000000001 111.142 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -89.26 -34.13 16.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 4.5099999999999998 110.884 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.94 138.34 95.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.677 0.751 . . . . 3.8999999999999999 110.815 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 87.4 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.655 2.237 . . . . 2.2599999999999998 112.35 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.08 139.49 14.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 2.6400000000000001 111.179 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.74 112.28 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 3.7799999999999998 110.916 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -129.26 -169.18 2.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 5.6799999999999997 110.881 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -114.53 79.57 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 3.4900000000000002 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 244' ' ' ASP . 3.8 t -107.33 159.95 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 2.7799999999999998 111.119 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.421 ' N ' HG12 ' A' ' 243' ' ' VAL . 0.6 OUTLIER -48.84 112.88 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 5.4800000000000004 110.829 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.5 pp -76.69 -33.11 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 3.3399999999999999 111.124 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -72.26 -39.2 68.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 4.0999999999999996 110.88 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.13 17.97 13.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 2.7400000000000002 111.194 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.52 ' CE1' HD21 ' A' ' 214' ' ' LEU . 9.5 t80 -70.62 138.23 50.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 6.8300000000000001 110.853 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -154.38 134.18 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 4.0099999999999998 110.887 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.74 HD11 HD12 ' A' ' 255' ' ' ILE . 0.5 OUTLIER -53.24 171.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 2.9399999999999999 110.94 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 97.7 p -89.58 -172.8 3.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 4.6600000000000001 110.842 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -85.76 -59.88 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 3.8900000000000001 111.157 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -37.2 62.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 3.8199999999999998 110.846 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -70.49 -29.77 66.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 3.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.754 HD11 HG11 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -52.82 -28.39 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 1.99 111.124 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -87.73 -36.49 17.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 4.6900000000000004 110.908 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.82 -17.48 50.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.708 -0.758 . . . . 1.73 112.512 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.3 tp -109.59 -30.37 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.96999999999999997 111.141 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -77.65 -40.07 43.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 2.96 110.901 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t -85.34 -47.16 10.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 2.48 110.862 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.1 mp 60.89 68.3 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 3.6800000000000002 110.863 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -119.76 153.65 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.249 -0.432 . . . . 10.94 110.903 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 CA-C-O 119.119 -0.823 . . . . 10.630000000000001 112.483 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . 0.93 'CO ' ' HE1' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.807 0.337 . . . . 14.220000000000001 110.875 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -101.48 149.69 23.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 16.690000000000001 110.931 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 115' ' ' THR . 2.1 tp -146.44 168.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 6.0899999999999999 111.126 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -92.31 116.29 28.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 3.02 111.152 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.566 ' HB3' HD11 ' A' ' 159' ' ' ILE . 16.9 p90 -139.67 136.57 34.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 5.1900000000000004 110.913 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.03 107.09 15.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 4.2699999999999996 110.823 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.788 HG23 HG23 ' A' ' 161' ' ' VAL . 18.1 mt -75.23 138.76 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 2.3599999999999999 111.142 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.66 ' HB2' HG22 ' A' ' 162' ' ' VAL . 2.0 m-80 -98.3 -74.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 4.79 110.863 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.35 145.47 47.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 5.9100000000000001 110.873 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -85.69 163.25 18.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 6.54 110.911 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.7 p -100.87 137.94 19.91 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.557 0.694 . . . . 3.3399999999999999 111.163 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -171.49 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.684 2.256 . . . . 2.71 112.335 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 56.64 22.97 7.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 4.0599999999999996 110.887 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -165.28 142.82 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 4.4500000000000002 110.895 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.45 142.52 58.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 2.5099999999999998 110.885 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -56.03 -25.2 43.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 5.1200000000000001 110.855 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -75.69 -38.83 58.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 3.1200000000000001 110.943 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.26 -51.12 67.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 2.4700000000000002 110.903 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.611 ' O ' HD12 ' A' ' 134' ' ' ILE . 6.4 p -62.1 -39.6 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.82999999999999996 111.164 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -68.12 -54.6 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 2.9500000000000002 110.882 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -62.16 -33.29 74.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 2.6800000000000002 110.93 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.596 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -63.21 -57.98 8.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.76000000000000001 111.098 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 130' ' ' VAL . 6.6 mt -67.51 -49.27 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 2.4900000000000002 111.111 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -49.58 -46.82 49.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 4.1799999999999997 110.915 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 140' ' ' VAL . 10.4 mtpt -78.63 -29.02 45.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 3.02 110.849 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.688 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -56.03 -54.14 48.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 1.3999999999999999 111.069 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.752 ' CZ ' HD11 ' A' ' 224' ' ' LEU . 1.3 t80 -61.2 -40.63 94.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 4.6200000000000001 110.882 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -55.22 -28.07 50.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 2.8500000000000001 110.891 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 136' ' ' LYS . 35.3 t -60.98 -49.48 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 1.79 111.137 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.678 ' HE1' HD12 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -70.61 -48.46 55.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 4.21 110.959 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.05 -20.39 38.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 3.5299999999999998 110.87 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.11 -31.88 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 2.7000000000000002 110.894 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.722 HG11 ' CG1' ' A' ' 255' ' ' ILE . 3.6 m -128.59 51.19 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 2.0099999999999998 111.139 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.67 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -151.73 140.57 13.68 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.559 0.695 . . . . 1.78 111.123 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.8 Cg_endo -69.76 -38.17 8.17 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.654 2.236 . . . . 1.96 112.323 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.54 ' O ' HD12 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -49.53 104.34 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 2.96 110.899 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.22 129.47 49.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 4.7699999999999996 110.889 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.507 ' HB3' HG23 ' A' ' 115' ' ' THR . 1.4 m-85 -138.34 153.54 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 11.19 110.886 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.6 t -104.29 132.28 50.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 2.77 110.809 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.34 147.3 31.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 3.4199999999999999 110.962 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 58.1 mt -135.68 119.07 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 2.8999999999999999 111.153 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.13 -39.91 57.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 3.0099999999999998 110.924 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 95.7 m -137.27 109.42 7.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 2.9900000000000002 111.131 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 173.05 -153.99 19.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 1.6699999999999999 112.494 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.98 135.61 51.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 5.5599999999999996 110.86 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.89 -175.15 2.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 2.0 111.041 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.33 -26.36 6.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 3.1099999999999999 110.902 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 116' ' ' TYR . 1.4 pp -135.58 141.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 3.5800000000000001 111.166 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 194' ' ' ASP . 0.5 OUTLIER -132.39 165.47 24.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.455 . . . . 2.1699999999999999 110.936 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.788 HG23 HG23 ' A' ' 118' ' ' ILE . 2.0 m -125.21 110.96 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 2.8100000000000001 111.146 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 119' ' ' ASN . 12.0 t -126.86 154.52 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 1.3100000000000001 111.158 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -123.05 137.73 54.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 3.52 110.858 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.95 174.56 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 2.23 111.102 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -125.71 169.4 12.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 4.8499999999999996 110.852 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.43 -138.39 28.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 2.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.07 129.96 35.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 1.8300000000000001 111.109 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -89.75 11.01 21.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 3.8900000000000001 110.899 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 58.85 18.4 39.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 4.0700000000000003 112.48 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -148.19 29.08 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.749 0.309 . . . . 7.1200000000000001 110.856 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.3 t70 64.37 47.41 3.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 6.7199999999999998 110.873 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -137.45 70.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 5.1500000000000004 110.871 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.59 159.83 23.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 2.1699999999999999 111.077 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -98.07 -169.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 9.5 110.9 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -143.67 -39.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 4.8600000000000003 110.858 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.43 166.58 21.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.721 -0.752 . . . . 1.76 112.524 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -50.12 118.74 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 3.6099999999999999 110.899 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.65 -55.12 0.75 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 2.8500000000000001 112.472 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.53 -118.78 4.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 1.6699999999999999 112.502 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.1 mm -74.1 140.19 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 1.8400000000000001 111.12 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.679 ' N ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -124.34 -5.12 7.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 2.9900000000000002 110.901 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.512 ' N ' HD22 ' A' ' 181' ' ' LEU . . . 179.82 131.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 1.25 111.109 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -113.58 143.08 45.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 3.9100000000000001 110.819 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -154.14 129.97 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 1.23 111.163 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.88 170.73 10.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 3.3700000000000001 110.858 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.99 171.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.88 112.481 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 160.51 49.45 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.692 2.261 . . . . 0.84999999999999998 112.374 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 157.05 -142.44 8.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.727 . . . . 1.1599999999999999 112.548 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 88.5 p -106.53 117.21 33.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 1.97 110.838 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.14 -58.59 3.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 1.4099999999999999 112.465 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.524 ' O ' HG22 ' A' ' 191' ' ' ILE . 10.6 mt -93.37 21.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 2.5699999999999998 111.155 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.79 -115.79 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 3.0 112.51 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.549 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . -88.43 44.95 3.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 1.3 112.496 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.411 ' CG ' HD11 ' A' ' 160' ' ' LEU . 11.6 m-20 -64.98 130.65 44.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 2.2200000000000002 110.813 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -107.49 109.63 21.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.04 111.104 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -113.81 110.62 20.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 4.8399999999999999 110.816 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -103.26 118.92 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 2.7000000000000002 110.888 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -50.77 145.63 6.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 7.0199999999999996 110.883 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.22 -21.66 23.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 8.1999999999999993 110.862 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -94.69 -6.39 43.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 4.5 110.83 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -73.48 -25.25 60.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 4.0899999999999999 110.852 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 18.3 t80 67.59 128.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 5.1699999999999999 110.861 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -105.57 172.19 6.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 6.3899999999999997 110.963 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.17 173.29 17.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 1.7 111.127 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -170.74 0.36 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 2.2000000000000002 111.156 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -67.13 -21.1 65.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 4.6399999999999997 110.866 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.26 -33.5 9.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 2.1200000000000001 110.878 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -54.19 177.17 0.3 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 2.5899999999999999 112.494 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -50.73 -88.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.733 -0.746 . . . . 1.96 112.473 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.9 m -76.33 98.54 4.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 1.5800000000000001 111.146 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.45 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.6 OUTLIER -72.89 123.02 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 3.1899999999999999 110.838 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 133' ' ' ALA . 1.4 tt -72.38 -35.85 68.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 2.2799999999999998 110.929 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.686 ' CZ ' HD23 ' A' ' 214' ' ' LEU . 2.9 p90 -71.86 -34.79 69.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 5.5300000000000002 110.859 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.686 HD23 ' CZ ' ' A' ' 213' ' ' PHE . 0.1 OUTLIER -82.68 -52.97 6.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 2.9199999999999999 110.922 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 94.4 m -55.07 -37.77 67.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.94999999999999996 111.175 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.26 85.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.97999999999999998 111.105 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.688 HG22 ' HA ' ' A' ' 137' ' ' ALA . 39.1 t -64.35 -39.94 87.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.02 111.145 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -69.32 -43.17 74.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 2.3500000000000001 110.824 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -70.32 -56.37 6.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 3.8500000000000001 110.9 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.461 HD12 ' HB1' ' A' ' 137' ' ' ALA . 76.5 mt -50.48 -33.82 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 2.4700000000000002 111.119 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.8 -43.01 99.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 1.1599999999999999 112.455 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -75.37 -29.14 59.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.836 0.35 . . . . 2.9700000000000002 110.906 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.49 -16.97 64.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 2.48 110.83 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.752 HD11 ' CZ ' ' A' ' 138' ' ' PHE . 7.1 mp -96.98 -23.03 16.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 2.1000000000000001 110.935 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 136.37 69.18 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 1.74 112.468 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.678 HD12 ' HE1' ' A' ' 141' ' ' TRP . 7.0 mt -160.44 134.62 7.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 3.3900000000000001 110.89 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -131.68 51.26 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 3.4900000000000002 112.5 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.8 m80 66.19 144.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 2.04 110.878 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.44 ' N ' ' HE3' ' A' ' 236' ' ' MET . 6.5 t -122.09 -79.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 4.5499999999999998 110.861 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 175.15 -32.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 4.6699999999999999 110.906 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 86.1 m-20 -45.66 105.84 0.5 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.543 0.687 . . . . 3.29 110.907 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.4 Cg_endo -69.82 172.56 12.48 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.633 2.222 . . . . 2.8300000000000001 112.342 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.8 30.56 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 3.4399999999999999 110.947 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -126.73 172.21 10.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 1.5700000000000001 111.111 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.452 ' O ' HG22 ' A' ' 235' ' ' VAL . 9.5 p -89.66 7.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 3.0899999999999999 111.155 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.657 ' CE ' HD22 ' A' ' 226' ' ' LEU . 1.9 mmm -88.02 -39.15 14.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 4.0199999999999996 110.837 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.52 143.29 20.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.661 0.743 . . . . 4.1900000000000004 110.886 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 70.41 1.6 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.704 2.269 . . . . 2.29 112.336 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.06 165.99 33.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 2.4300000000000002 111.085 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -131.49 113.13 13.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 3.7599999999999998 110.9 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -132.01 139.57 48.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 3.02 110.907 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -69.7 127.87 34.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 3.52 110.879 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.52 HG12 ' H ' ' A' ' 244' ' ' ASP . 0.3 OUTLIER -131.55 177.19 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 2.4199999999999999 111.131 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.52 ' H ' HG12 ' A' ' 243' ' ' VAL . 0.3 OUTLIER -72.55 125.34 27.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 3.1099999999999999 110.89 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 24.0 pt -57.09 -24.65 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 3.2999999999999998 111.115 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -77.81 -39.59 43.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 2.98 110.888 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.81 34.12 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 3.6899999999999999 111.158 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.96 19.34 4.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 3.9300000000000002 110.878 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -84.28 149.82 25.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 3.6299999999999999 110.87 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.646 HD21 ' OD2' ' A' ' 254' ' ' ASP . 0.3 OUTLIER -52.13 158.18 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 2.54 110.935 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.59 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.2 OUTLIER -154.69 -172.71 4.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 3.5600000000000001 110.865 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 64.63 -177.16 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 2.98 111.089 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -67.75 -22.05 65.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 3.5899999999999999 110.874 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.646 ' OD2' HD21 ' A' ' 250' ' ' LEU . 4.8 t0 -51.36 -30.01 17.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 3.4399999999999999 110.823 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.722 ' CG1' HG11 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -51.27 -29.96 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 1.5900000000000001 111.117 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -88.98 -31.42 18.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 6.4500000000000002 110.867 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.06 -18.27 40.45 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 1.78 112.482 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.721 ' CG2' HG23 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -101.4 -29.57 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 1.6200000000000001 111.133 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -79.78 -32.64 40.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 3.8199999999999998 110.919 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 12.4 m -85.67 -46.92 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 2.9199999999999999 110.857 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.8 mp 58.34 40.98 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 4.1299999999999999 110.937 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -146.48 134.15 21.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 10.82 110.874 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 119.103 -0.832 . . . . 10.19 112.438 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 64.1 m80 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.797 0.332 . . . . 7.6699999999999999 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -78.61 148.28 33.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 8.7899999999999991 110.93 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.46 146.43 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 2.8199999999999998 111.133 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.445 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 28.8 p -127.2 157.96 38.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 2.4300000000000002 111.09 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.0 151.46 31.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 4.4299999999999997 110.953 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -137.99 127.95 25.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 4.9900000000000002 110.901 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 82.9 mt -108.2 143.96 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 2.21 111.135 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -145.26 35.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 3.3999999999999999 110.856 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -133.23 152.56 51.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 4.75 110.908 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -146.49 117.9 7.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 7.3200000000000003 110.949 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 122' ' ' THR . 4.5 t -82.17 114.22 49.42 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.63 0.729 . . . . 2.8300000000000001 111.13 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -44.03 2.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.698 2.265 . . . . 2.23 112.315 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.6 -40.29 59.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 3.8900000000000001 110.841 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -101.38 159.68 15.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 3.2200000000000002 110.892 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.23 129.65 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.433 . . . . 3.9500000000000002 110.848 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -57.84 -22.68 49.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 6.9500000000000002 110.847 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.56 -32.09 47.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 3.3999999999999999 110.911 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.29 -43.85 48.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 2.9100000000000001 110.844 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.459 HG22 HD12 ' A' ' 134' ' ' ILE . 7.2 p -65.03 -36.42 77.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.93999999999999995 111.12 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.62 -54.65 36.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 3.2599999999999998 110.854 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -69.45 -36.8 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 4.6399999999999997 110.892 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -55.17 -57.75 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.71999999999999997 111.154 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.459 HD12 HG22 ' A' ' 130' ' ' VAL . 12.8 mt -68.4 -49.21 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 2.6699999999999999 111.166 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -51.95 -40.47 60.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 4.1600000000000001 110.867 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -78.2 -21.76 49.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 3.73 110.886 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.814 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.86 -53.11 60.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.92000000000000004 111.052 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.497 ' CD1' HD12 ' A' ' 220' ' ' ILE . 39.7 m-85 -57.12 -23.97 50.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 5.6699999999999999 110.851 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -39.57 51.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 2.6499999999999999 110.904 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.709 HG12 HD12 ' A' ' 250' ' ' LEU . 33.7 t -57.37 -44.69 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 2.1499999999999999 111.094 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.685 ' CE2' HD13 ' A' ' 224' ' ' LEU . 11.1 t90 -67.26 -59.34 3.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 9.6300000000000008 110.92 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -56.23 -23.87 38.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 2.0299999999999998 110.871 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -67.99 -12.39 60.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 2.8599999999999999 110.848 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.84 30.39 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 2.8799999999999999 111.136 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.592 HG21 HG13 ' A' ' 258' ' ' ILE . 0.8 OUTLIER -155.49 157.88 31.73 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.59 0.71 . . . . 2.2400000000000002 111.081 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -25.14 29.07 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.689 2.259 . . . . 2.6299999999999999 112.357 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.49 175.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 3.8599999999999999 110.91 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.32 -178.07 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 4.5999999999999996 110.926 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -135.63 151.75 50.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 7.1699999999999999 110.911 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.5 t -156.37 89.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 1.9299999999999999 110.825 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.43 137.52 54.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 2.3100000000000001 110.897 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.543 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -143.57 165.93 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 3.46 111.139 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.07 -29.99 5.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 3.9199999999999999 110.887 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 91.7 m -117.78 110.3 17.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 2.8799999999999999 111.177 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 142.54 -171.31 24.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 1.5700000000000001 112.489 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -110.47 157.81 19.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 5.1500000000000004 110.864 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -146.99 141.89 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 1.22 111.091 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.89 -15.67 62.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.428 . . . . 2.3700000000000001 110.892 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.514 HD13 ' HA3' ' A' ' 193' ' ' GLY . 39.6 mm -104.03 141.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 2.6299999999999999 111.111 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 161' ' ' VAL . 4.0 tt -130.78 134.43 46.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.5600000000000001 110.94 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.713 ' N ' HD23 ' A' ' 160' ' ' LEU . 55.9 t -124.86 110.76 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 1.3200000000000001 111.13 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.593 HG23 ' CD2' ' A' ' 160' ' ' LEU . 24.4 t -143.25 141.21 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 1.1100000000000001 111.152 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -81.19 152.72 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 3.71 110.865 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -161.58 167.23 25.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 1.3200000000000001 111.06 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -139.54 117.74 11.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 5.2599999999999998 110.851 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.06 -137.85 17.2 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.738 . . . . 1.8999999999999999 112.503 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -80.55 110.34 15.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 1.97 111.139 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.08 56.9 3.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 3.9500000000000002 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 52.0 27.23 21.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.73 . . . . 2.6899999999999999 112.465 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -163.08 -167.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.797 0.332 . . . . 6.0999999999999996 110.862 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -80.55 55.95 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 6.8200000000000003 110.894 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -137.93 34.67 2.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 6.9000000000000004 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.8 127.81 34.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 1.8400000000000001 111.149 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.81 -82.16 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 6.1900000000000004 110.861 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.78 -77.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 5.0199999999999996 110.853 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 126.36 -161.1 20.76 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.747 -0.74 . . . . 2.3999999999999999 112.469 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -53.32 119.3 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 3.6899999999999999 110.9 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.46 -14.03 62.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 2.5 112.465 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.87 -150.56 7.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 1.78 112.497 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 182' ' ' ALA . 17.3 mt -71.29 96.66 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 1.99 111.146 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.756 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.4 pp -48.18 -29.65 3.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 3.29 110.907 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.756 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 178.62 176.0 0.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 1.5600000000000001 111.09 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.35 120.77 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 3.2599999999999998 110.88 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -109.75 117.55 34.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.63 111.111 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -63.79 166.14 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 3.7200000000000002 110.876 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.92 172.61 0.27 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.729 -0.748 . . . . 0.83999999999999997 112.481 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -179.2 2.77 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.682 2.255 . . . . 0.94999999999999996 112.339 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.39 -136.88 8.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 1.28 112.5 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.2 p -108.72 130.97 55.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.924 0.392 . . . . 2.71 110.872 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.36 -85.39 0.18 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.761 -0.733 . . . . 1.25 112.451 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 191' ' ' ILE . 63.2 mt -71.09 -7.95 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 2.46 111.137 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.97 -84.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 2.77 112.504 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 159' ' ' ILE . . . -76.18 -2.35 72.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 1.22 112.504 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -49.03 114.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 2.2599999999999998 110.866 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -122.2 154.14 37.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 1.6000000000000001 111.106 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -133.14 149.52 52.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 2.7599999999999998 110.864 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.457 ' CE2' HG13 ' A' ' 161' ' ' VAL . 18.6 m-85 -130.0 143.87 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 2.8900000000000001 110.847 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 199' ' ' GLU . 0.3 OUTLIER -47.88 -73.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 5.6299999999999999 110.884 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 198' ' ' ASP . 3.7 tt0 63.8 -80.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 8.6300000000000008 110.909 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -14.04 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 6.2699999999999996 110.916 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -91.46 15.76 11.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 6.8200000000000003 110.917 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 67.23 122.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 6.3700000000000001 110.918 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.43 -170.64 1.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 7.2800000000000002 110.934 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.01 172.76 18.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 2.2599999999999998 111.181 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.78 -170.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 2.0899999999999999 111.163 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -57.17 -20.9 29.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 4.3099999999999996 110.851 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.32 -69.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 2.3100000000000001 110.838 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.51 -160.43 10.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.731 . . . . 3.0499999999999998 112.511 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 50.94 -161.85 1.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 2.29 112.498 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 97.4 m -64.95 104.75 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 2.02 111.177 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.89 141.76 58.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 2.8500000000000001 110.885 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -72.53 -54.21 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 2.6099999999999999 110.904 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.731 ' O ' HG23 ' A' ' 217' ' ' VAL . 0.1 OUTLIER -72.31 -51.97 18.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 5.3600000000000003 110.936 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.434 HD22 HG23 ' A' ' 243' ' ' VAL . 12.3 tp -49.31 -38.45 27.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 2.1099999999999999 110.967 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.557 HG21 HD22 ' A' ' 181' ' ' LEU . 60.2 m -79.75 -42.66 24.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.78000000000000003 111.127 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.65 -36.84 77.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.92000000000000004 111.138 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 137' ' ' ALA . 45.7 t -68.01 -43.84 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 1.02 111.145 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -54.2 -31.64 53.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 2.0099999999999998 110.888 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -33.11 64.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 3.8399999999999999 110.867 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.572 ' O ' HD12 ' A' ' 224' ' ' LEU . 40.9 mm -55.32 -50.38 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 1.54 111.129 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.95 -28.58 60.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.93000000000000005 112.453 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -47.52 75.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.33 . . . . 2.54 110.832 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.98 29.23 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.6000000000000001 110.864 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.685 HD13 ' CE2' ' A' ' 141' ' ' TRP . 9.0 mt -132.24 -39.96 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 1.8799999999999999 110.933 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.61 -30.86 0.2 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 1.74 112.482 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.497 HD13 ' HB ' ' A' ' 258' ' ' ILE . 1.3 mp -90.75 90.51 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 3.98 110.936 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.1 -89.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.712 -0.756 . . . . 3.5 112.504 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -118.71 89.84 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 1.9399999999999999 110.887 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.46 172.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 5.6600000000000001 110.853 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 8.2 t -112.92 -27.33 8.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 3.8300000000000001 110.879 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.721 ' CG ' ' HB1' ' A' ' 252' ' ' ALA . 8.7 m-20 -51.77 112.49 3.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.724 . . . . 3.2799999999999998 110.84 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.8 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 2.1299999999999999 112.318 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -27.31 69.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 4.0199999999999996 110.923 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.923 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -72.13 167.68 19.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 2.21 111.092 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.462 HG21 ' HE1' ' A' ' 248' ' ' PHE . 17.0 m -95.49 -15.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 5.0800000000000001 111.165 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.408 ' SD ' HD21 ' A' ' 250' ' ' LEU . 9.0 tpt -58.22 -21.9 49.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 4.8300000000000001 110.876 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -52.22 137.38 38.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.652 0.739 . . . . 3.7599999999999998 110.858 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 76.52 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.693 2.262 . . . . 2.3399999999999999 112.35 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.8 t -157.32 167.67 29.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 2.8799999999999999 111.193 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -115.14 112.22 22.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.263 -0.426 . . . . 3.7000000000000002 110.943 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -136.22 -169.6 2.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 2.8199999999999998 110.896 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -107.24 142.57 36.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 5.2699999999999996 110.917 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.434 HG23 HD22 ' A' ' 214' ' ' LEU . 98.7 t -149.47 143.05 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 2.3599999999999999 111.182 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.87 126.06 26.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 2.75 110.832 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.8 tt -58.09 -22.83 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 3.0899999999999999 111.132 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.25 -31.28 12.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 3.6400000000000001 110.916 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.93 33.53 2.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 2.0099999999999998 111.137 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.598 ' CE2' HG21 ' A' ' 217' ' ' VAL . 8.5 t80 -104.21 129.08 52.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 4.8499999999999996 110.916 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -176.55 129.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 3.2400000000000002 110.898 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 140' ' ' VAL . 3.8 mt -58.44 114.65 2.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 3.9100000000000001 110.9 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 252' ' ' ALA . 0.1 OUTLIER -132.02 108.2 9.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 4.2999999999999998 110.895 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.923 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 174.18 172.59 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 3.4700000000000002 111.1 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -18.64 49.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 3.23 110.915 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.475 ' HB2' HD21 ' A' ' 226' ' ' LEU . 1.3 p30 -52.4 -30.44 29.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 3.5899999999999999 110.868 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 68.6 mt -51.36 -29.0 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 2.8500000000000001 111.116 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -87.55 -33.13 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 5.1100000000000003 110.85 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.503 ' O ' HD12 ' A' ' 261' ' ' LEU . . . -72.58 -14.66 77.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 2.0800000000000001 112.47 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.714 ' O ' HD13 ' A' ' 261' ' ' LEU . 7.2 tp -92.29 -34.36 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.784 0.326 . . . . 1.7 111.137 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -79.31 -40.84 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 3.5299999999999998 110.941 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 t -79.9 -47.34 15.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 2.6800000000000002 110.867 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.714 HD13 ' O ' ' A' ' 258' ' ' ILE . 0.9 OUTLIER 55.02 91.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 4.2400000000000002 110.905 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -54.92 120.3 6.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 12.970000000000001 110.983 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.141 -0.81 . . . . 10.94 112.532 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.812 0.339 . . . . 7.3899999999999997 110.904 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -116.57 135.31 53.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 9.9000000000000004 110.932 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.701 HD13 HD21 ' A' ' 147' ' ' LEU . 0.1 OUTLIER -115.71 171.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.134 -0.485 . . . . 3.0600000000000001 111.126 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.2 p -114.25 146.96 39.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 2.5099999999999998 111.119 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.527 ' OH ' HD11 ' A' ' 118' ' ' ILE . 11.2 t80 -152.41 136.6 16.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 5.5 110.941 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -161.45 145.77 13.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 4.6799999999999997 110.868 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.527 HD11 ' OH ' ' A' ' 116' ' ' TYR . 18.7 mt -108.07 148.81 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 1.75 111.144 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -156.45 38.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 2.7999999999999998 110.907 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.455 ' OD1' HG12 ' A' ' 161' ' ' VAL . 6.3 p-10 -135.39 148.81 49.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 5.4100000000000001 110.92 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -147.86 122.51 9.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 5.5899999999999999 110.891 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.56 147.38 41.89 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.55 0.69 . . . . 2.9399999999999999 111.118 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -168.02 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.652 2.235 . . . . 2.8300000000000001 112.339 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 73.82 -62.29 0.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 3.8999999999999999 110.84 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.455 ' SD ' HG23 ' A' ' 205' ' ' THR . 36.2 mmt -100.92 137.26 39.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 3.4900000000000002 110.874 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.31 158.15 9.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 2.79 110.896 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -52.57 -30.96 33.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 9.1500000000000004 110.889 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.49 -45.38 72.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 2.8799999999999999 110.908 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.71 -44.72 93.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 2.3599999999999999 110.893 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.565 ' HA ' HD13 ' A' ' 212' ' ' LEU . 7.3 p -73.49 -37.02 49.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.95999999999999996 111.108 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -63.75 -54.5 34.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 2.7400000000000002 110.872 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -59.31 -33.47 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 2.5099999999999998 110.927 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.57 ' HB3' HD22 ' A' ' 212' ' ' LEU . . . -53.98 -46.15 71.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.87 111.119 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 2.3 mm -83.13 -44.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 2.71 111.17 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.69 -45.23 58.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 4.1200000000000001 110.923 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.66 ' O ' HG23 ' A' ' 140' ' ' VAL . 31.7 mttt -78.09 -20.48 52.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 3.0800000000000001 110.907 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.725 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -56.03 -53.69 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.85999999999999999 111.099 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -36.11 75.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 3.7999999999999998 110.885 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -28.1 69.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 3.1099999999999999 110.893 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 136' ' ' LYS . 21.4 t -65.28 -56.19 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 1.8400000000000001 111.124 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.642 ' O ' HG22 ' A' ' 145' ' ' THR . 1.0 OUTLIER -73.26 -34.41 65.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 3.9900000000000002 110.884 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.8 t -56.25 -23.49 36.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 1.97 110.874 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.28 -16.6 63.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 2.1299999999999999 110.885 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.428 HG21 HD22 ' A' ' 250' ' ' LEU . 13.2 t -114.41 -33.46 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 3.1800000000000002 111.121 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 141' ' ' TRP . 1.4 t -107.19 146.0 32.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.614 0.721 . . . . 3.1699999999999999 111.146 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -7.61 21.51 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 2.9100000000000001 112.313 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.805 HD13 HD23 ' A' ' 224' ' ' LEU . 0.2 OUTLIER -51.23 150.34 3.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 2.6899999999999999 110.965 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.59 -173.15 2.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 7.2999999999999998 110.923 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -135.56 119.83 17.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 6.9500000000000002 110.92 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -111.16 89.95 3.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 2.54 110.868 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.9 110.57 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 2.23 110.878 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.497 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.2 pp -146.33 162.84 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 3.0600000000000001 111.151 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -113.12 51.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 4.3600000000000003 110.851 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.7 t -175.63 160.17 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 4.2999999999999998 111.147 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.47 139.81 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 2.1899999999999999 112.491 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.82 164.3 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.357 . . . . 6.3899999999999997 110.86 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.02 136.77 23.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 1.8400000000000001 111.081 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.92 -45.48 64.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 2.54 110.867 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.612 HG22 ' HA3' ' A' ' 193' ' ' GLY . 1.7 pt -108.79 135.53 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 2.8500000000000001 111.079 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -133.19 125.46 29.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 2.77 110.922 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.778 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 3.4 t -94.52 112.57 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 1.3600000000000001 111.117 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.585 ' CG2' HD21 ' A' ' 160' ' ' LEU . 53.1 t -145.03 144.42 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 1.27 111.108 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -108.06 137.89 45.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 3.3399999999999999 110.896 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.519 ' HB3' ' HZ ' ' A' ' 174' ' ' PHE . . . -139.56 164.01 31.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 1.3500000000000001 111.105 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.32 126.42 52.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 5.1600000000000001 110.85 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.72 -142.46 20.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.738 . . . . 1.1899999999999999 112.516 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.02 124.42 24.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 1.3500000000000001 111.134 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -89.62 76.64 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 3.1200000000000001 110.833 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.27 45.72 64.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 2.4199999999999999 112.499 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.78 88.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 6.6399999999999997 110.843 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -166.35 -74.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 4.3300000000000001 110.865 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -137.36 93.74 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 4.0800000000000001 110.829 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.24 128.86 34.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 1.4199999999999999 111.116 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.519 ' HZ ' ' HB3' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -128.66 -37.23 1.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 6.5899999999999999 110.918 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.13 168.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 6.1299999999999999 110.86 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.85 -148.49 7.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 2.8999999999999999 112.473 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.27 135.09 27.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 4.9500000000000002 110.838 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.98 -19.12 6.14 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.738 . . . . 5.0999999999999996 112.497 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.16 -107.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 3.02 112.535 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.406 HG22 ' H ' ' A' ' 182' ' ' ALA . 26.4 mm -71.4 149.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.898 0.38 . . . . 2.9100000000000001 111.095 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 182' ' ' ALA . 1.4 mm? -115.49 -18.66 10.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 4.4400000000000004 110.884 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . 175.64 124.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.8300000000000001 111.098 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -104.09 164.07 11.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 5.0 110.818 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.519 ' HB2' ' CD ' ' A' ' 219' ' ' GLU . . . -179.68 109.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.89000000000000001 111.098 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -71.11 150.8 45.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 3.9300000000000002 110.935 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.6 -167.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 1.1399999999999999 112.474 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 160.76 48.53 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.658 2.238 . . . . 1.3700000000000001 112.355 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 147.1 -163.45 28.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.742 . . . . 1.1299999999999999 112.49 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.08 140.67 29.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.895 0.378 . . . . 2.3599999999999999 110.841 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.25 -64.96 2.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.681 -0.771 . . . . 1.3400000000000001 112.513 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.689 HG23 ' CG ' ' A' ' 194' ' ' ASP . 3.7 mp -118.74 61.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.36 . . . . 2.8199999999999998 111.131 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -88.62 46.33 3.32 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 3.48 112.444 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.612 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . 124.38 31.82 0.88 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 1.3700000000000001 112.472 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.689 ' CG ' HG23 ' A' ' 191' ' ' ILE . 38.2 m-20 -64.51 139.29 58.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.771 0.32 . . . . 2.9100000000000001 110.929 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.778 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -96.5 119.8 35.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 1.0900000000000001 111.104 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -115.18 109.88 18.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 3.9500000000000002 110.859 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -113.0 101.66 9.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 2.5 110.882 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.41 117.18 2.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 6.4000000000000004 110.857 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -64.22 -48.61 75.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 7.8200000000000003 110.942 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -50.16 -30.45 11.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 3.7999999999999998 110.895 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.44 ' OE2' HD12 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -63.4 -169.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 3.7200000000000002 110.882 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -125.31 116.73 22.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 4.3799999999999999 110.869 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.557 ' CZ3' HG21 ' A' ' 215' ' ' THR . 56.1 m95 -105.06 97.41 7.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 7.0999999999999996 110.957 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.85 172.95 6.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 1.8600000000000001 111.11 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.455 HG23 ' SD ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -70.42 173.57 6.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 1.9299999999999999 111.121 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.71 ' HD1' HG22 ' A' ' 245' ' ' ILE . 0.0 OUTLIER -59.12 -21.4 59.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.437 . . . . 9.2200000000000006 110.891 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.05 -64.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.95 110.833 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.08 -177.14 14.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.772 -0.727 . . . . 2.3799999999999999 112.478 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 51.47 -170.88 0.31 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 1.6399999999999999 112.519 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -56.7 99.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 1.5600000000000001 111.134 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.11 111.66 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 3.6899999999999999 110.867 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.57 HD22 ' HB3' ' A' ' 133' ' ' ALA . 0.5 OUTLIER -57.8 -35.65 71.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 2.1499999999999999 110.925 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.736 ' O ' HG23 ' A' ' 217' ' ' VAL . 13.1 m-85 -71.37 -62.43 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 4.75 110.859 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 241' ' ' LYS . 2.3 tp -51.34 -53.51 35.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 2.29 110.917 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.557 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 23.3 m -55.58 -49.4 72.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.78000000000000003 111.142 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.63 -44.2 76.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.71999999999999997 111.075 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.737 HG21 ' CE2' ' A' ' 248' ' ' PHE . 23.7 t -66.4 -46.57 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 1.02 111.104 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -54.02 -29.46 43.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 2.27 110.856 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.519 ' CD ' ' HB2' ' A' ' 184' ' ' ALA . 1.9 tt0 -74.59 -42.1 59.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 3.3599999999999999 110.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.508 ' O ' HD13 ' A' ' 224' ' ' LEU . 49.5 mm -51.21 -32.95 13.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 1.6399999999999999 111.095 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.65 -55.36 8.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 1.04 112.522 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -37.49 77.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 2.8399999999999999 110.811 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.0 p -65.23 -34.58 78.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 2.9700000000000002 110.878 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.805 HD23 HD13 ' A' ' 147' ' ' LEU . 7.1 mp -95.31 23.47 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 2.0699999999999998 110.902 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.44 98.89 0.27 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 1.95 112.513 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 18.7 tp -149.76 156.6 42.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.793 0.33 . . . . 3.1299999999999999 110.956 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.93 -109.16 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 2.8199999999999998 112.497 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.3 147.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 2.3700000000000001 110.875 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.27 -77.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 6.2599999999999998 110.894 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t 62.89 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 5.5300000000000002 110.886 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.0 159.49 68.47 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.635 0.731 . . . . 2.79 110.808 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -24.98 29.12 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 2.1600000000000001 112.361 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.6 -31.11 12.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 4.1200000000000001 110.941 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -52.46 172.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 2.23 111.093 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 235' ' ' VAL . 4.0 t -95.38 7.48 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 2.77 111.121 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -27.5 36.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 4.3399999999999999 110.875 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.447 ' O ' ' CG ' ' A' ' 237' ' ' PHE . 3.0 p90 -47.61 114.59 3.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.681 0.753 . . . . 8.6199999999999992 110.888 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 61.68 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.669 2.246 . . . . 2.0299999999999998 112.334 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.93 169.18 21.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 2.3999999999999999 111.113 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -109.13 113.01 25.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 3.3799999999999999 110.962 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.613 ' O ' HD22 ' A' ' 214' ' ' LEU . 1.1 tttp -135.29 123.57 23.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 3.5 110.902 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -66.58 141.37 57.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 3.3799999999999999 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 97.8 t -150.39 144.36 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 2.46 111.103 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.56 126.93 21.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 3.1200000000000001 110.872 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.71 HG22 ' HD1' ' A' ' 206' ' ' HIS . 1.9 pp -65.27 -25.38 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 3.4100000000000001 111.107 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.05 -39.5 23.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 3.8100000000000001 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.1 p -93.13 10.01 33.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 2.5600000000000001 111.13 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.737 ' CE2' HG21 ' A' ' 217' ' ' VAL . 23.8 t80 -79.42 122.84 26.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 4.9000000000000004 110.864 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -163.81 148.02 10.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 3.3599999999999999 110.883 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.702 ' CD2' HD12 ' A' ' 255' ' ' ILE . 0.6 OUTLIER -53.12 151.97 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 2.46 110.929 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.548 ' O ' HD23 ' A' ' 250' ' ' LEU . 6.3 t -89.2 -171.47 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 3.1299999999999999 110.9 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -84.06 -56.34 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 4.1799999999999997 111.12 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.71 -38.27 60.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 3.29 110.846 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.53 -29.05 65.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 3.02 110.858 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.702 HD12 ' CD2' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -54.3 -27.56 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.8300000000000001 111.147 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.0 mtp85 -87.79 -23.43 24.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 4.7400000000000002 110.87 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.45 -22.96 64.17 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.718 -0.753 . . . . 1.9299999999999999 112.504 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.449 HD13 ' CD1' ' A' ' 141' ' ' TRP . 6.5 tp -92.87 -31.05 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.329 . . . . 1.4099999999999999 111.155 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -78.9 -42.55 26.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 4.0700000000000003 110.911 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.423 ' C ' HD12 ' A' ' 261' ' ' LEU . 4.8 m -85.39 -46.0 11.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 4.6299999999999999 110.821 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.423 HD12 ' C ' ' A' ' 260' ' ' SER . 1.6 mp 58.89 77.82 0.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 6.2800000000000002 110.903 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.69 137.68 24.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 14.550000000000001 110.903 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 119.174 -0.792 . . . . 14.380000000000001 112.475 179.976 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.781 0.324 . . . . 15.23 110.898 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.751 ' O ' HD13 ' A' ' 114' ' ' ILE . 48.4 m-85 -73.41 147.21 44.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 17.960000000000001 110.873 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 113' ' ' TYR . 5.0 mm -132.92 169.94 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 6.7300000000000004 111.111 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.678 HG23 ' H ' ' A' ' 158' ' ' ASP . 5.5 t -91.06 116.38 28.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 3.1099999999999999 111.112 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -142.08 136.53 30.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 5.2800000000000002 110.935 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -107.93 103.28 12.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 6.75 110.917 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.426 HG21 ' CE1' ' A' ' 121' ' ' TYR . 23.7 mm -70.73 148.44 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 2.6299999999999999 111.145 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.556 ' ND2' HD21 ' A' ' 160' ' ' LEU . 33.3 m-20 -109.29 -75.09 0.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 4.2000000000000002 110.877 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -140.07 146.13 38.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 5.8799999999999999 110.883 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.44 ' HB3' HG11 ' A' ' 130' ' ' VAL . 24.8 m-85 -92.5 163.26 13.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.207 -0.451 . . . . 6.6100000000000003 110.913 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.32 159.32 29.65 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.564 0.697 . . . . 3.9399999999999999 111.156 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.8 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.671 2.248 . . . . 2.8100000000000001 112.345 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 73.84 -63.39 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 4.4500000000000002 110.819 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.409 ' HE2' ' HB2' ' A' ' 203' ' ' TRP . 0.0 OUTLIER -100.81 144.62 29.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 6.6500000000000004 110.881 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.09 161.82 15.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 3.5 110.901 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -21.92 48.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 7.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -79.78 -36.67 36.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 4.9900000000000002 110.895 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 1.2 m-20 -64.0 -44.02 93.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 2.4399999999999999 110.887 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.491 HG23 ' HG ' ' A' ' 212' ' ' LEU . 10.3 p -74.58 -34.59 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.92000000000000004 111.077 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.66 -54.61 11.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 2.5800000000000001 110.852 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -62.82 -33.33 75.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 2.9300000000000002 110.928 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.692 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -56.92 -58.73 6.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.88 111.125 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 9.5 pt -65.69 -28.31 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 3.1000000000000001 111.119 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -48.25 -56.12 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 4.3300000000000001 110.851 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -78.83 -26.17 44.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 2.8799999999999999 110.871 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 134' ' ' ILE . . . -55.59 -33.97 64.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.89000000000000001 111.114 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -73.69 -30.75 63.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 5.8300000000000001 110.842 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -78.99 -29.12 43.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 3.9500000000000002 110.935 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.655 HG11 HG11 ' A' ' 217' ' ' VAL . 72.6 t -50.73 -42.52 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 1.75 111.136 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.586 ' HZ2' HD11 ' A' ' 226' ' ' LEU . 0.5 OUTLIER -96.18 -44.88 7.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 4.0599999999999996 110.941 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.574 ' OG ' HD11 ' A' ' 114' ' ' ILE . 68.0 m -54.99 -24.99 26.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 3.4100000000000001 110.89 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -61.36 -21.39 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 2.6899999999999999 110.88 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.1 41.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 1.8400000000000001 111.121 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.716 HG21 HD11 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -155.62 128.6 4.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.595 0.712 . . . . 1.9299999999999999 111.183 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 78.15 1.0 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.707 2.271 . . . . 2.7200000000000002 112.383 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.64 102.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 3.8599999999999999 110.908 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.93 128.7 47.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 5.6200000000000001 110.882 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -138.81 152.41 47.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 10.720000000000001 110.895 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.01 152.23 23.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 3.0899999999999999 110.804 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -58.5 151.34 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 3.3700000000000001 110.863 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.842 HG22 ' H ' ' A' ' 154' ' ' THR . 3.0 mp -137.75 130.33 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 3.2000000000000002 111.161 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.15 -13.1 61.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 4.0499999999999998 110.901 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.842 ' H ' HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -94.0 -178.57 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 4.7699999999999996 111.122 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.18 48.22 2.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 3.0099999999999998 112.466 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.15 99.6 7.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.34 . . . . 7.3099999999999996 110.858 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.43 129.78 13.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.426 . . . . 1.6799999999999999 111.098 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.678 ' H ' HG23 ' A' ' 115' ' ' THR . 0.8 OUTLIER -77.04 -19.1 57.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 4.9500000000000002 110.844 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.758 HG22 ' CA ' ' A' ' 193' ' ' GLY . 8.2 pt -138.21 141.74 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 3.73 111.126 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.556 HD21 ' ND2' ' A' ' 119' ' ' ASN . 1.9 tm? -114.21 118.65 34.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 1.45 110.93 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 89.0 t -92.39 125.46 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 1.4099999999999999 111.143 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 163' ' ' PHE . 2.3 p -138.22 164.59 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 2.8399999999999999 111.123 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.4 ' H ' HG22 ' A' ' 162' ' ' VAL . 79.0 m-85 -137.52 101.09 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 7.4100000000000001 110.86 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -125.72 155.46 40.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 1.3400000000000001 111.107 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.93 127.4 53.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 5.5700000000000003 110.848 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.19 -144.51 13.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.691 -0.766 . . . . 1.21 112.505 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.7 123.04 18.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 1.26 111.088 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -95.15 25.4 4.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 3.0499999999999998 110.878 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.89 -23.03 30.86 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.694 -0.765 . . . . 2.4300000000000002 112.448 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -179.31 35.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 5.1900000000000004 110.886 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.98 -169.46 2.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 5.2999999999999998 110.886 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -77.05 114.55 15.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 3.96 110.819 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.4 128.8 34.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 1.26 111.101 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -131.21 170.66 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 6.0099999999999998 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -122.87 165.04 17.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 4.54 110.865 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.22 -142.09 1.49 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.725 -0.75 . . . . 2.3999999999999999 112.434 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -50.51 119.14 3.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 3.5299999999999998 110.926 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.11 -73.94 0.44 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.754 -0.736 . . . . 2.27 112.47 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -89.67 -143.26 9.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.751 . . . . 1.6799999999999999 112.513 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.481 HG21 ' HB2' ' A' ' 183' ' ' HIS . 24.5 mm -71.29 133.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.889 0.376 . . . . 2.1499999999999999 111.113 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 182' ' ' ALA . 0.4 OUTLIER -101.47 -14.12 17.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 2.7799999999999998 110.946 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.582 ' N ' HD12 ' A' ' 181' ' ' LEU . . . -178.88 125.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 1.5600000000000001 111.075 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.481 ' HB2' HG21 ' A' ' 180' ' ' ILE . 1.8 t-160 -143.67 106.93 4.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 3.4100000000000001 110.915 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -100.34 142.31 32.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.79000000000000004 111.148 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.39 170.03 16.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 2.4100000000000001 110.915 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -53.96 176.67 0.3 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.687 -0.768 . . . . 0.80000000000000004 112.49 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -169.92 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.677 2.252 . . . . 1.1100000000000001 112.367 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.54 -141.94 13.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 1.5700000000000001 112.51 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.1 m -127.03 146.26 50.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.928 0.394 . . . . 3.7400000000000002 110.873 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.22 -58.96 3.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.76 -0.733 . . . . 1.26 112.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.1 mm -106.12 -23.22 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.378 . . . . 2.3700000000000001 111.169 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.06 128.5 39.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 2.4900000000000002 112.509 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.758 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . 89.8 -15.44 59.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 1.1499999999999999 112.513 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -51.77 147.46 6.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 2.4300000000000002 110.871 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -121.34 109.39 14.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.90000000000000002 111.093 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -96.99 110.46 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 4.1699999999999999 110.864 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.566 ' HE2' HG13 ' A' ' 161' ' ' VAL . 41.3 m-85 -115.64 104.95 12.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 2.6600000000000001 110.886 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -51.7 113.45 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 7.2400000000000002 110.819 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.93 -41.18 77.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 7.2599999999999998 110.906 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.76 -51.06 59.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 4.4500000000000002 110.881 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -54.4 148.29 12.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 4.3399999999999999 110.862 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -89.27 121.44 31.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 6.4699999999999998 110.865 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.646 ' HB3' HD23 ' A' ' 212' ' ' LEU . 39.3 m95 -107.4 99.29 8.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 6.9000000000000004 110.912 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.2 t -157.1 134.14 10.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 4.8499999999999996 111.154 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.3 t -106.88 72.41 0.89 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 4.0700000000000003 111.135 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -82.66 -67.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 8.7899999999999991 110.86 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.5 m -114.23 -71.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 3.1400000000000001 110.843 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.41 4.75 1.32 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 3.7999999999999998 112.456 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.14 -161.43 0.97 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 2.52 112.467 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.9 m -59.2 96.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 1.5900000000000001 111.14 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.408 HD22 HD22 ' A' ' 214' ' ' LEU . 3.0 m-80 -88.38 127.41 35.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 2.79 110.88 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.646 HD23 ' HB3' ' A' ' 203' ' ' TRP . 0.7 OUTLIER -54.78 -37.98 66.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 3.5699999999999998 110.971 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.699 ' O ' HG23 ' A' ' 217' ' ' VAL . 8.5 p90 -72.29 -32.49 66.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 5.0199999999999996 110.903 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 211' ' ' ASN . 13.8 tp -74.82 -60.04 2.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 2.5899999999999999 110.963 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.451 ' CG2' HD13 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -55.45 -38.27 68.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 1.1599999999999999 111.166 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.96 74.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.93999999999999995 111.087 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 213' ' ' PHE . 58.7 t -49.18 -43.07 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.82999999999999996 111.109 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -36.66 71.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 3.1499999999999999 110.86 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.51 -42.83 58.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 3.9100000000000001 110.858 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.464 ' O ' HD13 ' A' ' 224' ' ' LEU . 45.2 mm -50.06 -39.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 1.3799999999999999 111.111 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.717 ' O ' HD23 ' A' ' 226' ' ' LEU . . . -76.11 -51.98 6.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.78 -0.724 . . . . 0.75 112.499 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -55.49 -26.86 44.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 2.27 110.867 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.702 ' O ' HD12 ' A' ' 224' ' ' LEU . 0.3 OUTLIER -95.27 24.73 4.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 1.96 110.905 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 223' ' ' SER . 1.4 mp -148.92 17.96 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 1.8400000000000001 110.94 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.512 ' O ' HD22 ' A' ' 226' ' ' LEU . . . 88.33 77.21 1.29 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.749 . . . . 1.6899999999999999 112.499 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.717 HD23 ' O ' ' A' ' 221' ' ' GLY . 2.2 mm? -130.27 179.56 5.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.358 . . . . 3.1099999999999999 110.942 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.61 -123.73 3.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.805 -0.712 . . . . 2.54 112.507 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.61 150.56 12.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 2.3999999999999999 110.815 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.3 m 61.0 -92.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 6.7599999999999998 110.843 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 32.3 m 59.6 -86.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.499 . . . . 4.5599999999999996 110.847 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.5 155.96 75.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.611 0.719 . . . . 2.52 110.864 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 233' ' ' LYS . 53.6 Cg_endo -69.76 168.79 20.55 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.717 2.278 . . . . 2.7999999999999998 112.335 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.7 41.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 4.8899999999999997 110.868 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.639 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -130.85 153.79 48.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 2.2400000000000002 111.082 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 99.7 t -56.05 -25.74 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 4.4199999999999999 111.097 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.447 ' SD ' HD12 ' A' ' 226' ' ' LEU . 1.5 tpp -66.4 -18.2 65.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 4.8399999999999999 110.85 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 239' ' ' THR . 10.0 t80 -109.72 82.22 2.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.657 0.742 . . . . 4.1900000000000004 110.861 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 104.93 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.651 2.234 . . . . 4.0599999999999996 112.345 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.416 HG21 ' CE2' ' A' ' 237' ' ' PHE . 1.8 t -157.29 127.77 6.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 2.6499999999999999 111.136 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -61.82 120.92 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 3.73 110.938 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -162.61 140.9 8.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 3.0299999999999998 110.892 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -58.59 125.24 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 4.9000000000000004 110.929 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.4 t -150.49 143.66 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 2.5699999999999998 111.117 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.51 122.02 8.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 4.0 110.902 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.607 HG22 ' CZ ' ' A' ' 213' ' ' PHE . 22.3 pt -74.74 -23.9 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 3.4500000000000002 111.092 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -87.22 -23.71 24.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 4.29 110.919 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.2 m -100.95 6.54 43.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 2.6400000000000001 111.176 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -50.24 132.8 24.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 4.1600000000000001 110.849 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -179.56 148.05 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 4.7599999999999998 110.87 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.721 HD11 HG13 ' A' ' 255' ' ' ILE . 0.5 OUTLIER -71.32 171.07 11.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 2.3399999999999999 110.928 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.56 ' O ' HD12 ' A' ' 255' ' ' ILE . 5.8 p -89.94 170.37 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 4.54 110.895 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.84 -53.75 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 4.0800000000000001 111.099 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -18.84 51.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 3.0299999999999998 110.923 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.639 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -70.43 -36.34 73.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 2.7200000000000002 110.847 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.721 HG13 HD11 ' A' ' 250' ' ' LEU . 2.1 mp -56.96 -32.17 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 3.0299999999999998 111.154 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -59.03 -26.11 64.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 9.9499999999999993 110.863 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -98.97 45.17 1.61 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 2.2599999999999998 112.467 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.716 HD11 HG21 ' A' ' 145' ' ' THR . 7.5 tp -176.69 -36.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.761 0.315 . . . . 1.26 111.105 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.21 -44.27 26.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 4.3200000000000003 110.905 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.6 t -72.87 -29.04 62.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 2.3500000000000001 110.89 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.88 -64.16 1.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 3.4399999999999999 110.895 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -94.86 142.52 27.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 12.970000000000001 110.927 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.142 -0.81 . . . . 11.15 112.469 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.771 0.32 . . . . 12.630000000000001 110.851 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.74 148.82 52.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 14.890000000000001 110.912 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 149' ' ' PHE . 2.2 tp -147.51 168.33 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 5.7000000000000002 111.091 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.647 HG23 ' HB3' ' A' ' 149' ' ' PHE . 2.7 p -93.28 116.69 29.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 2.6499999999999999 111.129 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -152.57 136.62 16.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 4.8799999999999999 110.941 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.666 ' CZ ' HD23 ' A' ' 160' ' ' LEU . 45.4 ptt85 -123.1 127.55 48.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 6.2300000000000004 110.896 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.9 pt -107.59 148.53 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 2.6400000000000001 111.141 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -149.02 -41.07 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 4.1100000000000003 110.882 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.474 ' OD1' HG13 ' A' ' 162' ' ' VAL . 32.8 m120 -96.2 150.38 20.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 5.21 110.919 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -147.7 134.28 19.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 6.29 110.902 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.641 HG21 ' CD1' ' A' ' 203' ' ' TRP . 0.8 OUTLIER -53.04 146.85 18.29 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.613 0.72 . . . . 3.1800000000000002 111.166 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 163.51 38.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 2.8500000000000001 112.327 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.54 16.13 9.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 3.8399999999999999 110.86 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.5 tpt -145.36 131.36 19.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 3.6099999999999999 110.867 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.34 135.22 57.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 3.2400000000000002 110.878 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -59.07 -20.16 50.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 5.7000000000000002 110.861 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -74.09 -30.5 62.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 3.8500000000000001 110.875 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.98 -44.94 75.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 3.4500000000000002 110.874 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.472 ' HA ' HD21 ' A' ' 212' ' ' LEU . 7.1 p -68.41 -28.33 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 1.3600000000000001 111.092 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -71.88 -47.97 49.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 3.23 110.841 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.57 -39.1 58.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 3.6499999999999999 110.9 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 213' ' ' PHE . . . -52.95 -58.73 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 1.3200000000000001 111.093 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 135' ' ' ARG . 2.8 pp -57.15 -28.55 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 4.3899999999999997 111.084 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.641 ' N ' HD12 ' A' ' 134' ' ' ILE . 6.9 ttm-85 -56.1 -41.23 74.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 3.4199999999999999 110.824 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -80.1 -19.65 46.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 3.0299999999999998 110.895 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.42 -38.54 34.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 1.3600000000000001 111.064 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.28 -25.71 58.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 5.8499999999999996 110.878 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -80.69 -51.15 9.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 2.79 110.888 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 136' ' ' LYS . 3.7 p -49.21 -42.28 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 2.5699999999999998 111.102 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.519 ' HH2' HD23 ' A' ' 226' ' ' LEU . 58.8 t-105 -75.84 -50.8 14.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 4.0499999999999998 110.882 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 76.7 p -55.15 -24.96 29.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 1.8 110.859 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.99 -31.61 30.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 3.0499999999999998 110.854 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.731 HG11 HG13 ' A' ' 255' ' ' ILE . 16.8 m -119.24 45.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 2.1299999999999999 111.167 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.52 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -155.46 135.44 8.3 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.565 0.698 . . . . 2.1200000000000001 111.124 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.52 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.4 Cg_endo -69.79 -23.74 30.31 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.697 2.265 . . . . 2.0 112.346 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.71 113.4 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 3.5899999999999999 110.935 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.32 129.12 39.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 5.2599999999999998 110.918 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.647 ' HB3' HG23 ' A' ' 115' ' ' THR . 0.5 OUTLIER -137.52 154.48 49.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.441 . . . . 11.84 110.886 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.9 t -101.86 122.8 44.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 3.0 110.845 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.25 142.27 43.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 2.5899999999999999 110.891 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 71.6 mt -113.24 117.6 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 2.9100000000000001 111.146 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.7 -39.84 59.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 5.4000000000000004 110.858 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 97.2 m -139.14 112.31 8.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 3.7999999999999998 111.14 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.25 -163.59 31.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.783 -0.722 . . . . 2.8599999999999999 112.481 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.73 143.85 38.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 4.9199999999999999 110.91 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.555 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -113.12 160.44 18.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 1.96 111.088 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.45 -34.31 61.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 3.48 110.897 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.723 HG23 ' O ' ' A' ' 193' ' ' GLY . 66.3 mt -104.7 141.04 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 2.5600000000000001 111.129 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.666 HD23 ' CZ ' ' A' ' 117' ' ' ARG . 1.7 tm? -121.64 117.31 26.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 1.73 110.93 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.57 HG13 ' HE2' ' A' ' 197' ' ' PHE . 97.0 t -95.45 110.99 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 1.74 111.096 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.567 ' CG2' HD11 ' A' ' 160' ' ' LEU . 40.8 t -149.7 142.21 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 1.27 111.123 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -80.4 152.8 28.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 4.0800000000000001 110.907 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.3 176.17 8.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 1.53 111.076 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -144.85 111.97 5.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 5.3200000000000003 110.893 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.12 -125.3 27.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 1.3300000000000001 112.502 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.68 114.86 23.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.333 . . . . 1.96 111.12 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -89.16 48.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 3.1699999999999999 110.923 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.85 45.81 5.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.731 . . . . 3.48 112.526 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.74 96.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.337 . . . . 8.3699999999999992 110.869 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.4 -74.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 4.6600000000000001 110.846 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -128.06 80.73 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 4.2599999999999998 110.868 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.22 113.26 19.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.75 111.084 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 141.31 43.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 5.8099999999999996 110.888 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 p30 178.69 -174.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 4.9900000000000002 110.86 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.65 106.04 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 2.5 112.521 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.26 118.96 2.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 5.8200000000000003 110.919 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 121.16 -41.44 1.9 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.748 . . . . 3.0899999999999999 112.533 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -75.91 -114.03 0.12 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 1.71 112.516 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.8 mm -92.44 135.18 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 2.0099999999999998 111.102 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 182' ' ' ALA . 0.5 OUTLIER -106.94 -20.84 13.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 3.3799999999999999 110.892 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.625 ' N ' HD12 ' A' ' 181' ' ' LEU . . . -179.62 124.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 1.6100000000000001 111.128 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -109.46 146.74 34.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 3.3799999999999999 110.842 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -155.76 122.34 5.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.71999999999999997 111.119 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.67 169.45 18.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 2.4100000000000001 110.897 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.16 177.55 0.27 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.711 -0.757 . . . . 1.0700000000000001 112.485 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 153.12 69.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.73 2.287 . . . . 1.3400000000000001 112.331 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.79 175.2 27.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.746 -0.74 . . . . 1.6499999999999999 112.513 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 88.9 p -58.72 158.89 7.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 2.0099999999999998 110.891 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.85 -102.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 1.23 112.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.64 -73.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 2.6800000000000002 111.11 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 50.54 -132.63 30.76 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 2.7999999999999998 112.51 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.723 ' O ' HG23 ' A' ' 159' ' ' ILE . . . -88.66 47.1 3.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 1.02 112.486 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.92 154.97 37.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 2.46 110.883 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -118.95 109.52 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 1.2 111.02 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -111.44 109.89 20.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 3.4500000000000002 110.812 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.57 ' HE2' HG13 ' A' ' 161' ' ' VAL . 52.6 m-85 -106.33 103.2 12.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 2.6800000000000002 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.66 101.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 7.5300000000000002 110.87 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.9 -29.15 26.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 7.1900000000000004 110.886 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -32.81 70.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 3.8500000000000001 110.838 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.84 -174.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 3.5 110.939 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -114.17 76.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 4.46 110.844 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.647 ' CH2' HG21 ' A' ' 215' ' ' THR . 0.6 OUTLIER -73.6 147.52 43.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 7.0099999999999998 110.938 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.436 HG21 ' H ' ' A' ' 209' ' ' GLY . 0.1 OUTLIER -156.66 173.09 17.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 1.74 111.143 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -173.86 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 2.4199999999999999 111.117 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -55.64 -48.97 74.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 4.6500000000000004 110.84 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -81.92 -25.09 35.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 2.8900000000000001 110.835 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.8 -172.13 0.39 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 3.29 112.474 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.436 ' H ' HG21 ' A' ' 204' ' ' THR . . . -50.47 -86.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 2.77 112.511 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -93.63 109.51 21.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 1.6000000000000001 111.127 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -49.92 114.31 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 3.7000000000000002 110.911 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 212' ' ' LEU . 0.1 OUTLIER -61.54 -35.77 78.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 3.1800000000000002 110.934 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.403 ' HB2' ' HB1' ' A' ' 133' ' ' ALA . 2.0 t80 -72.9 -57.93 3.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 5.3899999999999997 110.928 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.819 HD22 HG12 ' A' ' 243' ' ' VAL . 14.8 tp -47.9 -45.41 30.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 2.0899999999999999 110.889 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.647 HG21 ' CH2' ' A' ' 203' ' ' TRP . 24.8 m -59.37 -44.8 92.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.66000000000000003 111.102 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.28 80.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.91000000000000003 111.122 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.4 t -49.21 -50.47 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 1.05 111.159 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.788 ' NE2' 'CO ' ' A' ' 264' ' ' ' CO' . 50.1 t60 -54.08 -33.63 58.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 2.0 110.882 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.5 ' OE2' ' HB3' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -74.73 -41.57 59.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 3.98 110.855 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.458 ' O ' HD13 ' A' ' 224' ' ' LEU . 39.1 mm -53.37 -37.93 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 1.5 111.105 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.99 -53.56 5.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 0.81000000000000005 112.493 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -57.15 -24.92 57.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 2.4700000000000002 110.872 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.3 m -87.25 -17.58 32.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 1.5900000000000001 110.864 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 220' ' ' ILE . 6.2 mp -120.82 24.83 10.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 1.8700000000000001 110.95 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.87 106.52 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 1.98 112.466 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.812 HD11 ' HA ' ' A' ' 236' ' ' MET . 2.3 tm? -144.12 -67.01 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 4.0999999999999996 110.905 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.486 ' N ' HD13 ' A' ' 226' ' ' LEU . . . 67.13 121.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 3.48 112.486 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -51.71 152.68 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 2.2400000000000002 110.866 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 73.7 m -134.05 -77.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 3.9900000000000002 110.856 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 8.2 t 178.09 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 5.3300000000000001 110.895 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -48.4 108.01 0.85 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.612 0.72 . . . . 2.8199999999999998 110.883 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 157.02 61.85 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.717 2.278 . . . . 1.8500000000000001 112.314 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.14 17.9 8.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 5.8300000000000001 110.927 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.46 175.45 5.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 2.4100000000000001 111.099 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 218' ' ' HIS . 49.7 t -71.46 -18.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 5.0499999999999998 111.139 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.812 ' HA ' HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -57.05 -74.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 6.46 110.823 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -128.36 65.14 69.89 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.658 0.742 . . . . 6.6200000000000001 110.903 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -169.88 0.36 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.669 2.246 . . . . 6.0099999999999998 112.367 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.49 155.37 40.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 2.54 111.137 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -62.09 118.7 7.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 3.9500000000000002 110.912 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.64 -168.94 1.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 3.3599999999999999 110.922 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -132.75 102.55 5.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 4.1500000000000004 110.942 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.819 HG12 HD22 ' A' ' 214' ' ' LEU . 10.0 p -108.69 157.08 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 2.5499999999999998 111.108 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -58.63 114.64 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 2.6600000000000001 110.864 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -69.2 -25.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 3.52 111.118 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -28.6 32.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 3.8700000000000001 110.895 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.29 13.27 32.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 2.3799999999999999 111.153 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -51.28 164.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 5.0300000000000002 110.877 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -179.44 146.97 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 3.3700000000000001 110.863 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.675 HD23 ' CD1' ' A' ' 255' ' ' ILE . 40.7 tp -66.98 162.48 21.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 2.7599999999999998 110.91 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.77 145.22 25.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 5.0700000000000003 110.846 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -63.22 -71.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 3.2599999999999998 111.115 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.09 -35.06 59.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 3.7000000000000002 110.841 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -70.82 -29.99 66.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 2.8799999999999999 110.85 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.731 HG13 HG11 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -51.58 -28.51 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 1.9199999999999999 111.106 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.8 mtp85 -79.88 -37.77 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 5.8200000000000003 110.824 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.36 58.88 3.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.741 -0.742 . . . . 2.4100000000000001 112.505 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.417 HG21 ' CG2' ' A' ' 144' ' ' VAL . 5.2 tp -177.89 -39.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.321 . . . . 1.1699999999999999 111.151 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -73.55 -30.89 63.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 4.2599999999999998 110.901 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -42.53 99.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 3.52 110.865 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.82 153.04 43.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 4.0800000000000001 110.941 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 60.39 98.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 14.130000000000001 110.906 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 119.136 -0.814 . . . . 10.050000000000001 112.495 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . 0.788 'CO ' ' NE2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.485 ' N ' ' HZ2' ' A' ' 148' ' ' LYS . 1.1 t60 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.791 0.329 . . . . 8.6500000000000004 110.865 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.7 143.56 49.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 10.220000000000001 110.922 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.7 153.77 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 2.9700000000000002 111.118 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.629 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 30.5 p -117.09 143.81 45.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 1.95 111.142 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -146.96 136.67 23.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 4.46 110.875 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -135.21 126.23 27.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 4.3099999999999996 110.859 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.645 HG21 HG21 ' A' ' 134' ' ' ILE . 22.1 pt -104.82 133.96 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 3.1099999999999999 111.103 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -135.55 29.37 3.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 3.29 110.904 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -112.86 151.33 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 5.4199999999999999 110.926 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -147.69 145.23 28.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 6.5499999999999998 110.943 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' ' 125' ' ' MET . 0.0 OUTLIER -119.67 133.14 23.83 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.601 0.715 . . . . 3.3399999999999999 111.121 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -49.56 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.69 2.26 . . . . 3.02 112.329 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -30.99 15.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 4.3899999999999997 110.876 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.495 ' SD ' HG22 ' A' ' 205' ' ' THR . 24.7 mtp -108.01 164.57 12.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 5.3399999999999999 110.906 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -86.55 161.53 18.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 3.3900000000000001 110.873 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -25.49 36.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 7.4299999999999997 110.909 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -80.07 -41.17 26.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 5.1699999999999999 110.883 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -55.66 -53.03 61.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 2.25 110.873 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.746 HG23 ' CD2' ' A' ' 212' ' ' LEU . 7.4 p -67.1 -37.57 79.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 1.1200000000000001 111.161 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -61.44 -54.25 45.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 2.5499999999999998 110.845 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -70.37 -32.54 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 2.7999999999999998 110.955 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.24 -57.45 8.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.79000000000000004 111.079 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.71 HD12 ' O ' ' A' ' 130' ' ' VAL . 3.0 mp -76.06 -45.67 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 2.0899999999999999 111.129 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.61 -37.35 39.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 4.5 110.856 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -78.53 -30.68 47.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 3.9500000000000002 110.883 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.535 ' HB1' HG13 ' A' ' 220' ' ' ILE . . . -55.73 -35.96 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.98999999999999999 111.073 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -74.51 -28.15 60.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 3.6200000000000001 110.878 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.34 -50.42 10.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 2.7400000000000002 110.932 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.747 ' O ' HD12 ' A' ' 250' ' ' LEU . 6.2 p -50.09 -30.99 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 1.9099999999999999 111.143 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -88.76 -43.48 11.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 3.7999999999999998 110.926 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 70.7 p -54.75 -24.79 23.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.1600000000000001 110.871 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.31 -24.43 43.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 2.71 110.864 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.845 HG11 HG12 ' A' ' 255' ' ' ILE . 4.5 m -140.94 46.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 2.1000000000000001 111.103 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 m -155.76 132.06 5.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 1.5600000000000001 111.142 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -8.36 23.4 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.712 2.275 . . . . 1.8 112.364 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.65 147.01 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 2.7599999999999998 110.891 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.485 ' HZ2' ' N ' ' A' ' 112' ' ' HIS . 0.0 OUTLIER -118.38 137.24 53.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 5.0700000000000003 110.894 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -99.35 134.48 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 6.5899999999999999 110.923 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.4 t -123.87 89.91 3.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.77 110.836 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.88 119.92 19.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 2.5800000000000001 110.863 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.437 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -120.14 149.29 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 2.7999999999999998 111.086 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.43 -24.53 34.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 3.6899999999999999 110.893 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.2 m -139.77 132.16 28.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 3.4900000000000002 111.142 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.19 162.8 11.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.802 -0.713 . . . . 2.4500000000000002 112.516 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 42.0 mtt -95.02 166.39 11.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 7.3799999999999999 110.902 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -142.86 163.49 32.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 1.1499999999999999 111.093 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -25.53 65.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.7200000000000002 110.897 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.414 HD13 ' HA3' ' A' ' 193' ' ' GLY . 44.9 mm -104.02 84.54 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 3.0800000000000001 111.094 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.636 HD21 HG23 ' A' ' 162' ' ' VAL . 1.2 tm? -81.06 115.78 20.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 1.3799999999999999 110.945 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.591 ' N ' HD22 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -105.84 107.98 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.97 111.154 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.636 HG23 HD21 ' A' ' 160' ' ' LEU . 69.4 t -138.27 145.08 29.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 1.3 111.066 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -93.11 129.48 39.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 3.6299999999999999 110.866 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.513 ' HB3' ' OE2' ' A' ' 199' ' ' GLU . . . -111.09 178.39 4.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 1.26 111.117 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -144.02 112.24 6.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 4.5499999999999998 110.866 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 58.66 -131.15 51.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 1.27 112.521 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . . . -86.95 110.55 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 1.3500000000000001 111.096 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -85.36 53.64 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 3.1600000000000001 110.882 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 78.62 -57.74 4.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.733 -0.746 . . . . 3.0899999999999999 112.499 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -162.7 46.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 5.5599999999999996 110.882 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.31 -169.13 1.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 4.5999999999999996 110.869 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -76.75 96.4 4.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 3.79 110.911 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 167' ' ' ALA . . . -81.39 143.64 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 1.52 111.11 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -155.75 139.18 15.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 6.7999999999999998 110.906 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.17 -175.47 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 4.7800000000000002 110.841 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.74 99.32 1.09 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 2.6899999999999999 112.464 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.04 118.95 2.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 3.6800000000000002 110.865 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.16 -34.74 5.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 3.7000000000000002 112.479 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.79 -147.63 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 2.0 112.494 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.6 mm -71.62 89.47 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 2.6899999999999999 111.104 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.6 pp -45.2 -32.89 2.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 3.46 110.919 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.727 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 178.61 167.91 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.49 111.12 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -146.52 106.3 3.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 3.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -90.63 121.3 32.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.77000000000000002 111.106 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.94 151.68 42.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 2.75 110.873 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -50.68 167.33 0.47 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 1.0800000000000001 112.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 154.37 67.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 1.03 112.327 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 167.56 -110.03 0.37 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 1.78 112.48 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 93.3 p -131.28 142.25 50.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.401 . . . . 3.3399999999999999 110.806 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.08 -87.43 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 1.3999999999999999 112.484 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 191' ' ' ILE . 10.4 tt -91.94 14.93 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 3.4900000000000002 111.124 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -55.71 -68.47 1.67 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.783 -0.723 . . . . 2.71 112.492 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.414 ' HA3' HD13 ' A' ' 159' ' ' ILE . . . -85.62 2.85 87.81 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 1.4099999999999999 112.453 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.14 139.4 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.812 0.339 . . . . 2.6200000000000001 110.849 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.553 ' HB1' ' HG3' ' A' ' 219' ' ' GLU . . . -134.31 154.68 51.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 1.04 111.09 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.534 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 48.1 m80 -135.21 129.9 34.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 2.5 110.833 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -108.8 106.18 16.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 3.1000000000000001 110.888 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.45 82.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 5.7599999999999998 110.845 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.513 ' OE2' ' HB3' ' A' ' 164' ' ' ALA . 1.5 mm-40 -51.33 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 8.2599999999999998 110.843 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.92 28.83 5.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 4.6399999999999997 110.853 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -95.04 -80.97 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 4.5599999999999996 110.895 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 174.27 134.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 4.6399999999999997 110.867 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 95.27 5.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 6.8799999999999999 110.917 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 2.6 m -157.04 120.32 4.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 3.9199999999999999 111.117 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.495 HG22 ' SD ' ' A' ' 125' ' ' MET . 4.5 t -111.5 65.38 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 4.5599999999999996 111.169 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -88.47 -68.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 9.6099999999999994 110.866 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.81 -43.32 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 3.2400000000000002 110.909 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 242' ' ' TYR . . . -155.59 -112.76 0.42 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.751 . . . . 3.4500000000000002 112.469 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 40.63 -133.99 2.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 2.6600000000000001 112.475 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.49 97.05 9.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 1.8899999999999999 111.16 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.8 111.44 23.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 3.46 110.899 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.746 ' CD2' HG23 ' A' ' 130' ' ' VAL . 13.2 tp -51.45 -31.44 23.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 4.5700000000000003 110.918 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.96 -68.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 3.9700000000000002 110.871 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.615 HD22 ' CB ' ' A' ' 241' ' ' LYS . 3.6 mp -76.89 -36.83 56.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 3.8999999999999999 110.876 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.458 ' CG2' HD22 ' A' ' 181' ' ' LEU . 70.2 m -54.56 -45.8 73.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.72999999999999998 111.173 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.5 -44.65 76.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.82999999999999996 111.101 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.577 HG21 ' CZ ' ' A' ' 248' ' ' PHE . 29.4 t -51.35 -49.88 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.77000000000000002 111.171 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -55.29 -33.77 63.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 1.9199999999999999 110.832 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.553 ' HG3' ' HB1' ' A' ' 195' ' ' ALA . 1.7 tm-20 -74.52 -40.71 61.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 110.885 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.535 HG13 ' HB1' ' A' ' 137' ' ' ALA . 42.9 mm -50.78 -47.48 28.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 1.54 111.116 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.98 -23.99 70.44 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 0.96999999999999997 112.495 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -49.44 70.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 2.8599999999999999 110.869 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 43.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 1.8700000000000001 110.828 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.3 mt -144.33 -42.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 2.3900000000000001 110.923 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 168.71 -38.0 0.21 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.787 -0.72 . . . . 2.3300000000000001 112.529 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.19 177.91 7.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 3.3300000000000001 110.922 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.42 -77.62 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.729 . . . . 3.48 112.477 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -143.11 113.98 7.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.865 0.364 . . . . 1.8 110.866 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.1 t -92.35 -78.16 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 4.4800000000000004 110.902 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.4 t 176.85 -33.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 4.4199999999999999 110.853 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -49.55 108.13 0.92 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 2.4199999999999999 110.85 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.9 Cg_endo -69.79 167.78 23.48 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.688 2.259 . . . . 1.74 112.329 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.65 29.82 6.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 4.2400000000000002 110.931 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.73 -174.61 2.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 1.97 111.101 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 235' ' ' VAL . 11.6 t -93.56 -4.1 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 2.9199999999999999 111.112 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.433 ' HA ' ' HE3' ' A' ' 236' ' ' MET . 1.6 tpt -83.25 -41.66 18.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 3.6699999999999999 110.849 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.695 ' HB3' HG22 ' A' ' 239' ' ' THR . 0.1 OUTLIER -51.32 149.83 6.91 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.659 0.742 . . . . 3.6499999999999999 110.893 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -7.23 20.5 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.685 2.256 . . . . 2.7200000000000002 112.351 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.695 HG22 ' HB3' ' A' ' 237' ' ' PHE . 14.7 t -84.86 138.01 32.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 2.5699999999999998 111.139 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -66.25 145.44 55.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 3.8500000000000001 110.892 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.615 ' CB ' HD22 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -90.88 102.39 15.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 4.3700000000000001 110.888 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.405 ' HB2' ' HA3' ' A' ' 208' ' ' GLY . 18.6 p90 -91.8 44.37 1.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 6.2800000000000002 110.941 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.18 177.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 3.5899999999999999 111.141 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.753 ' HB3' HG22 ' A' ' 247' ' ' THR . 0.5 OUTLIER -59.79 126.26 26.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 3.1400000000000001 110.836 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 214' ' ' LEU . 25.0 pt -76.42 -30.28 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 3.4700000000000002 111.106 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -65.86 -39.57 90.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 4.9699999999999998 110.853 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.753 HG22 ' HB3' ' A' ' 244' ' ' ASP . 14.6 t -94.71 -4.77 46.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 3.2999999999999998 111.116 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 217' ' ' VAL . 21.6 t80 -51.84 144.18 11.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 5.0800000000000001 110.887 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -175.05 151.45 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 3.48 110.857 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 140' ' ' VAL . 0.8 OUTLIER -52.45 145.3 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 2.0800000000000001 110.932 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.613 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.2 OUTLIER -154.42 -172.24 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 3.5299999999999998 110.849 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . 65.56 161.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 3.77 111.118 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -22.89 51.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 3.2000000000000002 110.903 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -51.32 -29.75 16.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 3.6400000000000001 110.888 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.845 HG12 HG11 ' A' ' 144' ' ' VAL . 8.2 tt -50.74 -29.65 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 2.1499999999999999 111.164 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -92.34 -31.16 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 6.5899999999999999 110.827 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.06 -16.86 60.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.778 -0.725 . . . . 1.8400000000000001 112.494 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.712 ' O ' HD13 ' A' ' 261' ' ' LEU . 8.4 tp -93.33 -31.47 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.776 0.322 . . . . 1.02 111.121 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -78.43 -48.2 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 4.6799999999999997 110.912 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.41 -47.24 43.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 2.6699999999999999 110.876 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 258' ' ' ILE . 0.9 OUTLIER 56.04 93.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.514 . . . . 3.4300000000000002 110.907 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.68 34.32 1.28 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 10.630000000000001 110.894 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 119.128 -0.818 . . . . 10.09 112.496 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.812 0.339 . . . . 7.9100000000000001 110.835 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.676 ' O ' HD13 ' A' ' 114' ' ' ILE . 29.7 m-85 -109.45 148.84 30.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 9.9100000000000001 110.938 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 113' ' ' TYR . 11.2 mm -129.82 159.12 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 3.1099999999999999 111.109 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.416 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -146.99 142.28 27.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 2.1800000000000002 111.153 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.61 ' CD2' HD11 ' A' ' 159' ' ' ILE . 7.4 m-85 -127.56 152.43 47.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 6.5599999999999996 110.889 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -161.88 133.79 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 4.4500000000000002 110.904 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.584 HG23 ' CG2' ' A' ' 161' ' ' VAL . 86.8 mt -108.12 144.06 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 2.3900000000000001 111.122 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -108.96 -76.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 3.6800000000000002 110.881 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.81 -178.28 4.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 6.1100000000000003 110.9 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.731 ' HB2' HG11 ' A' ' 130' ' ' VAL . 13.1 p90 -140.85 163.23 33.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 5.3200000000000003 110.916 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.0 m -73.73 131.34 82.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.528 0.68 . . . . 2.9399999999999999 111.142 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -34.87 13.73 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.702 2.268 . . . . 2.3500000000000001 112.366 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -50.49 -53.73 27.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 4.9699999999999998 110.848 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 19.6 mmt -101.33 154.6 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 3.6600000000000001 110.888 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -59.1 149.09 28.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 2.9700000000000002 110.899 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -58.5 -20.87 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 4.8399999999999999 110.888 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.24 -37.28 61.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 3.7999999999999998 110.909 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 133' ' ' ALA . 11.7 m-20 -61.62 -52.2 65.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 3.0499999999999998 110.886 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.731 HG11 ' HB2' ' A' ' 121' ' ' TYR . 3.8 p -69.43 -30.0 43.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 1.1299999999999999 111.149 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.42 -48.73 47.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 3.3900000000000001 110.871 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -75.36 -33.56 61.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.461 . . . . 2.9900000000000002 110.925 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -51.45 -58.8 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.59 HD12 ' N ' ' A' ' 135' ' ' ARG . 2.9 pp -68.34 -28.01 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 4.1399999999999997 111.107 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.59 ' N ' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -50.61 -51.0 52.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 4.75 110.908 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -78.63 -32.07 47.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 3.2799999999999998 110.936 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.653 ' HB1' HD12 ' A' ' 220' ' ' ILE . . . -55.88 -34.85 65.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 1.25 111.111 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -73.96 -28.38 61.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 4.6600000000000001 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.07 -51.34 9.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 3.5499999999999998 110.913 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.9 p -51.15 -29.84 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 2.52 111.141 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -85.91 -51.38 6.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 3.8399999999999999 110.918 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.6 p -60.98 -17.23 50.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 1.79 110.894 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -50.4 -30.69 12.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 3.0299999999999998 110.936 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.749 HG11 ' CG1' ' A' ' 255' ' ' ILE . 33.6 m -133.39 36.42 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 2.0299999999999998 111.069 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.704 HG21 HD11 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -146.08 132.96 9.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.566 0.698 . . . . 1.6299999999999999 111.148 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 64.9 1.79 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.712 2.274 . . . . 2.1200000000000001 112.316 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 114' ' ' ILE . 2.7 mp -121.1 150.05 41.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 3.0600000000000001 110.899 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.0 174.34 6.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 4.6399999999999997 110.893 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -112.57 126.09 54.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 8.4299999999999997 110.903 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.5 t -133.38 89.99 2.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 2.2599999999999998 110.869 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -81.75 121.94 27.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 2.6600000000000001 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.461 HG22 ' H ' ' A' ' 154' ' ' THR . 38.0 mt -137.48 113.21 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 3.25 111.127 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.07 -28.92 27.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 4.0800000000000001 110.844 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.461 ' H ' HG22 ' A' ' 152' ' ' ILE . 94.9 m -160.73 110.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 3.98 111.13 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -173.32 -134.15 1.78 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.758 . . . . 2.3500000000000001 112.466 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 120.51 42.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.321 . . . . 5.5999999999999996 110.89 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.94 129.41 43.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 1.45 111.084 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.06 -18.73 28.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 2.4100000000000001 110.866 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.61 HD11 ' CD2' ' A' ' 116' ' ' TYR . 2.0 pp -138.82 127.04 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 3.1899999999999999 111.133 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.409 ' H ' HD12 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -136.24 166.38 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 2.3399999999999999 110.938 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.633 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 3.1 m -112.24 110.09 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 3.1000000000000001 111.074 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 163' ' ' PHE . 0.4 OUTLIER -120.66 174.71 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 1.74 111.123 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.501 ' H ' HG22 ' A' ' 162' ' ' VAL . 47.7 p90 -106.78 125.06 50.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 5.3200000000000003 110.904 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.418 ' HB2' ' HD2' ' A' ' 196' ' ' HIS . . . -125.71 148.34 49.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 1.6299999999999999 111.12 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.63 111.57 13.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 4.5599999999999996 110.853 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.61 -139.56 16.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 1.3899999999999999 112.457 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.06 111.09 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 2.0699999999999998 111.135 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -92.29 43.69 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 2.8700000000000001 110.823 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.83 95.53 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.721 -0.752 . . . . 2.8700000000000001 112.487 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.4 41.79 7.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.819 0.342 . . . . 6.3399999999999999 110.87 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.12 -168.81 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 4.4199999999999999 110.919 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -76.9 102.95 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 4.3899999999999997 110.853 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.73 112.3 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 1.53 111.093 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -70.01 -168.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 6.0800000000000001 110.868 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.53 ' HB3' HD12 ' A' ' 180' ' ' ILE . 4.6 t70 -131.95 -41.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 4.6900000000000004 110.915 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 123.22 -172.42 16.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 1.74 112.504 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.06 118.8 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.331 . . . . 4.7400000000000002 110.883 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.62 -47.34 1.05 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 2.54 112.485 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -88.86 -121.01 1.83 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.717 -0.754 . . . . 1.3799999999999999 112.477 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 175' ' ' ASP . 2.0 mp -71.32 148.51 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 3.3599999999999999 111.152 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.622 HD12 ' H ' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -113.8 -29.55 7.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 3.6299999999999999 110.935 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.622 ' H ' HD12 ' A' ' 181' ' ' LEU . . . -178.69 123.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 1.6299999999999999 111.096 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -94.97 162.94 13.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 3.1400000000000001 110.891 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -173.23 105.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.98999999999999999 111.048 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.88 170.19 4.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 2.73 110.867 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.09 165.87 1.13 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 1.23 112.458 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 165.24 31.71 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 0.98999999999999999 112.367 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.04 -136.44 5.03 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 1.3799999999999999 112.47 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.89 121.26 44.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 3.4300000000000002 110.832 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.21 -62.93 2.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.756 . . . . 1.72 112.505 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.525 ' O ' HG22 ' A' ' 191' ' ' ILE . 11.7 mt -93.95 21.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 2.4399999999999999 111.138 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.7 -106.99 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 2.7200000000000002 112.483 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.492 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . -92.07 37.66 3.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 1.1200000000000001 112.493 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -50.77 126.06 14.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.794 0.33 . . . . 2.1000000000000001 110.89 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.82 ' HB1' ' CE2' ' A' ' 197' ' ' PHE . . . -101.86 145.97 28.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 1.24 111.098 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.418 ' HD2' ' HB2' ' A' ' 164' ' ' ALA . 73.8 m80 -139.79 107.69 5.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 3.04 110.829 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.82 ' CE2' ' HB1' ' A' ' 195' ' ' ALA . 10.2 m-85 -143.82 108.52 4.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 3.3500000000000001 110.883 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 t70 179.38 -82.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 8.2200000000000006 110.832 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.41 153.57 28.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 7.7300000000000004 110.913 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 64.69 125.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 6.4699999999999998 110.905 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 63.57 70.45 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 4.5700000000000003 110.909 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -45.78 157.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 5.0499999999999998 110.87 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.62 ' CZ3' HG21 ' A' ' 215' ' ' THR . 66.2 m95 -105.35 175.05 5.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 7.2300000000000004 110.905 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.45 HG21 ' H ' ' A' ' 209' ' ' GLY . 0.0 OUTLIER -157.28 173.44 16.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 2.04 111.144 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -171.51 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 2.0600000000000001 111.142 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -67.01 -21.76 65.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 5.0199999999999996 110.876 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.6 m -103.62 -24.71 13.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 2.46 110.812 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -62.48 -160.43 0.18 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 2.25 112.503 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.45 ' H ' HG21 ' A' ' 204' ' ' THR . . . -60.6 -101.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 1.6399999999999999 112.492 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 210' ' ' THR . 2.4 t -80.42 103.57 10.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 3.6000000000000001 111.105 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 243' ' ' VAL . 9.8 m-20 -50.38 116.37 1.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 2.9900000000000002 110.929 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 203' ' ' TRP . 11.5 tp -60.76 -39.29 88.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 3.0699999999999998 110.954 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.521 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -72.39 -34.7 68.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 5.4000000000000004 110.881 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -55.07 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 2.9900000000000002 110.944 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.62 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 98.4 m -54.97 -38.47 67.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 1.1399999999999999 111.151 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.14 -32.25 61.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.84999999999999998 111.086 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 137' ' ' ALA . 5.0 t -70.64 -25.53 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.98999999999999999 111.135 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -69.57 -61.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 1.8400000000000001 110.868 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.406 ' CD ' ' HB3' ' A' ' 182' ' ' ALA . 3.4 mp0 -58.99 -50.02 75.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 4.7199999999999998 110.869 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.653 HD12 ' HB1' ' A' ' 137' ' ' ALA . 72.1 mt -51.42 -29.52 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 2.02 111.161 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.56 -44.36 16.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 0.75 112.492 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.59 -34.33 76.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 2.5899999999999999 110.83 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -28.91 18.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 2.3599999999999999 110.903 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.3 mp -93.73 -24.64 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 2.3399999999999999 110.923 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.526 ' O ' HD22 ' A' ' 226' ' ' LEU . . . 126.38 105.49 1.43 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 1.8100000000000001 112.489 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.619 HD21 ' O ' ' A' ' 257' ' ' GLY . 0.2 OUTLIER -149.37 -68.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 3.25 110.866 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 73.31 31.59 61.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 3.4199999999999999 112.468 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 21.6 m80 64.47 155.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 2.2200000000000002 110.877 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 59.4 m -124.84 -78.14 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 4.3600000000000003 110.86 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.16 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 4.4900000000000002 110.884 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -47.44 106.64 0.62 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.577 0.703 . . . . 3.2999999999999998 110.865 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.3 21.94 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 1.8899999999999999 112.359 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.0 mptt 50.65 29.96 4.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 5.5499999999999998 110.934 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.531 ' HB1' ' OD2' ' A' ' 254' ' ' ASP . . . -130.59 -168.88 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 2.1800000000000002 111.101 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.451 ' HB ' ' HE2' ' A' ' 236' ' ' MET . 55.3 t -50.42 -57.26 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 4.4500000000000002 111.13 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.451 ' HE2' ' HB ' ' A' ' 235' ' ' VAL . 9.8 mmt -59.41 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 3.3999999999999999 110.875 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 238' ' ' PRO . 0.2 OUTLIER 63.72 99.62 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.651 0.739 . . . . 4.54 110.915 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 237' ' ' PHE . 53.4 Cg_endo -69.83 77.95 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.693 2.262 . . . . 3.3599999999999999 112.283 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.4 p -145.46 125.53 13.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 2.6899999999999999 111.116 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -62.77 126.39 27.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 4.4199999999999999 110.875 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -150.69 92.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 4.1799999999999997 110.89 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -58.68 127.29 31.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 3.46 110.91 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.557 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 7.6 p -135.97 154.32 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 2.4100000000000001 111.167 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.19 113.15 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 2.8199999999999998 110.835 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.0 tt -74.28 -34.5 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.5499999999999998 111.163 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -24.02 67.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 2.8500000000000001 110.914 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 14.6 19.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 2.5699999999999998 111.168 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -51.36 156.97 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 5.1299999999999999 110.879 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -178.67 148.15 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 3.5600000000000001 110.88 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.14 161.11 2.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 2.8900000000000001 110.893 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.429 ' OG ' HG23 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -88.93 150.76 22.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 4.7800000000000002 110.874 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.434 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -68.96 -68.34 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 3.4300000000000002 111.106 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -53.31 -36.91 61.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 3.6000000000000001 110.853 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.531 ' OD2' ' HB1' ' A' ' 234' ' ' ALA . 25.0 m-20 -70.96 -29.23 65.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 3.27 110.838 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.749 ' CG1' HG11 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -51.09 -28.6 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.73 111.111 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -77.78 -37.19 49.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 5.7000000000000002 110.853 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.619 ' O ' HD21 ' A' ' 226' ' ' LEU . . . -78.63 57.11 4.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 2.6600000000000001 112.488 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.704 HD11 HG21 ' A' ' 145' ' ' THR . 4.9 tp -179.16 -40.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.85999999999999999 111.17 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -75.03 -45.07 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 3.0299999999999998 110.908 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.15 -47.2 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 2.1499999999999999 110.827 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 258' ' ' ILE . 2.3 tp 51.16 30.58 5.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 3.7599999999999998 110.944 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -126.55 -59.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 10.619999999999999 110.946 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 119.146 -0.808 . . . . 10.66 112.505 179.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.1 m80 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.846 0.355 . . . . 8.0500000000000007 110.823 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -114.77 142.77 46.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 9.5700000000000003 110.92 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.71 147.89 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 2.96 111.134 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.724 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 71.8 p -130.01 148.07 51.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 2.0600000000000001 111.128 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -145.57 173.28 12.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 4.2199999999999998 110.962 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -160.5 125.89 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 7.2400000000000002 110.838 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.718 HG21 HG13 ' A' ' 134' ' ' ILE . 1.6 pt -108.17 121.63 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 3.23 111.138 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -136.11 47.92 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 3.98 110.88 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.534 ' OD1' HG12 ' A' ' 161' ' ' VAL . 1.1 p-10 -137.5 153.23 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 5.6200000000000001 110.867 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -147.4 163.15 37.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 7.7999999999999998 110.883 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 p -125.37 151.72 70.3 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.712 . . . . 2.6200000000000001 111.155 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 169.08 19.75 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.713 2.276 . . . . 3.1800000000000002 112.337 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.1 t70 75.65 -52.06 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 6.0300000000000002 110.824 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.749 ' HG2' HG23 ' A' ' 205' ' ' THR . 3.7 mpp? -97.66 132.91 42.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 3.4300000000000002 110.895 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.99 155.75 10.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 3.48 110.879 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.06 -23.12 12.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 5.1299999999999999 110.851 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -41.01 84.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 3.8999999999999999 110.91 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.36 -54.67 44.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 2.6000000000000001 110.874 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.504 ' O ' HD13 ' A' ' 134' ' ' ILE . 6.1 p -62.21 -40.66 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.83999999999999997 111.111 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.13 -40.83 61.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 3.2999999999999998 110.875 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -74.61 -31.08 61.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 2.9199999999999999 110.932 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.24 -52.46 35.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 1.1499999999999999 111.096 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.718 HG13 HG21 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -83.02 -28.52 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 2.27 111.152 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -50.98 -55.08 19.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 6.5300000000000002 110.869 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -78.25 -25.94 47.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 3.6200000000000001 110.874 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.665 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.82 -37.26 68.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.80000000000000004 111.1 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -27.03 61.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 3.4300000000000002 110.852 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.97 -48.81 13.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 2.9700000000000002 110.886 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.461 ' O ' HD12 ' A' ' 250' ' ' LEU . 4.6 p -55.8 -27.07 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 2.1299999999999999 111.115 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.705 ' HE1' HD11 ' A' ' 258' ' ' ILE . 21.4 t90 -91.1 -54.37 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 9.5800000000000001 110.933 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.5 p -59.22 -18.4 36.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 1.71 110.841 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.2 -26.66 61.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 2.3599999999999999 110.921 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.605 HG11 HD13 ' A' ' 250' ' ' LEU . 7.1 p -103.85 -23.87 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 3.5499999999999998 111.114 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.731 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -106.57 145.26 30.67 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.56 0.695 . . . . 1.6799999999999999 111.15 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.731 ' HD2' HG22 ' A' ' 145' ' ' THR . 53.8 Cg_endo -69.76 -8.58 23.97 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.676 2.251 . . . . 1.9099999999999999 112.308 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -51.6 158.2 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 2.9399999999999999 110.881 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.23 138.71 52.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 6.1399999999999997 110.918 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -101.54 139.25 37.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 6.5700000000000003 110.871 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.71 ' HB3' HG22 ' A' ' 115' ' ' THR . 0.6 OUTLIER -143.0 90.04 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 1.6599999999999999 110.849 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -77.81 122.77 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 3.8999999999999999 110.889 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 154' ' ' THR . 15.7 pt -140.18 163.79 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 2.4399999999999999 111.14 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -109.59 28.9 8.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 3.71 110.888 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.457 ' O ' HD12 ' A' ' 152' ' ' ILE . 14.6 t -157.65 174.05 15.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 3.6000000000000001 111.145 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.62 -173.62 12.15 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.74 . . . . 1.5800000000000001 112.507 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.46 166.34 10.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 5.5599999999999996 110.873 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.724 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -144.62 146.94 32.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 1.1399999999999999 111.113 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -26.65 68.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 2.4399999999999999 110.879 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.8 mm -104.04 109.9 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 2.8700000000000001 111.173 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.674 HD22 ' N ' ' A' ' 161' ' ' VAL . 0.9 OUTLIER -111.22 119.35 38.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 1.49 110.94 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.674 ' N ' HD22 ' A' ' 160' ' ' LEU . 16.0 t -108.61 109.9 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 1.52 111.129 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.65 HG23 HD21 ' A' ' 160' ' ' LEU . 72.2 t -134.35 144.97 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 1.28 111.134 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -92.22 153.17 19.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 3.9300000000000002 110.895 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.537 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . . . -164.33 178.02 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 1.0800000000000001 111.118 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -145.04 111.54 5.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 5.1100000000000003 110.9 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 63.73 -147.67 50.67 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.712 -0.756 . . . . 1.1299999999999999 112.504 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.54 112.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 1.26 111.105 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -95.66 27.95 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 2.8700000000000001 110.812 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.52 18.21 60.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 2.8399999999999999 112.46 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -106.61 -74.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.763 0.316 . . . . 6.9299999999999997 110.89 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.19 -65.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 4.54 110.882 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -77.39 107.09 9.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 5.0999999999999996 110.868 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.32 159.64 23.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 1.8200000000000001 111.118 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.84 113.83 2.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 6.8300000000000001 110.818 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.96 -169.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 7.4699999999999998 110.907 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.99 97.82 2.11 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 2.2999999999999998 112.477 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -51.67 119.19 3.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 3.5 110.859 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.19 7.05 62.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 2.2999999999999998 112.475 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -114.76 -126.39 4.19 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 1.48 112.538 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 180' ' ' ILE . 3.6 mp -89.16 93.9 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 2.6800000000000002 111.129 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -49.9 -26.9 4.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 3.1400000000000001 110.858 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 181' ' ' LEU . . . 179.5 171.49 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 1.3100000000000001 111.107 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -160.14 106.26 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 3.0499999999999998 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.409 ' HB1' ' OG ' ' A' ' 223' ' ' SER . . . -110.75 109.84 20.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.79000000000000004 111.087 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.06 169.65 4.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 3.0600000000000001 110.927 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.39 173.8 0.25 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.98999999999999999 112.443 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 179.62 3.58 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.689 2.259 . . . . 0.93000000000000005 112.353 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 154.12 -128.79 2.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 1.3600000000000001 112.529 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.08 141.12 52.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.927 0.394 . . . . 2.0 110.85 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.5 -76.54 0.95 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.721 . . . . 1.1499999999999999 112.504 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 191' ' ' ILE . 11.1 tt -104.92 16.41 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 3.0499999999999998 111.13 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.88 -77.58 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 2.8300000000000001 112.473 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.94 2.22 81.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.775 -0.726 . . . . 1.0600000000000001 112.479 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.51 127.42 17.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.785 0.326 . . . . 2.21 110.873 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.87 146.39 50.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 1.4399999999999999 111.088 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.537 ' CD2' ' HB3' ' A' ' 164' ' ' ALA . 32.7 t-80 -113.76 149.89 34.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 6.0899999999999999 110.834 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.97 147.56 44.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 4.0499999999999998 110.889 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.74 -35.84 10.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 5.6200000000000001 110.84 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 63.28 -82.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 7.75 110.853 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -134.87 35.21 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 6.4699999999999998 110.868 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.8 -5.58 6.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 4.5099999999999998 110.865 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.17 73.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 8.5299999999999994 110.87 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -105.36 124.62 49.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 9.4399999999999995 110.96 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.465 HG21 ' N ' ' A' ' 209' ' ' GLY . 0.0 OUTLIER -157.47 153.45 27.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 2.3799999999999999 111.167 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.749 HG23 ' HG2' ' A' ' 125' ' ' MET . 0.1 OUTLIER -87.8 -172.51 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 2.27 111.148 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.508 ' HB3' HG21 ' A' ' 245' ' ' ILE . 25.5 p-80 -50.27 -48.32 54.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 4.4500000000000002 110.826 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.5 p -76.82 -38.03 54.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 2.75 110.857 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -51.77 172.11 0.28 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 2.2599999999999998 112.494 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.465 ' N ' HG21 ' A' ' 204' ' ' THR . . . -47.45 -85.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 1.55 112.472 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 88.3 m -79.36 98.34 6.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.815 0.341 . . . . 2.27 111.167 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.411 HD22 HG12 ' A' ' 243' ' ' VAL . 51.3 t-20 -51.14 115.48 1.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 3.3300000000000001 110.914 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -35.28 38.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 2.8500000000000001 110.9 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.414 ' O ' HG23 ' A' ' 217' ' ' VAL . 39.5 t80 -72.33 -53.6 11.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 5.2800000000000002 110.86 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.473 HD13 HG11 ' A' ' 243' ' ' VAL . 10.6 tp -51.86 -47.75 64.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 2.7799999999999998 110.933 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.582 HG23 HD22 ' A' ' 181' ' ' LEU . 0.7 OUTLIER -55.38 -51.23 67.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 1.0700000000000001 111.154 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.59 -48.88 74.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.70999999999999996 111.132 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.665 HG22 ' HA ' ' A' ' 137' ' ' ALA . 49.0 t -61.5 -20.49 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.72999999999999998 111.139 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -74.33 -46.25 42.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 2.02 110.891 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.75 -23.46 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 5.4800000000000004 110.859 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 224' ' ' LEU . 21.7 mm -65.56 -52.08 55.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 1.3200000000000001 111.118 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.96 -25.69 66.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 0.67000000000000004 112.438 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -51.33 70.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 2.5600000000000001 110.887 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.409 ' OG ' ' HB1' ' A' ' 184' ' ' ALA . 0.9 OUTLIER -91.26 46.14 1.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 1.8999999999999999 110.861 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 220' ' ' ILE . 1.2 mt -156.12 22.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 1.9399999999999999 110.913 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.27 5.28 89.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 1.78 112.487 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.473 ' HB2' HD13 ' A' ' 258' ' ' ILE . 19.4 tp -120.27 68.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 4.3200000000000003 110.906 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -86.05 -101.83 0.74 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.765 -0.731 . . . . 3.7000000000000002 112.443 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -118.46 153.61 33.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.338 . . . . 2.29 110.858 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.3 m -135.86 -75.91 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 4.3700000000000001 110.844 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.62 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 3.6600000000000001 110.864 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 30.7 m-20 -49.28 108.27 0.94 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.577 0.703 . . . . 3.3999999999999999 110.853 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 233' ' ' LYS . 53.7 Cg_endo -69.76 -179.82 3.18 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.658 2.238 . . . . 1.8600000000000001 112.337 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER 37.53 42.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 4.5999999999999996 110.897 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -128.91 -175.78 3.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 1.9199999999999999 111.117 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 43.0 t -93.05 -17.72 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 3.0299999999999998 111.117 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -82.23 -41.53 20.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 4.79 110.887 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -51.54 136.4 33.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.668 0.747 . . . . 3.7999999999999998 110.915 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.453 ' O ' HG23 ' A' ' 239' ' ' THR . 54.1 Cg_endo -69.77 77.77 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.258 . . . . 2.1000000000000001 112.355 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 238' ' ' PRO . 2.0 p -156.92 160.36 39.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 2.71 111.154 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -127.05 113.2 16.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 3.75 110.952 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.02 128.41 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.467 . . . . 3.1899999999999999 110.919 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -51.71 121.95 7.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 3.3999999999999999 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.473 HG11 HD13 ' A' ' 214' ' ' LEU . 11.3 p -122.18 148.8 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 2.71 111.168 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -54.98 113.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 4.0999999999999996 110.87 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.508 HG21 ' HB3' ' A' ' 206' ' ' HIS . 1.3 pp -76.75 -31.27 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 2.6200000000000001 111.117 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -36.04 78.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 2.8199999999999998 110.868 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 21.0 p -104.71 24.69 11.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 2.7799999999999998 111.155 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -51.78 134.34 30.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 5.7699999999999996 110.929 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -178.54 136.47 0.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 4.2400000000000002 110.838 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.646 HD22 HG13 ' A' ' 255' ' ' ILE . 0.4 OUTLIER -52.65 152.7 3.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 2.1400000000000001 110.887 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 252' ' ' ALA . 0.1 OUTLIER -154.54 -170.95 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 3.23 110.889 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.667 ' HB3' ' OD2' ' A' ' 254' ' ' ASP . . . 69.18 157.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 4.1399999999999997 111.079 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.27 -24.9 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 2.77 110.883 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.667 ' OD2' ' HB3' ' A' ' 252' ' ' ALA . 1.2 p30 -50.78 -29.9 12.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 3.04 110.83 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.646 HG13 HD22 ' A' ' 250' ' ' LEU . 17.8 tt -54.24 -29.67 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 1.97 111.123 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -83.1 -24.8 32.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 5.5999999999999996 110.852 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 261' ' ' LEU . . . -81.42 -44.85 7.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.815 -0.707 . . . . 2.54 112.479 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.705 HD11 ' HE1' ' A' ' 141' ' ' TRP . 5.7 tp -54.58 -36.93 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.81999999999999995 111.089 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -77.04 -49.72 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 3.4399999999999999 110.913 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 57.7 m -59.37 -27.27 65.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 2.6499999999999999 110.83 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 257' ' ' GLY . 1.7 mp -57.18 -25.92 59.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.104 -0.498 . . . . 3.4100000000000001 110.916 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -52.06 135.03 31.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 14.07 110.908 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 CA-C-O 119.127 -0.818 . . . . 12.01 112.467 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.857 0.36 . . . . 9.0199999999999996 110.807 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.586 ' C ' HD12 ' A' ' 114' ' ' ILE . 13.3 p90 -123.31 142.57 50.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 10.77 110.95 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.586 HD12 ' C ' ' A' ' 113' ' ' TYR . 1.7 mp -120.01 145.62 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 3.4700000000000002 111.174 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.51 134.56 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 2.3799999999999999 111.138 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -134.4 147.26 50.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 4.8300000000000001 110.903 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -153.06 152.63 31.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 3.9500000000000002 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.39 144.59 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 2.7599999999999998 111.109 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.44 ' HB3' HG22 ' A' ' 162' ' ' VAL . 13.7 m-80 -142.78 20.03 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 3.6600000000000001 110.886 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.444 ' OD1' HG12 ' A' ' 161' ' ' VAL . 6.6 p-10 -122.44 157.7 31.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 5.8099999999999996 110.91 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.92 106.41 3.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 7.6399999999999997 110.916 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.747 HG23 ' HB2' ' A' ' 203' ' ' TRP . 16.3 m -70.66 120.0 76.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.598 0.713 . . . . 3.3799999999999999 111.115 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -48.38 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.702 2.268 . . . . 2.6499999999999999 112.341 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -23.44 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 4.8200000000000003 110.906 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.727 ' HE3' HG22 ' A' ' 204' ' ' THR . 23.8 mmt -124.77 -174.56 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 3.2799999999999998 110.912 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.558 ' O ' HG12 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -86.9 162.06 17.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 3.0099999999999998 110.88 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -74.61 -20.91 59.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 6.5899999999999999 110.891 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.51 -54.44 5.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 5.0599999999999996 110.864 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -55.31 -40.18 70.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 4.0599999999999996 110.886 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 126' ' ' ASN . 9.3 p -74.35 -37.16 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.0700000000000001 111.121 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -62.68 -55.16 29.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 3.0099999999999998 110.878 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -65.89 -31.92 73.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 3.8300000000000001 110.933 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -50.94 -41.86 59.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 1.0800000000000001 111.105 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.582 HD12 ' CZ ' ' A' ' 197' ' ' PHE . 2.6 mm -79.31 -43.16 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 2.54 111.169 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.24 -30.25 49.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 3.9300000000000002 110.91 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -78.49 -27.3 46.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 3.1499999999999999 110.844 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.485 ' HB1' HG13 ' A' ' 220' ' ' ILE . . . -55.69 -33.03 63.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 1.21 111.121 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -73.85 -25.8 60.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 3.5600000000000001 110.905 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -79.08 -52.79 7.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 2.4300000000000002 110.935 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.14 -42.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 2.0800000000000001 111.098 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.489 ' CE3' HD11 ' A' ' 250' ' ' LEU . 9.3 m95 -75.54 -43.59 47.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 4.1200000000000001 110.925 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.0 t -62.6 -15.07 49.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 2.5800000000000001 110.894 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.34 -23.13 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 2.7999999999999998 110.883 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.489 HG11 HG12 ' A' ' 255' ' ' ILE . 0.0 OUTLIER -120.3 -32.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 2.6299999999999999 111.084 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.498 HG21 HG12 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -107.09 150.16 39.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.573 0.701 . . . . 2.5499999999999998 111.127 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -53.41 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.69 2.26 . . . . 3.2799999999999998 112.359 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tp 46.55 -165.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 3.8900000000000001 110.858 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.61 131.14 11.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 3.8100000000000001 110.862 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -115.47 144.93 43.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 6.4500000000000002 110.908 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.442 ' O ' HD13 ' A' ' 152' ' ' ILE . 11.8 t -156.99 90.76 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 2.29 110.853 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -91.11 107.13 19.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 2.77 110.878 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -122.89 139.57 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 2.4300000000000002 111.098 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -64.27 -24.02 67.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 3.4399999999999999 110.914 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.7 m -138.06 148.91 45.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.462 . . . . 3.0499999999999998 111.147 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.83 -173.28 19.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.756 -0.735 . . . . 1.77 112.458 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.8 mtt -110.65 145.87 37.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 5.4500000000000002 110.843 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.43 130.05 36.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 1.47 111.114 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.26 -22.6 66.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 3.54 110.864 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.0 mm -104.18 84.36 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 2.8799999999999999 111.164 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 161' ' ' VAL . 1.2 tm? -91.34 115.24 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 1.7 110.887 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.823 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 21.9 t -98.88 110.88 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 1.4399999999999999 111.126 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.555 ' CG2' HD11 ' A' ' 160' ' ' LEU . 46.3 t -138.97 139.96 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 1.4099999999999999 111.136 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -82.48 122.87 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 3.4199999999999999 110.87 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.99 178.38 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 1.45 111.08 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -145.18 126.93 15.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 8.0800000000000001 110.862 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.0 -134.1 32.04 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.752 -0.737 . . . . 1.4399999999999999 112.516 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.62 113.42 20.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 1.5800000000000001 111.075 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -90.87 154.04 19.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 3.4900000000000002 110.89 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.96 -14.0 54.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 3.4100000000000001 112.483 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.22 23.5 5.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.774 0.321 . . . . 7.5700000000000003 110.865 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.0 t70 63.4 52.94 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 6.6500000000000004 110.865 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -127.59 79.68 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 4.96 110.826 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.39 129.05 34.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 1.6299999999999999 111.082 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.09 173.08 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 10.06 110.903 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.605 ' OD2' HD12 ' A' ' 180' ' ' ILE . 13.9 t70 -125.58 -2.5 7.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 6.0700000000000003 110.866 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 77.36 148.1 2.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 2.1600000000000001 112.501 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.41 153.71 2.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 5.9500000000000002 110.901 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.74 -1.41 87.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.737 -0.744 . . . . 3.0600000000000001 112.452 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.37 -141.27 3.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 2.4900000000000002 112.453 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.702 HG21 ' CD2' ' A' ' 183' ' ' HIS . 2.8 mp -71.47 91.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 2.5600000000000001 111.127 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 182' ' ' ALA . 1.8 pp -48.28 -29.49 3.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 3.23 110.912 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.747 ' N ' HD12 ' A' ' 181' ' ' LEU . . . -179.62 178.0 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.8400000000000001 111.162 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.702 ' CD2' HG21 ' A' ' 180' ' ' ILE . 1.0 OUTLIER -153.03 130.14 11.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 4.1500000000000004 110.83 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -116.94 119.88 36.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.64000000000000001 111.106 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.38 165.27 9.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 2.54 110.83 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.25 173.14 0.28 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.734 -0.746 . . . . 0.90000000000000002 112.495 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -169.53 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.617 2.212 . . . . 1.24 112.344 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.12 -146.13 16.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 1.3700000000000001 112.437 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.4 m -94.69 154.54 17.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 1.8600000000000001 110.867 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 51.62 -103.81 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 1.3 112.447 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.23 -23.8 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 2.0600000000000001 111.141 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -57.0 99.61 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.775 -0.726 . . . . 2.5899999999999999 112.514 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 113.62 -12.08 23.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 1.1599999999999999 112.46 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.542 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 3.4 m-20 -49.96 145.35 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.356 . . . . 2.6400000000000001 110.826 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.823 ' HB3' ' HA ' ' A' ' 161' ' ' VAL . . . -131.97 135.3 46.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.82999999999999996 111.082 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -124.76 117.86 25.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 2.77 110.854 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.582 ' CZ ' HD12 ' A' ' 134' ' ' ILE . 8.0 m-85 -100.98 101.76 12.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 2.9199999999999999 110.838 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.646 ' OD1' HG21 ' A' ' 210' ' ' THR . 0.6 OUTLIER 50.63 93.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 5.7199999999999998 110.868 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.59 87.08 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 9.4900000000000002 110.882 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 34.3 t70 64.5 15.3 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 3.3799999999999999 110.876 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.72 -78.09 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 4.4699999999999998 110.885 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 178.41 124.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 4.2800000000000002 110.913 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.747 ' HB2' HG23 ' A' ' 122' ' ' THR . 1.4 m-90 -102.03 137.78 39.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 7.1699999999999999 110.928 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.727 HG22 ' HE3' ' A' ' 125' ' ' MET . 0.0 OUTLIER -157.11 169.05 25.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 1.96 111.16 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.41 HG23 ' SD ' ' A' ' 125' ' ' MET . 0.6 OUTLIER -75.31 173.89 10.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 1.9399999999999999 111.161 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -50.55 -30.31 12.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 5.1399999999999997 110.858 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.04 -37.63 17.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 2.27 110.851 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -56.45 -178.03 0.37 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.703 -0.76 . . . . 3.0 112.478 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -49.96 -64.18 3.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.765 -0.731 . . . . 2.4100000000000001 112.511 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.646 HG21 ' OD1' ' A' ' 198' ' ' ASP . 0.2 OUTLIER -97.73 102.13 13.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 1.8899999999999999 111.149 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.697 HD21 HD22 ' A' ' 214' ' ' LEU . 12.9 p30 -59.91 95.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 4.3700000000000001 110.865 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.491 ' C ' HD13 ' A' ' 212' ' ' LEU . 2.8 tm? -59.68 -32.83 70.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 2.8799999999999999 110.934 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.511 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 24.8 m-85 -66.56 -64.32 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 5.6799999999999997 110.868 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.697 HD22 HD21 ' A' ' 211' ' ' ASN . 2.9 tt -59.16 -46.68 87.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 2.5899999999999999 110.916 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 74.3 m -54.49 -26.28 30.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.73999999999999999 111.18 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.08 -42.73 75.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.76000000000000001 111.083 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.5 t -59.38 -46.88 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.83999999999999997 111.17 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -53.61 -31.83 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 2.04 110.838 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -74.75 -42.9 57.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 5.5700000000000003 110.845 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 224' ' ' LEU . 46.1 mm -51.1 -44.74 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 1.7 111.115 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.99 -32.66 52.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.90000000000000002 112.479 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -36.67 81.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 3.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.98 29.06 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 2.4300000000000002 110.861 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 220' ' ' ILE . 9.0 mt -139.7 -52.69 0.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 2.4399999999999999 110.945 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -176.41 -151.0 8.53 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.739 . . . . 2.2599999999999998 112.497 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 68.69 -75.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 3.8100000000000001 110.928 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 110.88 -74.39 0.21 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 2.9199999999999999 112.509 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -170.99 84.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 2.0099999999999998 110.853 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.15 171.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 4.54 110.836 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -25.18 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 4.1500000000000004 110.828 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 232' ' ' PRO . 0.7 OUTLIER -50.6 108.74 1.1 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.595 0.712 . . . . 2.2599999999999998 110.808 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 231' ' ' ASP . 53.6 Cg_endo -69.75 162.19 43.02 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 2.1899999999999999 112.336 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 58.36 22.56 9.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 5.4699999999999998 110.87 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 252' ' ' ALA . . . -111.19 158.59 18.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 1.98 111.071 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.86 -23.93 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 3.3900000000000001 111.157 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -49.46 22.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 4.1799999999999997 110.881 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -52.34 136.68 40.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.65 0.738 . . . . 4.0199999999999996 110.859 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 93.9 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.685 2.257 . . . . 2.54 112.323 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.9 t -156.96 153.38 27.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 3.2200000000000002 111.158 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -110.55 125.86 53.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 3.7799999999999998 110.908 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.03 96.25 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 4.0899999999999999 110.841 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -49.9 122.76 6.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 4.1600000000000001 110.953 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.3 p -120.22 153.49 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 2.7599999999999998 111.123 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.51 137.03 42.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 4.3200000000000003 110.911 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.07 -26.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 3.27 111.111 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -64.9 -39.36 93.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 4.3200000000000003 110.88 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 -10.85 24.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 3.5499999999999998 111.105 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.58 120.51 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 4.0599999999999996 110.89 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 175.64 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 4.4500000000000002 110.917 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.656 ' HB3' HD12 ' A' ' 255' ' ' ILE . 0.8 OUTLIER -87.29 150.98 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 2.23 110.867 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.648 ' H ' HD23 ' A' ' 250' ' ' LEU . 0.2 OUTLIER -154.83 -172.04 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 3.5099999999999998 110.868 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . . . 66.59 165.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 3.96 111.083 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -20.4 62.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 3.0899999999999999 110.892 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -51.07 -29.99 14.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 3.3599999999999999 110.825 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.656 HD12 ' HB3' ' A' ' 250' ' ' LEU . 1.0 OUTLIER -51.2 -29.63 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 2.1600000000000001 111.156 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 35.8 mtt85 -90.95 -33.83 15.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 6.4299999999999997 110.855 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.44 -25.8 21.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 2.0099999999999998 112.49 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.498 HG12 HG21 ' A' ' 145' ' ' THR . 6.5 tp -87.45 -29.17 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.767 0.318 . . . . 1.26 111.14 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -79.37 -37.75 36.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 3.3399999999999999 110.951 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.6 t -86.97 -32.88 19.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 2.1299999999999999 110.853 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.8 mp 54.18 87.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 4.3499999999999996 110.886 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -157.41 163.1 38.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 10.52 110.959 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 119.126 -0.819 . . . . 10.039999999999999 112.471 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 48.5 m80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.79 0.329 . . . . 16.460000000000001 110.819 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -125.03 149.24 47.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 13.76 110.949 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.731 HD13 ' HB2' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -152.64 152.52 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 5.2999999999999998 111.071 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.459 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -88.63 116.91 27.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 2.8799999999999999 111.138 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.497 ' CZ ' HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -137.51 136.27 37.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 8.0600000000000005 110.889 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.531 ' HG2' ' HB3' ' A' ' 157' ' ' ALA . 29.5 ptt180 -127.9 119.21 25.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 8.9199999999999999 110.878 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.9 pt -107.99 148.28 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 3.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -157.16 22.86 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 3.4399999999999999 110.856 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.533 HD21 HG12 ' A' ' 161' ' ' VAL . 2.5 p30 -142.03 153.87 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 4.1900000000000004 110.924 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -114.67 163.05 15.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 5.0999999999999996 110.933 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.508 ' OG1' HD21 ' A' ' 212' ' ' LEU . 86.1 m -120.29 133.86 24.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.598 0.713 . . . . 2.8999999999999999 111.124 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 122' ' ' THR . 53.2 Cg_endo -69.81 -177.6 1.97 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.69 2.26 . . . . 3.1499999999999999 112.33 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 72.39 -68.64 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 4.5999999999999996 110.836 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.88 147.7 25.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 4.3399999999999999 110.857 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -59.36 168.15 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 3.75 110.907 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.06 -22.46 50.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 6.1100000000000003 110.849 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -63.29 -44.05 96.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 4.3099999999999996 110.928 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.663 ' OD2' HD12 ' A' ' 212' ' ' LEU . 26.3 t0 -60.15 -53.3 59.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 3.9500000000000002 110.856 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.854 HG23 HD22 ' A' ' 212' ' ' LEU . 11.4 p -65.76 -29.57 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.85999999999999999 111.117 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.3 -53.48 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 3.4500000000000002 110.826 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -69.97 -33.45 72.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 3.6400000000000001 110.933 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.68 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -54.01 -59.25 4.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.148 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.472 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 3.3 pt -63.48 -28.36 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 3.3100000000000001 111.101 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -51.1 -59.29 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 5.7599999999999998 110.874 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.776 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -80.45 -21.44 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 3.3799999999999999 110.885 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.604 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -55.2 -54.75 39.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 1.1699999999999999 111.106 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.511 ' HA ' HD13 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -67.25 -23.27 65.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 5.8099999999999996 110.875 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.04 -28.14 43.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 3.3999999999999999 110.921 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 136' ' ' LYS . 90.0 t -68.45 -30.22 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 2.02 111.152 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.616 ' HD1' HD22 ' A' ' 224' ' ' LEU . 15.3 t-105 -93.31 -52.89 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 3.9700000000000002 110.891 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 p -55.14 -23.04 19.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 1.8799999999999999 110.817 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.51 -23.64 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 3.71 110.873 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.577 HG21 HG13 ' A' ' 255' ' ' ILE . 9.8 p -125.01 21.65 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 3.5800000000000001 111.134 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -128.32 134.13 25.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.586 0.707 . . . . 2.02 111.117 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 145' ' ' THR . 54.2 Cg_endo -69.73 -25.56 28.61 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.703 2.269 . . . . 1.8899999999999999 112.352 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.91 109.57 0.34 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 3.6299999999999999 110.895 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -121.99 129.6 52.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 5.1900000000000004 110.852 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.731 ' HB2' HD13 ' A' ' 114' ' ' ILE . 2.6 m-85 -138.02 154.27 49.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 12.16 110.867 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.19 126.37 49.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 3.3500000000000001 110.903 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -57.87 154.62 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 3.5 110.9 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.36 116.73 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 3.5299999999999998 111.127 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -39.24 58.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 3.7000000000000002 110.87 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 96.5 m -140.6 109.63 6.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 3.0600000000000001 111.129 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 162.48 -156.12 27.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 1.73 112.532 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -110.88 157.38 19.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 5.21 110.872 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.531 ' HB3' ' HG2' ' A' ' 117' ' ' ARG . . . -133.28 153.63 51.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 1.1499999999999999 111.088 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.62 -25.64 27.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 3.1200000000000001 110.869 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 193' ' ' GLY . 26.5 mt -121.39 137.41 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 2.3999999999999999 111.113 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.65 HD11 ' CG2' ' A' ' 162' ' ' VAL . 1.3 tm? -117.21 120.64 38.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 1.3999999999999999 110.904 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.639 ' N ' HD22 ' A' ' 160' ' ' LEU . 4.1 t -96.3 121.68 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 1.5600000000000001 111.1 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.65 ' CG2' HD11 ' A' ' 160' ' ' LEU . 10.9 t -147.87 141.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.3999999999999999 111.088 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -99.67 135.59 40.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 3.6899999999999999 110.863 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.63 133.18 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 1.73 111.075 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.33 156.69 18.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 5.4800000000000004 110.866 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 51.62 -137.27 31.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 1.0900000000000001 112.507 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.81 130.29 34.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 1.1599999999999999 111.107 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -88.58 6.96 35.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 2.6299999999999999 110.909 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.81 -17.35 55.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 2.54 112.481 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.37 33.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 5.6600000000000001 110.858 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.43 -167.75 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 4.6699999999999999 110.856 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -76.3 100.84 5.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 6.2000000000000002 110.858 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -53.5 128.44 28.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 1.3600000000000001 111.078 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -101.51 -168.98 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 6.1200000000000001 110.929 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -139.22 -41.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 4.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.33 -127.69 8.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 2.5600000000000001 112.487 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -51.77 119.06 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.814 0.34 . . . . 3.75 110.922 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.32 -33.52 5.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.715 -0.755 . . . . 3.0 112.515 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -109.63 -137.35 7.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.742 . . . . 2.2400000000000002 112.497 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.2 mm -72.1 135.82 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.348 . . . . 1.99 111.155 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.519 ' H ' HD22 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -97.62 -27.24 14.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 4.4400000000000004 110.882 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.539 ' HB2' ' HH2' ' A' ' 203' ' ' TRP . . . -179.26 124.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 1.8100000000000001 111.038 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -117.3 171.53 7.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 2.8900000000000001 110.861 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 194' ' ' ASP . . . -176.95 110.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.77000000000000002 111.085 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.57 157.08 24.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 2.5699999999999998 110.863 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -54.18 178.33 0.23 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 1.0700000000000001 112.477 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -172.99 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.656 2.237 . . . . 1.1899999999999999 112.355 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 136.49 -127.59 4.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 2.0800000000000001 112.524 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.23 130.6 52.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 2.5 110.855 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.22 -73.99 1.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.727 -0.749 . . . . 1.8 112.505 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 191' ' ' ILE . 23.4 mt -82.92 -4.12 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 2.7400000000000002 111.13 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.4 117.61 9.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 2.4100000000000001 112.508 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.704 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 85.31 -7.64 74.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.786 -0.721 . . . . 1.3100000000000001 112.459 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.486 ' O ' ' HB1' ' A' ' 184' ' ' ALA . 5.1 m-20 -50.53 139.23 16.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 2.1400000000000001 110.868 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.62 ' HB1' ' HE1' ' A' ' 197' ' ' PHE . . . -117.15 140.12 49.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 1.3200000000000001 111.112 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.07 110.62 12.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 4.1500000000000004 110.842 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.62 ' HE1' ' HB1' ' A' ' 195' ' ' ALA . 12.5 m-85 -116.48 111.74 20.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 2.8199999999999998 110.919 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.53 119.67 3.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 6.8700000000000001 110.816 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -50.13 -72.6 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 8.0800000000000001 110.889 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.11 87.69 4.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 5.3499999999999996 110.855 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -125.51 -82.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 4.25 110.889 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 172.65 81.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 4.7300000000000004 110.907 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.539 ' HH2' ' HB2' ' A' ' 182' ' ' ALA . 8.9 m95 -106.64 113.43 26.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 6.3700000000000001 110.926 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.4 m -156.85 133.28 9.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 2.9399999999999999 111.084 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.671 ' OG1' HD12 ' A' ' 245' ' ' ILE . 2.1 t -107.36 69.34 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 4.1100000000000003 111.128 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.74 -70.72 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 9.0600000000000005 110.887 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.7 m -117.38 -73.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 4.0199999999999996 110.885 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.27 -1.73 0.76 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 5.4400000000000004 112.521 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.01 -160.89 0.17 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 3.9100000000000001 112.495 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.12 95.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.799 0.333 . . . . 2.0899999999999999 111.147 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.406 ' HB3' ' HB ' ' A' ' 205' ' ' THR . 2.1 m-20 -104.32 150.12 24.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 2.9300000000000002 110.874 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.854 HD22 HG23 ' A' ' 130' ' ' VAL . 2.5 mt -54.95 -44.73 74.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 2.6699999999999999 110.942 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.708 ' O ' HG23 ' A' ' 217' ' ' VAL . 31.0 p90 -73.08 -37.17 66.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 5.1200000000000001 110.901 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.426 HD13 HG11 ' A' ' 243' ' ' VAL . 24.3 tp -64.75 -60.65 2.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 3.02 110.909 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.5 m -57.47 -40.59 78.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 1.1200000000000001 111.144 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.44 -51.78 67.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.82999999999999996 111.11 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 213' ' ' PHE . 73.5 t -51.6 -42.35 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.94999999999999996 111.162 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -56.82 -47.93 79.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 2.0699999999999998 110.833 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -65.21 -41.97 93.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 4.6200000000000001 110.91 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.535 HD12 ' HB1' ' A' ' 137' ' ' ALA . 85.5 mt -58.62 -32.4 46.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 1.97 111.115 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.93 -36.82 40.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 1.04 112.495 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -76.42 -39.33 53.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.781 0.324 . . . . 2.9300000000000002 110.826 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.88 -12.19 61.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 1.8 110.836 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.616 HD22 ' HD1' ' A' ' 141' ' ' TRP . 2.2 mp -114.83 19.8 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.8 132.48 0.97 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 2.25 112.493 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.553 HD22 ' SD ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -179.93 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 3.6699999999999999 110.909 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 145.18 -120.82 1.42 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.72 -0.752 . . . . 2.6600000000000001 112.462 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.401 ' HA ' ' HE1' ' A' ' 236' ' ' MET . 0.3 OUTLIER -179.98 37.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.801 0.334 . . . . 3.6600000000000001 110.855 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.29 -75.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 5.0300000000000002 110.842 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.55 -168.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 5.5899999999999999 110.844 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.97 155.51 2.04 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.715 . . . . 2.6099999999999999 110.871 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -49.25 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.69 2.26 . . . . 2.02 112.36 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -71.72 -27.97 63.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 5.2400000000000002 110.876 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.35 168.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 2.2999999999999998 111.139 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.522 HG22 ' OG ' ' A' ' 251' ' ' SER . 17.6 m -87.85 8.44 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 3.7599999999999998 111.108 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.553 ' SD ' HD22 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -80.72 0.72 33.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 4.3799999999999999 110.847 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.47 146.12 5.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.616 0.722 . . . . 4.9299999999999997 110.891 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.98 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.698 2.265 . . . . 3.0099999999999998 112.319 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.2 m -91.11 164.38 13.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 4.0599999999999996 111.147 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -62.57 124.98 22.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 4.5800000000000001 110.95 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.39 123.86 48.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 4.5800000000000001 110.907 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -54.68 123.14 12.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 7.3799999999999999 110.914 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.426 HG11 HD13 ' A' ' 214' ' ' LEU . 14.6 p -148.2 136.21 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 2.46 111.138 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.52 123.81 18.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 3.2200000000000002 110.841 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.671 HD12 ' OG1' ' A' ' 205' ' ' THR . 15.3 tt -60.52 -20.56 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 3.0699999999999998 111.107 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.21 -15.91 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 3.2000000000000002 110.88 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.5 m -106.81 1.21 24.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 2.1000000000000001 111.113 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -51.87 133.82 31.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 4.8300000000000001 110.873 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -176.79 153.05 1.02 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 3.2599999999999998 110.887 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 52.9 tp -52.06 160.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 2.8100000000000001 110.906 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.522 ' OG ' HG22 ' A' ' 235' ' ' VAL . 0.1 OUTLIER -88.81 -172.73 3.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 4.2199999999999998 110.865 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 255' ' ' ILE . . . -93.1 -70.43 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 3.8300000000000001 111.113 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.55 -32.66 51.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 3.29 110.858 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -30.46 67.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 2.5299999999999998 110.856 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.577 HG13 HG21 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -54.51 -28.17 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 1.7 111.091 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -82.09 -44.56 16.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 4.2800000000000002 110.885 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.89 62.53 3.25 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 2.3500000000000001 112.502 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.508 HD13 ' CZ2' ' A' ' 141' ' ' TRP . 3.6 tp -179.7 -41.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 1.02 111.144 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.559 ' HB2' HG22 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -78.14 -28.21 48.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 3.1400000000000001 110.901 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.2 t -75.79 -25.04 56.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 1.95 110.894 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 258' ' ' ILE . 6.6 mp -51.81 -74.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 3.3700000000000001 110.966 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -88.32 -37.98 15.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 13.029999999999999 110.906 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 CA-C-O 119.096 -0.835 . . . . 11.35 112.478 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ' CO' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_